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vPreface
United States Cancer Statistics: 2003 Incidence and Mortality is a joint
publication of the Centers for Disease Control and Prevention (CDC)
in Atlanta, Georgia; the National Cancer Institute (NCI) in Bethesda,
Maryland; and the North American Association of Central Cancer
Registries (NAACCR) in Springfield, Illinois. This is the fifth annual
joint report produced, in collaboration with NAACCR, by the two
federal programs that support population-based cancer registries in the
United States: CDC’s National Program of Cancer Registries (NPCR)
and NCI’s Surveillance, Epidemiology, and End Results (SEER)
Program. This report contains official federal government cancer
statistics for more than 1 million invasive cancer cases diagnosed during
2003 among residents of 47 states, including 6 metropolitan areas, and
the District of Columbia, and these geographic areas are inhabited by
about 96% of the U.S. population. Data from population-based central
cancer registries in these states and metropolitan areas meet the selected
criteria for inclusion in this report (see “Registry Eligibility Criteria” in
the Technical Notes).
In addition to cancer incidence data, we present cancer mortality data
collected and processed by CDC’s National Center for Health Statistics
(NCHS). Mortality statistics, based on records of deaths that occurred
during 2003, are available for all 50 states and the District of Columbia.
The age-adjusted incidence and death rates are adjusted to the 2000
U.S. standard population, consistent with rates published in previous
United States Cancer Statistics reports. Readers should not compare these
data with published cancer rates that were not adjusted to the 2000 U.S.
standard.
A Web-based version of the report with current (2003) and updated
(1999–2002) cancer incidence and mortality statistics is available at
http://www.cdc.gov/uscs. Mortality statistics for 1999–2003 are also
available. The Web-based version has been expanded this year to
include 3-year combined rates (2001–2003) and age-specific rates for 
27 cancer sites.
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Executive Summary
The Centers for Disease Control and Prevention (CDC) and the
National Cancer Institute (NCI), in collaboration with the North
American Association of Central Cancer Registries (NAACCR), are
pleased to release the fifth annual United States Cancer Statistics report.
This report provides official federal government cancer statistics for 
cases diagnosed in 2003 and for cancer deaths that occurred in 2003.
Cancer incidence statistics included in this report come from CDC’s
National Program of Cancer Registries (NPCR) and NCI’s Surveillance,
Epidemiology, and End Results (SEER) Program. Cancer mortality
statistics are from CDC’s National Vital Statistics System (NVSS). 
Incidence data from 47 states, including 6 metropolitan areas, and the
District of Columbia are presented in the report. The data obtained 
from NPCR and SEER registries in these areas cover 96% of the U.S.
population. Mortality data from NVSS are presented for all 50 states and
the District of Columbia and therefore cover 100% of the U.S.
population.
Cancer incidence and mortality statistics are reported for 68 selected
primary cancer sites and subsites for men of all ages and 72 selected
primary cancer sites and subsites for women of all ages. These data 
are presented in tables and graphs in the following categories: (1) by
geography—all U.S. combined, U.S. Census regions and divisions, states,
and selected metropolitan areas and (2) by race and ethnicity—all 
races combined, whites, blacks, Asians/Pacific Islanders, American
Indians/Alaska Natives, and Hispanics/Latinos. American Indian/Alaska
Native incidence data are classified according to race information
obtained from medical records and recorded in the registry. Additionally,
select NPCR registries linked their registry records with those of the
Indian Health Service (IHS), which provides medical services to
approximately 55% of the American Indian/Alaska Native population.
This IHS linkage helps address racial misclassification that exists in the
registries. American Indian/Alaska Native race is reported for mortality
data as recorded on the death certificate.
This year, several new features were added to the report. These items can
be found in the printed publication as listed in the Table of Contents or
on the USCS Web site at http://www.cdc.gov/uscs. The USCS Web site 
is a comprehensive source of 2003 data and contains (1) tables of age-
adjusted incidence and death rates for all the United States combined,
U.S. Census regions and divisions, states, and selected metropolitan areas,
by sex and race and ethnicity; (2) figures of the most commonly diagnosed
cancers and the leading causes of cancer death, by state, sex, and race and
ethnicity; (3) combined data for the years 2001–2003 for all tables and
graphs (which results in more stable incidence and death rates); (4) tables
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with information on over 12,000 cancer cases and 2,000 cancer deaths
among children and adolescents aged 19 years or younger, according to
the new third revision of the International Classification of Childhood Diseases
(ICCC-3); (5) tables of detailed malignant brain and central nervous
system cancer incidence data presented by age, sex, and specific cancer
type and subtype, as defined by the Consensus Conference on Cancer
Registration of Brain and Central Nervous System Tumors; (6) age-
adjusted rates (age-adjusted to the 2000 U.S. standard population), crude
rates, incidence and death counts, and 95% confidence intervals for all
data presented; and (7) tables of age-specific incidence and death rates for
27 cancer sites. The USCS Web site also contains updated information
for 1999–2002 diagnoses.
All rates in this report are age-adjusted to the 2000 U.S. standard
population. Age-adjustment allows researchers to compare data across
populations by controlling for the effect of age on populations with
different age distributions. In this report, population estimates for 2003
were obtained from the 2000 U.S. Census and slightly modified by 
SEER for the Native Hawaiian population. The specific modification
improves the accuracy of the rates for some racial and geographic
populations. Readers should be cautious when interpreting comparisons
between incidence rates and death rates. Slightly different population
estimates were used to calculate incidence and death rates because of the
slight difference in population denominators. In addition, readers should
not compare the rates published in this report with cancer rates that were
calculated using different methods or standardized to different populations.
Incidence rates for all ages are coded according to the third revision of
the International Classification of Diseases for Oncology (ICD-O-3). This
revision reclassified the behavior of some cancers (myelodysplastic
syndromes, chronic myeloproliferative diseases, specific types of brain 
and endometrial cancers, low malignant potential tumors of the ovary).
Readers should be cautious when comparing cases coded according 
to earlier versions of the ICD-O (cases diagnosed before 2001) with 
ICD-O-3-coded cases or with rates calculated using different classification
schemes. The USCS Web site contains updated statistics for 1999–2002
diagnoses; all cases on the Web site are coded according to the current
ICD-O-3 classification so that readers can accurately compare cancer
cases from all diagnosis years (1999–2003) listed on the USCS Web site.
In addition, all cases of childhood cancer listed on the USCS Web site
have been coded according to the current ICCC-3 revision, in order for
readers to accurately compare childhood cancer rates across all reported
diagnosis years (1999–2003).
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Major Findings
Rates are shown in parentheses where appropriate and are per 100,000
persons.
Cancer Among Men*
Three most common cancers among men:
• Prostate cancer (150.0)
• Lung cancer
➤ Second among white (85.8), black (106.1), Asian/Pacific Islander
(50.9), and American Indian/Alaska Native (54.0) men.
➤ Third among Hispanic men (48.6).
• Colorectal cancer 
➤ Second among Hispanic men (49.3).
➤ Third among white (59.2), black (69.4), Asian/Pacific Islander
(45.0), and American Indian/Alaska Native (41.9) men. 
Three leading causes of cancer death among men:
• Lung cancer (71.9)
➤ First among men of all racial and Hispanic origin populations.
• Prostate cancer
➤ Second among white (24.5), black (58.0), American Indian/Alaska
Native (18.2) and Hispanic (20.4) men.
• Colorectal cancer 
➤ Third among white (22.4), black (32.1), Asian/Pacific Islander
(14.0), American Indian/Alaska Native (15.4), and Hispanic
(16.9) men.
• Liver cancer 
➤ Second among Asian/Pacific Islander men (15.6).
Cancer Among Women*
Three most common cancers among women:
• Breast cancer (119.0)
➤ First among women of all racial and Hispanic origin
populations.
• Lung cancer
➤ Second among white (55.7) and American Indian/Alaska Native
(36.8) women.
➤ Third among black (50.4), Asian/Pacific Islander (26.2), and
Hispanic (26.2) women.
* All races combined rate is presented when ranking of cancer sites did not differ across race
and ethnicity; race- or ethnic-specific rates are presented when ranking differed depending on
race and ethnicity.
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• Colorectal cancer
➤ Second among black (52.5), Asian/Pacific Islander (31.2), and
Hispanic (34.7) women.
➤ Third among white (43.0) and American Indian/Alaska Native
(33.4) women.
Three leading causes of cancer death among women:
• Lung cancer
➤ First among white (42.2), black (40.3), Asian/Pacific Islander
(18.9), and American Indian/Alaska Native (26.6) women.
➤ Second among Hispanic women (14.9).
• Breast cancer
➤ First among Hispanic women (16.1).
➤ Second among white (24.6), black (34.1), Asian/Pacific Islander
(12.6), and American Indian/Alaska Native (14.3) women.
• Colorectal cancer (16.1)
➤ Third among women of all racial and Hispanic origin populations.
Racial or Ethnic Variations†
All cancers combined, men:
• Incidence rates are highest among blacks (611.0), followed by whites
(530.9), Hispanics (421.1), Asians/Pacific Islanders (329.3), and
American Indians/Alaska Natives (307.4).
• Death rates are highest among blacks (311.4), followed by whites
(230.6), Hispanics (158.1), American Indians/Alaska Natives (142.3),
and Asians/Pacific Islanders (138.4).
All cancers combined, women:
• Incidence rates are highest among whites (406.7), followed by blacks
(379.1), Hispanics (316.8), Asians/Pacific Islanders (263.9), and
American Indians/Alaska Natives (247.7).
• Death rates are highest among blacks (188.2), followed by whites
(159.7), American Indians/Alaska Natives (106.8), Hispanics (106.3),
and Asians/Pacific Islanders (97.3).
Among the five races and ethnicities presented: 
• American Indian/Alaska Native men have the lowest cancer incidence
rates; however, Asian/Pacific Islander men have the lowest cancer
death rates.
• White women have the highest cancer incidence rates; however,
black women have the highest cancer death rates.
• American Indian/Alaska Native women have the lowest cancer
incidence rates and the third highest cancer death rates. 
† Race- or ethnic-specific rates are presented for all cancer sites combined.
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Geographic Variations‡
Breast cancer:
• The incidence rate for the United States is 119.0.
➤ Incidence rates are highest in the Northeast U.S. Census region
(124.1), followed by the West (121.2) and Midwest (119.2) U.S.
Census regions.
➤ Registry incidence rates range from 102.1 to 138.8.
• The death rate for the United States is 25.2.
➤ Death rates are highest in the Northeast U.S. Census region
(26.2), followed by the Midwest (25.7), South (25.2), and West
(23.5) U.S. Census regions. 
➤ State death rates range from 16.7 to 30.8.
Prostate cancer:
• The incidence rate for the United States is 150.0.
➤ Incidence rates are highest in the Northeast U.S. Census region
(159.2), followed by the Midwest (152.6) and West (150.4) U.S.
Census regions.
➤ Registry incidence rates range from 124.6 to 204.7.
• The death rate for the United States is 26.6.
➤ Death rates are highest in the South U.S. Census region (27.5),
followed by the Midwest (26.7), Northeast (26.2), and West
(25.3) U.S. Census regions. 
➤ State death rates range from 16.1 to 37.4.
Lung cancer:
Men
• The incidence rate for the United States is 86.8.
➤ Incidence rates are highest in the Midwest U.S. Census region
(91.7), followed by the Northeast (83.4) and West (67.8) U.S.
Census regions.
➤ Registry incidence rates range from 40.7 to 129.2.
• The death rate for the United States is 71.9.
➤ Death rates are highest in the South U.S. Census region (81.8),
followed by the Midwest (75.0), Northeast (66.2), and West
(57.5) U.S. Census regions. 
➤ State death rates range from 33.7 to 111.2.
Women
• The incidence rate for the United States is 54.3.
➤ Incidence rates are highest in the Midwest U.S. Census region
(56.6), followed by the Northeast (55.2) and West (48.2) U.S.
Census regions.
➤ Registry incidence rates range from 22.3 to 74.1. 
‡ Geographic variations are presented for the four most common cancers. Incidence
rates are not available for the South U.S. Census region due to bias-correction rule for
suppression of rates (see Appendix D).
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• The death rate for the United States is 41.2.
➤ Death rates are highest in the South U.S. Census region (43.1),
followed by the Midwest (42.6), Northeast (40.1), and West
(37.8) U.S. Census regions. 
➤ State death rates range from 17.4 to 55.4.
Colorectal cancer: 
Men
• The incidence rate for the United States is 60.4.
➤ Incidence rates are highest in the Northeast U.S. Census region
(64.7), followed by the Midwest (63.2) and West (53.7) U.S.
Census regions.
➤ Registry incidence rates range from 45.7 to 70.6. 
• The death rate for the United States is 23.0.
➤ Death rates are highest in the Midwest U.S. Census region
(24.2), followed by the Northeast (24.0), South (23.2), and West
(20.2) U.S. Census regions.
➤ State death rates range from 16.1 to 29.3.
Women
• The incidence rate for the United States is 44.2.
➤ Incidence rates are highest in the Northeast U.S. Census region
(47.2), followed by the Midwest (45.5) and West (40.2) U.S.
Census regions.
➤ Registry incidence rates range from 36.0 to 52.0. 
• The death rate for the United States is 16.1.
➤ Death rates are highest in the Northeast and Midwest U.S.
Census regions (16.7), followed by the South (16.0) and West
(14.7) U.S. Census regions.
➤ State death rates range from 13.0 to 20.1. 
Two points should be kept in mind when interpreting the data in this
report. First, differences in rates among racial and ethnic populations
should be interpreted with caution. Recent studies involving cancer
mortality data show that death rates for whites and blacks are generally
reliable, whereas death rates for Asians/Pacific Islanders, American
Indians/Alaska Natives, and Hispanics are underestimated. Studies
involving cancer incidence data suggest similar results. Therefore,
incidence and mortality data published in this report may be
underestimated for some populations. Also, specific subpopulations,
which are not presented in this report because of small numbers and
possible misclassification, may have higher cancer incidence or death
rates than the U.S. population. For example, overall cancer mortality
among American Indians/Alaska Natives residing in the Alaska and the
Northern Plains regions is higher compared with the U.S. population;
the American Indian/Alaska Native population as a whole has lower
cancer mortality than the U.S. general population.
Second, geographic variations may be influenced by a number of
factors. For example, (1) areas in which a high percentage of the
population is screened for cancer will have more cancer cases diagnosed
than areas in which a low percentage of the population is screened, 
(2) rates for certain cancers differ among different racial and ethnic
populations (e.g., black men have higher prostate cancer rates than
other racial or ethnic groups); therefore, when comparing cancer rates
across geographic areas, the racial and ethnic makeup of that area
should be considered, and (3) the population burden of cancer in a
geographic area is determined by the number of cases diagnosed and 
the number of cancer deaths, not by the age-adjusted rate; therefore, 
a relatively high or low cancer age-adjusted rate may not be a reflection
of the true cancer burden within that geographic area. Crude rates,
which are a reflection of the cancer burden within a population, are
available on the USCS Web site (http://www.cdc.gov/uscs).
United States Cancer Statistics: 2003 Incidence and Mortality provides 
a basis for states and researchers to describe the variability in cancer
incidence and death rates across different populations and to identify
certain populations for evidence-based cancer control measures. Work
continues to ensure receipt of high-quality data from all NPCR and
SEER registries. Since the publication of our first report covering
diagnosis year 1999, additional registries have contributed high-quality
data every year, resulting in increased coverage of the U.S. population
with every new report. We expect that future reports will include high-
quality data from all state registries, thus allowing a more comprehensive
description of the cancer burden across racial, ethnic, and geographic
populations in the United States.
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Table 1.1.1.1M
Format for Numbering the Tables and Figures
The tables and figures in United States Cancer Statistics: 2003 Incidence and Mortality have 
a unique numbering system, and the diagrams below illustrate what each number or letter 
represents. There are three main sections of this report. The diagram specific to each 
section is repeated on the dividers.
Figure 3.1.M1
Consecutive numbering of states 
in alphabetical order beginning 
with the United States
M = males
F = females
1 = incidence rate
2 = death rate
3 = figures that display data for states
Figures 1 and 2 are maps of the 
United States.
Consecutive numbering based on table series
In the Table 1 series (U.S. rates), the second digit
indicates all cancer sites for all ages.
In the Table 2 series (e.g., regional, state, metropol-
itan area), the second digit indicates consecutive
numbering of cancer sites in alphabetical order
beginning with all cancer sites.
Specific types or categorization of rates
M = males
F = females
If no M or F, then table presents both sexes or cancer
that occurs only or primarily in either males or
females (e.g., prostate for males, ovary for females).
1 = incidence rate
2 = death rate
1 = U.S. rates
2 = geographic area rates
Organized by cancer site
Tables
Figures

Technical Notes

Background 
Cancer is the second leading cause of death among
Americans. One of every four deaths in the United
States is due to cancer.1,2 The American Cancer
Society estimates that in 2006, about 1,399,790
Americans will receive a new diagnosis of invasive
cancer, and 564,830 Americans will die of this
disease. These estimates do not include in situ
cancers or the more than 1 million cases of basal
and squamous cell skin cancers expected to be
diagnosed this year. The National Cancer Institute
(NCI) recently estimated that on January 1, 2003,
10.5 million Americans were alive with a history 
of invasive cancer.3
According to the 2006 Annual Report to the Nation
on the Status of Cancer,4 age-adjusted incidence rates
for all cancers combined were stable from 1995
through 2003 in men, but rates in women have
increased 0.3% annually since 1987. U.S. death
rates for all cancer sites combined decreased
significantly beginning in 1994.4 However, the
number of Americans diagnosed with cancer each
year is expected to double in the next 50 years,
from 1.3 million to 2.6 million. The anticipated
growth and aging of the U.S. population are factors
that will increase the number of people who are
diagnosed with and treated for cancer.5
For 2005, NCI estimated that direct medical costs
were about $74.0 billion for cancer treatment.6
The National Heart, Lung, and Blood Institute 
has estimated that in 2006, the overall annual cost
of cancer would be about $206.3 billion,7 broken
down as follows:
• Direct medical costs, including health
expenditures: $78.2 billion.
• Indirect costs associated with lost
productivity due to illness: $17.9 billion.
• Indirect costs associated with lost
productivity due to premature death:
$110.2 billion.
These costs are likely to increase because of the
anticipated growth and aging of the U.S. population.
There are effective primary and secondary
prevention measures that could substantially 
reduce the number of new cancer cases and 
prevent many cancer-related deaths. To reduce 
the nation’s cancer burden, we must reduce
behavioral and environmental exposures that
increase cancer risk, and we must ensure that 
high-quality screening services and evidence-based
treatments are available and accessible, particularly
to medically underserved populations.8,9
Cancer registries collect data about the occurrence
of cancer (incidence), the types of cancer
(morphology), the site in the body where the
cancer first occurred (primary site), the extent of
disease at the time of diagnosis (stage), the planned
first course of treatment, and the outcome of
treatment and clinical management (survival and
vital status).10,11 Cancer data are reported to
metropolitan-area, regional, and statewide cancer
registries from a variety of medical facilities,
including hospitals, physicians’ offices, radiation
facilities, freestanding surgical centers, and
pathology laboratories. Cancer death data are
recorded on death certificates that are sent to state
vital statistics offices. Death certificates contain
information regarding primary cancer site and
morphology as well as demographic information on
the decedent.
Information derived from population-based central
cancer registries and from death certificates is
critical to guide effective geographic area- or
population-specific cancer prevention and control
programs that focus on preventing behaviors that
put people at increased risk for cancer (e.g.,
smoking) and on reducing environmental risk
factors (e.g., occupational exposure to known
carcinogens). This information is also essential for
deciding which geographic areas should have
cancer screening programs and for making long-
term plans for adequate diagnostic and treatment
services. Local data can provide incentives for
community involvement and ownership of the
cancer issues. Pooled data at the national, regional,
state, and sub-state levels will help federal and state
public health officials establish, prioritize, and
monitor national public health surveillance
initiatives and track progress toward the national
goals and objectives set forth in Healthy People
2010,12 which contains a set of health objectives for
the nation for the first decade of the 21st century.
For more information on Healthy People 2010, visit
http://www.healthypeople.gov/document.
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Federal Programs
Surveillance, Epidemiology, and End
Results (SEER) Program
In 1971, Congress passed the National Cancer 
Act that mandated NCI to collect, analyze, and
disseminate data useful to prevent, diagnose, 
and treat cancer.13 This mandate led to the
establishment of the SEER Program.14 For more
than 30 years, NCI’s SEER Program has provided
statistics regarding cancer incidence, survival, and
mortality in the United States; monitored cancer
incidence trends in geographic and demographic
population groups; provided information on trends
in extent of disease at diagnosis, therapy, and
patient survival; promoted studies measuring
progress in cancer control and etiology; provided
specialty training in epidemiology, biostatistics,
surveillance research, and tumor registry
methodology, operations, and management; and
developed new statistical methods, models, and
software for analyzing and presenting national and
small-area statistics.
The SEER Program currently collects and
publishes cancer incidence and survival data 
from 14 population-based cancer registries and 
3 supplemental registries covering approximately
26% of the U.S. population (Appendix B). 
SEER registries provide complete coverage for
metropolitan regions and special populations
whose data are reported to their respective state
registries: the Alaska Native registry covers 16% 
of the state population; Arizona Indians, 5%;
Greater Bay Area (San Francisco-Oakland and San
Jose-Monterey), 19%; Los Angeles County, 28%;
the remainder of California, 53%; Atlanta and rural
Georgia, 37%; metropolitan Detroit, 41%; and
Seattle-Puget Sound, 69%. In addition, since 2001,
NCI funding for Kentucky, Louisiana, New Jersey,
and the remainder of California has provided
resources for these registries to meet the
requirements of the SEER Program regarding
completeness of case ascertainment, follow-up,
timeliness, and data quality metrics. Information
on more than 3 million in situ and invasive cancer
cases is included in the SEER database, and
approximately 170,000 new cases are added each
year within SEER coverage areas. (See
http://seer.cancer.gov/registries for the first
diagnosis year for which data were reported to NCI
for each SEER area.) The mortality data reported
by SEER are provided by the National Center for
Health Statistics (NCHS) of the Centers for
Disease Control and Prevention (CDC). A public-
use data set is issued each year by the SEER
Program for additional analyses. 
For more information on the SEER Program, visit
http://seer.cancer.gov.
National Program of Cancer 
Registries (NPCR) 
Recognizing the need for more complete local,
state, regional, and national cancer incidence data,
Congress established NPCR in 1992 by enacting
the Cancer Registries Amendment Act, Public 
Law 102-515; the program was reauthorized in
1998.15 Congress mandated CDC to provide funds
to state and territorial health departments (or their
authorized agencies) at a ratio of $3:$1 to match
state support for the central cancer registry. As 
of 2006, CDC funds a total of 49 registries: 45
states, the District of Columbia, and 3 territories
(Appendix B).
NPCR registries cover 96% of the U.S.
population. NPCR has the state and national
capacity to monitor the cancer burden; identify
cancer incidence variation for racial and ethnic
populations and for regions within a state, 
among states, and among regions; provide data 
for research; provide guidance for health resource
allocation; respond to public concerns and inquiries
about cancer; improve planning for future health
care needs; and evaluate cancer prevention and
control activities.16
In January 2001, NPCR registries began annually
reporting their incidence data to CDC from 
the first diagnosis year for which a state or
territorial cancer registry collected data with 
the assistance of NPCR funds (http://apps.nccd.
cdc.gov/cancercontacts/npcr/contacts.asp). Data
from the special population cancer registries or 
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the SEER metropolitan-area cancer registries
operating in Alaska, Arizona, California, Georgia,
Michigan, and Washington are reported to their
respective NPCR state cancer registry for inclusion
in the state’s incidence data and are transmitted to
CDC as part of the state’s annual data submission.
In January 2006, CDC received information on
more than 10 million invasive cancer cases diagnosed
during 1995–2003, and more than 1 million new
invasive cancer cases are added each year. In addition
to the United States Cancer Statistics (USCS) series,
NPCR disseminates (1) a public-use data set of
precalculated cancer incidence rates on CDC
WONDER (http://wonder.cdc.gov), (2) state cancer
burden data fact sheets intended for lay audiences,
(3) a U.S. county cancer incidence data set of rates
and counts for major cancer sites for selected
counties, and (4) an expanded USCS data set of
age-adjusted rates, crude rates, and case counts.
For more information on NPCR, visit http://www.
cdc.gov/cancer/npcr.
National Vital Statistics System (NVSS)
The nation’s vital statistics are available from
NVSS, which is maintained by CDC’s NCHS.
These vital statistics are provided through state-
operated registration systems and are based on vital
records filed in state vital statistics offices. The
recording of vital events is the responsibility of 
the individual states and independent registration
areas (e.g., District of Columbia, New York City,
territories) in which the event occurs. Legal
responsibility for the registration of vital events
rests with the individual states. Through its Vital
Statistics Cooperative Program, NCHS cooperates
with state vital statistics offices to develop and
recommend standard forms for data collection and
model procedures to ensure uniform registration 
of the events monitored by NVSS. Detailed annual
data on births, deaths (including infant deaths), 
and fetal deaths are available for the United States
and for states, counties, and other local areas. Data
variables include cause of death, age, race, Hispanic
origin, sex, marital status, place of birth, residence
of decedent, education level, and place of death.
Monthly provisional data on vital statistics are
available for the United States and each state. 
A public-use data set is issued each year by NCHS
for additional analyses. 
For more information on NCHS and its NVSS,
visit http://www.cdc.gov/nchs.
Collaborating Partner 
North American Association of Central
Cancer Registries (NAACCR)
Both federally funded registry programs (i.e., 
the SEER Program and NPCR) work closely 
with NAACCR to promote cancer incidence
surveillance in the United States and Canada.
Established in 1987, NAACCR is an organization
of population-based cancer registries, governmental
agencies, professional associations, and private
groups in North America interested in cancer
surveillance and dedicated to NAACCR’s mission.
Its mission is to reduce the burden of cancer in
North America by developing and promoting
cancer registration standards; providing education
and training; certifying population-based cancer
registries; evaluating and publishing data; and
promoting the use of cancer surveillance data and
systems for cancer control, epidemiologic research,
public health programs, and patient care. All state
and metropolitan-area registries participating in
NPCR and SEER, as well as all provincial and
territorial registries in Canada, are members of
NAACCR. A public online query system, CINA+
(Cancer in North America Plus) Online, is updated
annually with the most recent 5 years of incidence data
(see http://www.naaccr.org/cinap). Starting with the
1995 diagnosis year, the incidence data file is
updated annually for qualified researchers. For
more information about this file, contact the
NAACCR office (http://www.naaccr.org).
In 1992, NAACCR began annual reviews of
member registries’ data for completeness, accuracy,
and timeliness. In 1997, this process was formalized
into a certification program, whereby registries
report their data in December and NAACCR
evaluates the data using standard, objective
measures. Registries that meet the highest
standards for data quality are recognized through
certification.17-19
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In 1997, when NAACCR evaluated 1995 incidence
data, 9 NPCR registries and all 10 SEER registries
were certified. Nine years later, when NAACCR
evaluated the 2003 incidence in 2005, 37 NPCR
registries, 4 NPCR/SEER registries, and 9 SEER
registries were certified. (Data from San Francisco-
Oakland and San Jose-Monterey are combined and
evaluated as the Greater Bay Area.)
For more information on NAACCR, visit http://
www.naaccr.org.
Data Sources 
Incidence Data 
Data from the registries participating in NPCR
were reported to CDC as of January 31, 2006. 
Data from registries in the SEER Program were
reported to NCI as of November 1, 2005, and
made available through the SEER Program public-
use data file released in April 2006 (http://seer.
cancer.gov/publicdata). For this report, data from
California, Kentucky, Louisiana, and New Jersey
(states that are supported by both NPCR and
SEER) are presented as reported to CDC as of
January 31, 2006.
The primary source of cancer incidence data is
medical records. Staff at health care facilities
abstract cancer incidence data from patients’
medical records, enter the data into the facility’s
own cancer registry, if it has one, and then send the
data to the regional or state registry. Both NPCR
and SEER registries collect data using uniform
data items and codes as documented by NAACCR.
This uniformity ensures that data items collected
by the two federal programs are comparable.11,20
Information on primary site and histology was coded
according to the International Classification of Diseases
for Oncology, Third Edition (ICD-O-3)21 and
categorized according to the revised SEER recodes
dated January 27, 2003, which define standard
groupings of primary cancer sites (http://seer.cancer.
gov/siterecode/icdo3_d01272003).
NPCR and SEER cancer registries consider as
reportable all incident cases with a behavior code 
of 2 (in situ, noninvasive) or 3 (invasive, primary
site only) in ICD-O-3, with the exception of in situ
cancer of the cervix. Basal and squamous cell
carcinomas of the skin are also excluded, with 
the exception of those on the skin of the genital
organs.21 Several cancers are coded as malignant 
in ICD-O-3 (beginning with 2001 diagnoses) 
that were not previously coded as malignant in
ICD-O-2.21
Myleodysplastic syndromes (MDS) including
refractory anemias (histology codes 9980, 9982–9984,
9989) are now considered malignant in ICD-O-3.
Chronic myleoproliferative diseases (CMPDs)
including polycythemia vera and thrombocythemias
(histology codes 9950, 9960–9962) are also now
considered malignant in ICD-O-3.21 MDS and
CMPD arise in the bone marrow. MDS is
characterized by abnormal growth of blood cells in
the bone marrow and is a clonal disease, meaning a
large population of exactly alike abnormal cells
arise from a single abnormal cell.22 CMPD is the
overproduction of blood cells by the bone marrow;
polycythemia vera is the production of too many
red blood cells and thrombocythemia is the
production of too many platelets.22 CMPDs
sometimes become acute leukemia, in which too
many abnormal white blood cells are made.22 In 
this report, these cancers are included in the
“Miscellaneous” and “All Sites” categories. 
Papillary ependymomas (9393) and papillary
meningiomas (9538)—cancers that occur in the
central nervous system22—are also newly classified
as malignant according to ICD-O-3. In this report,
these cancers are included in the “Brain and Central
Nervous System” and “All Sites” categories.
Although these cancers were newly classified as
malignant beginning with 2001 diagnoses, USCS
reports published in 200423 and 200524 did not
include them in order to be consistent with other
cancer statistics reports and publications.3,4,25
Some endometrial tumors (8931) are also newly
classified as malignant in ICD-O-3. These cancers
were reported in USCS reports published in 200423
and 200524 and are still included in the “Corpus and
Uterus, Not Otherwise Specified (NOS)” and “All
Sites” categories.
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For consistency with USCS reports published in
200423 and 2005,24 and other reports that do not
include these cancers,3,4,25 an additional row of data
is presented in Tables 1.1.1.1M and 1.1.1.1F with
the heading “All Sites (excl. newly classified as
malignant)” and in Tables 2.1.1.1.M and 2.1.1.1F
with the heading “United States (excl. newly
classified as malignant).” These rows exclude all the
newly malignant histology codes described above
and listed as follows: 8931, 9393, 9538, 9950,
9960–9962, 9980, 9982–9984, 9989.21 Footnotes
describing these rows are provided in these tables.
Additional changes in ICD-O-3 apply to ovarian
cancer: low malignant potential tumors (8442,
8451, 8462, 8472, 8473) of the ovary are no longer
coded as malignant. Therefore, these cancers are
not accounted for in the ovarian cancer incidence
rate calculations included in tables and figures. 
A footnote is provided where appropriate to
remind readers of this exclusion. Pilocytic
astrocytomas (9421) are also not coded as
malignant in ICD-O-3; however, these cancers 
are included in this report.
This report also contains data for two rare cancers:
Kaposi sarcoma (KS) and mesothelioma. KS is 
a cancer of connective tissue such as cartilage,
bone, fat, muscle, and blood vessels. Since the 
vast majority of KS cases have developed in
association with human immunodeficiency virus
(HIV) infection and acquired immunodeficiency
syndrome (AIDS), HIV/AIDS is listed as the
underlying cause of death. Therefore, KS death
rates were not included in this report. Mesothelioma
is a cancer that generally occurs in the chest,
abdominal region, and areas surrounding the heart.
It is typically associated with exposure to asbestos.
Because KS and mesothelioma are considered
separate cancers for this report, they were removed
from counts of other primary cancer sites.
In situ bladder cancers were recoded to invasive
bladder cases because the information needed to
distinguish between in situ and invasive bladder
cases is not always available or reliable. Case counts
and rates for invasive cancers are included in this
report. This report also includes counts and rates
for in situ breast cancer cases among women; these
are reported separately and are not included in
counts or rates for the “All Sites” category. Case
counts and rates for leukemias were calculated for
acute and chronic lymphocytic leukemia, acute and
chronic myeloid leukemia, and other leukemias,
which include other myeloid/monocytic leukemias.
Nonreportable cancers and cancers in patients of
unknown sex or age were omitted from all
calculations, but cancers in patients of unknown
race were included in the “All Races” category.
Counts of cases used in this report are available at
http://www.cdc.gov/uscs (see “United States Cancer
Statistics on the Web”).
Mortality Data 
Cancer mortality statistics in this report are based
on information from all death certificates filed 
in the 50 states and the District of Columbia and
processed by NVSS at NCHS for deaths that
occurred in 2003 and were reported as of February
28, 2005. The U.S. Standard Certificate of Death,
which is used as a model by the states, was revised
in 2003.26 This report includes data for five areas
(California, Idaho, Montana, New York City, and
New York State), which implemented the 2003
revision of the U.S. Standard Certificate of Death
in 2003. The remaining 46 states and the District
of Columbia collected and reported death data 
in 2003 based on the 1989 revision of the U.S.
Standard Certificate of Death.26-29
The cancer mortality data were compiled in
accordance with World Health Organization
(WHO) regulations, which specify that member
nations classify and code causes of death in
accordance with the current revision of the
International Classification of Diseases (ICD). Starting
with deaths that occurred in 1999, the United
States began using the Tenth Revision of this
classification (ICD-10).30
Rules for coding cause(s) of death may sometimes
require modification when evidence suggests 
that such modifications will improve the quality 
of cause-of-death data. Prior to 1999, such
modifications were made only when a new revision
of the ICD was implemented. A process for
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updating the ICD was introduced with ICD-10
that allows for mid-revision changes. Minor
changes may be implemented every year, while
major changes may be implemented every 3 years
(e.g., 2003 data year). Updates to the ICD for 2003
do not have a significant impact on the data
presented in this report.
The ICD not only details disease classification 
but also provides definitions, tabulation lists, the
format of the death certificate, and the rules for
coding cause of death. Cause-of-death data
presented in this report were coded by procedures
outlined in annual issues of the NCHS Instruction
Manuals.31,32
Tabulations of cause-of-death statistics are based
solely on the underlying cause of death. The
underlying cause is defined by WHO as “the
disease or injury that initiated the train of events
leading directly to death, or the circumstances of
the accident or violence that produced the fatal
injury.”30 The underlying cause of death is selected
from the conditions entered by the physician in the
cause-of-death section of the death certificate.
Generally, more medical information is reported
on death certificates than is directly reflected in 
the underlying cause of death. This information 
is captured in NCHS multiple cause-of-death
statistics.33-35
Since 1968, NCHS has computerized the coding 
of the underlying cause of death in accordance with
WHO rules. In this system, called “Automated
Classification of Medical Entities” (ACME),36
multiple cause-of-death codes serve as inputs to 
the computer software that selects the underlying
cause of death. In addition, NCHS has developed
two computer systems as inputs to ACME.
Beginning with 1990 data, the Mortality Medical
Indexing, Classification, and Retrieval (MICAR)
system37,38 has been applied to automate coding of
multiple causes of death. Then, beginning with
data year 1993, SuperMICAR, an enhancement 
of the MICAR system, was applied to allow for
literal entry of the multiple cause-of-death text 
as reported by medical certifiers in the states.
Records that cannot be automatically processed by
MICAR or SuperMICAR are manually multiple-
cause coded and then further processed through
ACME. For 2003 mortality statistics, all of the
nation’s death records were multiple-cause coded
using SuperMICAR.
For consistency with the cancer incidence data,
cancer sites in mortality data were grouped
according to the revised SEER recodes dated
January 27, 2003. Because NCHS uses different
groupings for some sites, the death rates in this
report may differ slightly from those published by
NCHS. In addition, under the ICD, differences
occur in mortality and incidence coding. For
example, there are several codes for mesothelioma
in ICD-10 (depending on the primary site).
However, one code in ICD-O-3 captures all the
primary sites that mesothelioma affects. SEER
recodes for cancer mortality are at http://seer.cancer.
gov/codrecode/1969+_d09172004/index.html.
All states and the District of Columbia submitted
part or all of their 2003 mortality data in electronic
data files to NCHS. All states provided precoded
cause-of-death data to NCHS except Illinois and
West Virginia.39 For 2003, all states submitted
precoded demographic data (e.g., sex and race of
the deceased) for all deaths. Mortality data for the
entire United States refer to deaths that occurred
within the United States; data for geographic areas
are by the decedent’s place of residence. Deaths
among overseas armed forces personnel are not
included.
One index of the quality of reporting causes of
death is the proportion of death certificates coded
to ICD-10 codes R00–R99 (i.e., symptoms, signs,
and abnormal clinical and laboratory findings not
elsewhere classified). Although deaths occur for
which the underlying causes are impossible to
determine, the proportion classified as R00–R99
indicates the care and consideration given to the
cause-of-death statement by the medical certifier.
This proportion also may be used as a rough
measure of the specificity of the medical diagnoses
made by the certifier in various areas. In 2003, the
percentage of all reported deaths in the United
States assigned to symptoms, signs, and abnormal
clinical and laboratory findings not elsewhere
classified was 1.28%, which was slightly higher
than in 2002 (1.23%) but lower than in 2000
(1.33%) and 2001 (1.34%).39 In general, from 
1990 through 1999, the percentage of deaths from
this cause for all ages combined was fairly stable
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(1.08%–1.18%). In addition, causes of death are
more likely to be misclassified for populations
other than white as symptoms, signs, and abnormal
clinical and laboratory findings not elsewhere
classified, and this misclassification may affect
comparisons of cause-specific death data.40
Population Denominator Data 
The population estimates for the denominators of
incidence and death rates presented in this report
are race-specific (all races, whites, blacks,
Asians/Pacific Islanders, and American Indians/
Alaska Natives), Hispanic-specific, and sex-specific
county population estimates aggregated to the state
or metropolitan-area level. The county population
estimates that are incorporated into NCI’s SEER*
Stat software (http://www.seer.cancer.gov/seerstat)
to calculate cancer incidence and death rates are
available at http://www.seer.cancer.gov/popdata.
The SEER*Stat population estimates are a slight
modification of the annual time series of July 1
county population estimates (by age, sex, race, 
and Hispanic origin) produced by the Population
Estimates Program of the U.S. Bureau of the
Census (Census Bureau) with support from NCI
through an interagency agreement. The Census
Bureau’s population estimates and documentation
of the procedures used to develop them are
available at http://www.census.gov/popest/counties.
The estimates used in this report are postcensal
estimates for 2003 (based on the 2000 census) that
include bridged single-race estimates derived from
the multiple-race categories through collaboration
between the Census Bureau and CDC’s NCHS.
For more information on the 2000 bridged
population estimates, see http://www.cdc.gov/
nchs/about/major/dvs/popbridge/popbridge.htm.
Documentation regarding modifications made by
NCI to Census Bureau estimates is available at
http://www.seer.cancer.gov/popdata. Briefly, the
modification affects only population estimates 
for Hawaii and is based on information from the
Epidemiology Program of the Hawaii Cancer
Research Center. The modified population
estimates were obtained by SEER using survey 
data collected by the Hawaii Department of Health
to address concerns that the Native Hawaiian
population had been undercounted in previous
censuses. The “Hawaii-adjustment” to Census
Bureau estimates has the net result of reducing 
the estimated white population and increasing 
the estimated Asian/Pacific Islander population 
in the state. Census Bureau estimates for the total
population, black population, and American Indian
and Alaska Native populations in Hawaii are
unaffected.
Registry Eligibility Criteria 
Cancer incidence data included in this report are
from statewide or metropolitan-area cancer
registries that have high-quality cancer incidence
data for 2003 as demonstrated by meeting the
following data quality criteria for all cancer sites
combined:
• Case ascertainment is 90% or more complete.
The registry data include at least 90% of
the expected, unduplicated cases where the
expected cases are estimated by using
methods developed by NAACCR.18,19,25,41
Because some cancer patients receive
diagnostic or treatment services at 
more than one reporting facility, cancer
registries perform a procedure known 
as “unduplication” to ensure that each
cancer case is counted only once.42
• No more than 5% of cases are ascertained 
solely on the basis of a death certificate. The
proportion of cases ascertained solely on
the basis of a death certificate, with no
other information on the case available
after the registry has completed a routine
procedure known as “death clearance and
followback,”42-44 is another measure of the
completeness of case ascertainment.
• No more than 3% of cases are missing
information on sex. 
• No more than 3% of cases are missing
information on age.
• No more than 5% of cases are missing
information on race.
• At least 97% of the registry’s records passed a
set of single-field, interfield, and interrecord
computerized edits. Computerized edits are
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computer programs that test the validity
and logic of data components. For example,
if (a) a patient received a diagnosis of cancer
in 1999, (b) the patient’s age was reported
as 80 years, and (c) the patient’s year of
birth was reported as 1942, a computerized
edit could, without human intervention,
identify these components as incompatible.
The computerized edits applied to the data
in this report were designed by the SEER
Program for use by SEER registries.
During the 1990s, these edits were
expanded and incorporated into NAACCR
standards (http://www.naaccr.org) and into
the EDITS software designed and
maintained by CDC (http://www.cdc.gov/
cancer/npcr/tools/edits).
Complete state- and metropolitan-area–specific
measures for the data quality criteria are available
(Appendix C). Registry data that were not eligible
for inclusion in this report are shaded.
Populations Covered 
by This Report 
Incidence data on more than 1.2 million invasive
cancer cases (including approximately 12,000 cases
among children younger than 20 years) diagnosed
during 2003 and reported by 47 state cancer
registries (38 NPCR, 4 NPCR/SEER, and 5
SEER), the District of Columbia (NPCR), and 6
SEER metropolitan areas (Atlanta, Detroit, Los
Angeles, San Francisco-Oakland, San Jose-
Monterey, and Seattle-Puget Sound) are included
in this report. In total, the NPCR and SEER
cancer registries whose data are included in this
report cover 96% of the U.S. population (Figure 1)
(96% of the white, 97% of the black, 98% of the
Asian/Pacific Islander, 89% of the American
Indian/Alaska Native, and 96% of the Hispanic
populations). 
Mortality data on 556,890 deaths in 2003 from
malignant neoplasms (i.e., cancers) as recorded 
in the National Vital Statistics System from the 
50 states and the District of Columbia are included
in this report; therefore, with regard to mortality
data, 100% of the U.S. population is covered.39 In
2003, malignant neoplasms caused 23% of the total
deaths and were overall the second leading cause of
death in the United States.39 In Alaska, Maine,
Minnesota, Oregon, and Washington State, age-
adjusted death rates in 2003 indicated that cancer
was the leading cause of death.39
Statistical Methods 
Age-Adjusted Incidence and Death
Rates
The occurrence of many cancers increases with
age, as does cancer mortality. The age distribution
of a population (i.e., the number of people in
particular age groups) can change over time and
can be different in different geographic areas. 
Age-adjusting the rates ensures that differences 
in incidence or deaths from one year to another 
or from one geographic area to another are not 
due to differences in the age distribution of the
populations being compared.
The standard population used to age-adjust the
rates in this report is the 2000 U.S. standard
population, in accordance with a 1998 U.S.
Department of Health and Human Services
recommendation.45,46 The 2000 U.S. standard
population is based on the proportion of the 2000
population in specific age groups (younger than 1
year, 1–4 years, 5–9 years, 10–14 years, 15–19
years, . . . 85 years or older). The proportions of
the 2000 population in these age groups serve as
weights for calculating age-adjusted incidence or
death rates. However, NCHS uses a different set of
age groups in its age-adjustment of death rates.
Therefore the cancer death rates in this report may
differ slightly from those published by NCHS. In
addition, the 2000 U.S. standard population
weights are not race or sex specific, so they do not
adjust for differences in race or sex between
geographic areas or among populations being
compared. They do, however, provide the basis for
adjusting for differences in the age distributions
across groups defined by sex, race, geography, or
other categories.
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The 2000 U.S. standard population weights used
for this report are based on single years of age from
the Census P25-1130 series estimates of the 2000
U.S. population. For the 5-year age groups, the
single years of age populations are summed to form
the 5-year age groups. For more information, visit
http://seer.cancer.gov/stdpopulations/single_age.html.
These standard weights are used to compute age-
adjusted incidence and death rates by the method
of direct standardization as implemented in NCI’s
SEER*Stat software (http://www.seer.cancer.
gov/seerstat) and are described as follows:47
If Nj is the number of incident cases diagnosed in
2003 or the number of cancer deaths in 2003 in age
category j, and Pj is the population size at risk in
age category j, then the incidence or death rate Rj
in age category j is defined as
Rj = Nj/Pj
If wj is the 2000 U.S. standard population weight
for age category j, then the age-adjusted (directly
standardized) incidence or death rate Radj is
computed as
Radj = Rj wj Rj x 100,000
Note from the multiplier in the above formula that
incidence or death rates are expressed as cases or
deaths per 100,000 persons. For childhood cancers
coded according to ICCC-3, the multiplier in the
formula is 1,000,000 because the childhood cancer
rates are expressed per million persons.
Crude and Age-Specific Incidence and
Death Rates
Crude and age-specific rates are available at
http://www.cdc.gov/uscs (see “United States 
Cancer Statistics on the Web”). 
The crude and age-specific incidence rates equal
the total number of new cancer cases diagnosed 
in 2003 in the population category of interest,
divided by the at-risk population for that category,
and multiplied by 100,000 (cancers by primary site)
or by 1 million (ICCC-3 groupings of childhood
cancers).
The crude and age-specific death rates equal the
total number of cancer deaths in 2003 in the
population category of interest, divided by the at-
risk population for that category, and multiplied by
100,000.
Confidence Intervals
Confidence intervals reflect the range of variation
in estimates of cancer rates. The width of a
confidence interval depends on the amount of
variability in the data. Sources of variability include
the underlying occurrence of cancer as well as
uncertainty about when cancer is detected and
diagnosed, when a death from cancer occurs, and
when the data about the cancer are sent to the
registry or the state health department. In any
given year, when large numbers of a particular
cancer are diagnosed or when large numbers of
cancer patients die, the effects of random variability
are small compared with the large numbers, and
the confidence interval will be narrow. With 
rare cancers, however, the rates are small and 
the chance occurrence of more or fewer cases or
deaths in a given year can markedly affect the rate.
Under these circumstances, the confidence interval
will be wide to indicate uncertainty or instability 
in the cancer rate.
To estimate the extent of this uncertainty, a
statistical framework is applied.48 The standard
model used for rates for vital statistics is the
Poisson process,49 which assigns more uncertainty
to rare events relative to the size of the rate than 
it does to common events. The population risk
profile is positioned to influence the underlying
Poisson process from which rates arise, and only 
a single realization of that process is observed.
Parameters are estimated for the underlying disease
process. For this report, we estimated a single
parameter to represent the rate and its variability.
Of note, the Poisson model is capable of estimating
separate parameters that represent contributions 
to the rate from various population risk factors, 
the effects of cancer control interventions, and
other attributes of the population risk profile in 
any particular year.
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For this report, we used confidence intervals that
are expected to include the true underlying rate
95% of the time. Confidence intervals in this
report were computed by using SEER*Stat Version
6.2 software (http://www.seer.cancer.gov/seerstat)
and are based on the gamma method.50 These
gamma intervals are approximations to exact
Poisson confidence intervals. The gamma method
performs better than other methods, especially for
small incidence rates or for populations with age
distributions that differ from the standard age
distribution. Various factors such as population
heterogeneity can sometimes lead to “extra-
Poisson” variation in which the rates are more
variable than would be predicted by a Poisson
model. No attempt was made to correct for this. 
In addition, as discussed in “Interpreting the 
Data,” the confidence intervals do not account 
for systematic (i.e., nonrandom) biases in the
incidence rates.
Users of this report who want to know if the
differences between the rates of various groups 
are statistically significant might check whether 
the confidence intervals overlap. However, we
discourage the use of overlapping confidence
intervals to test for statistically significant
differences between two rates because the practice
more frequently fails to detect significant
differences than does standard hypothesis testing.51
Another consideration when comparing differences
between rates is their public health importance.
For some rates in this report, numerators and
denominators are large and standard errors are
therefore small, resulting in statistically significant
differences that may be so small as to lack
importance for decisions related to population-
based public health programs.
Suppression of Rates and Counts 
at the State, Regional, Division, 
and National Levels
When the numbers of cases (incidence) or deaths
(mortality) used to compute rates are small, those
rates tend to have poor reliability.49 Therefore, to
discourage misinterpretation or misuse of rates or
counts that are unstable because case or death
counts are small, these rates and counts are not
shown (cell suppression) in tables and figures if the
case or death counts are less than 16. A count of
less than about 16 results in a standard error of the
rate that is approximately 25% or more as large as
the rate itself. Similarly, a case count of less than
approximately 16 results in the width of the 95%
confidence interval around the rate being at least as
large as the rate itself. These relationships were
derived under the assumption of a Poisson process
and with the standard population age distribution
assumed to be similar to the observed population
age distribution.
Another important reason for using a cell
suppression threshold value is to protect the
confidentiality of patients whose data are included
in a report by reducing or eliminating the risk 
of identity disclosure.52,53 The cell suppression
threshold value of 16, which was selected to 
reduce misuse and misinterpretation of unstable
rates and counts in this report, is more than
sufficient to protect patient confidentiality given
the low level of geographic and clinical detail
provided in the report.54
Because the incidence and death rates shown in 
the state-, sex-, and race-specific bar graphs in
Figures 3.1.M1 through 3.58.F2 are presented 
in rank order, we applied a data suppression
criterion in addition to the threshold value of 16
cases. In these figures, incidence rates are not
ranked or shown for any sex-specific population
groups of less than 50,000 people.
U.S. Census Regions and Divisions
Rates for U.S. Census regions and divisions were
calculated by aggregating data reported from the
states in each region and division. Only data from
state registries that met the criteria for inclusion 
in this report (see “Registry Eligibility Criteria”)
were included in calculations of incidence rates 
for U.S. Census regions and divisions. There is a
potential for bias in the incidence rates for Census
regions and divisions where data for some states
were excluded. We estimated cancer rates for
Census regions or divisions with ineligible cancer
registries by assuming that the incidence-to-
mortality ratio in the portion of the region or
division that is covered by eligible registries is 
United States Cancer Statistics: 2003 Incidence and Mortality
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the same as the incidence-to-mortality ratio in 
the portion that is not covered by eligible cancer
registries (Appendix D). The age-adjusted
incidence rates for U.S. Census regions and
divisions are reported only if (1) at least 80% of 
the population for the Census region or division 
is covered by cancer registries that meet the criteria
for inclusion in this report and (2) the 95% confidence
intervals around the observed age-adjusted region
or division incidence rates based on data from
eligible registries for each of six major cancer sites
(prostate, female breast, male colorectal, female
colorectal, male lung and bronchus, female lung
and bronchus) included the estimate of the region
or division rate calculated using the methods
described in Appendix D.
On the basis of these analyses, we present in this
report the observed age-adjusted incidence rates
for all U.S. Census regions and divisions with the
exception of the South region, East South Central
division, and the Mountain division of the West
region. The estimate of rates based on the methods
described in Appendix D are not presented but are
used for determining the exclusion of observed
age-adjusted rates for Census regions and divisions.
Case counts for U.S. Census regions and divisions
are available at http://www.cdc.gov/uscs (see
“United States Cancer Statistics on the Web”) if all
state cancer registries in the region or division met
the criteria for inclusion in this report, unless the
count for exactly one state in the region or division
is suppressed due to a count of less than 16.
Total United States
Cancer incidence rates for the United States are
aggregate rates based on more than 1 million
cancer cases reported from central cancer registries
in 47 states, including 6 metropolitan areas, and 
the District of Columbia. The same statistical
criteria that were applied to rates and counts for
U.S. Census regions and divisions were also applied
to the rates for the entire United States (see “U.S.
Census Regions and Divisions” and Appendix D).
The cancer rates for the entire United States met
these criteria and are the best estimates of the U.S.
cancer burden available that are based on observed
data. The observed cancer rates are for 96% of the
U.S. population covered by eligible cancer registries.
Case counts for the U.S. incidence rates for all ages
combined are available at http://www.cdc.gov/uscs
(see “United States Cancer Statistics on the Web”).
The U.S. case counts are provided only to allow
readers to verify the crude rates (available at
http://www.cdc.gov/uscs [see “United States Cancer
Statistics on the Web”]) by recalculation. The U.S.
counts and U.S. cancer incidence rates in this
report pertain to the 96% of the U.S. population
covered by eligible cancer registries.
Interpreting the Data 
Age-adjusted rates are presented in this report. Crude
and age-specific rates have also been calculated 
and can be found at http://www.cdc.gov/uscs
(see “United States Cancer Statistics on the Web”).
Crude rates are helpful in determining burden and
specific needs for services for a given population,
compared with another population, regardless of
size. Crude rates are influenced by the underlying
age distribution of the state’s population. Even 
if two states have the same age-adjusted rates, 
the state with the relatively older population (as
demonstrated by having a higher median age) will
have higher crude rates because incidence or death
rates for most cancers increase with increasing age.
Ideally, crude, age-adjusted, and age-specific rates
are all used to plan for population-based cancer
prevention and control interventions.46
Incidence Data 
Published age-adjusted cancer incidence rates 
for diagnosis years before 1999 were calculated 
by using the 1970 U.S. standard population; for
mortality data, the 1940 standard population was
used. Beginning with the publication of data for the
1999 diagnosis year, cancer incidence rates were
age-adjusted to the 2000 U.S. standard population.
This change conforms to U.S. Department of
Health and Human Services policy for reporting
death and disease rates.45,46 This policy was
motivated by a need to standardize age-adjustment
procedures across government agencies.45 The
change to the 2000 U.S. standard updated the
calculation of age-adjusted rates to more closely
reflect the current age distribution of the U.S.
population and the current burden of cancer.
Because of the aging of the U.S. population, the
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2000 U.S. standard population gives more weight
to older age categories than did the 1940 and 1970
standard populations.5,46
Because cancer incidence increases with age, 
the change to the 2000 U.S. standard population
resulted in higher incidence rates for most cancers.
The data published here should not be compared
with cancer incidence rates adjusted to different
standard populations.
Incidence rates are also influenced by the choice 
of population denominators used in calculating 
the rates. Because some state health departments
use customized state population projections when
calculating incidence rates, the rates published in
this report may differ slightly from those published
by individual states. 
The new population estimates based on the 2000
census improve the accuracy of cancer incidence
rates (see “Population Denominator Data”).
Previously reported overall cancer rates, when
recalculated with the new denominators, do not
appear to change appreciably (Dr. Francis P.
Boscoe, New York State Cancer Registry, and Dr.
Barry Miller, NCI, personal communication, July
2003). However, rates for geographic areas with
small populations and for specific racial or ethnic
populations appear to be affected to a greater
degree and should be interpreted with caution.55
Furthermore, since corrections to the population
denominators extrapolated from the 1990 census
were larger in the late 1990s than earlier in the
decade, rates calculated for the late 1990s may be
subject to more change than rates calculated for 
the early 1990s. We published United States Cancer
Statistics: 1999 Incidence using extrapolated 1999
population estimates based on the 1990 census,
with the expectation that the 1999 incidence rates
would be revised when the intercensal (i.e., based
on both the 1990 census and the 2000 census) 
race-specific population estimates for 1999 became
available.56 The incidence rates published in United
States Cancer Statistics: 1999 Incidence have been
revised to incorporate the modified 1999
population denominators and are available at
http://www.cdc.gov/uscs (see “United States Cancer
Statistics on the Web”).
Statistical bias can arise if, within a region, division,
or country, the sub-area for which data are available
has rates that are substantially different from 
the rates in the sub-area for which data are not
available. Because of bias, rates for a U.S. Census
region or division, or the country, may not meet
statistical criteria for inclusion in this report. It is
possible to have some statistical bias even if the
percentage of coverage is high and large numbers
of cases are recorded. Where coverage is less than
100%, merely increasing the percentage of the
population covered may not reduce statistical bias
unless the covered population is similar to the
uncovered population in terms of cancer rates or
proportions. The U.S. counts and rates in this
report pertain to the 96% of the U.S. population
covered by eligible cancer registries. The 4% of 
the population that is not covered by eligible
cancer registries may have different cancer rates
than does the 96% that is covered, so reported
observed cancer rates may not be representative 
of the entire United States. Of note, however, 
the 95% confidence intervals around the observed
rates for the six specific major cancer sites (prostate,
female breast, male colorectal, female colorectal,
male lung and bronchus, and female lung and
bronchus) contain the rates for the entire United
States that were estimated using the method
described in Appendix D for those same sites.
Furthermore, the estimated rates for the entire
United States and the observed rates for the same
sites that are published in this report did not differ
by more than 0.4%. This observation provides
strong support that the reported rates are
representative of those for the entire United States.
Data quality is routinely evaluated by NPCR and
the SEER Program.57,58 Some evaluation activities
are conducted intermittently to find missing cases
or to identify errors in the data. Although the
cancer registries whose data are included in this
report meet data quality criteria for all invasive
sites combined, the completeness and quality of
site-specific data may vary. The observed rates 
may have been influenced by differences in the
timeliness, completeness, and accuracy of the data
from one registry to another, from one reporting
period to another, and from one primary cancer
site to another.
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Completeness and accuracy of the site-specific data
may also be affected by the time interval allowed
for reporting data to the two federal programs. 
For this report of 2003 data, the NPCR and 
SEER time interval for reporting data differed 
by 3 months. NPCR allowed an interval of 25
months after the close of the diagnosis year (data
submission by January 31, 2006), and SEER
allowed a shorter interval of 22 months after the
close of the diagnosis year (data submission by
November 1, 2005). 
Delays in reporting cancer cases can affect timely
and accurate calculation of cancer incidence rates.57
Cases are reported continuously to state and
metropolitan-area cancer registries in accordance
with statutory and contractual reporting
requirements. After the initial submission of the
most recent year’s data to the federal funding
agency, cancer registries continue to revise and
update their data on the basis of new information
received. Therefore, some cancer cases for the
2003 diagnosis year will likely have been reported
to state and metropolitan-area cancer registries
after these registries submitted their 2003 data 
to CDC or NCI. For this reason, incidence rates
and case counts reported directly by state- or
metropolitan-area cancer registries may differ 
from those in this publication. Reporting delays
appear to be more common for cancers that are
usually diagnosed and treated in nonhospital
settings such as physician offices (e.g., early-stage
prostate and breast cancer, melanoma of the skin).
NCI routinely models SEER reporting patterns
and estimates that the delay-adjusted 2003
incidence rate for all sites combined is about 
4% higher than the observed 2003 age-adjusted
incidence rate. Delay adjustments for 2003 SEER
age-adjusted rates vary: melanoma is 7%, prostate
cancer is 4%, and breast cancer is 3% (Dr. Brenda
K. Edwards, NCI, personal communication,
September 2006). Updates to observed data and
reported cancer rates are due to improvements in
the registry database gained through additional
knowledge that only comes with increased time 
and effort (Dr. Brenda K. Edwards, NCI, personal
communication, September 2006). Methods to
adjust incidence rates for reporting delay were 
not applied to the data in this report.59
Each year, not only do state cancer registries
submit data for a new diagnosis year to CDC or
NCI, but they also submit an updated version 
of previous years’ data. Federal agencies in turn
update their cancer incidence statistics with each
data submission and document the states’ data
submission date whenever the data are published.
These continual updates by state and federal
agencies illustrate the dynamic nature of cancer
surveillance and the attention to detail that is
characteristic of cancer registries. Each year 
when USCS is published, we publish updates to
previous years’ data at http://www.cdc.gov/uscs
(see “United States Cancer Statistics on the Web”).
Users of cancer incidence data published by federal
agencies should be mindful of the data submission
date for all data used in their comparisons. See
“United States Cancer Statistics on the Web” for
more information.
Geographic variation in cancer incidence rates 
may be the result of regional differences in the
exposure of the population to known or unknown
risk factors.60-63 Differences may arise because 
of differences in sociodemographic population
characteristics (e.g., age, race and ethnicity,
geographic region, urban or rural residence),
screening use, health-related behaviors (e.g.,
behaviors related to tobacco use, diet, physical
activity), exposure to cancer-causing agents, or
registry operations factors (e.g., completeness,
timeliness, specificity in coding cancer sites).
Cancer researchers are investigating variability
associated with known factors that affect cancer
rates and risks by using model-based statistical
techniques and other approaches for surveillance
research. Differences in registry operations are
being evaluated to ensure consistency and quality
in reporting data.
Mortality Data 
The cancer mortality statistics in this report are
influenced by the accuracy of information on the
death certificate. Cause of death determined by
autopsy combined with clinical data is considered
the best estimate of the true cause of death.64
Autopsy studies of mortality data coded according
to the eighth or ninth revision of ICD (ICD-8A 
or ICD-9) indicate that, when neoplasms (i.e.,
cancers) are an underlying cause of death, the
sensitivity of death certificates was 87%–93%, and
their predictive value positive was 85%–96%.64-66
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However, these studies are limited by selection
bias, and currently less than 10% of deaths in the
United States are autopsied.67 The percentage of
cancers coded as the underlying cause of death 
on the death certificate that agree with the cancer
diagnosis in the medical record is an indication 
of the reliability with which underlying cause of
death can be determined from the death certificate.
Available studies show that 78%–85% of malignant
neoplasms coded as an underlying cause of death
on death certificates agreed with the clinical cancer
diagnosis in medical records under ICD-8A or
ICD-9,68-70 with a range of 69% for larynx cancer 
to 98% for prostate cancer under ICD-9. These
results underscore the need to further monitor the
accuracy of cancer mortality data overall and by
anatomic site.
Some cancer patients may die with cancer (rather
than die of it) as an underlying cause of death.
Comparing the original cancer diagnosis in the
medical record with those cancers later coded as 
an underlying cause of death on death certificates 
is a way of measuring if a person died with cancer
rather than of it. Findings from an 11-year study
under ICD-9 showed that about 83% of malignant
neoplasms recorded on the medical record in ICD
for oncology were also coded as an underlying
cause of death from death certificates;70 this
percentage ranged from 72% for larynx cancer to
97% for myeloma. This SEER study suggests that
misattribution bias (i.e., the mistaken assignment 
of cancer as the underlying cause of death because
the decedent received a diagnosis of cancer) affects
how cancer is recorded on death certificates.71
In collaboration with the Social Security
Administration and the National Association 
for Public Health Statistics and Information
Systems, NCHS is developing a Model Vital 
Event Re-Engineered System to improve the
accuracy and timeliness of vital statistics
disseminated through NVSS. Under the system,
standard certificates for births and deaths will 
be revised, and state data systems will be re-
engineered to better accommodate revisions,
special studies or projects, and linkage with other
health promotion programs. With regard to
mortality statistics, handbooks have been revised
for professionals who complete death certificates.72
(Also see “Data Sources, Mortality Data”).
Race and Ethnicity in Cancer Data 
The NAACCR Race and Ethnicity Identifier
Assessment Project confirmed the importance 
of publishing cancer rates by race and ethnicity.73
In cancer incidence, race and ethnicity information
is abstracted from medical records and then
grouped into race and ethnicity categories.20
Although state registries across the country use
standardized data items and codes for both race 
and ethnicity (i.e., Hispanic origin), the initial
collection of this information by health care
facilities and practitioners and the procedures 
for assigning and verifying codes for race and
ethnicity are not well standardized.73 Thus, some
inconsistency is expected in this information.
In cancer mortality, race and Hispanic origin 
are reported separately on the death certificate 
by the funeral director as provided by an informant
or, in the absence of an informant, on the basis 
of observation.39 Inconsistencies in the collection
and coding of data on race and Hispanic origin 
and their effect on mortality statistics have 
been described previously.74 The net effect of
misclassification is an underestimation of deaths
and death rates for races other than white or 
black. In addition, under-coverage of minority
populations in the census and resultant population
estimates introduce biases into death rates by
race.74-76 For the white population, published death
rates are overstated by an estimated 1% and for the
black population by 5%, resulting principally from
undercounts of these populations in the census.
In this report, cancer incidence and mortality data
are presented for all races combined and by race
(whites, blacks, Asians/Pacific Islanders, and
American Indians/Alaska Natives) and ethnicity
(Hispanics). Data for Asians/Pacific Islanders and
American Indians/Alaska Natives are presented
only for the nation and for states with a population
of at least 50,000 per sex because of concerns
regarding the relatively small sizes of these
populations in some states (see Figures 3.1.M1–
3.58.F2). Race-specific incidence counts and rates
are based on Race1 (NAACCR data element 160),20
Race2 (NAACCR data element 161),20 and IHS
Link (NAACCR data element 192).20 If Race1 
is white and Race2 is a specified race other than
white, then the value from Race2 is used. After 
United States Cancer Statistics: 2003 Incidence and Mortality
14
this check, if race is still white, unknown, or other
non-specified race and there is a positive IHS Link,
then the race is set to American Indian/Alaska Native.
Asians/Pacific Islanders
Data for Asians/Pacific Islanders were included for
the first time in United States Cancer Statistics: 2000
Incidence.77 The Asian/Pacific Islander population in
the United States is approximately 12.4 million or
4.3% of the 2003 U.S. population, substantially
smaller than the white or black populations.78 The
Asian/Pacific Islander population is concentrated 
in several states: California, Hawaii, Illinois, New
Jersey, New York, Texas, and Washington.79,80
Grouping Asians and Pacific Islanders into 
one racial population can mask differences in
subpopulations. The U.S. Asian/Pacific Islander
population is not a homogeneous group. Rather, 
it comprises many subpopulations that differ 
in language, culture, and length of residence in 
the United States.78,81 The three largest Asian
subpopulations in the United States are Chinese,
Filipino, and Asian Indian.80 Although state cancer
registries have designated codes for race that allow
them to document the occurrence of cancer in 23
different Asian/Pacific Islander subpopulations,20
the subpopulations are grouped into a single
Asian/Pacific Islander race group in this report
because of small numbers and concerns regarding
the possible misclassification of race for
Asian/Pacific Islander subpopulations.
Studies show that a person self-reported as
Asian/Pacific Islander in a census or survey 
was sometimes reported as white on the death
certificate.82,83 Death rates are understated for
Asians/Pacific Islanders by approximately 11%.74
Studies are under way to examine the
misclassification of race for Asian/Pacific 
Islander subpopulations and the underreporting 
of Asian/Pacific Islander race in cancer incidence
data (Dr. Holly L. Howe, NAACCR, personal
communication, August 2005).
Hispanics
Data for Hispanics were included for the first time
in United States Cancer Statistics: 2001 Incidence and
Mortality.23 The Office of Management and Budget
defines Hispanics (or Latinos) as persons of Cuban,
Mexican, Puerto Rican, South or Central
American, or other Spanish culture or origin
regardless of race.84 Hispanics have one of the
highest growth rates among minority groups in the
United States with approximately 39.9 million in
the 2003 U.S. population, similar in size to the
U.S. black population.78,85,86 The three largest
Hispanic subpopulations living in the United States
are Mexicans, Puerto Ricans, and Cubans. States
with 1 million or more Hispanics include Arizona,
California, Florida, Illinois, New Jersey, New York,
and Texas.85
NAACCR convened an expert panel to develop 
a best practices approach to improving Hispanic
identification and is addressing Hispanic origin
misclassification in central cancer registries. 
All NPCR and some SEER registries assigned
Hispanic ethnicity through the standardized use 
of the NAACCR Hispanic Identification Algorithm
(NHIA).87 NHIA uses a combination of NAACCR
variables to directly or indirectly classify cancer
cases as Hispanic for analytic purposes. Cases
reported as having Spanish/Hispanic origin (as
indicated by NAACCR data element 190 with
values 1–6)20 are directly identified as Hispanic in
the dataset. Cases reported as non-Spanish/non-
Hispanic, Spanish surname only, or unknown
whether Spanish (NAACCR data element 190 
with a value of 0, 7, or 9)20 are evaluated for
possible Hispanic ethnicity through indirect
identification. The ultimate goal of the algorithm 
is to classify these cases as Hispanic or non-
Hispanic on the basis of an evaluation of the
strength of the birthplace, race, and/or surname
associations with Hispanic ethnicity. After applying
NHIA, cases not classified as Hispanic are classified
as non-Hispanic, leaving no cases with unknown
Hispanic status. More detailed information on the
algorithm is available at http://www.naaccr.org.88
In this report, NHIA-classified case counts and
incidence rates for Hispanics are presented for 35
NPCR, 3 NPCR/SEER, and 9 SEER registries.
The following NPCR registries have opted not to
present state-specific, NHIA-classified Hispanic
counts and rates: Florida, Illinois, Kentucky,
Pennsylvania, South Carolina, and Wisconsin
(male colorectal cancer rates only). The counts 
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and rates for Hawaii and metropolitan Seattle-
Puget Sound are not presented since NHIA was
not completed by these registries. Some registries
may have a small percentage of Hispanics in their
states. Quality reviews of NHIA and the data
elements that make up NHIA, including but not
limited to Hispanic ethnicity, race, birthplace,
surname, and maiden name for women, have been
conducted.89 National rates include data from
registries that opted not to present state-specific,
NHIA-classified Hispanic counts and incidence
rates. Preliminary data analyses showed that
exclusion of these registry data did not appreciably
change the overall incidence rates.
Death counts and rates for Hispanics are presented
at the national and state levels for all 50 states and
for the District of Columbia. Hispanic origin is
assigned to cancer mortality data on the basis of
information collected from death certificates.
The National Longitudinal Mortality Study
examined the reliability of Hispanic origin and
reported a 89.7% record-by-record agreement and
a net underreporting of Hispanic origin on death
certificates by 7% compared with self-reports on
the surveys.74 Death rates for the Hispanic-origin
population are also affected by under-coverage 
of this population group in the census and the
resultant population estimates; the estimated 
net correction, taking into account both sources 
of bias, is 1.6%.76
American Indians/Alaska Natives
Data for American Indians/Alaska Natives were
included for the first time in United States Cancer
Statistics: 2002 Incidence and Mortality.24 More than
560 American Indian tribes are recognized by
individual states and the federal government.9,90,91
The American Indian/Alaska Native population 
in the United States is approximately 2.8 million 
or 1.0% of the 2003 U.S. population, substantially
smaller than the white or black populations and
smaller than the Asian/Pacific Islander population.78
The American Indian/Alaska Native population 
is concentrated in several states: Alaska, Arizona,
California, New Mexico, New York, North
Carolina, Oklahoma, Texas, and Washington.78
Previous studies have found racial misclassification
to contribute to lower death rates and lower cancer
incidence rates among the American Indian/Alaska
Native population. Based on a comparison of race
reported on death certificates during 1979–1989
with nine Current Population Survey files for the
years 1973–1985 from the National Longitudinal
Mortality Study conducted by the U.S. Bureau 
of the Census, record-by-record agreement was
only 57% for American Indians.74 When the net
agreement of counts by race was examined between
the two sources, almost 40% more persons were
reported as American Indian/Alaska Native in the
Current Population Survey files than on the death
certificates.74 For cancer incidence rates among this
population, the range of underestimation is similar.
Studies that estimate misclassification among
American Indians/Alaska Natives using cancer
registry data report these rates are underreported
by 40%–57%, depending on the region of the
country.91-93
Studies measuring racial misclassification with
cancer registry data have linked cases with Indian
Health Service (IHS) administrative records.91-93
IHS provides medical services to American
Indians/Alaska Natives who are members of
federally recognized tribes, estimated to be
approximately 55% of the American Indian/Alaska
Native population (Dr. David Espey, IHS, personal
communication, July 2005). IHS coverage of 
these populations varies by region, does not 
include American Indians/Alaska Natives who 
are members of non-federally recognized tribes,
and underrepresents those who live in certain
urban areas. However, American Indians/Alaska
Natives who live outside of service counties may
continue to receive IHS services or may have
received services before moving. To address
American Indian/Alaska Native misclassification 
in cancer registry data, in 2004, all NPCR and 15
SEER registries linked to the IHS administrative
records database for cases diagnosed during
1995–2002 and 1988–2002, respectively. Results 
of the linkage were captured in a new data element,
IHS Link (NAACCR data element 192),20 that 
was sent back to state cancer registries. The results
of this linkage led to the decision that NPCR
registries will continue to link with IHS annually 
if they contribute 90% of all new American
Indian/Alaska Native cases. Also, state registries
with more than 0.8% of the total cases will
continue to link with IHS annually. The remainder
of NPCR registries will link every 5 years, or
sooner if required. Therefore, in 2005, 24 NPCR
registries (22 NPCR-only supported, including 
the SEER metropolitan registries in WA and 
MI, plus 2 NPCR/SEER-supported [CA, NJ]
registries) linked with IHS. SEER registries
provide complete coverage for special populations
whose data are reported to their respective state
registries: Alaska Natives, 16% and Arizona
Indians, 5%. In 2005, the SEER registries did 
not link with IHS.
California opted not to present state-specific
American Indian/Alaska Native case counts,
incidence rates, death counts, and death rates.
National death counts and rates consist of data
obtained from all 50 states and the District of
Columbia. American Indian/Alaska Native race 
for these data is obtained from information on the
death certificate.
United States Cancer Statistics
on the Web
The USCS Web site (http://www.cdc.gov/uscs) is a
comprehensive source of 2003 incidence and
mortality data. All the tables and figures in this
report are available on the site. 
In addition to the data published in this report, the
following data presentation for all years (1999,
2000, 2001, 2002, 2003, and 2001–2003) are only
available on the Web:
• Cancer incidence and death rates for 2001–2003.
Combining years of data adds stability to
the rates and allows for less suppression of
smaller cancer sites or smaller race
populations. The population coverage for
incidence data for these combined years is
90% of the U.S. population. The methods
for calculating rates and their confidence
intervals, as well as the suppression of data
at the state, regional, division, and national
levels, are the same for single year and
combined years of data. See “Statistical
Methods” for more information
• Childhood cancer incidence rates according 
to the third edition of the International
Classification of Childhood Cancer (ICCC-3).
ICCC-3 was published in 200594 and
categorized according to the SEER recodes
(http://seer.cancer.gov/iccc/seericcc.html).
According to ICCC-3, childhood cancers
are categorized into 12 main groups
classified primarily by morphology. A 
new grouping was created in ICCC-3 
for refractory anemia, myelodysplastic
syndrome, and other myeloproliferative
diseases, in order to be consistent with
changes in ICD-O-3. These cancers
represent 3%–9% of the hematologic
malignancies in children.
• Childhood cancer incidence and death rates by
the SEER site recodes.
The incidence data are presented in this
format to make them comparable with
other published mortality data. This format
allows the incidence data for childhood
cancers to be categorized into the same
groups as adult cancers. Although these
groupings are not as appropriate for
children as they are for adults, they are
necessary to allow comparisons between
childhood incidence and childhood
mortality.
• Detailed malignant brain and central nervous
system cancer incidence data. 
The Benign Brain Tumor Cancer Registries
Amendment Act changed NPCR’s definition
of reportable tumors to include benign
central nervous system (CNS) tumors.
Subsequently, in addition to NPCR, both
SEER and the Commission on Cancer
(CoC) agreed to require reporting of
nonmalignant brain tumors, beginning 
with cases diagnosed on or after January 1,
2004. A table of CNS tumors categorized
by histology groupings is presented and
includes malignant incident cases only.
These groupings were agreed upon by a
consensus conference at the Society for
Neuro-Oncology annual meeting in 2000.95
In 2007, cases for nonmalignant brain
tumors will be added, and an increase in
rates will be seen in the following histology
groups and subgroups: (groups) tumors 
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of the cranial and spinal nerves; tumors 
of the sellar region and (subgroups) unique
astrocytoma variants and for neuronal/glial,
neuronal; meningioma; and hemangioma.
• Crude incidence and death rates for Tables 1
and 2.
• Age-specific incidence and death rates for 27
cancer sites that are listed in the “Cancer
Incidence and Mortality by U.S. Census
Region and Division, State, and Metropolitan-
area” section.
• New case (incident) and death counts.
• Population data.
• Cancer incidence and death rates for men and
women combined.
• State rankings of incidence and mortality for
selected major cancers.
• State versus national comparisons of incidence
and death rates for the most common cancers.
Previously published data based on 1999–2002
cancer cases as reported to CDC as of January 31,
2006, and as reported to NCI as of November 1,
2005, and made available through the SEER
Program public use file (see “Interpreting the Data:
Incidence Data”) have been updated. All updated
data are coded and classified according to current
standards (i.e., ICD-O-3 and 2000 U.S. standard
population) in order to be comparable across
diagnosis years. The population coverage for
incidence rates is as follows:
➤ 1999 incidence: 90% of the U.S. population
➤ 2000 incidence: 91% of the U.S. population
➤ 2001 incidence: 92% of the U.S. population
➤ 2002 incidence: 92% of the U.S. population
All data presented on the Web version can be
downloaded for use in other applications. A
portable document file (PDF) that mirrors this
report is also available for download.
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Cancer Incidence and Mortality
for All Ages: 
All Areas Combined
Table 1.1.1.1M
Consecutive numbering based on table series
In the series, the second digit indicates all 
cancer sites for all ages.
Specific types or categorization of rates
M = males
F = females
If no M or F, then table presents both sexes.
1 = incidence rate
2 = death rate
1 = U.S. rates
Organized by cancer site
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Figure 1: Geographic Areas Contributing Data to 
United States Cancer Statistics: 2003 Incidence and Mortality
Note: Shaded areas represent statewide and metropolitan cancer registries that met the following data quality criteria for cancer 
incidence: case ascertainment is at least 90% complete; > 97% of cases pass a standard set of computerized edits; < 5% of cases 
were ascertained by death certificate only; < 3% of cases are missing information on sex; < 5% of cases are missing information on 
race; < 3% of cases are missing information on age.  See Appendix C for registry-specific data quality information.  Incidence data 
cover approximately 96% of the U.S. population.  Mortality data are from the National Vital Statistics System and cover 100% of the 
U.S. population.25
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Table 1.1.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by Primary Site
and Race and Ethnicity, United States†‡
Males, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
All Sites 541.8 (540.5-543.1) 530.9 (529.5-532.3) 611.0 (606.1-615.8) 329.3 (323.5-335.1) 307.4 (294.0-321.3) 421.1 (416.4-425.9)
All Sites (excl. newly classified as malignant)¶ 534.9 (533.6-536.2) 523.8 (522.5-525.2) 606.0 (601.3-610.9) 325.4 (319.6-331.2) 304.1 (290.8-317.9) 415.1 (410.5-419.8)
Oral Cavity and Pharynx 15.8 ( 15.6- 16.0) 15.5 ( 15.3- 15.8) 17.4 ( 16.7- 18.2) 10.1 ( 9.1- 11.0) 11.6 ( 9.2- 14.6) 10.4 ( 9.7- 11.2)
Lip 1.2 ( 1.2- 1.3) 1.3 ( 1.3- 1.4) ∼ ∼ ∼ 0.6 ( 0.5- 0.9)
Tongue 4.1 ( 4.0- 4.2) 4.2 ( 4.1- 4.3) 3.8 ( 3.5- 4.2) 1.9 ( 1.5- 2.4) 1.8 ( 1.0- 3.3) 2.4 ( 2.0- 2.7)
Salivary Gland 1.6 ( 1.5- 1.7) 1.6 ( 1.5- 1.7) 1.1 ( 0.9- 1.4) 1.0 ( 0.8- 1.4) ∼ 1.1 ( 0.9- 1.4)
Floor of Mouth 1.0 ( 0.9- 1.0) 1.0 ( 0.9- 1.0) 1.5 ( 1.3- 1.7) ∼ ∼ 0.5 ( 0.3- 0.6)
Gum and Other Mouth 1.9 ( 1.8- 2.0) 1.9 ( 1.8- 1.9) 2.3 ( 2.0- 2.6) 1.0 ( 0.7- 1.4) ∼ 1.5 ( 1.2- 1.8)
Nasopharynx 0.8 ( 0.8- 0.9) 0.6 ( 0.6- 0.7) 1.2 ( 1.0- 1.4) 3.7 ( 3.2- 4.3) ∼ 0.6 ( 0.4- 0.8)
Tonsil 2.6 ( 2.5- 2.6) 2.6 ( 2.5- 2.7) 2.7 ( 2.4- 3.0) 0.9 ( 0.7- 1.3) 1.6 ( 0.9- 2.9) 1.8 ( 1.5- 2.1)
Oropharynx 0.7 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 1.2 ( 1.1- 1.5) ∼ ∼ 0.5 ( 0.3- 0.7)
Hypopharynx 1.4 ( 1.3- 1.5) 1.3 ( 1.2- 1.3) 2.8 ( 2.5- 3.2) 0.8 ( 0.6- 1.2) ∼ 1.2 ( 1.0- 1.5)
Other Oral Cavity and Pharynx 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.7 ( 0.5- 0.8) ∼ ∼ 0.4 ( 0.2- 0.6)
Digestive System 106.9 (106.3-107.4) 103.1 (102.4-103.7) 132.6 (130.3-134.9) 101.9 ( 98.7-105.2) 80.1 ( 73.3- 87.5) 102.4 (100.1-104.8)
Esophagus 8.6 ( 8.4- 8.7) 8.4 ( 8.2- 8.6) 11.1 ( 10.5- 11.8) 3.9 ( 3.2- 4.6) 5.8 ( 4.1- 8.2) 5.3 ( 4.8- 5.9)
Stomach 10.0 ( 9.8- 10.2) 8.9 ( 8.8- 9.1) 16.9 ( 16.0- 17.7) 17.0 ( 15.7- 18.4) 10.2 ( 7.7- 13.4) 14.5 ( 13.7- 15.5)
Small Intestine 2.1 ( 2.0- 2.2) 2.0 ( 1.9- 2.1) 3.1 ( 2.7- 3.4) 1.0 ( 0.7- 1.4) ∼ 1.6 ( 1.3- 1.9)
Colon and Rectum 60.4 ( 59.9- 60.8) 59.2 ( 58.7- 59.7) 69.4 ( 67.8- 71.1) 45.0 ( 42.8- 47.2) 41.9 ( 36.9- 47.5) 49.3 ( 47.7- 51.0)
Colon excluding Rectum 42.7 ( 42.3- 43.1) 41.6 ( 41.2- 42.0) 52.9 ( 51.4- 54.4) 29.8 ( 28.1- 31.7) 29.0 ( 24.8- 33.9) 33.8 ( 32.5- 35.2)
Rectum and Rectosigmoid Junction 17.7 ( 17.5- 17.9) 17.6 ( 17.3- 17.8) 16.5 ( 15.8- 17.4) 15.1 ( 13.9- 16.4) 12.8 ( 10.2- 16.0) 15.5 ( 14.6- 16.4)
Anus, Anal Canal and Anorectum 1.3 ( 1.2- 1.4) 1.3 ( 1.2- 1.3) 1.5 ( 1.3- 1.7) 0.7 ( 0.4- 1.0) ∼ 0.8 ( 0.7- 1.1)
Liver and Intrahepatic Bile Duct 8.2 ( 8.1- 8.4) 7.2 ( 7.1- 7.4) 11.4 ( 10.7- 12.0) 20.4 ( 19.0- 21.8) 8.4 ( 6.5- 10.8) 14.9 ( 14.1- 15.8)
Gallbladder 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 0.8) 1.0 ( 0.8- 1.3) 1.4 ( 1.0- 1.9) ∼ 1.2 ( 1.0- 1.5)
Other Biliary 2.0 ( 2.0- 2.1) 2.0 ( 1.9- 2.1) 1.5 ( 1.3- 1.8) 3.0 ( 2.5- 3.7) ∼ 2.7 ( 2.3- 3.1)
Pancreas 12.6 ( 12.4- 12.8) 12.3 ( 12.1- 12.5) 15.9 ( 15.1- 16.7) 8.8 ( 7.9- 9.9) 7.2 ( 5.3- 9.7) 10.9 ( 10.2- 11.7)
Retroperitoneum 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ 0.4 ( 0.3- 0.6)
Peritoneum, Omentum and Mesentery 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Other Digestive Organs 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.4) 0.5 ( 0.4- 0.6) 0.4 ( 0.3- 0.7) ∼ 0.6 ( 0.4- 0.8)
Respiratory System 95.1 ( 94.5- 95.6) 93.7 ( 93.1- 94.3) 118.5 (116.4-120.7) 54.8 ( 52.4- 57.3) 59.4 ( 53.5- 65.9) 56.3 ( 54.6- 58.1)
Nose, Nasal Cavity and Middle Ear 0.9 ( 0.8- 0.9) 0.8 ( 0.8- 0.9) 0.8 ( 0.7- 1.0) 0.8 ( 0.5- 1.1) ∼ 0.9 ( 0.7- 1.2)
Larynx 7.1 ( 6.9- 7.2) 6.7 ( 6.6- 6.9) 11.3 ( 10.7- 11.9) 2.9 ( 2.4- 3.5) 4.5 ( 3.1- 6.6) 6.5 ( 5.9- 7.1)
Lung and Bronchus 86.8 ( 86.3- 87.3) 85.8 ( 85.3- 86.4) 106.1 (104.1-108.2) 50.9 ( 48.6- 53.3) 54.0 ( 48.4- 60.3) 48.6 ( 47.0- 50.3)
Pleura 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ 0.3 ( 0.2- 0.4)
Bones and Joints 1.0 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 0.8 ( 0.6- 0.9) 0.7 ( 0.5- 1.0) ∼ 1.0 ( 0.8- 1.2)
Soft Tissue including Heart 3.5 ( 3.4- 3.6) 3.5 ( 3.4- 3.6) 3.4 ( 3.1- 3.7) 2.6 ( 2.2- 3.2) ∼ 2.7 ( 2.3- 3.0)
Skin excluding Basal and Squamous 22.3 ( 22.0- 22.6) 24.3 ( 24.0- 24.6) 1.7 ( 1.5- 2.0) 2.3 ( 1.8- 2.9) 5.0 ( 3.4- 7.1) 5.0 ( 4.5- 5.6)
Melanomas of the Skin 20.5 ( 20.2- 20.7) 22.5 ( 22.2- 22.7) 0.9 ( 0.7- 1.1) 1.5 ( 1.1- 2.0) 4.2 ( 2.9- 6.3) 4.1 ( 3.6- 4.6)
Other Non-Epithelial Skin 1.8 ( 1.8- 1.9) 1.9 ( 1.8- 1.9) 0.8 ( 0.7- 1.0) 0.8 ( 0.5- 1.1) ∼ 0.9 ( 0.7- 1.2)
Breast 1.5 ( 1.4- 1.5) 1.4 ( 1.4- 1.5) 1.9 ( 1.7- 2.2) 0.9 ( 0.7- 1.3) ∼ 1.0 ( 0.7- 1.2)
Male Genital System 156.3 (155.6-157.0) 146.0 (145.2-146.7) 224.3 (221.4-227.2) 82.9 ( 80.0- 85.9) 75.8 ( 69.3- 82.9) 133.2 (130.5-135.8)
Prostate 150.0 (149.3-150.7) 138.9 (138.2-139.6) 221.8 (218.9-224.7) 81.1 ( 78.2- 84.1) 72.2 ( 65.8- 79.2) 127.7 (125.1-130.4)
Testis 5.2 ( 5.1- 5.3) 6.0 ( 5.8- 6.1) 1.3 ( 1.2- 1.5) 1.1 ( 0.9- 1.5) 2.9 ( 2.1- 4.4) 3.8 ( 3.5- 4.1)
Penis 0.9 ( 0.8- 0.9) 0.9 ( 0.8- 0.9) 1.0 ( 0.8- 1.2) ∼ ∼ 1.5 ( 1.2- 1.8)
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Table 1.1.1.1M: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by Primary Site
and Race and Ethnicity, United States†‡ (continued)
Males, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
Other Male Genital Organs 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ 0.2 ( 0.1- 0.3)
Urinary System 56.7 ( 56.2- 57.1) 58.7 ( 58.3- 59.2) 38.3 ( 37.1- 39.5) 25.0 ( 23.4- 26.7) 29.8 ( 25.8- 34.5) 39.3 ( 37.8- 40.8)
Urinary Bladder∗∗ 36.9 ( 36.5- 37.2) 38.8 ( 38.5- 39.2) 18.2 ( 17.3- 19.1) 14.8 ( 13.5- 16.2) 15.0 ( 11.9- 18.7) 20.9 ( 19.8- 22.0)
Kidney and Renal Pelvis 18.6 ( 18.3- 18.8) 18.7 ( 18.4- 18.9) 19.3 ( 18.5- 20.2) 9.3 ( 8.4- 10.3) 14.4 ( 11.8- 17.5) 17.5 ( 16.6- 18.5)
Ureter 0.8 ( 0.8- 0.9) 0.9 ( 0.8- 0.9) 0.3 ( 0.2- 0.5) 0.6 ( 0.4- 1.0) ∼ 0.5 ( 0.4- 0.8)
Other Urinary Organs 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.6) ∼ ∼ 0.3 ( 0.2- 0.5)
Eye and Orbit 1.0 ( 0.9- 1.0) 1.0 ( 1.0- 1.1) 0.2 ( 0.2- 0.3) ∼ ∼ 0.6 ( 0.5- 0.8)
Brain and Other Nervous System 7.7 ( 7.5- 7.8) 8.1 ( 8.0- 8.3) 4.9 ( 4.5- 5.3) 4.0 ( 3.4- 4.7) 3.4 ( 2.2- 5.2) 6.0 ( 5.5- 6.5)
Brain 7.3 ( 7.1- 7.4) 7.7 ( 7.5- 7.9) 4.5 ( 4.1- 4.9) 3.8 ( 3.2- 4.4) 3.2 ( 2.0- 4.9) 5.7 ( 5.2- 6.2)
Cranial Nerves and Other Nervous System 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼ 0.3 ( 0.2- 0.4)
Endocrine System 5.0 ( 4.9- 5.2) 5.2 ( 5.1- 5.3) 3.3 ( 2.9- 3.6) 4.4 ( 3.8- 5.1) 1.8 ( 1.1- 3.2) 3.6 ( 3.3- 4.0)
Thyroid 4.3 ( 4.2- 4.4) 4.5 ( 4.4- 4.6) 2.4 ( 2.1- 2.7) 3.6 ( 3.1- 4.2) ∼ 3.1 ( 2.8- 3.5)
Other Endocrine including Thymus 0.7 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 0.9 ( 0.7- 1.1) 0.8 ( 0.6- 1.1) ∼ 0.5 ( 0.4- 0.7)
Lymphomas 25.2 ( 25.0- 25.5) 25.8 ( 25.5- 26.1) 18.2 ( 17.5- 19.0) 15.7 ( 14.4- 17.0) 15.7 ( 12.8- 19.2) 21.8 ( 20.8- 22.8)
Hodgkin Lymphoma 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.3) 2.6 ( 2.3- 2.9) 1.6 ( 1.3- 2.0) 1.6 ( 0.9- 3.1) 2.9 ( 2.6- 3.2)
Non-Hodgkin Lymphoma 22.2 ( 21.9- 22.4) 22.6 ( 22.3- 22.9) 15.6 ( 14.9- 16.4) 14.1 ( 12.9- 15.3) 14.1 ( 11.3- 17.5) 18.9 ( 18.0- 19.9)
Myeloma 6.4 ( 6.3- 6.6) 5.9 ( 5.8- 6.1) 12.1 ( 11.4- 12.8) 3.4 ( 2.8- 4.1) 3.3 ( 2.0- 5.2) 6.4 ( 5.8- 7.0)
Leukemias 14.9 ( 14.7- 15.1) 15.1 ( 14.9- 15.4) 11.0 ( 10.3- 11.6) 8.2 ( 7.4- 9.2) 4.8 ( 3.4- 6.8) 10.9 ( 10.2- 11.6)
Acute Lymphocytic 1.6 ( 1.6- 1.7) 1.7 ( 1.7- 1.8) 0.9 ( 0.8- 1.1) 1.6 ( 1.3- 2.0) ∼ 2.2 ( 2.0- 2.5)
Chronic Lymphocytic 4.9 ( 4.8- 5.1) 4.9 ( 4.8- 5.1) 3.5 ( 3.1- 3.8) 1.0 ( 0.7- 1.5) ∼ 2.3 ( 1.9- 2.7)
Acute Myeloid 4.4 ( 4.3- 4.5) 4.5 ( 4.4- 4.6) 3.4 ( 3.0- 3.7) 3.1 ( 2.6- 3.7) ∼ 3.5 ( 3.1- 4.0)
Chronic Myeloid 1.8 ( 1.7- 1.9) 1.8 ( 1.7- 1.9) 1.7 ( 1.5- 2.0) 1.3 ( 1.0- 1.7) ∼ 1.3 ( 1.1- 1.6)
Other Leukemias 2.1 ( 2.0- 2.2) 2.2 ( 2.1- 2.3) 1.5 ( 1.3- 1.8) 1.1 ( 0.8- 1.5) ∼ 1.6 ( 1.3- 1.9)
Mesothelioma 2.0 ( 1.9- 2.0) 2.1 ( 2.0- 2.2) 1.1 ( 0.9- 1.3) 0.7 ( 0.5- 1.1) ∼ 1.3 ( 1.1- 1.7)
Kaposi Sarcoma 0.9 ( 0.8- 0.9) 0.7 ( 0.6- 0.8) 1.8 ( 1.6- 2.1) ∼ ∼ 1.8 ( 1.6- 2.1)
Miscellaneous 19.7 ( 19.5- 20.0) 19.7 ( 19.4- 19.9) 19.6 ( 18.7- 20.5) 11.0 ( 10.0- 12.2) 12.6 ( 9.9- 16.0) 17.5 ( 16.5- 18.5)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix C for data
quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
¶ Excludes some endometrial cancers; papillary ependymomas and papillary meningiomas; chronic myeloproliferative diseases; and myelodysplastic syndromes. These cancers are
newly classified and reported as malignant cancers according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∗∗ Includes invasive and in situ.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by Primary Site
and Race and Ethnicity, United States†‡
Females, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
All Sites 403.6 (402.6-404.6) 406.7 (405.6-407.8) 379.1 (376.1-382.2) 263.9 (259.6-268.3) 247.7 (237.6-258.1) 316.8 (313.4-320.2)
All Sites (excl. newly classified as malignant)¶ 399.2 (398.2-400.2) 402.3 (401.2-403.4) 375.6 (372.6-378.6) 260.5 (256.2-264.8) 245.3 (235.3-255.7) 312.9 (309.6-316.3)
Oral Cavity and Pharynx 5.9 ( 5.8- 6.1) 5.9 ( 5.7- 6.0) 5.5 ( 5.1- 5.9) 4.8 ( 4.3- 5.5) 3.9 ( 2.7- 5.4) 3.5 ( 3.2- 3.9)
Lip 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.4) ∼ ∼ ∼ ∼
Tongue 1.5 ( 1.5- 1.6) 1.6 ( 1.5- 1.6) 1.1 ( 0.9- 1.3) 0.9 ( 0.7- 1.2) ∼ 1.0 ( 0.8- 1.2)
Salivary Gland 0.9 ( 0.8- 0.9) 0.9 ( 0.8- 0.9) 0.9 ( 0.7- 1.0) 0.7 ( 0.5- 1.0) ∼ 0.6 ( 0.5- 0.8)
Floor of Mouth 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ 0.3 ( 0.2- 0.4)
Gum and Other Mouth 1.3 ( 1.2- 1.3) 1.2 ( 1.2- 1.3) 1.3 ( 1.1- 1.4) 0.7 ( 0.5- 1.0) ∼ 0.8 ( 0.6- 1.0)
Nasopharynx 0.3 ( 0.3- 0.4) 0.2 ( 0.2- 0.3) 0.4 ( 0.3- 0.5) 1.7 ( 1.4- 2.1) ∼ 0.2 ( 0.2- 0.3)
Tonsil 0.6 ( 0.6- 0.6) 0.6 ( 0.6- 0.7) 0.7 ( 0.5- 0.8) ∼ ∼ 0.2 ( 0.2- 0.4)
Oropharynx 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Hypopharynx 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.4 ( 0.3- 0.5) ∼ ∼ 0.1 ( 0.1- 0.2)
Other Oral Cavity and Pharynx 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼
Digestive System 71.3 ( 70.9- 71.7) 68.6 ( 68.2- 69.0) 88.4 ( 86.9- 89.9) 63.7 ( 61.5- 66.0) 55.8 ( 50.9- 61.1) 68.4 ( 66.8- 70.0)
Esophagus 2.0 ( 1.9- 2.1) 1.9 ( 1.8- 1.9) 3.3 ( 3.0- 3.6) 1.0 ( 0.7- 1.3) ∼ 1.4 ( 1.2- 1.7)
Stomach 4.9 ( 4.8- 5.0) 4.2 ( 4.1- 4.3) 8.4 ( 7.9- 8.9) 10.3 ( 9.4- 11.2) 4.4 ( 3.1- 6.1) 8.9 ( 8.3- 9.5)
Small Intestine 1.5 ( 1.5- 1.6) 1.4 ( 1.3- 1.5) 2.5 ( 2.2- 2.7) 0.8 ( 0.6- 1.1) ∼ 1.2 ( 1.0- 1.4)
Colon and Rectum 44.2 ( 43.8- 44.5) 43.0 ( 42.6- 43.3) 52.5 ( 51.3- 53.6) 31.2 ( 29.7- 32.8) 33.4 ( 29.6- 37.6) 34.7 ( 33.5- 35.9)
Colon excluding Rectum 33.5 ( 33.2- 33.8) 32.5 ( 32.2- 32.8) 41.6 ( 40.6- 42.6) 21.7 ( 20.4- 23.1) 25.9 ( 22.6- 29.6) 25.4 ( 24.5- 26.5)
Rectum and Rectosigmoid Junction 10.7 ( 10.5- 10.8) 10.5 ( 10.3- 10.7) 10.9 ( 10.4- 11.4) 9.5 ( 8.7- 10.4) 7.5 ( 5.8- 9.6) 9.2 ( 8.6- 9.8)
Anus, Anal Canal and Anorectum 1.6 ( 1.6- 1.7) 1.7 ( 1.6- 1.8) 1.5 ( 1.3- 1.7) 0.7 ( 0.4- 0.9) ∼ 1.4 ( 1.2- 1.7)
Liver and Intrahepatic Bile Duct 3.0 ( 2.9- 3.0) 2.7 ( 2.6- 2.7) 3.5 ( 3.2- 3.8) 7.6 ( 6.9- 8.4) 3.7 ( 2.5- 5.3) 5.5 ( 5.0- 6.0)
Gallbladder 1.3 ( 1.3- 1.4) 1.3 ( 1.2- 1.3) 1.5 ( 1.3- 1.7) 1.7 ( 1.4- 2.2) 2.8 ( 1.8- 4.2) 2.7 ( 2.4- 3.1)
Other Biliary 1.3 ( 1.2- 1.4) 1.3 ( 1.2- 1.3) 1.3 ( 1.1- 1.5) 2.0 ( 1.6- 2.4) ∼ 2.0 ( 1.8- 2.4)
Pancreas 9.8 ( 9.6- 9.9) 9.5 ( 9.3- 9.7) 12.6 ( 12.0- 13.2) 7.2 ( 6.4- 8.0) 6.2 ( 4.6- 8.1) 9.0 ( 8.4- 9.6)
Retroperitoneum 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.5 ( 0.4- 0.6) 0.3 ( 0.1- 0.4) ∼ 0.3 ( 0.3- 0.5)
Peritoneum, Omentum and Mesentery 1.0 ( 1.0- 1.1) 1.1 ( 1.0- 1.1) 0.4 ( 0.3- 0.6) 0.7 ( 0.5- 1.0) ∼ 0.7 ( 0.6- 0.9)
Other Digestive Organs 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.5) ∼ 0.5 ( 0.4- 0.7)
Respiratory System 56.5 ( 56.2- 56.9) 57.8 ( 57.4- 58.2) 53.1 ( 52.0- 54.3) 27.0 ( 25.6- 28.5) 37.6 ( 33.6- 41.9) 27.4 ( 26.4- 28.5)
Nose, Nasal Cavity and Middle Ear 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.6) ∼ 0.3 ( 0.2- 0.4)
Larynx 1.6 ( 1.5- 1.6) 1.5 ( 1.5- 1.6) 2.1 ( 1.9- 2.3) 0.4 ( 0.2- 0.6) ∼ 0.8 ( 0.6- 1.0)
Lung and Bronchus 54.3 ( 54.0- 54.7) 55.7 ( 55.3- 56.1) 50.4 ( 49.3- 51.6) 26.2 ( 24.8- 27.7) 36.8 ( 32.8- 41.1) 26.2 ( 25.2- 27.2)
Pleura 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.2) ∼ ∼ ∼
Bones and Joints 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 0.9) 0.6 ( 0.5- 0.7) 0.6 ( 0.4- 0.8) ∼ 0.9 ( 0.7- 1.0)
Soft Tissue including Heart 2.6 ( 2.5- 2.6) 2.5 ( 2.4- 2.6) 2.8 ( 2.6- 3.1) 1.9 ( 1.5- 2.3) ∼ 2.7 ( 2.4- 3.0)
Skin excluding Basal and Squamous 14.4 ( 14.2- 14.5) 16.0 ( 15.7- 16.2) 1.8 ( 1.6- 2.1) 1.9 ( 1.5- 2.3) 2.6 ( 1.7- 3.8) 5.2 ( 4.8- 5.6)
Melanomas of the Skin 13.2 ( 13.1- 13.4) 14.9 ( 14.7- 15.1) 0.9 ( 0.8- 1.1) 1.2 ( 0.9- 1.5) 2.0 ( 1.3- 3.1) 4.3 ( 3.9- 4.7)
Other Non-Epithelial Skin 1.1 ( 1.1- 1.2) 1.1 ( 1.0- 1.1) 0.9 ( 0.8- 1.0) 0.7 ( 0.5- 1.0) ∼ 0.9 ( 0.8- 1.1)
Breast 119.0 (118.5-119.6) 120.3 (119.7-120.9) 109.5 (107.9-111.2) 76.5 ( 74.3- 78.8) 63.8 ( 58.9- 69.0) 86.6 ( 84.9- 88.4)
Female Genital System 47.5 ( 47.1- 47.8) 47.9 ( 47.5- 48.3) 43.8 ( 42.8- 44.8) 31.9 ( 30.5- 33.4) 31.0 ( 27.6- 34.7) 45.0 ( 43.8- 46.3)
Cervix 8.1 ( 8.0- 8.3) 7.7 ( 7.5- 7.8) 11.1 ( 10.6- 11.6) 7.0 ( 6.3- 7.7) 6.2 ( 4.8- 7.9) 13.0 ( 12.4- 13.6)
Corpus 22.1 ( 21.9- 22.4) 22.7 ( 22.4- 23.0) 18.2 ( 17.5- 18.8) 13.7 ( 12.8- 14.7) 13.5 ( 11.2- 16.1) 17.5 ( 16.7- 18.3)
Uterus, NOS 0.8 ( 0.7- 0.8) 0.7 ( 0.6- 0.7) 1.4 ( 1.2- 1.5) 0.5 ( 0.3- 0.7) ∼ 0.7 ( 0.6- 0.9)
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Table 1.1.1.1F: Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by Primary Site
and Race and Ethnicity, United States†‡ (continued)
Females, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander§ Alaska Native§ Hispanic§‖
Ovary∗∗ 12.9 ( 12.7- 13.1) 13.3 ( 13.1- 13.5) 10.0 ( 9.5- 10.5) 9.1 ( 8.3- 9.9) 9.5 ( 7.6- 11.7) 10.7 ( 10.1- 11.3)
Vagina 0.7 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 1.0 ( 0.8- 1.2) 0.4 ( 0.3- 0.6) ∼ 0.9 ( 0.7- 1.1)
Vulva 2.2 ( 2.2- 2.3) 2.3 ( 2.2- 2.4) 1.6 ( 1.4- 1.8) 0.7 ( 0.5- 0.9) ∼ 1.7 ( 1.4- 1.9)
Other Female Genital Organs 0.6 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 0.6 ( 0.5- 0.8) 0.6 ( 0.4- 0.8) ∼ 0.5 ( 0.4- 0.7)
Urinary System 19.7 ( 19.5- 20.0) 20.3 ( 20.0- 20.5) 16.6 ( 16.0- 17.3) 9.4 ( 8.6- 10.3) 14.9 ( 12.4- 17.7) 16.0 ( 15.3- 16.8)
Urinary Bladder†† 9.5 ( 9.4- 9.7) 10.0 ( 9.8- 10.2) 6.4 ( 6.0- 6.8) 4.3 ( 3.7- 5.0) 4.1 ( 2.8- 5.8) 5.3 ( 4.9- 5.8)
Kidney and Renal Pelvis 9.7 ( 9.5- 9.8) 9.8 ( 9.6- 9.9) 9.8 ( 9.3- 10.3) 4.7 ( 4.1- 5.3) 10.4 ( 8.4- 12.8) 10.3 ( 9.7- 10.9)
Ureter 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.2 ( 0.1- 0.2) 0.4 ( 0.2- 0.6) ∼ 0.2 ( 0.2- 0.4)
Other Urinary Organs 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Eye and Orbit 0.7 ( 0.6- 0.7) 0.7 ( 0.7- 0.8) 0.2 ( 0.2- 0.3) 0.3 ( 0.1- 0.5) ∼ 0.4 ( 0.3- 0.6)
Brain and Other Nervous System 5.6 ( 5.4- 5.7) 5.9 ( 5.8- 6.0) 3.5 ( 3.2- 3.8) 3.0 ( 2.6- 3.5) 1.7 ( 1.0- 2.8) 4.8 ( 4.5- 5.3)
Brain 5.1 ( 4.9- 5.2) 5.4 ( 5.3- 5.5) 3.0 ( 2.7- 3.3) 2.8 ( 2.4- 3.3) 1.7 ( 1.0- 2.8) 4.4 ( 4.1- 4.8)
Cranial Nerves and Other Nervous System 0.5 ( 0.5- 0.5) 0.5 ( 0.5- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼ 0.4 ( 0.3- 0.5)
Endocrine System 13.4 ( 13.2- 13.6) 13.9 ( 13.6- 14.1) 8.7 ( 8.2- 9.1) 13.4 ( 12.5- 14.3) 5.6 ( 4.4- 7.2) 12.4 ( 11.8- 13.0)
Thyroid 12.7 ( 12.5- 12.9) 13.2 ( 13.0- 13.5) 7.9 ( 7.5- 8.3) 12.5 ( 11.7- 13.4) 5.2 ( 4.0- 6.8) 11.8 ( 11.3- 12.4)
Other Endocrine including Thymus 0.7 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 0.8 ( 0.7- 0.9) 0.8 ( 0.6- 1.1) ∼ 0.5 ( 0.4- 0.7)
Lymphomas 18.3 ( 18.0- 18.5) 18.7 ( 18.5- 19.0) 13.2 ( 12.6- 13.7) 11.6 ( 10.7- 12.6) 10.9 ( 8.8- 13.3) 16.4 ( 15.7- 17.2)
Hodgkin Lymphoma 2.4 ( 2.4- 2.5) 2.5 ( 2.4- 2.6) 2.2 ( 2.0- 2.4) 0.8 ( 0.6- 1.1) ∼ 2.1 ( 1.8- 2.3)
Non-Hodgkin Lymphoma 15.8 ( 15.6- 16.0) 16.2 ( 16.0- 16.4) 11.0 ( 10.5- 11.5) 10.8 ( 9.9- 11.8) 9.9 ( 7.9- 12.3) 14.4 ( 13.7- 15.1)
Myeloma 4.3 ( 4.2- 4.4) 3.8 ( 3.7- 3.9) 8.8 ( 8.3- 9.3) 2.6 ( 2.2- 3.1) 2.5 ( 1.6- 3.9) 4.7 ( 4.3- 5.1)
Leukemias 9.1 ( 8.9- 9.2) 9.2 ( 9.1- 9.4) 6.9 ( 6.5- 7.4) 5.5 ( 4.9- 6.2) 6.3 ( 4.7- 8.1) 8.0 ( 7.5- 8.5)
Acute Lymphocytic 1.2 ( 1.2- 1.3) 1.3 ( 1.2- 1.4) 0.6 ( 0.5- 0.7) 1.2 ( 0.9- 1.5) ∼ 1.8 ( 1.6- 2.0)
Chronic Lymphocytic 2.6 ( 2.5- 2.7) 2.6 ( 2.5- 2.7) 1.7 ( 1.5- 1.9) 0.6 ( 0.4- 0.9) 1.8 ( 1.0- 3.0) 1.3 ( 1.1- 1.6)
Acute Myeloid 3.0 ( 2.9- 3.1) 3.1 ( 3.0- 3.2) 2.6 ( 2.3- 2.8) 2.4 ( 2.0- 2.9) 2.3 ( 1.4- 3.6) 2.9 ( 2.6- 3.3)
Chronic Myeloid 1.0 ( 1.0- 1.1) 1.0 ( 1.0- 1.1) 1.0 ( 0.8- 1.1) 0.6 ( 0.4- 0.9) ∼ 1.0 ( 0.8- 1.2)
Other Leukemias 1.2 ( 1.2- 1.3) 1.2 ( 1.2- 1.3) 1.1 ( 0.9- 1.3) 0.7 ( 0.5- 1.0) ∼ 1.0 ( 0.8- 1.2)
Mesothelioma 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.1- 0.3) ∼ ∼ 0.5 ( 0.3- 0.6)
Kaposi Sarcoma 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.3 ( 0.2- 0.3) ∼ ∼ 0.3 ( 0.2- 0.4)
Miscellaneous 14.2 ( 14.0- 14.3) 13.9 ( 13.7- 14.1) 15.2 ( 14.6- 15.8) 9.6 ( 8.8- 10.6) 8.7 ( 6.8- 11.0) 13.6 ( 12.9- 14.4)
Breast, in situ ‡‡ 28.4 ( 28.1- 28.6) 28.6 ( 28.3- 28.9) 24.8 ( 24.0- 25.5) 22.0 ( 20.8- 23.2) 11.1 ( 9.2- 13.5) 18.8 ( 18.0- 19.6)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix C for data
quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
¶ Excludes some endometrial cancers; papillary ependymomas and papillary meningiomas; chronic myeloproliferative diseases; and myelodysplastic syndromes. These cancers are
newly classified and reported as malignant cancers according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∗∗ Ovary excludes cancers newly classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
†† Includes invasive and in situ.
‡‡ Rates for in situ female breast cancer are listed separately and are not included in rates for the "all sites" category.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.2M: Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by Primary Site and
Race and Ethnicity, United States†
Males, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 234.1 (233.3-235.0) 230.6 (229.7-231.6) 311.4 (307.9-315.0) 138.4 (134.5-142.3) 142.3 (133.2-152.0) 158.1 (155.1-161.1)
Oral Cavity and Pharynx 4.1 ( 3.9- 4.2) 3.8 ( 3.7- 3.9) 6.9 ( 6.4- 7.4) 3.7 ( 3.1- 4.3) 2.1 ( 1.1- 3.7) 2.7 ( 2.3- 3.1)
Lip 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Tongue 0.9 ( 0.9- 1.0) 0.9 ( 0.9- 1.0) 1.3 ( 1.1- 1.5) 0.5 ( 0.3- 0.8) ∼ 0.7 ( 0.5- 0.9)
Salivary Gland 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Floor of Mouth 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Gum and Other Mouth 0.5 ( 0.5- 0.6) 0.5 ( 0.4- 0.5) 0.8 ( 0.7- 1.0) ∼ ∼ 0.3 ( 0.2- 0.4)
Nasopharynx 0.3 ( 0.3- 0.3) 0.2 ( 0.2- 0.3) 0.5 ( 0.3- 0.6) 1.6 ( 1.2- 2.0) ∼ 0.2 ( 0.1- 0.4)
Tonsil 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.5 ( 0.4- 0.7) ∼ ∼ 0.2 ( 0.1- 0.3)
Oropharynx 0.4 ( 0.3- 0.4) 0.3 ( 0.3- 0.3) 0.8 ( 0.6- 1.0) ∼ ∼ 0.3 ( 0.2- 0.5)
Hypopharynx 0.2 ( 0.2- 0.2) 0.2 ( 0.1- 0.2) 0.4 ( 0.3- 0.6) ∼ ∼ ∼
Other Oral Cavity and Pharynx 0.9 ( 0.9- 1.0) 0.8 ( 0.8- 0.9) 2.2 ( 1.9- 2.5) ∼ ∼ 0.8 ( 0.6- 1.0)
Digestive System 58.0 ( 57.6- 58.4) 55.9 ( 55.4- 56.3) 81.6 ( 79.9- 83.5) 53.1 ( 50.7- 55.5) 42.8 ( 38.0- 48.3) 51.6 ( 50.0- 53.3)
Esophagus 7.7 ( 7.6- 7.9) 7.7 ( 7.5- 7.9) 9.7 ( 9.1- 10.3) 3.2 ( 2.7- 3.9) 4.4 ( 3.0- 6.4) 3.9 ( 3.4- 4.3)
Stomach 5.7 ( 5.6- 5.8) 5.0 ( 4.9- 5.1) 11.4 ( 10.8- 12.1) 10.4 ( 9.3- 11.5) 6.5 ( 4.6- 8.9) 8.6 ( 7.9- 9.3)
Small Intestine 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.4) 0.7 ( 0.6- 0.9) ∼ ∼ 0.4 ( 0.2- 0.5)
Colon and Rectum 23.0 ( 22.7- 23.2) 22.4 ( 22.1- 22.7) 32.1 ( 31.0- 33.3) 14.0 ( 12.8- 15.3) 15.4 ( 12.4- 19.0) 16.9 ( 16.0- 17.9)
Colon excluding Rectum 19.2 ( 18.9- 19.4) 18.7 ( 18.4- 18.9) 27.5 ( 26.4- 28.6) 11.3 ( 10.2- 12.4) 12.8 ( 10.1- 16.2) 13.9 ( 13.0- 14.8)
Rectum and Rectosigmoid Junction 3.8 ( 3.7- 3.9) 3.7 ( 3.6- 3.9) 4.6 ( 4.2- 5.1) 2.7 ( 2.2- 3.4) 2.5 ( 1.5- 4.2) 3.0 ( 2.6- 3.5)
Anus, Anal Canal and Anorectum 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 7.4 ( 7.2- 7.5) 6.7 ( 6.6- 6.9) 10.3 ( 9.7- 10.9) 15.6 ( 14.4- 16.9) 7.6 ( 5.8- 10.0) 11.0 ( 10.2- 11.7)
Gallbladder 0.5 ( 0.5- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.7 ( 0.4- 1.1) ∼ 0.7 ( 0.5- 0.9)
Other Biliary 0.6 ( 0.6- 0.6) 0.6 ( 0.6- 0.6) 0.5 ( 0.3- 0.6) 0.8 ( 0.5- 1.2) ∼ 0.5 ( 0.3- 0.7)
Pancreas 12.0 ( 11.9- 12.2) 11.9 ( 11.7- 12.1) 15.5 ( 14.7- 16.3) 7.7 ( 6.8- 8.7) 6.1 ( 4.4- 8.4) 9.2 ( 8.5- 10.0)
Retroperitoneum 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Other Digestive Organs 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.6 ( 0.5- 0.8) ∼ ∼ 0.4 ( 0.2- 0.6)
Respiratory System 74.7 ( 74.2- 75.1) 73.8 ( 73.3- 74.3) 98.7 ( 96.7-100.7) 39.2 ( 37.2- 41.4) 40.0 ( 35.4- 45.2) 36.9 ( 35.5- 38.4)
Nose, Nasal Cavity and Middle Ear 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Larynx 2.4 ( 2.3- 2.4) 2.2 ( 2.1- 2.2) 5.1 ( 4.7- 5.6) 0.8 ( 0.5- 1.1) ∼ 1.9 ( 1.6- 2.3)
Lung and Bronchus 71.9 ( 71.4- 72.4) 71.2 ( 70.7- 71.7) 93.1 ( 91.2- 95.0) 38.2 ( 36.2- 40.3) 38.3 ( 33.8- 43.4) 34.8 ( 33.4- 36.2)
Pleura 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Bones and Joints 0.5 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.7) 0.3 ( 0.2- 0.5) ∼ 0.5 ( 0.4- 0.7)
Soft Tissue including Heart 1.4 ( 1.3- 1.5) 1.4 ( 1.3- 1.5) 1.5 ( 1.3- 1.8) 0.6 ( 0.4- 0.9) ∼ 0.9 ( 0.7- 1.2)
Skin excluding Basal and Squamous 5.3 ( 5.1- 5.4) 5.8 ( 5.7- 6.0) 1.1 ( 0.9- 1.4) 0.9 ( 0.6- 1.3) ∼ 1.8 ( 1.5- 2.1)
Melanomas of the Skin 3.9 ( 3.8- 4.0) 4.4 ( 4.3- 4.5) 0.4 ( 0.3- 0.6) 0.6 ( 0.3- 0.9) ∼ 1.0 ( 0.8- 1.3)
Other Non-Epithelial Skin 1.4 ( 1.3- 1.4) 1.5 ( 1.4- 1.5) 0.7 ( 0.6- 0.9) ∼ ∼ 0.7 ( 0.5- 1.0)
Breast 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.5 ( 0.3- 0.6) ∼ ∼ ∼
Male Genital System 27.0 ( 26.7- 27.3) 25.0 ( 24.7- 25.3) 58.6 ( 56.9- 60.3) 11.2 ( 10.0- 12.5) 18.4 ( 14.8- 22.6) 20.9 ( 19.7- 22.2)
Prostate 26.6 ( 26.3- 26.9) 24.5 ( 24.2- 24.8) 58.0 ( 56.4- 59.7) 11.0 ( 9.8- 12.3) 18.2 ( 14.6- 22.4) 20.4 ( 19.2- 21.6)
Testis 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ 0.2 ( 0.2- 0.3)
Penis 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.4 ( 0.2- 0.5) ∼ ∼ 0.3 ( 0.2- 0.5)
Other Male Genital Organs 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
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Table 1.1.1.2M: Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by Primary Site and
Race and Ethnicity, United States† (continued)
Males, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Urinary System 13.7 ( 13.5- 13.9) 14.2 ( 14.0- 14.4) 11.7 ( 11.0- 12.4) 5.3 ( 4.6- 6.2) 7.9 ( 5.9- 10.4) 9.2 ( 8.5- 10.0)
Urinary Bladder 7.4 ( 7.2- 7.5) 7.7 ( 7.5- 7.9) 5.4 ( 5.0- 6.0) 2.6 ( 2.1- 3.3) 2.4 ( 1.3- 4.2) 4.1 ( 3.6- 4.6)
Kidney and Renal Pelvis 6.1 ( 5.9- 6.2) 6.2 ( 6.0- 6.3) 6.1 ( 5.6- 6.6) 2.5 ( 2.0- 3.1) 5.5 ( 4.0- 7.6) 5.1 ( 4.5- 5.6)
Ureter 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Other Urinary Organs 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼ ∼
Eye and Orbit 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Brain and Other Nervous System 5.4 ( 5.2- 5.5) 5.7 ( 5.6- 5.9) 3.4 ( 3.1- 3.7) 2.3 ( 1.9- 2.9) 2.7 ( 1.6- 4.4) 3.3 ( 2.9- 3.7)
Endocrine System 0.7 ( 0.7- 0.8) 0.8 ( 0.7- 0.8) 0.6 ( 0.5- 0.8) 0.6 ( 0.4- 0.9) ∼ 0.7 ( 0.6- 1.0)
Thyroid 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.3 ( 0.2- 0.4) ∼ ∼ 0.5 ( 0.3- 0.7)
Other Endocrine including Thymus 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼ 0.2 ( 0.2- 0.4)
Lymphoma 9.9 ( 9.7- 10.0) 10.3 ( 10.1- 10.5) 6.3 ( 5.8- 6.8) 6.4 ( 5.6- 7.3) 4.3 ( 2.9- 6.2) 6.9 ( 6.3- 7.5)
Hodgkin Lymphoma 0.5 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼ 0.5 ( 0.3- 0.7)
Non-Hodgkin Lymphoma 9.3 ( 9.1- 9.5) 9.7 ( 9.5- 9.9) 5.8 ( 5.4- 6.3) 6.0 ( 5.2- 6.9) 3.8 ( 2.6- 5.7) 6.4 ( 5.8- 7.0)
Myeloma 4.6 ( 4.5- 4.7) 4.3 ( 4.2- 4.5) 8.4 ( 7.8- 9.0) 1.7 ( 1.3- 2.2) 3.6 ( 2.2- 5.8) 3.2 ( 2.8- 3.6)
Leukemias 9.9 ( 9.8- 10.1) 10.3 ( 10.1- 10.5) 8.4 ( 7.8- 9.0) 4.1 ( 3.5- 4.8) 3.6 ( 2.4- 5.4) 6.3 ( 5.7- 6.9)
Acute Lymphocytic 0.6 ( 0.6- 0.7) 0.6 ( 0.6- 0.7) 0.5 ( 0.4- 0.7) 0.3 ( 0.2- 0.5) ∼ 0.8 ( 0.7- 1.0)
Chronic Lymphocytic 2.2 ( 2.1- 2.3) 2.3 ( 2.2- 2.4) 1.8 ( 1.6- 2.1) 0.5 ( 0.3- 0.8) ∼ 0.9 ( 0.7- 1.2)
Acute Myeloid 3.6 ( 3.5- 3.7) 3.8 ( 3.7- 3.9) 2.8 ( 2.5- 3.1) 1.6 ( 1.3- 2.1) ∼ 2.4 ( 2.1- 2.8)
Chronic Myeloid 0.6 ( 0.5- 0.6) 0.5 ( 0.5- 0.6) 0.8 ( 0.6- 1.0) ∼ ∼ 0.4 ( 0.2- 0.5)
Other Leukemias 2.9 ( 2.8- 3.0) 3.0 ( 2.9- 3.1) 2.5 ( 2.1- 2.8) 1.5 ( 1.1- 2.0) ∼ 1.8 ( 1.5- 2.2)
Mesothelioma 1.7 ( 1.6- 1.7) 1.8 ( 1.7- 1.9) 0.9 ( 0.7- 1.1) 0.5 ( 0.3- 0.8) ∼ 1.1 ( 0.9- 1.4)
Miscellaneous 16.9 ( 16.6- 17.1) 16.6 ( 16.4- 16.9) 22.3 ( 21.3- 23.2) 8.3 ( 7.3- 9.3) 12.9 ( 10.2- 16.2) 11.8 ( 11.0- 12.7)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Table 1.1.1.2F: Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by Primary Site and
Race and Ethnicity, United States†
Females, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
All Sites 160.5 (159.9-161.1) 159.7 (159.1-160.4) 188.2 (186.1-190.4) 97.3 ( 94.6-100.1) 106.8 (100.3-113.7) 106.3 (104.3-108.4)
Oral Cavity and Pharynx 1.5 ( 1.4- 1.5) 1.4 ( 1.4- 1.5) 1.6 ( 1.5- 1.9) 1.2 ( 0.9- 1.6) 1.8 ( 1.0- 2.9) 0.9 ( 0.7- 1.1)
Lip 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Tongue 0.4 ( 0.4- 0.4) 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.6) ∼ 0.3 ( 0.2- 0.4)
Salivary Gland 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) 0.2 ( 0.1- 0.2) ∼ ∼ ∼
Floor of Mouth 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Gum and Other Mouth 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Nasopharynx 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) 0.5 ( 0.3- 0.7) ∼ ∼
Tonsil 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼
Oropharynx 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼ ∼
Hypopharynx 0.0 ( 0.0- 0.1) 0.0 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Other Oral Cavity and Pharynx 0.3 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) 0.4 ( 0.3- 0.5) ∼ ∼ ∼
Digestive System 35.5 ( 35.2- 35.8) 33.9 ( 33.7- 34.2) 50.0 ( 48.9- 51.2) 33.5 ( 31.9- 35.2) 25.2 ( 22.1- 28.7) 32.0 ( 30.9- 33.2)
Esophagus 1.7 ( 1.7- 1.8) 1.7 ( 1.6- 1.7) 2.9 ( 2.6- 3.2) 0.6 ( 0.4- 0.9) ∼ 1.0 ( 0.8- 1.2)
Stomach 3.0 ( 2.9- 3.0) 2.6 ( 2.5- 2.7) 5.4 ( 5.1- 5.8) 6.1 ( 5.4- 6.8) 3.2 ( 2.2- 4.6) 5.0 ( 4.6- 5.5)
Small Intestine 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) 0.4 ( 0.4- 0.6) ∼ ∼ 0.3 ( 0.2- 0.4)
Colon and Rectum 16.1 ( 15.9- 16.2) 15.5 ( 15.3- 15.7) 22.7 ( 22.0- 23.5) 10.7 ( 9.8- 11.7) 9.7 ( 7.7- 12.0) 10.8 ( 10.2- 11.5)
Colon excluding Rectum 13.8 ( 13.7- 14.0) 13.3 ( 13.1- 13.5) 20.1 ( 19.4- 20.8) 9.0 ( 8.2- 9.9) 7.9 ( 6.2- 10.0) 9.3 ( 8.7- 9.9)
Rectum and Rectosigmoid Junction 2.2 ( 2.2- 2.3) 2.2 ( 2.1- 2.3) 2.7 ( 2.4- 2.9) 1.7 ( 1.4- 2.1) 1.8 ( 1.0- 2.9) 1.5 ( 1.3- 1.8)
Anus, Anal Canal and Anorectum 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Liver and Intrahepatic Bile Duct 3.1 ( 3.0- 3.2) 2.8 ( 2.8- 2.9) 4.0 ( 3.7- 4.3) 7.4 ( 6.6- 8.2) 3.2 ( 2.2- 4.5) 5.2 ( 4.7- 5.7)
Gallbladder 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 0.8) 0.8 ( 0.7- 1.0) 0.8 ( 0.6- 1.1) ∼ 1.2 ( 1.0- 1.4)
Other Biliary 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.5) 0.6 ( 0.4- 0.8) ∼ 0.4 ( 0.3- 0.6)
Pancreas 9.2 ( 9.1- 9.4) 9.0 ( 8.8- 9.1) 12.5 ( 11.9- 13.0) 6.7 ( 6.0- 7.5) 5.2 ( 3.8- 6.9) 7.4 ( 6.9- 8.0)
Retroperitoneum 0.1 ( 0.0- 0.1) 0.1 ( 0.0- 0.1) ∼ ∼ ∼ ∼
Peritoneum, Omentum and Mesentery 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.2 ( 0.2- 0.3) ∼ ∼ 0.2 ( 0.2- 0.4)
Other Digestive Organs 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.5) ∼ ∼ 0.3 ( 0.2- 0.4)
Respiratory System 41.9 ( 41.6- 42.2) 42.9 ( 42.5- 43.2) 41.2 ( 40.2- 42.2) 19.1 ( 17.9- 20.3) 26.9 ( 23.6- 30.5) 15.2 ( 14.4- 16.0)
Nose, Nasal Cavity and Middle Ear 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Larynx 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.7 ( 0.6- 0.9) ∼ ∼ ∼
Lung and Bronchus 41.2 ( 40.9- 41.6) 42.2 ( 41.9- 42.6) 40.3 ( 39.3- 41.3) 18.9 ( 17.7- 20.1) 26.6 ( 23.3- 30.2) 14.9 ( 14.2- 15.7)
Pleura 0.0 ( 0.0- 0.0) 0.0 ( 0.0- 0.0) ∼ ∼ ∼ ∼
Trachea and Other Respiratory Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Bones and Joints 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼ 0.3 ( 0.2- 0.4)
Soft Tissue including Heart 1.1 ( 1.1- 1.2) 1.1 ( 1.1- 1.2) 1.4 ( 1.2- 1.6) 0.5 ( 0.3- 0.7) ∼ 0.8 ( 0.7- 1.0)
Skin excluding Basal and Squamous 2.2 ( 2.1- 2.2) 2.4 ( 2.3- 2.5) 0.7 ( 0.6- 0.8) 0.3 ( 0.2- 0.6) ∼ 0.8 ( 0.6- 1.0)
Melanomas of the Skin 1.7 ( 1.7- 1.8) 2.0 ( 1.9- 2.0) 0.4 ( 0.3- 0.6) ∼ ∼ 0.6 ( 0.4- 0.8)
Other Non-Epithelial Skin 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.2- 0.3) ∼ ∼ 0.2 ( 0.1- 0.3)
Breast 25.2 ( 24.9- 25.4) 24.6 ( 24.3- 24.8) 34.1 ( 33.2- 35.0) 12.6 ( 11.7- 13.6) 14.3 ( 12.0- 16.9) 16.1 ( 15.4- 16.9)
Female Genital System 16.4 ( 16.2- 16.5) 16.2 ( 16.0- 16.4) 20.1 ( 19.4- 20.8) 10.2 ( 9.4- 11.1) 10.0 ( 8.1- 12.3) 12.6 ( 12.0- 13.3)
Cervix 2.5 ( 2.4- 2.6) 2.2 ( 2.2- 2.3) 4.7 ( 4.3- 5.0) 2.4 ( 2.0- 2.9) 2.7 ( 1.8- 3.9) 3.0 ( 2.7- 3.3)
Corpus 2.0 ( 1.9- 2.0) 1.9 ( 1.8- 1.9) 3.3 ( 3.0- 3.6) 0.8 ( 0.6- 1.1) ∼ 1.2 ( 1.0- 1.4)
Uterus, NOS 2.2 ( 2.1- 2.2) 2.0 ( 1.9- 2.1) 3.8 ( 3.5- 4.1) 1.7 ( 1.4- 2.1) ∼ 1.8 ( 1.6- 2.1)
Ovary 8.8 ( 8.7- 9.0) 9.2 ( 9.0- 9.3) 7.5 ( 7.0- 7.9) 5.0 ( 4.4- 5.6) 6.2 ( 4.7- 8.1) 6.0 ( 5.5- 6.5)
continued
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Table 1.1.1.2F: Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by Primary Site and
Race and Ethnicity, United States† (continued)
Females, 2003
Asian/Paciﬁc American Indian/
Primary Site All Races White Black Islander‡ Alaska Native‡ Hispanic‡§
Vagina 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.4 ( 0.3- 0.5) ∼ ∼ 0.2 ( 0.1- 0.3)
Vulva 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.2 ( 0.2- 0.3) ∼ ∼ 0.3 ( 0.2- 0.4)
Other Female Genital Organs 0.2 ( 0.2- 0.2) 0.2 ( 0.2- 0.2) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.2)
Urinary System 5.1 ( 5.0- 5.2) 5.2 ( 5.1- 5.3) 5.6 ( 5.3- 6.0) 2.0 ( 1.6- 2.4) 4.7 ( 3.4- 6.3) 4.1 ( 3.7- 4.5)
Urinary Bladder 2.2 ( 2.1- 2.3) 2.2 ( 2.1- 2.3) 2.7 ( 2.4- 2.9) 0.8 ( 0.6- 1.2) ∼ 1.4 ( 1.1- 1.6)
Kidney and Renal Pelvis 2.7 ( 2.7- 2.8) 2.8 ( 2.7- 2.9) 2.7 ( 2.5- 3.0) 1.1 ( 0.8- 1.5) 3.2 ( 2.1- 4.6) 2.6 ( 2.3- 3.0)
Ureter 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Other Urinary Organs 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.2 ( 0.1- 0.2) ∼ ∼ ∼
Eye and Orbit 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼ ∼ ∼
Brain and Other Nervous System 3.6 ( 3.5- 3.7) 3.9 ( 3.8- 4.0) 2.1 ( 1.9- 2.3) 1.5 ( 1.2- 1.9) 1.5 ( 0.9- 2.5) 2.4 ( 2.1- 2.7)
Endocrine System 0.7 ( 0.7- 0.8) 0.7 ( 0.7- 0.8) 0.7 ( 0.6- 0.9) 0.8 ( 0.6- 1.1) ∼ 0.8 ( 0.6- 1.0)
Thyroid 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.6 ( 0.4- 0.9) ∼ 0.5 ( 0.4- 0.7)
Other Endocrine including Thymus 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Lymphoma 6.3 ( 6.1- 6.4) 6.5 ( 6.4- 6.6) 4.5 ( 4.2- 4.9) 4.3 ( 3.8- 5.0) 4.2 ( 3.0- 5.8) 5.0 ( 4.6- 5.5)
Hodgkin Lymphoma 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼ 0.3 ( 0.2- 0.4)
Non-Hodgkin Lymphoma 5.9 ( 5.8- 6.0) 6.1 ( 6.0- 6.2) 4.3 ( 3.9- 4.6) 4.2 ( 3.6- 4.8) 3.6 ( 2.5- 5.1) 4.7 ( 4.3- 5.2)
Myeloma 3.1 ( 3.0- 3.2) 2.8 ( 2.7- 2.9) 6.3 ( 5.9- 6.7) 1.3 ( 1.0- 1.6) 3.4 ( 2.3- 5.0) 2.7 ( 2.4- 3.1)
Leukemias 5.6 ( 5.5- 5.7) 5.7 ( 5.6- 5.8) 5.3 ( 4.9- 5.6) 3.2 ( 2.7- 3.7) 3.8 ( 2.6- 5.3) 4.2 ( 3.8- 4.6)
Acute Lymphocytic 0.4 ( 0.3- 0.4) 0.4 ( 0.4- 0.4) 0.2 ( 0.2- 0.3) 0.4 ( 0.2- 0.6) ∼ 0.6 ( 0.4- 0.7)
Chronic Lymphocytic 1.0 ( 1.0- 1.1) 1.1 ( 1.0- 1.1) 1.0 ( 0.9- 1.2) ∼ ∼ 0.4 ( 0.3- 0.6)
Acute Myeloid 2.2 ( 2.1- 2.3) 2.3 ( 2.2- 2.3) 1.9 ( 1.7- 2.2) 1.5 ( 1.2- 1.9) ∼ 1.6 ( 1.3- 1.8)
Chronic Myeloid 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼ 0.2 ( 0.1- 0.3)
Other Leukemias 1.7 ( 1.6- 1.7) 1.7 ( 1.6- 1.8) 1.7 ( 1.5- 1.9) 1.0 ( 0.7- 1.3) ∼ 1.4 ( 1.2- 1.7)
Mesothelioma 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) ∼ ∼ ∼ 0.2 ( 0.1- 0.4)
Miscellaneous 11.7 ( 11.5- 11.9) 11.6 ( 11.4- 11.8) 14.1 ( 13.5- 14.7) 6.4 ( 5.7- 7.1) 8.1 ( 6.3- 10.2) 8.1 ( 7.6- 8.7)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska Native).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (site, race, ethnicity).
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Figure 2: Geographic Areas Contributing Data to 
United States Cancer Statistics: 2003 Incidence and Mortality, 
by U.S. Census Region and Division 
State contributing
mortality data
State contributing
incidence and 
mortality data
Note: Shaded areas represent statewide and metropolitan cancer registries that met the following data quality criteria for cancer 
incidence: case ascertainment is at least 90% complete; > 97% of cases pass a standard set of computerized edits; < 5% of cases 
were ascertained by death certificate only; < 3% of cases are missing information on sex; < 5% of cases are missing information on 
race; < 3% of cases are missing information on age.  See Appendix C for registry-specific data quality information.  Incidence data
cover approximately 96% of the U.S. population.  Mortality data are from the National Vital Statistics System and cover 100% of the 
U.S. population.
U.S. Census regions and divisions that met criteria for display of region-specific incidence rates in Table 2 series. 
All U.S. Census regions and divisions met criteria for display of region-specific death rates.
Table 2.1.1.1M: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 541.8 (540.5- 543.1) 530.9 (529.5- 532.3) 611.0 (606.1- 615.8) 421.1 (416.4- 425.9)
United States (excl. newly classified as malignant)¶ 534.9 (533.6- 536.2) 523.8 (522.5- 525.2) 606.0 (601.3- 610.9) 415.1 (410.5- 419.8)
Northeast 572.4 (569.5- 575.4) 565.9 (562.8- 569.0) 599.5 (588.7- 610.4) 476.1 (463.5- 489.0)
New England 574.7 (569.0- 580.6) 573.6 (567.7- 579.6) 538.3 (508.3- 570.0) 452.7 (419.1- 488.9)
Connecticut 574.5 (562.9- 586.3) 576.6 (564.5- 589.0) 569.9 (523.0- 621.3) 451.1 (398.7- 510.0)
Maine 602.0 (583.3- 621.1) 599.6 (580.9- 618.8) ∼ ∼
Massachusetts 571.6 (562.9- 580.3) 572.3 (563.4- 581.4) 517.1 (475.2- 562.5) 409.9 (364.0- 461.3)
New Hampshire 558.6 (539.4- 578.4) 537.8 (518.9- 557.4) ∼ 990.8 (634.3-1502.7)
Rhode Island 589.0 (567.9- 610.7) 590.8 (569.1- 613.2) 563.5 (450.6- 704.7) 544.2 (424.5- 692.1)
Vermont 565.0 (538.0- 593.0) 564.9 (537.9- 593.2) ∼ ∼
Middle Atlantic 571.7 (568.2- 575.1) 562.8 (559.1- 566.5) 606.7 (595.2- 618.3) 479.6 (466.1- 493.5)
New Jersey 595.1 (587.4- 602.8) 585.5 (577.3- 593.8) 656.8 (630.5- 684.2) 486.8 (459.7- 515.5)
New York 554.6 (549.5- 559.6) 549.3 (543.8- 554.8) 560.0 (545.3- 575.1) 481.7 (465.1- 498.9)
Pennsylvania 581.0 (575.0- 587.0) 566.6 (560.5- 572.8) 677.6 (652.8- 703.2) -
Midwest 549.7 (547.0- 552.4) 529.1 (526.3- 531.8) 641.2 (630.0- 652.5) 388.5 (371.8- 406.0)
East North Central 554.8 (551.5- 558.1) 530.6 (527.2- 534.0) 647.7 (635.5- 660.1) 392.7 (373.9- 412.5)
Illinois 568.2 (561.7- 574.7) 550.6 (543.7- 557.5) 630.9 (610.3- 652.1) -
Indiana 532.6 (523.8- 541.5) 517.6 (508.7- 526.7) 610.6 (572.6- 650.9) 381.5 (323.7- 449.7)
Michigan 598.5 (591.2- 605.8) 566.6 (559.1- 574.2) 744.9 (719.4- 771.1) 387.5 (340.3- 441.3)
Detroit 645.7 (633.6- 658.0) 615.2 (601.8- 628.7) 770.4 (740.4- 801.4) 416.5 (343.0- 505.2)
Ohio 522.5 (516.3- 528.8) 487.9 (481.6- 494.3) 568.6 (546.5- 591.6) 504.8 (441.6- 576.8)
Wisconsin 541.2 (532.1- 550.4) 531.9 (522.8- 541.3) 750.8 (683.6- 825.2) 390.0 (320.2- 473.8)
West North Central 538.8 (534.0- 543.6) 526.3 (521.5- 531.2) 605.4 (577.5- 634.4) 371.9 (335.7- 411.8)
Iowa 536.1 (524.3- 548.2) 520.8 (509.0- 532.8) 521.8 (416.4- 654.0) 390.7 (290.4- 521.7)
Kansas 549.6 (536.6- 562.9) 530.7 (517.5- 544.1) 617.5 (544.9- 698.0) 399.4 (331.5- 480.2)
Minnesota 556.5 (546.7- 566.5) 542.0 (532.1- 552.1) 636.3 (545.6- 742.2) 391.0 (300.5- 504.1)
Missouri 523.5 (514.7- 532.3) 515.9 (506.8- 525.1) 602.5 (567.9- 639.1) 345.1 (276.4- 430.9)
Nebraska 534.4 (518.5- 550.7) 516.9 (501.0- 533.3) 634.1 (519.3- 771.4) 330.8 (246.2- 442.6)
North Dakota 514.2 (489.5- 540.0) 512.6 (487.6- 538.7) ∼ ∼
South Dakota 547.7 (524.2- 572.1) 545.1 (521.2- 570.0) ∼ ∼
South
South Atlantic 534.0 (531.1- 536.9) 520.7 (517.6- 523.8) 602.7 (594.3- 611.2) 458.4 (447.0- 470.1)
Delaware 565.4 (541.6- 590.2) 534.6 (509.6- 560.7) 710.3 (633.4- 796.2) 497.7 (333.5- 738.1)
District of Columbia 569.7 (539.1- 601.6) 481.0 (433.6- 533.6) 604.2 (564.4- 646.3) 363.3 (235.9- 548.3)
Florida 529.9 (525.2- 534.5) 527.7 (522.8- 532.6) 558.9 (541.4- 577.0) -
Georgia 555.1 (546.5- 563.8) 537.4 (527.9- 547.0) 634.3 (613.6- 655.6) 282.1 (237.1- 335.2)
Atlanta 537.6 (521.8- 554.0) 511.9 (493.8- 530.7) 632.1 (596.3- 670.2) 270.4 (203.6- 357.3)
Maryland 556.1 (546.4- 565.9) 538.8 (527.9- 549.9) 591.1 (568.5- 614.7) 420.5 (359.2- 490.5)
North Carolina 510.7 (503.2- 518.3) 492.3 (484.2- 500.5) 606.7 (586.0- 628.1) 329.1 (274.5- 393.8)
South Carolina 556.5 (545.6- 567.6) 532.9 (520.7- 545.3) 627.9 (602.7- 654.1) -
Virginia 524.3 (516.1- 532.6) 502.8 (493.9- 511.8) 613.2 (590.4- 636.8) 363.3 (309.5- 425.7)
West Virginia 539.2 (524.3- 554.4) 538.9 (523.8- 554.4) 546.7 (453.1- 655.8) 380.8 (221.5- 621.0)
East South Central
Alabama 522.5 (512.4- 532.7) 509.2 (498.1- 520.5) 540.5 (516.9- 565.1) 335.3 (250.0- 445.7)
Kentucky 589.6 (578.3- 601.1) 578.2 (566.7- 590.0) 676.3 (623.6- 733.1) -
Mississippi 547.6 (534.3- 561.2) 514.9 (499.9- 530.4) 637.2 (608.8- 666.8) 248.8 (158.9- 379.4)
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Table 2.1.1.1M: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
Tennessee
West South Central 540.2 (536.1- 544.3) 522.9 (518.6- 527.2) 641.4 (627.5- 655.6) 404.0 (394.1- 414.2)
Arkansas 561.2 (548.3- 574.3) 552.2 (538.6- 566.1) 607.1 (564.2- 652.8) 149.4 ( 97.0- 231.2)
Louisiana 605.1 (593.8- 616.6) 583.3 (570.5- 596.4) 661.0 (636.4- 686.4) 472.3 (400.8- 556.9)
Oklahoma 553.1 (541.6- 564.9) 543.1 (531.0- 555.5) 621.4 (565.0- 682.8) 434.4 (356.0- 530.5)
Texas 519.9 (514.8- 525.0) 502.6 (497.3- 507.9) 640.2 (620.8- 660.2) 404.3 (394.1- 414.7)
West 509.4 (506.5- 512.3) 511.4 (508.3- 514.5) 573.5 (558.2- 589.3) 397.3 (389.8- 404.9)
Mountain
Arizona
Colorado 491.5 (480.9- 502.3) 476.6 (465.9- 487.5) 509.9 (444.3- 586.1) 419.5 (388.2- 453.3)
Idaho 532.4 (513.7- 551.6) 535.1 (516.2- 554.6) ∼ 543.5 (419.7- 699.7)
Montana 552.2 (530.8- 574.2) 544.7 (523.1- 567.0) ∼ 713.0 (454.2-1134.3)
Nevada 536.5 (521.7- 551.7) 541.2 (525.5- 557.4) 453.2 (395.1- 521.4) 422.4 (370.1- 482.2)
New Mexico 468.4 (453.7- 483.5) 486.1 (470.5- 502.2) 337.5 (242.7- 465.7) 387.8 (364.0- 413.0)
Utah 502.5 (486.8- 518.7) 508.9 (492.9- 525.4) 460.5 (267.7- 796.9) 459.8 (384.0- 551.1)
Wyoming
Pacific 509.9 (506.7- 513.2) 512.9 (509.3- 516.5) 590.3 (573.7- 607.4) 395.1 (386.8- 403.6)
Alaska 505.2 (471.2- 542.0) 486.3 (449.1- 527.1) 443.4 (258.4- 787.9) 326.8 (146.0- 880.6)
California 502.2 (498.5- 506.0) 506.3 (502.2- 510.5) 590.7 (573.2- 608.7) 396.0 (387.5- 404.7)
San Francisco-Oakland 499.6 (489.3- 510.1) 511.7 (499.2- 524.4) 567.8 (530.3- 607.7) 372.8 (343.4- 404.4)
San Jose-Monterey 504.1 (489.5- 519.1) 532.7 (515.7- 550.2) 562.4 (452.4- 703.3) 387.9 (354.2- 424.8)
Los Angeles 493.4 (486.1- 500.9) 487.8 (479.4- 496.4) 605.4 (579.0- 633.0) 391.6 (377.8- 405.9)
Hawaii 481.7 (464.3- 499.6) 594.8 (556.6- 635.3) 612.2 (420.5- 876.0) -
Oregon 512.8 (501.9- 523.9) 500.5 (489.5- 511.6) 601.7 (488.8- 739.2) 361.6 (298.1- 437.0)
Washington 557.2 (548.1- 566.4) 549.9 (540.5- 559.4) 599.8 (534.7- 672.8) 378.7 (329.6- 434.5)
Seattle-Puget Sound 573.1 (561.8- 584.5) 586.1 (574.1- 598.3) 589.9 (521.3- 667.6) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix C for
data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
¶ Excludes some endometrial cancers; papillary ependymomas and papillary meningiomas; chronic myeloproliferative diseases; and myelodysplastic syndromes. These
cancers are newly classified and reported as malignant cancers according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see Appendix D) for each
of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California, and Washington state rates each include cases from the SEER
metropolitan areas.
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Table 2.1.1.1F: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 403.6 (402.6- 404.6) 406.7 (405.6- 407.8) 379.1 (376.1- 382.2) 316.8 (313.4- 320.2)
United States (excl. newly classified as malignant)¶ 399.2 (398.2- 400.2) 402.3 (401.2- 403.4) 375.6 (372.6- 378.6) 312.9 (309.6- 316.3)
Northeast 432.3 (430.0- 434.6) 437.9 (435.4- 440.4) 367.5 (361.0- 374.2) 336.5 (328.2- 345.0)
New England 440.7 (436.2- 445.3) 444.0 (439.3- 448.7) 341.9 (322.5- 362.3) 337.6 (314.3- 362.5)
Connecticut 431.9 (422.9- 441.0) 439.6 (430.0- 449.3) 361.9 (331.5- 394.6) 376.2 (336.8- 419.6)
Maine 445.6 (431.1- 460.5) 444.1 (429.6- 459.1) ∼ ∼
Massachusetts 447.8 (441.0- 454.7) 453.8 (446.7- 461.0) 319.9 (293.3- 348.5) 302.4 (270.5- 337.6)
New Hampshire 437.4 (422.1- 453.1) 424.4 (409.2- 440.0) ∼ 361.8 (225.5- 572.5)
Rhode Island 430.9 (414.9- 447.5) 432.5 (415.9- 449.7) 373.4 (297.9- 465.1) 397.1 (319.5- 491.1)
Vermont 437.1 (415.7- 459.6) 436.6 (415.1- 459.2) ∼ ∼
Middle Atlantic 429.4 (426.8- 432.1) 435.6 (432.6- 438.5) 370.6 (363.6- 377.7) 336.2 (327.4- 345.3)
New Jersey 442.7 (436.9- 448.6) 451.2 (444.7- 457.8) 398.7 (382.5- 415.4) 339.7 (321.8- 358.5)
New York 421.2 (417.4- 425.0) 432.1 (427.8- 436.5) 343.2 (334.4- 352.2) 337.6 (326.9- 348.6)
Pennsylvania 433.8 (429.2- 438.5) 431.5 (426.6- 436.4) 417.8 (402.2- 433.9) -
Midwest 409.4 (407.4- 411.5) 404.9 (402.8- 407.1) 402.5 (395.3- 409.8) 317.9 (304.8- 331.6)
East North Central 410.5 (408.0- 413.0) 406.0 (403.3- 408.6) 401.1 (393.3- 409.0) 314.4 (299.8- 329.6)
Illinois 413.6 (408.8- 418.4) 414.6 (409.3- 419.9) 405.4 (392.2- 419.0) -
Indiana 399.2 (392.5- 406.0) 394.7 (387.8- 401.8) 384.7 (359.9- 411.0) 351.6 (301.3- 409.1)
Michigan 428.1 (422.6- 433.5) 422.3 (416.5- 428.2) 428.4 (412.6- 444.6) 276.2 (241.7- 315.0)
Detroit 445.7 (437.0- 454.5) 452.6 (442.5- 462.9) 434.6 (416.4- 453.5) 270.8 (218.6- 333.5)
Ohio 396.0 (391.2- 400.8) 386.3 (381.3- 391.4) 367.7 (353.1- 382.8) 412.2 (363.1- 466.8)
Wisconsin 416.6 (409.3- 423.9) 414.7 (407.3- 422.3) 434.1 (394.7- 477.0) 345.8 (287.8- 413.8)
West North Central 407.2 (403.5- 411.0) 402.9 (399.0- 406.8) 411.1 (392.6- 430.3) 335.2 (305.2- 367.7)
Iowa 416.8 (407.2- 426.5) 406.5 (396.9- 416.3) 413.1 (328.6- 514.2) 255.7 (185.7- 348.6)
Kansas 408.0 (397.8- 418.4) 398.6 (388.2- 409.3) 466.3 (414.6- 522.8) 339.1 (285.4- 401.6)
Minnesota 413.0 (405.4- 420.8) 408.6 (400.8- 416.5) 384.2 (326.4- 451.2) 320.5 (251.9- 406.4)
Missouri 404.4 (397.6- 411.4) 404.3 (397.1- 411.7) 408.7 (385.9- 432.5) 401.3 (336.0- 477.3)
Nebraska 403.3 (390.6- 416.2) 400.7 (387.8- 413.9) 346.9 (278.1- 429.1) 320.5 (243.3- 419.9)
North Dakota 373.3 (353.7- 393.8) 368.3 (348.4- 389.1) ∼ ∼
South Dakota 391.6 (373.2- 410.9) 393.4 (374.3- 413.4) ∼ ∼
South
South Atlantic 394.4 (392.2- 396.7) 398.7 (396.2- 401.2) 373.8 (368.6- 379.1) 329.4 (321.2- 337.8)
Delaware 419.8 (401.4- 438.9) 415.5 (395.3- 436.7) 440.9 (392.6- 494.1) 361.0 (236.7- 540.2)
District of Columbia 405.7 (383.5- 429.1) 391.2 (351.5- 436.1) 391.7 (365.3- 420.2) 249.0 (174.4- 351.6)
Florida 397.5 (393.7- 401.3) 402.4 (398.3- 406.5) 369.8 (358.2- 381.7) -
Georgia 395.1 (389.1- 401.2) 402.4 (395.4- 409.6) 381.9 (369.7- 394.4) 284.9 (247.1- 327.9)
Atlanta 402.0 (390.9- 413.3) 411.8 (398.1- 425.8) 400.1 (379.3- 422.0) 277.2 (223.8- 341.9)
Maryland 433.7 (426.2- 441.2) 438.9 (430.0- 447.9) 402.6 (387.9- 417.8) 331.5 (290.6- 377.4)
North Carolina 367.5 (362.0- 373.1) 371.3 (365.1- 377.7) 350.6 (338.2- 363.4) 268.7 (227.1- 317.3)
South Carolina 389.2 (381.2- 397.3) 397.7 (388.3- 407.3) 361.2 (345.9- 377.0) -
Virginia 381.1 (375.0- 387.2) 383.9 (377.0- 390.8) 369.0 (354.7- 383.8) 311.8 (273.7- 354.7)
West Virginia 412.1 (400.4- 424.1) 412.9 (401.0- 425.2) 383.6 (318.3- 459.5) 311.8 (183.0- 509.3)
East South Central
Alabama 351.3 (344.1- 358.6) 355.0 (346.7- 363.4) 336.7 (321.8- 352.1) 264.0 (198.3- 347.7)
Kentucky 437.9 (429.4- 446.5) 431.8 (423.1- 440.7) 473.9 (437.9- 512.1) -
Mississippi 360.5 (351.2- 370.1) 363.7 (352.4- 375.3) 354.0 (337.0- 371.8) 211.4 (138.0- 315.2)
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Table 2.1.1.1F: All Cancer Sites Combined. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
Tennessee
West South Central 383.8 (380.8- 386.8) 381.8 (378.5- 385.0) 392.7 (384.0- 401.5) 303.4 (296.3- 310.7)
Arkansas 368.5 (359.1- 378.2) 369.8 (359.6- 380.2) 333.9 (308.3- 361.2) 147.0 ( 95.6- 221.8)
Louisiana 398.7 (390.8- 406.8) 398.7 (389.2- 408.3) 402.4 (387.1- 418.2) 263.3 (219.5- 313.5)
Oklahoma 403.9 (395.1- 412.9) 400.1 (390.6- 409.7) 410.2 (372.7- 450.6) 383.3 (320.5- 458.1)
Texas 378.9 (375.1- 382.7) 376.7 (372.7- 380.7) 397.0 (384.9- 409.4) 304.0 (296.7- 311.5)
West 391.1 (388.8- 393.3) 401.4 (399.0- 403.9) 374.9 (364.5- 385.6) 310.2 (304.7- 315.7)
Mountain
Arizona
Colorado 399.1 (390.6- 407.6) 398.3 (389.7- 407.2) 339.5 (295.2- 389.3) 342.2 (317.8- 368.1)
Idaho 396.2 (381.4- 411.5) 398.7 (383.7- 414.2) ∼ 392.1 (300.1- 509.9)
Montana 396.3 (379.4- 413.8) 392.0 (374.7- 409.9) ∼ 319.4 (185.3- 537.9)
Nevada 411.4 (399.5- 423.6) 418.3 (405.4- 431.5) 387.3 (339.9- 440.3) 260.6 (229.6- 295.6)
New Mexico 340.4 (329.0- 352.1) 357.2 (345.0- 369.9) 255.5 (182.7- 348.8) 266.8 (249.3- 285.1)
Utah 343.0 (331.2- 355.1) 347.2 (335.1- 359.7) 352.9 (202.1- 589.7) 310.9 (258.9- 372.3)
Wyoming
Pacific 393.2 (390.7- 395.7) 405.9 (403.0- 408.8) 377.9 (366.7- 389.3) 313.4 (307.4- 319.5)
Alaska 382.6 (356.9- 409.9) 357.5 (328.9- 388.2) 363.4 (221.8- 587.3) ∼
California 382.1 (379.2- 385.0) 396.7 (393.3- 400.0) 376.1 (364.5- 388.0) 311.1 (304.9- 317.3)
San Francisco-Oakland 381.7 (373.8- 389.8) 413.1 (403.0- 423.4) 379.6 (353.9- 406.9) 278.8 (258.0- 301.0)
San Jose-Monterey 375.6 (364.5- 387.0) 399.9 (386.7- 413.4) 319.8 (252.1- 404.8) 303.1 (277.8- 330.3)
Los Angeles 370.5 (365.0- 376.0) 383.5 (377.0- 390.2) 379.0 (362.0- 396.6) 287.3 (278.1- 296.8)
Hawaii 369.5 (355.5- 384.0) 423.4 (392.7- 456.6) ∼ -
Oregon 417.7 (408.7- 426.9) 409.5 (400.3- 418.8) 423.2 (340.6- 521.6) 329.2 (277.2- 389.6)
Washington 446.8 (439.5- 454.2) 451.7 (443.9- 459.6) 397.7 (350.5- 450.0) 377.3 (335.1- 424.4)
Seattle-Puget Sound 450.8 (441.9- 459.9) 470.1 (460.4- 480.0) 382.5 (334.0- 436.8) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See Appendix C for
data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
¶ Excludes some endometrial cancers; papillary ependymomas and papillary meningiomas; chronic myeloproliferative diseases; and myelodysplastic syndromes. These
cancers are newly classified and reported as malignant cancers according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are presented for
regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and if the 95% confidence intervals
around the observed region/division rates for each of four major cancers include "bias-corrected" estimated region/division rates (see Appendix D) for each
of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California, and Washington state rates each include cases from the SEER
metropolitan areas.
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continued
Table 2.1.1.2M: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 234.1 (233.3- 235.0) 230.6 (229.7- 231.6) 311.4 (307.9- 315.0) 158.1 (155.1- 161.1)
Northeast 229.9 (228.0- 231.8) 229.5 (227.5- 231.5) 272.5 (264.9- 280.3) 158.9 (151.2- 167.0)
New England 232.0 (228.2- 235.7) 232.5 (228.7- 236.4) 267.1 (244.1- 292.0) 120.7 (102.9- 141.1)
Connecticut 224.7 (217.4- 232.2) 225.1 (217.5- 232.9) 248.9 (215.1- 287.7) 148.4 (117.1- 186.9)
Maine 243.8 (231.8- 256.4) 243.9 (231.7- 256.5) ∼ ∼
Massachusetts 235.5 (229.9- 241.3) 235.9 (230.1- 241.8) 284.1 (250.5- 321.5) 112.0 ( 87.3- 142.8)
New Hampshire 228.6 (216.0- 241.8) 230.1 (217.4- 243.5) ∼ ∼
Rhode Island 230.1 (216.9- 243.9) 230.9 (217.4- 245.1) 268.4 (185.3- 383.5) 105.3 ( 58.5- 182.2)
Vermont 223.6 (206.3- 242.1) 224.3 (206.9- 242.9) ∼ ∼
Middle Atlantic 229.2 (227.0- 231.4) 228.4 (226.0- 230.8) 273.2 (265.2- 281.5) 164.2 (155.9- 173.0)
New Jersey 234.4 (229.5- 239.4) 232.9 (227.6- 238.2) 310.4 (291.1- 330.8) 147.9 (132.6- 165.0)
New York 213.5 (210.3- 216.7) 214.9 (211.4- 218.4) 232.1 (222.2- 242.4) 170.7 (160.2- 181.7)
Pennsylvania 247.0 (243.1- 251.0) 242.1 (238.1- 246.2) 338.6 (320.6- 357.5) 161.6 (132.9- 195.7)
Midwest 241.0 (239.2- 242.8) 236.2 (234.3- 238.1) 325.0 (316.7- 333.5) 132.2 (121.9- 143.2)
East North Central 244.8 (242.6- 247.1) 239.4 (237.1- 241.8) 323.6 (314.7- 332.8) 127.9 (116.7- 140.1)
Illinois 244.9 (240.6- 249.3) 236.9 (232.4- 241.6) 333.5 (317.9- 349.8) 118.4 (104.2- 134.4)
Indiana 258.6 (252.4- 265.0) 253.8 (247.4- 260.3) 359.7 (329.5- 392.3) 88.6 ( 62.0- 126.5)
Michigan 237.3 (232.6- 242.0) 231.6 (226.7- 236.5) 301.2 (284.7- 318.5) 171.6 (139.0- 211.2)
Ohio 252.2 (247.8- 256.6) 247.7 (243.1- 252.3) 319.1 (301.9- 337.1) 169.3 (131.8- 216.4)
Wisconsin 227.8 (221.8- 233.9) 225.6 (219.6- 231.8) 351.2 (300.1- 410.4) 107.3 ( 73.3- 156.0)
West North Central 232.3 (229.1- 235.5) 229.4 (226.1- 232.7) 334.5 (312.8- 357.5) 149.0 (124.8- 177.3)
Iowa 231.8 (224.0- 239.8) 231.0 (223.1- 239.1) 341.0 (248.7- 463.2) 175.2 (102.6- 283.9)
Kansas 226.7 (218.3- 235.4) 225.3 (216.6- 234.2) 299.0 (247.7- 358.6) 138.3 ( 97.9- 192.8)
Minnesota 221.0 (214.7- 227.5) 220.0 (213.6- 226.6) 294.5 (227.0- 379.4) 165.4 (105.0- 250.9)
Missouri 250.1 (244.0- 256.4) 244.5 (238.2- 251.0) 346.5 (319.1- 376.1) 156.0 (106.9- 224.5)
Nebraska 219.0 (208.7- 229.7) 214.8 (204.5- 225.6) 414.7 (317.6- 535.9) 155.9 ( 93.2- 250.2)
North Dakota 220.8 (204.7- 238.0) 219.9 (203.7- 237.2) ∼ ∼
South Dakota 232.6 (217.3- 248.8) 230.8 (215.3- 247.2) ∼ ∼
South 246.5 (245.0- 248.0) 237.7 (236.1- 239.3) 325.7 (320.7- 330.8) 160.0 (155.2- 165.0)
South Atlantic 237.6 (235.6- 239.6) 228.8 (226.8- 230.9) 310.0 (303.6- 316.5) 152.1 (145.2- 159.3)
Delaware 246.9 (230.8- 264.0) 237.2 (220.2- 255.2) 322.4 (269.5- 384.8) ∼
District of Columbia 258.4 (237.3- 281.0) 171.4 (142.3- 206.2) 314.1 (284.9- 345.6) ∼
Florida 222.1 (219.1- 225.2) 220.2 (217.1- 223.4) 276.5 (263.3- 290.3) 166.8 (158.9- 175.0)
Georgia 250.2 (244.1- 256.3) 236.9 (230.3- 243.6) 312.2 (296.7- 328.3) 75.7 ( 50.2- 110.9)
Maryland 238.2 (231.6- 244.9) 230.3 (223.0- 237.8) 289.3 (272.3- 307.2) 79.2 ( 52.8- 115.5)
North Carolina 250.4 (245.0- 256.0) 239.7 (233.9- 245.7) 319.5 (303.7- 336.1) 57.0 ( 35.6- 89.5)
South Carolina 261.1 (253.4- 269.1) 240.9 (232.5- 249.6) 342.3 (322.8- 362.7) ∼
Virginia 247.1 (241.2- 253.0) 234.0 (227.7- 240.4) 339.7 (322.0- 358.3) 112.5 ( 82.2- 152.0)
West Virginia 262.9 (252.3- 273.9) 262.2 (251.4- 273.3) 321.3 (249.1- 409.6) ∼
East South Central 279.2 (275.3- 283.2) 269.4 (265.2- 273.6) 349.5 (337.5- 361.8) 65.0 ( 45.5- 91.8)
Alabama 275.4 (267.8- 283.1) 261.6 (253.4- 270.1) 340.0 (320.6- 360.3) ∼
Kentucky 289.6 (281.4- 298.0) 286.8 (278.4- 295.5) 358.5 (319.0- 402.3) 141.7 ( 78.5- 251.2)
Mississippi 283.8 (273.9- 294.1) 262.4 (251.2- 274.0) 353.4 (331.4- 376.4) ∼
Tennessee 273.1 (266.3- 279.9) 264.9 (257.8- 272.1) 356.2 (332.3- 381.6) ∼
West South Central 245.4 (242.6- 248.3) 237.3 (234.3- 240.3) 347.2 (336.5- 358.2) 170.2 (163.3- 177.2)
Arkansas 266.7 (257.6- 276.1) 255.9 (246.4- 265.6) 374.6 (340.3- 411.7) ∼
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Table 2.1.1.2M: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 286.6 (278.5- 294.8) 266.7 (257.8- 275.9) 361.6 (342.8- 381.3) 144.4 (102.4- 201.3)
Oklahoma 251.0 (243.0- 259.1) 252.0 (243.6- 260.7) 301.3 (260.7- 347.0) 193.5 (138.9- 267.7)
Texas 231.8 (228.3- 235.4) 225.9 (222.2- 229.6) 339.7 (324.8- 355.2) 171.5 (164.5- 178.8)
West 210.2 (208.4- 212.0) 213.8 (211.9- 215.8) 282.2 (271.1- 293.8) 160.0 (155.2- 164.9)
Mountain 211.5 (208.2- 214.8) 213.4 (210.0- 216.8) 253.5 (226.8- 283.2) 191.8 (181.5- 202.7)
Arizona 210.4 (204.6- 216.3) 213.3 (207.3- 219.4) 234.9 (188.8- 290.7) 194.1 (175.6- 214.3)
Colorado 206.5 (199.2- 213.9) 206.4 (199.0- 214.1) 274.6 (223.1- 337.7) 201.2 (178.1- 227.1)
Idaho 220.9 (208.6- 233.7) 221.9 (209.5- 234.9) ∼ 204.0 (128.6- 315.0)
Montana 217.5 (203.8- 231.9) 217.6 (203.8- 232.3) ∼ ∼
Nevada 245.0 (234.6- 255.8) 253.2 (242.1- 264.8) 233.4 (188.4- 289.7) 146.4 (114.6- 186.2)
New Mexico 209.8 (199.7- 220.4) 213.2 (202.6- 224.3) 287.2 (190.3- 421.4) 196.3 (178.6- 215.6)
Utah 173.0 (163.5- 182.9) 172.9 (163.3- 183.0) ∼ 173.4 (122.4- 242.6)
Wyoming 226.8 (206.8- 248.3) 225.4 (205.3- 247.1) ∼ 270.9 (160.1- 438.7)
Pacific 209.8 (207.7- 211.9) 214.2 (211.9- 216.6) 288.6 (276.3- 301.4) 148.8 (143.5- 154.3)
Alaska 233.8 (208.2- 262.4) 234.3 (205.6- 267.0) ∼ ∼
California 205.1 (202.7- 207.6) 209.1 (206.4- 211.8) 292.1 (279.1- 305.6) 148.3 (142.9- 153.9)
Hawaii 198.2 (187.1- 209.9) 230.6 (206.8- 256.9) ∼ 403.9 (299.2- 540.4)
Oregon 227.7 (220.3- 235.2) 228.4 (220.9- 236.1) 340.3 (252.2- 454.9) 94.8 ( 63.7- 138.5)
Washington 224.8 (218.8- 230.8) 226.7 (220.6- 233.0) 253.5 (209.3- 306.4) 141.6 (109.9- 180.9)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
U
nited States C
ancer Statistics: 2003 Incidence and M
ortality
42
Table 2.1.1.2F: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 160.5 (159.9- 161.1) 159.7 (159.1- 160.4) 188.2 (186.1- 190.4) 106.3 (104.3- 108.4)
Northeast 162.8 (161.4- 164.1) 164.1 (162.6- 165.5) 172.7 (168.1- 177.3) 98.8 ( 94.2- 103.7)
New England 163.3 (160.7- 166.0) 164.2 (161.4- 167.0) 174.8 (160.5- 190.1) 83.2 ( 71.1- 97.0)
Connecticut 154.3 (149.2- 159.7) 154.4 (149.0- 160.0) 169.9 (148.6- 193.5) 93.9 ( 73.6- 118.7)
Maine 178.1 (169.3- 187.4) 178.3 (169.4- 187.6) ∼ ∼
Massachusetts 166.1 (162.1- 170.1) 167.1 (163.0- 171.4) 187.4 (166.4- 210.4) 75.3 ( 58.9- 95.6)
New Hampshire 163.8 (154.6- 173.4) 163.7 (154.5- 173.5) ∼ ∼
Rhode Island 164.3 (154.8- 174.3) 167.4 (157.5- 177.9) 126.1 ( 81.4- 189.0) 77.1 ( 44.6- 127.8)
Vermont 153.2 (140.8- 166.6) 154.3 (141.8- 167.8) ∼ ∼
Middle Atlantic 162.6 (161.0- 164.2) 164.0 (162.3- 165.8) 172.6 (167.8- 177.5) 101.1 ( 96.1- 106.4)
New Jersey 170.2 (166.7- 173.8) 171.2 (167.3- 175.1) 192.4 (181.0- 204.4) 90.7 ( 81.0- 101.3)
New York 157.0 (154.7- 159.3) 161.6 (159.0- 164.2) 152.0 (146.1- 158.1) 103.1 ( 97.0- 109.5)
Pennsylvania 165.8 (163.1- 168.6) 163.1 (160.2- 166.0) 208.1 (197.1- 219.6) 118.3 ( 97.6- 142.3)
Midwest 164.7 (163.4- 166.0) 162.4 (161.1- 163.8) 202.0 (196.8- 207.2) 90.3 ( 82.9- 98.3)
East North Central 166.8 (165.3- 168.4) 164.3 (162.6- 165.9) 201.2 (195.6- 206.9) 90.7 ( 82.4- 99.7)
Illinois 166.3 (163.3- 169.3) 162.4 (159.2- 165.7) 209.2 (199.5- 219.2) 85.4 ( 74.8- 97.2)
Indiana 173.3 (169.0- 177.7) 172.0 (167.6- 176.6) 205.5 (187.2- 225.1) 80.4 ( 56.2- 112.8)
Michigan 163.4 (160.1- 166.7) 159.6 (156.2- 163.2) 193.1 (182.4- 204.2) 101.8 ( 79.6- 128.9)
Ohio 173.0 (169.9- 176.1) 171.7 (168.5- 175.0) 195.8 (185.1- 207.0) 123.4 ( 96.0- 156.9)
Wisconsin 153.5 (149.3- 157.9) 151.5 (147.2- 155.9) 211.1 (182.5- 243.4) 74.9 ( 48.2- 113.0)
West North Central 159.9 (157.6- 162.2) 158.5 (156.2- 160.9) 206.7 (193.4- 220.8) 88.5 ( 72.5- 107.3)
Iowa 157.0 (151.4- 162.8) 157.1 (151.4- 163.0) 197.1 (139.6- 271.8) 116.1 ( 66.8- 191.4)
Kansas 157.9 (151.7- 164.2) 156.4 (150.1- 162.9) 199.9 (166.2- 238.7) 77.1 ( 50.9- 113.3)
Minnesota 156.1 (151.5- 160.8) 156.1 (151.4- 161.0) 184.8 (141.4- 238.7) 84.2 ( 49.4- 138.5)
Missouri 169.4 (165.1- 173.8) 166.1 (161.6- 170.8) 215.5 (198.8- 233.2) 95.5 ( 63.2- 140.0)
Nebraska 152.2 (144.7- 160.0) 151.9 (144.3- 159.8) 187.2 (136.8- 251.6) 88.8 ( 48.8- 153.9)
North Dakota 149.9 (138.0- 162.6) 148.2 (136.3- 161.1) ∼ ∼
South Dakota 158.9 (147.6- 171.0) 158.4 (146.8- 170.8) ∼ ∼
South 161.8 (160.8- 162.8) 158.1 (157.0- 159.3) 189.6 (186.7- 192.6) 105.2 (102.0- 108.5)
South Atlantic 159.3 (157.9- 160.7) 155.7 (154.2- 157.2) 183.1 (179.4- 186.9) 98.7 ( 94.1- 103.5)
Delaware 169.5 (158.0- 181.6) 165.0 (152.7- 178.2) 211.3 (177.0- 250.7) ∼
District of Columbia 166.3 (152.5- 181.2) 134.2 (111.7- 162.2) 186.8 (169.1- 206.4) ∼
Florida 150.5 (148.3- 152.8) 149.2 (146.8- 151.6) 174.7 (166.5- 183.1) 105.0 ( 99.8- 110.4)
Georgia 164.8 (160.9- 168.8) 160.1 (155.7- 164.7) 184.1 (175.4- 193.1) 70.1 ( 50.2- 96.0)
Maryland 166.2 (161.6- 170.9) 160.4 (155.2- 165.8) 191.7 (181.2- 202.6) 53.6 ( 36.9- 76.0)
North Carolina 160.4 (156.8- 164.1) 157.8 (153.8- 161.9) 174.7 (165.9- 183.9) 32.1 ( 18.9- 53.2)
South Carolina 165.2 (160.1- 170.5) 158.9 (153.1- 164.9) 185.1 (174.2- 196.7) ∼
Virginia 165.0 (161.0- 169.0) 161.1 (156.8- 165.6) 193.8 (183.3- 204.8) 125.3 ( 98.9- 157.2)
West Virginia 176.8 (169.4- 184.5) 177.0 (169.5- 184.9) 199.8 (154.6- 255.7) ∼
East South Central 171.5 (169.0- 174.1) 167.6 (164.8- 170.4) 194.2 (187.3- 201.2) 55.2 ( 39.0- 76.6)
Alabama 163.2 (158.5- 168.1) 160.0 (154.6- 165.5) 176.9 (166.2- 188.2) ∼
Kentucky 181.6 (176.3- 187.1) 179.2 (173.7- 184.9) 228.1 (203.2- 255.3) 129.0 ( 70.4- 221.5)
Mississippi 166.2 (160.0- 172.7) 156.1 (149.0- 163.6) 190.6 (178.1- 203.9) ∼
Tennessee 173.7 (169.3- 178.2) 168.9 (164.3- 173.7) 211.0 (197.2- 225.6) ∼
West South Central 160.9 (159.0- 162.9) 157.2 (155.1- 159.2) 202.9 (196.5- 209.4) 111.9 (107.3- 116.6)
Arkansas 163.4 (157.3- 169.7) 160.9 (154.4- 167.6) 189.7 (170.5- 210.6) ∼
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Table 2.1.1.2F: All Cancer Sites Combined. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 180.8 (175.5- 186.2) 170.2 (164.3- 176.4) 211.1 (199.9- 222.8) 83.2 ( 59.4- 113.8)
Oklahoma 164.8 (159.3- 170.5) 166.7 (160.8- 172.8) 197.0 (170.8- 226.3) 84.0 ( 54.4- 127.3)
Texas 155.3 (152.9- 157.7) 152.2 (149.7- 154.8) 201.2 (192.4- 210.3) 113.6 (108.9- 118.4)
West 151.2 (149.9- 152.6) 154.9 (153.5- 156.4) 186.9 (179.5- 194.5) 113.2 (109.9- 116.6)
Mountain 147.0 (144.6- 149.4) 148.0 (145.6- 150.6) 169.0 (151.2- 188.5) 128.5 (121.4- 135.9)
Arizona 144.5 (140.2- 148.8) 144.5 (140.2- 149.0) 188.5 (154.6- 228.2) 132.7 (120.2- 146.2)
Colorado 146.2 (141.1- 151.5) 147.3 (142.0- 152.8) 151.5 (121.0- 187.9) 137.6 (121.5- 155.4)
Idaho 154.5 (145.4- 164.1) 155.2 (145.9- 164.9) ∼ ∼
Montana 155.4 (145.2- 166.3) 153.7 (143.3- 164.8) ∼ ∼
Nevada 169.6 (161.9- 177.6) 172.6 (164.3- 181.2) 181.5 (148.2- 220.8) 93.3 ( 73.1- 117.9)
New Mexico 141.1 (133.9- 148.6) 146.7 (139.0- 154.8) 131.5 ( 80.2- 204.3) 137.6 (124.9- 151.4)
Utah 124.2 (117.2- 131.7) 124.9 (117.7- 132.5) ∼ 91.1 ( 62.0- 130.9)
Wyoming 159.4 (144.7- 175.3) 160.4 (145.5- 176.5) ∼ ∼
Pacific 153.0 (151.5- 154.6) 158.2 (156.4- 160.0) 190.2 (182.2- 198.5) 108.1 (104.4- 111.9)
Alaska 156.3 (138.9- 175.5) 147.9 (128.4- 169.7) ∼ ∼
California 150.4 (148.6- 152.2) 154.9 (152.9- 157.0) 191.5 (183.1- 200.2) 107.8 (104.0- 111.7)
Hawaii 122.9 (115.0- 131.1) 147.7 (130.0- 167.8) ∼ 234.9 (169.9- 320.4)
Oregon 168.4 (162.8- 174.2) 170.0 (164.3- 175.9) 134.9 ( 88.5- 198.4) 74.5 ( 49.7- 108.8)
Washington 165.6 (161.1- 170.1) 168.2 (163.5- 173.0) 195.6 (161.4- 235.4) 108.8 ( 84.0- 139.3)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.2.1.1M: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 7.7 ( 7.5- 7.8) 8.1 ( 8.0- 8.3) 4.9 ( 4.5- 5.3) 6.0 ( 5.5- 6.5)
Northeast 8.2 ( 7.8- 8.5) 8.6 ( 8.2- 9.0) 4.6 ( 3.8- 5.6) 5.4 ( 4.3- 6.7)
New England 8.3 ( 7.6- 9.0) 8.7 ( 7.9- 9.4) ∼ 4.5 ( 2.5- 9.3)
Connecticut 8.3 ( 7.0- 9.8) 8.8 ( 7.3- 10.4) ∼ ∼
Maine 8.3 ( 6.2- 10.9) 8.0 ( 6.0- 10.6) ∼ ∼
Massachusetts 8.1 ( 7.2- 9.2) 8.6 ( 7.5- 9.7) ∼ ∼
New Hampshire 8.4 ( 6.2- 11.1) 8.4 ( 6.2- 11.2) ∼ ∼
Rhode Island 10.3 ( 7.7- 13.5) 11.0 ( 8.3- 14.5) ∼ ∼
Vermont 6.7 ( 4.1- 10.4) 6.8 ( 4.2- 10.5) ∼ ∼
Middle Atlantic 8.1 ( 7.7- 8.5) 8.5 ( 8.1- 9.0) 4.9 ( 4.0- 6.0) 5.5 ( 4.3- 7.0)
New Jersey 9.2 ( 8.3- 10.2) 9.7 ( 8.7- 10.8) 4.6 ( 2.9- 7.5) 6.5 ( 4.1- 10.6)
New York 7.7 ( 7.1- 8.3) 8.2 ( 7.6- 8.9) 5.2 ( 4.0- 6.8) 5.3 ( 3.9- 7.2)
Pennsylvania 7.9 ( 7.2- 8.6) 8.2 ( 7.5- 9.0) 4.4 ( 2.7- 7.0) -
Midwest 7.6 ( 7.3- 7.9) 7.9 ( 7.6- 8.2) 4.5 ( 3.7- 5.5) 5.6 ( 3.9- 8.1)
East North Central 7.5 ( 7.1- 7.9) 7.9 ( 7.5- 8.3) 4.4 ( 3.5- 5.5) 5.5 ( 3.7- 8.3)
Illinois 7.5 ( 6.8- 8.3) 8.1 ( 7.3- 9.0) 4.6 ( 3.1- 6.8) -
Indiana 7.9 ( 6.9- 9.1) 8.4 ( 7.3- 9.6) ∼ ∼
Michigan 7.4 ( 6.6- 8.2) 7.9 ( 7.0- 8.8) 3.9 ( 2.4- 6.2) ∼
Detroit 6.2 ( 5.1- 7.5) 7.2 ( 5.9- 8.8) ∼ ∼
Ohio 7.3 ( 6.6- 8.1) 7.4 ( 6.7- 8.2) 5.1 ( 3.3- 7.8) ∼
Wisconsin 7.5 ( 6.5- 8.7) 7.7 ( 6.7- 8.9) ∼ ∼
West North Central 7.8 ( 7.3- 8.4) 8.0 ( 7.4- 8.6) 5.2 ( 3.1- 8.8) 5.8 ( 2.4- 13.6)
Iowa 8.0 ( 6.6- 9.6) 8.0 ( 6.6- 9.7) ∼ ∼
Kansas 8.1 ( 6.6- 9.9) 8.6 ( 7.0- 10.5) ∼ ∼
Minnesota 7.3 ( 6.3- 8.5) 7.3 ( 6.2- 8.5) ∼ ∼
Missouri 8.0 ( 6.9- 9.1) 8.0 ( 6.9- 9.2) 6.8 ( 3.7- 12.3) ∼
Nebraska 7.1 ( 5.4- 9.2) 7.4 ( 5.6- 9.6) ∼ ∼
North Dakota 7.7 ( 4.9- 11.7) 7.9 ( 4.9- 12.1) ∼ ∼
South Dakota 10.0 ( 7.0- 13.8) 10.8 ( 7.6- 15.0) ∼ ∼
South
South Atlantic 7.6 ( 7.3- 8.0) 8.1 ( 7.8- 8.5) 5.0 ( 4.4- 5.8) 6.7 ( 5.5- 8.1)
Delaware 5.3 ( 3.3- 8.3) 6.0 ( 3.6- 9.5) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 7.8 ( 7.2- 8.4) 8.0 ( 7.3- 8.6) 6.4 ( 4.7- 8.6) -
Georgia 6.8 ( 6.0- 7.8) 7.6 ( 6.6- 8.7) 4.8 ( 3.2- 7.0) ∼
Atlanta 6.9 ( 5.4- 8.9) 7.7 ( 5.9- 10.3) 4.6 ( 2.1- 9.9) ∼
Maryland 8.3 ( 7.2- 9.5) 8.9 ( 7.6- 10.5) 5.9 ( 4.1- 8.6) ∼
North Carolina 7.8 ( 6.9- 8.8) 8.6 ( 7.6- 9.8) 4.6 ( 3.1- 6.8) ∼
South Carolina 7.2 ( 6.0- 8.6) 8.4 ( 6.9- 10.1) 3.3 ( 1.9- 5.8) -
Virginia 7.8 ( 6.9- 8.9) 8.4 ( 7.3- 9.7) 5.5 ( 3.7- 8.1) ∼
West Virginia 8.7 ( 6.9- 10.9) 8.9 ( 7.0- 11.1) ∼ ∼
East South Central
Alabama 7.5 ( 6.4- 8.8) 8.5 ( 7.1- 10.1) 4.2 ( 2.4- 7.0) ∼
Kentucky 7.8 ( 6.6- 9.2) 7.7 ( 6.5- 9.2) ∼ -
Mississippi 6.2 ( 4.9- 7.8) 7.8 ( 6.0- 9.9) ∼ ∼
Tennessee
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Table 2.2.1.1M: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 7.9 ( 7.4- 8.4) 8.3 ( 7.8- 8.9) 5.0 ( 4.0- 6.3) 6.5 ( 5.5- 7.8)
Arkansas 7.3 ( 6.0- 9.0) 7.4 ( 5.9- 9.2) ∼ ∼
Louisiana 7.4 ( 6.3- 8.7) 8.3 ( 6.9- 10.0) 5.3 ( 3.5- 7.9) ∼
Oklahoma 8.1 ( 6.8- 9.7) 8.1 ( 6.7- 9.8) ∼ ∼
Texas 8.0 ( 7.4- 8.7) 8.5 ( 7.9- 9.2) 4.4 ( 3.1- 6.3) 6.4 ( 5.3- 7.7)
West 7.5 ( 7.1- 7.8) 8.0 ( 7.6- 8.3) 6.3 ( 4.9- 8.1) 5.7 ( 4.9- 6.6)
Mountain
Arizona
Colorado 6.9 ( 5.8- 8.3) 6.7 ( 5.6- 8.1) ∼ 5.3 ( 2.8- 10.8)
Idaho 8.1 ( 6.1- 10.7) 8.4 ( 6.3- 11.0) ∼ ∼
Montana 8.1 ( 5.7- 11.3) 7.8 ( 5.4- 11.1) ∼ ∼
Nevada 7.5 ( 5.9- 9.5) 8.1 ( 6.3- 10.3) ∼ ∼
New Mexico 5.9 ( 4.4- 7.8) 5.8 ( 4.3- 7.9) ∼ ∼
Utah 6.8 ( 5.2- 8.8) 6.8 ( 5.2- 8.8) ∼ ∼
Wyoming
Pacific 7.6 ( 7.2- 8.0) 8.2 ( 7.8- 8.7) 6.6 ( 5.0- 8.6) 5.9 ( 5.0- 6.9)
Alaska 6.0 ( 3.3- 12.3) 7.4 ( 4.0- 15.4) ∼ ∼
California 7.4 ( 7.0- 7.9) 8.0 ( 7.5- 8.6) 6.3 ( 4.7- 8.4) 5.9 ( 5.0- 7.0)
San Francisco-Oakland 7.1 ( 6.0- 8.5) 7.9 ( 6.5- 9.6) ∼ ∼
San Jose-Monterey 9.2 ( 7.4- 11.4) 10.6 ( 8.4- 13.3) ∼ 10.6 ( 5.6- 19.3)
Los Angeles 6.9 ( 6.1- 7.8) 7.5 ( 6.6- 8.6) 6.2 ( 3.8- 9.8) 6.4 ( 4.9- 8.4)
Hawaii 4.7 ( 3.1- 6.8) ∼ ∼ -
Oregon 8.1 ( 6.8- 9.6) 8.4 ( 7.1- 9.9) ∼ ∼
Washington 9.0 ( 7.9- 10.2) 9.3 ( 8.2- 10.6) ∼ ∼
Seattle-Puget Sound 9.5 ( 8.1- 11.0) 9.9 ( 8.5- 11.6) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.2.1.1F: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 5.6 ( 5.4- 5.7) 5.9 ( 5.8- 6.0) 3.5 ( 3.2- 3.8) 4.8 ( 4.5- 5.3)
Northeast 6.1 ( 5.8- 6.4) 6.4 ( 6.1- 6.7) 3.7 ( 3.1- 4.4) 4.8 ( 3.9- 5.9)
New England 6.2 ( 5.7- 6.8) 6.4 ( 5.8- 7.0) ∼ 4.1 ( 2.2- 7.8)
Connecticut 6.2 ( 5.2- 7.5) 6.6 ( 5.5- 8.0) ∼ ∼
Maine 5.7 ( 4.1- 7.8) 5.6 ( 4.0- 7.7) ∼ ∼
Massachusetts 6.5 ( 5.7- 7.4) 6.8 ( 5.9- 7.8) ∼ ∼
New Hampshire 5.6 ( 4.0- 7.8) 5.6 ( 3.9- 7.9) ∼ ∼
Rhode Island 6.3 ( 4.4- 8.7) 6.2 ( 4.3- 8.8) ∼ ∼
Vermont 4.9 ( 2.8- 8.2) 5.0 ( 2.9- 8.3) ∼ ∼
Middle Atlantic 6.0 ( 5.7- 6.4) 6.4 ( 6.0- 6.7) 3.8 ( 3.2- 4.6) 4.9 ( 3.9- 6.1)
New Jersey 6.2 ( 5.5- 7.0) 6.9 ( 6.0- 7.8) 2.6 ( 1.5- 4.3) 5.9 ( 3.9- 8.8)
New York 6.2 ( 5.7- 6.7) 6.7 ( 6.1- 7.3) 4.1 ( 3.2- 5.2) 4.2 ( 3.1- 5.5)
Pennsylvania 5.7 ( 5.2- 6.3) 5.7 ( 5.1- 6.3) 4.3 ( 2.9- 6.2) -
Midwest 5.4 ( 5.2- 5.7) 5.7 ( 5.4- 5.9) 3.2 ( 2.6- 3.9) 5.1 ( 3.6- 7.2)
East North Central 5.5 ( 5.2- 5.8) 5.8 ( 5.4- 6.1) 3.1 ( 2.4- 3.8) 5.3 ( 3.6- 7.8)
Illinois 5.0 ( 4.5- 5.6) 5.6 ( 5.0- 6.3) 2.4 ( 1.5- 3.7) -
Indiana 5.5 ( 4.7- 6.3) 5.6 ( 4.8- 6.6) ∼ ∼
Michigan 5.7 ( 5.1- 6.4) 5.7 ( 5.0- 6.5) 5.3 ( 3.7- 7.3) ∼
Detroit 5.6 ( 4.7- 6.7) 5.6 ( 4.5- 6.9) 5.2 ( 3.4- 7.6) ∼
Ohio 5.5 ( 4.9- 6.1) 5.8 ( 5.2- 6.5) ∼ ∼
Wisconsin 6.1 ( 5.3- 7.1) 6.2 ( 5.3- 7.3) ∼ ∼
West North Central 5.3 ( 4.9- 5.8) 5.5 ( 5.0- 6.0) 3.8 ( 2.3- 6.1) ∼
Iowa 5.9 ( 4.7- 7.2) 5.7 ( 4.5- 7.0) ∼ ∼
Kansas 6.2 ( 5.0- 7.7) 6.4 ( 5.1- 8.0) ∼ ∼
Minnesota 5.2 ( 4.4- 6.2) 5.5 ( 4.6- 6.5) ∼ ∼
Missouri 5.2 ( 4.5- 6.1) 5.5 ( 4.6- 6.4) ∼ ∼
Nebraska 4.6 ( 3.3- 6.2) 4.6 ( 3.3- 6.3) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 5.1 ( 3.1- 8.0) 5.5 ( 3.4- 8.7) ∼ ∼
South
South Atlantic 5.2 ( 5.0- 5.5) 5.6 ( 5.3- 5.9) 3.6 ( 3.1- 4.1) 5.6 ( 4.6- 6.8)
Delaware 3.8 ( 2.2- 6.1) ∼ ∼ ∼
District of Columbia 6.1 ( 3.6- 10.1) ∼ ∼ ∼
Florida 5.2 ( 4.8- 5.7) 5.4 ( 4.9- 6.0) 3.8 ( 2.7- 5.1) -
Georgia 5.3 ( 4.6- 6.0) 6.0 ( 5.2- 7.0) 3.6 ( 2.6- 5.1) ∼
Atlanta 4.7 ( 3.6- 6.1) 5.4 ( 3.9- 7.2) 4.1 ( 2.2- 7.2) ∼
Maryland 5.6 ( 4.7- 6.5) 6.2 ( 5.1- 7.4) 3.5 ( 2.3- 5.3) ∼
North Carolina 5.2 ( 4.6- 5.9) 5.6 ( 4.8- 6.5) 3.8 ( 2.6- 5.3) ∼
South Carolina 5.2 ( 4.3- 6.2) 6.3 ( 5.1- 7.7) ∼ -
Virginia 4.9 ( 4.2- 5.7) 5.0 ( 4.2- 5.8) 3.8 ( 2.5- 5.6) ∼
West Virginia 6.4 ( 5.0- 8.2) 6.5 ( 5.0- 8.4) ∼ ∼
East South Central
Alabama 4.9 ( 4.1- 5.9) 5.8 ( 4.7- 7.0) ∼ ∼
Kentucky 5.4 ( 4.5- 6.5) 5.5 ( 4.5- 6.6) ∼ -
Mississippi 5.6 ( 4.4- 6.9) 6.4 ( 4.9- 8.2) 3.8 ( 2.3- 6.1) ∼
Tennessee
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Table 2.2.1.1F: Brain and Other Nervous System. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 5.5 ( 5.2- 5.9) 5.9 ( 5.5- 6.3) 3.5 ( 2.8- 4.4) 4.7 ( 3.9- 5.6)
Arkansas 5.3 ( 4.2- 6.6) 5.5 ( 4.3- 7.1) ∼ ∼
Louisiana 4.8 ( 4.0- 5.8) 5.9 ( 4.8- 7.3) 2.6 ( 1.6- 4.3) ∼
Oklahoma 5.6 ( 4.6- 6.8) 6.0 ( 4.9- 7.4) ∼ ∼
Texas 5.7 ( 5.3- 6.2) 5.9 ( 5.4- 6.4) 4.2 ( 3.1- 5.6) 4.6 ( 3.7- 5.5)
West 5.6 ( 5.3- 5.9) 6.0 ( 5.7- 6.3) 3.8 ( 2.8- 5.0) 4.6 ( 4.0- 5.3)
Mountain
Arizona
Colorado 6.0 ( 5.0- 7.1) 6.2 ( 5.2- 7.4) ∼ 5.1 ( 2.7- 9.0)
Idaho 6.1 ( 4.4- 8.3) 6.2 ( 4.5- 8.5) ∼ ∼
Montana 5.6 ( 3.7- 8.2) 5.7 ( 3.8- 8.4) ∼ ∼
Nevada 6.2 ( 4.8- 7.9) 6.4 ( 4.9- 8.3) ∼ ∼
New Mexico 3.8 ( 2.6- 5.2) 3.7 ( 2.5- 5.2) ∼ ∼
Utah 6.5 ( 5.0- 8.3) 6.6 ( 5.1- 8.5) ∼ ∼
Wyoming
Pacific 5.5 ( 5.2- 5.9) 6.1 ( 5.7- 6.4) 3.5 ( 2.6- 4.8) 4.9 ( 4.3- 5.7)
Alaska ∼ ∼ ∼ ∼
California 5.4 ( 5.0- 5.7) 5.9 ( 5.5- 6.3) 3.3 ( 2.3- 4.5) 4.9 ( 4.2- 5.8)
San Francisco-Oakland 5.9 ( 4.9- 7.0) 6.6 ( 5.3- 8.2) ∼ 6.4 ( 3.7- 10.6)
San Jose-Monterey 4.3 ( 3.2- 5.7) 4.6 ( 3.3- 6.3) ∼ ∼
Los Angeles 4.3 ( 3.8- 5.0) 4.8 ( 4.1- 5.6) ∼ 4.6 ( 3.5- 5.8)
Hawaii 3.2 ( 2.0- 4.9) ∼ ∼ -
Oregon 6.9 ( 5.8- 8.2) 6.9 ( 5.7- 8.3) ∼ ∼
Washington 6.3 ( 5.5- 7.3) 6.4 ( 5.5- 7.5) ∼ ∼
Seattle-Puget Sound 6.4 ( 5.4- 7.6) 6.7 ( 5.6- 8.0) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.2.1.2M: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 5.4 ( 5.2- 5.5) 5.7 ( 5.6- 5.9) 3.4 ( 3.1- 3.7) 3.3 ( 2.9- 3.7)
Northeast 4.8 ( 4.6- 5.1) 5.2 ( 4.9- 5.5) 2.9 ( 2.2- 3.7) 3.0 ( 2.2- 4.3)
New England 5.2 ( 4.7- 5.8) 5.3 ( 4.8- 5.9) ∼ ∼
Connecticut 5.5 ( 4.4- 6.7) 5.8 ( 4.6- 7.2) ∼ ∼
Maine 5.0 ( 3.4- 7.2) 5.1 ( 3.5- 7.2) ∼ ∼
Massachusetts 4.9 ( 4.1- 5.7) 4.9 ( 4.1- 5.8) ∼ ∼
New Hampshire 4.9 ( 3.3- 7.1) 5.0 ( 3.3- 7.2) ∼ ∼
Rhode Island 5.9 ( 4.0- 8.4) 6.2 ( 4.2- 9.0) ∼ ∼
Vermont 7.2 ( 4.5- 11.2) 7.3 ( 4.5- 11.3) ∼ ∼
Middle Atlantic 4.7 ( 4.4- 5.0) 5.1 ( 4.8- 5.5) 2.9 ( 2.2- 3.8) 3.3 ( 2.3- 4.7)
New Jersey 4.6 ( 4.0- 5.4) 5.1 ( 4.4- 5.9) ∼ ∼
New York 4.5 ( 4.1- 5.0) 5.0 ( 4.5- 5.5) 2.8 ( 1.9- 4.0) 3.6 ( 2.4- 5.5)
Pennsylvania 5.0 ( 4.5- 5.6) 5.3 ( 4.7- 5.9) ∼ ∼
Midwest 5.4 ( 5.1- 5.6) 5.6 ( 5.3- 5.9) 3.6 ( 2.8- 4.5) 1.7 ( 1.0- 3.4)
East North Central 5.2 ( 4.9- 5.5) 5.5 ( 5.1- 5.8) 3.3 ( 2.5- 4.3) 1.7 ( 0.9- 3.7)
Illinois 4.2 ( 3.7- 4.8) 4.6 ( 4.0- 5.2) ∼ ∼
Indiana 5.8 ( 4.9- 6.7) 5.9 ( 5.0- 6.9) ∼ ∼
Michigan 5.6 ( 4.9- 6.3) 5.8 ( 5.1- 6.6) 4.3 ( 2.6- 6.7) ∼
Ohio 5.4 ( 4.8- 6.0) 5.6 ( 5.0- 6.4) 3.2 ( 1.8- 5.6) ∼
Wisconsin 5.5 ( 4.7- 6.5) 5.7 ( 4.8- 6.8) ∼ ∼
West North Central 5.8 ( 5.3- 6.3) 5.9 ( 5.4- 6.5) 5.2 ( 2.9- 8.8) ∼
Iowa 6.2 ( 5.0- 7.6) 6.2 ( 5.0- 7.7) ∼ ∼
Kansas 6.2 ( 4.9- 7.7) 6.4 ( 5.0- 8.0) ∼ ∼
Minnesota 5.5 ( 4.6- 6.6) 5.7 ( 4.7- 6.8) ∼ ∼
Missouri 5.5 ( 4.6- 6.5) 5.5 ( 4.6- 6.5) ∼ ∼
Nebraska 5.1 ( 3.6- 6.9) 5.3 ( 3.8- 7.2) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 9.4 ( 6.6- 13.2) 10.0 ( 7.0- 14.0) ∼ ∼
South 5.5 ( 5.3- 5.7) 6.0 ( 5.7- 6.2) 3.4 ( 3.0- 3.9) 3.5 ( 2.9- 4.3)
South Atlantic 5.2 ( 4.9- 5.5) 5.6 ( 5.3- 5.9) 3.2 ( 2.7- 3.9) 3.4 ( 2.5- 4.6)
Delaware 4.6 ( 2.8- 7.5) 4.9 ( 2.8- 8.1) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.9 ( 4.5- 5.4) 5.1 ( 4.7- 5.6) 3.7 ( 2.4- 5.6) 3.8 ( 2.7- 5.2)
Georgia 4.4 ( 3.7- 5.2) 4.9 ( 4.1- 6.0) 2.5 ( 1.5- 4.2) ∼
Maryland 6.0 ( 5.1- 7.1) 7.1 ( 5.9- 8.5) 3.0 ( 1.8- 5.2) ∼
North Carolina 5.8 ( 5.1- 6.7) 6.2 ( 5.4- 7.2) 4.6 ( 3.0- 7.0) ∼
South Carolina 5.6 ( 4.6- 6.9) 6.6 ( 5.2- 8.2) ∼ ∼
Virginia 5.2 ( 4.4- 6.1) 5.8 ( 4.9- 6.8) 2.9 ( 1.6- 5.1) ∼
West Virginia 5.4 ( 4.0- 7.2) 5.5 ( 4.0- 7.3) ∼ ∼
East South Central 5.8 ( 5.3- 6.4) 6.2 ( 5.6- 6.9) 3.6 ( 2.6- 5.0) ∼
Alabama 5.5 ( 4.5- 6.7) 5.9 ( 4.7- 7.3) 3.9 ( 2.3- 6.6) ∼
Kentucky 5.4 ( 4.4- 6.6) 5.6 ( 4.6- 6.9) ∼ ∼
Mississippi 6.5 ( 5.2- 8.2) 7.3 ( 5.6- 9.4) 4.9 ( 2.8- 8.1) ∼
Tennessee 6.1 ( 5.2- 7.1) 6.6 ( 5.6- 7.7) ∼ ∼
West South Central 6.0 ( 5.6- 6.4) 6.4 ( 6.0- 6.9) 3.8 ( 2.9- 5.0) 3.7 ( 2.8- 4.8)
Arkansas 6.7 ( 5.4- 8.3) 6.9 ( 5.5- 8.7) ∼ ∼
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Table 2.2.1.2M: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 5.9 ( 4.8- 7.1) 7.1 ( 5.7- 8.7) ∼ ∼
Oklahoma 6.5 ( 5.3- 7.9) 6.9 ( 5.6- 8.4) ∼ ∼
Texas 5.9 ( 5.3- 6.4) 6.2 ( 5.6- 6.8) 4.5 ( 3.1- 6.6) 3.6 ( 2.8- 4.8)
West 5.6 ( 5.3- 5.9) 6.0 ( 5.7- 6.3) 3.8 ( 2.7- 5.3) 3.5 ( 2.9- 4.2)
Mountain 5.8 ( 5.3- 6.3) 6.0 ( 5.5- 6.6) ∼ 3.6 ( 2.4- 5.3)
Arizona 5.0 ( 4.2- 6.0) 5.1 ( 4.2- 6.1) ∼ ∼
Colorado 6.4 ( 5.3- 7.7) 6.7 ( 5.5- 8.1) ∼ ∼
Idaho 8.2 ( 6.1- 10.9) 8.3 ( 6.2- 11.0) ∼ ∼
Montana 6.4 ( 4.3- 9.3) 6.4 ( 4.3- 9.4) ∼ ∼
Nevada 5.5 ( 4.1- 7.4) 5.8 ( 4.3- 7.8) ∼ ∼
New Mexico 4.9 ( 3.5- 6.7) 5.3 ( 3.8- 7.2) ∼ ∼
Utah 6.2 ( 4.6- 8.2) 6.4 ( 4.8- 8.5) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 5.5 ( 5.2- 5.8) 6.0 ( 5.6- 6.4) 4.1 ( 2.8- 5.8) 3.5 ( 2.8- 4.3)
Alaska ∼ ∼ ∼ ∼
California 5.2 ( 4.8- 5.6) 5.7 ( 5.3- 6.2) 3.7 ( 2.5- 5.5) 3.2 ( 2.5- 4.0)
Hawaii 3.8 ( 2.4- 5.7) ∼ ∼ ∼
Oregon 6.6 ( 5.5- 8.0) 6.8 ( 5.6- 8.2) ∼ ∼
Washington 6.9 ( 5.9- 8.0) 6.9 ( 5.9- 8.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.2.1.2F: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 3.6 ( 3.5- 3.7) 3.9 ( 3.8- 4.0) 2.1 ( 1.9- 2.3) 2.4 ( 2.1- 2.7)
Northeast 3.1 ( 2.9- 3.3) 3.4 ( 3.1- 3.6) 1.8 ( 1.3- 2.3) 1.5 ( 1.0- 2.2)
New England 3.5 ( 3.1- 4.0) 3.6 ( 3.2- 4.1) ∼ ∼
Connecticut 2.9 ( 2.2- 3.7) 3.0 ( 2.3- 3.9) ∼ ∼
Maine 4.2 ( 2.9- 6.0) 4.2 ( 2.9- 6.1) ∼ ∼
Massachusetts 3.8 ( 3.2- 4.5) 3.8 ( 3.2- 4.6) ∼ ∼
New Hampshire 3.3 ( 2.1- 5.0) 3.2 ( 2.0- 5.0) ∼ ∼
Rhode Island 4.5 ( 3.0- 6.6) 4.6 ( 3.0- 6.9) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.0 ( 2.7- 3.2) 3.3 ( 3.0- 3.5) 1.7 ( 1.2- 2.2) 1.5 ( 0.9- 2.2)
New Jersey 2.5 ( 2.1- 3.0) 2.7 ( 2.3- 3.3) ∼ ∼
New York 2.8 ( 2.5- 3.1) 3.2 ( 2.8- 3.6) 1.4 ( 0.9- 2.1) 1.4 ( 0.8- 2.3)
Pennsylvania 3.5 ( 3.1- 4.0) 3.7 ( 3.2- 4.2) 2.7 ( 1.6- 4.3) ∼
Midwest 3.9 ( 3.7- 4.2) 4.2 ( 4.0- 4.5) 1.7 ( 1.3- 2.2) 2.3 ( 1.3- 3.9)
East North Central 3.9 ( 3.7- 4.2) 4.3 ( 4.0- 4.5) 1.5 ( 1.1- 2.1) 2.7 ( 1.5- 4.6)
Illinois 3.8 ( 3.4- 4.3) 4.3 ( 3.8- 4.9) ∼ ∼
Indiana 4.1 ( 3.5- 4.9) 4.4 ( 3.7- 5.2) ∼ ∼
Michigan 3.8 ( 3.3- 4.4) 4.2 ( 3.6- 4.8) ∼ ∼
Ohio 3.8 ( 3.3- 4.3) 4.1 ( 3.6- 4.7) ∼ ∼
Wisconsin 4.3 ( 3.5- 5.1) 4.4 ( 3.6- 5.2) ∼ ∼
West North Central 4.0 ( 3.6- 4.4) 4.2 ( 3.8- 4.6) ∼ ∼
Iowa 5.1 ( 4.1- 6.3) 5.1 ( 4.1- 6.4) ∼ ∼
Kansas 4.3 ( 3.3- 5.5) 4.2 ( 3.2- 5.5) ∼ ∼
Minnesota 4.0 ( 3.2- 4.8) 4.1 ( 3.4- 5.0) ∼ ∼
Missouri 3.6 ( 3.0- 4.3) 3.9 ( 3.2- 4.7) ∼ ∼
Nebraska 3.8 ( 2.7- 5.3) 4.0 ( 2.8- 5.5) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 3.6 ( 3.4- 3.8) 3.9 ( 3.7- 4.1) 2.4 ( 2.1- 2.7) 2.2 ( 1.8- 2.7)
South Atlantic 3.3 ( 3.1- 3.5) 3.6 ( 3.4- 3.9) 2.2 ( 1.8- 2.6) 2.6 ( 1.9- 3.4)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.2 ( 2.9- 3.6) 3.4 ( 3.0- 3.8) 2.4 ( 1.6- 3.5) 2.8 ( 2.0- 3.7)
Georgia 3.5 ( 3.0- 4.1) 3.9 ( 3.3- 4.7) 2.2 ( 1.4- 3.4) ∼
Maryland 2.9 ( 2.3- 3.6) 3.4 ( 2.7- 4.4) ∼ ∼
North Carolina 3.8 ( 3.2- 4.4) 4.3 ( 3.7- 5.1) 2.0 ( 1.2- 3.3) ∼
South Carolina 3.9 ( 3.1- 4.8) 4.4 ( 3.5- 5.6) ∼ ∼
Virginia 2.7 ( 2.3- 3.3) 3.1 ( 2.5- 3.8) ∼ ∼
West Virginia 3.2 ( 2.3- 4.5) 3.1 ( 2.2- 4.4) ∼ ∼
East South Central 4.4 ( 4.0- 4.8) 4.8 ( 4.3- 5.3) 2.7 ( 2.0- 3.7) ∼
Alabama 3.4 ( 2.8- 4.2) 4.0 ( 3.1- 5.0) ∼ ∼
Kentucky 4.6 ( 3.7- 5.6) 4.7 ( 3.8- 5.8) ∼ ∼
Mississippi 3.7 ( 2.8- 4.8) 3.9 ( 2.8- 5.3) 3.4 ( 2.0- 5.7) ∼
Tennessee 5.4 ( 4.6- 6.2) 5.8 ( 4.9- 6.7) ∼ ∼
West South Central 3.7 ( 3.4- 4.0) 3.9 ( 3.5- 4.2) 2.6 ( 2.0- 3.5) 2.0 ( 1.5- 2.8)
Arkansas 3.7 ( 2.8- 4.8) 3.8 ( 2.9- 5.1) ∼ ∼
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Table 2.2.1.2F: Brain and Other Nervous System. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 4.2 ( 3.4- 5.1) 4.7 ( 3.7- 5.9) 2.6 ( 1.5- 4.2) ∼
Oklahoma 4.2 ( 3.4- 5.3) 4.5 ( 3.5- 5.7) ∼ ∼
Texas 3.5 ( 3.1- 3.8) 3.6 ( 3.2- 4.0) 2.5 ( 1.7- 3.7) 2.1 ( 1.6- 2.9)
West 3.8 ( 3.6- 4.0) 4.1 ( 3.9- 4.4) 2.1 ( 1.4- 3.1) 2.9 ( 2.4- 3.5)
Mountain 3.6 ( 3.2- 4.0) 3.7 ( 3.4- 4.2) ∼ 2.7 ( 1.9- 3.9)
Arizona 3.1 ( 2.5- 3.8) 3.1 ( 2.5- 3.9) ∼ ∼
Colorado 3.7 ( 3.0- 4.7) 3.9 ( 3.1- 4.9) ∼ ∼
Idaho 4.3 ( 2.9- 6.2) 4.4 ( 3.0- 6.4) ∼ ∼
Montana 4.8 ( 3.1- 7.3) 5.1 ( 3.3- 7.7) ∼ ∼
Nevada 4.0 ( 2.9- 5.4) 4.3 ( 3.1- 5.8) ∼ ∼
New Mexico 3.1 ( 2.1- 4.5) 3.4 ( 2.3- 5.0) ∼ ∼
Utah 3.4 ( 2.3- 4.8) 3.5 ( 2.4- 5.0) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.9 ( 3.6- 4.1) 4.3 ( 4.0- 4.6) 2.1 ( 1.4- 3.2) 3.0 ( 2.4- 3.7)
Alaska ∼ ∼ ∼ ∼
California 3.7 ( 3.4- 3.9) 4.1 ( 3.8- 4.5) 1.9 ( 1.1- 2.9) 3.0 ( 2.4- 3.7)
Hawaii 3.6 ( 2.4- 5.4) ∼ ∼ ∼
Oregon 4.2 ( 3.4- 5.3) 4.4 ( 3.5- 5.5) ∼ ∼
Washington 4.9 ( 4.2- 5.8) 5.1 ( 4.3- 6.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.3.1.1: Breast. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 119.0 (118.5- 119.6) 120.3 (119.7- 120.9) 109.5 (107.9- 111.2) 86.6 ( 84.9- 88.4)
Northeast 124.1 (122.9- 125.4) 126.5 (125.1- 127.8) 102.1 ( 98.7- 105.6) 93.8 ( 89.6- 98.2)
New England 127.8 (125.4- 130.3) 129.6 (127.0- 132.2) 98.4 ( 88.3- 109.4) 93.8 ( 82.1- 107.0)
Connecticut 127.8 (122.9- 132.8) 130.1 (124.9- 135.5) 108.6 ( 92.4- 127.0) 108.6 ( 88.5- 132.8)
Maine 127.0 (119.4- 135.1) 126.2 (118.6- 134.4) ∼ ∼
Massachusetts 130.1 (126.5- 133.9) 133.0 (129.2- 137.0) 90.6 ( 77.0- 106.2) 86.1 ( 70.1- 105.5)
New Hampshire 122.3 (114.3- 130.7) 121.1 (113.1- 129.6) ∼ ∼
Rhode Island 122.4 (113.8- 131.6) 124.7 (115.7- 134.3) 96.8 ( 61.4- 149.3) 93.0 ( 58.8- 144.3)
Vermont 127.7 (116.3- 140.2) 128.0 (116.5- 140.6) ∼ ∼
Middle Atlantic 122.9 (121.5- 124.3) 125.2 (123.7- 126.8) 102.6 ( 98.9- 106.3) 93.9 ( 89.4- 98.7)
New Jersey 126.4 (123.2- 129.6) 129.8 (126.3- 133.4) 105.9 ( 97.8- 114.6) 91.9 ( 83.1- 101.5)
New York 122.3 (120.3- 124.4) 126.1 (123.7- 128.5) 96.2 ( 91.6- 101.0) 96.5 ( 90.9- 102.3)
Pennsylvania 121.4 (118.9- 124.0) 121.5 (118.8- 124.1) 116.3 (108.1- 125.0) -
Midwest 119.2 (118.1- 120.3) 118.5 (117.3- 119.7) 111.5 (107.8- 115.3) 80.8 ( 74.5- 87.6)
East North Central 118.2 (116.8- 119.5) 117.3 (115.9- 118.8) 111.7 (107.6- 115.9) 80.3 ( 73.3- 87.9)
Illinois 117.2 (114.7- 119.9) 117.7 (114.8- 120.5) 114.6 (107.7- 121.8) -
Indiana 110.8 (107.3- 114.5) 109.3 (105.7- 113.1) 102.9 ( 90.3- 116.9) 81.0 ( 59.1- 110.3)
Michigan 123.0 (120.0- 125.9) 123.4 (120.2- 126.6) 114.0 (106.0- 122.4) 77.4 ( 60.1- 99.1)
Detroit 127.0 (122.3- 131.7) 130.5 (125.0- 136.1) 120.3 (110.9- 130.3) 58.6 ( 36.4- 91.8)
Ohio 117.1 (114.5- 119.7) 113.9 (111.2- 116.7) 108.3 (100.4- 116.6) 102.3 ( 79.0- 131.1)
Wisconsin 122.0 (118.1- 126.1) 122.3 (118.3- 126.5) 112.0 ( 92.9- 134.7) 70.4 ( 47.1- 104.0)
West North Central 121.6 (119.6- 123.8) 121.2 (119.0- 123.3) 110.4 (101.1- 120.4) 83.0 ( 68.8- 99.8)
Iowa 120.1 (115.0- 125.5) 116.1 (110.9- 121.5) 111.9 ( 71.8- 168.8) 87.7 ( 49.0- 151.0)
Kansas 122.9 (117.3- 128.8) 120.9 (115.1- 127.0) 138.7 (111.6- 170.7) 87.0 ( 61.3- 121.9)
Minnesota 125.3 (121.1- 129.6) 125.1 (120.8- 129.5) 92.6 ( 67.5- 127.0) 57.8 ( 32.3- 102.0)
Missouri 119.3 (115.6- 123.1) 120.4 (116.4- 124.5) 108.5 ( 97.0- 121.0) 93.7 ( 63.9- 134.8)
Nebraska 120.3 (113.4- 127.5) 122.1 (115.0- 129.6) 86.9 ( 55.3- 132.2) 76.8 ( 44.3- 132.6)
North Dakota 118.1 (107.0- 130.2) 116.7 (105.5- 129.0) ∼ ∼
South Dakota 123.4 (113.0- 134.6) 123.9 (113.1- 135.5) ∼ ∼
South
South Atlantic 116.3 (115.1- 117.5) 117.4 (116.1- 118.8) 110.5 (107.8- 113.4) 89.6 ( 85.4- 94.0)
Delaware 120.3 (110.5- 130.8) 119.4 (108.6- 131.2) 121.7 ( 97.9- 150.4) ∼
District of Columbia 125.8 (113.4- 139.4) 139.7 (116.3- 168.6) 114.4 (100.0- 130.8) ∼
Florida 111.3 (109.2- 113.3) 113.2 (111.0- 115.4) 100.0 ( 94.1- 106.2) -
Georgia 120.5 (117.2- 123.9) 122.2 (118.3- 126.1) 118.1 (111.5- 125.0) 72.1 ( 55.3- 93.9)
Atlanta 129.4 (123.3- 135.7) 129.7 (122.2- 137.5) 135.3 (123.8- 147.9) 69.3 ( 46.4- 103.3)
Maryland 131.3 (127.2- 135.4) 134.6 (129.7- 139.6) 114.6 (107.1- 122.6) 88.0 ( 68.4- 112.6)
North Carolina 111.5 (108.4- 114.6) 112.5 (109.0- 116.0) 109.0 (102.2- 116.2) 80.4 ( 58.9- 109.1)
South Carolina 119.6 (115.2- 124.2) 120.7 (115.5- 126.1) 116.3 (107.8- 125.4) -
Virginia 116.6 (113.2- 120.0) 118.7 (114.9- 122.6) 108.7 (101.2- 116.8) 98.2 ( 78.2- 122.8)
West Virginia 112.5 (106.3- 119.0) 113.1 (106.8- 119.7) 90.5 ( 60.2- 132.2) ∼
East South Central
Alabama 106.7 (102.7- 110.8) 106.0 (101.5- 110.7) 104.8 ( 96.6- 113.5) 87.9 ( 51.7- 143.3)
Kentucky 118.3 (113.9- 122.9) 117.0 (112.4- 121.7) 124.1 (106.3- 144.2) -
Mississippi 103.2 ( 98.2- 108.5) 101.9 ( 95.9- 108.2) 102.9 ( 93.9- 112.5) ∼
Tennessee
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Table 2.3.1.1: Breast. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 113.9 (112.3- 115.6) 113.2 (111.5- 115.0) 116.5 (111.9- 121.3) 80.2 ( 76.6- 83.9)
Arkansas 110.9 (105.7- 116.3) 110.9 (105.3- 116.8) 95.9 ( 82.5- 111.0) ∼
Louisiana 118.9 (114.5- 123.3) 119.0 (113.8- 124.3) 119.6 (111.5- 128.3) 80.2 ( 57.2- 109.7)
Oklahoma 122.5 (117.6- 127.6) 123.3 (118.0- 128.8) 120.1 (100.5- 142.7) 101.2 ( 72.1- 142.6)
Texas 111.5 (109.5- 113.5) 110.4 (108.2- 112.6) 118.0 (111.6- 124.7) 80.0 ( 76.4- 83.8)
West 121.2 (120.0- 122.5) 125.4 (124.0- 126.8) 112.0 (106.5- 117.8) 86.4 ( 83.6- 89.2)
Mountain
Arizona
Colorado 128.8 (124.1- 133.7) 129.2 (124.4- 134.3) 108.1 ( 84.3- 137.4) 96.6 ( 84.3- 110.4)
Idaho 118.7 (110.6- 127.2) 120.0 (111.7- 128.7) ∼ 78.4 ( 44.4- 139.3)
Montana 122.7 (113.3- 132.7) 120.5 (110.9- 130.8) ∼ ∼
Nevada 110.1 (104.0- 116.4) 112.8 (106.2- 119.8) 93.8 ( 72.1- 121.3) 74.0 ( 58.2- 93.8)
New Mexico 102.1 ( 96.0- 108.6) 108.4 (101.7- 115.5) ∼ 73.8 ( 64.9- 83.6)
Utah 108.6 (102.0- 115.5) 110.0 (103.2- 117.2) ∼ 95.1 ( 68.0- 131.8)
Wyoming
Pacific 122.5 (121.0- 123.9) 127.6 (126.0- 129.2) 114.0 (108.0- 120.2) 87.2 ( 84.1- 90.4)
Alaska 132.1 (117.8- 148.1) 123.6 (107.7- 141.6) ∼ ∼
California 119.2 (117.5- 120.8) 125.2 (123.4- 127.1) 113.7 (107.4- 120.2) 86.9 ( 83.8- 90.2)
San Francisco-Oakland 122.2 (117.7- 126.8) 138.0 (132.2- 144.1) 109.6 ( 96.0- 124.7) 86.5 ( 75.2- 99.2)
San Jose-Monterey 117.3 (111.2- 123.7) 125.7 (118.4- 133.4) 85.8 ( 53.6- 136.5) 81.2 ( 69.0- 95.3)
Los Angeles 112.3 (109.3- 115.4) 116.9 (113.3- 120.6) 116.4 (107.2- 126.3) 77.7 ( 73.1- 82.6)
Hawaii 119.6 (111.6- 128.1) 139.5 (122.1- 159.4) ∼ -
Oregon 128.9 (124.0- 134.1) 127.4 (122.4- 132.7) 115.4 ( 75.1- 172.0) 73.9 ( 52.7- 103.2)
Washington 136.6 (132.5- 140.7) 138.6 (134.3- 143.0) 118.6 ( 94.1- 148.2) 100.0 ( 80.2- 124.6)
Seattle-Puget Sound 138.8 (133.9- 143.9) 146.2 (140.8- 151.7) 117.3 ( 91.7- 148.8) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
U
nited States C
ancer Statistics: 2003 Incidence and M
ortality
54
Table 2.3.1.2: Breast. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 25.2 ( 24.9- 25.4) 24.6 ( 24.3- 24.8) 34.1 ( 33.2- 35.0) 16.1 ( 15.4- 16.9)
Northeast 26.2 ( 25.6- 26.7) 26.1 ( 25.5- 26.7) 30.8 ( 28.9- 32.8) 15.7 ( 13.9- 17.6)
New England 24.5 ( 23.5- 25.6) 24.5 ( 23.4- 25.6) 31.7 ( 26.0- 38.5) 10.7 ( 6.9- 16.2)
Connecticut 23.6 ( 21.6- 25.8) 23.2 ( 21.1- 25.4) 31.1 ( 22.6- 41.9) ∼
Maine 27.3 ( 23.8- 31.2) 27.2 ( 23.8- 31.2) ∼ ∼
Massachusetts 24.3 ( 22.8- 25.9) 24.4 ( 22.8- 26.1) 34.7 ( 26.3- 45.2) 12.5 ( 6.7- 22.2)
New Hampshire 24.6 ( 21.1- 28.6) 24.6 ( 21.1- 28.6) ∼ ∼
Rhode Island 23.9 ( 20.3- 28.0) 24.5 ( 20.8- 28.9) ∼ ∼
Vermont 26.1 ( 21.1- 32.1) 26.4 ( 21.3- 32.5) ∼ ∼
Middle Atlantic 26.8 ( 26.1- 27.4) 26.7 ( 26.0- 27.4) 30.7 ( 28.8- 32.8) 16.5 ( 14.6- 18.6)
New Jersey 28.5 ( 27.1- 30.0) 28.5 ( 26.9- 30.1) 34.3 ( 29.6- 39.5) 13.5 ( 10.1- 17.9)
New York 25.8 ( 24.9- 26.8) 26.1 ( 25.0- 27.2) 28.1 ( 25.6- 30.7) 17.1 ( 14.7- 19.7)
Pennsylvania 26.9 ( 25.8- 28.1) 26.4 ( 25.3- 27.6) 34.4 ( 30.0- 39.3) 20.7 ( 13.2- 31.7)
Midwest 25.7 ( 25.2- 26.2) 24.9 ( 24.4- 25.5) 35.8 ( 33.6- 38.0) 15.4 ( 12.5- 18.8)
East North Central 26.1 ( 25.5- 26.7) 25.2 ( 24.6- 25.9) 35.1 ( 32.9- 37.5) 14.3 ( 11.3- 17.9)
Illinois 26.3 ( 25.1- 27.5) 24.7 ( 23.5- 26.0) 38.6 ( 34.6- 43.0) 13.2 ( 9.4- 18.2)
Indiana 26.5 ( 24.8- 28.3) 25.9 ( 24.2- 27.7) 36.3 ( 28.9- 45.0) ∼
Michigan 24.9 ( 23.7- 26.3) 23.8 ( 22.5- 25.2) 33.4 ( 29.1- 38.1) ∼
Ohio 27.9 ( 26.6- 29.2) 27.4 ( 26.1- 28.7) 32.6 ( 28.3- 37.3) ∼
Wisconsin 23.7 ( 22.0- 25.4) 23.4 ( 21.7- 25.2) 29.4 ( 20.2- 42.2) ∼
West North Central 24.7 ( 23.8- 25.6) 24.3 ( 23.4- 25.3) 39.3 ( 33.8- 45.6) 19.3 ( 12.1- 29.4)
Iowa 23.1 ( 20.9- 25.4) 22.9 ( 20.8- 25.3) ∼ ∼
Kansas 26.9 ( 24.3- 29.6) 26.5 ( 23.9- 29.3) 40.0 ( 26.0- 59.1) ∼
Minnesota 22.8 ( 21.0- 24.6) 23.1 ( 21.3- 25.1) ∼ ∼
Missouri 26.7 ( 25.0- 28.5) 25.3 ( 23.5- 27.1) 43.8 ( 36.6- 52.1) ∼
Nebraska 23.3 ( 20.5- 26.6) 23.3 ( 20.4- 26.6) ∼ ∼
North Dakota 23.2 ( 18.6- 28.8) 23.4 ( 18.7- 29.1) ∼ ∼
South Dakota 26.1 ( 21.6- 31.5) 27.1 ( 22.3- 32.8) ∼ ∼
South 25.2 ( 24.8- 25.7) 23.6 ( 23.1- 24.0) 35.2 ( 33.9- 36.4) 16.2 ( 15.0- 17.5)
South Atlantic 24.8 ( 24.3- 25.4) 23.1 ( 22.5- 23.7) 33.3 ( 31.8- 34.9) 15.8 ( 14.0- 17.7)
Delaware 25.1 ( 20.8- 30.2) 23.4 ( 18.8- 28.9) 34.1 ( 21.9- 51.5) ∼
District of Columbia 29.7 ( 24.0- 36.7) 23.3 ( 14.5- 38.4) 34.0 ( 26.5- 43.5) ∼
Florida 22.7 ( 21.8- 23.6) 22.0 ( 21.0- 22.9) 29.7 ( 26.5- 33.2) 17.3 ( 15.3- 19.6)
Georgia 26.1 ( 24.6- 27.7) 23.4 ( 21.8- 25.2) 34.5 ( 31.0- 38.4) ∼
Maryland 26.7 ( 24.9- 28.6) 24.3 ( 22.3- 26.4) 35.0 ( 30.8- 39.6) ∼
North Carolina 25.3 ( 23.9- 26.8) 23.4 ( 21.9- 25.0) 33.5 ( 29.8- 37.6) ∼
South Carolina 25.0 ( 23.0- 27.1) 22.9 ( 20.7- 25.3) 31.6 ( 27.2- 36.6) ∼
Virginia 27.0 ( 25.4- 28.6) 25.4 ( 23.6- 27.2) 36.2 ( 31.8- 41.0) ∼
West Virginia 25.4 ( 22.6- 28.6) 25.3 ( 22.4- 28.5) ∼ ∼
East South Central 26.3 ( 25.3- 27.3) 24.3 ( 23.3- 25.4) 36.7 ( 33.8- 39.8) ∼
Alabama 25.3 ( 23.4- 27.3) 23.2 ( 21.2- 25.4) 33.4 ( 28.9- 38.5) ∼
Kentucky 25.2 ( 23.2- 27.3) 24.1 ( 22.1- 26.3) 43.5 ( 33.2- 56.3) ∼
Mississippi 26.9 ( 24.3- 29.6) 23.3 ( 20.5- 26.4) 35.3 ( 30.0- 41.2) ∼
Tennessee 27.7 ( 26.0- 29.6) 25.7 ( 23.9- 27.7) 40.3 ( 34.5- 46.8) ∼
West South Central 25.5 ( 24.8- 26.3) 24.0 ( 23.2- 24.9) 38.8 ( 36.1- 41.7) 16.7 ( 15.1- 18.5)
Arkansas 23.5 ( 21.2- 26.0) 22.0 ( 19.6- 24.6) 34.4 ( 26.6- 43.9) ∼
continued
C
ancer Incidence and M
ortality, by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
55
Table 2.3.1.2: Breast. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 30.8 ( 28.6- 33.1) 26.3 ( 24.0- 28.9) 42.9 ( 38.0- 48.3) ∼
Oklahoma 26.1 ( 23.9- 28.4) 26.7 ( 24.3- 29.2) 31.9 ( 22.0- 44.9) ∼
Texas 24.5 ( 23.6- 25.5) 23.4 ( 22.4- 24.4) 38.0 ( 34.3- 41.9) 17.0 ( 15.3- 18.9)
West 23.5 ( 23.0- 24.0) 24.2 ( 23.6- 24.8) 31.0 ( 28.1- 34.1) 16.4 ( 15.2- 17.7)
Mountain 23.3 ( 22.4- 24.3) 23.7 ( 22.7- 24.7) 28.7 ( 21.8- 37.4) 17.4 ( 14.9- 20.2)
Arizona 22.4 ( 20.7- 24.2) 22.5 ( 20.8- 24.4) 41.0 ( 25.9- 62.4) 18.0 ( 13.9- 23.2)
Colorado 23.2 ( 21.2- 25.4) 23.7 ( 21.7- 26.0) ∼ 18.5 ( 12.9- 25.8)
Idaho 24.7 ( 21.2- 28.8) 25.3 ( 21.6- 29.4) ∼ ∼
Montana 20.7 ( 17.1- 25.0) 20.8 ( 17.1- 25.2) ∼ ∼
Nevada 26.8 ( 23.8- 30.1) 26.7 ( 23.5- 30.2) 33.8 ( 20.8- 53.0) 17.0 ( 9.4- 29.2)
New Mexico 22.5 ( 19.7- 25.7) 23.8 ( 20.7- 27.2) ∼ 18.3 ( 13.9- 23.7)
Utah 23.7 ( 20.7- 27.1) 24.2 ( 21.1- 27.7) ∼ ∼
Wyoming 24.1 ( 18.6- 30.9) 24.7 ( 19.0- 31.7) ∼ ∼
Pacific 23.6 ( 23.0- 24.2) 24.5 ( 23.8- 25.2) 31.6 ( 28.4- 34.9) 16.1 ( 14.8- 17.6)
Alaska 23.1 ( 17.1- 30.9) 23.4 ( 16.3- 32.7) ∼ ∼
California 23.5 ( 22.8- 24.3) 24.3 ( 23.5- 25.1) 32.5 ( 29.2- 36.2) 16.3 ( 14.9- 17.8)
Hawaii 16.7 ( 13.8- 20.0) 23.9 ( 17.1- 33.4) ∼ ∼
Oregon 26.1 ( 23.9- 28.4) 26.4 ( 24.2- 28.8) ∼ ∼
Washington 23.9 ( 22.3- 25.7) 24.1 ( 22.4- 26.0) 25.6 ( 14.6- 42.4) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.4.1.1: Breast, In Situ . Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 28.4 ( 28.1- 28.6) 28.6 ( 28.3- 28.9) 24.8 ( 24.0- 25.5) 18.8 ( 18.0- 19.6)
Northeast 35.2 ( 34.5- 35.8) 35.9 ( 35.2- 36.6) 25.0 ( 23.4- 26.8) 25.0 ( 22.9- 27.3)
New England 42.4 ( 41.0- 43.9) 42.8 ( 41.3- 44.3) 31.6 ( 26.0- 38.2) 33.1 ( 26.7- 41.1)
Connecticut 41.7 ( 38.9- 44.6) 43.0 ( 40.0- 46.2) 29.0 ( 20.9- 39.4) 35.4 ( 24.8- 50.1)
Maine 34.5 ( 30.6- 39.0) 34.6 ( 30.6- 39.1) ∼ ∼
Massachusetts 47.9 ( 45.6- 50.2) 48.5 ( 46.1- 50.9) 34.7 ( 26.5- 45.0) 33.4 ( 24.5- 45.7)
New Hampshire 42.3 ( 37.7- 47.4) 41.1 ( 36.5- 46.2) ∼ ∼
Rhode Island 27.0 ( 23.0- 31.6) 27.2 ( 23.0- 32.0) ∼ ∼
Vermont 35.9 ( 30.0- 42.8) 35.5 ( 29.6- 42.4) ∼ ∼
Middle Atlantic 32.6 ( 31.9- 33.4) 33.1 ( 32.3- 34.0) 24.3 ( 22.5- 26.1) 23.7 ( 21.4- 26.1)
New Jersey 37.2 ( 35.5- 39.0) 38.4 ( 36.5- 40.4) 27.2 ( 23.1- 31.7) 21.6 ( 17.4- 26.6)
New York 32.6 ( 31.5- 33.7) 33.7 ( 32.4- 34.9) 21.9 ( 19.8- 24.3) 25.3 ( 22.5- 28.4)
Pennsylvania 29.5 ( 28.2- 30.8) 29.2 ( 27.9- 30.5) 28.0 ( 24.1- 32.5) -
Midwest 27.4 ( 26.8- 27.9) 27.0 ( 26.5- 27.6) 25.8 ( 24.1- 27.7) 21.1 ( 17.9- 24.7)
East North Central 27.9 ( 27.3- 28.6) 27.6 ( 26.9- 28.3) 26.0 ( 24.1- 28.1) 21.0 ( 17.6- 25.1)
Illinois 28.2 ( 26.9- 29.5) 28.7 ( 27.3- 30.1) 23.7 ( 20.6- 27.1) -
Indiana 25.9 ( 24.2- 27.7) 25.5 ( 23.7- 27.4) 25.7 ( 19.7- 33.2) ∼
Michigan 32.8 ( 31.3- 34.4) 32.4 ( 30.8- 34.1) 30.1 ( 26.1- 34.7) 17.4 ( 10.2- 29.2)
Detroit 34.8 ( 32.3- 37.3) 36.5 ( 33.7- 39.6) 30.2 ( 25.5- 35.5) ∼
Ohio 26.2 ( 25.0- 27.5) 25.5 ( 24.2- 26.8) 24.8 ( 21.1- 29.0) 23.4 ( 13.5- 39.2)
Wisconsin 24.3 ( 22.6- 26.2) 24.2 ( 22.4- 26.1) 28.5 ( 19.4- 41.2) ∼
West North Central 26.0 ( 25.0- 27.0) 25.8 ( 24.8- 26.8) 24.6 ( 20.3- 29.6) 21.0 ( 14.0- 30.6)
Iowa 25.9 ( 23.5- 28.5) 25.1 ( 22.8- 27.7) ∼ ∼
Kansas 26.1 ( 23.5- 28.9) 25.2 ( 22.6- 28.1) ∼ ∼
Minnesota 29.0 ( 27.0- 31.2) 28.5 ( 26.4- 30.6) 29.0 ( 16.3- 51.6) ∼
Missouri 24.1 ( 22.5- 25.9) 24.3 ( 22.6- 26.2) 24.0 ( 18.8- 30.3) ∼
Nebraska 27.4 ( 24.1- 31.1) 27.5 ( 24.2- 31.3) ∼ ∼
North Dakota 19.2 ( 14.8- 24.6) 19.4 ( 14.9- 25.1) ∼ ∼
South Dakota 23.8 ( 19.3- 29.1) 24.1 ( 19.4- 29.6) ∼ ∼
South
South Atlantic 28.0 ( 27.4- 28.6) 28.7 ( 28.0- 29.4) 25.8 ( 24.4- 27.2) 22.7 ( 20.6- 25.0)
Delaware 36.3 ( 31.0- 42.4) 38.5 ( 32.4- 45.6) 23.0 ( 13.8- 37.3) ∼
District of Columbia 25.5 ( 20.1- 32.1) 36.4 ( 24.8- 54.1) 19.9 ( 14.3- 27.7) ∼
Florida 26.7 ( 25.7- 27.7) 27.1 ( 26.0- 28.2) 24.3 ( 21.4- 27.4) -
Georgia 29.2 ( 27.6- 30.9) 30.1 ( 28.2- 32.1) 27.0 ( 23.9- 30.4) 20.9 ( 12.4- 35.0)
Atlanta 35.3 ( 32.2- 38.6) 37.3 ( 33.3- 41.6) 32.6 ( 27.2- 39.1) ∼
Maryland 30.8 ( 28.8- 32.8) 32.0 ( 29.6- 34.5) 28.6 ( 24.9- 32.8) 24.5 ( 15.2- 38.9)
North Carolina 26.9 ( 25.4- 28.4) 27.9 ( 26.2- 29.7) 23.6 ( 20.5- 27.1) ∼
South Carolina 26.0 ( 24.0- 28.2) 27.3 ( 24.8- 29.9) 23.4 ( 19.7- 27.7) -
Virginia 30.5 ( 28.9- 32.3) 30.7 ( 28.8- 32.8) 29.7 ( 25.8- 34.1) 24.0 ( 14.8- 38.3)
West Virginia 24.3 ( 21.5- 27.5) 24.4 ( 21.6- 27.7) ∼ ∼
East South Central
Alabama 24.6 ( 22.7- 26.6) 25.0 ( 22.8- 27.3) 24.5 ( 20.6- 28.9) ∼
Kentucky 22.9 ( 21.0- 25.0) 22.3 ( 20.4- 24.4) 22.7 ( 15.4- 32.5) -
Mississippi 21.7 ( 19.4- 24.1) 23.8 ( 20.9- 27.0) 16.6 ( 13.1- 20.7) ∼
Tennessee
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Table 2.4.1.1: Breast, In Situ . Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 23.3 ( 22.5- 24.0) 23.1 ( 22.3- 23.9) 22.2 ( 20.2- 24.4) 13.2 ( 11.8- 14.7)
Arkansas 24.0 ( 21.6- 26.6) 24.0 ( 21.4- 26.8) 21.0 ( 15.1- 28.7) ∼
Louisiana 21.7 ( 19.9- 23.7) 23.2 ( 20.9- 25.6) 18.4 ( 15.3- 22.0) ∼
Oklahoma 24.3 ( 22.2- 26.7) 25.2 ( 22.8- 27.8) 19.5 ( 12.3- 29.8) ∼
Texas 23.3 ( 22.4- 24.3) 22.6 ( 21.6- 23.6) 25.1 ( 22.1- 28.3) 13.2 ( 11.8- 14.8)
West 26.9 ( 26.3- 27.5) 27.1 ( 26.5- 27.8) 24.7 ( 22.1- 27.5) 17.1 ( 15.9- 18.4)
Mountain
Arizona
Colorado 30.4 ( 28.1- 32.8) 30.0 ( 27.7- 32.5) 29.0 ( 17.5- 46.3) 19.6 ( 14.3- 26.4)
Idaho 23.3 ( 19.8- 27.2) 23.1 ( 19.6- 27.1) ∼ ∼
Montana 29.5 ( 25.1- 34.6) 28.8 ( 24.3- 34.1) ∼ ∼
Nevada 19.4 ( 16.9- 22.1) 18.5 ( 15.9- 21.5) 28.8 ( 17.4- 46.4) ∼
New Mexico 19.5 ( 16.9- 22.5) 21.1 ( 18.2- 24.4) ∼ 10.7 ( 7.5- 14.9)
Utah 24.2 ( 21.1- 27.6) 24.6 ( 21.4- 28.1) ∼ ∼
Wyoming
Pacific 27.4 ( 26.7- 28.1) 27.7 ( 26.9- 28.5) 24.5 ( 21.8- 27.5) 17.7 ( 16.3- 19.2)
Alaska 34.2 ( 27.2- 42.8) 32.5 ( 24.8- 42.4) ∼ ∼
California 26.1 ( 25.3- 26.8) 26.5 ( 25.7- 27.4) 24.3 ( 21.4- 27.4) 17.7 ( 16.3- 19.2)
San Francisco-Oakland 29.8 ( 27.6- 32.2) 30.6 ( 27.9- 33.5) 22.4 ( 16.5- 29.8) 19.5 ( 14.4- 25.9)
San Jose-Monterey 26.2 ( 23.4- 29.3) 26.0 ( 22.7- 29.6) ∼ 17.3 ( 11.8- 24.8)
Los Angeles 24.0 ( 22.6- 25.4) 24.4 ( 22.8- 26.2) 24.7 ( 20.5- 29.5) 16.9 ( 14.8- 19.2)
Hawaii 31.4 ( 27.4- 35.9) 31.4 ( 23.6- 41.8) ∼ -
Oregon 27.9 ( 25.6- 30.3) 27.7 ( 25.3- 30.2) ∼ ∼
Washington 32.6 ( 30.7- 34.7) 32.5 ( 30.5- 34.7) 35.1 ( 22.3- 53.4) 16.6 ( 9.6- 29.0)
Seattle-Puget Sound 34.1 ( 31.7- 36.6) 35.2 ( 32.6- 38.0) 34.9 ( 21.7- 54.2) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ In situ cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.5.1.1: Cervix Uteri. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 8.1 ( 8.0- 8.3) 7.7 ( 7.5- 7.8) 11.1 ( 10.6- 11.6) 13.0 ( 12.4- 13.6)
Northeast 7.8 ( 7.5- 8.2) 7.3 ( 6.9- 7.6) 11.2 ( 10.1- 12.4) 12.5 ( 11.0- 14.0)
New England 6.2 ( 5.6- 6.8) 6.0 ( 5.5- 6.6) 7.9 ( 5.3- 11.5) 11.2 ( 8.0- 15.9)
Connecticut 6.8 ( 5.7- 8.1) 6.3 ( 5.1- 7.7) 13.2 ( 8.1- 20.8) 19.8 ( 12.8- 30.9)
Maine 8.0 ( 6.0- 10.5) 8.0 ( 6.0- 10.5) ∼ ∼
Massachusetts 5.2 ( 4.5- 6.1) 5.1 ( 4.3- 6.0) ∼ ∼
New Hampshire 6.6 ( 4.8- 8.9) 6.5 ( 4.7- 8.8) ∼ ∼
Rhode Island 6.8 ( 4.8- 9.4) 6.6 ( 4.6- 9.3) ∼ ∼
Vermont 7.3 ( 4.7- 11.1) 7.4 ( 4.8- 11.3) ∼ ∼
Middle Atlantic 8.4 ( 8.0- 8.8) 7.8 ( 7.3- 8.2) 11.7 ( 10.5- 13.0) 12.6 ( 11.1- 14.3)
New Jersey 9.5 ( 8.6- 10.4) 9.0 ( 8.0- 10.0) 13.5 ( 10.8- 16.8) 15.4 ( 12.2- 19.4)
New York 8.5 ( 8.0- 9.1) 7.5 ( 6.9- 8.2) 12.1 ( 10.5- 13.9) 11.9 ( 10.0- 14.0)
Pennsylvania 7.6 ( 7.0- 8.3) 7.4 ( 6.7- 8.1) 9.0 ( 6.9- 11.7) -
Midwest 7.8 ( 7.5- 8.1) 7.2 ( 6.9- 7.5) 12.1 ( 10.9- 13.4) 15.4 ( 13.0- 18.2)
East North Central 8.1 ( 7.7- 8.4) 7.4 ( 7.0- 7.7) 11.9 ( 10.7- 13.3) 15.2 ( 12.5- 18.5)
Illinois 9.3 ( 8.5- 10.0) 8.2 ( 7.5- 9.0) 14.5 ( 12.1- 17.2) -
Indiana 7.8 ( 6.8- 8.8) 7.8 ( 6.8- 8.9) 6.1 ( 3.5- 10.2) 25.1 ( 15.2- 42.2)
Michigan 7.6 ( 6.8- 8.4) 6.6 ( 5.9- 7.5) 11.6 ( 9.2- 14.4) ∼
Detroit 8.4 ( 7.2- 9.7) 6.9 ( 5.7- 8.4) 12.6 ( 9.7- 16.1) ∼
Ohio 8.1 ( 7.4- 8.8) 7.5 ( 6.8- 8.3) 10.2 ( 7.9- 13.0) 20.4 ( 11.1- 35.6)
Wisconsin 6.6 ( 5.7- 7.6) 6.1 ( 5.2- 7.1) 15.5 ( 9.0- 25.8) ∼
West North Central 7.3 ( 6.8- 7.9) 6.9 ( 6.3- 7.4) 12.9 ( 9.9- 16.6) 16.1 ( 11.1- 23.5)
Iowa 7.4 ( 6.1- 8.9) 7.1 ( 5.8- 8.6) ∼ ∼
Kansas 7.9 ( 6.5- 9.6) 7.5 ( 6.0- 9.2) ∼ ∼
Minnesota 6.7 ( 5.8- 7.8) 6.3 ( 5.3- 7.4) ∼ ∼
Missouri 7.9 ( 6.9- 9.0) 7.3 ( 6.3- 8.4) 13.0 ( 9.3- 17.8) ∼
Nebraska 7.6 ( 5.8- 9.7) 7.3 ( 5.6- 9.5) ∼ ∼
North Dakota 6.4 ( 3.8- 10.2) 6.0 ( 3.5- 9.9) ∼ ∼
South Dakota 4.4 ( 2.5- 7.3) ∼ ∼ ∼
South
South Atlantic 8.4 ( 8.1- 8.7) 7.8 ( 7.5- 8.2) 10.8 ( 9.9- 11.7) 12.2 ( 10.7- 13.8)
Delaware 5.9 ( 3.8- 8.7) 5.0 ( 2.9- 8.2) ∼ ∼
District of Columbia 13.3 ( 9.4- 18.5) ∼ 12.4 ( 7.9- 19.2) ∼
Florida 9.2 ( 8.6- 9.8) 9.0 ( 8.4- 9.8) 12.0 ( 10.0- 14.2) -
Georgia 9.6 ( 8.7- 10.6) 8.7 ( 7.7- 9.9) 12.2 ( 10.2- 14.5) 18.3 ( 10.7- 31.4)
Atlanta 8.6 ( 7.2- 10.3) 8.2 ( 6.5- 10.4) 9.9 ( 7.2- 13.7) ∼
Maryland 9.3 ( 8.2- 10.5) 8.4 ( 7.1- 9.8) 10.6 ( 8.4- 13.2) ∼
North Carolina 7.0 ( 6.2- 7.8) 6.1 ( 5.3- 7.1) 9.1 ( 7.2- 11.3) 16.9 ( 9.4- 32.0)
South Carolina 8.2 ( 7.0- 9.5) 7.0 ( 5.7- 8.5) 11.1 ( 8.6- 14.2) -
Virginia 6.3 ( 5.5- 7.1) 5.9 ( 5.1- 6.9) 8.1 ( 6.2- 10.6) ∼
West Virginia 9.3 ( 7.5- 11.5) 9.4 ( 7.5- 11.6) ∼ ∼
East South Central
Alabama 8.4 ( 7.2- 9.6) 7.7 ( 6.4- 9.1) 10.7 ( 8.2- 13.7) ∼
Kentucky 8.8 ( 7.6- 10.2) 8.1 ( 6.9- 9.5) 17.1 ( 11.0- 25.5) -
Mississippi 7.6 ( 6.3- 9.2) 6.6 ( 5.1- 8.6) 10.3 ( 7.6- 13.8) ∼
Tennessee
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Table 2.5.1.1: Cervix Uteri. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 9.8 ( 9.4- 10.3) 9.7 ( 9.1- 10.2) 12.2 ( 10.7- 13.8) 14.7 ( 13.3- 16.3)
Arkansas 9.8 ( 8.2- 11.6) 10.0 ( 8.2- 12.0) 10.5 ( 6.4- 16.2) ∼
Louisiana 9.0 ( 7.8- 10.4) 7.3 ( 6.0- 8.8) 13.7 ( 11.0- 16.8) ∼
Oklahoma 9.4 ( 8.0- 10.9) 9.4 ( 7.9- 11.2) ∼ ∼
Texas 10.1 ( 9.5- 10.7) 10.1 ( 9.5- 10.8) 11.7 ( 9.8- 13.9) 15.0 ( 13.5- 16.6)
West 7.6 ( 7.3- 7.9) 7.5 ( 7.1- 7.8) 7.9 ( 6.5- 9.5) 12.1 ( 11.2- 13.1)
Mountain
Arizona
Colorado 6.8 ( 5.8- 8.0) 6.7 ( 5.6- 7.9) ∼ 7.5 ( 4.6- 12.0)
Idaho 6.5 ( 4.7- 8.8) 6.4 ( 4.6- 8.8) ∼ ∼
Montana 6.0 ( 4.0- 8.8) 5.8 ( 3.7- 8.7) ∼ ∼
Nevada 9.8 ( 8.1- 11.9) 9.8 ( 7.9- 12.0) ∼ 9.5 ( 5.1- 18.2)
New Mexico 6.9 ( 5.3- 8.8) 7.0 ( 5.3- 9.1) ∼ 6.5 ( 4.1- 9.8)
Utah 4.9 ( 3.6- 6.5) 4.8 ( 3.5- 6.5) ∼ ∼
Wyoming
Pacific 7.7 ( 7.4- 8.1) 7.7 ( 7.3- 8.1) 8.1 ( 6.7- 9.9) 13.0 ( 11.9- 14.2)
Alaska ∼ ∼ ∼ ∼
California 8.1 ( 7.7- 8.5) 8.2 ( 7.7- 8.7) 7.9 ( 6.4- 9.7) 13.2 ( 12.1- 14.5)
San Francisco-Oakland 5.9 ( 5.0- 7.1) 5.9 ( 4.7- 7.3) 7.8 ( 4.5- 12.6) 9.7 ( 6.4- 14.3)
San Jose-Monterey 6.8 ( 5.3- 8.4) 6.4 ( 4.8- 8.4) ∼ 10.7 ( 6.8- 16.5)
Los Angeles 10.9 ( 9.9- 11.8) 11.6 ( 10.5- 12.8) 8.6 ( 6.3- 11.5) 16.5 ( 14.6- 18.7)
Hawaii 8.8 ( 6.6- 11.5) ∼ ∼ -
Oregon 6.3 ( 5.2- 7.6) 6.2 ( 5.0- 7.5) ∼ ∼
Washington 6.8 ( 6.0- 7.8) 6.8 ( 5.9- 7.9) ∼ 14.6 ( 8.0- 26.7)
Seattle-Puget Sound 6.8 ( 5.8- 8.1) 6.9 ( 5.7- 8.2) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.5.1.2: Cervix Uteri. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 2.5 ( 2.4- 2.6) 2.2 ( 2.2- 2.3) 4.7 ( 4.3- 5.0) 3.0 ( 2.7- 3.3)
Northeast 2.3 ( 2.1- 2.4) 2.0 ( 1.8- 2.2) 4.7 ( 4.0- 5.5) 2.9 ( 2.2- 3.9)
New England 1.6 ( 1.4- 1.9) 1.6 ( 1.3- 1.9) ∼ ∼
Connecticut 1.8 ( 1.3- 2.5) 1.7 ( 1.2- 2.5) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.3 ( 1.0- 1.8) 1.4 ( 1.0- 1.8) ∼ ∼
New Hampshire 2.3 ( 1.3- 3.7) 2.3 ( 1.3- 3.8) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.5 ( 2.3- 2.7) 2.1 ( 1.9- 2.3) 5.0 ( 4.2- 5.9) 3.1 ( 2.4- 4.1)
New Jersey 2.7 ( 2.3- 3.2) 2.3 ( 1.8- 2.8) 6.5 ( 4.6- 9.0) ∼
New York 2.6 ( 2.4- 3.0) 2.2 ( 1.9- 2.5) 5.0 ( 4.0- 6.2) 3.6 ( 2.6- 4.9)
Pennsylvania 2.1 ( 1.8- 2.4) 1.9 ( 1.6- 2.3) 3.7 ( 2.4- 5.5) ∼
Midwest 2.4 ( 2.2- 2.5) 2.1 ( 2.0- 2.3) 4.7 ( 4.0- 5.6) 3.0 ( 1.9- 4.7)
East North Central 2.4 ( 2.2- 2.6) 2.1 ( 1.9- 2.3) 4.7 ( 3.9- 5.7) 3.2 ( 1.9- 5.3)
Illinois 2.8 ( 2.4- 3.2) 2.2 ( 1.8- 2.6) 6.4 ( 4.9- 8.3) ∼
Indiana 2.8 ( 2.2- 3.4) 2.7 ( 2.1- 3.4) ∼ ∼
Michigan 1.9 ( 1.5- 2.3) 1.7 ( 1.3- 2.1) 3.1 ( 1.9- 4.8) ∼
Ohio 2.5 ( 2.1- 2.9) 2.4 ( 2.0- 2.8) 4.2 ( 2.8- 6.1) ∼
Wisconsin 1.8 ( 1.4- 2.4) 1.6 ( 1.2- 2.1) ∼ ∼
West North Central 2.3 ( 2.0- 2.6) 2.1 ( 1.8- 2.4) 4.8 ( 3.0- 7.3) ∼
Iowa 2.8 ( 2.1- 3.8) 2.6 ( 1.9- 3.6) ∼ ∼
Kansas 2.4 ( 1.7- 3.4) 2.3 ( 1.6- 3.3) ∼ ∼
Minnesota 1.8 ( 1.3- 2.4) 1.6 ( 1.1- 2.2) ∼ ∼
Missouri 2.8 ( 2.2- 3.4) 2.5 ( 2.0- 3.2) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.9 ( 2.7- 3.0) 2.6 ( 2.4- 2.7) 4.8 ( 4.4- 5.3) 3.5 ( 3.0- 4.1)
South Atlantic 2.6 ( 2.4- 2.8) 2.3 ( 2.1- 2.5) 4.4 ( 3.8- 5.0) 2.3 ( 1.7- 3.1)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.8 ( 2.5- 3.2) 2.6 ( 2.2- 2.9) 5.2 ( 4.0- 6.8) 2.5 ( 1.8- 3.5)
Georgia 2.7 ( 2.2- 3.2) 2.4 ( 1.9- 3.1) 3.9 ( 2.8- 5.4) ∼
Maryland 2.0 ( 1.6- 2.6) 1.4 ( 1.0- 2.0) 3.6 ( 2.4- 5.4) ∼
North Carolina 2.3 ( 1.9- 2.8) 2.0 ( 1.6- 2.6) 3.6 ( 2.5- 5.1) ∼
South Carolina 3.1 ( 2.4- 3.9) 2.3 ( 1.6- 3.2) 5.7 ( 3.9- 8.1) ∼
Virginia 2.5 ( 2.1- 3.1) 2.3 ( 1.8- 2.9) 4.2 ( 2.8- 6.1) ∼
West Virginia 4.0 ( 2.9- 5.5) 4.2 ( 3.0- 5.8) ∼ ∼
East South Central 3.3 ( 2.9- 3.6) 2.6 ( 2.3- 3.0) 6.6 ( 5.4- 7.9) ∼
Alabama 3.0 ( 2.3- 3.7) 2.5 ( 1.8- 3.4) 5.1 ( 3.4- 7.3) ∼
Kentucky 3.9 ( 3.1- 4.8) 3.5 ( 2.8- 4.5) ∼ ∼
Mississippi 3.7 ( 2.8- 4.8) 1.7 ( 1.0- 2.8) 8.1 ( 5.7- 11.3) ∼
Tennessee 2.9 ( 2.3- 3.5) 2.4 ( 1.9- 3.1) 6.1 ( 4.0- 9.1) ∼
West South Central 3.1 ( 2.9- 3.4) 2.9 ( 2.7- 3.3) 4.7 ( 3.8- 5.8) 4.5 ( 3.7- 5.5)
Arkansas 3.3 ( 2.4- 4.4) 3.5 ( 2.5- 4.8) ∼ ∼
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Table 2.5.1.2: Cervix Uteri. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 2.8 ( 2.2- 3.6) 1.8 ( 1.2- 2.6) 5.3 ( 3.7- 7.4) ∼
Oklahoma 3.0 ( 2.2- 3.9) 2.8 ( 2.0- 3.8) ∼ ∼
Texas 3.2 ( 2.9- 3.6) 3.1 ( 2.8- 3.5) 5.1 ( 3.8- 6.7) 4.7 ( 3.8- 5.7)
West 2.2 ( 2.0- 2.3) 2.1 ( 1.9- 2.2) 3.3 ( 2.5- 4.5) 2.6 ( 2.2- 3.1)
Mountain 2.1 ( 1.8- 2.4) 2.0 ( 1.7- 2.3) ∼ 2.1 ( 1.4- 3.1)
Arizona 2.3 ( 1.8- 2.9) 2.0 ( 1.5- 2.7) ∼ ∼
Colorado 1.8 ( 1.3- 2.4) 1.7 ( 1.2- 2.4) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.3 ( 1.5- 3.4) 2.1 ( 1.3- 3.2) ∼ ∼
New Mexico 2.3 ( 1.5- 3.5) 2.5 ( 1.5- 3.8) ∼ ∼
Utah 2.2 ( 1.3- 3.4) 2.3 ( 1.4- 3.5) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.2 ( 2.0- 2.4) 2.1 ( 1.9- 2.3) 3.4 ( 2.4- 4.6) 2.8 ( 2.3- 3.4)
Alaska ∼ ∼ ∼ ∼
California 2.2 ( 2.0- 2.5) 2.2 ( 1.9- 2.4) 3.2 ( 2.2- 4.5) 2.7 ( 2.2- 3.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.1 ( 1.5- 2.9) 2.1 ( 1.5- 2.9) ∼ ∼
Washington 2.0 ( 1.5- 2.5) 1.8 ( 1.3- 2.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.6.1.1M: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 60.4 ( 59.9- 60.8) 59.2 ( 58.7- 59.7) 69.4 ( 67.8- 71.1) 49.3 ( 47.7- 51.0)
Northeast 64.7 ( 63.7- 65.7) 64.1 ( 63.1- 65.2) 67.8 ( 64.0- 71.7) 53.1 ( 48.9- 57.8)
New England 63.6 ( 61.7- 65.6) 63.7 ( 61.8- 65.8) 56.7 ( 46.9- 68.5) 49.6 ( 38.4- 63.6)
Connecticut 61.7 ( 58.0- 65.7) 61.9 ( 58.0- 66.0) 65.0 ( 48.7- 86.5) 59.5 ( 39.9- 86.8)
Maine 68.3 ( 62.0- 75.0) 68.3 ( 62.0- 75.1) ∼ ∼
Massachusetts 66.1 ( 63.2- 69.2) 66.7 ( 63.6- 69.8) 49.9 ( 37.4- 66.3) 45.2 ( 30.5- 66.2)
New Hampshire 56.5 ( 50.4- 63.2) 53.5 ( 47.6- 60.1) ∼ ∼
Rhode Island 62.3 ( 55.6- 69.6) 63.4 ( 56.5- 71.1) ∼ ∼
Vermont 58.3 ( 49.7- 68.1) 58.9 ( 50.3- 68.8) ∼ ∼
Middle Atlantic 65.1 ( 63.9- 66.2) 64.3 ( 63.0- 65.5) 69.1 ( 65.1- 73.3) 53.6 ( 49.0- 58.6)
New Jersey 66.9 ( 64.3- 69.6) 65.7 ( 63.0- 68.5) 80.3 ( 70.8- 91.0) 48.7 ( 40.6- 58.5)
New York 62.2 ( 60.5- 63.9) 61.5 ( 59.7- 63.4) 62.0 ( 57.0- 67.4) 55.9 ( 50.1- 62.3)
Pennsylvania 67.7 ( 65.7- 69.8) 66.8 ( 64.7- 68.9) 76.6 ( 68.2- 85.8) -
Midwest 63.2 ( 62.2- 64.1) 61.0 ( 60.1- 62.0) 76.1 ( 72.2- 80.2) 47.8 ( 42.1- 54.4)
East North Central 63.0 ( 61.9- 64.2) 60.4 ( 59.3- 61.6) 77.0 ( 72.8- 81.5) 48.5 ( 42.0- 55.9)
Illinois 68.4 ( 66.1- 70.7) 66.7 ( 64.4- 69.2) 80.9 ( 73.4- 89.0) -
Indiana 61.7 ( 58.7- 64.8) 60.7 ( 57.7- 63.9) 65.6 ( 53.4- 80.2) 51.8 ( 31.6- 84.0)
Michigan 60.4 ( 58.1- 62.8) 56.2 ( 53.8- 58.6) 89.6 ( 80.7- 99.3) 45.3 ( 30.0- 68.0)
Detroit 63.9 ( 60.1- 67.9) 58.6 ( 54.5- 63.0) 86.7 ( 76.7- 97.9) 48.9 ( 26.4- 88.9)
Ohio 61.5 ( 59.3- 63.7) 57.6 ( 55.5- 59.9) 64.0 ( 56.6- 72.3) 59.0 ( 39.7- 88.0)
Wisconsin 60.9 ( 57.9- 64.1) 60.2 ( 57.1- 63.5) 71.1 ( 51.6- 98.6) -
West North Central 63.4 ( 61.8- 65.1) 62.4 ( 60.7- 64.1) 71.0 ( 61.5- 81.9) 45.9 ( 33.7- 62.1)
Iowa 64.9 ( 60.8- 69.2) 64.4 ( 60.3- 68.7) ∼ ∼
Kansas 65.0 ( 60.5- 69.7) 63.6 ( 59.1- 68.4) 65.6 ( 43.2- 96.7) 42.9 ( 24.1- 75.8)
Minnesota 59.2 ( 56.0- 62.5) 58.0 ( 54.8- 61.4) 45.5 ( 24.0- 85.3) ∼
Missouri 63.5 ( 60.5- 66.7) 62.2 ( 59.0- 65.4) 78.0 ( 65.6- 92.5) ∼
Nebraska 69.6 ( 63.9- 75.7) 68.7 ( 62.9- 74.8) ∼ ∼
North Dakota 69.8 ( 60.9- 79.7) 70.2 ( 61.2- 80.3) ∼ ∼
South Dakota 59.8 ( 52.2- 68.3) 58.8 ( 51.1- 67.4) ∼ ∼
South
South Atlantic 58.6 ( 57.6- 59.6) 57.2 ( 56.2- 58.2) 66.4 ( 63.6- 69.3) 57.1 ( 53.0- 61.4)
Delaware 61.6 ( 53.8- 70.3) 59.3 ( 51.1- 68.5) 71.0 ( 47.1- 105.3) ∼
District of Columbia 56.3 ( 46.7- 67.3) 49.5 ( 35.0- 69.8) 58.3 ( 46.2- 72.8) ∼
Florida 57.0 ( 55.5- 58.6) 56.6 ( 55.0- 58.2) 58.6 ( 52.9- 64.9) -
Georgia 60.1 ( 57.3- 63.1) 57.7 ( 54.6- 61.0) 71.1 ( 64.2- 78.7) 30.1 ( 16.9- 52.5)
Atlanta 56.4 ( 51.2- 62.1) 50.6 ( 44.9- 56.9) 79.7 ( 66.4- 95.6) ∼
Maryland 60.2 ( 57.0- 63.5) 58.8 ( 55.2- 62.6) 65.2 ( 57.5- 73.8) 46.1 ( 27.0- 75.1)
North Carolina 55.9 ( 53.4- 58.5) 53.9 ( 51.2- 56.7) 66.6 ( 59.8- 74.1) 25.4 ( 13.7- 48.1)
South Carolina 62.3 ( 58.6- 66.1) 58.9 ( 54.9- 63.2) 74.2 ( 65.5- 83.8) -
Virginia 57.1 ( 54.4- 59.9) 55.3 ( 52.4- 58.4) 68.7 ( 61.2- 77.0) 28.1 ( 15.2- 50.6)
West Virginia 70.6 ( 65.2- 76.4) 70.6 ( 65.2- 76.5) 73.3 ( 41.1- 122.5) ∼
East South Central
Alabama 60.9 ( 57.5- 64.6) 59.7 ( 55.9- 63.7) 66.1 ( 57.9- 75.2) ∼
Kentucky 68.2 ( 64.4- 72.3) 67.3 ( 63.3- 71.5) 90.8 ( 71.9- 114.2) -
Mississippi 63.8 ( 59.3- 68.7) 61.6 ( 56.4- 67.3) 71.2 ( 61.9- 81.6) ∼
Tennessee
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Table 2.6.1.1M: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 60.2 ( 58.8- 61.6) 58.5 ( 57.0- 59.9) 74.3 ( 69.5- 79.3) 48.0 ( 44.6- 51.6)
Arkansas 60.5 ( 56.2- 65.0) 59.1 ( 54.7- 63.8) 65.1 ( 51.7- 81.3) ∼
Louisiana 69.9 ( 66.0- 73.9) 68.2 ( 63.8- 72.8) 75.1 ( 67.0- 84.1) 48.1 ( 27.5- 83.8)
Oklahoma 62.4 ( 58.5- 66.5) 61.2 ( 57.1- 65.5) 73.7 ( 54.5- 98.4) ∼
Texas 57.6 ( 55.9- 59.4) 56.0 ( 54.2- 57.8) 76.1 ( 69.3- 83.4) 48.4 ( 45.0- 52.2)
West 53.7 ( 52.7- 54.6) 53.2 ( 52.2- 54.2) 62.0 ( 56.8- 67.5) 44.9 ( 42.4- 47.5)
Mountain
Arizona
Colorado 50.0 ( 46.6- 53.7) 49.5 ( 46.1- 53.3) 56.9 ( 36.1- 90.1) 48.1 ( 38.0- 60.8)
Idaho 53.3 ( 47.5- 59.8) 53.6 ( 47.7- 60.1) ∼ ∼
Montana 48.5 ( 42.3- 55.5) 47.2 ( 40.9- 54.2) ∼ ∼
Nevada 58.1 ( 53.1- 63.4) 57.6 ( 52.4- 63.2) 73.5 ( 48.7- 110.6) 38.0 ( 23.9- 60.4)
New Mexico 50.2 ( 45.4- 55.3) 51.7 ( 46.7- 57.2) ∼ 52.0 ( 43.6- 61.9)
Utah 51.7 ( 46.7- 57.2) 52.0 ( 46.9- 57.6) ∼ ∼
Wyoming
Pacific 54.2 ( 53.1- 55.3) 53.7 ( 52.5- 54.8) 62.4 ( 57.0- 68.4) 44.1 ( 41.3- 47.0)
Alaska 59.5 ( 47.6- 74.6) 48.1 ( 36.1- 64.1) ∼ ∼
California 54.1 ( 52.8- 55.3) 54.3 ( 52.9- 55.6) 63.6 ( 57.8- 70.0) 44.2 ( 41.3- 47.1)
San Francisco-Oakland 54.8 ( 51.4- 58.4) 55.4 ( 51.3- 59.7) 54.9 ( 43.3- 69.0) 48.5 ( 38.3- 61.0)
San Jose-Monterey 45.7 ( 41.3- 50.4) 48.3 ( 43.2- 53.8) ∼ 35.9 ( 26.4- 48.7)
Los Angeles 55.3 ( 52.9- 57.9) 52.5 ( 49.7- 55.4) 76.5 ( 67.2- 86.9) 41.4 ( 37.0- 46.4)
Hawaii 63.9 ( 57.7- 70.7) 65.9 ( 53.9- 80.5) ∼ -
Oregon 54.8 ( 51.2- 58.5) 52.3 ( 48.7- 56.0) ∼ ∼
Washington 52.2 ( 49.4- 55.1) 51.5 ( 48.6- 54.5) 45.2 ( 28.7- 70.9) 41.4 ( 26.6- 63.7)
Seattle-Puget Sound 51.4 ( 48.1- 54.9) 52.0 ( 48.5- 55.8) 36.3 ( 21.7- 61.5) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.6.1.1F: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 44.2 ( 43.8- 44.5) 43.0 ( 42.6- 43.3) 52.5 ( 51.3- 53.6) 34.7 ( 33.5- 35.9)
Northeast 47.2 ( 46.5- 48.0) 46.8 ( 46.0- 47.6) 47.3 ( 44.9- 49.7) 39.4 ( 36.4- 42.5)
New England 45.9 ( 44.5- 47.4) 45.8 ( 44.3- 47.3) 46.5 ( 39.3- 54.7) 35.9 ( 28.2- 45.3)
Connecticut 44.0 ( 41.3- 47.0) 43.6 ( 40.7- 46.6) 50.6 ( 39.5- 64.2) 43.8 ( 30.5- 61.7)
Maine 46.7 ( 42.2- 51.7) 46.7 ( 42.2- 51.7) ∼ ∼
Massachusetts 47.4 ( 45.3- 49.6) 47.6 ( 45.4- 49.9) 46.4 ( 36.3- 58.6) 28.4 ( 18.9- 41.8)
New Hampshire 47.6 ( 42.7- 53.0) 45.6 ( 40.8- 51.0) ∼ ∼
Rhode Island 42.8 ( 38.1- 48.1) 43.8 ( 38.9- 49.4) ∼ ∼
Vermont 42.0 ( 35.7- 49.4) 41.5 ( 35.2- 48.9) ∼ ∼
Middle Atlantic 47.7 ( 46.9- 48.6) 47.2 ( 46.3- 48.1) 47.3 ( 44.8- 49.9) 39.8 ( 36.7- 43.1)
New Jersey 49.0 ( 47.1- 50.9) 47.6 ( 45.6- 49.7) 54.6 ( 48.6- 61.2) 41.7 ( 35.2- 49.1)
New York 46.8 ( 45.6- 48.1) 46.3 ( 44.9- 47.7) 44.7 ( 41.5- 48.1) 39.7 ( 36.0- 43.7)
Pennsylvania 48.2 ( 46.8- 49.8) 48.1 ( 46.6- 49.7) 47.7 ( 42.5- 53.3) -
Midwest 45.5 ( 44.8- 46.2) 43.9 ( 43.2- 44.6) 56.7 ( 54.0- 59.6) 32.3 ( 28.0- 37.2)
East North Central 45.5 ( 44.7- 46.3) 43.6 ( 42.7- 44.4) 56.2 ( 53.3- 59.3) 30.9 ( 26.1- 36.3)
Illinois 47.2 ( 45.6- 48.8) 44.9 ( 43.2- 46.6) 60.1 ( 55.0- 65.6) -
Indiana 45.2 ( 43.0- 47.5) 43.7 ( 41.5- 46.0) 62.8 ( 52.9- 74.1) 44.4 ( 26.2- 71.2)
Michigan 45.0 ( 43.2- 46.7) 43.2 ( 41.4- 45.1) 53.8 ( 48.2- 59.8) 24.1 ( 14.3- 38.8)
Detroit 46.3 ( 43.6- 49.2) 44.1 ( 41.1- 47.4) 55.8 ( 49.3- 62.9) ∼
Ohio 44.0 ( 42.5- 45.6) 41.6 ( 40.0- 43.2) 49.5 ( 44.2- 55.3) 35.3 ( 22.2- 54.4)
Wisconsin 46.5 ( 44.1- 48.9) 45.7 ( 43.3- 48.2) 62.5 ( 47.8- 81.1) 36.0 ( 19.8- 63.1)
West North Central 45.5 ( 44.3- 46.8) 44.5 ( 43.2- 45.7) 59.9 ( 52.8- 67.7) 38.8 ( 28.7- 51.7)
Iowa 48.4 ( 45.3- 51.7) 47.2 ( 44.2- 50.5) ∼ ∼
Kansas 46.6 ( 43.3- 50.1) 44.6 ( 41.3- 48.2) 73.9 ( 54.0- 99.1) 43.6 ( 25.2- 72.0)
Minnesota 42.7 ( 40.3- 45.2) 42.2 ( 39.8- 44.7) 44.2 ( 25.7- 73.4) ∼
Missouri 45.7 ( 43.5- 48.0) 44.3 ( 42.0- 46.7) 58.8 ( 50.3- 68.4) ∼
Nebraska 46.9 ( 42.8- 51.3) 46.5 ( 42.3- 51.0) ∼ ∼
North Dakota 39.3 ( 33.3- 46.2) 39.2 ( 33.2- 46.3) ∼ ∼
South Dakota 47.7 ( 41.6- 54.5) 47.7 ( 41.4- 54.7) ∼ ∼
South
South Atlantic 43.7 ( 43.0- 44.4) 41.6 ( 40.8- 42.4) 52.7 ( 50.7- 54.7) 42.4 ( 39.4- 45.6)
Delaware 45.0 ( 39.2- 51.5) 42.7 ( 36.6- 49.8) 50.9 ( 35.2- 71.8) ∼
District of Columbia 48.3 ( 41.0- 56.9) 27.6 ( 17.6- 43.9) 57.0 ( 47.4- 68.7) ∼
Florida 43.0 ( 41.8- 44.2) 42.0 ( 40.8- 43.3) 50.2 ( 45.9- 54.8) -
Georgia 42.5 ( 40.5- 44.5) 39.9 ( 37.7- 42.2) 50.4 ( 46.0- 55.2) 36.3 ( 23.0- 55.5)
Atlanta 42.0 ( 38.4- 45.9) 37.3 ( 33.2- 41.8) 53.0 ( 45.4- 61.7) ∼
Maryland 47.5 ( 45.1- 50.1) 43.4 ( 40.6- 46.2) 58.3 ( 52.7- 64.4) 37.3 ( 23.6- 56.8)
North Carolina 40.4 ( 38.6- 42.3) 38.1 ( 36.1- 40.1) 49.6 ( 45.0- 54.6) 24.7 ( 12.9- 44.9)
South Carolina 46.0 ( 43.3- 48.8) 42.4 ( 39.5- 45.6) 55.4 ( 49.5- 61.9) -
Virginia 43.0 ( 41.0- 45.1) 41.2 ( 39.0- 43.5) 52.5 ( 47.1- 58.3) 34.7 ( 22.2- 52.6)
West Virginia 52.0 ( 48.0- 56.3) 51.0 ( 47.0- 55.3) 83.4 ( 55.1- 122.9) ∼
East South Central
Alabama 40.5 ( 38.2- 43.0) 38.8 ( 36.2- 41.6) 46.9 ( 41.5- 52.9) ∼
Kentucky 51.9 ( 49.1- 54.9) 51.0 ( 48.1- 54.1) 68.7 ( 55.3- 84.4) -
Mississippi 46.3 ( 43.1- 49.8) 42.7 ( 39.0- 46.8) 55.5 ( 48.8- 62.9) ∼
Tennessee
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Table 2.6.1.1F: Colon and Rectum. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 41.7 ( 40.7- 42.7) 39.6 ( 38.5- 40.6) 55.6 ( 52.3- 59.0) 30.3 ( 28.0- 32.8)
Arkansas 42.7 ( 39.6- 46.0) 41.3 ( 38.1- 44.8) 50.7 ( 41.1- 62.1) ∼
Louisiana 48.9 ( 46.1- 51.7) 44.4 ( 41.4- 47.6) 61.6 ( 55.7- 68.1) ∼
Oklahoma 43.0 ( 40.2- 46.0) 41.2 ( 38.3- 44.3) 54.2 ( 41.1- 70.4) ∼
Texas 39.5 ( 38.3- 40.8) 38.0 ( 36.7- 39.3) 52.8 ( 48.3- 57.6) 30.4 ( 28.1- 33.0)
West 40.2 ( 39.5- 40.9) 40.1 ( 39.3- 40.9) 50.0 ( 46.2- 54.1) 31.7 ( 29.9- 33.6)
Mountain
Arizona
Colorado 40.4 ( 37.7- 43.2) 40.3 ( 37.5- 43.2) 35.8 ( 22.1- 55.5) 37.9 ( 29.7- 47.8)
Idaho 40.1 ( 35.5- 45.1) 39.9 ( 35.3- 45.0) ∼ ∼
Montana 42.6 ( 37.3- 48.5) 42.0 ( 36.7- 48.1) ∼ ∼
Nevada 40.9 ( 37.1- 44.9) 40.0 ( 36.1- 44.3) 50.2 ( 33.7- 73.0) 28.8 ( 18.8- 43.4)
New Mexico 36.2 ( 32.6- 40.2) 37.9 ( 34.0- 42.1) ∼ 31.3 ( 25.4- 38.2)
Utah 36.0 ( 32.3- 40.1) 36.3 ( 32.5- 40.5) ∼ ∼
Wyoming
Pacific 40.4 ( 39.6- 41.3) 40.2 ( 39.4- 41.2) 50.9 ( 46.8- 55.3) 31.4 ( 29.4- 33.4)
Alaska 36.5 ( 28.6- 46.2) 26.7 ( 19.2- 36.5) ∼ ∼
California 39.7 ( 38.8- 40.7) 39.7 ( 38.7- 40.8) 51.2 ( 46.9- 55.8) 31.1 ( 29.1- 33.3)
San Francisco-Oakland 40.0 ( 37.5- 42.7) 41.4 ( 38.3- 44.7) 44.2 ( 35.6- 54.4) 29.7 ( 23.0- 37.8)
San Jose-Monterey 40.2 ( 36.6- 44.0) 41.7 ( 37.6- 46.2) ∼ 30.7 ( 22.7- 40.8)
Los Angeles 41.5 ( 39.7- 43.4) 40.1 ( 38.0- 42.3) 56.0 ( 49.5- 63.1) 28.2 ( 25.3- 31.5)
Hawaii 39.3 ( 34.9- 44.1) 38.6 ( 30.0- 49.7) ∼ -
Oregon 42.9 ( 40.1- 45.8) 41.6 ( 38.8- 44.6) ∼ ∼
Washington 43.5 ( 41.2- 45.8) 42.7 ( 40.3- 45.1) 49.5 ( 33.4- 71.3) 31.8 ( 19.7- 49.6)
Seattle-Puget Sound 42.9 ( 40.2- 45.7) 43.0 ( 40.2- 46.1) 50.2 ( 33.3- 73.4) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.6.1.2M: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 23.0 ( 22.7- 23.2) 22.4 ( 22.1- 22.7) 32.1 ( 31.0- 33.3) 16.9 ( 16.0- 17.9)
Northeast 24.0 ( 23.4- 24.6) 24.0 ( 23.3- 24.7) 28.2 ( 25.7- 30.8) 18.9 ( 16.2- 21.9)
New England 22.1 ( 20.9- 23.2) 22.3 ( 21.2- 23.6) 22.3 ( 15.7- 31.0) ∼
Connecticut 21.0 ( 18.8- 23.3) 21.2 ( 18.9- 23.7) 22.8 ( 13.0- 38.6) ∼
Maine 21.7 ( 18.2- 25.7) 21.9 ( 18.4- 25.9) ∼ ∼
Massachusetts 22.9 ( 21.1- 24.7) 23.2 ( 21.4- 25.2) 23.2 ( 14.1- 36.8) ∼
New Hampshire 21.8 ( 18.0- 26.2) 22.0 ( 18.2- 26.5) ∼ ∼
Rhode Island 22.5 ( 18.5- 27.1) 22.7 ( 18.6- 27.5) ∼ ∼
Vermont 20.1 ( 15.2- 26.2) 19.9 ( 15.1- 26.0) ∼ ∼
Middle Atlantic 24.7 ( 23.9- 25.4) 24.6 ( 23.9- 25.4) 28.9 ( 26.3- 31.8) 20.4 ( 17.5- 23.7)
New Jersey 25.7 ( 24.1- 27.4) 25.8 ( 24.1- 27.6) 32.5 ( 26.3- 39.9) 20.0 ( 14.6- 27.2)
New York 23.3 ( 22.3- 24.4) 23.3 ( 22.2- 24.5) 27.8 ( 24.4- 31.6) 20.0 ( 16.5- 24.2)
Pennsylvania 25.7 ( 24.5- 27.0) 25.6 ( 24.3- 26.9) 29.5 ( 24.4- 35.4) 24.6 ( 13.8- 41.5)
Midwest 24.2 ( 23.6- 24.8) 23.5 ( 22.9- 24.1) 35.1 ( 32.4- 38.0) 13.9 ( 10.7- 18.1)
East North Central 24.7 ( 24.0- 25.4) 23.9 ( 23.1- 24.6) 35.6 ( 32.6- 38.8) 14.0 ( 10.4- 18.8)
Illinois 27.3 ( 25.8- 28.8) 25.9 ( 24.4- 27.5) 41.6 ( 36.1- 47.8) 13.6 ( 8.7- 20.7)
Indiana 26.4 ( 24.4- 28.5) 25.8 ( 23.8- 28.0) 37.7 ( 28.5- 49.5) ∼
Michigan 22.4 ( 21.0- 23.9) 21.5 ( 20.0- 23.1) 30.8 ( 25.7- 36.8) ∼
Ohio 24.3 ( 23.0- 25.8) 23.7 ( 22.3- 25.2) 32.8 ( 27.3- 39.1) ∼
Wisconsin 22.2 ( 20.3- 24.1) 21.8 ( 19.9- 23.8) 30.3 ( 16.7- 53.2) ∼
West North Central 23.2 ( 22.2- 24.2) 22.8 ( 21.8- 23.9) 32.6 ( 26.2- 40.5) ∼
Iowa 24.5 ( 22.0- 27.2) 24.3 ( 21.8- 27.0) ∼ ∼
Kansas 20.8 ( 18.3- 23.5) 20.2 ( 17.6- 23.0) ∼ ∼
Minnesota 22.5 ( 20.5- 24.6) 22.3 ( 20.3- 24.5) ∼ ∼
Missouri 23.4 ( 21.5- 25.4) 23.0 ( 21.0- 25.0) 30.8 ( 23.1- 40.7) ∼
Nebraska 25.0 ( 21.5- 28.8) 24.7 ( 21.3- 28.6) ∼ ∼
North Dakota 22.9 ( 18.0- 29.0) 22.7 ( 17.7- 28.8) ∼ ∼
South Dakota 24.1 ( 19.4- 29.8) 23.3 ( 18.5- 29.0) ∼ ∼
South 23.2 ( 22.8- 23.7) 22.0 ( 21.5- 22.5) 33.6 ( 32.0- 35.2) 16.6 ( 15.1- 18.2)
South Atlantic 22.3 ( 21.7- 22.9) 21.1 ( 20.4- 21.7) 31.6 ( 29.6- 33.8) 16.3 ( 14.1- 18.8)
Delaware 27.1 ( 21.9- 33.3) 27.5 ( 21.9- 34.2) ∼ ∼
District of Columbia 27.2 ( 20.6- 35.5) ∼ 35.7 ( 26.1- 47.8) ∼
Florida 20.6 ( 19.6- 21.5) 19.9 ( 19.0- 20.9) 30.3 ( 26.0- 35.2) 18.0 ( 15.5- 20.9)
Georgia 23.6 ( 21.8- 25.6) 21.9 ( 19.9- 24.1) 31.1 ( 26.3- 36.6) ∼
Maryland 22.6 ( 20.6- 24.7) 21.6 ( 19.4- 24.0) 28.9 ( 23.8- 34.9) ∼
North Carolina 22.7 ( 21.1- 24.5) 21.5 ( 19.8- 23.4) 30.1 ( 25.4- 35.6) ∼
South Carolina 22.7 ( 20.5- 25.2) 20.4 ( 18.0- 23.1) 32.0 ( 26.4- 38.6) ∼
Virginia 24.1 ( 22.2- 26.0) 22.1 ( 20.2- 24.1) 36.8 ( 31.2- 43.4) ∼
West Virginia 27.2 ( 23.9- 31.0) 26.8 ( 23.4- 30.6) ∼ ∼
East South Central 25.4 ( 24.2- 26.6) 24.2 ( 22.9- 25.5) 33.4 ( 29.8- 37.4) ∼
Alabama 23.8 ( 21.5- 26.2) 22.5 ( 20.0- 25.1) 29.0 ( 23.6- 35.5) ∼
Kentucky 28.5 ( 25.9- 31.3) 28.3 ( 25.6- 31.2) 33.0 ( 21.6- 49.1) ∼
Mississippi 23.4 ( 20.6- 26.5) 20.8 ( 17.7- 24.3) 32.6 ( 26.2- 40.2) ∼
Tennessee 25.5 ( 23.4- 27.7) 23.8 ( 21.7- 26.0) 41.5 ( 33.5- 51.2) ∼
West South Central 23.9 ( 23.0- 24.8) 22.6 ( 21.6- 23.5) 38.5 ( 34.9- 42.3) 17.1 ( 15.0- 19.4)
Arkansas 25.8 ( 23.0- 28.9) 24.3 ( 21.5- 27.5) 40.0 ( 29.3- 53.6) ∼
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Table 2.6.1.2M: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 29.3 ( 26.7- 32.1) 27.9 ( 25.0- 31.1) 35.4 ( 29.6- 42.1) ∼
Oklahoma 24.5 ( 22.1- 27.2) 24.6 ( 22.0- 27.4) 31.8 ( 20.1- 49.0) ∼
Texas 22.2 ( 21.2- 23.4) 20.9 ( 19.8- 22.0) 41.0 ( 35.9- 46.7) 17.5 ( 15.3- 19.9)
West 20.2 ( 19.6- 20.7) 20.4 ( 19.8- 21.0) 25.4 ( 22.2- 29.1) 17.2 ( 15.6- 18.8)
Mountain 20.5 ( 19.5- 21.6) 20.8 ( 19.8- 21.9) 24.6 ( 16.7- 35.9) 20.5 ( 17.3- 24.3)
Arizona 21.9 ( 20.1- 23.9) 22.4 ( 20.5- 24.4) ∼ 24.1 ( 18.0- 32.2)
Colorado 19.1 ( 16.9- 21.5) 18.9 ( 16.7- 21.3) ∼ 18.4 ( 12.3- 27.4)
Idaho 20.8 ( 17.1- 25.0) 20.8 ( 17.1- 25.1) ∼ ∼
Montana 17.5 ( 13.7- 21.9) 17.5 ( 13.7- 22.1) ∼ ∼
Nevada 26.4 ( 23.0- 30.3) 27.9 ( 24.3- 32.1) ∼ ∼
New Mexico 18.5 ( 15.6- 21.8) 19.0 ( 16.0- 22.5) ∼ 20.7 ( 15.3- 27.5)
Utah 16.1 ( 13.3- 19.4) 15.9 ( 13.1- 19.2) ∼ ∼
Wyoming 22.6 ( 16.6- 30.3) 21.8 ( 15.9- 29.4) ∼ ∼
Pacific 20.0 ( 19.4- 20.7) 20.2 ( 19.5- 20.9) 25.7 ( 22.2- 29.8) 16.0 ( 14.3- 17.8)
Alaska 18.6 ( 11.7- 29.2) 18.4 ( 10.8- 30.7) ∼ ∼
California 20.1 ( 19.3- 20.9) 20.4 ( 19.5- 21.3) 26.5 ( 22.7- 30.8) 16.0 ( 14.3- 18.0)
Hawaii 22.6 ( 19.0- 26.8) 20.1 ( 13.8- 29.1) ∼ ∼
Oregon 19.5 ( 17.4- 21.8) 19.7 ( 17.6- 22.1) ∼ ∼
Washington 19.6 ( 17.9- 21.5) 19.6 ( 17.8- 21.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.6.1.2F: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 16.1 ( 15.9- 16.2) 15.5 ( 15.3- 15.7) 22.7 ( 22.0- 23.5) 10.8 ( 10.2- 11.5)
Northeast 16.7 ( 16.3- 17.2) 16.5 ( 16.1- 17.0) 20.2 ( 18.7- 21.9) 11.9 ( 10.3- 13.7)
New England 15.9 ( 15.1- 16.8) 15.8 ( 15.0- 16.7) 19.3 ( 14.8- 24.8) 13.6 ( 9.0- 20.1)
Connecticut 14.6 ( 13.1- 16.3) 14.5 ( 12.9- 16.2) 18.1 ( 11.7- 27.0) ∼
Maine 17.2 ( 14.5- 20.2) 17.3 ( 14.7- 20.4) ∼ ∼
Massachusetts 15.9 ( 14.7- 17.2) 15.6 ( 14.4- 16.9) 21.4 ( 14.8- 30.2) ∼
New Hampshire 18.8 ( 15.8- 22.2) 18.8 ( 15.8- 22.3) ∼ ∼
Rhode Island 16.6 ( 13.7- 20.0) 17.0 ( 14.0- 20.6) ∼ ∼
Vermont 15.4 ( 11.7- 20.2) 15.6 ( 11.8- 20.4) ∼ ∼
Middle Atlantic 17.0 ( 16.5- 17.5) 16.8 ( 16.3- 17.4) 20.3 ( 18.6- 22.0) 11.7 ( 10.0- 13.6)
New Jersey 19.0 ( 17.9- 20.2) 18.5 ( 17.2- 19.7) 25.9 ( 21.7- 30.6) 9.1 ( 6.2- 13.1)
New York 16.6 ( 15.9- 17.4) 16.7 ( 15.9- 17.5) 17.9 ( 15.9- 20.1) 12.5 ( 10.4- 14.9)
Pennsylvania 16.4 ( 15.6- 17.3) 16.0 ( 15.2- 16.9) 21.4 ( 18.0- 25.4) ∼
Midwest 16.7 ( 16.3- 17.1) 16.2 ( 15.7- 16.6) 23.9 ( 22.1- 25.8) 8.0 ( 5.8- 10.7)
East North Central 16.8 ( 16.3- 17.3) 16.2 ( 15.7- 16.7) 24.3 ( 22.3- 26.3) 8.3 ( 5.9- 11.6)
Illinois 16.8 ( 15.9- 17.8) 15.7 ( 14.8- 16.7) 25.8 ( 22.5- 29.5) 7.9 ( 4.9- 12.4)
Indiana 16.1 ( 14.8- 17.4) 15.9 ( 14.6- 17.4) 20.2 ( 14.7- 27.2) ∼
Michigan 15.8 ( 14.8- 16.8) 15.0 ( 14.0- 16.1) 21.8 ( 18.3- 25.8) ∼
Ohio 18.8 ( 17.9- 19.9) 18.3 ( 17.3- 19.4) 25.8 ( 22.0- 30.1) ∼
Wisconsin 15.1 ( 13.8- 16.5) 14.7 ( 13.4- 16.1) 23.7 ( 14.8- 36.7) ∼
West North Central 16.4 ( 15.6- 17.1) 16.1 ( 15.4- 16.9) 21.8 ( 17.6- 26.8) ∼
Iowa 16.3 ( 14.6- 18.2) 16.4 ( 14.6- 18.3) ∼ ∼
Kansas 15.7 ( 13.9- 17.8) 15.6 ( 13.7- 17.7) ∼ ∼
Minnesota 16.0 ( 14.6- 17.6) 15.8 ( 14.4- 17.4) ∼ ∼
Missouri 17.2 ( 15.9- 18.7) 16.8 ( 15.5- 18.3) 22.3 ( 17.2- 28.6) ∼
Nebraska 15.5 ( 13.2- 18.1) 15.5 ( 13.2- 18.2) ∼ ∼
North Dakota 14.8 ( 11.4- 19.1) 14.6 ( 11.2- 19.0) ∼ ∼
South Dakota 17.2 ( 13.8- 21.5) 16.2 ( 12.8- 20.5) ∼ ∼
South 16.0 ( 15.6- 16.3) 14.8 ( 14.5- 15.2) 23.2 ( 22.2- 24.3) 10.5 ( 9.5- 11.6)
South Atlantic 15.3 ( 14.9- 15.8) 14.2 ( 13.8- 14.7) 21.2 ( 20.0- 22.6) 11.0 ( 9.5- 12.7)
Delaware 18.9 ( 15.3- 23.3) 18.2 ( 14.4- 23.1) 24.2 ( 13.7- 40.3) ∼
District of Columbia 14.5 ( 10.7- 19.7) ∼ 17.3 ( 12.2- 24.5) ∼
Florida 13.6 ( 13.0- 14.3) 13.1 ( 12.4- 13.8) 19.4 ( 16.7- 22.4) 11.7 ( 10.0- 13.6)
Georgia 16.1 ( 14.9- 17.4) 14.1 ( 12.8- 15.4) 23.0 ( 20.0- 26.4) ∼
Maryland 16.8 ( 15.4- 18.3) 14.8 ( 13.2- 16.5) 24.3 ( 20.6- 28.5) ∼
North Carolina 15.0 ( 13.9- 16.1) 14.2 ( 13.0- 15.4) 18.3 ( 15.5- 21.5) ∼
South Carolina 17.4 ( 15.7- 19.1) 15.8 ( 14.0- 17.7) 22.0 ( 18.3- 26.2) ∼
Virginia 16.0 ( 14.8- 17.3) 14.8 ( 13.5- 16.1) 22.5 ( 19.0- 26.4) ∼
West Virginia 20.1 ( 17.7- 22.8) 19.9 ( 17.5- 22.7) ∼ ∼
East South Central 17.7 ( 16.9- 18.5) 16.3 ( 15.5- 17.2) 25.8 ( 23.4- 28.5) ∼
Alabama 15.8 ( 14.3- 17.3) 14.4 ( 12.9- 16.2) 21.1 ( 17.5- 25.2) ∼
Kentucky 19.5 ( 17.8- 21.4) 18.9 ( 17.1- 20.8) 32.6 ( 23.6- 44.0) ∼
Mississippi 18.9 ( 16.9- 21.2) 15.9 ( 13.7- 18.4) 26.8 ( 22.2- 32.1) ∼
Tennessee 17.4 ( 16.0- 18.8) 15.9 ( 14.5- 17.4) 29.2 ( 24.2- 35.0) ∼
West South Central 16.2 ( 15.6- 16.8) 15.0 ( 14.4- 15.7) 26.3 ( 24.0- 28.7) 9.9 ( 8.6- 11.4)
Arkansas 17.1 ( 15.2- 19.2) 15.5 ( 13.6- 17.7) 29.0 ( 21.9- 37.9) ∼
continued
C
ancer Incidence and M
ortality, by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
69
Table 2.6.1.2F: Colon and Rectum. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 19.5 ( 17.8- 21.3) 17.0 ( 15.2- 19.1) 27.1 ( 23.1- 31.5) ∼
Oklahoma 16.0 ( 14.3- 17.8) 16.3 ( 14.5- 18.3) 18.3 ( 11.0- 28.8) ∼
Texas 15.3 ( 14.5- 16.0) 14.3 ( 13.5- 15.1) 26.1 ( 22.9- 29.5) 10.2 ( 8.8- 11.7)
West 14.7 ( 14.3- 15.2) 14.7 ( 14.3- 15.2) 22.9 ( 20.4- 25.7) 11.1 ( 10.1- 12.2)
Mountain 14.9 ( 14.1- 15.7) 14.9 ( 14.2- 15.7) 21.6 ( 15.5- 29.6) 15.2 ( 12.8- 18.0)
Arizona 14.9 ( 13.5- 16.3) 15.0 ( 13.7- 16.5) 25.5 ( 14.3- 42.7) 16.4 ( 12.1- 21.8)
Colorado 15.3 ( 13.7- 17.1) 15.6 ( 13.9- 17.5) ∼ 18.0 ( 12.4- 25.4)
Idaho 14.3 ( 11.6- 17.4) 14.1 ( 11.5- 17.3) ∼ ∼
Montana 15.4 ( 12.3- 19.2) 15.2 ( 12.0- 19.0) ∼ ∼
Nevada 15.4 ( 13.1- 18.0) 14.5 ( 12.2- 17.2) ∼ ∼
New Mexico 13.9 ( 11.7- 16.5) 14.1 ( 11.8- 16.8) ∼ 15.1 ( 11.0- 20.2)
Utah 13.3 ( 11.1- 15.9) 13.6 ( 11.3- 16.3) ∼ ∼
Wyoming 19.9 ( 15.0- 26.2) 19.9 ( 14.9- 26.2) ∼ ∼
Pacific 14.7 ( 14.2- 15.2) 14.6 ( 14.1- 15.2) 23.2 ( 20.5- 26.3) 9.8 ( 8.6- 11.0)
Alaska 17.4 ( 11.8- 24.9) 17.2 ( 10.8- 26.2) ∼ ∼
California 14.4 ( 13.8- 15.0) 14.2 ( 13.6- 14.8) 23.8 ( 20.9- 27.0) 9.6 ( 8.4- 10.8)
Hawaii 13.0 ( 10.6- 16.0) 13.6 ( 8.7- 21.2) ∼ ∼
Oregon 17.0 ( 15.3- 18.9) 17.2 ( 15.4- 19.1) ∼ ∼
Washington 15.2 ( 13.9- 16.6) 15.1 ( 13.8- 16.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.7.1.1: Corpus and Uterus, NOS. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 22.9 ( 22.6- 23.1) 23.4 ( 23.1- 23.6) 19.5 ( 18.8- 20.2) 18.2 ( 17.5- 19.1)
Northeast 28.2 ( 27.6- 28.8) 29.0 ( 28.4- 29.7) 21.4 ( 19.8- 23.0) 19.8 ( 17.9- 21.9)
New England 28.4 ( 27.3- 29.6) 28.8 ( 27.6- 30.0) 17.8 ( 13.6- 23.0) 21.3 ( 15.9- 28.3)
Connecticut 27.8 ( 25.5- 30.2) 28.7 ( 26.3- 31.3) 18.3 ( 12.0- 27.0) 22.6 ( 14.2- 35.4)
Maine 29.5 ( 25.9- 33.6) 29.4 ( 25.8- 33.6) ∼ ∼
Massachusetts 28.4 ( 26.7- 30.2) 28.8 ( 27.0- 30.7) 17.7 ( 12.0- 25.6) 20.9 ( 13.4- 32.2)
New Hampshire 27.7 ( 24.0- 31.9) 26.7 ( 23.0- 30.9) ∼ ∼
Rhode Island 27.6 ( 23.7- 32.2) 28.1 ( 24.0- 32.9) ∼ ∼
Vermont 32.6 ( 27.0- 39.2) 32.9 ( 27.3- 39.7) ∼ ∼
Middle Atlantic 28.1 ( 27.4- 28.8) 29.1 ( 28.3- 29.8) 21.8 ( 20.1- 23.5) 19.6 ( 17.5- 21.8)
New Jersey 27.4 ( 25.9- 28.9) 28.2 ( 26.6- 29.9) 23.3 ( 19.5- 27.6) 19.9 ( 15.8- 24.9)
New York 27.3 ( 26.3- 28.3) 28.3 ( 27.2- 29.5) 21.5 ( 19.3- 23.8) 20.0 ( 17.5- 22.7)
Pennsylvania 29.7 ( 28.5- 31.0) 30.6 ( 29.3- 32.0) 21.2 ( 17.7- 25.1) -
Midwest 24.7 ( 24.2- 25.2) 25.0 ( 24.4- 25.5) 18.8 ( 17.2- 20.4) 19.4 ( 16.3- 23.1)
East North Central 24.8 ( 24.2- 25.5) 25.1 ( 24.5- 25.8) 18.7 ( 17.0- 20.5) 17.4 ( 14.2- 21.2)
Illinois 24.0 ( 22.9- 25.2) 24.9 ( 23.6- 26.2) 17.8 ( 15.1- 20.9) -
Indiana 23.6 ( 22.0- 25.3) 23.9 ( 22.2- 25.7) 19.1 ( 13.9- 25.7) ∼
Michigan 25.8 ( 24.4- 27.1) 25.3 ( 23.9- 26.8) 24.0 ( 20.3- 28.1) 20.3 ( 11.7- 33.9)
Detroit 25.3 ( 23.2- 27.4) 25.7 ( 23.3- 28.2) 24.8 ( 20.5- 29.6) ∼
Ohio 24.7 ( 23.6- 26.0) 25.3 ( 24.0- 26.6) 13.5 ( 10.9- 16.7) 31.1 ( 18.8- 49.5)
Wisconsin 26.7 ( 24.8- 28.6) 26.5 ( 24.6- 28.4) 25.7 ( 16.9- 38.5) ∼
West North Central 24.4 ( 23.5- 25.4) 24.6 ( 23.6- 25.6) 19.5 ( 15.6- 24.2) 27.6 ( 19.2- 38.9)
Iowa 26.3 ( 23.9- 28.9) 26.5 ( 24.0- 29.1) ∼ ∼
Kansas 21.9 ( 19.5- 24.4) 21.4 ( 19.0- 24.0) 27.5 ( 15.9- 44.5) ∼
Minnesota 24.9 ( 23.1- 26.9) 24.9 ( 23.0- 27.0) ∼ ∼
Missouri 23.1 ( 21.5- 24.8) 23.5 ( 21.8- 25.3) 20.3 ( 15.5- 26.2) ∼
Nebraska 28.6 ( 25.3- 32.2) 28.6 ( 25.2- 32.3) ∼ ∼
North Dakota 23.1 ( 18.4- 28.8) 23.7 ( 18.8- 29.6) ∼ ∼
South Dakota 25.8 ( 21.2- 31.3) 26.2 ( 21.5- 31.9) ∼ ∼
South
South Atlantic 20.2 ( 19.7- 20.7) 20.5 ( 20.0- 21.1) 19.6 ( 18.4- 20.8) 19.1 ( 17.1- 21.2)
Delaware 26.1 ( 21.7- 31.3) 26.7 ( 21.8- 32.6) 24.3 ( 14.1- 39.9) ∼
District of Columbia 20.8 ( 16.0- 26.9) 18.6 ( 11.1- 32.5) 19.6 ( 14.1- 27.3) ∼
Florida 19.7 ( 18.9- 20.6) 20.0 ( 19.1- 21.0) 19.7 ( 17.1- 22.7) -
Georgia 18.5 ( 17.3- 19.9) 19.2 ( 17.7- 20.9) 17.5 ( 14.9- 20.4) ∼
Atlanta 18.8 ( 16.5- 21.4) 20.8 ( 17.8- 24.1) 16.2 ( 12.3- 21.2) ∼
Maryland 24.0 ( 22.3- 25.9) 24.1 ( 22.1- 26.3) 23.6 ( 20.1- 27.5) ∼
North Carolina 18.4 ( 17.1- 19.6) 18.4 ( 17.1- 19.9) 18.5 ( 15.7- 21.7) ∼
South Carolina 19.2 ( 17.5- 21.1) 19.3 ( 17.2- 21.5) 19.4 ( 15.9- 23.4) -
Virginia 21.0 ( 19.6- 22.5) 21.1 ( 19.6- 22.8) 19.4 ( 16.3- 23.1) 21.1 ( 12.6- 34.8)
West Virginia 26.2 ( 23.3- 29.4) 26.7 ( 23.7- 30.0) ∼ ∼
East South Central
Alabama 16.9 ( 15.4- 18.6) 16.0 ( 14.3- 17.9) 21.0 ( 17.4- 25.2) ∼
Kentucky 23.0 ( 21.1- 25.1) 22.4 ( 20.5- 24.5) 25.2 ( 17.4- 35.4) -
Mississippi 17.1 ( 15.1- 19.3) 16.9 ( 14.5- 19.7) 19.0 ( 15.1- 23.5) ∼
Tennessee
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Table 2.7.1.1: Corpus and Uterus, NOS. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 18.0 ( 17.4- 18.7) 18.2 ( 17.5- 19.0) 17.3 ( 15.5- 19.3) 18.7 ( 16.9- 20.5)
Arkansas 18.7 ( 16.7- 21.0) 19.4 ( 17.1- 21.9) 13.9 ( 8.9- 20.5) ∼
Louisiana 16.4 ( 14.8- 18.1) 15.9 ( 14.1- 18.0) 18.1 ( 15.0- 21.8) ∼
Oklahoma 20.6 ( 18.7- 22.8) 20.8 ( 18.7- 23.1) 18.6 ( 11.3- 29.1) ∼
Texas 17.7 ( 16.9- 18.5) 17.9 ( 17.1- 18.8) 17.2 ( 14.7- 20.0) 19.0 ( 17.2- 20.9)
West 21.3 ( 20.8- 21.9) 21.9 ( 21.3- 22.4) 18.9 ( 16.6- 21.4) 16.6 ( 15.4- 17.9)
Mountain
Arizona
Colorado 21.4 ( 19.5- 23.5) 21.4 ( 19.4- 23.5) ∼ 20.1 ( 14.8- 26.9)
Idaho 17.7 ( 14.7- 21.2) 18.0 ( 14.9- 21.6) ∼ ∼
Montana 21.1 ( 17.3- 25.5) 21.3 ( 17.5- 25.9) ∼ ∼
Nevada 20.6 ( 18.1- 23.5) 21.2 ( 18.4- 24.4) ∼ ∼
New Mexico 18.2 ( 15.7- 21.1) 18.7 ( 16.0- 21.7) ∼ 11.8 ( 8.4- 16.2)
Utah 24.4 ( 21.3- 27.8) 24.8 ( 21.6- 28.3) ∼ ∼
Wyoming
Pacific 21.5 ( 20.9- 22.1) 22.1 ( 21.4- 22.8) 19.4 ( 16.9- 22.1) 17.3 ( 16.0- 18.8)
Alaska 19.3 ( 14.1- 26.1) 19.9 ( 14.0- 28.1) ∼ ∼
California 20.6 ( 20.0- 21.3) 21.3 ( 20.6- 22.1) 19.7 ( 17.1- 22.6) 16.9 ( 15.5- 18.4)
San Francisco-Oakland 22.0 ( 20.1- 24.0) 22.9 ( 20.6- 25.4) 19.0 ( 13.6- 26.1) 14.0 ( 9.7- 19.7)
San Jose-Monterey 21.8 ( 19.2- 24.6) 23.5 ( 20.4- 26.9) ∼ 14.3 ( 9.4- 21.3)
Los Angeles 20.9 ( 19.6- 22.3) 22.4 ( 20.8- 24.1) 19.8 ( 16.1- 24.2) 16.9 ( 14.7- 19.2)
Hawaii 24.2 ( 20.7- 28.3) 26.8 ( 19.6- 36.6) ∼ -
Oregon 23.5 ( 21.4- 25.7) 22.8 ( 20.7- 25.1) ∼ ∼
Washington 24.4 ( 22.7- 26.2) 25.1 ( 23.3- 27.0) ∼ 25.2 ( 14.8- 41.4)
Seattle-Puget Sound 24.7 ( 22.7- 26.9) 26.5 ( 24.2- 28.9) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.7.1.2: Corpus and Uterus, NOS. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 4.1 ( 4.0- 4.2) 3.9 ( 3.8- 4.0) 7.1 ( 6.6- 7.5) 3.0 ( 2.7- 3.4)
Northeast 4.7 ( 4.5- 5.0) 4.4 ( 4.2- 4.7) 8.1 ( 7.1- 9.1) 3.3 ( 2.5- 4.3)
New England 4.0 ( 3.6- 4.5) 3.9 ( 3.5- 4.4) 7.6 ( 4.8- 11.4) ∼
Connecticut 4.0 ( 3.2- 5.0) 3.6 ( 2.8- 4.6) ∼ ∼
Maine 4.3 ( 3.1- 6.1) 4.4 ( 3.1- 6.2) ∼ ∼
Massachusetts 4.4 ( 3.7- 5.1) 4.3 ( 3.7- 5.1) ∼ ∼
New Hampshire 2.7 ( 1.6- 4.3) 2.7 ( 1.7- 4.3) ∼ ∼
Rhode Island 3.0 ( 1.8- 4.7) 3.1 ( 1.9- 5.0) ∼ ∼
Vermont 4.3 ( 2.5- 7.4) 4.4 ( 2.5- 7.5) ∼ ∼
Middle Atlantic 5.0 ( 4.7- 5.2) 4.6 ( 4.3- 4.9) 8.1 ( 7.1- 9.3) 3.5 ( 2.6- 4.6)
New Jersey 5.0 ( 4.4- 5.7) 4.8 ( 4.2- 5.5) 8.0 ( 5.8- 10.8) ∼
New York 5.1 ( 4.7- 5.5) 4.6 ( 4.2- 5.1) 8.6 ( 7.3- 10.2) 3.7 ( 2.6- 5.1)
Pennsylvania 4.7 ( 4.3- 5.2) 4.6 ( 4.1- 5.1) 7.0 ( 5.1- 9.4) ∼
Midwest 4.5 ( 4.3- 4.7) 4.4 ( 4.2- 4.6) 6.5 ( 5.6- 7.5) 2.3 ( 1.3- 4.0)
East North Central 4.5 ( 4.2- 4.7) 4.3 ( 4.0- 4.6) 6.5 ( 5.5- 7.6) ∼
Illinois 4.2 ( 3.7- 4.7) 4.0 ( 3.5- 4.6) 6.0 ( 4.5- 7.9) ∼
Indiana 4.9 ( 4.2- 5.7) 4.9 ( 4.1- 5.7) ∼ ∼
Michigan 4.8 ( 4.2- 5.4) 4.4 ( 3.9- 5.0) 7.8 ( 5.8- 10.4) ∼
Ohio 4.3 ( 3.9- 4.9) 4.3 ( 3.8- 4.8) 5.7 ( 4.0- 7.9) ∼
Wisconsin 4.2 ( 3.6- 5.0) 4.1 ( 3.4- 4.9) ∼ ∼
West North Central 4.6 ( 4.2- 5.0) 4.5 ( 4.2- 5.0) 6.4 ( 4.2- 9.3) ∼
Iowa 4.6 ( 3.7- 5.7) 4.7 ( 3.8- 5.9) ∼ ∼
Kansas 3.5 ( 2.6- 4.5) 3.3 ( 2.4- 4.4) ∼ ∼
Minnesota 4.9 ( 4.1- 5.8) 4.9 ( 4.1- 5.8) ∼ ∼
Missouri 4.5 ( 3.9- 5.3) 4.3 ( 3.6- 5.1) 7.2 ( 4.5- 11.1) ∼
Nebraska 5.5 ( 4.2- 7.2) 5.6 ( 4.2- 7.4) ∼ ∼
North Dakota 4.6 ( 2.7- 7.6) 4.8 ( 2.8- 7.9) ∼ ∼
South Dakota 4.3 ( 2.7- 6.9) 4.5 ( 2.8- 7.2) ∼ ∼
South 3.8 ( 3.6- 3.9) 3.3 ( 3.1- 3.5) 6.8 ( 6.3- 7.4) 2.9 ( 2.4- 3.5)
South Atlantic 3.9 ( 3.7- 4.1) 3.4 ( 3.2- 3.7) 6.6 ( 5.9- 7.4) 3.2 ( 2.4- 4.1)
Delaware 4.9 ( 3.2- 7.5) 4.0 ( 2.3- 6.8) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 3.6 ( 3.3- 4.0) 3.4 ( 3.0- 3.7) 6.8 ( 5.3- 8.7) 3.4 ( 2.5- 4.5)
Georgia 4.0 ( 3.4- 4.7) 3.4 ( 2.8- 4.1) 6.6 ( 5.0- 8.6) ∼
Maryland 4.3 ( 3.6- 5.1) 3.9 ( 3.1- 4.9) 5.9 ( 4.2- 8.1) ∼
North Carolina 4.1 ( 3.6- 4.7) 3.5 ( 3.0- 4.2) 7.3 ( 5.6- 9.4) ∼
South Carolina 3.5 ( 2.8- 4.4) 2.6 ( 2.0- 3.5) 6.6 ( 4.6- 9.1) ∼
Virginia 4.0 ( 3.4- 4.6) 3.5 ( 2.9- 4.3) 6.4 ( 4.6- 8.6) ∼
West Virginia 4.0 ( 2.9- 5.3) 4.0 ( 3.0- 5.4) ∼ ∼
East South Central 3.8 ( 3.4- 4.2) 3.2 ( 2.8- 3.6) 7.5 ( 6.2- 9.1) ∼
Alabama 3.7 ( 3.0- 4.6) 2.7 ( 2.0- 3.5) 8.0 ( 5.8- 10.7) ∼
Kentucky 4.0 ( 3.3- 4.9) 3.7 ( 2.9- 4.6) ∼ ∼
Mississippi 4.0 ( 3.1- 5.1) 2.9 ( 2.0- 4.1) 7.3 ( 5.0- 10.4) ∼
Tennessee 3.6 ( 3.0- 4.3) 3.2 ( 2.6- 3.9) 6.2 ( 4.0- 9.3) ∼
West South Central 3.5 ( 3.3- 3.8) 3.2 ( 2.9- 3.5) 6.8 ( 5.7- 8.1) 2.7 ( 2.1- 3.6)
Arkansas 4.1 ( 3.2- 5.3) 3.6 ( 2.7- 4.7) 9.0 ( 5.2- 14.6) ∼
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Table 2.7.1.2: Corpus and Uterus, NOS. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.4 ( 2.7- 4.2) 2.3 ( 1.7- 3.2) 6.6 ( 4.7- 8.9) ∼
Oklahoma 3.7 ( 3.0- 4.7) 3.8 ( 2.9- 4.8) ∼ ∼
Texas 3.4 ( 3.1- 3.8) 3.2 ( 2.8- 3.6) 6.3 ( 4.8- 8.1) 2.7 ( 2.0- 3.5)
West 3.7 ( 3.5- 4.0) 3.7 ( 3.4- 3.9) 7.4 ( 6.0- 9.1) 3.1 ( 2.6- 3.7)
Mountain 3.2 ( 2.9- 3.6) 3.3 ( 2.9- 3.6) ∼ 3.7 ( 2.6- 5.2)
Arizona 2.7 ( 2.1- 3.3) 2.7 ( 2.1- 3.3) ∼ ∼
Colorado 3.1 ( 2.4- 4.0) 3.2 ( 2.5- 4.1) ∼ ∼
Idaho 3.4 ( 2.2- 5.2) 3.5 ( 2.2- 5.3) ∼ ∼
Montana 3.8 ( 2.3- 6.0) 3.9 ( 2.4- 6.3) ∼ ∼
Nevada 2.7 ( 1.8- 3.9) 2.5 ( 1.6- 3.7) ∼ ∼
New Mexico 3.6 ( 2.5- 5.0) 3.6 ( 2.5- 5.1) ∼ ∼
Utah 4.6 ( 3.3- 6.2) 4.6 ( 3.3- 6.3) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.0 ( 3.7- 4.2) 3.9 ( 3.6- 4.1) 8.1 ( 6.5- 10.0) 2.9 ( 2.3- 3.6)
Alaska ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 3.9 ( 3.5- 4.2) 8.4 ( 6.7- 10.4) 2.9 ( 2.3- 3.6)
Hawaii 4.4 ( 3.0- 6.4) ∼ ∼ ∼
Oregon 3.7 ( 2.9- 4.7) 3.7 ( 2.9- 4.7) ∼ ∼
Washington 4.0 ( 3.4- 4.8) 4.1 ( 3.4- 4.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.8.1.1M: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 8.6 ( 8.4- 8.7) 8.4 ( 8.2- 8.6) 11.1 ( 10.5- 11.8) 5.3 ( 4.8- 5.9)
Northeast 9.5 ( 9.1- 9.9) 9.4 ( 9.0- 9.8) 11.8 ( 10.4- 13.5) 7.8 ( 6.3- 9.8)
New England 10.9 ( 10.1- 11.7) 10.9 ( 10.1- 11.7) 13.0 ( 8.4- 19.8) 8.5 ( 4.6- 15.4)
Connecticut 10.1 ( 8.6- 11.8) 10.0 ( 8.5- 11.8) ∼ ∼
Maine 11.7 ( 9.3- 14.7) 11.6 ( 9.1- 14.6) ∼ ∼
Massachusetts 11.2 ( 10.0- 12.5) 11.4 ( 10.2- 12.8) ∼ ∼
New Hampshire 12.6 ( 9.9- 15.9) 12.4 ( 9.7- 15.8) ∼ ∼
Rhode Island 11.1 ( 8.3- 14.4) 10.7 ( 8.0- 14.2) ∼ ∼
Vermont 6.6 ( 4.0- 10.4) 6.3 ( 3.7- 10.1) ∼ ∼
Middle Atlantic 9.0 ( 8.6- 9.4) 8.9 ( 8.4- 9.3) 11.7 ( 10.2- 13.5) 7.8 ( 6.0- 9.9)
New Jersey 8.5 ( 7.6- 9.5) 8.3 ( 7.3- 9.3) 13.0 ( 9.5- 17.6) ∼
New York 8.5 ( 7.9- 9.2) 8.3 ( 7.6- 9.0) 12.0 ( 9.9- 14.4) 9.3 ( 7.0- 12.2)
Pennsylvania 10.0 ( 9.2- 10.8) 10.0 ( 9.2- 10.8) 10.3 ( 7.5- 14.1) -
Midwest 9.4 ( 9.0- 9.7) 9.1 ( 8.8- 9.5) 11.1 ( 9.7- 12.8) 6.0 ( 3.9- 8.9)
East North Central 9.6 ( 9.2- 10.0) 9.4 ( 8.9- 9.8) 10.9 ( 9.4- 12.7) 6.2 ( 3.9- 9.7)
Illinois 9.5 ( 8.7- 10.4) 9.6 ( 8.7- 10.6) 9.4 ( 7.0- 12.4) -
Indiana 8.9 ( 7.8- 10.2) 8.7 ( 7.6- 9.9) 14.1 ( 8.7- 22.3) ∼
Michigan 10.3 ( 9.3- 11.3) 10.2 ( 9.2- 11.2) 10.2 ( 7.4- 13.9) ∼
Detroit 9.6 ( 8.2- 11.2) 9.4 ( 7.9- 11.3) 10.7 ( 7.4- 15.1) ∼
Ohio 9.0 ( 8.3- 9.9) 8.6 ( 7.8- 9.5) 9.0 ( 6.4- 12.5) ∼
Wisconsin 10.4 ( 9.2- 11.7) 9.8 ( 8.6- 11.1) 34.2 ( 20.7- 56.3) ∼
West North Central 8.9 ( 8.3- 9.5) 8.7 ( 8.1- 9.3) 12.5 ( 8.8- 17.6) ∼
Iowa 9.9 ( 8.4- 11.7) 10.0 ( 8.4- 11.8) ∼ ∼
Kansas 8.3 ( 6.8- 10.1) 8.1 ( 6.6- 9.9) ∼ ∼
Minnesota 8.8 ( 7.6- 10.1) 8.6 ( 7.4- 9.9) ∼ ∼
Missouri 9.2 ( 8.1- 10.4) 8.8 ( 7.6- 10.1) 14.4 ( 9.4- 21.7) ∼
Nebraska 8.0 ( 6.2- 10.3) 7.9 ( 6.0- 10.2) ∼ ∼
North Dakota 6.7 ( 4.1- 10.4) 6.9 ( 4.2- 10.7) ∼ ∼
South Dakota 8.7 ( 6.0- 12.3) 8.3 ( 5.6- 12.0) ∼ ∼
South
South Atlantic 8.7 ( 8.4- 9.1) 8.3 ( 7.9- 8.7) 11.6 ( 10.5- 12.9) 5.9 ( 4.6- 7.4)
Delaware 12.1 ( 8.9- 16.3) 10.3 ( 7.1- 14.7) ∼ ∼
District of Columbia 11.0 ( 7.1- 16.5) ∼ 14.8 ( 9.1- 23.0) ∼
Florida 7.9 ( 7.3- 8.5) 7.9 ( 7.3- 8.5) 8.5 ( 6.5- 11.1) -
Georgia 9.9 ( 8.7- 11.1) 8.7 ( 7.5- 10.1) 14.7 ( 11.8- 18.2) ∼
Atlanta 8.5 ( 6.6- 11.0) 7.1 ( 5.0- 9.9) 12.1 ( 7.8- 19.1) ∼
Maryland 8.9 ( 7.7- 10.3) 8.3 ( 7.0- 9.8) 10.0 ( 7.3- 13.9) ∼
North Carolina 8.2 ( 7.3- 9.2) 8.3 ( 7.3- 9.4) 8.3 ( 6.2- 11.2) ∼
South Carolina 10.1 ( 8.7- 11.7) 7.9 ( 6.5- 9.6) 18.2 ( 14.2- 23.1) -
Virginia 8.8 ( 7.7- 9.9) 8.5 ( 7.4- 9.8) 10.7 ( 7.9- 14.4) ∼
West Virginia 10.6 ( 8.6- 13.0) 10.6 ( 8.6- 13.0) ∼ ∼
East South Central
Alabama 8.7 ( 7.5- 10.1) 7.9 ( 6.6- 9.5) 12.1 ( 9.0- 16.3) ∼
Kentucky 9.2 ( 7.8- 10.7) 9.2 ( 7.8- 10.8) ∼ -
Mississippi 8.6 ( 7.0- 10.4) 6.8 ( 5.2- 8.9) 13.2 ( 9.6- 17.9) ∼
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Table 2.8.1.1M: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 7.7 ( 7.2- 8.2) 7.3 ( 6.8- 7.9) 10.5 ( 8.8- 12.5) 4.9 ( 3.8- 6.2)
Arkansas 6.7 ( 5.4- 8.3) 6.2 ( 4.9- 7.9) ∼ ∼
Louisiana 9.0 ( 7.7- 10.5) 8.3 ( 6.9- 10.1) 11.3 ( 8.4- 15.2) ∼
Oklahoma 8.5 ( 7.2- 10.1) 8.4 ( 7.0- 10.0) ∼ ∼
Texas 7.4 ( 6.8- 8.0) 7.2 ( 6.6- 7.8) 10.2 ( 7.9- 13.1) 4.9 ( 3.8- 6.3)
West 6.9 ( 6.6- 7.2) 7.2 ( 6.8- 7.6) 7.6 ( 5.9- 9.8) 4.3 ( 3.6- 5.2)
Mountain
Arizona
Colorado 7.9 ( 6.6- 9.4) 7.9 ( 6.5- 9.4) ∼ ∼
Idaho 8.0 ( 5.9- 10.7) 7.9 ( 5.8- 10.7) ∼ ∼
Montana 6.1 ( 4.1- 9.0) 6.1 ( 4.0- 9.0) ∼ ∼
Nevada 8.1 ( 6.4- 10.2) 8.0 ( 6.3- 10.2) ∼ ∼
New Mexico 5.3 ( 3.8- 7.1) 5.7 ( 4.2- 7.8) ∼ ∼
Utah 5.2 ( 3.7- 7.1) 5.4 ( 3.9- 7.4) ∼ ∼
Wyoming
Pacific 6.9 ( 6.5- 7.2) 7.2 ( 6.8- 7.6) 7.6 ( 5.8- 9.9) 4.4 ( 3.5- 5.4)
Alaska 6.5 ( 3.7- 12.8) 7.0 ( 3.8- 14.8) ∼ ∼
California 6.3 ( 5.9- 6.7) 6.6 ( 6.2- 7.1) 7.9 ( 6.0- 10.4) 4.3 ( 3.4- 5.3)
San Francisco-Oakland 5.7 ( 4.6- 6.9) 6.4 ( 5.1- 8.0) ∼ ∼
San Jose-Monterey 6.0 ( 4.5- 8.0) 6.7 ( 4.9- 9.0) ∼ ∼
Los Angeles 6.1 ( 5.3- 6.9) 6.3 ( 5.4- 7.4) 8.3 ( 5.4- 12.4) 4.3 ( 2.9- 6.3)
Hawaii 5.6 ( 3.8- 7.9) ∼ ∼ -
Oregon 9.6 ( 8.2- 11.2) 9.5 ( 8.0- 11.1) ∼ ∼
Washington 8.3 ( 7.3- 9.6) 8.5 ( 7.4- 9.8) ∼ ∼
Seattle-Puget Sound 8.2 ( 6.8- 9.7) 8.5 ( 7.1- 10.1) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.8.1.1F: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 2.0 ( 1.9- 2.1) 1.9 ( 1.8- 1.9) 3.3 ( 3.0- 3.6) 1.4 ( 1.2- 1.7)
Northeast 2.4 ( 2.3- 2.6) 2.3 ( 2.1- 2.4) 3.9 ( 3.2- 4.6) 2.3 ( 1.6- 3.2)
New England 2.5 ( 2.2- 2.9) 2.5 ( 2.1- 2.8) ∼ ∼
Connecticut 2.3 ( 1.7- 3.0) 2.2 ( 1.6- 3.0) ∼ ∼
Maine 2.6 ( 1.6- 4.1) 2.6 ( 1.6- 4.1) ∼ ∼
Massachusetts 2.5 ( 2.0- 3.0) 2.4 ( 1.9- 2.9) ∼ ∼
New Hampshire 2.7 ( 1.6- 4.3) 2.5 ( 1.5- 4.1) ∼ ∼
Rhode Island 2.4 ( 1.4- 4.0) 2.3 ( 1.3- 4.0) ∼ ∼
Vermont 5.1 ( 3.0- 8.3) 4.9 ( 2.9- 8.1) ∼ ∼
Middle Atlantic 2.4 ( 2.2- 2.6) 2.2 ( 2.0- 2.4) 3.8 ( 3.1- 4.6) 2.4 ( 1.6- 3.3)
New Jersey 2.5 ( 2.1- 3.0) 2.4 ( 2.0- 2.9) 4.0 ( 2.5- 6.1) ∼
New York 2.4 ( 2.1- 2.7) 2.1 ( 1.9- 2.5) 3.6 ( 2.7- 4.7) 2.2 ( 1.4- 3.4)
Pennsylvania 2.4 ( 2.0- 2.7) 2.2 ( 1.8- 2.5) 4.3 ( 2.8- 6.2) -
Midwest 1.9 ( 1.8- 2.1) 1.8 ( 1.6- 1.9) 3.1 ( 2.5- 3.8) ∼
East North Central 2.1 ( 1.9- 2.3) 1.9 ( 1.8- 2.1) 3.3 ( 2.6- 4.1) ∼
Illinois 2.0 ( 1.7- 2.3) 1.7 ( 1.4- 2.1) 3.2 ( 2.1- 4.7) -
Indiana 2.1 ( 1.6- 2.6) 2.0 ( 1.5- 2.6) ∼ ∼
Michigan 2.3 ( 1.9- 2.8) 2.1 ( 1.7- 2.6) 3.7 ( 2.4- 5.5) ∼
Detroit 2.6 ( 2.0- 3.4) 2.2 ( 1.6- 3.0) 4.2 ( 2.6- 6.5) ∼
Ohio 2.0 ( 1.6- 2.3) 1.7 ( 1.4- 2.1) 3.1 ( 1.9- 4.8) ∼
Wisconsin 2.4 ( 1.9- 3.1) 2.4 ( 1.9- 3.0) ∼ ∼
West North Central 1.5 ( 1.3- 1.8) 1.5 ( 1.3- 1.7) ∼ ∼
Iowa 1.6 ( 1.1- 2.3) 1.6 ( 1.1- 2.3) ∼ ∼
Kansas 1.4 ( 0.9- 2.2) 1.4 ( 0.8- 2.2) ∼ ∼
Minnesota 1.7 ( 1.2- 2.3) 1.7 ( 1.2- 2.3) ∼ ∼
Missouri 1.7 ( 1.3- 2.2) 1.6 ( 1.2- 2.2) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 2.1 ( 1.9- 2.3) 1.9 ( 1.7- 2.0) 3.2 ( 2.8- 3.8) 1.5 ( 1.0- 2.3)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.9 ( 1.7- 2.2) 1.8 ( 1.5- 2.1) 3.8 ( 2.7- 5.2) -
Georgia 2.3 ( 1.9- 2.8) 1.7 ( 1.3- 2.2) 4.0 ( 2.9- 5.5) ∼
Atlanta 2.0 ( 1.3- 3.0) ∼ ∼ ∼
Maryland 2.7 ( 2.1- 3.3) 2.7 ( 2.1- 3.5) 2.8 ( 1.6- 4.6) ∼
North Carolina 1.8 ( 1.4- 2.2) 1.5 ( 1.1- 2.0) 2.8 ( 1.8- 4.2) ∼
South Carolina 2.0 ( 1.5- 2.7) 1.9 ( 1.3- 2.6) ∼ -
Virginia 2.1 ( 1.7- 2.6) 2.0 ( 1.5- 2.5) 3.0 ( 1.8- 4.7) ∼
West Virginia 2.4 ( 1.6- 3.5) 2.4 ( 1.6- 3.5) ∼ ∼
East South Central
Alabama 1.8 ( 1.4- 2.4) 1.4 ( 1.0- 2.1) 3.3 ( 2.0- 5.2) ∼
Kentucky 1.9 ( 1.4- 2.6) 1.8 ( 1.3- 2.5) ∼ -
Mississippi 1.2 ( 0.7- 1.9) ∼ ∼ ∼
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Table 2.8.1.1F: Esophagus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 1.6 ( 1.4- 1.8) 1.4 ( 1.2- 1.7) 3.1 ( 2.4- 4.1) 1.3 ( 0.9- 2.0)
Arkansas 1.4 ( 0.9- 2.1) ∼ ∼ ∼
Louisiana 1.9 ( 1.4- 2.6) 1.5 ( 1.0- 2.3) 3.0 ( 1.8- 4.7) ∼
Oklahoma 1.6 ( 1.1- 2.3) 1.7 ( 1.1- 2.4) ∼ ∼
Texas 1.6 ( 1.3- 1.8) 1.5 ( 1.2- 1.7) 3.0 ( 2.0- 4.3) 1.4 ( 0.9- 2.0)
West 1.8 ( 1.7- 2.0) 1.8 ( 1.7- 2.0) 3.5 ( 2.5- 4.7) 1.2 ( 0.8- 1.6)
Mountain
Arizona
Colorado 1.6 ( 1.1- 2.3) 1.5 ( 1.0- 2.1) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana 2.7 ( 1.6- 4.7) 2.9 ( 1.6- 4.9) ∼ ∼
Nevada 2.5 ( 1.7- 3.7) 2.5 ( 1.6- 3.8) ∼ ∼
New Mexico 1.5 ( 0.9- 2.6) 1.7 ( 1.0- 2.8) ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.8 ( 1.7- 2.0) 1.9 ( 1.7- 2.1) 3.4 ( 2.4- 4.7) 1.1 ( 0.8- 1.6)
Alaska ∼ ∼ ∼ ∼
California 1.8 ( 1.6- 2.0) 1.8 ( 1.6- 2.0) 3.2 ( 2.2- 4.6) 1.1 ( 0.7- 1.5)
San Francisco-Oakland 1.9 ( 1.3- 2.5) 2.1 ( 1.4- 3.0) ∼ ∼
San Jose-Monterey 1.9 ( 1.2- 3.0) 1.9 ( 1.1- 3.1) ∼ ∼
Los Angeles 1.7 ( 1.3- 2.1) 1.7 ( 1.3- 2.2) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon 2.2 ( 1.6- 3.0) 2.2 ( 1.6- 2.9) ∼ ∼
Washington 2.1 ( 1.6- 2.7) 2.1 ( 1.6- 2.7) ∼ ∼
Seattle-Puget Sound 2.1 ( 1.5- 2.8) 2.1 ( 1.5- 2.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.8.1.2M: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 7.7 ( 7.6- 7.9) 7.7 ( 7.5- 7.9) 9.7 ( 9.1- 10.3) 3.9 ( 3.4- 4.3)
Northeast 8.6 ( 8.2- 9.0) 8.7 ( 8.3- 9.1) 9.2 ( 7.9- 10.7) 6.4 ( 5.0- 8.2)
New England 10.3 ( 9.5- 11.1) 10.3 ( 9.5- 11.1) 13.0 ( 8.5- 19.6) 10.9 ( 6.3- 18.5)
Connecticut 9.1 ( 7.7- 10.7) 8.7 ( 7.2- 10.3) ∼ ∼
Maine 10.3 ( 8.1- 13.2) 10.4 ( 8.1- 13.3) ∼ ∼
Massachusetts 11.0 ( 9.8- 12.3) 11.3 ( 10.0- 12.6) ∼ ∼
New Hampshire 12.8 ( 10.0- 16.2) 12.8 ( 10.0- 16.2) ∼ ∼
Rhode Island 8.3 ( 6.0- 11.3) 8.0 ( 5.6- 11.0) ∼ ∼
Vermont 8.8 ( 5.7- 13.0) 8.9 ( 5.8- 13.1) ∼ ∼
Middle Atlantic 8.0 ( 7.6- 8.4) 8.1 ( 7.6- 8.5) 8.8 ( 7.4- 10.3) 5.7 ( 4.3- 7.6)
New Jersey 7.4 ( 6.5- 8.3) 7.3 ( 6.4- 8.2) 10.7 ( 7.6- 15.1) ∼
New York 7.5 ( 6.9- 8.1) 7.7 ( 7.0- 8.4) 7.5 ( 5.9- 9.5) 6.2 ( 4.4- 8.6)
Pennsylvania 9.0 ( 8.3- 9.8) 9.0 ( 8.3- 9.8) 10.1 ( 7.3- 13.8) ∼
Midwest 8.5 ( 8.1- 8.8) 8.4 ( 8.0- 8.7) 10.7 ( 9.3- 12.3) 2.2 ( 1.3- 4.1)
East North Central 8.7 ( 8.3- 9.2) 8.6 ( 8.2- 9.1) 10.9 ( 9.3- 12.6) ∼
Illinois 8.1 ( 7.3- 8.9) 7.9 ( 7.1- 8.8) 10.4 ( 8.0- 13.5) ∼
Indiana 8.4 ( 7.3- 9.6) 8.2 ( 7.1- 9.4) 12.8 ( 7.7- 20.8) ∼
Michigan 9.5 ( 8.6- 10.4) 9.4 ( 8.4- 10.4) 11.1 ( 8.1- 14.9) ∼
Ohio 8.9 ( 8.1- 9.8) 9.0 ( 8.1- 9.9) 9.0 ( 6.4- 12.6) ∼
Wisconsin 8.8 ( 7.6- 10.0) 8.6 ( 7.4- 9.8) ∼ ∼
West North Central 7.9 ( 7.3- 8.5) 7.8 ( 7.3- 8.5) 10.2 ( 6.8- 15.0) ∼
Iowa 8.1 ( 6.7- 9.7) 8.2 ( 6.8- 9.9) ∼ ∼
Kansas 7.5 ( 6.0- 9.2) 7.5 ( 6.0- 9.3) ∼ ∼
Minnesota 7.7 ( 6.6- 8.9) 7.8 ( 6.7- 9.1) ∼ ∼
Missouri 7.7 ( 6.7- 8.9) 7.4 ( 6.4- 8.6) 12.8 ( 8.0- 19.9) ∼
Nebraska 8.3 ( 6.4- 10.6) 8.3 ( 6.4- 10.7) ∼ ∼
North Dakota 8.9 ( 5.9- 13.0) 8.4 ( 5.5- 12.5) ∼ ∼
South Dakota 8.5 ( 5.8- 12.1) 8.6 ( 5.8- 12.3) ∼ ∼
South 7.3 ( 7.1- 7.6) 7.0 ( 6.7- 7.2) 10.1 ( 9.3- 11.0) 3.4 ( 2.7- 4.2)
South Atlantic 7.5 ( 7.1- 7.8) 7.1 ( 6.7- 7.5) 9.9 ( 8.9- 11.1) 4.0 ( 3.0- 5.3)
Delaware 8.1 ( 5.5- 11.8) 8.3 ( 5.5- 12.3) ∼ ∼
District of Columbia 10.0 ( 6.3- 15.2) ∼ 13.9 ( 8.5- 22.0) ∼
Florida 6.8 ( 6.3- 7.4) 6.8 ( 6.3- 7.4) 7.1 ( 5.3- 9.5) 4.9 ( 3.6- 6.5)
Georgia 7.9 ( 6.9- 9.0) 6.8 ( 5.7- 8.0) 12.3 ( 9.7- 15.5) ∼
Maryland 7.8 ( 6.7- 9.1) 7.9 ( 6.6- 9.4) 8.4 ( 5.9- 11.9) ∼
North Carolina 7.2 ( 6.3- 8.1) 7.2 ( 6.2- 8.2) 7.8 ( 5.7- 10.7) ∼
South Carolina 8.8 ( 7.5- 10.3) 7.0 ( 5.6- 8.6) 15.1 ( 11.5- 19.7) ∼
Virginia 7.9 ( 6.9- 9.0) 7.6 ( 6.6- 8.9) 10.4 ( 7.6- 14.0) ∼
West Virginia 8.7 ( 6.9- 10.9) 8.8 ( 7.0- 11.0) ∼ ∼
East South Central 8.1 ( 7.4- 8.7) 7.3 ( 6.7- 8.0) 12.8 ( 10.7- 15.2) ∼
Alabama 7.4 ( 6.2- 8.7) 6.5 ( 5.3- 8.0) 11.8 ( 8.6- 16.1) ∼
Kentucky 8.8 ( 7.5- 10.3) 8.6 ( 7.3- 10.2) ∼ ∼
Mississippi 9.2 ( 7.5- 11.2) 7.3 ( 5.6- 9.5) 14.6 ( 10.7- 19.7) ∼
Tennessee 7.6 ( 6.6- 8.8) 7.0 ( 5.9- 8.2) 12.1 ( 8.3- 17.4) ∼
West South Central 6.7 ( 6.2- 7.1) 6.5 ( 6.1- 7.0) 8.4 ( 6.9- 10.2) 2.9 ( 2.1- 3.9)
Arkansas 5.9 ( 4.6- 7.4) 5.8 ( 4.5- 7.4) ∼ ∼
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Table 2.8.1.2M: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 8.2 ( 7.0- 9.6) 8.1 ( 6.7- 9.8) 8.7 ( 6.2- 12.1) ∼
Oklahoma 6.7 ( 5.5- 8.2) 6.8 ( 5.5- 8.3) ∼ ∼
Texas 6.5 ( 5.9- 7.1) 6.3 ( 5.7- 6.9) 9.1 ( 6.9- 11.9) 2.8 ( 2.0- 3.9)
West 6.8 ( 6.5- 7.2) 7.2 ( 6.9- 7.6) 6.7 ( 5.2- 8.6) 3.6 ( 2.9- 4.4)
Mountain 7.8 ( 7.2- 8.4) 8.0 ( 7.4- 8.7) ∼ 5.8 ( 4.1- 8.0)
Arizona 7.9 ( 6.9- 9.1) 8.1 ( 7.0- 9.3) ∼ ∼
Colorado 7.8 ( 6.5- 9.3) 7.9 ( 6.5- 9.5) ∼ ∼
Idaho 8.1 ( 6.0- 10.8) 8.1 ( 5.9- 10.8) ∼ ∼
Montana 8.2 ( 5.8- 11.5) 8.5 ( 5.9- 11.8) ∼ ∼
Nevada 7.6 ( 6.0- 9.6) 8.3 ( 6.6- 10.6) ∼ ∼
New Mexico 8.0 ( 6.2- 10.3) 8.7 ( 6.7- 11.2) ∼ 7.4 ( 4.3- 12.1)
Utah 4.7 ( 3.3- 6.6) 4.8 ( 3.3- 6.7) ∼ ∼
Wyoming 11.8 ( 7.6- 18.0) 11.7 ( 7.4- 17.9) ∼ ∼
Pacific 6.5 ( 6.1- 6.8) 6.9 ( 6.5- 7.3) 6.8 ( 5.2- 9.0) 2.8 ( 2.2- 3.7)
Alaska 9.4 ( 4.8- 17.8) ∼ ∼ ∼
California 5.9 ( 5.5- 6.4) 6.3 ( 5.8- 6.7) 7.2 ( 5.4- 9.6) 2.8 ( 2.1- 3.7)
Hawaii 4.1 ( 2.7- 6.2) ∼ ∼ ∼
Oregon 8.7 ( 7.3- 10.2) 8.9 ( 7.5- 10.5) ∼ ∼
Washington 8.2 ( 7.1- 9.4) 8.4 ( 7.3- 9.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.8.1.2F: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.7- 1.8) 1.7 ( 1.6- 1.7) 2.9 ( 2.6- 3.2) 1.0 ( 0.8- 1.2)
Northeast 2.0 ( 1.8- 2.1) 1.9 ( 1.7- 2.1) 3.1 ( 2.5- 3.8) 1.6 ( 1.1- 2.4)
New England 2.0 ( 1.7- 2.3) 1.9 ( 1.6- 2.2) ∼ ∼
Connecticut 1.8 ( 1.3- 2.4) 1.6 ( 1.1- 2.3) ∼ ∼
Maine 1.8 ( 1.0- 3.0) 1.8 ( 1.0- 3.1) ∼ ∼
Massachusetts 2.1 ( 1.7- 2.6) 2.1 ( 1.6- 2.6) ∼ ∼
New Hampshire 2.1 ( 1.2- 3.5) 2.1 ( 1.2- 3.6) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.0 ( 1.8- 2.2) 1.9 ( 1.7- 2.1) 3.1 ( 2.5- 3.8) 1.8 ( 1.2- 2.7)
New Jersey 1.8 ( 1.4- 2.2) 1.7 ( 1.4- 2.2) ∼ ∼
New York 2.1 ( 1.9- 2.4) 2.0 ( 1.7- 2.3) 2.9 ( 2.2- 3.9) 1.8 ( 1.0- 2.8)
Pennsylvania 2.0 ( 1.7- 2.3) 1.8 ( 1.5- 2.1) 4.2 ( 2.8- 6.2) ∼
Midwest 1.8 ( 1.7- 1.9) 1.8 ( 1.6- 1.9) 2.5 ( 1.9- 3.1) ∼
East North Central 1.9 ( 1.7- 2.0) 1.8 ( 1.6- 2.0) 2.5 ( 1.9- 3.2) ∼
Illinois 1.8 ( 1.5- 2.2) 1.7 ( 1.4- 2.1) 2.5 ( 1.6- 3.9) ∼
Indiana 1.7 ( 1.3- 2.1) 1.5 ( 1.1- 2.0) ∼ ∼
Michigan 1.9 ( 1.6- 2.3) 1.9 ( 1.5- 2.3) ∼ ∼
Ohio 1.8 ( 1.5- 2.2) 1.8 ( 1.5- 2.1) 2.5 ( 1.4- 4.1) ∼
Wisconsin 2.1 ( 1.7- 2.7) 2.2 ( 1.7- 2.8) ∼ ∼
West North Central 1.7 ( 1.5- 1.9) 1.7 ( 1.4- 1.9) ∼ ∼
Iowa 2.0 ( 1.4- 2.8) 2.0 ( 1.4- 2.8) ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 1.7 ( 1.3- 2.3) 1.8 ( 1.3- 2.4) ∼ ∼
Missouri 2.0 ( 1.6- 2.5) 2.0 ( 1.5- 2.5) ∼ ∼
Nebraska 1.7 ( 1.0- 2.7) 1.7 ( 1.0- 2.8) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.7 ( 1.6- 1.8) 1.5 ( 1.4- 1.6) 3.0 ( 2.6- 3.4) 0.8 ( 0.5- 1.1)
South Atlantic 1.8 ( 1.7- 2.0) 1.6 ( 1.4- 1.7) 3.1 ( 2.6- 3.6) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.8 ( 1.6- 2.1) 1.5 ( 1.3- 1.8) 4.6 ( 3.3- 6.1) ∼
Georgia 1.8 ( 1.4- 2.3) 1.5 ( 1.1- 2.0) 2.9 ( 1.9- 4.2) ∼
Maryland 2.2 ( 1.7- 2.8) 2.3 ( 1.8- 3.1) ∼ ∼
North Carolina 1.3 ( 1.0- 1.7) 1.1 ( 0.8- 1.5) 2.4 ( 1.4- 3.7) ∼
South Carolina 2.2 ( 1.7- 2.9) 1.6 ( 1.1- 2.3) 4.0 ( 2.5- 6.1) ∼
Virginia 1.6 ( 1.3- 2.1) 1.5 ( 1.1- 2.0) 2.5 ( 1.4- 4.1) ∼
West Virginia 2.3 ( 1.5- 3.4) 2.3 ( 1.5- 3.5) ∼ ∼
East South Central 1.5 ( 1.3- 1.8) 1.3 ( 1.0- 1.5) 3.0 ( 2.2- 4.0) ∼
Alabama 1.5 ( 1.1- 2.0) 1.1 ( 0.7- 1.7) 2.8 ( 1.6- 4.6) ∼
Kentucky 1.3 ( 0.9- 1.9) 1.3 ( 0.8- 1.9) ∼ ∼
Mississippi 1.3 ( 0.8- 2.0) ∼ ∼ ∼
Tennessee 1.8 ( 1.4- 2.4) 1.5 ( 1.1- 2.0) 4.6 ( 2.7- 7.3) ∼
West South Central 1.5 ( 1.3- 1.7) 1.4 ( 1.2- 1.6) 2.7 ( 2.0- 3.6) 0.9 ( 0.5- 1.5)
Arkansas 1.6 ( 1.0- 2.4) 1.3 ( 0.8- 2.0) ∼ ∼
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Table 2.8.1.2F: Esophagus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 1.7 ( 1.2- 2.3) 1.6 ( 1.0- 2.3) ∼ ∼
Oklahoma 1.2 ( 0.8- 1.8) 1.3 ( 0.9- 2.0) ∼ ∼
Texas 1.5 ( 1.3- 1.8) 1.4 ( 1.2- 1.7) 3.0 ( 2.0- 4.3) 1.0 ( 0.6- 1.6)
West 1.5 ( 1.4- 1.7) 1.6 ( 1.4- 1.7) 2.6 ( 1.8- 3.7) 1.0 ( 0.7- 1.3)
Mountain 1.5 ( 1.3- 1.8) 1.5 ( 1.3- 1.8) ∼ ∼
Arizona 1.4 ( 1.0- 1.9) 1.4 ( 1.0- 1.9) ∼ ∼
Colorado 1.4 ( 1.0- 2.1) 1.5 ( 1.0- 2.2) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.6 ( 0.9- 2.5) 1.8 ( 1.0- 2.9) ∼ ∼
New Mexico 1.6 ( 1.0- 2.7) ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.6 ( 1.4- 1.7) 1.6 ( 1.4- 1.8) 2.6 ( 1.7- 3.8) 0.8 ( 0.5- 1.3)
Alaska ∼ ∼ ∼ ∼
California 1.5 ( 1.4- 1.7) 1.6 ( 1.4- 1.8) 2.5 ( 1.6- 3.7) 0.9 ( 0.6- 1.3)
Hawaii ∼ ∼ ∼ ∼
Oregon 1.5 ( 1.0- 2.2) 1.6 ( 1.1- 2.3) ∼ ∼
Washington 1.8 ( 1.3- 2.3) 1.8 ( 1.3- 2.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.9.1.1M: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 3.1 ( 3.0- 3.2) 3.2 ( 3.1- 3.3) 2.6 ( 2.3- 2.9) 2.9 ( 2.6- 3.2)
Northeast 3.7 ( 3.4- 3.9) 3.9 ( 3.7- 4.2) 2.3 ( 1.8- 3.0) 3.5 ( 2.7- 4.6)
New England 3.6 ( 3.1- 4.0) 3.7 ( 3.3- 4.2) ∼ ∼
Connecticut 4.2 ( 3.3- 5.4) 4.4 ( 3.4- 5.7) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 3.6 ( 2.9- 4.3) 3.8 ( 3.1- 4.6) ∼ ∼
New Hampshire 3.6 ( 2.3- 5.6) 3.8 ( 2.4- 5.8) ∼ ∼
Rhode Island 4.1 ( 2.5- 6.2) 4.3 ( 2.6- 6.7) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.7 ( 3.4- 4.0) 4.0 ( 3.7- 4.3) 2.3 ( 1.7- 3.0) 3.6 ( 2.8- 4.8)
New Jersey 4.1 ( 3.5- 4.8) 4.6 ( 3.9- 5.4) ∼ 3.2 ( 1.8- 6.6)
New York 3.5 ( 3.1- 3.9) 3.9 ( 3.4- 4.4) 2.2 ( 1.5- 3.3) 3.8 ( 2.7- 5.4)
Pennsylvania 3.8 ( 3.3- 4.4) 3.8 ( 3.3- 4.4) 2.7 ( 1.6- 4.7) -
Midwest 3.2 ( 3.0- 3.4) 3.2 ( 3.0- 3.4) 2.7 ( 2.1- 3.5) 2.4 ( 1.5- 4.1)
East North Central 3.2 ( 3.0- 3.4) 3.2 ( 3.0- 3.5) 2.7 ( 2.1- 3.6) 2.0 ( 1.2- 4.0)
Illinois 3.0 ( 2.6- 3.5) 3.0 ( 2.5- 3.5) 2.5 ( 1.5- 4.2) -
Indiana 3.4 ( 2.8- 4.2) 3.5 ( 2.8- 4.3) ∼ ∼
Michigan 2.8 ( 2.4- 3.4) 2.7 ( 2.2- 3.3) 3.7 ( 2.3- 6.0) ∼
Detroit 3.4 ( 2.6- 4.3) 3.4 ( 2.5- 4.6) ∼ ∼
Ohio 3.6 ( 3.1- 4.2) 3.6 ( 3.1- 4.2) ∼ ∼
Wisconsin 3.2 ( 2.6- 4.0) 3.3 ( 2.7- 4.2) ∼ ∼
West North Central 3.3 ( 2.9- 3.7) 3.3 ( 2.9- 3.7) ∼ ∼
Iowa 2.9 ( 2.1- 3.9) 2.9 ( 2.1- 4.0) ∼ ∼
Kansas 3.4 ( 2.5- 4.6) 3.1 ( 2.2- 4.3) ∼ ∼
Minnesota 3.8 ( 3.0- 4.6) 3.5 ( 2.8- 4.4) ∼ ∼
Missouri 3.0 ( 2.4- 3.7) 3.2 ( 2.5- 4.0) ∼ ∼
Nebraska 3.3 ( 2.2- 4.8) 3.4 ( 2.3- 5.0) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 2.7 ( 2.5- 2.9) 2.8 ( 2.6- 3.0) 2.6 ( 2.2- 3.1) 2.7 ( 2.0- 3.7)
Delaware 4.4 ( 2.6- 7.2) 5.2 ( 2.9- 8.6) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.9 ( 2.6- 3.3) 2.9 ( 2.5- 3.4) 3.5 ( 2.4- 5.1) -
Georgia 1.8 ( 1.4- 2.3) 1.8 ( 1.3- 2.4) 2.0 ( 1.3- 3.4) ∼
Atlanta 1.5 ( 0.9- 2.7) 1.8 ( 1.0- 3.3) ∼ ∼
Maryland 3.2 ( 2.6- 4.0) 3.9 ( 3.0- 4.9) ∼ ∼
North Carolina 2.4 ( 2.0- 3.0) 2.4 ( 1.9- 3.0) 3.2 ( 2.0- 5.0) ∼
South Carolina 2.9 ( 2.2- 3.8) 3.3 ( 2.4- 4.4) ∼ -
Virginia 2.9 ( 2.3- 3.5) 2.9 ( 2.3- 3.6) 2.5 ( 1.4- 4.5) ∼
West Virginia 2.6 ( 1.6- 4.0) 2.3 ( 1.4- 3.6) ∼ ∼
East South Central
Alabama 2.7 ( 2.0- 3.5) 2.5 ( 1.8- 3.5) 3.0 ( 1.7- 5.2) ∼
Kentucky 2.8 ( 2.2- 3.7) 2.8 ( 2.1- 3.8) ∼ -
Mississippi 3.3 ( 2.4- 4.5) 3.2 ( 2.1- 4.8) ∼ ∼
Tennessee
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Table 2.9.1.1M: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 2.9 ( 2.6- 3.2) 2.8 ( 2.5- 3.1) 2.8 ( 2.1- 3.8) 2.6 ( 2.0- 3.5)
Arkansas 2.8 ( 2.0- 4.0) 2.8 ( 1.9- 4.1) ∼ ∼
Louisiana 3.3 ( 2.6- 4.3) 3.9 ( 3.0- 5.2) ∼ ∼
Oklahoma 2.8 ( 2.0- 3.8) 2.6 ( 1.8- 3.7) ∼ ∼
Texas 2.8 ( 2.4- 3.1) 2.7 ( 2.3- 3.0) 3.5 ( 2.4- 5.2) 2.4 ( 1.8- 3.2)
West 3.0 ( 2.8- 3.2) 3.2 ( 2.9- 3.4) 2.4 ( 1.6- 3.6) 3.0 ( 2.5- 3.6)
Mountain
Arizona
Colorado 2.6 ( 2.0- 3.5) 2.7 ( 2.0- 3.7) ∼ ∼
Idaho 3.5 ( 2.2- 5.3) 3.6 ( 2.3- 5.5) ∼ ∼
Montana 4.3 ( 2.6- 6.9) 4.7 ( 2.8- 7.4) ∼ ∼
Nevada 1.8 ( 1.1- 3.0) 1.8 ( 1.1- 3.1) ∼ ∼
New Mexico 2.9 ( 1.9- 4.3) 3.2 ( 2.0- 4.8) ∼ ∼
Utah 2.4 ( 1.5- 3.7) 2.5 ( 1.6- 3.9) ∼ ∼
Wyoming
Pacific 3.0 ( 2.8- 3.3) 3.3 ( 3.0- 3.5) 2.5 ( 1.6- 3.8) 3.2 ( 2.6- 4.0)
Alaska ∼ ∼ ∼ ∼
California 2.9 ( 2.7- 3.2) 3.1 ( 2.8- 3.4) 2.5 ( 1.6- 4.0) 3.3 ( 2.7- 4.1)
San Francisco-Oakland 2.7 ( 2.0- 3.5) 3.1 ( 2.2- 4.2) ∼ ∼
San Jose-Monterey 3.6 ( 2.6- 5.0) 4.2 ( 2.9- 5.9) ∼ ∼
Los Angeles 3.0 ( 2.5- 3.6) 3.5 ( 2.9- 4.2) ∼ 3.4 ( 2.4- 4.8)
Hawaii ∼ ∼ ∼ -
Oregon 3.1 ( 2.3- 4.0) 3.2 ( 2.4- 4.2) ∼ ∼
Washington 3.7 ( 3.1- 4.5) 4.0 ( 3.3- 4.9) ∼ ∼
Seattle-Puget Sound 4.0 ( 3.2- 5.1) 4.5 ( 3.6- 5.7) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.9.1.1F: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 2.4 ( 2.4- 2.5) 2.5 ( 2.4- 2.6) 2.2 ( 2.0- 2.4) 2.1 ( 1.8- 2.3)
Northeast 3.0 ( 2.8- 3.2) 3.1 ( 2.9- 3.3) 2.7 ( 2.2- 3.3) 2.9 ( 2.3- 3.7)
New England 3.1 ( 2.7- 3.5) 3.2 ( 2.8- 3.7) ∼ ∼
Connecticut 3.0 ( 2.2- 3.9) 3.1 ( 2.2- 4.1) ∼ ∼
Maine 3.2 ( 2.0- 4.9) 3.2 ( 2.0- 5.0) ∼ ∼
Massachusetts 3.1 ( 2.6- 3.8) 3.3 ( 2.6- 4.0) ∼ ∼
New Hampshire 2.6 ( 1.5- 4.3) 2.7 ( 1.6- 4.4) ∼ ∼
Rhode Island 3.3 ( 2.0- 5.2) 3.5 ( 2.0- 5.6) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.0 ( 2.8- 3.2) 3.1 ( 2.8- 3.3) 2.6 ( 2.1- 3.3) 2.9 ( 2.2- 3.8)
New Jersey 3.1 ( 2.6- 3.7) 3.2 ( 2.6- 3.9) 3.1 ( 1.9- 4.8) ∼
New York 2.9 ( 2.6- 3.3) 3.1 ( 2.7- 3.5) 2.2 ( 1.6- 3.0) 3.1 ( 2.2- 4.2)
Pennsylvania 3.0 ( 2.6- 3.5) 3.0 ( 2.5- 3.5) 3.4 ( 2.1- 5.1) -
Midwest 2.6 ( 2.4- 2.8) 2.6 ( 2.5- 2.8) 2.2 ( 1.7- 2.7) 2.5 ( 1.6- 4.0)
East North Central 2.6 ( 2.4- 2.8) 2.7 ( 2.4- 2.9) 2.3 ( 1.8- 2.9) 2.5 ( 1.5- 4.1)
Illinois 2.6 ( 2.2- 3.0) 2.7 ( 2.2- 3.1) 2.3 ( 1.4- 3.5) -
Indiana 2.3 ( 1.8- 2.9) 2.3 ( 1.8- 2.9) ∼ ∼
Michigan 2.5 ( 2.1- 3.0) 2.5 ( 2.1- 3.1) 2.4 ( 1.4- 3.8) ∼
Detroit 2.5 ( 1.9- 3.3) 2.6 ( 1.8- 3.6) ∼ ∼
Ohio 2.6 ( 2.2- 3.1) 2.7 ( 2.2- 3.2) ∼ ∼
Wisconsin 3.2 ( 2.6- 4.0) 3.3 ( 2.6- 4.1) ∼ ∼
West North Central 2.6 ( 2.3- 2.9) 2.6 ( 2.3- 3.0) ∼ ∼
Iowa 3.2 ( 2.3- 4.2) 3.1 ( 2.2- 4.2) ∼ ∼
Kansas 1.9 ( 1.2- 2.8) 1.8 ( 1.2- 2.7) ∼ ∼
Minnesota 3.1 ( 2.4- 3.8) 3.1 ( 2.4- 3.9) ∼ ∼
Missouri 2.3 ( 1.8- 2.9) 2.5 ( 1.9- 3.2) ∼ ∼
Nebraska 2.6 ( 1.6- 4.0) 2.8 ( 1.7- 4.3) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 2.3 ( 2.1- 2.5) 2.3 ( 2.1- 2.5) 2.2 ( 1.9- 2.6) 2.1 ( 1.6- 2.8)
Delaware 4.1 ( 2.4- 6.6) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.2 ( 1.9- 2.6) 2.3 ( 2.0- 2.7) 1.8 ( 1.1- 2.8) -
Georgia 1.9 ( 1.5- 2.4) 2.0 ( 1.5- 2.6) 1.9 ( 1.2- 2.9) ∼
Atlanta 1.7 ( 1.1- 2.6) 1.9 ( 1.1- 3.2) ∼ ∼
Maryland 2.6 ( 2.0- 3.3) 2.5 ( 1.8- 3.4) 2.8 ( 1.8- 4.3) ∼
North Carolina 2.3 ( 1.8- 2.8) 2.3 ( 1.8- 2.9) 2.2 ( 1.4- 3.4) ∼
South Carolina 1.8 ( 1.3- 2.5) 1.8 ( 1.2- 2.7) ∼ -
Virginia 2.8 ( 2.3- 3.4) 2.6 ( 2.0- 3.3) 2.9 ( 1.9- 4.5) ∼
West Virginia 2.0 ( 1.2- 3.2) 2.0 ( 1.2- 3.2) ∼ ∼
East South Central
Alabama 1.8 ( 1.3- 2.4) 2.0 ( 1.4- 2.9) ∼ ∼
Kentucky 2.2 ( 1.7- 3.0) 2.3 ( 1.7- 3.1) ∼ -
Mississippi 2.1 ( 1.4- 3.0) 2.6 ( 1.6- 3.9) ∼ ∼
Tennessee
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Table 2.9.1.1F: Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 2.1 ( 1.9- 2.4) 2.2 ( 1.9- 2.4) 2.0 ( 1.5- 2.7) 1.9 ( 1.4- 2.5)
Arkansas 3.2 ( 2.3- 4.3) 2.6 ( 1.7- 3.7) ∼ ∼
Louisiana 2.2 ( 1.6- 2.9) 2.4 ( 1.7- 3.4) ∼ ∼
Oklahoma 2.1 ( 1.5- 2.9) 2.5 ( 1.7- 3.5) ∼ ∼
Texas 2.0 ( 1.7- 2.3) 2.1 ( 1.8- 2.4) 1.8 ( 1.2- 2.8) 1.9 ( 1.4- 2.5)
West 2.1 ( 2.0- 2.3) 2.3 ( 2.1- 2.5) 1.9 ( 1.3- 2.7) 1.7 ( 1.3- 2.1)
Mountain
Arizona
Colorado 2.9 ( 2.2- 3.7) 3.0 ( 2.3- 3.8) ∼ ∼
Idaho 3.1 ( 1.9- 4.8) 3.1 ( 1.9- 4.8) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.8 ( 1.1- 2.8) 1.8 ( 1.1- 3.0) ∼ ∼
New Mexico 1.9 ( 1.2- 3.1) 2.0 ( 1.2- 3.3) ∼ ∼
Utah 2.4 ( 1.6- 3.6) 2.5 ( 1.6- 3.7) ∼ ∼
Wyoming
Pacific 2.1 ( 1.9- 2.2) 2.2 ( 2.0- 2.5) 1.9 ( 1.2- 2.8) 1.6 ( 1.3- 2.1)
Alaska ∼ ∼ ∼ ∼
California 2.0 ( 1.8- 2.2) 2.2 ( 2.0- 2.5) 2.0 ( 1.3- 3.0) 1.6 ( 1.3- 2.1)
San Francisco-Oakland 1.9 ( 1.4- 2.7) 2.2 ( 1.5- 3.3) ∼ ∼
San Jose-Monterey 1.9 ( 1.2- 2.9) 2.3 ( 1.4- 3.7) ∼ ∼
Los Angeles 2.0 ( 1.6- 2.4) 2.2 ( 1.8- 2.8) ∼ 1.7 ( 1.1- 2.5)
Hawaii ∼ ∼ ∼ -
Oregon 2.5 ( 1.8- 3.3) 2.5 ( 1.8- 3.4) ∼ ∼
Washington 2.2 ( 1.7- 2.8) 2.4 ( 1.9- 3.1) ∼ ∼
Seattle-Puget Sound 2.4 ( 1.8- 3.1) 2.6 ( 1.9- 3.5) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.9.1.2M: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 0.5 ( 0.5- 0.6) 0.6 ( 0.5- 0.6) 0.5 ( 0.4- 0.6) 0.5 ( 0.3- 0.7)
Northeast 0.5 ( 0.4- 0.6) 0.5 ( 0.5- 0.7) ∼ ∼
New England 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.6 ( 0.3- 0.9) 0.6 ( 0.4- 1.0) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) ∼ ∼
New Jersey 0.5 ( 0.3- 0.8) 0.6 ( 0.4- 0.9) ∼ ∼
New York 0.5 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ ∼
Pennsylvania 0.7 ( 0.5- 0.9) 0.7 ( 0.5- 1.0) ∼ ∼
Midwest 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) ∼ ∼
East North Central 0.6 ( 0.5- 0.7) 0.6 ( 0.5- 0.7) ∼ ∼
Illinois 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.8) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.9) 0.6 ( 0.4- 0.9) ∼ ∼
Ohio 0.7 ( 0.5- 1.0) 0.7 ( 0.5- 1.0) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.7) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.6 ( 0.5- 0.6) 0.6 ( 0.5- 0.7) 0.5 ( 0.3- 0.7) 0.4 ( 0.2- 0.7)
South Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) 0.5 ( 0.3- 0.8) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina 0.7 ( 0.4- 1.0) 0.7 ( 0.4- 1.1) ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.6 ( 0.5- 0.9) 0.7 ( 0.5- 0.9) ∼ ∼
Alabama 0.8 ( 0.5- 1.3) ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.7 ( 0.6- 0.9) 0.7 ( 0.6- 0.9) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.9.1.2M: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.6 ( 0.5- 0.8) 0.7 ( 0.5- 0.9) ∼ ∼
West 0.5 ( 0.4- 0.6) 0.5 ( 0.5- 0.6) ∼ 0.6 ( 0.4- 1.0)
Mountain 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.5 ( 0.4- 0.7) 0.6 ( 0.5- 0.7) ∼ 0.6 ( 0.3- 1.1)
Alaska ∼ ∼ ∼ ∼
California 0.5 ( 0.4- 0.6) 0.6 ( 0.5- 0.7) ∼ 0.6 ( 0.3- 1.1)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington 0.7 ( 0.4- 1.1) 0.7 ( 0.4- 1.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.9.1.2F: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.4) 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4)
Northeast 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
New England 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.7) ∼ ∼
New Jersey 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.9) ∼ ∼
New York 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ ∼
Pennsylvania 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.8) ∼ ∼
Midwest 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) ∼ ∼
East North Central 0.4 ( 0.3- 0.5) 0.4 ( 0.4- 0.5) ∼ ∼
Illinois 0.4 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.8) ∼ ∼
Ohio 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.5 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 0.7 ( 0.4- 1.1) 0.7 ( 0.4- 1.2) ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.4) 0.3 ( 0.2- 0.4) ∼
South Atlantic 0.3 ( 0.3- 0.4) 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.4) 0.2 ( 0.2- 0.4) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina 0.4 ( 0.2- 0.6) ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.5 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.9.1.2F: Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
West 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Mountain 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.3 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.10.1.1M: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 0.9 ( 0.8- 0.9) 0.7 ( 0.6- 0.8) 1.8 ( 1.6- 2.1) 1.8 ( 1.6- 2.1)
Northeast 1.1 ( 0.9- 1.2) 0.7 ( 0.6- 0.9) 2.8 ( 2.2- 3.5) 2.2 ( 1.6- 3.2)
New England 0.7 ( 0.5- 1.0) 0.6 ( 0.4- 0.8) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.9 ( 0.6- 1.3) 0.6 ( 0.3- 0.9) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.2 ( 1.0- 1.3) 0.8 ( 0.7- 1.0) 2.9 ( 2.3- 3.7) 2.5 ( 1.7- 3.6)
New Jersey 1.1 ( 0.8- 1.5) 0.9 ( 0.6- 1.3) ∼ ∼
New York 1.6 ( 1.4- 1.9) 1.1 ( 0.9- 1.4) 3.5 ( 2.6- 4.7) 3.4 ( 2.3- 5.1)
Pennsylvania 0.5 ( 0.4- 0.8) 0.4 ( 0.2- 0.6) ∼ -
Midwest 0.3 ( 0.3- 0.4) 0.2 ( 0.2- 0.3) 0.9 ( 0.6- 1.5) ∼
East North Central 0.4 ( 0.3- 0.5) 0.3 ( 0.2- 0.4) 1.0 ( 0.6- 1.6) ∼
Illinois 0.7 ( 0.5- 0.9) 0.5 ( 0.4- 0.8) ∼ -
Indiana ∼ ∼ ∼ ∼
Michigan 0.4 ( 0.2- 0.6) ∼ ∼ ∼
Detroit 0.9 ( 0.5- 1.5) ∼ ∼ ∼
Ohio ∼ ∼ ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 1.1 ( 0.9- 1.2) 0.8 ( 0.7- 1.0) 1.9 ( 1.6- 2.4) 2.0 ( 1.4- 2.8)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.6 ( 1.3- 1.9) 1.5 ( 1.2- 1.8) 2.3 ( 1.5- 3.7) -
Georgia 1.4 ( 1.0- 1.8) 0.8 ( 0.5- 1.3) 2.8 ( 1.9- 4.3) ∼
Atlanta 2.6 ( 1.9- 3.7) ∼ 4.9 ( 3.3- 9.2) ∼
Maryland 1.1 ( 0.7- 1.6) ∼ 2.6 ( 1.6- 4.6) ∼
North Carolina 0.5 ( 0.3- 0.8) ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia 0.5 ( 0.3- 0.9) ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi ∼ ∼ ∼ ∼
Tennessee
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Table 2.10.1.1M: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 0.8 ( 0.7- 1.0) 0.7 ( 0.6- 0.9) 1.6 ( 1.1- 2.4) 1.5 ( 1.0- 2.3)
Arkansas ∼ ∼ ∼ ∼
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 1.0 ( 0.8- 1.2) 0.8 ( 0.7- 1.1) 2.2 ( 1.4- 3.6) 1.6 ( 1.1- 2.4)
West 1.1 ( 1.0- 1.3) 1.1 ( 1.0- 1.3) 2.3 ( 1.6- 3.5) 1.9 ( 1.5- 2.4)
Mountain
Arizona
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.3 ( 1.1- 1.4) 1.3 ( 1.1- 1.4) 2.5 ( 1.7- 3.8) 1.9 ( 1.5- 2.5)
Alaska ∼ ∼ ∼ ∼
California 1.5 ( 1.3- 1.7) 1.5 ( 1.3- 1.7) 2.8 ( 1.8- 4.2) 1.9 ( 1.5- 2.6)
San Francisco-Oakland 2.4 ( 1.8- 3.2) 3.0 ( 2.2- 4.1) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 2.0 ( 1.6- 2.5) 1.9 ( 1.5- 2.5) ∼ 1.7 ( 1.1- 2.8)
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington 0.6 ( 0.4- 1.0) 0.6 ( 0.4- 1.1) ∼ ∼
Seattle-Puget Sound ∼ ∼ ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.10.1.1F: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4)
Northeast 0.2 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) 0.6 ( 0.4- 1.0) ∼
New England ∼ ∼ ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.2 ( 0.1- 0.3) 0.1 ( 0.1- 0.1) 0.7 ( 0.4- 1.0) ∼
New Jersey ∼ ∼ ∼ ∼
New York 0.3 ( 0.2- 0.4) 0.1 ( 0.1- 0.2) 0.9 ( 0.5- 1.5) ∼
Pennsylvania ∼ ∼ ∼ -
Midwest 0.0 ( 0.0- 0.1) ∼ ∼ ∼
East North Central ∼ ∼ ∼ ∼
Illinois ∼ ∼ ∼ -
Indiana ∼ ∼ ∼ ∼
Michigan ∼ ∼ ∼ ∼
Detroit ∼ ∼ ∼ ∼
Ohio ∼ ∼ ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central ∼ ∼ ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.1) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.2 ( 0.1- 0.4) ∼ ∼ -
Georgia ∼ ∼ ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi ∼ ∼ ∼ ∼
Tennessee
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Table 2.10.1.1F: Kaposi Sarcoma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 0.1 ( 0.1- 0.2) 0.1 ( 0.1- 0.2) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas ∼ ∼ ∼ ∼
West 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.1) ∼ ∼
Mountain
Arizona
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 0.1 ( 0.1- 0.1) 0.1 ( 0.1- 0.2) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.1 ( 0.1- 0.2) ∼ ∼ ∼
San Francisco-Oakland ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles ∼ ∼ ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
Seattle-Puget Sound ∼ ∼ ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.11.1.1M: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 18.6 ( 18.3- 18.8) 18.7 ( 18.4- 18.9) 19.3 ( 18.5- 20.2) 17.5 ( 16.6- 18.5)
Northeast 19.5 ( 19.0- 20.1) 19.8 ( 19.2- 20.4) 17.7 ( 16.0- 19.6) 14.1 ( 12.1- 16.3)
New England 18.7 ( 17.7- 19.8) 18.9 ( 17.9- 20.0) 16.2 ( 11.7- 22.7) 19.1 ( 12.8- 28.2)
Connecticut 19.1 ( 17.1- 21.3) 19.0 ( 16.9- 21.4) 19.9 ( 12.5- 32.5) ∼
Maine 15.7 ( 12.8- 19.0) 15.6 ( 12.7- 18.9) ∼ ∼
Massachusetts 19.2 ( 17.7- 20.9) 19.6 ( 18.0- 21.3) 14.3 ( 8.3- 24.2) 21.3 ( 12.2- 36.8)
New Hampshire 18.9 ( 15.5- 22.9) 19.1 ( 15.7- 23.1) ∼ ∼
Rhode Island 19.7 ( 16.0- 24.0) 20.3 ( 16.5- 24.9) ∼ ∼
Vermont 18.1 ( 13.6- 23.8) 18.3 ( 13.7- 24.1) ∼ ∼
Middle Atlantic 19.8 ( 19.2- 20.5) 20.1 ( 19.4- 20.8) 17.9 ( 16.0- 19.9) 13.3 ( 11.3- 15.7)
New Jersey 19.5 ( 18.1- 20.9) 19.4 ( 17.9- 20.9) 21.4 ( 17.1- 26.9) 11.9 ( 8.2- 17.4)
New York 19.2 ( 18.3- 20.1) 20.2 ( 19.1- 21.2) 14.1 ( 12.0- 16.7) 14.0 ( 11.5- 17.1)
Pennsylvania 20.8 ( 19.7- 22.0) 20.5 ( 19.3- 21.7) 23.8 ( 19.4- 29.0) -
Midwest 18.7 ( 18.2- 19.2) 18.3 ( 17.8- 18.8) 22.4 ( 20.4- 24.6) 16.4 ( 13.3- 20.2)
East North Central 19.0 ( 18.4- 19.6) 18.5 ( 17.8- 19.1) 23.0 ( 20.8- 25.4) 15.7 ( 12.4- 20.0)
Illinois 21.5 ( 20.3- 22.8) 21.2 ( 19.9- 22.6) 25.0 ( 21.2- 29.5) -
Indiana 19.8 ( 18.2- 21.6) 19.7 ( 18.0- 21.5) 20.6 ( 14.4- 29.2) ∼
Michigan 18.3 ( 17.1- 19.6) 17.7 ( 16.4- 19.1) 23.1 ( 18.8- 28.2) 21.0 ( 12.5- 36.9)
Detroit 19.8 ( 17.8- 22.1) 19.0 ( 16.7- 21.4) 25.2 ( 20.1- 31.4) ∼
Ohio 16.6 ( 15.5- 17.7) 15.7 ( 14.6- 16.9) 21.4 ( 17.3- 26.4) ∼
Wisconsin 18.9 ( 17.2- 20.7) 18.7 ( 17.0- 20.5) 20.6 ( 11.0- 39.2) ∼
West North Central 18.2 ( 17.3- 19.1) 17.9 ( 17.0- 18.8) 19.2 ( 14.8- 25.0) 18.9 ( 12.0- 29.8)
Iowa 19.1 ( 17.0- 21.5) 18.5 ( 16.4- 20.9) ∼ ∼
Kansas 16.5 ( 14.3- 18.9) 16.4 ( 14.2- 18.9) ∼ ∼
Minnesota 20.1 ( 18.3- 22.1) 19.8 ( 18.0- 21.8) ∼ ∼
Missouri 17.6 ( 16.1- 19.3) 17.5 ( 15.9- 19.3) 20.0 ( 14.2- 27.9) ∼
Nebraska 17.6 ( 14.8- 20.8) 17.7 ( 14.9- 21.0) ∼ ∼
North Dakota 16.1 ( 12.0- 21.4) 16.3 ( 12.1- 21.7) ∼ ∼
South Dakota 15.3 ( 11.6- 19.9) 13.2 ( 9.7- 17.6) ∼ ∼
South
South Atlantic 18.2 ( 17.6- 18.7) 18.2 ( 17.6- 18.8) 18.4 ( 17.0- 19.9) 16.8 ( 14.7- 19.1)
Delaware 17.3 ( 13.4- 22.2) 16.1 ( 12.1- 21.3) ∼ ∼
District of Columbia 13.2 ( 9.0- 18.9) ∼ 14.0 ( 8.6- 21.9) ∼
Florida 18.1 ( 17.2- 19.0) 18.6 ( 17.6- 19.5) 14.2 ( 11.7- 17.4) -
Georgia 18.1 ( 16.6- 19.7) 17.6 ( 16.0- 19.5) 20.0 ( 16.5- 24.2) ∼
Atlanta 17.0 ( 14.4- 20.1) 16.8 ( 13.8- 20.5) 18.9 ( 13.3- 27.1) ∼
Maryland 18.5 ( 16.8- 20.3) 18.8 ( 16.9- 21.0) 18.5 ( 14.9- 23.0) ∼
North Carolina 20.1 ( 18.7- 21.7) 19.1 ( 17.6- 20.8) 25.3 ( 21.3- 30.0) 42.3 ( 23.0- 73.6)
South Carolina 17.8 ( 15.9- 19.8) 18.2 ( 16.0- 20.6) 16.7 ( 13.0- 21.5) -
Virginia 17.1 ( 15.7- 18.6) 17.2 ( 15.6- 18.9) 17.7 ( 14.2- 22.1) ∼
West Virginia 16.6 ( 14.2- 19.5) 16.8 ( 14.3- 19.7) ∼ ∼
East South Central
Alabama 18.2 ( 16.4- 20.2) 18.4 ( 16.4- 20.7) 17.4 ( 13.5- 22.3) ∼
Kentucky 22.2 ( 20.1- 24.5) 22.1 ( 19.9- 24.5) 21.1 ( 12.9- 34.0) -
Mississippi 19.0 ( 16.7- 21.7) 19.1 ( 16.3- 22.3) 20.0 ( 15.4- 25.8) ∼
Tennessee
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Table 2.11.1.1M: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 20.9 ( 20.2- 21.8) 20.9 ( 20.1- 21.8) 21.7 ( 19.3- 24.4) 22.0 ( 19.8- 24.4)
Arkansas 19.0 ( 16.7- 21.5) 19.3 ( 16.8- 22.0) 17.2 ( 10.8- 26.5) ∼
Louisiana 20.4 ( 18.4- 22.6) 20.5 ( 18.2- 23.0) 20.2 ( 16.2- 25.0) ∼
Oklahoma 21.8 ( 19.6- 24.2) 21.9 ( 19.5- 24.5) 18.6 ( 10.7- 31.9) ∼
Texas 21.2 ( 20.3- 22.3) 21.1 ( 20.1- 22.2) 23.9 ( 20.4- 28.0) 22.1 ( 19.9- 24.5)
West 16.4 ( 15.9- 17.0) 16.9 ( 16.4- 17.5) 16.7 ( 14.4- 19.5) 16.9 ( 15.5- 18.5)
Mountain
Arizona
Colorado 17.1 ( 15.2- 19.2) 17.1 ( 15.1- 19.3) ∼ 20.9 ( 14.5- 30.1)
Idaho 17.3 ( 14.2- 21.0) 17.4 ( 14.2- 21.1) ∼ ∼
Montana 17.4 ( 13.8- 21.7) 16.1 ( 12.6- 20.4) ∼ ∼
Nevada 15.4 ( 13.0- 18.2) 15.9 ( 13.3- 18.9) ∼ 24.6 ( 12.7- 45.6)
New Mexico 13.9 ( 11.5- 16.7) 13.8 ( 11.3- 16.7) ∼ 17.9 ( 13.3- 24.0)
Utah 14.6 ( 12.1- 17.6) 14.8 ( 12.2- 17.9) ∼ ∼
Wyoming
Pacific 16.6 ( 16.1- 17.2) 17.3 ( 16.6- 17.9) 17.7 ( 15.1- 20.7) 16.4 ( 14.9- 18.2)
Alaska 16.3 ( 10.9- 25.1) 13.9 ( 8.5- 23.6) ∼ ∼
California 16.4 ( 15.7- 17.0) 17.4 ( 16.6- 18.2) 17.3 ( 14.5- 20.5) 16.6 ( 15.0- 18.4)
San Francisco-Oakland 14.5 ( 12.8- 16.3) 15.7 ( 13.7- 18.1) 17.3 ( 11.4- 25.6) 16.8 ( 11.0- 25.2)
San Jose-Monterey 14.7 ( 12.4- 17.4) 15.8 ( 13.1- 19.0) ∼ 19.2 ( 12.5- 29.3)
Los Angeles 15.8 ( 14.6- 17.2) 17.8 ( 16.2- 19.4) 14.1 ( 10.5- 18.9) 15.6 ( 13.1- 18.6)
Hawaii 16.0 ( 13.0- 19.5) 15.9 ( 10.3- 24.1) ∼ -
Oregon 16.3 ( 14.4- 18.4) 15.6 ( 13.8- 17.7) ∼ ∼
Washington 18.4 ( 16.8- 20.1) 18.1 ( 16.5- 19.9) ∼ 16.7 ( 9.8- 30.6)
Seattle-Puget Sound 19.7 ( 17.7- 21.8) 20.2 ( 18.1- 22.5) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.11.1.1F: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 9.7 ( 9.5- 9.8) 9.8 ( 9.6- 9.9) 9.8 ( 9.3- 10.3) 10.3 ( 9.7- 10.9)
Northeast 9.6 ( 9.3- 10.0) 9.7 ( 9.4- 10.1) 8.8 ( 7.8- 9.9) 8.7 ( 7.4- 10.2)
New England 9.6 ( 8.9- 10.3) 9.8 ( 9.1- 10.5) 6.9 ( 4.4- 10.4) 9.7 ( 6.0- 15.0)
Connecticut 9.1 ( 7.9- 10.6) 9.2 ( 7.9- 10.8) ∼ 16.7 ( 9.2- 28.9)
Maine 10.4 ( 8.3- 13.0) 10.6 ( 8.4- 13.2) ∼ ∼
Massachusetts 9.9 ( 8.9- 10.9) 10.1 ( 9.1- 11.3) ∼ ∼
New Hampshire 8.2 ( 6.3- 10.7) 8.1 ( 6.2- 10.6) ∼ ∼
Rhode Island 9.3 ( 7.1- 12.2) 9.6 ( 7.2- 12.6) ∼ ∼
Vermont 10.6 ( 7.5- 14.7) 10.7 ( 7.6- 14.9) ∼ ∼
Middle Atlantic 9.6 ( 9.2- 10.0) 9.7 ( 9.3- 10.2) 9.1 ( 8.0- 10.2) 8.5 ( 7.1- 10.1)
New Jersey 9.3 ( 8.5- 10.2) 9.4 ( 8.5- 10.4) 8.5 ( 6.3- 11.3) 5.5 ( 3.5- 8.5)
New York 9.1 ( 8.6- 9.7) 9.4 ( 8.7- 10.0) 8.0 ( 6.7- 9.5) 9.0 ( 7.3- 11.0)
Pennsylvania 10.5 ( 9.8- 11.2) 10.3 ( 9.6- 11.1) 12.2 ( 9.6- 15.2) -
Midwest 10.4 ( 10.0- 10.7) 10.2 ( 9.9- 10.6) 10.8 ( 9.6- 12.0) 12.6 ( 10.1- 15.6)
East North Central 10.4 ( 10.0- 10.8) 10.3 ( 9.9- 10.8) 10.7 ( 9.4- 12.0) 12.1 ( 9.4- 15.5)
Illinois 10.4 ( 9.7- 11.2) 10.5 ( 9.7- 11.4) 10.9 ( 8.9- 13.3) -
Indiana 11.6 ( 10.5- 12.8) 11.6 ( 10.4- 12.8) 11.6 ( 7.6- 17.0) ∼
Michigan 10.8 ( 9.9- 11.7) 10.3 ( 9.4- 11.3) 12.6 ( 10.1- 15.7) ∼
Detroit 10.4 ( 9.1- 11.8) 10.3 ( 8.8- 12.0) 11.1 ( 8.3- 14.5) ∼
Ohio 9.4 ( 8.7- 10.2) 9.4 ( 8.6- 10.2) 7.8 ( 5.9- 10.3) ∼
Wisconsin 10.7 ( 9.6- 11.9) 10.7 ( 9.5- 11.9) ∼ ∼
West North Central 10.2 ( 9.6- 10.8) 10.0 ( 9.4- 10.6) 11.4 ( 8.5- 14.9) 14.9 ( 9.2- 23.5)
Iowa 11.2 ( 9.6- 12.9) 10.8 ( 9.3- 12.5) ∼ ∼
Kansas 9.0 ( 7.6- 10.7) 8.6 ( 7.2- 10.3) ∼ ∼
Minnesota 10.2 ( 9.0- 11.5) 10.1 ( 8.9- 11.4) ∼ ∼
Missouri 10.8 ( 9.7- 12.0) 10.8 ( 9.6- 12.0) 11.5 ( 8.0- 16.1) ∼
Nebraska 9.0 ( 7.2- 11.2) 8.6 ( 6.8- 10.8) ∼ ∼
North Dakota 8.7 ( 6.0- 12.4) 8.6 ( 5.9- 12.4) ∼ ∼
South Dakota 8.9 ( 6.4- 12.3) 8.9 ( 6.3- 12.4) ∼ ∼
South
South Atlantic 9.3 ( 8.9- 9.6) 9.2 ( 8.8- 9.6) 9.6 ( 8.8- 10.5) 8.4 ( 7.1- 9.8)
Delaware 9.1 ( 6.6- 12.4) 9.6 ( 6.7- 13.4) ∼ ∼
District of Columbia 8.4 ( 5.5- 12.8) ∼ 10.0 ( 6.2- 16.2) ∼
Florida 9.4 ( 8.9- 10.0) 9.6 ( 9.0- 10.2) 8.1 ( 6.4- 10.0) -
Georgia 9.6 ( 8.6- 10.6) 9.7 ( 8.6- 10.8) 9.7 ( 7.8- 11.9) ∼
Atlanta 9.0 ( 7.4- 10.8) 9.4 ( 7.5- 11.8) 8.6 ( 5.8- 12.6) ∼
Maryland 9.1 ( 8.1- 10.3) 8.3 ( 7.1- 9.6) 11.5 ( 9.2- 14.4) ∼
North Carolina 9.2 ( 8.3- 10.1) 8.9 ( 8.0- 10.0) 9.7 ( 7.7- 12.0) ∼
South Carolina 10.6 ( 9.3- 12.0) 10.4 ( 8.9- 12.1) 11.2 ( 8.7- 14.3) -
Virginia 8.2 ( 7.3- 9.2) 8.2 ( 7.2- 9.3) 8.7 ( 6.6- 11.3) ∼
West Virginia 7.9 ( 6.3- 9.7) 7.8 ( 6.3- 9.7) ∼ ∼
East South Central
Alabama 9.4 ( 8.2- 10.6) 9.2 ( 7.9- 10.7) 10.1 ( 7.6- 13.1) ∼
Kentucky 11.9 ( 10.5- 13.4) 12.2 ( 10.7- 13.8) ∼ -
Mississippi 9.5 ( 8.0- 11.2) 9.1 ( 7.4- 11.1) 10.2 ( 7.4- 13.6) ∼
Tennessee
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Table 2.11.1.1F: Kidney and Renal Pelvis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and
Ethnicity, United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 11.1 ( 10.6- 11.6) 11.0 ( 10.5- 11.6) 11.3 ( 9.8- 12.9) 12.3 ( 10.9- 13.9)
Arkansas 9.7 ( 8.2- 11.4) 9.2 ( 7.7- 11.0) 12.7 ( 8.1- 19.1) ∼
Louisiana 12.0 ( 10.6- 13.4) 12.6 ( 11.0- 14.4) 10.7 ( 8.4- 13.6) ∼
Oklahoma 9.8 ( 8.4- 11.3) 9.3 ( 7.9- 10.9) ∼ ∼
Texas 11.3 ( 10.7- 12.0) 11.4 ( 10.7- 12.1) 11.3 ( 9.4- 13.7) 12.3 ( 10.9- 13.9)
West 8.5 ( 8.2- 8.9) 8.9 ( 8.5- 9.3) 7.9 ( 6.5- 9.6) 10.5 ( 9.5- 11.6)
Mountain
Arizona
Colorado 8.2 ( 7.1- 9.5) 8.2 ( 7.0- 9.6) ∼ 9.9 ( 6.1- 15.4)
Idaho 9.2 ( 7.1- 11.8) 9.3 ( 7.1- 11.9) ∼ ∼
Montana 8.1 ( 5.9- 11.0) 8.0 ( 5.8- 11.0) ∼ ∼
Nevada 8.6 ( 7.0- 10.6) 9.0 ( 7.2- 11.2) ∼ 17.1 ( 9.6- 29.4)
New Mexico 9.1 ( 7.3- 11.2) 8.9 ( 7.1- 11.1) ∼ 9.8 ( 6.7- 14.0)
Utah 7.6 ( 5.9- 9.6) 7.7 ( 6.0- 9.8) ∼ ∼
Wyoming
Pacific 8.6 ( 8.2- 8.9) 9.0 ( 8.6- 9.5) 8.1 ( 6.6- 9.9) 10.4 ( 9.3- 11.6)
Alaska 10.2 ( 6.4- 15.8) ∼ ∼ ∼
California 8.3 ( 7.9- 8.8) 9.0 ( 8.5- 9.5) 8.0 ( 6.4- 9.9) 10.5 ( 9.4- 11.7)
San Francisco-Oakland 8.3 ( 7.2- 9.6) 9.6 ( 8.1- 11.3) 8.5 ( 5.1- 13.7) 7.6 ( 4.6- 12.1)
San Jose-Monterey 8.4 ( 6.8- 10.3) 9.3 ( 7.4- 11.6) ∼ 12.7 ( 8.0- 19.6)
Los Angeles 7.7 ( 6.9- 8.5) 8.4 ( 7.4- 9.4) 7.1 ( 5.0- 9.9) 8.3 ( 6.8- 10.2)
Hawaii 6.5 ( 4.7- 8.7) ∼ ∼ -
Oregon 9.0 ( 7.7- 10.4) 8.6 ( 7.3- 10.0) ∼ ∼
Washington 9.9 ( 8.8- 11.1) 9.8 ( 8.7- 11.1) ∼ ∼
Seattle-Puget Sound 10.2 ( 8.9- 11.7) 10.3 ( 9.0- 11.9) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.11.1.2M: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 6.1 ( 5.9- 6.2) 6.2 ( 6.0- 6.3) 6.1 ( 5.6- 6.6) 5.1 ( 4.5- 5.6)
Northeast 5.6 ( 5.3- 5.9) 5.7 ( 5.4- 6.1) 5.8 ( 4.7- 7.0) 3.1 ( 2.2- 4.4)
New England 5.8 ( 5.2- 6.4) 5.9 ( 5.3- 6.6) ∼ ∼
Connecticut 5.9 ( 4.8- 7.2) 6.2 ( 5.0- 7.6) ∼ ∼
Maine 4.6 ( 3.1- 6.7) 4.7 ( 3.2- 6.7) ∼ ∼
Massachusetts 5.9 ( 5.0- 6.9) 6.1 ( 5.2- 7.1) ∼ ∼
New Hampshire 5.5 ( 3.7- 7.9) 5.5 ( 3.7- 8.0) ∼ ∼
Rhode Island 6.8 ( 4.7- 9.5) 7.1 ( 4.9- 10.0) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 5.6 ( 5.2- 5.9) 5.7 ( 5.3- 6.0) 6.0 ( 4.9- 7.4) 3.2 ( 2.2- 4.6)
New Jersey 5.9 ( 5.1- 6.7) 5.9 ( 5.1- 6.8) 7.0 ( 4.5- 10.8) ∼
New York 5.0 ( 4.5- 5.5) 5.2 ( 4.7- 5.8) 5.0 ( 3.6- 6.8) 3.7 ( 2.4- 5.7)
Pennsylvania 6.1 ( 5.6- 6.8) 6.1 ( 5.5- 6.8) 7.7 ( 5.2- 11.2) ∼
Midwest 6.7 ( 6.4- 7.0) 6.7 ( 6.4- 7.0) 7.1 ( 6.0- 8.5) 4.3 ( 2.8- 6.8)
East North Central 6.5 ( 6.2- 6.9) 6.6 ( 6.2- 7.0) 7.0 ( 5.8- 8.5) 3.5 ( 2.0- 6.1)
Illinois 6.8 ( 6.1- 7.5) 6.7 ( 5.9- 7.5) 8.8 ( 6.5- 11.8) ∼
Indiana 6.8 ( 5.8- 7.9) 6.9 ( 5.9- 8.1) ∼ ∼
Michigan 6.3 ( 5.6- 7.1) 6.3 ( 5.5- 7.1) 7.4 ( 5.1- 10.6) ∼
Ohio 6.6 ( 5.9- 7.3) 6.7 ( 6.0- 7.5) 5.1 ( 3.1- 8.1) ∼
Wisconsin 6.1 ( 5.1- 7.2) 6.1 ( 5.2- 7.2) ∼ ∼
West North Central 6.9 ( 6.3- 7.4) 6.9 ( 6.3- 7.5) 7.6 ( 4.8- 12.0) ∼
Iowa 6.8 ( 5.5- 8.3) 6.9 ( 5.6- 8.4) ∼ ∼
Kansas 6.3 ( 4.9- 7.9) 6.5 ( 5.1- 8.2) ∼ ∼
Minnesota 6.7 ( 5.6- 7.9) 6.9 ( 5.8- 8.1) ∼ ∼
Missouri 7.2 ( 6.2- 8.3) 7.0 ( 6.0- 8.2) 10.6 ( 6.4- 17.1) ∼
Nebraska 5.9 ( 4.3- 7.9) 6.1 ( 4.5- 8.2) ∼ ∼
North Dakota 9.1 ( 6.1- 13.2) 9.2 ( 6.2- 13.5) ∼ ∼
South Dakota 7.5 ( 5.0- 11.0) 7.0 ( 4.5- 10.4) ∼ ∼
South 6.2 ( 6.0- 6.5) 6.3 ( 6.1- 6.6) 6.0 ( 5.4- 6.8) 5.5 ( 4.7- 6.5)
South Atlantic 5.7 ( 5.4- 6.0) 5.8 ( 5.4- 6.1) 5.4 ( 4.6- 6.4) 3.7 ( 2.7- 4.9)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 5.3 ( 4.8- 5.8) 5.4 ( 5.0- 6.0) 4.0 ( 2.5- 6.2) 4.1 ( 3.0- 5.6)
Georgia 6.3 ( 5.4- 7.4) 6.3 ( 5.3- 7.5) 6.8 ( 4.6- 9.7) ∼
Maryland 4.4 ( 3.6- 5.4) 4.4 ( 3.5- 5.6) 4.4 ( 2.6- 7.3) ∼
North Carolina 6.5 ( 5.6- 7.5) 6.4 ( 5.5- 7.5) 7.2 ( 4.9- 10.3) ∼
South Carolina 5.7 ( 4.6- 7.0) 6.5 ( 5.2- 8.0) ∼ ∼
Virginia 6.5 ( 5.6- 7.6) 6.4 ( 5.4- 7.5) 7.9 ( 5.5- 11.3) ∼
West Virginia 5.8 ( 4.4- 7.6) 5.9 ( 4.4- 7.7) ∼ ∼
East South Central 6.7 ( 6.1- 7.3) 6.8 ( 6.2- 7.5) 6.3 ( 4.8- 8.1) ∼
Alabama 6.3 ( 5.2- 7.6) 6.5 ( 5.3- 8.0) 5.8 ( 3.6- 9.0) ∼
Kentucky 7.4 ( 6.1- 8.9) 7.4 ( 6.1- 9.0) ∼ ∼
Mississippi 6.6 ( 5.2- 8.3) 7.0 ( 5.3- 9.1) 5.6 ( 3.3- 9.2) ∼
Tennessee 6.5 ( 5.6- 7.7) 6.5 ( 5.5- 7.7) 7.3 ( 4.4- 11.8) ∼
West South Central 7.1 ( 6.6- 7.6) 7.1 ( 6.6- 7.6) 7.5 ( 6.0- 9.3) 7.0 ( 5.7- 8.6)
Arkansas 5.6 ( 4.3- 7.1) 5.2 ( 3.9- 6.8) ∼ ∼
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Table 2.11.1.2M: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 7.9 ( 6.7- 9.4) 8.0 ( 6.5- 9.7) 8.1 ( 5.5- 11.6) ∼
Oklahoma 7.8 ( 6.5- 9.3) 7.8 ( 6.4- 9.4) ∼ ∼
Texas 7.0 ( 6.4- 7.6) 7.1 ( 6.5- 7.8) 7.2 ( 5.2- 9.8) 7.2 ( 5.8- 8.8)
West 5.6 ( 5.3- 5.9) 5.8 ( 5.5- 6.2) 4.9 ( 3.7- 6.5) 5.4 ( 4.6- 6.3)
Mountain 6.0 ( 5.4- 6.5) 5.9 ( 5.3- 6.5) ∼ 7.0 ( 5.1- 9.4)
Arizona 5.5 ( 4.6- 6.6) 5.5 ( 4.6- 6.6) ∼ 6.6 ( 3.7- 11.5)
Colorado 5.8 ( 4.6- 7.1) 5.6 ( 4.5- 7.0) ∼ ∼
Idaho 7.9 ( 5.8- 10.6) 7.7 ( 5.6- 10.5) ∼ ∼
Montana 5.9 ( 3.8- 8.7) 5.5 ( 3.5- 8.3) ∼ ∼
Nevada 5.9 ( 4.5- 7.8) 5.9 ( 4.4- 7.9) ∼ ∼
New Mexico 7.0 ( 5.3- 9.2) 6.7 ( 5.0- 9.0) ∼ 8.1 ( 4.8- 13.1)
Utah 5.1 ( 3.6- 7.1) 5.2 ( 3.7- 7.2) ∼ ∼
Wyoming 7.1 ( 4.0- 12.1) 7.3 ( 4.1- 12.3) ∼ ∼
Pacific 5.5 ( 5.1- 5.8) 5.8 ( 5.5- 6.2) 4.6 ( 3.3- 6.3) 4.8 ( 4.0- 5.9)
Alaska ∼ ∼ ∼ ∼
California 5.4 ( 5.1- 5.9) 5.9 ( 5.4- 6.3) 5.0 ( 3.6- 6.9) 4.9 ( 4.0- 6.0)
Hawaii 4.8 ( 3.2- 6.9) ∼ ∼ ∼
Oregon 5.5 ( 4.5- 6.8) 5.8 ( 4.6- 7.1) ∼ ∼
Washington 5.6 ( 4.8- 6.6) 5.7 ( 4.8- 6.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
U
nited States C
ancer Statistics: 2003 Incidence and M
ortality
100
Table 2.11.1.2F: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 2.7 ( 2.7- 2.8) 2.8 ( 2.7- 2.9) 2.7 ( 2.5- 3.0) 2.6 ( 2.3- 3.0)
Northeast 2.5 ( 2.3- 2.7) 2.6 ( 2.4- 2.8) 1.9 ( 1.4- 2.4) 1.4 ( 0.9- 2.1)
New England 2.4 ( 2.1- 2.8) 2.4 ( 2.1- 2.8) ∼ ∼
Connecticut 2.2 ( 1.6- 2.9) 2.1 ( 1.5- 2.9) ∼ ∼
Maine 2.9 ( 1.9- 4.5) 3.0 ( 1.9- 4.6) ∼ ∼
Massachusetts 2.2 ( 1.8- 2.7) 2.2 ( 1.8- 2.8) ∼ ∼
New Hampshire 3.0 ( 1.9- 4.6) 3.0 ( 1.9- 4.7) ∼ ∼
Rhode Island 3.6 ( 2.3- 5.5) 3.5 ( 2.1- 5.4) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.5 ( 2.3- 2.7) 2.6 ( 2.4- 2.9) 1.8 ( 1.3- 2.3) 1.6 ( 1.0- 2.4)
New Jersey 2.7 ( 2.3- 3.2) 3.0 ( 2.5- 3.5) ∼ ∼
New York 2.3 ( 2.0- 2.6) 2.4 ( 2.1- 2.7) 1.7 ( 1.1- 2.5) 1.8 ( 1.1- 2.8)
Pennsylvania 2.7 ( 2.4- 3.1) 2.7 ( 2.4- 3.1) 2.5 ( 1.4- 4.1) ∼
Midwest 3.1 ( 2.9- 3.3) 3.1 ( 2.9- 3.3) 3.1 ( 2.5- 3.8) ∼
East North Central 3.0 ( 2.8- 3.2) 3.0 ( 2.8- 3.3) 3.1 ( 2.5- 3.9) ∼
Illinois 2.8 ( 2.4- 3.2) 2.7 ( 2.3- 3.2) 3.8 ( 2.6- 5.4) ∼
Indiana 3.0 ( 2.5- 3.7) 3.1 ( 2.5- 3.7) ∼ ∼
Michigan 3.0 ( 2.6- 3.5) 3.0 ( 2.5- 3.5) 3.0 ( 1.8- 4.7) ∼
Ohio 3.1 ( 2.7- 3.6) 3.2 ( 2.8- 3.7) 2.6 ( 1.5- 4.2) ∼
Wisconsin 3.2 ( 2.6- 3.9) 3.2 ( 2.6- 3.9) ∼ ∼
West North Central 3.2 ( 2.9- 3.6) 3.2 ( 2.9- 3.6) ∼ ∼
Iowa 3.1 ( 2.4- 4.0) 3.1 ( 2.4- 4.1) ∼ ∼
Kansas 3.1 ( 2.2- 4.1) 3.1 ( 2.2- 4.2) ∼ ∼
Minnesota 2.7 ( 2.1- 3.4) 2.7 ( 2.1- 3.4) ∼ ∼
Missouri 4.1 ( 3.4- 4.8) 4.1 ( 3.4- 4.9) ∼ ∼
Nebraska 3.2 ( 2.2- 4.6) 3.1 ( 2.1- 4.6) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.8 ( 2.7- 3.0) 2.8 ( 2.7- 3.0) 3.0 ( 2.6- 3.4) 2.9 ( 2.4- 3.5)
South Atlantic 2.6 ( 2.4- 2.7) 2.5 ( 2.3- 2.7) 2.7 ( 2.3- 3.2) 1.7 ( 1.1- 2.4)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.3 ( 2.1- 2.6) 2.4 ( 2.1- 2.7) 2.1 ( 1.3- 3.3) 1.8 ( 1.2- 2.6)
Georgia 2.6 ( 2.1- 3.2) 2.7 ( 2.2- 3.4) 2.3 ( 1.5- 3.5) ∼
Maryland 2.9 ( 2.3- 3.6) 2.5 ( 1.9- 3.2) 4.4 ( 2.9- 6.5) ∼
North Carolina 2.9 ( 2.4- 3.4) 2.9 ( 2.3- 3.5) 2.8 ( 1.8- 4.2) ∼
South Carolina 3.0 ( 2.3- 3.8) 2.8 ( 2.1- 3.7) 3.5 ( 2.1- 5.5) ∼
Virginia 2.3 ( 1.9- 2.8) 2.4 ( 1.9- 3.0) ∼ ∼
West Virginia 2.3 ( 1.5- 3.4) 2.3 ( 1.5- 3.4) ∼ ∼
East South Central 2.9 ( 2.6- 3.2) 2.9 ( 2.5- 3.3) 3.0 ( 2.2- 4.0) ∼
Alabama 2.5 ( 1.9- 3.1) 2.5 ( 1.9- 3.3) ∼ ∼
Kentucky 2.8 ( 2.1- 3.5) 2.8 ( 2.2- 3.6) ∼ ∼
Mississippi 3.6 ( 2.7- 4.6) 3.5 ( 2.5- 4.9) ∼ ∼
Tennessee 3.0 ( 2.4- 3.6) 2.9 ( 2.3- 3.6) ∼ ∼
West South Central 3.3 ( 3.1- 3.6) 3.3 ( 3.1- 3.7) 3.7 ( 2.9- 4.7) 4.1 ( 3.3- 5.1)
Arkansas 2.9 ( 2.2- 3.9) 2.8 ( 2.0- 3.8) ∼ ∼
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Table 2.11.1.2F: Kidney and Renal Pelvis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.7 ( 3.0- 4.6) 4.0 ( 3.1- 5.0) 3.3 ( 2.0- 5.0) ∼
Oklahoma 3.0 ( 2.3- 3.9) 3.0 ( 2.3- 4.0) ∼ ∼
Texas 3.4 ( 3.0- 3.8) 3.4 ( 3.0- 3.8) 4.0 ( 2.9- 5.5) 4.3 ( 3.4- 5.4)
West 2.4 ( 2.2- 2.6) 2.5 ( 2.3- 2.7) 2.3 ( 1.6- 3.3) 3.1 ( 2.6- 3.7)
Mountain 2.6 ( 2.3- 2.9) 2.5 ( 2.2- 2.9) ∼ 3.6 ( 2.5- 5.0)
Arizona 2.6 ( 2.0- 3.2) 2.4 ( 1.9- 3.1) ∼ ∼
Colorado 2.5 ( 1.8- 3.2) 2.4 ( 1.8- 3.2) ∼ ∼
Idaho 2.5 ( 1.4- 4.0) 2.5 ( 1.5- 4.1) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.8 ( 1.9- 4.0) 2.9 ( 2.0- 4.3) ∼ ∼
New Mexico 3.4 ( 2.4- 4.8) 3.6 ( 2.5- 5.1) ∼ ∼
Utah 2.2 ( 1.3- 3.3) 2.1 ( 1.3- 3.3) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.3 ( 2.2- 2.5) 2.5 ( 2.3- 2.7) 2.3 ( 1.5- 3.4) 2.9 ( 2.4- 3.7)
Alaska ∼ ∼ ∼ ∼
California 2.3 ( 2.1- 2.6) 2.5 ( 2.2- 2.8) 2.1 ( 1.3- 3.2) 2.9 ( 2.3- 3.7)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.4 ( 1.8- 3.2) 2.5 ( 1.8- 3.3) ∼ ∼
Washington 2.5 ( 2.0- 3.2) 2.5 ( 2.0- 3.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
U
nited States C
ancer Statistics: 2003 Incidence and M
ortality
102
Table 2.12.1.1M: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 7.1 ( 6.9- 7.2) 6.7 ( 6.6- 6.9) 11.3 ( 10.7- 11.9) 6.5 ( 5.9- 7.1)
Northeast 7.2 ( 6.9- 7.6) 7.0 ( 6.7- 7.4) 9.6 ( 8.3- 11.0) 8.3 ( 6.8- 10.2)
New England 6.9 ( 6.3- 7.6) 7.0 ( 6.3- 7.7) 7.1 ( 3.9- 12.5) ∼
Connecticut 6.6 ( 5.4- 8.0) 6.8 ( 5.6- 8.3) ∼ ∼
Maine 6.4 ( 4.6- 8.7) 6.4 ( 4.7- 8.7) ∼ ∼
Massachusetts 7.2 ( 6.2- 8.2) 7.2 ( 6.2- 8.2) ∼ ∼
New Hampshire 5.4 ( 3.6- 7.8) 5.2 ( 3.5- 7.6) ∼ ∼
Rhode Island 8.7 ( 6.3- 11.7) 8.8 ( 6.3- 12.0) ∼ ∼
Vermont 8.6 ( 5.6- 12.8) 8.7 ( 5.6- 13.0) ∼ ∼
Middle Atlantic 7.3 ( 6.9- 7.7) 7.0 ( 6.6- 7.4) 9.9 ( 8.5- 11.5) 8.3 ( 6.7- 10.3)
New Jersey 7.2 ( 6.3- 8.0) 7.0 ( 6.1- 8.0) 9.2 ( 6.5- 13.1) 7.3 ( 4.4- 12.0)
New York 7.3 ( 6.8- 7.9) 7.1 ( 6.5- 7.8) 9.2 ( 7.5- 11.4) 8.7 ( 6.6- 11.3)
Pennsylvania 7.4 ( 6.7- 8.1) 6.9 ( 6.3- 7.6) 12.5 ( 9.4- 16.5) -
Midwest 7.1 ( 6.8- 7.4) 6.7 ( 6.4- 7.0) 11.1 ( 9.7- 12.7) 5.8 ( 4.0- 8.4)
East North Central 7.3 ( 6.9- 7.6) 6.8 ( 6.5- 7.2) 11.0 ( 9.5- 12.7) 5.8 ( 3.8- 8.8)
Illinois 7.7 ( 7.0- 8.5) 7.1 ( 6.3- 7.9) 13.3 ( 10.5- 16.7) -
Indiana 8.0 ( 7.0- 9.1) 7.4 ( 6.4- 8.5) 14.5 ( 9.4- 22.2) ∼
Michigan 6.7 ( 6.0- 7.5) 6.4 ( 5.7- 7.3) 9.5 ( 6.9- 12.9) ∼
Detroit 7.2 ( 6.0- 8.6) 6.9 ( 5.6- 8.4) 9.4 ( 6.4- 13.4) ∼
Ohio 7.2 ( 6.5- 8.0) 6.9 ( 6.2- 7.7) 7.7 ( 5.4- 10.9) ∼
Wisconsin 6.6 ( 5.7- 7.7) 6.4 ( 5.4- 7.5) ∼ ∼
West North Central 6.6 ( 6.1- 7.2) 6.4 ( 5.9- 7.0) 11.9 ( 8.4- 16.9) ∼
Iowa 7.5 ( 6.2- 9.1) 7.3 ( 6.0- 8.8) ∼ ∼
Kansas 7.1 ( 5.7- 8.7) 6.9 ( 5.5- 8.6) ∼ ∼
Minnesota 5.6 ( 4.6- 6.7) 5.3 ( 4.3- 6.4) ∼ ∼
Missouri 7.7 ( 6.7- 8.8) 7.5 ( 6.4- 8.6) 11.8 ( 7.3- 18.5) ∼
Nebraska 5.7 ( 4.2- 7.6) 5.8 ( 4.2- 7.7) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 5.0 ( 3.0- 7.9) 4.9 ( 2.9- 7.9) ∼ ∼
South
South Atlantic 8.3 ( 7.9- 8.6) 7.7 ( 7.3- 8.1) 11.7 ( 10.6- 12.9) 8.3 ( 6.8- 10.1)
Delaware 7.9 ( 5.4- 11.5) 7.7 ( 5.0- 11.6) ∼ ∼
District of Columbia 9.7 ( 6.1- 14.9) ∼ ∼ ∼
Florida 8.6 ( 8.0- 9.2) 8.4 ( 7.8- 9.0) 12.1 ( 9.7- 15.2) -
Georgia 8.4 ( 7.4- 9.5) 7.5 ( 6.5- 8.7) 12.1 ( 9.5- 15.3) ∼
Atlanta 6.9 ( 5.3- 9.1) 6.4 ( 4.6- 9.0) 8.2 ( 5.1- 13.9) ∼
Maryland 6.9 ( 5.9- 8.1) 6.8 ( 5.6- 8.2) 7.7 ( 5.5- 11.0) ∼
North Carolina 7.9 ( 7.0- 8.9) 7.3 ( 6.3- 8.4) 10.6 ( 8.2- 13.8) ∼
South Carolina 10.5 ( 9.1- 12.1) 8.8 ( 7.4- 10.6) 16.4 ( 12.7- 21.1) -
Virginia 7.3 ( 6.4- 8.3) 6.4 ( 5.4- 7.5) 12.4 ( 9.4- 16.4) ∼
West Virginia 7.9 ( 6.3- 10.0) 7.7 ( 6.1- 9.8) ∼ ∼
East South Central
Alabama 8.4 ( 7.2- 9.7) 7.4 ( 6.2- 8.9) 12.3 ( 9.0- 16.5) ∼
Kentucky 9.2 ( 7.8- 10.7) 8.7 ( 7.4- 10.3) 17.1 ( 10.1- 28.8) -
Mississippi 9.3 ( 7.7- 11.2) 8.3 ( 6.6- 10.5) 11.5 ( 8.1- 16.2) ∼
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Table 2.12.1.1M: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 7.8 ( 7.3- 8.3) 7.1 ( 6.6- 7.6) 14.3 ( 12.4- 16.6) 7.1 ( 5.8- 8.6)
Arkansas 8.3 ( 6.8- 10.0) 7.2 ( 5.8- 9.0) 17.4 ( 11.0- 26.9) ∼
Louisiana 9.8 ( 8.4- 11.3) 7.9 ( 6.5- 9.5) 15.9 ( 12.5- 20.2) ∼
Oklahoma 7.6 ( 6.4- 9.1) 7.3 ( 5.9- 8.8) ∼ ∼
Texas 7.3 ( 6.8- 8.0) 6.9 ( 6.3- 7.5) 13.2 ( 10.7- 16.3) 7.4 ( 6.1- 9.0)
West 5.0 ( 4.7- 5.3) 4.9 ( 4.6- 5.3) 8.8 ( 7.0- 11.0) 4.6 ( 3.9- 5.6)
Mountain
Arizona
Colorado 3.5 ( 2.7- 4.6) 3.5 ( 2.7- 4.6) ∼ ∼
Idaho 6.2 ( 4.4- 8.7) 6.3 ( 4.4- 8.8) ∼ ∼
Montana 5.0 ( 3.2- 7.6) 4.7 ( 2.9- 7.4) ∼ ∼
Nevada 5.8 ( 4.4- 7.7) 6.3 ( 4.7- 8.3) ∼ ∼
New Mexico 5.0 ( 3.6- 6.8) 5.4 ( 3.9- 7.4) ∼ ∼
Utah 2.4 ( 1.5- 3.9) 2.4 ( 1.4- 3.9) ∼ ∼
Wyoming
Pacific 5.1 ( 4.8- 5.5) 5.1 ( 4.7- 5.4) 9.5 ( 7.6- 12.0) 4.6 ( 3.7- 5.7)
Alaska ∼ ∼ ∼ ∼
California 5.3 ( 4.9- 5.7) 5.2 ( 4.8- 5.6) 9.6 ( 7.5- 12.1) 4.8 ( 3.9- 5.9)
San Francisco-Oakland 5.3 ( 4.3- 6.5) 5.1 ( 3.9- 6.5) 11.1 ( 6.4- 18.3) ∼
San Jose-Monterey 3.2 ( 2.2- 4.6) 3.5 ( 2.3- 5.2) ∼ ∼
Los Angeles 5.2 ( 4.5- 6.1) 4.9 ( 4.1- 5.8) 8.8 ( 6.0- 12.9) 4.5 ( 3.1- 6.5)
Hawaii 5.1 ( 3.4- 7.2) ∼ ∼ -
Oregon 5.3 ( 4.3- 6.6) 5.4 ( 4.3- 6.6) ∼ ∼
Washington 4.4 ( 3.6- 5.2) 4.3 ( 3.5- 5.2) ∼ ∼
Seattle-Puget Sound 4.6 ( 3.6- 5.7) 4.6 ( 3.6- 5.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.12.1.1F: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 1.6 ( 1.5- 1.6) 1.5 ( 1.5- 1.6) 2.1 ( 1.9- 2.3) 0.8 ( 0.6- 1.0)
Northeast 1.7 ( 1.6- 1.9) 1.7 ( 1.5- 1.9) 2.3 ( 1.8- 2.9) 1.1 ( 0.7- 1.7)
New England 2.0 ( 1.7- 2.3) 1.9 ( 1.6- 2.3) ∼ ∼
Connecticut 1.4 ( 0.9- 2.0) 1.3 ( 0.8- 2.0) ∼ ∼
Maine 2.4 ( 1.5- 3.8) 2.4 ( 1.5- 3.9) ∼ ∼
Massachusetts 2.0 ( 1.6- 2.6) 2.0 ( 1.5- 2.6) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 2.6 ( 1.5- 4.3) 2.5 ( 1.4- 4.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.7 ( 1.5- 1.8) 1.6 ( 1.4- 1.8) 2.3 ( 1.8- 3.0) 1.0 ( 0.6- 1.7)
New Jersey 1.3 ( 1.0- 1.7) 1.2 ( 0.9- 1.6) ∼ ∼
New York 1.7 ( 1.5- 1.9) 1.6 ( 1.3- 1.9) 2.2 ( 1.6- 3.1) 1.4 ( 0.8- 2.3)
Pennsylvania 1.9 ( 1.6- 2.2) 1.8 ( 1.5- 2.2) 2.7 ( 1.6- 4.3) -
Midwest 1.6 ( 1.5- 1.8) 1.5 ( 1.4- 1.6) 3.0 ( 2.4- 3.7) ∼
East North Central 1.7 ( 1.6- 1.9) 1.5 ( 1.4- 1.7) 3.2 ( 2.5- 3.9) ∼
Illinois 1.8 ( 1.5- 2.2) 1.5 ( 1.2- 1.9) 3.9 ( 2.8- 5.5) -
Indiana 1.8 ( 1.4- 2.4) 1.7 ( 1.3- 2.3) ∼ ∼
Michigan 1.5 ( 1.2- 1.9) 1.4 ( 1.1- 1.8) 2.5 ( 1.4- 4.1) ∼
Detroit 1.4 ( 1.0- 2.0) 1.3 ( 0.8- 2.0) ∼ ∼
Ohio 1.9 ( 1.6- 2.3) 1.8 ( 1.4- 2.1) 2.6 ( 1.5- 4.2) ∼
Wisconsin 1.4 ( 1.0- 1.9) 1.2 ( 0.8- 1.6) ∼ ∼
West North Central 1.5 ( 1.2- 1.7) 1.4 ( 1.2- 1.7) ∼ ∼
Iowa 1.6 ( 1.0- 2.3) 1.6 ( 1.0- 2.3) ∼ ∼
Kansas 1.2 ( 0.7- 2.0) 1.2 ( 0.7- 1.9) ∼ ∼
Minnesota 1.2 ( 0.8- 1.7) 1.2 ( 0.8- 1.7) ∼ ∼
Missouri 1.8 ( 1.3- 2.3) 1.7 ( 1.2- 2.3) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 1.7 ( 1.6- 1.8) 1.7 ( 1.6- 1.9) 1.7 ( 1.4- 2.1) 0.9 ( 0.6- 1.5)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.6 ( 1.4- 1.9) 1.6 ( 1.4- 1.9) ∼ -
Georgia 1.9 ( 1.5- 2.3) 1.9 ( 1.5- 2.5) 1.8 ( 1.0- 2.9) ∼
Atlanta 2.2 ( 1.5- 3.3) 2.0 ( 1.1- 3.3) ∼ ∼
Maryland 1.3 ( 0.9- 1.7) 1.0 ( 0.6- 1.6) 2.0 ( 1.2- 3.4) ∼
North Carolina 1.7 ( 1.4- 2.2) 1.7 ( 1.3- 2.2) ∼ ∼
South Carolina 1.6 ( 1.2- 2.2) 1.7 ( 1.1- 2.4) ∼ -
Virginia 1.6 ( 1.3- 2.1) 1.7 ( 1.3- 2.3) ∼ ∼
West Virginia 3.0 ( 2.1- 4.3) 2.9 ( 2.0- 4.2) ∼ ∼
East South Central
Alabama 1.6 ( 1.2- 2.2) 1.8 ( 1.2- 2.5) ∼ ∼
Kentucky 2.6 ( 2.0- 3.4) 2.6 ( 1.9- 3.4) ∼ -
Mississippi 1.3 ( 0.8- 2.0) ∼ ∼ ∼
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Table 2.12.1.1F: Larynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 1.7 ( 1.5- 1.9) 1.6 ( 1.4- 1.9) 2.2 ( 1.6- 2.9) ∼
Arkansas 1.8 ( 1.2- 2.6) 1.8 ( 1.1- 2.7) ∼ ∼
Louisiana 2.1 ( 1.6- 2.8) 2.1 ( 1.5- 3.0) ∼ ∼
Oklahoma 1.9 ( 1.4- 2.7) 2.0 ( 1.4- 2.8) ∼ ∼
Texas 1.5 ( 1.3- 1.8) 1.5 ( 1.2- 1.7) 2.6 ( 1.7- 3.9) ∼
West 1.1 ( 0.9- 1.2) 1.1 ( 1.0- 1.3) 1.3 ( 0.8- 2.2) 0.8 ( 0.5- 1.1)
Mountain
Arizona
Colorado 1.3 ( 0.9- 1.9) 1.3 ( 0.9- 1.9) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.5 ( 0.9- 2.5) 1.7 ( 0.9- 2.7) ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.0 ( 0.9- 1.1) 1.1 ( 0.9- 1.2) 1.3 ( 0.8- 2.2) 0.7 ( 0.4- 1.0)
Alaska ∼ ∼ ∼ ∼
California 0.9 ( 0.8- 1.1) 1.0 ( 0.8- 1.2) 1.5 ( 0.8- 2.4) 0.6 ( 0.4- 1.0)
San Francisco-Oakland 0.8 ( 0.5- 1.3) 1.0 ( 0.6- 1.7) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 0.8 ( 0.6- 1.1) 0.8 ( 0.5- 1.1) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon 1.3 ( 0.9- 2.0) 1.3 ( 0.8- 2.0) ∼ ∼
Washington 1.2 ( 0.9- 1.7) 1.3 ( 0.9- 1.9) ∼ ∼
Seattle-Puget Sound 1.0 ( 0.6- 1.5) 1.1 ( 0.7- 1.7) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.12.1.2M: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 2.4 ( 2.3- 2.4) 2.2 ( 2.1- 2.2) 5.1 ( 4.7- 5.6) 1.9 ( 1.6- 2.3)
Northeast 2.3 ( 2.2- 2.5) 2.2 ( 2.0- 2.4) 4.5 ( 3.7- 5.6) 2.7 ( 1.8- 4.0)
New England 2.1 ( 1.8- 2.5) 2.2 ( 1.8- 2.6) ∼ ∼
Connecticut 2.3 ( 1.6- 3.2) 2.4 ( 1.7- 3.4) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.3 ( 1.7- 2.9) 2.2 ( 1.7- 2.9) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.4 ( 2.2- 2.7) 2.2 ( 2.0- 2.5) 4.8 ( 3.8- 6.0) 2.9 ( 1.8- 4.3)
New Jersey 2.5 ( 2.0- 3.0) 2.2 ( 1.7- 2.7) 5.9 ( 3.7- 9.4) ∼
New York 2.4 ( 2.1- 2.8) 2.2 ( 1.9- 2.6) 4.1 ( 3.0- 5.7) 4.0 ( 2.5- 6.2)
Pennsylvania 2.4 ( 2.0- 2.8) 2.2 ( 1.9- 2.7) 5.3 ( 3.3- 8.2) ∼
Midwest 2.3 ( 2.1- 2.4) 2.1 ( 1.9- 2.2) 5.0 ( 4.1- 6.2) ∼
East North Central 2.4 ( 2.1- 2.6) 2.1 ( 1.9- 2.4) 4.8 ( 3.8- 6.1) ∼
Illinois 2.5 ( 2.1- 3.0) 2.2 ( 1.8- 2.7) 4.9 ( 3.2- 7.4) ∼
Indiana 2.1 ( 1.6- 2.8) 1.9 ( 1.4- 2.6) ∼ ∼
Michigan 2.5 ( 2.1- 3.0) 2.2 ( 1.8- 2.7) 5.4 ( 3.5- 8.2) ∼
Ohio 2.6 ( 2.2- 3.1) 2.4 ( 2.0- 2.9) 4.3 ( 2.6- 6.9) ∼
Wisconsin 1.6 ( 1.2- 2.2) 1.5 ( 1.1- 2.1) ∼ ∼
West North Central 2.1 ( 1.8- 2.4) 1.9 ( 1.6- 2.2) 6.0 ( 3.5- 10.0) ∼
Iowa 2.4 ( 1.6- 3.3) 2.3 ( 1.6- 3.2) ∼ ∼
Kansas 2.5 ( 1.7- 3.5) 2.1 ( 1.3- 3.1) ∼ ∼
Minnesota 1.0 ( 0.6- 1.5) 0.9 ( 0.6- 1.5) ∼ ∼
Missouri 2.5 ( 2.0- 3.2) 2.3 ( 1.8- 3.0) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.8 ( 2.6- 2.9) 2.4 ( 2.3- 2.6) 5.3 ( 4.7- 6.0) 1.8 ( 1.3- 2.4)
South Atlantic 2.8 ( 2.6- 3.0) 2.5 ( 2.3- 2.7) 5.3 ( 4.5- 6.2) 1.6 ( 1.0- 2.5)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.8 ( 2.5- 3.2) 2.7 ( 2.4- 3.1) 4.9 ( 3.4- 7.0) 1.9 ( 1.2- 3.1)
Georgia 2.7 ( 2.1- 3.4) 2.3 ( 1.7- 3.0) 4.1 ( 2.5- 6.4) ∼
Maryland 3.1 ( 2.4- 4.0) 2.7 ( 2.0- 3.6) 5.3 ( 3.3- 8.4) ∼
North Carolina 2.4 ( 1.9- 3.0) 2.0 ( 1.5- 2.6) 4.9 ( 3.1- 7.4) ∼
South Carolina 3.3 ( 2.5- 4.3) 2.4 ( 1.7- 3.5) 6.7 ( 4.2- 10.3) ∼
Virginia 2.7 ( 2.1- 3.4) 2.3 ( 1.8- 3.1) 5.1 ( 3.2- 8.0) ∼
West Virginia 3.3 ( 2.3- 4.8) 3.2 ( 2.2- 4.7) ∼ ∼
East South Central 3.0 ( 2.6- 3.4) 2.7 ( 2.3- 3.2) 4.7 ( 3.5- 6.3) ∼
Alabama 2.8 ( 2.1- 3.7) 2.4 ( 1.7- 3.3) 5.0 ( 3.0- 8.1) ∼
Kentucky 2.9 ( 2.1- 3.9) 2.9 ( 2.1- 3.9) ∼ ∼
Mississippi 3.1 ( 2.2- 4.4) 3.2 ( 2.1- 4.8) ∼ ∼
Tennessee 3.0 ( 2.4- 3.8) 2.7 ( 2.0- 3.5) 6.7 ( 3.9- 11.0) ∼
West South Central 2.5 ( 2.3- 2.8) 2.2 ( 1.9- 2.5) 5.9 ( 4.6- 7.5) 1.9 ( 1.3- 2.9)
Arkansas 2.0 ( 1.3- 3.0) 1.9 ( 1.1- 2.9) ∼ ∼
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Table 2.12.1.2M: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.6 ( 2.8- 4.7) 2.6 ( 1.8- 3.7) 7.1 ( 4.7- 10.4) ∼
Oklahoma 2.1 ( 1.4- 3.0) 2.1 ( 1.4- 3.0) ∼ ∼
Texas 2.4 ( 2.1- 2.8) 2.2 ( 1.9- 2.6) 5.7 ( 4.0- 8.1) 1.9 ( 1.2- 2.8)
West 1.8 ( 1.7- 2.0) 1.8 ( 1.6- 2.0) 5.4 ( 4.0- 7.3) 1.8 ( 1.3- 2.4)
Mountain 1.8 ( 1.5- 2.1) 1.8 ( 1.5- 2.1) ∼ 2.2 ( 1.2- 3.8)
Arizona 1.8 ( 1.3- 2.4) 1.7 ( 1.2- 2.4) ∼ ∼
Colorado 1.9 ( 1.3- 2.8) 2.0 ( 1.3- 2.9) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.7 ( 1.0- 3.0) 1.9 ( 1.1- 3.3) ∼ ∼
New Mexico 2.5 ( 1.5- 3.9) 2.6 ( 1.5- 4.1) ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.8 ( 1.7- 2.1) 1.8 ( 1.6- 2.0) 6.0 ( 4.4- 8.1) 1.6 ( 1.1- 2.4)
Alaska ∼ ∼ ∼ ∼
California 1.9 ( 1.6- 2.1) 1.8 ( 1.5- 2.0) 6.5 ( 4.8- 8.8) 1.7 ( 1.1- 2.5)
Hawaii ∼ ∼ ∼ ∼
Oregon 1.8 ( 1.2- 2.5) 1.8 ( 1.2- 2.6) ∼ ∼
Washington 1.9 ( 1.4- 2.5) 1.9 ( 1.4- 2.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.12.1.2F: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.7 ( 0.6- 0.9) ∼
Northeast 0.5 ( 0.4- 0.6) 0.4 ( 0.4- 0.5) 0.9 ( 0.6- 1.3) ∼
New England 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.8) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) 0.9 ( 0.6- 1.3) ∼
New Jersey 0.4 ( 0.2- 0.6) ∼ ∼ ∼
New York 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Pennsylvania 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Midwest 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.5) 1.0 ( 0.7- 1.5) ∼
East North Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) 1.0 ( 0.7- 1.5) ∼
Illinois 0.7 ( 0.5- 0.9) 0.6 ( 0.5- 0.9) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.8) 0.4 ( 0.3- 0.7) ∼ ∼
Ohio 0.5 ( 0.3- 0.7) 0.4 ( 0.3- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.5 ( 0.4- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri 0.6 ( 0.4- 0.9) 0.6 ( 0.3- 0.9) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.5) 0.6 ( 0.5- 0.8) ∼
South Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) 0.7 ( 0.5- 1.0) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Georgia 0.6 ( 0.4- 1.0) 0.6 ( 0.4- 1.0) ∼ ∼
Maryland 0.5 ( 0.3- 0.9) ∼ ∼ ∼
North Carolina 0.5 ( 0.3- 0.8) 0.4 ( 0.3- 0.7) ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.12.1.2F: Larynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 0.9 ( 0.6- 1.4) 0.9 ( 0.5- 1.5) ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.5 ( 0.4- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
West 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
Mountain 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.4 ( 0.3- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.13.1.1M: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 14.9 ( 14.7- 15.1) 15.1 ( 14.9- 15.4) 11.0 ( 10.3- 11.6) 10.9 ( 10.2- 11.6)
Northeast 15.9 ( 15.4- 16.4) 16.2 ( 15.7- 16.8) 9.9 ( 8.6- 11.4) 12.8 ( 10.8- 15.1)
New England 15.5 ( 14.6- 16.5) 15.6 ( 14.6- 16.6) 10.1 ( 6.4- 15.7) 11.0 ( 6.5- 18.4)
Connecticut 16.3 ( 14.4- 18.4) 16.8 ( 14.8- 19.1) ∼ ∼
Maine 16.1 ( 13.2- 19.6) 15.7 ( 12.8- 19.1) ∼ ∼
Massachusetts 14.4 ( 13.0- 15.8) 14.6 ( 13.2- 16.1) 10.6 ( 5.9- 19.2) ∼
New Hampshire 16.9 ( 13.7- 20.7) 15.8 ( 12.7- 19.6) ∼ ∼
Rhode Island 14.5 ( 11.4- 18.3) 14.8 ( 11.5- 18.8) ∼ ∼
Vermont 19.1 ( 14.4- 25.1) 19.0 ( 14.2- 25.0) ∼ ∼
Middle Atlantic 16.0 ( 15.5- 16.6) 16.5 ( 15.9- 17.1) 9.9 ( 8.5- 11.5) 13.0 ( 10.9- 15.6)
New Jersey 16.6 ( 15.3- 17.9) 16.8 ( 15.4- 18.2) 14.0 ( 10.4- 18.7) 17.3 ( 12.5- 24.0)
New York 15.8 ( 15.0- 16.7) 16.5 ( 15.6- 17.5) 9.0 ( 7.3- 11.0) 11.5 ( 9.1- 14.5)
Pennsylvania 16.1 ( 15.1- 17.1) 16.4 ( 15.3- 17.5) 8.3 ( 5.8- 11.8) -
Midwest 15.8 ( 15.4- 16.3) 15.8 ( 15.3- 16.3) 11.1 ( 9.7- 12.7) 9.4 ( 7.1- 12.6)
East North Central 15.4 ( 14.9- 16.0) 15.6 ( 15.0- 16.2) 10.7 ( 9.2- 12.4) 8.6 ( 6.2- 12.1)
Illinois 16.7 ( 15.6- 17.8) 17.4 ( 16.1- 18.6) 11.3 ( 8.7- 14.6) -
Indiana 13.6 ( 12.2- 15.1) 13.7 ( 12.3- 15.3) ∼ ∼
Michigan 16.0 ( 14.8- 17.3) 16.1 ( 14.8- 17.4) 11.4 ( 8.6- 15.1) ∼
Detroit 16.3 ( 14.5- 18.4) 17.5 ( 15.3- 20.0) 12.5 ( 9.1- 17.0) ∼
Ohio 13.4 ( 12.4- 14.5) 13.3 ( 12.3- 14.5) 9.1 ( 6.5- 12.6) ∼
Wisconsin 18.1 ( 16.4- 19.9) 17.9 ( 16.2- 19.7) 19.5 ( 10.0- 38.0) ∼
West North Central 16.7 ( 15.8- 17.5) 16.3 ( 15.5- 17.2) 13.2 ( 9.4- 18.3) 12.5 ( 6.6- 22.6)
Iowa 17.2 ( 15.1- 19.5) 17.1 ( 15.0- 19.5) ∼ ∼
Kansas 17.1 ( 14.9- 19.6) 15.8 ( 13.6- 18.2) ∼ ∼
Minnesota 19.2 ( 17.4- 21.2) 18.6 ( 16.8- 20.5) ∼ ∼
Missouri 14.9 ( 13.4- 16.4) 15.1 ( 13.6- 16.8) 10.3 ( 6.5- 16.4) ∼
Nebraska 14.9 ( 12.4- 17.9) 14.0 ( 11.5- 17.0) ∼ ∼
North Dakota 16.2 ( 12.1- 21.5) 16.5 ( 12.3- 21.9) ∼ ∼
South Dakota 15.4 ( 11.6- 20.0) 15.5 ( 11.6- 20.4) ∼ ∼
South
South Atlantic 13.4 ( 12.9- 13.8) 13.7 ( 13.2- 14.2) 10.4 ( 9.4- 11.6) 11.4 ( 9.8- 13.4)
Delaware 10.1 ( 7.1- 14.1) 10.1 ( 6.8- 14.5) ∼ ∼
District of Columbia 12.9 ( 8.6- 18.7) ∼ 13.7 ( 8.2- 21.7) ∼
Florida 13.9 ( 13.2- 14.7) 14.3 ( 13.5- 15.2) 9.1 ( 7.0- 11.8) -
Georgia 16.3 ( 14.8- 17.9) 16.4 ( 14.8- 18.3) 13.6 ( 10.9- 17.1) 17.9 ( 8.1- 37.5)
Atlanta 15.9 ( 13.3- 19.0) 17.1 ( 13.9- 21.0) 12.6 ( 8.5- 19.3) ∼
Maryland 11.7 ( 10.3- 13.2) 12.5 ( 10.9- 14.3) 9.5 ( 6.9- 13.2) ∼
North Carolina 11.5 ( 10.4- 12.7) 11.6 ( 10.4- 13.0) 9.3 ( 7.0- 12.4) 5.5 ( 3.1- 21.1)
South Carolina 14.9 ( 13.1- 17.0) 16.5 ( 14.3- 18.9) 8.1 ( 5.5- 11.6) -
Virginia 11.6 ( 10.4- 12.9) 11.1 ( 9.8- 12.5) 11.8 ( 8.8- 15.7) ∼
West Virginia 15.6 ( 13.1- 18.4) 16.0 ( 13.5- 18.9) ∼ ∼
East South Central
Alabama 10.9 ( 9.4- 12.5) 11.7 ( 10.0- 13.6) 7.3 ( 4.8- 10.8) ∼
Kentucky 14.7 ( 13.0- 16.7) 15.0 ( 13.2- 17.1) ∼ -
Mississippi 11.6 ( 9.7- 13.8) 11.8 ( 9.5- 14.5) 11.3 ( 7.8- 15.9) ∼
Tennessee
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Table 2.13.1.1M: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 15.6 ( 14.9- 16.3) 15.5 ( 14.8- 16.3) 13.0 ( 11.1- 15.2) 10.6 ( 9.2- 12.3)
Arkansas 16.1 ( 13.9- 18.6) 16.2 ( 13.9- 18.9) 10.5 ( 5.8- 18.3) ∼
Louisiana 14.8 ( 13.0- 16.7) 15.3 ( 13.2- 17.6) 13.6 ( 10.4- 17.7) ∼
Oklahoma 16.8 ( 14.8- 19.0) 16.9 ( 14.8- 19.3) ∼ ∼
Texas 15.5 ( 14.6- 16.4) 15.2 ( 14.3- 16.2) 13.4 ( 10.7- 16.6) 10.5 ( 9.0- 12.2)
West 14.5 ( 14.0- 15.0) 14.7 ( 14.2- 15.2) 13.6 ( 11.3- 16.2) 10.4 ( 9.3- 11.6)
Mountain
Arizona
Colorado 15.3 ( 13.5- 17.4) 14.9 ( 13.0- 16.9) ∼ 12.2 ( 7.7- 19.4)
Idaho 18.9 ( 15.5- 22.9) 18.6 ( 15.2- 22.6) ∼ ∼
Montana 17.6 ( 13.8- 22.1) 17.2 ( 13.4- 21.8) ∼ ∼
Nevada 16.6 ( 14.0- 19.7) 16.4 ( 13.6- 19.7) ∼ ∼
New Mexico 15.9 ( 13.3- 18.9) 16.8 ( 14.0- 20.1) ∼ 10.7 ( 7.2- 15.7)
Utah 14.9 ( 12.3- 17.9) 14.7 ( 12.1- 17.7) ∼ ∼
Wyoming
Pacific 14.0 ( 13.5- 14.6) 14.3 ( 13.7- 14.9) 14.0 ( 11.6- 16.9) 10.3 ( 9.1- 11.6)
Alaska 7.8 ( 4.8- 14.2) 9.5 ( 5.7- 17.6) ∼ ∼
California 14.1 ( 13.4- 14.7) 14.5 ( 13.8- 15.2) 13.6 ( 11.1- 16.7) 10.2 ( 9.0- 11.6)
San Francisco-Oakland 11.7 ( 10.2- 13.4) 12.5 ( 10.6- 14.7) 11.8 ( 7.0- 19.1) 8.5 ( 4.9- 14.6)
San Jose-Monterey 14.7 ( 12.2- 17.5) 15.2 ( 12.4- 18.5) ∼ 12.7 ( 6.9- 22.3)
Los Angeles 14.4 ( 13.2- 15.7) 15.1 ( 13.7- 16.7) 12.7 ( 9.1- 17.6) 9.6 ( 7.8- 11.9)
Hawaii 12.3 ( 9.7- 15.5) 16.0 ( 10.1- 24.8) ∼ -
Oregon 11.6 ( 10.0- 13.4) 11.1 ( 9.5- 12.9) ∼ ∼
Washington 16.1 ( 14.6- 17.8) 15.6 ( 14.1- 17.3) 20.7 ( 10.5- 40.7) ∼
Seattle-Puget Sound 16.8 ( 14.9- 18.9) 17.2 ( 15.2- 19.4) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.13.1.1F: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 9.1 ( 8.9- 9.2) 9.2 ( 9.1- 9.4) 6.9 ( 6.5- 7.4) 8.0 ( 7.5- 8.5)
Northeast 9.6 ( 9.2- 9.9) 9.8 ( 9.5- 10.2) 6.6 ( 5.7- 7.5) 8.2 ( 7.0- 9.6)
New England 9.2 ( 8.5- 9.9) 9.3 ( 8.7- 10.1) 5.7 ( 3.5- 8.9) 6.1 ( 3.5- 10.5)
Connecticut 8.0 ( 6.8- 9.3) 8.2 ( 6.9- 9.8) ∼ ∼
Maine 9.0 ( 7.0- 11.5) 9.0 ( 7.0- 11.5) ∼ ∼
Massachusetts 9.7 ( 8.7- 10.8) 10.0 ( 8.9- 11.1) ∼ ∼
New Hampshire 9.1 ( 6.9- 11.7) 9.0 ( 6.8- 11.6) ∼ ∼
Rhode Island 10.1 ( 7.8- 13.1) 10.0 ( 7.6- 13.1) ∼ ∼
Vermont 9.5 ( 6.5- 13.6) 9.4 ( 6.4- 13.5) ∼ ∼
Middle Atlantic 9.7 ( 9.3- 10.1) 10.0 ( 9.6- 10.5) 6.7 ( 5.8- 7.7) 8.5 ( 7.1- 10.0)
New Jersey 9.5 ( 8.6- 10.4) 9.7 ( 8.8- 10.7) 6.8 ( 4.8- 9.3) 8.3 ( 5.8- 11.7)
New York 9.9 ( 9.3- 10.5) 10.4 ( 9.7- 11.1) 6.7 ( 5.5- 8.1) 8.8 ( 7.2- 10.8)
Pennsylvania 9.7 ( 9.0- 10.4) 9.8 ( 9.0- 10.6) 6.8 ( 4.9- 9.1) -
Midwest 9.4 ( 9.1- 9.7) 9.3 ( 9.0- 9.6) 7.6 ( 6.7- 8.7) 9.1 ( 7.1- 11.6)
East North Central 9.2 ( 8.8- 9.6) 9.1 ( 8.7- 9.5) 7.7 ( 6.6- 8.9) 8.4 ( 6.3- 11.2)
Illinois 9.8 ( 9.1- 10.6) 10.1 ( 9.3- 11.0) 7.9 ( 6.2- 10.1) -
Indiana 8.0 ( 7.1- 9.0) 7.9 ( 7.0- 9.0) 7.5 ( 4.4- 12.0) ∼
Michigan 9.3 ( 8.5- 10.1) 9.0 ( 8.1- 9.9) 8.1 ( 6.0- 10.6) ∼
Detroit 9.5 ( 8.2- 10.8) 9.7 ( 8.3- 11.4) 7.7 ( 5.4- 10.6) ∼
Ohio 8.2 ( 7.5- 9.0) 7.9 ( 7.2- 8.7) 6.8 ( 4.9- 9.1) ∼
Wisconsin 11.1 ( 9.9- 12.3) 11.1 ( 9.9- 12.4) ∼ ∼
West North Central 9.9 ( 9.3- 10.5) 9.7 ( 9.2- 10.4) 7.3 ( 5.1- 10.3) 11.8 ( 7.0- 19.2)
Iowa 11.0 ( 9.5- 12.7) 10.7 ( 9.2- 12.4) ∼ ∼
Kansas 10.0 ( 8.4- 11.7) 9.2 ( 7.7- 10.9) ∼ ∼
Minnesota 11.1 ( 9.9- 12.5) 10.7 ( 9.5- 12.1) ∼ ∼
Missouri 8.5 ( 7.5- 9.6) 8.6 ( 7.5- 9.7) 7.2 ( 4.5- 11.0) ∼
Nebraska 10.4 ( 8.5- 12.6) 10.6 ( 8.6- 13.0) ∼ ∼
North Dakota 9.4 ( 6.4- 13.4) 9.9 ( 6.8- 14.1) ∼ ∼
South Dakota 8.1 ( 5.6- 11.4) 8.1 ( 5.6- 11.7) ∼ ∼
South
South Atlantic 8.3 ( 8.0- 8.7) 8.7 ( 8.3- 9.0) 6.6 ( 5.9- 7.3) 8.6 ( 7.3- 10.0)
Delaware 5.5 ( 3.5- 8.2) 5.5 ( 3.4- 8.7) ∼ ∼
District of Columbia 5.6 ( 3.3- 9.3) ∼ ∼ ∼
Florida 9.0 ( 8.5- 9.6) 9.3 ( 8.7- 10.0) 7.4 ( 5.8- 9.3) -
Georgia 9.5 ( 8.6- 10.5) 9.6 ( 8.5- 10.8) 9.1 ( 7.3- 11.3) ∼
Atlanta 8.3 ( 6.7- 10.0) 8.9 ( 7.0- 11.2) 7.0 ( 4.4- 10.8) ∼
Maryland 7.4 ( 6.5- 8.5) 8.1 ( 6.9- 9.4) 5.2 ( 3.6- 7.2) ∼
North Carolina 7.3 ( 6.5- 8.1) 7.7 ( 6.8- 8.7) 5.8 ( 4.3- 7.6) ∼
South Carolina 8.2 ( 7.0- 9.4) 8.4 ( 7.1- 9.9) 6.6 ( 4.7- 9.1) -
Virginia 8.0 ( 7.1- 8.9) 8.0 ( 7.1- 9.1) 5.2 ( 3.6- 7.2) ∼
West Virginia 8.2 ( 6.6- 10.2) 8.3 ( 6.7- 10.3) ∼ ∼
East South Central
Alabama 7.4 ( 6.4- 8.5) 7.7 ( 6.5- 9.1) 6.5 ( 4.6- 8.9) ∼
Kentucky 11.2 ( 9.9- 12.7) 10.7 ( 9.4- 12.2) 11.0 ( 6.2- 18.2) -
Mississippi 7.7 ( 6.4- 9.2) 8.1 ( 6.5- 10.1) 6.0 ( 4.0- 8.7) ∼
Tennessee
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Table 2.13.1.1F: Leukemias. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 9.6 ( 9.2- 10.1) 9.8 ( 9.3- 10.3) 7.1 ( 6.0- 8.4) 7.8 ( 6.7- 9.0)
Arkansas 9.5 ( 8.0- 11.1) 9.7 ( 8.1- 11.6) ∼ ∼
Louisiana 8.7 ( 7.5- 9.9) 9.3 ( 7.9- 10.9) 6.7 ( 4.9- 9.1) ∼
Oklahoma 9.7 ( 8.4- 11.2) 9.7 ( 8.2- 11.3) ∼ ∼
Texas 9.9 ( 9.3- 10.5) 9.9 ( 9.3- 10.6) 7.5 ( 5.9- 9.4) 7.8 ( 6.7- 9.1)
West 8.8 ( 8.5- 9.1) 8.9 ( 8.5- 9.3) 7.7 ( 6.3- 9.3) 7.8 ( 7.0- 8.7)
Mountain
Arizona
Colorado 9.6 ( 8.4- 11.1) 9.0 ( 7.7- 10.4) ∼ ∼
Idaho 11.9 ( 9.5- 14.8) 12.0 ( 9.6- 15.0) ∼ ∼
Montana 9.1 ( 6.7- 12.2) 8.8 ( 6.4- 12.0) ∼ ∼
Nevada 9.0 ( 7.3- 11.0) 8.6 ( 6.8- 10.7) ∼ ∼
New Mexico 8.7 ( 6.9- 10.8) 8.9 ( 7.1- 11.2) ∼ ∼
Utah 8.5 ( 6.8- 10.5) 8.7 ( 6.9- 10.8) ∼ ∼
Wyoming
Pacific 8.6 ( 8.2- 9.0) 8.8 ( 8.4- 9.2) 7.8 ( 6.3- 9.6) 8.1 ( 7.2- 9.1)
Alaska ∼ ∼ ∼ ∼
California 8.4 ( 8.0- 8.9) 8.8 ( 8.3- 9.3) 7.2 ( 5.7- 9.1) 7.9 ( 7.0- 9.0)
San Francisco-Oakland 6.8 ( 5.7- 7.9) 7.6 ( 6.3- 9.2) ∼ ∼
San Jose-Monterey 8.3 ( 6.7- 10.1) 9.0 ( 7.2- 11.2) ∼ 8.1 ( 4.5- 13.7)
Los Angeles 8.3 ( 7.5- 9.1) 8.6 ( 7.7- 9.6) 7.6 ( 5.4- 10.6) 6.6 ( 5.3- 8.1)
Hawaii 9.5 ( 7.4- 12.2) ∼ ∼ -
Oregon 7.3 ( 6.1- 8.6) 7.1 ( 5.9- 8.5) ∼ ∼
Washington 10.5 ( 9.4- 11.6) 10.1 ( 9.0- 11.4) ∼ ∼
Seattle-Puget Sound 11.2 ( 9.8- 12.7) 11.2 ( 9.7- 12.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.13.1.2M: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 9.9 ( 9.8- 10.1) 10.3 ( 10.1- 10.5) 8.4 ( 7.8- 9.0) 6.3 ( 5.7- 6.9)
Northeast 9.8 ( 9.4- 10.2) 10.3 ( 9.8- 10.7) 6.1 ( 5.0- 7.3) 5.5 ( 4.2- 7.1)
New England 9.9 ( 9.1- 10.7) 10.1 ( 9.3- 10.9) 7.4 ( 4.1- 13.0) ∼
Connecticut 11.5 ( 9.9- 13.3) 11.8 ( 10.1- 13.7) ∼ ∼
Maine 10.4 ( 8.1- 13.3) 10.6 ( 8.2- 13.5) ∼ ∼
Massachusetts 9.5 ( 8.4- 10.7) 9.7 ( 8.6- 11.0) ∼ ∼
New Hampshire 9.3 ( 6.8- 12.3) 9.4 ( 6.9- 12.5) ∼ ∼
Rhode Island 6.9 ( 4.8- 9.7) 7.3 ( 5.1- 10.3) ∼ ∼
Vermont 8.7 ( 5.5- 13.2) 8.8 ( 5.5- 13.3) ∼ ∼
Middle Atlantic 9.8 ( 9.3- 10.2) 10.3 ( 9.8- 10.9) 5.9 ( 4.8- 7.2) 5.9 ( 4.5- 7.8)
New Jersey 10.0 ( 9.0- 11.1) 10.4 ( 9.4- 11.6) 8.5 ( 5.6- 12.6) 4.5 ( 2.3- 8.7)
New York 8.9 ( 8.3- 9.6) 9.7 ( 9.0- 10.5) 4.4 ( 3.2- 6.0) 6.0 ( 4.3- 8.5)
Pennsylvania 10.7 ( 9.9- 11.6) 11.0 ( 10.2- 12.0) 7.2 ( 4.8- 10.5) ∼
Midwest 10.9 ( 10.5- 11.3) 11.1 ( 10.7- 11.6) 9.1 ( 7.8- 10.6) 5.2 ( 3.3- 8.0)
East North Central 10.7 ( 10.3- 11.2) 10.9 ( 10.5- 11.5) 9.2 ( 7.7- 10.8) 4.0 ( 2.3- 7.0)
Illinois 11.4 ( 10.4- 12.4) 11.6 ( 10.6- 12.7) 10.3 ( 7.8- 13.6) 3.3 ( 1.4- 7.5)
Indiana 11.0 ( 9.8- 12.5) 11.1 ( 9.7- 12.5) 11.0 ( 6.2- 18.7) ∼
Michigan 9.9 ( 9.0- 10.9) 10.2 ( 9.2- 11.3) 7.7 ( 5.4- 10.9) ∼
Ohio 11.0 ( 10.1- 11.9) 11.3 ( 10.3- 12.3) 8.6 ( 6.0- 12.1) ∼
Wisconsin 10.2 ( 9.0- 11.6) 10.3 ( 9.0- 11.7) ∼ ∼
West North Central 11.3 ( 10.6- 12.1) 11.5 ( 10.8- 12.2) 8.3 ( 5.4- 12.7) ∼
Iowa 12.2 ( 10.4- 14.2) 12.2 ( 10.4- 14.2) ∼ ∼
Kansas 11.3 ( 9.5- 13.4) 11.6 ( 9.7- 13.7) ∼ ∼
Minnesota 11.3 ( 9.9- 12.8) 11.3 ( 9.9- 12.9) ∼ ∼
Missouri 10.7 ( 9.5- 12.1) 11.0 ( 9.7- 12.5) 6.9 ( 3.9- 12.2) ∼
Nebraska 10.2 ( 8.1- 12.8) 10.2 ( 8.0- 12.8) ∼ ∼
North Dakota 11.8 ( 8.3- 16.4) 12.0 ( 8.5- 16.7) ∼ ∼
South Dakota 14.0 ( 10.4- 18.4) 14.6 ( 10.9- 19.3) ∼ ∼
South 9.7 ( 9.4- 10.0) 9.9 ( 9.6- 10.3) 8.7 ( 7.9- 9.6) 6.7 ( 5.7- 7.7)
South Atlantic 9.6 ( 9.2- 10.0) 9.9 ( 9.5- 10.3) 8.0 ( 7.0- 9.1) 7.1 ( 5.6- 8.8)
Delaware 9.1 ( 6.2- 13.0) 8.5 ( 5.5- 12.7) ∼ ∼
District of Columbia 7.5 ( 4.3- 12.3) ∼ ∼ ∼
Florida 10.2 ( 9.6- 10.9) 10.5 ( 9.8- 11.3) 7.7 ( 5.7- 10.4) 7.8 ( 6.2- 9.8)
Georgia 8.8 ( 7.7- 10.0) 8.8 ( 7.5- 10.2) 9.1 ( 6.6- 12.3) ∼
Maryland 8.8 ( 7.5- 10.2) 9.3 ( 7.9- 11.0) 6.5 ( 4.1- 10.0) ∼
North Carolina 9.4 ( 8.3- 10.5) 9.7 ( 8.6- 11.0) 8.0 ( 5.7- 11.1) ∼
South Carolina 10.6 ( 9.0- 12.4) 11.8 ( 9.9- 14.0) 5.9 ( 3.5- 9.5) ∼
Virginia 8.7 ( 7.6- 9.9) 8.8 ( 7.6- 10.2) 9.0 ( 6.3- 12.6) ∼
West Virginia 10.9 ( 8.9- 13.4) 11.1 ( 9.0- 13.6) ∼ ∼
East South Central 9.7 ( 9.0- 10.5) 10.0 ( 9.2- 10.8) 8.0 ( 6.3- 10.1) ∼
Alabama 8.8 ( 7.5- 10.3) 8.6 ( 7.2- 10.3) 9.2 ( 6.3- 13.1) ∼
Kentucky 9.9 ( 8.4- 11.6) 10.0 ( 8.5- 11.7) ∼ ∼
Mississippi 10.2 ( 8.4- 12.4) 11.0 ( 8.7- 13.7) 8.2 ( 5.2- 12.4) ∼
Tennessee 10.0 ( 8.7- 11.4) 10.5 ( 9.2- 12.1) 5.5 ( 2.9- 9.8) ∼
West South Central 9.9 ( 9.4- 10.5) 10.0 ( 9.4- 10.6) 11.1 ( 9.3- 13.3) 6.4 ( 5.2- 7.9)
Arkansas 11.3 ( 9.4- 13.4) 11.8 ( 9.8- 14.2) ∼ ∼
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Table 2.13.1.2M: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 9.5 ( 8.1- 11.1) 8.9 ( 7.4- 10.7) 12.0 ( 8.7- 16.1) ∼
Oklahoma 10.6 ( 9.0- 12.4) 10.6 ( 8.9- 12.6) ∼ ∼
Texas 9.7 ( 9.0- 10.4) 9.7 ( 9.0- 10.6) 11.2 ( 8.6- 14.4) 6.2 ( 5.0- 7.7)
West 9.3 ( 9.0- 9.7) 9.9 ( 9.5- 10.3) 9.8 ( 7.8- 12.2) 6.3 ( 5.5- 7.3)
Mountain 9.5 ( 8.8- 10.3) 9.7 ( 9.0- 10.5) ∼ 5.5 ( 4.0- 7.6)
Arizona 8.5 ( 7.4- 9.7) 8.8 ( 7.6- 10.1) ∼ 7.3 ( 4.1- 12.5)
Colorado 9.4 ( 7.9- 11.1) 9.4 ( 7.8- 11.2) ∼ ∼
Idaho 13.3 ( 10.4- 16.7) 13.5 ( 10.6- 17.1) ∼ ∼
Montana 10.4 ( 7.6- 14.1) 10.8 ( 7.8- 14.6) ∼ ∼
Nevada 10.6 ( 8.5- 13.2) 11.0 ( 8.7- 13.8) ∼ ∼
New Mexico 9.6 ( 7.5- 12.0) 10.1 ( 7.9- 12.7) ∼ 6.1 ( 3.6- 10.2)
Utah 8.5 ( 6.5- 10.9) 8.3 ( 6.3- 10.8) ∼ ∼
Wyoming 10.5 ( 6.4- 16.4) 10.7 ( 6.6- 16.7) ∼ ∼
Pacific 9.3 ( 8.8- 9.7) 9.9 ( 9.4- 10.5) 10.3 ( 8.1- 13.0) 6.6 ( 5.6- 7.9)
Alaska 9.2 ( 4.6- 17.7) ∼ ∼ ∼
California 9.1 ( 8.6- 9.7) 9.8 ( 9.2- 10.4) 10.7 ( 8.4- 13.7) 6.7 ( 5.6- 7.9)
Hawaii 7.0 ( 5.0- 9.5) 11.7 ( 6.7- 19.4) ∼ ∼
Oregon 9.5 ( 8.0- 11.1) 9.5 ( 8.0- 11.2) ∼ ∼
Washington 10.4 ( 9.1- 11.7) 10.7 ( 9.4- 12.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.13.1.2F: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 5.6 ( 5.5- 5.7) 5.7 ( 5.6- 5.8) 5.3 ( 4.9- 5.6) 4.2 ( 3.8- 4.6)
Northeast 5.4 ( 5.1- 5.6) 5.6 ( 5.3- 5.8) 4.6 ( 3.9- 5.4) 3.6 ( 2.8- 4.6)
New England 5.6 ( 5.1- 6.1) 5.7 ( 5.2- 6.2) 4.6 ( 2.6- 7.7) ∼
Connecticut 5.9 ( 4.9- 7.0) 6.0 ( 4.9- 7.2) ∼ ∼
Maine 5.6 ( 4.2- 7.6) 5.7 ( 4.2- 7.6) ∼ ∼
Massachusetts 5.7 ( 5.0- 6.5) 5.9 ( 5.1- 6.7) ∼ ∼
New Hampshire 4.6 ( 3.1- 6.5) 4.5 ( 3.1- 6.4) ∼ ∼
Rhode Island 5.8 ( 4.1- 8.0) 5.7 ( 4.0- 8.1) ∼ ∼
Vermont 5.5 ( 3.3- 8.8) 5.5 ( 3.3- 8.9) ∼ ∼
Middle Atlantic 5.3 ( 5.0- 5.6) 5.5 ( 5.2- 5.9) 4.6 ( 3.8- 5.5) 3.9 ( 3.0- 5.1)
New Jersey 5.7 ( 5.1- 6.4) 6.0 ( 5.3- 6.8) 4.4 ( 2.8- 6.6) 4.4 ( 2.5- 7.2)
New York 5.0 ( 4.6- 5.4) 5.3 ( 4.8- 5.8) 4.3 ( 3.3- 5.4) 3.9 ( 2.8- 5.3)
Pennsylvania 5.5 ( 5.0- 6.1) 5.6 ( 5.1- 6.1) 5.7 ( 4.0- 7.8) ∼
Midwest 6.0 ( 5.7- 6.2) 6.0 ( 5.8- 6.3) 5.7 ( 4.9- 6.6) 3.5 ( 2.2- 5.3)
East North Central 6.0 ( 5.7- 6.3) 6.0 ( 5.7- 6.3) 5.6 ( 4.7- 6.6) 4.0 ( 2.4- 6.2)
Illinois 5.7 ( 5.2- 6.3) 5.8 ( 5.2- 6.4) 5.6 ( 4.1- 7.4) ∼
Indiana 5.9 ( 5.1- 6.7) 5.9 ( 5.1- 6.8) 6.9 ( 3.9- 11.4) ∼
Michigan 5.6 ( 5.0- 6.3) 5.7 ( 5.0- 6.4) 5.4 ( 3.7- 7.6) ∼
Ohio 6.2 ( 5.6- 6.8) 6.3 ( 5.7- 7.0) 5.1 ( 3.5- 7.2) ∼
Wisconsin 6.8 ( 5.9- 7.7) 6.7 ( 5.8- 7.7) ∼ ∼
West North Central 6.0 ( 5.6- 6.5) 6.0 ( 5.5- 6.5) 6.2 ( 4.1- 9.1) ∼
Iowa 6.1 ( 5.0- 7.3) 5.9 ( 4.9- 7.2) ∼ ∼
Kansas 6.4 ( 5.3- 7.8) 6.4 ( 5.2- 7.8) ∼ ∼
Minnesota 6.1 ( 5.3- 7.1) 6.1 ( 5.2- 7.1) ∼ ∼
Missouri 5.9 ( 5.1- 6.8) 5.9 ( 5.1- 6.8) 6.0 ( 3.5- 9.6) ∼
Nebraska 6.7 ( 5.2- 8.4) 6.7 ( 5.2- 8.5) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 5.3 ( 3.5- 8.0) 5.1 ( 3.2- 7.9) ∼ ∼
South 5.6 ( 5.4- 5.8) 5.7 ( 5.5- 5.9) 5.3 ( 4.9- 5.9) 4.7 ( 4.1- 5.5)
South Atlantic 5.4 ( 5.2- 5.7) 5.5 ( 5.2- 5.8) 5.5 ( 4.8- 6.2) 5.5 ( 4.5- 6.7)
Delaware 6.8 ( 4.6- 9.6) 7.0 ( 4.7- 10.4) ∼ ∼
District of Columbia 5.2 ( 3.1- 8.6) ∼ ∼ ∼
Florida 5.1 ( 4.7- 5.5) 5.1 ( 4.7- 5.6) 5.5 ( 4.1- 7.2) 5.9 ( 4.7- 7.3)
Georgia 5.7 ( 5.0- 6.5) 6.1 ( 5.2- 7.0) 5.2 ( 3.8- 7.0) ∼
Maryland 5.1 ( 4.3- 6.0) 5.4 ( 4.5- 6.4) 4.0 ( 2.6- 5.9) ∼
North Carolina 5.7 ( 5.0- 6.4) 5.6 ( 4.9- 6.4) 6.4 ( 4.8- 8.3) ∼
South Carolina 5.6 ( 4.7- 6.7) 5.6 ( 4.5- 6.9) 5.5 ( 3.7- 7.8) ∼
Virginia 5.7 ( 5.0- 6.5) 5.6 ( 4.8- 6.5) 6.4 ( 4.6- 8.7) ∼
West Virginia 6.2 ( 4.9- 7.9) 6.4 ( 5.0- 8.1) ∼ ∼
East South Central 6.1 ( 5.6- 6.6) 6.0 ( 5.5- 6.6) 6.2 ( 5.0- 7.5) ∼
Alabama 6.0 ( 5.1- 7.0) 6.3 ( 5.2- 7.5) 5.7 ( 3.9- 8.1) ∼
Kentucky 6.7 ( 5.7- 7.8) 6.4 ( 5.4- 7.5) ∼ ∼
Mississippi 6.4 ( 5.2- 7.8) 6.3 ( 4.9- 8.0) 6.1 ( 4.1- 8.9) ∼
Tennessee 5.6 ( 4.8- 6.4) 5.6 ( 4.8- 6.5) 5.6 ( 3.6- 8.5) ∼
West South Central 5.7 ( 5.3- 6.0) 5.9 ( 5.5- 6.3) 4.4 ( 3.5- 5.4) 4.1 ( 3.3- 5.0)
Arkansas 5.2 ( 4.2- 6.5) 5.1 ( 4.0- 6.4) ∼ ∼
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Table 2.13.1.2F: Leukemias. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 5.8 ( 4.9- 6.8) 6.0 ( 4.9- 7.3) 5.0 ( 3.4- 7.1) ∼
Oklahoma 5.7 ( 4.7- 6.9) 6.0 ( 4.9- 7.2) ∼ ∼
Texas 5.7 ( 5.3- 6.2) 6.0 ( 5.5- 6.5) 4.0 ( 2.8- 5.5) 4.0 ( 3.2- 5.0)
West 5.3 ( 5.1- 5.6) 5.5 ( 5.3- 5.8) 5.4 ( 4.2- 6.8) 3.9 ( 3.4- 4.6)
Mountain 5.5 ( 5.0- 6.0) 5.5 ( 5.1- 6.0) ∼ 3.8 ( 2.7- 5.2)
Arizona 5.6 ( 4.8- 6.5) 5.6 ( 4.8- 6.6) ∼ 4.4 ( 2.5- 7.4)
Colorado 6.0 ( 5.0- 7.2) 6.0 ( 5.0- 7.2) ∼ ∼
Idaho 6.9 ( 5.2- 9.2) 7.1 ( 5.3- 9.4) ∼ ∼
Montana 5.5 ( 3.8- 8.0) 5.4 ( 3.6- 7.9) ∼ ∼
Nevada 5.2 ( 3.9- 6.8) 5.6 ( 4.1- 7.3) ∼ ∼
New Mexico 5.1 ( 3.8- 6.8) 5.3 ( 3.9- 7.1) ∼ 4.9 ( 2.8- 8.2)
Utah 3.7 ( 2.6- 5.2) 3.6 ( 2.5- 5.1) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 5.3 ( 5.0- 5.6) 5.6 ( 5.2- 5.9) 5.5 ( 4.2- 7.1) 4.0 ( 3.3- 4.7)
Alaska ∼ ∼ ∼ ∼
California 5.3 ( 5.0- 5.7) 5.6 ( 5.2- 6.0) 5.7 ( 4.3- 7.4) 3.9 ( 3.3- 4.7)
Hawaii 4.1 ( 2.8- 6.0) ∼ ∼ ∼
Oregon 5.7 ( 4.7- 6.8) 5.8 ( 4.8- 7.0) ∼ ∼
Washington 5.4 ( 4.6- 6.2) 5.5 ( 4.7- 6.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.14.1.1M: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 8.2 ( 8.1- 8.4) 7.2 ( 7.1- 7.4) 11.4 ( 10.7- 12.0) 14.9 ( 14.1- 15.8)
Northeast 9.2 ( 8.8- 9.5) 7.9 ( 7.6- 8.3) 13.8 ( 12.3- 15.5) 16.9 ( 14.8- 19.4)
New England 8.1 ( 7.4- 8.8) 7.3 ( 6.6- 8.0) 15.5 ( 10.8- 22.1) 18.1 ( 12.3- 26.6)
Connecticut 8.6 ( 7.3- 10.2) 8.1 ( 6.8- 9.7) ∼ 17.7 ( 9.0- 34.0)
Maine 5.9 ( 4.2- 8.2) 5.9 ( 4.1- 8.1) ∼ ∼
Massachusetts 8.4 ( 7.4- 9.5) 7.2 ( 6.3- 8.3) 17.6 ( 10.4- 28.9) ∼
New Hampshire 5.0 ( 3.3- 7.3) 4.7 ( 3.0- 6.9) ∼ ∼
Rhode Island 11.7 ( 8.9- 15.1) 10.7 ( 8.0- 14.1) ∼ ∼
Vermont 7.1 ( 4.4- 10.9) 6.8 ( 4.2- 10.7) ∼ ∼
Middle Atlantic 9.6 ( 9.1- 10.0) 8.2 ( 7.7- 8.6) 13.6 ( 12.0- 15.4) 16.7 ( 14.4- 19.4)
New Jersey 9.5 ( 8.5- 10.5) 8.4 ( 7.5- 9.5) 11.6 ( 8.4- 16.0) 11.4 ( 7.8- 16.8)
New York 9.9 ( 9.3- 10.6) 8.3 ( 7.7- 9.1) 12.3 ( 10.4- 14.7) 18.3 ( 15.4- 21.8)
Pennsylvania 9.1 ( 8.3- 9.8) 7.8 ( 7.1- 8.5) 19.0 ( 15.3- 23.7) -
Midwest 6.7 ( 6.4- 7.0) 5.9 ( 5.6- 6.1) 13.2 ( 11.7- 14.9) 13.3 ( 10.5- 16.9)
East North Central 7.1 ( 6.7- 7.5) 6.3 ( 5.9- 6.7) 12.7 ( 11.1- 14.5) 14.6 ( 11.3- 18.9)
Illinois 7.2 ( 6.5- 8.0) 6.6 ( 5.9- 7.4) 9.0 ( 6.8- 11.9) -
Indiana 6.6 ( 5.7- 7.7) 6.0 ( 5.1- 7.1) 15.3 ( 9.8- 23.4) ∼
Michigan 8.5 ( 7.6- 9.4) 7.3 ( 6.5- 8.2) 14.9 ( 11.7- 18.9) 18.9 ( 10.2- 35.3)
Detroit 9.5 ( 8.1- 11.1) 8.0 ( 6.5- 9.7) 14.0 ( 10.4- 18.6) ∼
Ohio 6.0 ( 5.4- 6.7) 5.0 ( 4.4- 5.7) 14.3 ( 11.0- 18.4) ∼
Wisconsin 7.0 ( 6.0- 8.1) 6.7 ( 5.7- 7.9) ∼ ∼
West North Central 5.8 ( 5.3- 6.3) 5.0 ( 4.5- 5.5) 16.4 ( 12.4- 21.7) ∼
Iowa 4.9 ( 3.8- 6.2) 4.3 ( 3.3- 5.6) ∼ ∼
Kansas 5.4 ( 4.2- 6.9) 4.9 ( 3.7- 6.4) ∼ ∼
Minnesota 5.4 ( 4.5- 6.5) 4.6 ( 3.7- 5.6) ∼ ∼
Missouri 7.1 ( 6.2- 8.2) 5.9 ( 5.0- 7.0) 17.6 ( 12.4- 25.0) ∼
Nebraska 6.0 ( 4.4- 7.9) 5.3 ( 3.8- 7.2) ∼ ∼
North Dakota 5.1 ( 2.9- 8.5) ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 7.4 ( 7.0- 7.7) 6.8 ( 6.5- 7.2) 8.2 ( 7.3- 9.3) 10.6 ( 9.0- 12.5)
Delaware 7.3 ( 4.8- 10.7) 6.9 ( 4.3- 10.6) ∼ ∼
District of Columbia 12.3 ( 8.2- 17.8) ∼ 12.0 ( 7.1- 19.5) ∼
Florida 8.8 ( 8.2- 9.4) 8.5 ( 7.9- 9.1) 10.7 ( 8.4- 13.6) -
Georgia 6.1 ( 5.2- 7.1) 5.5 ( 4.6- 6.6) 7.5 ( 5.4- 10.2) ∼
Atlanta 6.9 ( 5.3- 9.0) 5.6 ( 3.9- 8.0) 8.5 ( 5.3- 14.4) ∼
Maryland 6.9 ( 5.9- 8.1) 5.2 ( 4.2- 6.4) 10.3 ( 7.7- 13.9) ∼
North Carolina 6.5 ( 5.7- 7.4) 6.5 ( 5.6- 7.5) 5.7 ( 4.1- 8.0) ∼
South Carolina 6.0 ( 4.9- 7.3) 6.1 ( 4.9- 7.6) 5.3 ( 3.3- 8.4) -
Virginia 7.1 ( 6.2- 8.1) 5.9 ( 5.0- 7.0) 8.5 ( 6.1- 11.8) ∼
West Virginia 5.5 ( 4.1- 7.3) 5.4 ( 4.0- 7.3) ∼ ∼
East South Central
Alabama 6.5 ( 5.4- 7.7) 6.0 ( 4.9- 7.4) 7.5 ( 5.1- 11.0) ∼
Kentucky 7.0 ( 5.8- 8.4) 6.7 ( 5.5- 8.1) ∼ -
Mississippi 9.3 ( 7.6- 11.2) 8.5 ( 6.7- 10.8) 8.6 ( 5.7- 12.8) ∼
Tennessee
continued
C
ancer Incidence and M
ortality, by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
119
Table 2.14.1.1M: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 9.5 ( 9.0- 10.1) 8.7 ( 8.2- 9.3) 13.3 ( 11.5- 15.4) 19.3 ( 17.2- 21.6)
Arkansas 5.2 ( 4.1- 6.7) 5.4 ( 4.1- 7.0) ∼ ∼
Louisiana 9.2 ( 7.9- 10.7) 7.7 ( 6.3- 9.3) 13.5 ( 10.4- 17.3) ∼
Oklahoma 6.4 ( 5.2- 7.8) 5.5 ( 4.3- 6.9) ∼ ∼
Texas 10.8 ( 10.1- 11.6) 10.0 ( 9.3- 10.8) 15.0 ( 12.4- 18.3) 19.8 ( 17.6- 22.2)
West 9.5 ( 9.1- 9.9) 7.9 ( 7.5- 8.3) 13.3 ( 11.1- 15.9) 13.6 ( 12.4- 15.0)
Mountain
Arizona
Colorado 7.1 ( 5.9- 8.5) 6.0 ( 4.9- 7.4) ∼ 15.0 ( 9.7- 23.0)
Idaho 4.1 ( 2.6- 6.1) 3.8 ( 2.4- 5.8) ∼ ∼
Montana 4.0 ( 2.5- 6.4) ∼ ∼ ∼
Nevada 9.4 ( 7.5- 11.7) 9.4 ( 7.4- 11.9) ∼ 21.8 ( 11.7- 40.6)
New Mexico 10.1 ( 8.1- 12.5) 9.7 ( 7.7- 12.3) ∼ 13.3 ( 9.4- 18.7)
Utah 4.0 ( 2.7- 5.7) 3.3 ( 2.2- 4.9) ∼ ∼
Wyoming
Pacific 10.3 ( 9.8- 10.7) 8.4 ( 8.0- 8.9) 13.3 ( 11.0- 16.1) 13.5 ( 12.1- 15.0)
Alaska 12.4 ( 7.5- 20.9) 9.8 ( 5.1- 19.2) ∼ ∼
California 10.9 ( 10.4- 11.5) 9.2 ( 8.7- 9.8) 13.4 ( 10.9- 16.3) 13.7 ( 12.3- 15.3)
San Francisco-Oakland 13.0 ( 11.5- 14.8) 10.2 ( 8.6- 12.1) 15.4 ( 9.8- 23.5) 16.1 ( 11.0- 23.6)
San Jose-Monterey 11.2 ( 9.2- 13.6) 8.4 ( 6.5- 10.8) ∼ 12.1 ( 7.6- 20.1)
Los Angeles 11.4 ( 10.4- 12.6) 9.1 ( 8.0- 10.3) 13.7 ( 10.1- 18.6) 12.1 ( 10.0- 14.8)
Hawaii 14.5 ( 11.7- 17.9) ∼ ∼ -
Oregon 6.5 ( 5.3- 7.8) 5.3 ( 4.2- 6.5) ∼ ∼
Washington 8.1 ( 7.1- 9.3) 6.9 ( 5.9- 8.0) ∼ ∼
Seattle-Puget Sound 9.1 ( 7.8- 10.6) 7.6 ( 6.4- 9.1) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.14.1.1F: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 3.0 ( 2.9- 3.0) 2.7 ( 2.6- 2.7) 3.5 ( 3.2- 3.8) 5.5 ( 5.0- 6.0)
Northeast 3.1 ( 2.9- 3.3) 2.8 ( 2.6- 3.0) 4.0 ( 3.3- 4.8) 5.3 ( 4.2- 6.5)
New England 2.5 ( 2.2- 2.9) 2.4 ( 2.1- 2.8) ∼ ∼
Connecticut 2.6 ( 1.9- 3.4) 2.4 ( 1.7- 3.2) ∼ ∼
Maine 1.7 ( 1.0- 3.0) 1.8 ( 1.0- 3.1) ∼ ∼
Massachusetts 2.6 ( 2.1- 3.2) 2.5 ( 2.0- 3.1) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 4.3 ( 2.9- 6.4) 4.2 ( 2.7- 6.4) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.3 ( 3.1- 3.6) 3.0 ( 2.7- 3.2) 4.1 ( 3.3- 4.9) 5.2 ( 4.1- 6.5)
New Jersey 3.2 ( 2.7- 3.7) 2.9 ( 2.4- 3.5) 4.0 ( 2.5- 6.0) ∼
New York 3.9 ( 3.5- 4.2) 3.5 ( 3.1- 3.9) 3.9 ( 3.0- 4.9) 6.6 ( 5.2- 8.4)
Pennsylvania 2.7 ( 2.4- 3.1) 2.4 ( 2.0- 2.8) 4.6 ( 3.0- 6.6) -
Midwest 2.6 ( 2.4- 2.7) 2.4 ( 2.2- 2.5) 4.0 ( 3.3- 4.8) 5.1 ( 3.5- 7.3)
East North Central 2.6 ( 2.4- 2.8) 2.4 ( 2.2- 2.6) 3.6 ( 2.9- 4.4) 5.2 ( 3.4- 7.8)
Illinois 2.6 ( 2.3- 3.0) 2.4 ( 2.0- 2.8) 3.8 ( 2.6- 5.4) -
Indiana 2.6 ( 2.1- 3.3) 2.5 ( 2.0- 3.2) ∼ ∼
Michigan 2.9 ( 2.5- 3.4) 2.7 ( 2.3- 3.2) 3.8 ( 2.4- 5.6) ∼
Detroit 3.2 ( 2.5- 4.1) 2.9 ( 2.2- 3.9) 4.2 ( 2.6- 6.4) ∼
Ohio 2.2 ( 1.8- 2.6) 2.0 ( 1.7- 2.4) 2.7 ( 1.6- 4.3) ∼
Wisconsin 2.8 ( 2.3- 3.5) 2.6 ( 2.0- 3.2) ∼ ∼
West North Central 2.5 ( 2.2- 2.8) 2.3 ( 2.0- 2.6) 6.3 ( 4.2- 9.2) ∼
Iowa 2.2 ( 1.5- 3.0) 2.2 ( 1.5- 3.0) ∼ ∼
Kansas 2.9 ( 2.1- 3.9) 2.6 ( 1.8- 3.6) ∼ ∼
Minnesota 2.1 ( 1.6- 2.7) 1.8 ( 1.3- 2.4) ∼ ∼
Missouri 3.1 ( 2.5- 3.7) 2.8 ( 2.3- 3.5) 5.6 ( 3.2- 9.2) ∼
Nebraska 2.2 ( 1.4- 3.4) 2.3 ( 1.4- 3.6) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 2.6 ( 2.4- 2.8) 2.4 ( 2.2- 2.6) 2.8 ( 2.4- 3.3) 4.5 ( 3.6- 5.6)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.9 ( 2.6- 3.2) 2.8 ( 2.5- 3.1) 2.9 ( 1.9- 4.2) -
Georgia 2.6 ( 2.1- 3.1) 2.2 ( 1.7- 2.8) 3.4 ( 2.3- 4.9) ∼
Atlanta 2.9 ( 2.0- 4.1) 2.0 ( 1.1- 3.3) ∼ ∼
Maryland 2.7 ( 2.2- 3.4) 2.2 ( 1.6- 3.0) 3.2 ( 2.0- 4.9) ∼
North Carolina 1.9 ( 1.6- 2.4) 1.7 ( 1.3- 2.2) 2.1 ( 1.3- 3.3) ∼
South Carolina 2.4 ( 1.8- 3.1) 2.4 ( 1.7- 3.2) ∼ -
Virginia 2.7 ( 2.2- 3.2) 2.5 ( 1.9- 3.1) 3.1 ( 1.9- 4.7) ∼
West Virginia 2.5 ( 1.7- 3.6) 2.5 ( 1.7- 3.6) ∼ ∼
East South Central
Alabama 2.2 ( 1.7- 2.9) 1.7 ( 1.2- 2.4) 3.5 ( 2.2- 5.5) ∼
Kentucky 2.0 ( 1.5- 2.7) 2.0 ( 1.5- 2.7) ∼ -
Mississippi 3.8 ( 2.9- 4.9) 3.6 ( 2.6- 5.0) 3.7 ( 2.2- 6.0) ∼
Tennessee
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Table 2.14.1.1F: Liver and Intrahepatic Bile Duct. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95%
Conﬁdence Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 3.7 ( 3.4- 4.0) 3.5 ( 3.2- 3.8) 3.8 ( 3.0- 4.8) 7.3 ( 6.2- 8.6)
Arkansas 2.2 ( 1.5- 3.0) 2.1 ( 1.5- 3.1) ∼ ∼
Louisiana 2.8 ( 2.2- 3.5) 2.5 ( 1.9- 3.4) 3.0 ( 1.8- 4.7) ∼
Oklahoma 2.8 ( 2.1- 3.7) 2.1 ( 1.5- 2.9) ∼ ∼
Texas 4.3 ( 4.0- 4.8) 4.1 ( 3.7- 4.6) 4.7 ( 3.5- 6.3) 7.5 ( 6.3- 8.8)
West 3.4 ( 3.2- 3.6) 2.8 ( 2.6- 3.0) 3.5 ( 2.6- 4.7) 5.1 ( 4.4- 5.9)
Mountain
Arizona
Colorado 3.0 ( 2.3- 3.8) 2.6 ( 2.0- 3.4) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 3.1 ( 2.1- 4.4) 2.4 ( 1.5- 3.6) ∼ ∼
New Mexico 3.5 ( 2.4- 4.9) 3.5 ( 2.4- 5.0) ∼ 6.5 ( 4.0- 10.1)
Utah 2.3 ( 1.5- 3.6) 2.0 ( 1.2- 3.1) ∼ ∼
Wyoming
Pacific 3.5 ( 3.3- 3.8) 2.9 ( 2.6- 3.1) 3.6 ( 2.5- 4.9) 5.0 ( 4.2- 5.9)
Alaska ∼ ∼ ∼ ∼
California 3.7 ( 3.4- 4.0) 3.0 ( 2.7- 3.3) 3.8 ( 2.7- 5.2) 5.0 ( 4.2- 5.9)
San Francisco-Oakland 4.7 ( 3.8- 5.7) 3.2 ( 2.3- 4.3) ∼ ∼
San Jose-Monterey 3.6 ( 2.6- 4.9) 2.5 ( 1.6- 3.8) ∼ ∼
Los Angeles 3.7 ( 3.1- 4.3) 3.3 ( 2.7- 3.9) 3.3 ( 1.9- 5.5) 4.3 ( 3.2- 5.7)
Hawaii 5.1 ( 3.6- 7.1) ∼ ∼ -
Oregon 2.8 ( 2.1- 3.7) 2.5 ( 1.9- 3.4) ∼ ∼
Washington 2.8 ( 2.3- 3.5) 2.5 ( 1.9- 3.1) ∼ ∼
Seattle-Puget Sound 3.0 ( 2.3- 3.8) 2.5 ( 1.8- 3.3) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.14.1.2M: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 7.4 ( 7.2- 7.5) 6.7 ( 6.6- 6.9) 10.3 ( 9.7- 10.9) 11.0 ( 10.2- 11.7)
Northeast 7.2 ( 6.9- 7.6) 6.6 ( 6.3- 6.9) 11.2 ( 9.8- 12.8) 10.1 ( 8.4- 12.2)
New England 6.8 ( 6.2- 7.4) 6.3 ( 5.7- 6.9) 13.2 ( 8.8- 19.7) 9.7 ( 5.6- 16.6)
Connecticut 6.7 ( 5.5- 8.1) 6.5 ( 5.3- 8.0) ∼ ∼
Maine 5.1 ( 3.5- 7.2) 5.0 ( 3.5- 7.1) ∼ ∼
Massachusetts 7.2 ( 6.3- 8.3) 6.4 ( 5.4- 7.4) 17.3 ( 10.1- 28.7) ∼
New Hampshire 5.9 ( 4.1- 8.4) 5.8 ( 4.0- 8.3) ∼ ∼
Rhode Island 8.0 ( 5.8- 10.9) 7.5 ( 5.3- 10.4) ∼ ∼
Vermont 6.1 ( 3.6- 9.8) 6.1 ( 3.6- 9.9) ∼ ∼
Middle Atlantic 7.4 ( 7.0- 7.8) 6.7 ( 6.3- 7.1) 10.9 ( 9.5- 12.6) 10.2 ( 8.3- 12.5)
New Jersey 7.8 ( 6.9- 8.7) 7.2 ( 6.3- 8.2) 12.3 ( 8.8- 17.1) 6.4 ( 3.6- 11.2)
New York 7.2 ( 6.6- 7.8) 6.4 ( 5.9- 7.1) 9.2 ( 7.5- 11.4) 11.2 ( 8.8- 14.3)
Pennsylvania 7.4 ( 6.8- 8.1) 6.8 ( 6.1- 7.5) 14.2 ( 10.9- 18.4) ∼
Midwest 6.6 ( 6.3- 6.9) 6.0 ( 5.7- 6.3) 12.2 ( 10.7- 13.9) 10.1 ( 7.7- 13.4)
East North Central 6.9 ( 6.5- 7.3) 6.3 ( 5.9- 6.7) 11.2 ( 9.6- 12.9) 10.8 ( 8.0- 14.6)
Illinois 7.6 ( 6.9- 8.4) 7.1 ( 6.3- 7.9) 9.8 ( 7.4- 12.9) 9.0 ( 6.0- 14.0)
Indiana 6.1 ( 5.2- 7.2) 5.8 ( 4.9- 6.9) 10.5 ( 6.1- 17.4) ∼
Michigan 7.2 ( 6.4- 8.0) 6.3 ( 5.5- 7.2) 12.6 ( 9.6- 16.5) ∼
Ohio 6.4 ( 5.7- 7.1) 5.7 ( 5.1- 6.5) 12.2 ( 9.1- 16.1) ∼
Wisconsin 6.8 ( 5.8- 7.9) 6.5 ( 5.5- 7.6) ∼ ∼
West North Central 6.1 ( 5.6- 6.6) 5.4 ( 4.9- 5.9) 18.2 ( 13.7- 24.2) ∼
Iowa 5.1 ( 4.0- 6.4) 4.9 ( 3.8- 6.2) ∼ ∼
Kansas 5.2 ( 4.0- 6.7) 5.1 ( 3.9- 6.6) ∼ ∼
Minnesota 6.9 ( 5.8- 8.1) 5.9 ( 4.9- 7.1) ∼ ∼
Missouri 6.9 ( 5.9- 8.0) 5.6 ( 4.7- 6.6) 21.7 ( 15.4- 30.2) ∼
Nebraska 5.3 ( 3.9- 7.2) 4.8 ( 3.4- 6.7) ∼ ∼
North Dakota 6.5 ( 3.9- 10.1) 6.0 ( 3.5- 9.6) ∼ ∼
South Dakota 5.0 ( 3.0- 7.9) 5.0 ( 2.9- 8.0) ∼ ∼
South 7.5 ( 7.3- 7.8) 7.1 ( 6.9- 7.4) 9.0 ( 8.2- 9.8) 10.7 ( 9.6- 12.0)
South Atlantic 6.9 ( 6.6- 7.3) 6.5 ( 6.2- 6.9) 8.2 ( 7.2- 9.2) 7.0 ( 5.6- 8.6)
Delaware 6.7 ( 4.4- 10.1) 5.7 ( 3.3- 9.2) ∼ ∼
District of Columbia 8.2 ( 5.0- 13.0) ∼ ∼ ∼
Florida 7.4 ( 6.9- 8.0) 7.3 ( 6.7- 7.9) 8.7 ( 6.6- 11.4) 7.6 ( 6.0- 9.5)
Georgia 6.5 ( 5.6- 7.5) 6.1 ( 5.1- 7.2) 7.2 ( 5.1- 10.1) ∼
Maryland 7.5 ( 6.4- 8.7) 5.9 ( 4.8- 7.2) 11.5 ( 8.5- 15.5) ∼
North Carolina 6.7 ( 5.8- 7.6) 6.5 ( 5.6- 7.5) 7.3 ( 5.2- 10.1) ∼
South Carolina 7.0 ( 5.8- 8.3) 7.0 ( 5.7- 8.6) 6.0 ( 3.8- 9.2) ∼
Virginia 6.4 ( 5.5- 7.4) 5.3 ( 4.5- 6.4) 9.0 ( 6.4- 12.5) ∼
West Virginia 6.4 ( 4.8- 8.5) 6.4 ( 4.8- 8.5) ∼ ∼
East South Central 7.9 ( 7.2- 8.6) 7.4 ( 6.7- 8.1) 9.9 ( 8.0- 12.1) ∼
Alabama 7.8 ( 6.6- 9.2) 7.4 ( 6.1- 9.0) 9.0 ( 6.2- 12.8) ∼
Kentucky 7.5 ( 6.2- 9.0) 7.2 ( 5.9- 8.7) ∼ ∼
Mississippi 10.5 ( 8.6- 12.6) 9.7 ( 7.6- 12.2) 11.6 ( 8.0- 16.4) ∼
Tennessee 7.0 ( 6.0- 8.1) 6.6 ( 5.5- 7.8) 9.3 ( 5.9- 14.2) ∼
West South Central 8.6 ( 8.1- 9.1) 8.2 ( 7.7- 8.8) 10.3 ( 8.7- 12.2) 14.0 ( 12.2- 16.1)
Arkansas 6.6 ( 5.3- 8.2) 6.5 ( 5.1- 8.2) ∼ ∼
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Table 2.14.1.2M: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 10.2 ( 8.8- 11.8) 10.4 ( 8.7- 12.3) 10.0 ( 7.3- 13.6) ∼
Oklahoma 6.3 ( 5.1- 7.7) 6.1 ( 4.8- 7.6) ∼ ∼
Texas 9.0 ( 8.3- 9.7) 8.5 ( 7.8- 9.2) 11.3 ( 9.1- 14.2) 14.5 ( 12.6- 16.6)
West 8.0 ( 7.7- 8.4) 7.0 ( 6.6- 7.3) 12.4 ( 10.3- 14.9) 11.6 ( 10.4- 12.9)
Mountain 6.7 ( 6.2- 7.3) 6.4 ( 5.8- 7.0) 10.0 ( 6.2- 17.0) 12.4 ( 10.1- 15.3)
Arizona 7.3 ( 6.3- 8.5) 7.1 ( 6.1- 8.3) ∼ 15.6 ( 11.0- 22.2)
Colorado 7.1 ( 5.9- 8.5) 6.7 ( 5.5- 8.2) ∼ 15.0 ( 9.3- 23.6)
Idaho 4.3 ( 2.8- 6.5) 4.2 ( 2.7- 6.4) ∼ ∼
Montana 5.6 ( 3.7- 8.3) 5.1 ( 3.3- 7.8) ∼ ∼
Nevada 8.1 ( 6.3- 10.2) 8.0 ( 6.2- 10.3) ∼ ∼
New Mexico 7.9 ( 6.2- 10.1) 7.8 ( 6.0- 10.1) ∼ 10.6 ( 7.2- 15.5)
Utah 3.7 ( 2.5- 5.4) 3.1 ( 2.0- 4.7) ∼ ∼
Wyoming 6.4 ( 3.6- 11.0) ∼ ∼ ∼
Pacific 8.6 ( 8.2- 9.1) 7.3 ( 6.9- 7.7) 12.8 ( 10.4- 15.6) 11.3 ( 9.9- 12.8)
Alaska 11.2 ( 6.0- 20.1) ∼ ∼ ∼
California 9.1 ( 8.6- 9.6) 7.8 ( 7.3- 8.3) 12.6 ( 10.2- 15.6) 11.6 ( 10.2- 13.1)
Hawaii 9.9 ( 7.5- 12.8) ∼ ∼ ∼
Oregon 6.4 ( 5.2- 7.7) 5.7 ( 4.6- 6.9) ∼ ∼
Washington 7.2 ( 6.2- 8.4) 6.2 ( 5.3- 7.3) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.14.1.2F: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 3.1 ( 3.0- 3.2) 2.8 ( 2.8- 2.9) 4.0 ( 3.7- 4.3) 5.2 ( 4.7- 5.7)
Northeast 2.9 ( 2.7- 3.1) 2.7 ( 2.5- 2.9) 3.4 ( 2.8- 4.1) 4.1 ( 3.1- 5.2)
New England 2.6 ( 2.3- 3.0) 2.6 ( 2.2- 2.9) ∼ ∼
Connecticut 2.8 ( 2.2- 3.6) 2.9 ( 2.2- 3.8) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.6 ( 2.1- 3.2) 2.4 ( 1.9- 2.9) ∼ ∼
New Hampshire 2.4 ( 1.4- 4.0) 2.2 ( 1.2- 3.7) ∼ ∼
Rhode Island 4.2 ( 2.8- 6.2) 4.4 ( 3.0- 6.6) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.0 ( 2.7- 3.2) 2.8 ( 2.6- 3.0) 3.4 ( 2.8- 4.2) 4.0 ( 3.0- 5.2)
New Jersey 3.0 ( 2.6- 3.5) 3.0 ( 2.6- 3.6) ∼ ∼
New York 2.9 ( 2.6- 3.2) 2.7 ( 2.4- 3.1) 3.0 ( 2.2- 4.0) 4.4 ( 3.1- 5.9)
Pennsylvania 3.0 ( 2.6- 3.4) 2.7 ( 2.3- 3.1) 5.6 ( 3.9- 7.8) ∼
Midwest 2.8 ( 2.6- 3.0) 2.6 ( 2.4- 2.8) 4.2 ( 3.4- 5.0) 5.3 ( 3.6- 7.6)
East North Central 2.9 ( 2.7- 3.1) 2.7 ( 2.5- 2.9) 3.8 ( 3.1- 4.7) 5.4 ( 3.5- 8.1)
Illinois 3.0 ( 2.7- 3.5) 2.8 ( 2.4- 3.3) 4.0 ( 2.8- 5.7) ∼
Indiana 3.0 ( 2.5- 3.7) 2.8 ( 2.3- 3.5) ∼ ∼
Michigan 3.0 ( 2.6- 3.5) 2.8 ( 2.4- 3.3) 3.6 ( 2.3- 5.3) ∼
Ohio 2.5 ( 2.2- 3.0) 2.5 ( 2.1- 2.9) 2.8 ( 1.6- 4.4) ∼
Wisconsin 2.7 ( 2.2- 3.4) 2.5 ( 2.0- 3.2) ∼ ∼
West North Central 2.6 ( 2.3- 2.9) 2.4 ( 2.1- 2.7) 5.9 ( 3.8- 8.7) ∼
Iowa 2.1 ( 1.5- 2.9) 2.0 ( 1.4- 2.9) ∼ ∼
Kansas 2.6 ( 1.9- 3.6) 2.6 ( 1.9- 3.7) ∼ ∼
Minnesota 2.5 ( 1.9- 3.1) 2.2 ( 1.7- 2.9) ∼ ∼
Missouri 3.1 ( 2.6- 3.8) 2.8 ( 2.2- 3.5) 6.7 ( 4.0- 10.5) ∼
Nebraska 2.1 ( 1.3- 3.2) 1.9 ( 1.1- 3.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 3.2 ( 3.1- 3.4) 3.0 ( 2.8- 3.1) 4.1 ( 3.7- 4.6) 5.3 ( 4.6- 6.1)
South Atlantic 2.8 ( 2.6- 3.0) 2.6 ( 2.4- 2.8) 3.7 ( 3.1- 4.2) 4.0 ( 3.1- 5.0)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.8 ( 2.5- 3.1) 2.7 ( 2.4- 3.0) 3.9 ( 2.7- 5.4) 3.9 ( 3.0- 5.1)
Georgia 2.9 ( 2.4- 3.5) 2.6 ( 2.1- 3.2) 3.8 ( 2.6- 5.3) ∼
Maryland 2.9 ( 2.3- 3.6) 2.3 ( 1.7- 3.0) 3.8 ( 2.5- 5.7) ∼
North Carolina 2.8 ( 2.3- 3.3) 2.5 ( 2.0- 3.1) 3.3 ( 2.2- 4.8) ∼
South Carolina 3.1 ( 2.4- 3.9) 2.5 ( 1.8- 3.3) 4.7 ( 3.1- 6.9) ∼
Virginia 2.8 ( 2.3- 3.4) 2.5 ( 2.0- 3.2) 3.4 ( 2.1- 5.1) ∼
West Virginia 2.9 ( 2.0- 4.1) 2.8 ( 2.0- 4.0) ∼ ∼
East South Central 3.4 ( 3.0- 3.7) 2.9 ( 2.6- 3.3) 5.2 ( 4.1- 6.4) ∼
Alabama 3.3 ( 2.6- 4.0) 2.4 ( 1.8- 3.1) 6.3 ( 4.4- 8.8) ∼
Kentucky 2.8 ( 2.2- 3.6) 2.8 ( 2.2- 3.6) ∼ ∼
Mississippi 4.3 ( 3.3- 5.5) 3.9 ( 2.8- 5.3) 5.0 ( 3.2- 7.6) ∼
Tennessee 3.3 ( 2.8- 4.0) 3.0 ( 2.4- 3.7) 4.2 ( 2.5- 6.8) ∼
West South Central 3.9 ( 3.6- 4.2) 3.8 ( 3.4- 4.1) 4.4 ( 3.5- 5.4) 6.6 ( 5.5- 7.8)
Arkansas 3.8 ( 2.9- 4.8) 3.8 ( 2.9- 5.0) ∼ ∼
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Table 2.14.1.2F: Liver and Intrahepatic Bile Duct. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.4 ( 2.7- 4.2) 3.1 ( 2.4- 4.1) 3.6 ( 2.3- 5.5) ∼
Oklahoma 3.0 ( 2.3- 3.8) 2.9 ( 2.1- 3.8) ∼ ∼
Texas 4.3 ( 3.9- 4.7) 4.0 ( 3.6- 4.5) 5.4 ( 4.1- 7.1) 6.8 ( 5.7- 8.1)
West 3.5 ( 3.3- 3.7) 3.0 ( 2.8- 3.3) 4.6 ( 3.5- 6.0) 5.4 ( 4.7- 6.2)
Mountain 2.7 ( 2.4- 3.1) 2.5 ( 2.2- 2.9) ∼ 5.1 ( 3.8- 6.9)
Arizona 2.7 ( 2.1- 3.3) 2.4 ( 1.9- 3.1) ∼ 5.8 ( 3.4- 9.5)
Colorado 2.9 ( 2.2- 3.7) 2.5 ( 1.8- 3.3) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.1 ( 1.3- 3.2) 1.9 ( 1.1- 3.0) ∼ ∼
New Mexico 4.2 ( 3.0- 5.7) 4.4 ( 3.1- 6.0) ∼ 6.4 ( 3.9- 10.0)
Utah 3.1 ( 2.1- 4.5) 3.0 ( 2.0- 4.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.9 ( 3.6- 4.1) 3.3 ( 3.0- 3.6) 5.1 ( 3.8- 6.6) 5.5 ( 4.7- 6.5)
Alaska ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 3.3 ( 3.0- 3.6) 5.3 ( 4.0- 6.9) 5.5 ( 4.7- 6.5)
Hawaii 4.1 ( 2.8- 6.0) ∼ ∼ ∼
Oregon 3.1 ( 2.3- 4.0) 2.9 ( 2.2- 3.9) ∼ ∼
Washington 3.6 ( 3.0- 4.4) 3.4 ( 2.8- 4.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.15.1.1M: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 86.8 ( 86.3- 87.3) 85.8 ( 85.3- 86.4) 106.1 (104.1- 108.2) 48.6 ( 47.0- 50.3)
Northeast 83.4 ( 82.3- 84.6) 83.8 ( 82.6- 85.0) 85.9 ( 81.7- 90.2) 52.3 ( 48.0- 56.9)
New England 82.8 ( 80.6- 85.0) 83.4 ( 81.1- 85.7) 78.0 ( 66.5- 91.3) 48.2 ( 36.5- 62.9)
Connecticut 81.4 ( 77.1- 86.0) 81.2 ( 76.7- 85.9) 93.0 ( 74.3- 116.6) 48.2 ( 30.5- 73.7)
Maine 97.9 ( 90.4- 105.8) 98.3 ( 90.8- 106.3) ∼ ∼
Massachusetts 79.0 ( 75.8- 82.3) 80.2 ( 76.9- 83.7) 68.0 ( 52.7- 87.2) 29.2 ( 17.0- 48.3)
New Hampshire 77.2 ( 70.2- 84.9) 76.2 ( 69.1- 83.8) ∼ ∼
Rhode Island 91.6 ( 83.4- 100.5) 91.8 ( 83.3- 100.9) ∼ ∼
Vermont 90.1 ( 79.4- 101.9) 90.6 ( 79.8- 102.5) ∼ ∼
Middle Atlantic 83.7 ( 82.4- 85.0) 84.0 ( 82.6- 85.4) 86.8 ( 82.4- 91.4) 52.9 ( 48.3- 57.8)
New Jersey 80.5 ( 77.6- 83.4) 80.0 ( 77.0- 83.1) 95.8 ( 85.7- 107.0) 55.3 ( 46.1- 66.2)
New York 79.9 ( 78.0- 81.8) 81.8 ( 79.7- 83.9) 70.8 ( 65.5- 76.4) 51.8 ( 46.4- 57.9)
Pennsylvania 90.8 ( 88.5- 93.2) 88.9 ( 86.5- 91.4) 116.9 (106.5- 128.2) -
Midwest 91.7 ( 90.6- 92.8) 89.4 ( 88.3- 90.6) 122.2 (117.3- 127.2) 49.3 ( 43.3- 56.2)
East North Central 93.6 ( 92.3- 95.0) 90.8 ( 89.4- 92.2) 123.7 (118.3- 129.2) 49.0 ( 42.3- 56.8)
Illinois 92.4 ( 89.8- 95.1) 90.5 ( 87.7- 93.3) 114.5 (105.8- 123.8) -
Indiana 102.0 ( 98.2- 106.0) 100.4 ( 96.5- 104.5) 127.0 (109.8- 146.6) 57.4 ( 36.0- 90.7)
Michigan 96.5 ( 93.6- 99.5) 91.8 ( 88.8- 94.9) 140.9 (129.9- 152.7) 54.8 ( 37.7- 79.3)
Detroit 105.5 (100.6- 110.6) 97.7 ( 92.4- 103.2) 144.6 (131.7- 158.6) 66.0 ( 39.3- 109.6)
Ohio 93.3 ( 90.6- 95.9) 90.3 ( 87.6- 93.0) 111.3 (101.6- 121.8) 75.5 ( 51.9- 109.0)
Wisconsin 83.1 ( 79.5- 86.7) 80.7 ( 77.1- 84.4) 161.3 (130.0- 200.4) ∼
West North Central 87.4 ( 85.5- 89.4) 86.7 ( 84.7- 88.7) 114.2 (102.2- 127.6) 49.8 ( 36.4- 67.3)
Iowa 90.7 ( 85.8- 95.7) 90.2 ( 85.4- 95.3) 90.2 ( 50.8- 160.1) ∼
Kansas 88.6 ( 83.4- 94.1) 87.8 ( 82.4- 93.4) 113.3 ( 83.6- 151.2) 64.2 ( 36.7- 107.1)
Minnesota 71.8 ( 68.2- 75.4) 71.6 ( 68.1- 75.4) 87.3 ( 55.9- 135.9) ∼
Missouri 103.8 ( 99.9- 107.8) 103.1 ( 99.1- 107.3) 116.8 (101.7- 134.0) ∼
Nebraska 79.7 ( 73.6- 86.2) 77.9 ( 71.8- 84.4) 164.9 (106.9- 247.7) ∼
North Dakota 71.4 ( 62.4- 81.5) 72.1 ( 62.9- 82.4) ∼ ∼
South Dakota 78.8 ( 70.0- 88.4) 79.2 ( 70.3- 89.1) ∼ ∼
South
South Atlantic 92.8 ( 91.7- 94.1) 91.7 ( 90.4- 93.0) 103.6 (100.0- 107.2) 58.9 ( 54.8- 63.3)
Delaware 99.2 ( 89.3- 110.1) 92.5 ( 82.3- 103.9) 158.8 (122.5- 204.8) ∼
District of Columbia 84.5 ( 72.9- 97.5) 56.8 ( 41.0- 78.5) 102.8 ( 86.8- 121.2) ∼
Florida 89.9 ( 88.0- 91.8) 89.7 ( 87.7- 91.7) 97.3 ( 89.9- 105.2) -
Georgia 103.2 ( 99.5- 107.1) 102.5 ( 98.4- 106.9) 109.7 (101.0- 119.1) 41.4 ( 23.9- 68.6)
Atlanta 86.3 ( 79.7- 93.3) 81.4 ( 74.0- 89.5) 104.2 ( 89.3- 121.6) ∼
Maryland 83.6 ( 79.8- 87.6) 81.6 ( 77.4- 86.1) 97.1 ( 87.7- 107.4) 64.4 ( 40.5- 98.4)
North Carolina 94.5 ( 91.2- 97.8) 93.2 ( 89.7- 96.8) 101.0 ( 92.5- 110.2) 32.0 ( 17.3- 58.0)
South Carolina 101.6 ( 96.9- 106.4) 99.5 ( 94.3- 105.0) 108.6 ( 98.2- 119.9) -
Virginia 90.3 ( 86.8- 93.8) 89.0 ( 85.2- 92.9) 106.7 ( 97.2- 117.0) ∼
West Virginia 106.7 (100.2- 113.6) 106.4 ( 99.8- 113.4) 106.7 ( 67.6- 162.3) ∼
East South Central
Alabama 104.9 (100.4- 109.6) 106.7 (101.7- 111.9) 97.4 ( 87.5- 108.3) ∼
Kentucky 129.2 (123.9- 134.6) 129.5 (124.1- 135.1) 132.9 (110.2- 159.8) -
Mississippi 111.9 (105.9- 118.1) 104.7 ( 98.0- 111.8) 132.7 (119.8- 146.7) ∼
Tennessee
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Table 2.15.1.1M: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 96.1 ( 94.4- 97.8) 93.0 ( 91.1- 94.8) 127.2 (120.9- 133.7) 49.0 ( 45.4- 52.8)
Arkansas 111.5 (105.8- 117.4) 110.7 (104.7- 117.0) 115.7 ( 97.5- 136.6) ∼
Louisiana 108.9 (104.1- 113.9) 105.0 ( 99.6- 110.7) 124.5 (113.9- 136.0) 60.7 ( 35.8- 101.0)
Oklahoma 106.0 (101.0- 111.2) 105.6 (100.3- 111.2) 106.6 ( 83.6- 134.9) 76.8 ( 44.0- 130.6)
Texas 89.0 ( 86.9- 91.1) 85.4 ( 83.2- 87.6) 134.6 (125.6- 144.2) 48.5 ( 44.9- 52.4)
West 67.8 ( 66.7- 68.8) 68.0 ( 66.8- 69.1) 89.6 ( 83.5- 96.2) 41.9 ( 39.4- 44.5)
Mountain
Arizona
Colorado 63.1 ( 59.3- 67.2) 62.2 ( 58.2- 66.3) 92.5 ( 64.7- 132.3) 43.2 ( 33.6- 55.5)
Idaho 71.2 ( 64.4- 78.6) 71.8 ( 64.9- 79.3) ∼ ∼
Montana 78.8 ( 70.8- 87.6) 77.7 ( 69.7- 86.6) ∼ ∼
Nevada 83.0 ( 77.3- 89.2) 85.1 ( 79.0- 91.7) 62.7 ( 42.9- 94.2) 37.7 ( 24.6- 58.8)
New Mexico 52.5 ( 47.6- 57.8) 54.3 ( 49.2- 60.0) ∼ 41.1 ( 33.4- 50.3)
Utah 40.7 ( 36.3- 45.6) 40.6 ( 36.1- 45.6) ∼ 64.1 ( 36.0- 110.9)
Wyoming
Pacific 68.8 ( 67.6- 70.0) 69.2 ( 67.8- 70.5) 91.3 ( 84.7- 98.4) 41.6 ( 38.8- 44.5)
Alaska 90.8 ( 76.1- 108.5) 88.1 ( 72.0- 108.2) ∼ ∼
California 65.4 ( 64.0- 66.8) 65.3 ( 63.8- 66.9) 92.0 ( 85.0- 99.5) 40.8 ( 38.0- 43.8)
San Francisco-Oakland 65.1 ( 61.4- 69.0) 61.0 ( 56.7- 65.6) 105.8 ( 89.7- 124.3) 42.6 ( 32.4- 55.4)
San Jose-Monterey 57.6 ( 52.6- 63.0) 58.3 ( 52.6- 64.4) ∼ 41.2 ( 30.2- 55.8)
Los Angeles 58.3 ( 55.7- 60.9) 56.6 ( 53.7- 59.6) 90.6 ( 80.4- 102.0) 39.4 ( 34.9- 44.3)
Hawaii 68.3 ( 61.8- 75.3) 79.5 ( 65.8- 95.8) ∼ -
Oregon 77.4 ( 73.2- 81.8) 77.1 ( 72.8- 81.6) 128.3 ( 78.9- 204.9) 79.5 ( 49.7- 122.8)
Washington 80.5 ( 77.0- 84.1) 80.5 ( 76.9- 84.3) 81.4 ( 58.6- 112.8) 46.3 ( 29.5- 70.9)
Seattle-Puget Sound 83.0 ( 78.7- 87.6) 84.1 ( 79.5- 88.9) 80.9 ( 57.0- 115.0) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.15.1.1F: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 54.3 ( 54.0- 54.7) 55.7 ( 55.3- 56.1) 50.4 ( 49.3- 51.6) 26.2 ( 25.2- 27.2)
Northeast 55.2 ( 54.4- 56.0) 56.7 ( 55.8- 57.6) 47.9 ( 45.5- 50.4) 26.2 ( 23.8- 28.7)
New England 59.9 ( 58.3- 61.6) 60.7 ( 59.0- 62.4) 47.2 ( 40.0- 55.4) 37.0 ( 29.1- 46.6)
Connecticut 58.4 ( 55.1- 61.8) 59.4 ( 56.0- 63.0) 47.7 ( 37.0- 60.7) 38.8 ( 26.1- 56.0)
Maine 62.7 ( 57.5- 68.5) 62.4 ( 57.1- 68.1) ∼ ∼
Massachusetts 61.5 ( 59.0- 64.1) 62.7 ( 60.1- 65.4) 45.5 ( 35.6- 57.4) 30.2 ( 20.1- 44.3)
New Hampshire 58.6 ( 53.0- 64.6) 58.1 ( 52.6- 64.1) ∼ ∼
Rhode Island 59.1 ( 53.2- 65.4) 59.6 ( 53.6- 66.3) ∼ ∼
Vermont 51.7 ( 44.5- 59.9) 52.2 ( 45.0- 60.5) ∼ ∼
Middle Atlantic 53.6 ( 52.7- 54.6) 55.2 ( 54.2- 56.2) 48.0 ( 45.5- 50.6) 24.7 ( 22.2- 27.4)
New Jersey 55.3 ( 53.3- 57.4) 57.3 ( 55.1- 59.7) 50.5 ( 44.8- 56.8) 26.6 ( 21.5- 32.6)
New York 52.6 ( 51.3- 53.9) 56.1 ( 54.5- 57.6) 40.0 ( 37.0- 43.1) 23.3 ( 20.5- 26.4)
Pennsylvania 54.2 ( 52.6- 55.8) 53.0 ( 51.3- 54.7) 67.5 ( 61.3- 74.2) -
Midwest 56.6 ( 55.9- 57.4) 56.0 ( 55.2- 56.8) 64.4 ( 61.5- 67.4) 30.0 ( 25.8- 34.7)
East North Central 57.9 ( 56.9- 58.8) 57.3 ( 56.4- 58.3) 63.7 ( 60.6- 66.9) 30.2 ( 25.6- 35.6)
Illinois 57.3 ( 55.5- 59.1) 57.7 ( 55.8- 59.7) 62.1 ( 56.9- 67.6) -
Indiana 62.5 ( 59.9- 65.2) 62.6 ( 59.8- 65.4) 59.5 ( 49.9- 70.5) 42.4 ( 25.1- 68.3)
Michigan 60.4 ( 58.4- 62.5) 59.8 ( 57.6- 62.0) 64.2 ( 58.1- 70.7) 34.6 ( 22.5- 51.6)
Detroit 66.6 ( 63.2- 70.0) 69.5 ( 65.6- 73.5) 60.3 ( 53.5- 67.6) ∼
Ohio 56.1 ( 54.3- 57.9) 54.6 ( 52.8- 56.5) 65.4 ( 59.3- 72.0) 43.9 ( 28.1- 66.0)
Wisconsin 53.5 ( 51.0- 56.2) 52.6 ( 50.0- 55.4) 72.4 ( 56.7- 91.7) ∼
West North Central 53.8 ( 52.5- 55.2) 53.0 ( 51.6- 54.4) 68.3 ( 60.7- 76.6) 28.9 ( 20.3- 40.2)
Iowa 50.7 ( 47.5- 54.2) 50.5 ( 47.2- 54.0) ∼ ∼
Kansas 51.7 ( 48.1- 55.4) 50.8 ( 47.2- 54.7) 63.8 ( 45.3- 87.7) ∼
Minnesota 50.7 ( 48.0- 53.5) 50.1 ( 47.4- 52.9) 52.5 ( 31.8- 83.7) ∼
Missouri 62.0 ( 59.3- 64.7) 61.2 ( 58.4- 64.0) 73.0 ( 63.4- 83.6) ∼
Nebraska 49.9 ( 45.5- 54.6) 50.0 ( 45.6- 54.8) ∼ ∼
North Dakota 49.6 ( 42.7- 57.5) 45.4 ( 38.7- 53.1) ∼ ∼
South Dakota 44.4 ( 38.4- 51.2) 44.6 ( 38.5- 51.6) ∼ ∼
South
South Atlantic 56.5 ( 55.7- 57.3) 59.1 ( 58.2- 60.0) 44.9 ( 43.1- 46.8) 28.1 ( 25.7- 30.7)
Delaware 71.7 ( 64.3- 79.8) 72.2 ( 64.1- 81.2) 74.5 ( 55.1- 99.1) ∼
District of Columbia 50.0 ( 42.5- 58.7) 44.6 ( 31.9- 63.2) 53.4 ( 44.1- 64.7) ∼
Florida 59.6 ( 58.2- 61.1) 61.9 ( 60.4- 63.5) 39.9 ( 36.1- 44.1) -
Georgia 53.0 ( 50.8- 55.3) 56.7 ( 54.1- 59.5) 42.7 ( 38.5- 47.1) 23.0 ( 12.5- 39.8)
Atlanta 47.4 ( 43.5- 51.6) 50.3 ( 45.5- 55.6) 42.6 ( 35.7- 50.7) ∼
Maryland 58.0 ( 55.3- 60.9) 60.9 ( 57.6- 64.3) 52.8 ( 47.4- 58.7) 26.5 ( 14.9- 44.1)
North Carolina 53.7 ( 51.6- 55.9) 56.7 ( 54.3- 59.2) 41.4 ( 37.2- 46.0) 32.0 ( 17.5- 55.0)
South Carolina 52.2 ( 49.3- 55.2) 56.1 ( 52.7- 59.7) 40.5 ( 35.4- 46.1) -
Virginia 53.0 ( 50.7- 55.3) 54.0 ( 51.5- 56.7) 50.9 ( 45.6- 56.7) 26.2 ( 15.0- 43.3)
West Virginia 62.6 ( 58.2- 67.3) 63.2 ( 58.7- 68.0) ∼ ∼
East South Central
Alabama 49.8 ( 47.2- 52.6) 54.9 ( 51.7- 58.2) 31.8 ( 27.3- 36.8) ∼
Kentucky 74.1 ( 70.6- 77.6) 73.5 ( 69.9- 77.2) 88.3 ( 72.9- 106.1) -
Mississippi 52.3 ( 48.8- 56.0) 55.7 ( 51.5- 60.3) 43.9 ( 38.0- 50.6) ∼
Tennessee
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Table 2.15.1.1F: Lung and Bronchus. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 53.2 ( 52.1- 54.3) 53.8 ( 52.6- 55.0) 50.2 ( 47.1- 53.5) 23.9 ( 21.8- 26.1)
Arkansas 54.6 ( 51.1- 58.3) 56.7 ( 52.9- 60.8) 37.6 ( 29.2- 47.8) ∼
Louisiana 57.6 ( 54.6- 60.7) 60.9 ( 57.3- 64.7) 49.6 ( 44.3- 55.5) ∼
Oklahoma 62.2 ( 58.8- 65.7) 61.3 ( 57.7- 65.1) 70.9 ( 55.6- 89.4) ∼
Texas 50.3 ( 48.9- 51.7) 50.6 ( 49.1- 52.1) 51.1 ( 46.7- 55.8) 23.8 ( 21.6- 26.1)
West 48.2 ( 47.4- 49.0) 50.5 ( 49.6- 51.4) 53.9 ( 49.9- 58.2) 25.7 ( 24.1- 27.5)
Mountain
Arizona
Colorado 45.6 ( 42.7- 48.6) 46.3 ( 43.4- 49.5) 30.6 ( 18.0- 49.3) 37.3 ( 29.0- 47.4)
Idaho 48.6 ( 43.5- 54.2) 48.4 ( 43.2- 54.0) ∼ ∼
Montana 53.0 ( 47.0- 59.6) 52.2 ( 46.2- 59.0) ∼ ∼
Nevada 71.4 ( 66.5- 76.6) 74.6 ( 69.3- 80.3) 66.0 ( 46.9- 91.3) 40.1 ( 27.1- 57.9)
New Mexico 34.9 ( 31.3- 38.8) 37.2 ( 33.3- 41.4) ∼ 21.0 ( 16.1- 26.9)
Utah 22.3 ( 19.3- 25.6) 22.3 ( 19.3- 25.7) ∼ ∼
Wyoming
Pacific 48.8 ( 48.0- 49.8) 51.7 ( 50.7- 52.7) 54.9 ( 50.6- 59.5) 24.9 ( 23.1- 26.8)
Alaska 57.0 ( 46.7- 69.1) 53.8 ( 42.2- 67.8) ∼ ∼
California 46.0 ( 45.0- 47.0) 48.5 ( 47.4- 49.7) 54.6 ( 50.1- 59.3) 24.2 ( 22.4- 26.1)
San Francisco-Oakland 48.0 ( 45.2- 51.0) 52.1 ( 48.5- 55.9) 62.4 ( 52.2- 74.2) 19.9 ( 14.5- 26.9)
San Jose-Monterey 42.6 ( 38.9- 46.6) 47.8 ( 43.3- 52.7) ∼ 22.5 ( 15.6- 31.5)
Los Angeles 38.8 ( 37.0- 40.7) 40.2 ( 38.0- 42.4) 50.9 ( 44.7- 57.8) 18.6 ( 16.1- 21.3)
Hawaii 37.3 ( 33.0- 42.0) 49.8 ( 39.8- 62.3) ∼ -
Oregon 59.0 ( 55.7- 62.6) 58.9 ( 55.5- 62.5) ∼ 60.8 ( 38.2- 93.1)
Washington 60.6 ( 57.9- 63.4) 62.5 ( 59.6- 65.5) 57.8 ( 39.7- 81.8) 31.5 ( 19.1- 49.9)
Seattle-Puget Sound 61.3 ( 58.0- 64.8) 65.1 ( 61.4- 68.9) 42.6 ( 26.6- 65.1) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.15.1.2M: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 71.9 ( 71.4- 72.4) 71.2 ( 70.7- 71.7) 93.1 ( 91.2- 95.0) 34.8 ( 33.4- 36.2)
Northeast 66.2 ( 65.2- 67.2) 66.5 ( 65.4- 67.6) 74.6 ( 70.7- 78.7) 33.4 ( 30.0- 37.1)
New England 67.0 ( 65.0- 69.0) 67.3 ( 65.3- 69.4) 68.0 ( 57.1- 80.8) 26.5 ( 18.8- 36.9)
Connecticut 61.2 ( 57.4- 65.2) 61.7 ( 57.8- 65.9) 62.3 ( 47.0- 82.6) 39.4 ( 24.2- 62.4)
Maine 79.5 ( 72.7- 86.8) 79.2 ( 72.5- 86.5) ∼ ∼
Massachusetts 67.1 ( 64.2- 70.2) 67.3 ( 64.2- 70.4) 70.2 ( 54.5- 89.7) 19.5 ( 11.0- 34.4)
New Hampshire 66.8 ( 60.1- 74.0) 67.1 ( 60.4- 74.4) ∼ ∼
Rhode Island 73.2 ( 65.8- 81.2) 73.9 ( 66.4- 82.2) ∼ ∼
Vermont 58.8 ( 50.2- 68.6) 59.4 ( 50.7- 69.2) ∼ ∼
Middle Atlantic 65.9 ( 64.8- 67.1) 66.2 ( 64.9- 67.5) 75.3 ( 71.2- 79.7) 34.3 ( 30.6- 38.4)
New Jersey 65.7 ( 63.2- 68.4) 65.5 ( 62.7- 68.3) 86.7 ( 76.8- 97.7) 32.9 ( 26.0- 41.6)
New York 60.8 ( 59.2- 62.5) 62.2 ( 60.3- 64.1) 59.9 ( 55.1- 65.2) 34.7 ( 30.2- 39.8)
Pennsylvania 72.9 ( 70.7- 75.0) 71.4 ( 69.3- 73.6) 101.3 ( 91.6- 111.9) 34.5 ( 21.7- 53.2)
Midwest 75.0 ( 74.0- 76.0) 73.5 ( 72.4- 74.5) 103.1 ( 98.6- 107.8) 30.4 ( 25.5- 36.1)
East North Central 76.8 ( 75.6- 78.1) 75.1 ( 73.8- 76.4) 103.6 ( 98.7- 108.8) 29.8 ( 24.4- 36.2)
Illinois 74.3 ( 71.9- 76.7) 72.3 ( 69.8- 74.9) 98.5 ( 90.4- 107.3) 24.0 ( 17.9- 32.0)
Indiana 87.8 ( 84.2- 91.5) 86.8 ( 83.1- 90.6) 112.0 ( 95.7- 130.7) ∼
Michigan 73.5 ( 70.9- 76.1) 71.2 ( 68.5- 73.9) 99.8 ( 90.4- 110.0) 50.5 ( 32.8- 76.0)
Ohio 82.9 ( 80.4- 85.4) 81.2 ( 78.6- 83.8) 107.7 ( 98.0- 118.3) 42.4 ( 24.1- 71.8)
Wisconsin 63.9 ( 60.8- 67.2) 62.6 ( 59.5- 65.9) 137.3 (105.7- 177.5) ∼
West North Central 70.9 ( 69.2- 72.7) 70.1 ( 68.3- 71.9) 100.5 ( 89.0- 113.3) 33.1 ( 22.1- 48.3)
Iowa 71.2 ( 66.9- 75.7) 70.9 ( 66.6- 75.4) 105.5 ( 58.4- 184.3) ∼
Kansas 72.8 ( 68.1- 77.8) 73.6 ( 68.7- 78.7) 65.1 ( 43.0- 95.8) ∼
Minnesota 59.3 ( 56.0- 62.7) 58.9 ( 55.6- 62.3) 77.8 ( 47.6- 125.7) ∼
Missouri 84.1 ( 80.6- 87.8) 83.2 ( 79.6- 87.0) 103.6 ( 89.2- 120.1) ∼
Nebraska 64.7 ( 59.2- 70.5) 61.2 ( 55.8- 67.1) 213.4 (145.9- 305.8) ∼
North Dakota 54.2 ( 46.4- 63.1) 54.7 ( 46.7- 63.7) ∼ ∼
South Dakota 66.4 ( 58.4- 75.3) 65.6 ( 57.4- 74.6) ∼ ∼
South 81.8 ( 81.0- 82.7) 80.2 ( 79.3- 81.2) 98.6 ( 95.9- 101.3) 37.2 ( 34.9- 39.6)
South Atlantic 76.9 ( 75.8- 78.0) 75.5 ( 74.4- 76.7) 90.3 ( 87.0- 93.8) 38.4 ( 35.0- 42.0)
Delaware 81.6 ( 72.6- 91.5) 78.4 ( 68.9- 88.9) 110.8 ( 81.2- 150.1) ∼
District of Columbia 73.4 ( 62.5- 85.8) 56.1 ( 39.8- 78.3) 87.0 ( 72.3- 104.2) ∼
Florida 70.0 ( 68.4- 71.7) 70.2 ( 68.5- 72.0) 73.3 ( 66.9- 80.4) 41.7 ( 37.9- 45.8)
Georgia 84.8 ( 81.4- 88.4) 83.0 ( 79.2- 87.0) 96.0 ( 87.6- 105.1) ∼
Maryland 74.8 ( 71.1- 78.5) 71.7 ( 67.6- 75.9) 92.5 ( 83.2- 102.7) ∼
North Carolina 82.3 ( 79.2- 85.4) 80.8 ( 77.5- 84.2) 93.8 ( 85.5- 102.7) ∼
South Carolina 89.7 ( 85.2- 94.3) 86.3 ( 81.4- 91.4) 104.3 ( 93.9- 115.7) ∼
Virginia 77.3 ( 74.1- 80.6) 75.9 ( 72.5- 79.6) 93.4 ( 84.4- 103.2) 34.1 ( 18.7- 59.5)
West Virginia 90.9 ( 84.8- 97.3) 91.5 ( 85.4- 98.1) 75.8 ( 43.5- 125.0) ∼
East South Central 101.2 ( 98.8- 103.5) 100.4 ( 98.0- 103.0) 109.0 (102.5- 115.8) ∼
Alabama 97.1 ( 92.8- 101.7) 97.2 ( 92.3- 102.3) 99.1 ( 89.0- 110.1) ∼
Kentucky 111.2 (106.3- 116.4) 111.1 (106.0- 116.4) 121.2 ( 99.5- 147.3) ∼
Mississippi 102.2 ( 96.4- 108.3) 98.6 ( 91.9- 105.6) 114.5 (102.4- 127.8) ∼
Tennessee 96.9 ( 93.0- 101.0) 95.6 ( 91.5- 99.9) 112.4 ( 99.5- 126.8) ∼
West South Central 80.3 ( 78.7- 81.9) 77.9 ( 76.2- 79.6) 112.0 (106.1- 118.2) 37.3 ( 34.1- 40.7)
Arkansas 96.4 ( 91.0- 102.0) 93.4 ( 87.8- 99.3) 126.6 (107.3- 148.6) ∼
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Table 2.15.1.2M: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 94.4 ( 89.8- 99.1) 89.3 ( 84.3- 94.7) 113.4 (103.2- 124.5) 51.0 ( 27.7- 90.2)
Oklahoma 85.4 ( 80.9- 90.2) 86.4 ( 81.6- 91.5) 103.3 ( 80.5- 131.4) ∼
Texas 73.6 ( 71.7- 75.6) 71.6 ( 69.6- 73.7) 110.2 (102.0- 119.1) 36.9 ( 33.7- 40.4)
West 57.5 ( 56.6- 58.5) 58.4 ( 57.4- 59.4) 79.8 ( 74.0- 86.0) 33.6 ( 31.4- 35.9)
Mountain 57.8 ( 56.1- 59.6) 58.5 ( 56.8- 60.3) 76.4 ( 62.3- 93.5) 44.3 ( 39.5- 49.7)
Arizona 61.6 ( 58.6- 64.8) 63.0 ( 59.8- 66.3) 77.6 ( 51.9- 113.7) 46.2 ( 37.4- 56.9)
Colorado 54.0 ( 50.4- 57.8) 53.8 ( 50.1- 57.7) 82.0 ( 55.5- 120.8) 46.5 ( 35.9- 59.8)
Idaho 55.5 ( 49.4- 62.1) 55.8 ( 49.7- 62.5) ∼ ∼
Montana 66.1 ( 58.7- 74.1) 66.0 ( 58.5- 74.2) ∼ ∼
Nevada 75.3 ( 69.7- 81.3) 77.8 ( 71.9- 84.2) 65.5 ( 45.2- 97.3) 32.5 ( 19.8- 53.5)
New Mexico 51.7 ( 46.8- 57.1) 53.3 ( 48.1- 58.9) ∼ 42.5 ( 34.4- 52.1)
Utah 33.7 ( 29.6- 38.3) 33.9 ( 29.7- 38.5) ∼ ∼
Wyoming 65.6 ( 55.2- 77.7) 65.8 ( 55.2- 78.0) ∼ ∼
Pacific 57.4 ( 56.3- 58.5) 58.3 ( 57.1- 59.6) 80.7 ( 74.3- 87.5) 29.8 ( 27.4- 32.3)
Alaska 78.3 ( 64.4- 95.4) 81.2 ( 65.4- 101.1) ∼ ∼
California 54.5 ( 53.2- 55.7) 54.8 ( 53.4- 56.2) 81.3 ( 74.6- 88.5) 29.3 ( 26.9- 31.9)
Hawaii 50.4 ( 44.8- 56.4) 57.6 ( 46.3- 71.5) ∼ ∼
Oregon 67.7 ( 63.7- 71.8) 68.4 ( 64.3- 72.6) 104.8 ( 59.1- 179.1) ∼
Washington 66.8 ( 63.6- 70.1) 67.4 ( 64.1- 70.9) 75.0 ( 51.4- 108.0) 30.2 ( 16.4- 52.4)
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.15.1.2F: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 41.2 ( 40.9- 41.6) 42.2 ( 41.9- 42.6) 40.3 ( 39.3- 41.3) 14.9 ( 14.2- 15.7)
Northeast 40.1 ( 39.5- 40.8) 41.3 ( 40.6- 42.1) 36.0 ( 34.0- 38.2) 13.8 ( 12.0- 15.7)
New England 44.0 ( 42.6- 45.4) 44.7 ( 43.3- 46.2) 36.9 ( 30.5- 44.3) 10.4 ( 6.5- 16.1)
Connecticut 41.0 ( 38.3- 43.8) 41.8 ( 39.0- 44.8) 32.0 ( 23.4- 42.8) ∼
Maine 49.9 ( 45.3- 55.0) 50.0 ( 45.4- 55.2) ∼ ∼
Massachusetts 45.7 ( 43.6- 47.9) 46.7 ( 44.5- 49.0) 41.1 ( 31.5- 52.9) ∼
New Hampshire 41.3 ( 36.7- 46.4) 41.5 ( 36.9- 46.6) ∼ ∼
Rhode Island 40.7 ( 35.9- 46.0) 41.4 ( 36.4- 46.9) ∼ ∼
Vermont 40.9 ( 34.5- 48.3) 41.3 ( 34.8- 48.8) ∼ ∼
Middle Atlantic 38.8 ( 38.0- 39.6) 40.0 ( 39.2- 40.9) 36.0 ( 33.8- 38.2) 14.2 ( 12.3- 16.3)
New Jersey 40.9 ( 39.2- 42.7) 41.8 ( 39.9- 43.8) 41.1 ( 35.9- 46.8) 13.8 ( 10.0- 18.6)
New York 37.4 ( 36.3- 38.5) 40.0 ( 38.7- 41.3) 30.0 ( 27.4- 32.8) 14.4 ( 12.1- 16.9)
Pennsylvania 39.6 ( 38.2- 40.9) 39.1 ( 37.7- 40.6) 46.9 ( 41.7- 52.6) 14.4 ( 7.9- 24.7)
Midwest 42.6 ( 42.0- 43.3) 42.3 ( 41.6- 43.0) 50.2 ( 47.7- 52.9) 13.4 ( 10.5- 16.8)
East North Central 43.8 ( 43.0- 44.6) 43.5 ( 42.7- 44.4) 50.1 ( 47.3- 53.0) 13.7 ( 10.5- 17.7)
Illinois 42.8 ( 41.2- 44.3) 42.8 ( 41.2- 44.5) 49.3 ( 44.7- 54.3) 11.7 ( 7.9- 17.0)
Indiana 50.0 ( 47.7- 52.4) 49.7 ( 47.3- 52.2) 57.3 ( 47.8- 68.1) ∼
Michigan 44.1 ( 42.4- 45.9) 43.7 ( 41.8- 45.6) 47.5 ( 42.2- 53.3) ∼
Ohio 44.9 ( 43.3- 46.5) 44.8 ( 43.1- 46.5) 49.4 ( 44.1- 55.2) 29.8 ( 16.9- 49.2)
Wisconsin 36.1 ( 34.0- 38.3) 35.4 ( 33.3- 37.6) 63.6 ( 48.2- 83.0) ∼
West North Central 40.0 ( 38.8- 41.1) 39.7 ( 38.5- 40.9) 51.0 ( 44.4- 58.3) 12.0 ( 6.6- 20.3)
Iowa 38.4 ( 35.6- 41.4) 38.7 ( 35.8- 41.7) ∼ ∼
Kansas 39.8 ( 36.7- 43.1) 39.8 ( 36.6- 43.2) 41.9 ( 27.0- 62.1) ∼
Minnesota 36.8 ( 34.6- 39.2) 36.9 ( 34.6- 39.3) 45.8 ( 26.2- 76.2) ∼
Missouri 45.9 ( 43.6- 48.2) 45.5 ( 43.2- 48.0) 53.1 ( 44.9- 62.2) ∼
Nebraska 35.5 ( 31.9- 39.4) 35.2 ( 31.5- 39.2) ∼ ∼
North Dakota 36.3 ( 30.5- 43.1) 34.5 ( 28.8- 41.3) ∼ ∼
South Dakota 33.8 ( 28.7- 39.7) 34.3 ( 29.0- 40.4) ∼ ∼
South 43.1 ( 42.6- 43.6) 44.4 ( 43.8- 45.0) 38.2 ( 36.9- 39.6) 14.5 ( 13.3- 15.8)
South Atlantic 42.7 ( 42.0- 43.4) 44.3 ( 43.5- 45.1) 36.7 ( 35.0- 38.4) 13.8 ( 12.2- 15.7)
Delaware 48.4 ( 42.4- 55.1) 49.2 ( 42.6- 56.7) 47.4 ( 32.0- 68.1) ∼
District of Columbia 37.0 ( 30.6- 44.7) 22.3 ( 13.6- 37.4) 44.2 ( 35.8- 54.7) ∼
Florida 42.1 ( 40.9- 43.3) 43.7 ( 42.4- 44.9) 29.7 ( 26.4- 33.3) 14.5 ( 12.6- 16.6)
Georgia 42.8 ( 40.8- 44.9) 46.1 ( 43.7- 48.6) 33.7 ( 30.0- 37.8) ∼
Maryland 44.8 ( 42.5- 47.3) 45.4 ( 42.7- 48.4) 46.1 ( 41.0- 51.8) ∼
North Carolina 41.3 ( 39.5- 43.2) 43.6 ( 41.5- 45.8) 32.6 ( 28.8- 36.7) ∼
South Carolina 41.7 ( 39.2- 44.4) 43.9 ( 40.9- 47.1) 34.8 ( 30.2- 40.1) ∼
Virginia 43.2 ( 41.2- 45.3) 43.5 ( 41.2- 45.9) 46.1 ( 41.1- 51.7) ∼
West Virginia 48.8 ( 45.0- 53.0) 49.3 ( 45.4- 53.5) ∼ ∼
East South Central 46.9 ( 45.5- 48.2) 48.8 ( 47.3- 50.3) 37.2 ( 34.2- 40.4) ∼
Alabama 42.2 ( 39.8- 44.8) 46.1 ( 43.2- 49.1) 28.7 ( 24.4- 33.5) ∼
Kentucky 55.4 ( 52.4- 58.5) 55.2 ( 52.1- 58.3) 62.7 ( 49.9- 77.8) ∼
Mississippi 42.0 ( 38.9- 45.3) 45.1 ( 41.3- 49.2) 33.5 ( 28.4- 39.4) ∼
Tennessee 47.0 ( 44.7- 49.4) 47.6 ( 45.1- 50.2) 45.0 ( 38.6- 52.1) ∼
West South Central 41.6 ( 40.6- 42.6) 42.0 ( 40.9- 43.1) 43.2 ( 40.2- 46.3) 15.2 ( 13.5- 17.1)
Arkansas 46.0 ( 42.9- 49.4) 48.7 ( 45.2- 52.4) 27.7 ( 20.6- 36.6) ∼
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Table 2.15.1.2F: Lung and Bronchus. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 46.5 ( 43.9- 49.3) 48.0 ( 44.9- 51.4) 42.6 ( 37.7- 48.1) ∼
Oklahoma 45.4 ( 42.6- 48.5) 45.9 ( 42.8- 49.2) 61.1 ( 46.8- 78.6) ∼
Texas 39.0 ( 37.8- 40.3) 39.0 ( 37.7- 40.3) 44.5 ( 40.4- 49.0) 15.5 ( 13.7- 17.4)
West 37.8 ( 37.1- 38.5) 39.7 ( 38.9- 40.4) 42.7 ( 39.2- 46.5) 16.1 ( 14.8- 17.5)
Mountain 36.2 ( 35.0- 37.5) 36.9 ( 35.7- 38.2) 41.1 ( 32.6- 51.3) 21.8 ( 18.9- 25.0)
Arizona 37.8 ( 35.7- 40.0) 39.0 ( 36.7- 41.4) 41.6 ( 26.6- 62.7) 20.4 ( 15.6- 26.4)
Colorado 32.8 ( 30.4- 35.4) 32.6 ( 30.1- 35.2) 41.7 ( 26.5- 63.1) 24.7 ( 17.9- 33.2)
Idaho 40.3 ( 35.6- 45.4) 40.3 ( 35.6- 45.4) ∼ ∼
Montana 42.7 ( 37.4- 48.6) 42.1 ( 36.7- 48.2) ∼ ∼
Nevada 54.1 ( 49.8- 58.6) 57.7 ( 53.0- 62.7) 40.4 ( 25.8- 61.4) 27.2 ( 16.4- 43.1)
New Mexico 30.5 ( 27.2- 34.1) 32.6 ( 29.0- 36.5) ∼ 20.9 ( 16.1- 26.8)
Utah 17.4 ( 14.8- 20.3) 17.1 ( 14.4- 20.0) ∼ ∼
Wyoming 36.6 ( 29.7- 44.8) 36.3 ( 29.4- 44.6) ∼ ∼
Pacific 38.4 ( 37.6- 39.2) 41.0 ( 40.1- 41.9) 42.9 ( 39.1- 47.0) 14.2 ( 12.8- 15.7)
Alaska 38.2 ( 29.8- 48.5) 35.1 ( 26.0- 46.7) ∼ ∼
California 36.4 ( 35.5- 37.3) 38.4 ( 37.4- 39.4) 42.2 ( 38.3- 46.5) 13.9 ( 12.5- 15.4)
Hawaii 27.0 ( 23.4- 31.0) 41.4 ( 32.2- 53.2) ∼ ∼
Oregon 46.9 ( 43.9- 50.0) 47.3 ( 44.3- 50.6) ∼ ∼
Washington 47.6 ( 45.2- 50.1) 49.5 ( 47.0- 52.2) 49.5 ( 32.5- 72.5) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.16.1.1M: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 20.5 ( 20.2- 20.7) 22.5 ( 22.2- 22.7) 0.9 ( 0.7- 1.1) 4.1 ( 3.6- 4.6)
Northeast 21.1 ( 20.5- 21.7) 22.5 ( 21.9- 23.1) ∼ 4.3 ( 3.3- 5.8)
New England 27.5 ( 26.2- 28.8) 27.5 ( 26.2- 28.8) ∼ ∼
Connecticut 27.6 ( 25.1- 30.3) 28.9 ( 26.2- 31.8) ∼ ∼
Maine 27.7 ( 23.8- 32.1) 27.8 ( 23.9- 32.2) ∼ ∼
Massachusetts 24.4 ( 22.6- 26.2) 24.2 ( 22.4- 26.1) ∼ ∼
New Hampshire 34.4 ( 29.9- 39.5) 31.1 ( 26.7- 36.0) ∼ ∼
Rhode Island 30.5 ( 25.9- 35.7) 31.2 ( 26.4- 36.7) ∼ ∼
Vermont 38.3 ( 31.6- 46.2) 38.0 ( 31.2- 45.9) ∼ ∼
Middle Atlantic 18.8 ( 18.2- 19.5) 20.6 ( 19.9- 21.3) ∼ 4.3 ( 3.2- 5.8)
New Jersey 24.8 ( 23.2- 26.4) 28.2 ( 26.4- 30.1) ∼ 5.4 ( 3.1- 9.6)
New York 14.3 ( 13.5- 15.1) 15.8 ( 14.9- 16.8) ∼ 4.3 ( 2.9- 6.3)
Pennsylvania 21.7 ( 20.5- 22.9) 22.1 ( 20.9- 23.4) ∼ -
Midwest 18.3 ( 17.8- 18.7) 18.9 ( 18.3- 19.4) ∼ 2.8 ( 1.7- 4.8)
East North Central 18.3 ( 17.7- 18.9) 19.1 ( 18.5- 19.8) ∼ 3.1 ( 1.8- 5.4)
Illinois 16.5 ( 15.4- 17.6) 17.7 ( 16.5- 19.0) ∼ -
Indiana 16.9 ( 15.4- 18.5) 17.5 ( 15.9- 19.2) ∼ ∼
Michigan 21.4 ( 20.1- 22.8) 23.1 ( 21.6- 24.6) ∼ ∼
Detroit 20.2 ( 18.2- 22.5) 25.5 ( 22.9- 28.3) ∼ ∼
Ohio 19.5 ( 18.4- 20.8) 19.5 ( 18.3- 20.8) ∼ ∼
Wisconsin 15.8 ( 14.3- 17.4) 16.3 ( 14.8- 18.0) ∼ ∼
West North Central 18.1 ( 17.3- 19.0) 18.3 ( 17.4- 19.2) ∼ ∼
Iowa 18.8 ( 16.7- 21.2) 17.1 ( 15.0- 19.4) ∼ ∼
Kansas 21.1 ( 18.6- 23.8) 21.2 ( 18.6- 24.0) ∼ ∼
Minnesota 20.0 ( 18.2- 21.9) 20.4 ( 18.5- 22.4) ∼ ∼
Missouri 15.6 ( 14.1- 17.2) 16.9 ( 15.3- 18.6) ∼ ∼
Nebraska 18.2 ( 15.4- 21.5) 16.7 ( 14.0- 19.9) ∼ ∼
North Dakota 13.9 ( 10.1- 18.7) 14.4 ( 10.5- 19.4) ∼ ∼
South Dakota 15.8 ( 12.0- 20.5) 16.4 ( 12.4- 21.3) ∼ ∼
South
South Atlantic 21.8 ( 21.2- 22.4) 25.6 ( 24.9- 26.3) 0.9 ( 0.6- 1.4) 5.8 ( 4.6- 7.3)
Delaware 20.6 ( 16.3- 25.9) 23.2 ( 18.2- 29.3) ∼ ∼
District of Columbia 10.2 ( 6.7- 15.2) 16.2 ( 9.0- 29.5) ∼ ∼
Florida 21.2 ( 20.3- 22.2) 23.3 ( 22.3- 24.4) ∼ -
Georgia 24.2 ( 22.5- 26.1) 30.5 ( 28.3- 32.8) ∼ ∼
Atlanta 26.8 ( 23.5- 30.6) 36.4 ( 32.0- 41.5) ∼ ∼
Maryland 23.9 ( 22.0- 26.0) 31.1 ( 28.5- 33.8) ∼ ∼
North Carolina 19.9 ( 18.5- 21.5) 24.2 ( 22.4- 26.0) ∼ ∼
South Carolina 25.8 ( 23.5- 28.3) 31.5 ( 28.6- 34.7) ∼ -
Virginia 20.2 ( 18.7- 21.9) 24.0 ( 22.1- 26.0) ∼ ∼
West Virginia 18.6 ( 15.9- 21.7) 19.1 ( 16.4- 22.3) ∼ ∼
East South Central
Alabama 16.7 ( 14.9- 18.6) 20.9 ( 18.6- 23.3) ∼ ∼
Kentucky 24.2 ( 22.0- 26.6) 24.0 ( 21.7- 26.5) ∼ -
Mississippi 13.9 ( 11.9- 16.3) 18.7 ( 15.9- 21.9) ∼ ∼
Tennessee
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Table 2.16.1.1M: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 17.4 ( 16.7- 18.2) 19.2 ( 18.4- 20.0) 1.8 ( 1.1- 2.9) 3.2 ( 2.4- 4.3)
Arkansas 14.2 ( 12.2- 16.5) 15.7 ( 13.5- 18.3) ∼ ∼
Louisiana 13.5 ( 11.9- 15.3) 17.1 ( 15.0- 19.5) ∼ ∼
Oklahoma 21.3 ( 19.1- 23.8) 22.9 ( 20.4- 25.6) ∼ ∼
Texas 18.1 ( 17.2- 19.1) 19.5 ( 18.5- 20.5) ∼ 3.2 ( 2.4- 4.4)
West 23.2 ( 22.6- 23.8) 26.1 ( 25.4- 26.8) ∼ 3.9 ( 3.2- 4.7)
Mountain
Arizona
Colorado 22.2 ( 20.0- 24.5) 23.4 ( 21.1- 25.9) ∼ ∼
Idaho 29.3 ( 25.1- 34.0) 29.3 ( 25.1- 34.1) ∼ ∼
Montana 19.1 ( 15.3- 23.7) 19.3 ( 15.4- 24.0) ∼ ∼
Nevada 22.3 ( 19.4- 25.6) 24.8 ( 21.6- 28.5) ∼ ∼
New Mexico 20.3 ( 17.3- 23.7) 22.3 ( 19.1- 26.0) ∼ ∼
Utah 28.3 ( 24.8- 32.3) 29.3 ( 25.7- 33.4) ∼ ∼
Wyoming
Pacific 23.2 ( 22.5- 23.9) 26.5 ( 25.7- 27.3) ∼ 3.8 ( 3.0- 4.7)
Alaska 13.2 ( 9.3- 20.2) 15.8 ( 11.1- 24.4) ∼ ∼
California 22.7 ( 21.9- 23.5) 26.1 ( 25.2- 27.1) ∼ 3.6 ( 2.9- 4.6)
San Francisco-Oakland 18.5 ( 16.6- 20.6) 24.0 ( 21.4- 26.9) ∼ ∼
San Jose-Monterey 22.6 ( 19.6- 25.9) 26.1 ( 22.5- 30.2) ∼ ∼
Los Angeles 18.1 ( 16.8- 19.6) 23.0 ( 21.2- 24.9) ∼ 3.2 ( 2.1- 4.8)
Hawaii 19.9 ( 16.5- 23.8) 60.1 ( 48.5- 74.3) ∼ -
Oregon 24.5 ( 22.2- 27.0) 24.9 ( 22.5- 27.5) ∼ ∼
Washington 26.6 ( 24.7- 28.6) 27.9 ( 25.8- 30.0) ∼ ∼
Seattle-Puget Sound 27.4 ( 25.0- 29.9) 30.5 ( 27.9- 33.3) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.16.1.1F: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 13.2 ( 13.1- 13.4) 14.9 ( 14.7- 15.1) 0.9 ( 0.8- 1.1) 4.3 ( 3.9- 4.7)
Northeast 13.6 ( 13.2- 14.0) 14.7 ( 14.2- 15.2) 0.8 ( 0.6- 1.2) 3.5 ( 2.7- 4.4)
New England 18.6 ( 17.6- 19.6) 18.5 ( 17.5- 19.5) ∼ ∼
Connecticut 17.9 ( 16.1- 20.0) 19.3 ( 17.3- 21.6) ∼ ∼
Maine 17.4 ( 14.5- 20.8) 17.0 ( 14.1- 20.4) ∼ ∼
Massachusetts 17.3 ( 16.0- 18.8) 17.3 ( 15.9- 18.8) ∼ ∼
New Hampshire 25.3 ( 21.6- 29.4) 21.0 ( 17.7- 24.9) ∼ ∼
Rhode Island 16.9 ( 13.8- 20.6) 16.2 ( 13.0- 20.0) ∼ ∼
Vermont 28.5 ( 23.1- 35.0) 27.8 ( 22.4- 34.4) ∼ ∼
Middle Atlantic 11.8 ( 11.4- 12.3) 13.2 ( 12.7- 13.8) 0.9 ( 0.6- 1.3) 3.3 ( 2.5- 4.3)
New Jersey 14.8 ( 13.7- 15.9) 17.3 ( 16.0- 18.7) ∼ 5.8 ( 3.8- 8.7)
New York 8.7 ( 8.2- 9.3) 10.0 ( 9.4- 10.7) ∼ 2.2 ( 1.5- 3.3)
Pennsylvania 14.8 ( 13.9- 15.7) 15.0 ( 14.1- 16.0) ∼ -
Midwest 12.9 ( 12.6- 13.3) 13.6 ( 13.1- 14.0) 1.1 ( 0.7- 1.5) 4.7 ( 3.2- 6.7)
East North Central 12.8 ( 12.3- 13.2) 13.5 ( 13.0- 14.0) 1.2 ( 0.8- 1.7) 4.9 ( 3.3- 7.3)
Illinois 10.6 ( 9.8- 11.4) 11.4 ( 10.5- 12.4) ∼ -
Indiana 11.6 ( 10.4- 12.8) 11.8 ( 10.6- 13.2) ∼ ∼
Michigan 16.1 ( 15.0- 17.2) 17.7 ( 16.5- 19.0) ∼ ∼
Detroit 14.9 ( 13.3- 16.7) 19.8 ( 17.6- 22.2) ∼ ∼
Ohio 13.0 ( 12.1- 13.9) 13.2 ( 12.3- 14.2) ∼ ∼
Wisconsin 12.6 ( 11.3- 14.0) 13.1 ( 11.8- 14.6) ∼ ∼
West North Central 13.3 ( 12.6- 14.1) 13.6 ( 12.9- 14.4) ∼ ∼
Iowa 13.6 ( 11.8- 15.6) 12.7 ( 11.0- 14.7) ∼ ∼
Kansas 15.9 ( 13.9- 18.1) 16.2 ( 14.0- 18.5) ∼ ∼
Minnesota 16.5 ( 14.9- 18.1) 17.1 ( 15.5- 18.8) ∼ ∼
Missouri 10.0 ( 8.9- 11.1) 11.2 ( 10.0- 12.6) ∼ ∼
Nebraska 12.2 ( 10.1- 14.8) 9.5 ( 7.6- 11.9) ∼ ∼
North Dakota 11.7 ( 8.4- 16.2) 12.4 ( 8.8- 17.1) ∼ ∼
South Dakota 12.6 ( 9.3- 16.7) 13.6 ( 10.1- 18.2) ∼ ∼
South
South Atlantic 13.2 ( 12.8- 13.6) 16.4 ( 15.9- 16.9) 1.1 ( 0.8- 1.4) 5.0 ( 4.0- 6.1)
Delaware 15.2 ( 11.8- 19.4) 16.2 ( 12.2- 21.2) ∼ ∼
District of Columbia 7.7 ( 4.9- 11.9) 17.7 ( 10.3- 31.6) ∼ ∼
Florida 12.1 ( 11.4- 12.8) 13.7 ( 12.9- 14.5) 2.0 ( 1.2- 3.1) -
Georgia 14.4 ( 13.3- 15.6) 19.9 ( 18.4- 21.6) ∼ ∼
Atlanta 16.9 ( 14.8- 19.3) 25.9 ( 22.6- 29.6) ∼ ∼
Maryland 16.5 ( 15.1- 18.0) 23.1 ( 21.0- 25.3) ∼ ∼
North Carolina 12.4 ( 11.4- 13.5) 15.7 ( 14.4- 17.2) ∼ ∼
South Carolina 14.1 ( 12.6- 15.8) 19.2 ( 17.1- 21.6) ∼ -
Virginia 12.6 ( 11.5- 13.7) 15.7 ( 14.3- 17.2) ∼ ∼
West Virginia 11.8 ( 9.8- 14.2) 12.1 ( 10.0- 14.6) ∼ ∼
East South Central
Alabama 10.4 ( 9.2- 11.8) 13.6 ( 11.9- 15.4) ∼ ∼
Kentucky 16.3 ( 14.7- 18.1) 15.8 ( 14.1- 17.6) ∼ -
Mississippi 10.3 ( 8.7- 12.0) 15.3 ( 12.9- 18.0) ∼ ∼
Tennessee
continued
C
ancer Incidence and M
ortality, by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
137
Table 2.16.1.1F: Melanomas of the Skin. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 9.8 ( 9.4- 10.3) 11.2 ( 10.7- 11.8) ∼ 2.7 ( 2.1- 3.4)
Arkansas 7.2 ( 5.9- 8.8) 8.3 ( 6.7- 10.1) ∼ ∼
Louisiana 7.7 ( 6.6- 8.9) 10.1 ( 8.6- 11.8) ∼ ∼
Oklahoma 13.4 ( 11.8- 15.2) 15.1 ( 13.3- 17.2) ∼ ∼
Texas 10.0 ( 9.5- 10.7) 11.1 ( 10.5- 11.9) ∼ 2.6 ( 2.0- 3.3)
West 15.3 ( 14.9- 15.8) 17.4 ( 16.9- 18.0) 1.2 ( 0.7- 2.0) 5.2 ( 4.5- 5.9)
Mountain
Arizona
Colorado 14.5 ( 13.0- 16.2) 15.4 ( 13.8- 17.2) ∼ ∼
Idaho 19.7 ( 16.5- 23.4) 20.3 ( 17.0- 24.1) ∼ ∼
Montana 14.4 ( 11.1- 18.4) 15.0 ( 11.6- 19.3) ∼ ∼
Nevada 16.1 ( 13.8- 18.7) 18.5 ( 15.8- 21.5) ∼ ∼
New Mexico 14.6 ( 12.3- 17.3) 16.3 ( 13.7- 19.3) ∼ 5.3 ( 3.2- 8.5)
Utah 19.7 ( 17.0- 22.8) 20.7 ( 17.8- 23.8) ∼ ∼
Wyoming
Pacific 15.1 ( 14.6- 15.6) 17.5 ( 16.9- 18.1) ∼ 5.1 ( 4.4- 5.9)
Alaska 7.0 ( 4.2- 11.7) 9.3 ( 5.5- 15.4) ∼ ∼
California 14.0 ( 13.4- 14.5) 16.2 ( 15.6- 16.9) ∼ 4.9 ( 4.2- 5.7)
San Francisco-Oakland 10.7 ( 9.4- 12.2) 14.1 ( 12.3- 16.2) ∼ ∼
San Jose-Monterey 12.2 ( 10.3- 14.4) 15.2 ( 12.7- 18.0) ∼ ∼
Los Angeles 10.1 ( 9.2- 11.0) 12.8 ( 11.6- 14.1) ∼ 3.9 ( 2.9- 5.1)
Hawaii 12.2 ( 9.7- 15.2) 35.2 ( 26.6- 46.5) ∼ -
Oregon 19.1 ( 17.1- 21.2) 19.3 ( 17.3- 21.5) ∼ ∼
Washington 20.6 ( 19.0- 22.2) 22.3 ( 20.5- 24.1) ∼ ∼
Seattle-Puget Sound 21.1 ( 19.2- 23.1) 24.4 ( 22.2- 26.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.16.1.2M: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 3.9 ( 3.8- 4.0) 4.4 ( 4.3- 4.5) 0.4 ( 0.3- 0.6) 1.0 ( 0.8- 1.3)
Northeast 3.7 ( 3.4- 3.9) 4.1 ( 3.8- 4.3) ∼ ∼
New England 4.1 ( 3.6- 4.6) 4.3 ( 3.8- 4.9) ∼ ∼
Connecticut 3.6 ( 2.7- 4.6) 3.8 ( 2.9- 5.0) ∼ ∼
Maine 3.6 ( 2.3- 5.5) 3.6 ( 2.3- 5.5) ∼ ∼
Massachusetts 4.6 ( 3.9- 5.5) 4.9 ( 4.1- 5.9) ∼ ∼
New Hampshire 5.4 ( 3.6- 7.7) 5.4 ( 3.7- 7.8) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.5 ( 3.2- 3.8) 4.0 ( 3.7- 4.3) ∼ ∼
New Jersey 3.7 ( 3.1- 4.4) 4.2 ( 3.5- 5.0) ∼ ∼
New York 3.0 ( 2.7- 3.4) 3.5 ( 3.1- 4.0) ∼ ∼
Pennsylvania 4.1 ( 3.6- 4.7) 4.5 ( 4.0- 5.1) ∼ ∼
Midwest 3.5 ( 3.3- 3.8) 3.8 ( 3.6- 4.1) ∼ ∼
East North Central 3.6 ( 3.3- 3.9) 4.0 ( 3.7- 4.3) ∼ ∼
Illinois 3.3 ( 2.8- 3.8) 3.8 ( 3.2- 4.4) ∼ ∼
Indiana 4.3 ( 3.5- 5.2) 4.6 ( 3.8- 5.6) ∼ ∼
Michigan 3.6 ( 3.1- 4.3) 4.1 ( 3.4- 4.8) ∼ ∼
Ohio 3.7 ( 3.2- 4.3) 4.1 ( 3.6- 4.8) ∼ ∼
Wisconsin 3.1 ( 2.4- 3.8) 3.2 ( 2.5- 4.0) ∼ ∼
West North Central 3.5 ( 3.1- 3.9) 3.6 ( 3.2- 4.0) ∼ ∼
Iowa 3.1 ( 2.2- 4.1) 3.1 ( 2.3- 4.2) ∼ ∼
Kansas 4.0 ( 3.0- 5.3) 4.3 ( 3.2- 5.6) ∼ ∼
Minnesota 2.7 ( 2.1- 3.5) 2.9 ( 2.2- 3.7) ∼ ∼
Missouri 4.0 ( 3.3- 4.9) 4.3 ( 3.5- 5.2) ∼ ∼
Nebraska 4.2 ( 2.9- 5.9) 4.3 ( 3.0- 6.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 4.0 ( 3.8- 4.2) 4.7 ( 4.5- 4.9) 0.4 ( 0.3- 0.7) 1.2 ( 0.8- 1.7)
South Atlantic 4.1 ( 3.9- 4.4) 4.9 ( 4.6- 5.2) ∼ 1.3 ( 0.7- 2.2)
Delaware 6.0 ( 3.7- 9.3) 6.9 ( 4.2- 10.7) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.4 ( 3.9- 4.8) 4.8 ( 4.4- 5.3) ∼ 1.6 ( 0.9- 2.6)
Georgia 3.4 ( 2.8- 4.2) 4.3 ( 3.4- 5.3) ∼ ∼
Maryland 3.7 ( 2.9- 4.6) 4.8 ( 3.8- 5.9) ∼ ∼
North Carolina 3.8 ( 3.2- 4.5) 4.6 ( 3.8- 5.5) ∼ ∼
South Carolina 4.7 ( 3.7- 5.9) 6.0 ( 4.8- 7.5) ∼ ∼
Virginia 4.3 ( 3.6- 5.2) 5.3 ( 4.4- 6.3) ∼ ∼
West Virginia 5.7 ( 4.2- 7.5) 5.9 ( 4.3- 7.8) ∼ ∼
East South Central 4.0 ( 3.6- 4.5) 4.6 ( 4.1- 5.2) ∼ ∼
Alabama 4.0 ( 3.2- 5.1) 5.0 ( 3.9- 6.3) ∼ ∼
Kentucky 4.8 ( 3.8- 6.0) 5.0 ( 4.0- 6.3) ∼ ∼
Mississippi 3.4 ( 2.4- 4.7) 4.5 ( 3.2- 6.3) ∼ ∼
Tennessee 3.7 ( 2.9- 4.5) 4.2 ( 3.4- 5.1) ∼ ∼
West South Central 3.8 ( 3.5- 4.2) 4.3 ( 3.9- 4.8) ∼ 1.1 ( 0.6- 1.8)
Arkansas 3.5 ( 2.5- 4.7) 3.9 ( 2.8- 5.3) ∼ ∼
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Table 2.16.1.2M: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.5 ( 2.7- 4.5) 4.5 ( 3.4- 5.8) ∼ ∼
Oklahoma 5.2 ( 4.1- 6.4) 5.8 ( 4.6- 7.3) ∼ ∼
Texas 3.7 ( 3.3- 4.2) 4.1 ( 3.6- 4.7) ∼ 1.1 ( 0.6- 1.9)
West 4.2 ( 4.0- 4.5) 4.8 ( 4.5- 5.1) ∼ 1.2 ( 0.8- 1.7)
Mountain 4.5 ( 4.0- 4.9) 4.7 ( 4.2- 5.2) ∼ ∼
Arizona 4.4 ( 3.6- 5.3) 4.7 ( 3.8- 5.6) ∼ ∼
Colorado 3.9 ( 3.0- 5.0) 4.1 ( 3.2- 5.3) ∼ ∼
Idaho 4.6 ( 3.0- 6.8) 4.7 ( 3.1- 7.0) ∼ ∼
Montana 4.4 ( 2.7- 6.9) 4.6 ( 2.8- 7.3) ∼ ∼
Nevada 4.7 ( 3.5- 6.4) 5.4 ( 4.0- 7.2) ∼ ∼
New Mexico 4.2 ( 2.9- 6.0) 4.2 ( 2.8- 6.1) ∼ ∼
Utah 5.7 ( 4.1- 7.7) 5.9 ( 4.3- 8.0) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.1 ( 3.8- 4.4) 4.9 ( 4.5- 5.2) ∼ 1.2 ( 0.7- 1.8)
Alaska ∼ ∼ ∼ ∼
California 4.1 ( 3.8- 4.5) 5.0 ( 4.6- 5.4) ∼ 1.2 ( 0.8- 1.9)
Hawaii 3.3 ( 2.1- 5.1) ∼ ∼ ∼
Oregon 4.8 ( 3.8- 6.0) 5.0 ( 4.0- 6.2) ∼ ∼
Washington 4.0 ( 3.2- 4.8) 4.3 ( 3.5- 5.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.16.1.2F: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.7- 1.8) 2.0 ( 1.9- 2.0) 0.4 ( 0.3- 0.6) 0.6 ( 0.4- 0.8)
Northeast 1.8 ( 1.7- 2.0) 2.1 ( 1.9- 2.2) ∼ ∼
New England 2.0 ( 1.7- 2.3) 2.1 ( 1.8- 2.5) ∼ ∼
Connecticut 1.9 ( 1.3- 2.6) 2.0 ( 1.5- 2.8) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.1 ( 1.7- 2.6) 2.3 ( 1.8- 2.8) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.8 ( 1.6- 1.9) 2.0 ( 1.8- 2.2) ∼ ∼
New Jersey 1.7 ( 1.4- 2.1) 2.0 ( 1.6- 2.5) ∼ ∼
New York 1.6 ( 1.4- 1.9) 2.0 ( 1.7- 2.3) ∼ ∼
Pennsylvania 2.0 ( 1.7- 2.3) 2.2 ( 1.8- 2.6) ∼ ∼
Midwest 1.6 ( 1.4- 1.7) 1.7 ( 1.6- 1.8) ∼ ∼
East North Central 1.5 ( 1.4- 1.7) 1.7 ( 1.5- 1.9) ∼ ∼
Illinois 1.5 ( 1.3- 1.9) 1.7 ( 1.4- 2.1) ∼ ∼
Indiana 1.6 ( 1.2- 2.1) 1.6 ( 1.2- 2.1) ∼ ∼
Michigan 1.2 ( 0.9- 1.5) 1.3 ( 1.0- 1.7) ∼ ∼
Ohio 1.7 ( 1.4- 2.0) 1.9 ( 1.5- 2.3) ∼ ∼
Wisconsin 1.8 ( 1.3- 2.3) 1.9 ( 1.4- 2.5) ∼ ∼
West North Central 1.6 ( 1.4- 1.9) 1.7 ( 1.5- 2.0) ∼ ∼
Iowa 1.2 ( 0.7- 1.9) 1.2 ( 0.8- 1.9) ∼ ∼
Kansas 2.0 ( 1.4- 2.9) 2.2 ( 1.5- 3.2) ∼ ∼
Minnesota 1.6 ( 1.1- 2.1) 1.6 ( 1.2- 2.2) ∼ ∼
Missouri 1.6 ( 1.2- 2.1) 1.8 ( 1.3- 2.4) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 3.9 ( 2.3- 6.4) 3.6 ( 2.0- 6.1) ∼ ∼
South 1.8 ( 1.7- 1.9) 2.1 ( 2.0- 2.2) 0.5 ( 0.3- 0.6) 0.6 ( 0.4- 0.9)
South Atlantic 1.9 ( 1.8- 2.1) 2.3 ( 2.1- 2.5) 0.4 ( 0.3- 0.7) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.0 ( 1.7- 2.3) 2.2 ( 1.9- 2.5) ∼ ∼
Georgia 1.6 ( 1.3- 2.1) 2.1 ( 1.6- 2.7) ∼ ∼
Maryland 1.6 ( 1.2- 2.2) 2.0 ( 1.4- 2.7) ∼ ∼
North Carolina 2.1 ( 1.7- 2.6) 2.5 ( 2.1- 3.1) ∼ ∼
South Carolina 1.7 ( 1.2- 2.3) 2.1 ( 1.5- 3.0) ∼ ∼
Virginia 2.5 ( 2.0- 3.0) 2.9 ( 2.4- 3.6) ∼ ∼
West Virginia 2.3 ( 1.5- 3.5) 2.4 ( 1.6- 3.6) ∼ ∼
East South Central 1.7 ( 1.4- 2.0) 1.9 ( 1.7- 2.3) ∼ ∼
Alabama 1.5 ( 1.1- 2.1) 1.9 ( 1.3- 2.6) ∼ ∼
Kentucky 2.0 ( 1.5- 2.7) 2.1 ( 1.6- 2.9) ∼ ∼
Mississippi 1.0 ( 0.6- 1.7) ∼ ∼ ∼
Tennessee 1.9 ( 1.5- 2.4) 2.1 ( 1.6- 2.7) ∼ ∼
West South Central 1.7 ( 1.5- 1.9) 1.9 ( 1.7- 2.1) ∼ ∼
Arkansas 2.0 ( 1.3- 2.8) 2.1 ( 1.4- 3.1) ∼ ∼
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Table 2.16.1.2F: Melanomas of the Skin. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 1.0 ( 0.7- 1.5) 1.1 ( 0.7- 1.7) ∼ ∼
Oklahoma 2.0 ( 1.4- 2.7) 2.2 ( 1.6- 3.1) ∼ ∼
Texas 1.7 ( 1.5- 2.0) 1.9 ( 1.7- 2.2) ∼ ∼
West 1.7 ( 1.6- 1.9) 2.0 ( 1.8- 2.2) ∼ 0.7 ( 0.5- 1.0)
Mountain 1.8 ( 1.6- 2.1) 2.0 ( 1.7- 2.3) ∼ ∼
Arizona 1.5 ( 1.1- 2.1) 1.7 ( 1.2- 2.2) ∼ ∼
Colorado 1.6 ( 1.1- 2.2) 1.7 ( 1.2- 2.4) ∼ ∼
Idaho 2.6 ( 1.6- 4.2) 2.7 ( 1.6- 4.3) ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.1 ( 1.3- 3.2) 2.3 ( 1.4- 3.5) ∼ ∼
New Mexico 2.0 ( 1.2- 3.2) 2.3 ( 1.4- 3.6) ∼ ∼
Utah 1.8 ( 1.1- 2.9) 1.9 ( 1.1- 3.0) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.7 ( 1.5- 1.9) 2.0 ( 1.8- 2.2) ∼ 0.7 ( 0.4- 1.0)
Alaska ∼ ∼ ∼ ∼
California 1.6 ( 1.4- 1.8) 1.9 ( 1.7- 2.2) ∼ 0.6 ( 0.4- 1.0)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.0 ( 1.4- 2.8) 2.1 ( 1.5- 2.9) ∼ ∼
Washington 2.1 ( 1.6- 2.7) 2.3 ( 1.8- 2.9) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.17.1.1M: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 2.0 ( 1.9- 2.0) 2.1 ( 2.0- 2.2) 1.1 ( 0.9- 1.3) 1.3 ( 1.1- 1.7)
Northeast 2.3 ( 2.1- 2.5) 2.4 ( 2.2- 2.6) 1.0 ( 0.5- 1.6) ∼
New England 2.1 ( 1.8- 2.5) 2.2 ( 1.8- 2.6) ∼ ∼
Connecticut 2.0 ( 1.4- 2.8) 2.1 ( 1.5- 3.0) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 2.3 ( 1.8- 2.9) 2.3 ( 1.8- 3.0) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.3 ( 2.1- 2.6) 2.5 ( 2.3- 2.8) 1.0 ( 0.6- 1.7) ∼
New Jersey 2.9 ( 2.4- 3.6) 3.3 ( 2.7- 4.0) ∼ ∼
New York 1.7 ( 1.4- 2.0) 1.8 ( 1.5- 2.2) ∼ ∼
Pennsylvania 2.8 ( 2.4- 3.2) 2.9 ( 2.5- 3.4) ∼ -
Midwest 2.0 ( 1.8- 2.2) 2.0 ( 1.9- 2.2) 1.2 ( 0.7- 1.8) ∼
East North Central 2.2 ( 2.0- 2.4) 2.2 ( 2.0- 2.5) 1.2 ( 0.8- 2.0) ∼
Illinois 2.5 ( 2.1- 3.0) 2.8 ( 2.3- 3.3) ∼ -
Indiana 2.2 ( 1.7- 2.9) 2.2 ( 1.7- 2.9) ∼ ∼
Michigan 1.9 ( 1.5- 2.3) 1.9 ( 1.5- 2.5) ∼ ∼
Detroit 1.4 ( 0.9- 2.1) 1.5 ( 0.9- 2.4) ∼ ∼
Ohio 2.1 ( 1.7- 2.5) 2.0 ( 1.6- 2.4) ∼ ∼
Wisconsin 2.1 ( 1.5- 2.7) 2.1 ( 1.5- 2.8) ∼ ∼
West North Central 1.6 ( 1.4- 1.9) 1.7 ( 1.4- 2.0) ∼ ∼
Iowa 1.1 ( 0.6- 1.8) 1.1 ( 0.6- 1.9) ∼ ∼
Kansas 1.6 ( 1.0- 2.5) 1.5 ( 0.9- 2.4) ∼ ∼
Minnesota 2.5 ( 1.9- 3.3) 2.5 ( 1.9- 3.3) ∼ ∼
Missouri 1.4 ( 1.0- 2.0) 1.6 ( 1.1- 2.2) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 1.9 ( 1.7- 2.1) 2.0 ( 1.8- 2.2) 1.2 ( 0.8- 1.7) 1.4 ( 0.8- 2.3)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.8 ( 1.6- 2.1) 1.9 ( 1.6- 2.2) ∼ -
Georgia 1.3 ( 0.9- 1.9) 1.5 ( 1.0- 2.1) ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland 1.8 ( 1.3- 2.5) 2.1 ( 1.5- 3.0) ∼ ∼
North Carolina 1.9 ( 1.5- 2.5) 2.0 ( 1.5- 2.6) ∼ ∼
South Carolina 1.8 ( 1.2- 2.6) 2.2 ( 1.5- 3.3) ∼ -
Virginia 2.7 ( 2.1- 3.4) 2.7 ( 2.0- 3.5) ∼ ∼
West Virginia 2.6 ( 1.7- 4.0) 2.7 ( 1.7- 4.1) ∼ ∼
East South Central
Alabama 1.3 ( 0.9- 2.0) 1.6 ( 1.0- 2.4) ∼ ∼
Kentucky 1.5 ( 0.9- 2.3) 1.5 ( 0.9- 2.3) ∼ -
Mississippi 1.7 ( 1.0- 2.8) 2.1 ( 1.3- 3.5) ∼ ∼
Tennessee
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Table 2.17.1.1M: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 1.7 ( 1.5- 2.0) 1.8 ( 1.5- 2.0) ∼ 1.1 ( 0.6- 1.8)
Arkansas 1.8 ( 1.1- 2.8) 1.9 ( 1.2- 3.0) ∼ ∼
Louisiana 2.2 ( 1.6- 3.1) 2.6 ( 1.8- 3.7) ∼ ∼
Oklahoma 1.3 ( 0.8- 2.1) 1.4 ( 0.9- 2.2) ∼ ∼
Texas 1.6 ( 1.4- 2.0) 1.7 ( 1.4- 2.0) ∼ 1.0 ( 0.6- 1.8)
West 1.8 ( 1.6- 2.0) 1.9 ( 1.8- 2.2) ∼ 1.3 ( 0.9- 1.8)
Mountain
Arizona
Colorado 1.0 ( 0.6- 1.7) 1.1 ( 0.6- 1.7) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 1.9 ( 1.7- 2.1) 2.1 ( 1.9- 2.3) ∼ 1.2 ( 0.8- 1.8)
Alaska ∼ ∼ ∼ ∼
California 1.8 ( 1.5- 2.0) 1.9 ( 1.7- 2.2) ∼ 1.2 ( 0.8- 1.9)
San Francisco-Oakland 1.5 ( 0.9- 2.2) 1.5 ( 0.9- 2.4) ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 1.7 ( 1.3- 2.2) 1.9 ( 1.4- 2.5) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon 2.5 ( 1.8- 3.5) 2.5 ( 1.8- 3.4) ∼ ∼
Washington 2.3 ( 1.7- 3.0) 2.4 ( 1.8- 3.1) ∼ ∼
Seattle-Puget Sound 2.5 ( 1.8- 3.4) 2.7 ( 2.0- 3.7) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.17.1.1F: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 0.4 ( 0.4- 0.4) 0.4 ( 0.4- 0.5) 0.2 ( 0.1- 0.3) 0.5 ( 0.3- 0.6)
Northeast 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
New England 0.5 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.4 ( 0.2- 0.7) 0.5 ( 0.3- 0.8) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
New Jersey 0.6 ( 0.4- 0.9) 0.7 ( 0.5- 1.0) ∼ ∼
New York 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Pennsylvania 0.4 ( 0.3- 0.5) 0.4 ( 0.2- 0.5) ∼ -
Midwest 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
East North Central 0.5 ( 0.4- 0.6) 0.5 ( 0.5- 0.7) ∼ ∼
Illinois 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ -
Indiana 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.8) ∼ ∼
Michigan 0.6 ( 0.4- 0.9) 0.7 ( 0.5- 1.0) ∼ ∼
Detroit ∼ ∼ ∼ ∼
Ohio 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Wisconsin 0.5 ( 0.3- 0.9) 0.6 ( 0.3- 0.9) ∼ ∼
West North Central 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 0.6 ( 0.3- 0.9) 0.6 ( 0.3- 1.0) ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 0.4 ( 0.3- 0.5) 0.4 ( 0.4- 0.5) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.5 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ -
Georgia ∼ ∼ ∼ ∼
Atlanta ∼ ∼ ∼ ∼
Maryland 0.5 ( 0.3- 0.9) ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ -
Virginia 0.4 ( 0.2- 0.7) ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ -
Mississippi ∼ ∼ ∼ ∼
Tennessee
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Table 2.17.1.1F: Mesothelioma. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
West 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ 0.6 ( 0.4- 0.9)
Mountain
Arizona
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming
Pacific 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ 0.6 ( 0.4- 1.0)
Alaska ∼ ∼ ∼ ∼
California 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ 0.6 ( 0.4- 1.0)
San Francisco-Oakland ∼ ∼ ∼ ∼
San Jose-Monterey ∼ ∼ ∼ ∼
Los Angeles 0.4 ( 0.2- 0.6) 0.5 ( 0.3- 0.8) ∼ ∼
Hawaii ∼ ∼ ∼ -
Oregon ∼ ∼ ∼ ∼
Washington 0.6 ( 0.3- 0.9) 0.6 ( 0.3- 0.9) ∼ ∼
Seattle-Puget Sound ∼ ∼ ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.17.1.2M: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 1.7 ( 1.6- 1.7) 1.8 ( 1.7- 1.9) 0.9 ( 0.7- 1.1) 1.1 ( 0.9- 1.4)
Northeast 1.9 ( 1.7- 2.1) 2.0 ( 1.8- 2.2) 1.1 ( 0.7- 1.9) ∼
New England 2.1 ( 1.8- 2.5) 2.2 ( 1.9- 2.6) ∼ ∼
Connecticut 2.2 ( 1.5- 3.1) 2.4 ( 1.6- 3.3) ∼ ∼
Maine 3.9 ( 2.5- 5.9) 4.0 ( 2.6- 6.0) ∼ ∼
Massachusetts 1.9 ( 1.4- 2.5) 2.0 ( 1.5- 2.6) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.8 ( 1.6- 2.0) 2.0 ( 1.7- 2.2) 1.1 ( 0.6- 1.9) ∼
New Jersey 2.3 ( 1.8- 2.8) 2.5 ( 2.0- 3.1) ∼ ∼
New York 1.2 ( 1.0- 1.5) 1.4 ( 1.1- 1.7) ∼ ∼
Pennsylvania 2.3 ( 1.9- 2.7) 2.3 ( 1.9- 2.7) ∼ ∼
Midwest 1.8 ( 1.6- 1.9) 1.8 ( 1.7- 2.0) ∼ ∼
East North Central 1.9 ( 1.7- 2.1) 2.0 ( 1.8- 2.2) ∼ ∼
Illinois 1.9 ( 1.5- 2.3) 2.1 ( 1.7- 2.6) ∼ ∼
Indiana 1.8 ( 1.3- 2.4) 1.8 ( 1.3- 2.5) ∼ ∼
Michigan 1.6 ( 1.3- 2.1) 1.7 ( 1.3- 2.2) ∼ ∼
Ohio 2.1 ( 1.7- 2.5) 2.1 ( 1.7- 2.6) ∼ ∼
Wisconsin 2.2 ( 1.6- 2.9) 2.3 ( 1.7- 3.0) ∼ ∼
West North Central 1.4 ( 1.2- 1.7) 1.5 ( 1.2- 1.8) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 2.6 ( 1.9- 3.4) 2.6 ( 2.0- 3.4) ∼ ∼
Missouri 1.0 ( 0.7- 1.5) 1.1 ( 0.7- 1.6) ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.5 ( 1.3- 1.6) 1.6 ( 1.4- 1.7) 0.7 ( 0.5- 1.0) 0.9 ( 0.6- 1.4)
South Atlantic 1.5 ( 1.4- 1.7) 1.6 ( 1.5- 1.8) 0.8 ( 0.5- 1.3) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.6 ( 1.3- 1.9) 1.7 ( 1.4- 2.0) ∼ ∼
Georgia 1.0 ( 0.6- 1.4) 1.1 ( 0.7- 1.7) ∼ ∼
Maryland 1.6 ( 1.1- 2.3) 1.8 ( 1.2- 2.6) ∼ ∼
North Carolina 1.5 ( 1.1- 2.0) 1.7 ( 1.2- 2.3) ∼ ∼
South Carolina 1.5 ( 0.9- 2.3) 1.6 ( 0.9- 2.5) ∼ ∼
Virginia 2.0 ( 1.5- 2.6) 2.2 ( 1.6- 2.9) ∼ ∼
West Virginia 1.8 ( 1.1- 3.0) 1.9 ( 1.1- 3.1) ∼ ∼
East South Central 1.3 ( 1.0- 1.6) 1.4 ( 1.1- 1.8) ∼ ∼
Alabama 1.7 ( 1.1- 2.4) 1.9 ( 1.3- 2.8) ∼ ∼
Kentucky 1.1 ( 0.6- 1.7) 1.1 ( 0.6- 1.8) ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee 1.1 ( 0.8- 1.7) 1.2 ( 0.8- 1.9) ∼ ∼
West South Central 1.4 ( 1.2- 1.6) 1.5 ( 1.2- 1.7) ∼ 1.1 ( 0.6- 1.9)
Arkansas ∼ ∼ ∼ ∼
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Table 2.17.1.2M: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 1.9 ( 1.4- 2.8) 2.2 ( 1.5- 3.2) ∼ ∼
Oklahoma 1.3 ( 0.8- 2.0) 1.4 ( 0.9- 2.2) ∼ ∼
Texas 1.4 ( 1.1- 1.7) 1.5 ( 1.2- 1.8) ∼ ∼
West 1.7 ( 1.5- 1.8) 1.8 ( 1.6- 2.0) ∼ 1.3 ( 0.9- 1.8)
Mountain 1.3 ( 1.1- 1.6) 1.4 ( 1.1- 1.7) ∼ ∼
Arizona 1.4 ( 1.0- 2.0) 1.4 ( 1.0- 2.0) ∼ ∼
Colorado 1.4 ( 0.9- 2.1) 1.5 ( 0.9- 2.2) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.8 ( 1.6- 2.0) 2.0 ( 1.8- 2.2) ∼ 1.4 ( 0.9- 2.0)
Alaska ∼ ∼ ∼ ∼
California 1.6 ( 1.4- 1.8) 1.7 ( 1.5- 2.0) ∼ 1.3 ( 0.9- 2.0)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.7 ( 1.9- 3.6) 2.7 ( 1.9- 3.7) ∼ ∼
Washington 2.7 ( 2.0- 3.4) 2.8 ( 2.1- 3.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.17.1.2F: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 0.3 ( 0.3- 0.3) 0.3 ( 0.3- 0.3) ∼ 0.2 ( 0.1- 0.4)
Northeast 0.3 ( 0.2- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼
New England 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.5) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.3 ( 0.2- 0.4) 0.3 ( 0.3- 0.4) ∼ ∼
New Jersey 0.4 ( 0.2- 0.6) 0.4 ( 0.3- 0.7) ∼ ∼
New York 0.2 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Pennsylvania 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Midwest 0.4 ( 0.3- 0.4) 0.4 ( 0.3- 0.5) ∼ ∼
East North Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Illinois 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.8) ∼ ∼
Ohio 0.4 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
South Atlantic 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.17.1.2F: Mesothelioma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
West 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
Mountain 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.18.1.1M: Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 6.4 ( 6.3- 6.6) 5.9 ( 5.8- 6.1) 12.1 ( 11.4- 12.8) 6.4 ( 5.8- 7.0)
Northeast 6.4 ( 6.1- 6.7) 6.0 ( 5.6- 6.3) 11.1 ( 9.6- 12.8) 8.0 ( 6.3- 10.0)
New England 6.3 ( 5.7- 6.9) 6.2 ( 5.6- 6.9) 9.3 ( 5.7- 15.0) ∼
Connecticut 5.9 ( 4.8- 7.2) 5.6 ( 4.5- 6.9) ∼ ∼
Maine 5.5 ( 3.8- 7.7) 5.5 ( 3.9- 7.8) ∼ ∼
Massachusetts 6.3 ( 5.4- 7.3) 6.5 ( 5.6- 7.5) ∼ ∼
New Hampshire 8.4 ( 6.1- 11.2) 8.1 ( 5.9- 10.9) ∼ ∼
Rhode Island 7.2 ( 5.0- 10.0) 6.5 ( 4.4- 9.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 6.4 ( 6.1- 6.8) 5.9 ( 5.5- 6.2) 11.3 ( 9.7- 13.1) 8.7 ( 6.9- 11.0)
New Jersey 6.1 ( 5.4- 7.0) 5.7 ( 4.9- 6.6) 10.7 ( 7.5- 15.1) 7.2 ( 4.3- 12.0)
New York 7.2 ( 6.6- 7.8) 6.5 ( 5.9- 7.1) 11.9 ( 9.7- 14.5) 9.6 ( 7.2- 12.7)
Pennsylvania 5.6 ( 5.0- 6.2) 5.2 ( 4.6- 5.8) 10.6 ( 7.7- 14.5) -
Midwest 6.7 ( 6.4- 7.0) 6.2 ( 5.9- 6.5) 12.7 ( 11.1- 14.5) 5.3 ( 3.5- 7.9)
East North Central 6.7 ( 6.3- 7.0) 6.1 ( 5.7- 6.5) 12.4 ( 10.7- 14.4) 4.8 ( 3.0- 7.8)
Illinois 7.2 ( 6.5- 8.0) 6.3 ( 5.6- 7.1) 14.8 ( 11.6- 18.7) -
Indiana 6.6 ( 5.6- 7.7) 5.9 ( 5.0- 7.0) 16.9 ( 10.7- 25.9) ∼
Michigan 7.3 ( 6.5- 8.2) 6.8 ( 6.0- 7.7) 10.5 ( 7.6- 14.3) ∼
Detroit 7.8 ( 6.5- 9.3) 6.7 ( 5.4- 8.3) 12.5 ( 8.9- 17.2) ∼
Ohio 5.2 ( 4.6- 5.9) 4.8 ( 4.2- 5.4) 9.5 ( 6.8- 13.2) ∼
Wisconsin 7.3 ( 6.3- 8.5) 7.1 ( 6.1- 8.3) ∼ ∼
West North Central 6.8 ( 6.2- 7.3) 6.5 ( 5.9- 7.0) 14.1 ( 10.0- 19.5) ∼
Iowa 6.4 ( 5.1- 7.8) 6.1 ( 4.9- 7.5) ∼ ∼
Kansas 5.8 ( 4.6- 7.4) 5.7 ( 4.4- 7.3) ∼ ∼
Minnesota 8.0 ( 6.8- 9.2) 7.7 ( 6.5- 9.0) ∼ ∼
Missouri 5.9 ( 5.0- 7.0) 5.4 ( 4.5- 6.5) 12.3 ( 7.8- 19.1) ∼
Nebraska 7.2 ( 5.4- 9.3) 6.9 ( 5.1- 9.0) ∼ ∼
North Dakota 6.9 ( 4.3- 10.5) 7.1 ( 4.4- 10.9) ∼ ∼
South Dakota 9.0 ( 6.2- 12.7) 8.8 ( 6.0- 12.5) ∼ ∼
South
South Atlantic 6.3 ( 6.0- 6.6) 5.4 ( 5.1- 5.7) 11.9 ( 10.7- 13.2) 5.9 ( 4.6- 7.4)
Delaware 4.7 ( 2.8- 7.7) ∼ ∼ ∼
District of Columbia 8.3 ( 4.9- 13.3) ∼ ∼ ∼
Florida 6.1 ( 5.6- 6.6) 5.5 ( 5.0- 6.0) 12.0 ( 9.5- 15.2) -
Georgia 7.2 ( 6.2- 8.3) 5.7 ( 4.7- 6.8) 14.2 ( 11.1- 18.0) ∼
Atlanta 7.8 ( 6.0- 10.2) 6.5 ( 4.6- 9.2) 12.6 ( 8.2- 19.8) ∼
Maryland 5.8 ( 4.9- 7.0) 5.0 ( 4.0- 6.2) 8.3 ( 5.7- 12.0) ∼
North Carolina 6.1 ( 5.3- 7.0) 5.3 ( 4.5- 6.2) 10.2 ( 7.7- 13.6) ∼
South Carolina 8.4 ( 7.0- 9.9) 6.6 ( 5.3- 8.1) 14.4 ( 10.6- 19.3) -
Virginia 6.2 ( 5.4- 7.2) 4.7 ( 3.9- 5.7) 12.4 ( 9.3- 16.4) ∼
West Virginia 5.7 ( 4.2- 7.5) 5.2 ( 3.8- 7.0) ∼ ∼
East South Central
Alabama 5.9 ( 4.8- 7.1) 5.3 ( 4.2- 6.6) 8.7 ( 5.8- 12.6) ∼
Kentucky 5.5 ( 4.5- 6.8) 5.0 ( 4.0- 6.3) ∼ -
Mississippi 6.3 ( 4.9- 8.0) 5.7 ( 4.2- 7.7) 8.2 ( 5.3- 12.3) ∼
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Table 2.18.1.1M: Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 7.3 ( 6.8- 7.7) 6.4 ( 5.9- 6.9) 14.3 ( 12.3- 16.7) 6.4 ( 5.2- 7.8)
Arkansas 7.7 ( 6.3- 9.5) 6.2 ( 4.8- 7.9) 20.7 ( 13.4- 30.9) ∼
Louisiana 7.9 ( 6.7- 9.4) 5.7 ( 4.5- 7.2) 15.1 ( 11.4- 19.6) ∼
Oklahoma 6.5 ( 5.3- 7.9) 5.8 ( 4.6- 7.2) ∼ ∼
Texas 7.2 ( 6.6- 7.8) 6.7 ( 6.1- 7.3) 12.3 ( 9.7- 15.5) 6.4 ( 5.2- 7.8)
West 6.0 ( 5.7- 6.4) 5.9 ( 5.6- 6.2) 13.1 ( 10.8- 15.8) 6.2 ( 5.3- 7.3)
Mountain
Arizona
Colorado 5.7 ( 4.5- 7.1) 5.7 ( 4.5- 7.2) ∼ 7.6 ( 4.1- 14.0)
Idaho 4.7 ( 3.1- 6.9) 4.8 ( 3.2- 7.1) ∼ ∼
Montana 8.5 ( 6.0- 11.8) 8.6 ( 6.1- 12.0) ∼ ∼
Nevada 4.8 ( 3.4- 6.6) 4.7 ( 3.3- 6.7) ∼ ∼
New Mexico 8.2 ( 6.3- 10.5) 8.2 ( 6.3- 10.6) ∼ 6.5 ( 3.9- 10.7)
Utah 7.2 ( 5.4- 9.5) 7.5 ( 5.6- 9.8) ∼ ∼
Wyoming
Pacific 6.0 ( 5.7- 6.4) 5.8 ( 5.4- 6.2) 13.8 ( 11.3- 16.8) 6.2 ( 5.1- 7.4)
Alaska ∼ ∼ ∼ ∼
California 6.1 ( 5.7- 6.5) 5.8 ( 5.4- 6.3) 13.5 ( 10.9- 16.7) 6.0 ( 5.0- 7.3)
San Francisco-Oakland 6.2 ( 5.1- 7.5) 6.0 ( 4.8- 7.6) 10.5 ( 5.8- 17.7) ∼
San Jose-Monterey 7.0 ( 5.4- 9.0) 7.2 ( 5.3- 9.5) ∼ ∼
Los Angeles 7.0 ( 6.1- 7.9) 6.5 ( 5.5- 7.5) 14.7 ( 10.7- 19.9) 6.2 ( 4.5- 8.3)
Hawaii 4.2 ( 2.7- 6.2) ∼ ∼ -
Oregon 5.1 ( 4.1- 6.3) 4.9 ( 3.9- 6.1) ∼ ∼
Washington 6.9 ( 5.9- 8.0) 6.6 ( 5.6- 7.7) ∼ ∼
Seattle-Puget Sound 6.9 ( 5.7- 8.3) 6.7 ( 5.5- 8.1) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.18.1.1F: Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 4.3 ( 4.2- 4.4) 3.8 ( 3.7- 3.9) 8.8 ( 8.3- 9.3) 4.7 ( 4.3- 5.1)
Northeast 4.6 ( 4.4- 4.9) 4.1 ( 3.9- 4.4) 9.0 ( 7.9- 10.1) 5.2 ( 4.2- 6.4)
New England 4.1 ( 3.7- 4.5) 4.0 ( 3.6- 4.5) 7.3 ( 4.5- 11.1) ∼
Connecticut 4.0 ( 3.2- 5.0) 3.9 ( 3.1- 4.9) ∼ ∼
Maine 3.8 ( 2.6- 5.5) 3.9 ( 2.7- 5.6) ∼ ∼
Massachusetts 4.1 ( 3.5- 4.8) 4.0 ( 3.3- 4.7) ∼ ∼
New Hampshire 4.8 ( 3.3- 6.8) 4.7 ( 3.2- 6.7) ∼ ∼
Rhode Island 3.9 ( 2.5- 5.8) 4.0 ( 2.6- 6.1) ∼ ∼
Vermont 4.6 ( 2.7- 7.7) 4.4 ( 2.5- 7.4) ∼ ∼
Middle Atlantic 4.8 ( 4.5- 5.1) 4.2 ( 3.9- 4.5) 9.2 ( 8.1- 10.4) 5.6 ( 4.5- 6.9)
New Jersey 4.7 ( 4.1- 5.3) 4.1 ( 3.5- 4.8) 8.8 ( 6.5- 11.7) 4.2 ( 2.3- 7.0)
New York 4.8 ( 4.4- 5.2) 4.0 ( 3.6- 4.4) 8.9 ( 7.5- 10.5) 5.9 ( 4.6- 7.6)
Pennsylvania 4.9 ( 4.4- 5.4) 4.4 ( 3.9- 4.9) 10.0 ( 7.7- 12.8) -
Midwest 4.2 ( 4.0- 4.5) 3.8 ( 3.6- 4.0) 8.7 ( 7.7- 9.9) 5.8 ( 4.0- 8.1)
East North Central 4.2 ( 4.0- 4.5) 3.7 ( 3.5- 4.0) 8.6 ( 7.5- 9.8) 6.1 ( 4.0- 8.9)
Illinois 5.1 ( 4.6- 5.7) 4.4 ( 3.9- 5.0) 10.1 ( 8.1- 12.5) -
Indiana 3.8 ( 3.2- 4.6) 3.5 ( 2.9- 4.2) 6.9 ( 4.0- 11.4) ∼
Michigan 4.2 ( 3.6- 4.7) 3.5 ( 3.0- 4.0) 8.7 ( 6.5- 11.3) ∼
Detroit 5.1 ( 4.2- 6.1) 3.8 ( 2.9- 4.8) 9.8 ( 7.2- 13.0) ∼
Ohio 3.8 ( 3.4- 4.3) 3.5 ( 3.0- 4.0) 6.9 ( 5.0- 9.3) ∼
Wisconsin 3.8 ( 3.1- 4.5) 3.6 ( 2.9- 4.3) ∼ ∼
West North Central 4.3 ( 3.9- 4.7) 4.0 ( 3.6- 4.4) 9.7 ( 7.0- 13.1) ∼
Iowa 3.9 ( 3.0- 4.9) 3.7 ( 2.8- 4.7) ∼ ∼
Kansas 4.2 ( 3.3- 5.4) 3.8 ( 2.9- 4.9) ∼ ∼
Minnesota 4.1 ( 3.4- 5.0) 4.0 ( 3.3- 4.9) ∼ ∼
Missouri 4.3 ( 3.6- 5.0) 3.8 ( 3.1- 4.5) 9.6 ( 6.3- 13.9) ∼
Nebraska 5.5 ( 4.2- 7.3) 5.3 ( 3.9- 7.0) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 4.2 ( 2.6- 6.8) 4.4 ( 2.7- 7.1) ∼ ∼
South
South Atlantic 4.4 ( 4.2- 4.7) 3.6 ( 3.3- 3.8) 8.7 ( 7.9- 9.6) 4.8 ( 3.8- 5.9)
Delaware 3.8 ( 2.3- 6.1) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.2 ( 3.9- 4.6) 3.6 ( 3.2- 4.0) 9.8 ( 8.0- 11.9) -
Georgia 4.8 ( 4.2- 5.5) 3.8 ( 3.2- 4.6) 8.0 ( 6.3- 10.1) ∼
Atlanta 4.7 ( 3.5- 6.1) 4.1 ( 2.8- 5.8) 6.6 ( 4.1- 10.4) ∼
Maryland 4.1 ( 3.4- 4.9) 3.1 ( 2.4- 4.0) 7.1 ( 5.2- 9.5) ∼
North Carolina 4.4 ( 3.8- 5.1) 3.5 ( 2.9- 4.2) 8.4 ( 6.6- 10.7) ∼
South Carolina 5.8 ( 4.9- 6.9) 4.0 ( 3.2- 5.1) 11.9 ( 9.2- 15.1) -
Virginia 4.2 ( 3.6- 4.9) 3.2 ( 2.6- 3.9) 7.7 ( 5.7- 10.2) ∼
West Virginia 4.6 ( 3.5- 6.1) 4.2 ( 3.1- 5.6) ∼ ∼
East South Central
Alabama 3.8 ( 3.1- 4.7) 2.9 ( 2.2- 3.7) 7.4 ( 5.3- 10.0) ∼
Kentucky 4.3 ( 3.5- 5.3) 3.8 ( 3.0- 4.7) ∼ -
Mississippi 4.6 ( 3.6- 5.8) 3.0 ( 2.1- 4.2) 8.7 ( 6.2- 12.0) ∼
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Table 2.18.1.1F: Myeloma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 4.6 ( 4.3- 5.0) 4.0 ( 3.6- 4.3) 9.1 ( 7.8- 10.6) 4.0 ( 3.2- 5.0)
Arkansas 3.9 ( 3.0- 5.0) 3.5 ( 2.6- 4.6) ∼ ∼
Louisiana 4.7 ( 3.9- 5.7) 3.0 ( 2.2- 3.9) 9.8 ( 7.5- 12.6) ∼
Oklahoma 4.4 ( 3.5- 5.4) 4.0 ( 3.1- 5.0) ∼ ∼
Texas 4.8 ( 4.4- 5.3) 4.2 ( 3.8- 4.7) 9.1 ( 7.3- 11.3) 4.1 ( 3.3- 5.1)
West 3.9 ( 3.7- 4.1) 3.7 ( 3.5- 3.9) 9.2 ( 7.6- 11.0) 4.6 ( 3.9- 5.3)
Mountain
Arizona
Colorado 4.2 ( 3.4- 5.2) 3.7 ( 2.9- 4.6) ∼ ∼
Idaho 3.1 ( 1.9- 4.7) 3.1 ( 1.9- 4.8) ∼ ∼
Montana 4.3 ( 2.8- 6.6) 4.5 ( 2.9- 6.9) ∼ ∼
Nevada 2.7 ( 1.8- 3.8) 2.2 ( 1.4- 3.4) ∼ ∼
New Mexico 3.8 ( 2.7- 5.3) 3.7 ( 2.5- 5.2) ∼ ∼
Utah 3.3 ( 2.2- 4.7) 3.3 ( 2.2- 4.7) ∼ ∼
Wyoming
Pacific 4.0 ( 3.7- 4.2) 3.8 ( 3.5- 4.1) 8.9 ( 7.2- 10.9) 4.9 ( 4.1- 5.7)
Alaska ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 3.7 ( 3.4- 4.1) 9.4 ( 7.6- 11.5) 4.9 ( 4.1- 5.8)
San Francisco-Oakland 4.0 ( 3.3- 5.0) 3.9 ( 3.0- 5.1) 7.7 ( 4.4- 12.7) ∼
San Jose-Monterey 4.5 ( 3.4- 5.9) 4.7 ( 3.4- 6.4) ∼ ∼
Los Angeles 4.7 ( 4.1- 5.3) 4.2 ( 3.5- 4.9) 10.0 ( 7.4- 13.3) 4.7 ( 3.5- 6.2)
Hawaii 3.7 ( 2.4- 5.4) ∼ ∼ -
Oregon 2.7 ( 2.0- 3.5) 2.6 ( 1.9- 3.4) ∼ ∼
Washington 4.5 ( 3.8- 5.4) 4.7 ( 4.0- 5.6) ∼ ∼
Seattle-Puget Sound 4.7 ( 3.8- 5.7) 5.0 ( 4.0- 6.1) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.18.1.2M: Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 4.6 ( 4.5- 4.7) 4.3 ( 4.2- 4.5) 8.4 ( 7.8- 9.0) 3.2 ( 2.8- 3.6)
Northeast 4.4 ( 4.1- 4.6) 4.2 ( 3.9- 4.4) 7.7 ( 6.5- 9.1) 2.3 ( 1.5- 3.5)
New England 4.4 ( 3.9- 4.9) 4.3 ( 3.8- 4.8) 10.6 ( 6.3- 17.3) ∼
Connecticut 4.0 ( 3.1- 5.2) 3.7 ( 2.8- 4.9) ∼ ∼
Maine 4.5 ( 3.0- 6.7) 4.6 ( 3.0- 6.7) ∼ ∼
Massachusetts 4.3 ( 3.6- 5.1) 4.3 ( 3.6- 5.2) ∼ ∼
New Hampshire 3.9 ( 2.4- 6.0) 3.7 ( 2.3- 5.8) ∼ ∼
Rhode Island 4.7 ( 3.0- 7.1) 4.3 ( 2.6- 6.7) ∼ ∼
Vermont 7.0 ( 4.2- 11.2) 7.1 ( 4.2- 11.3) ∼ ∼
Middle Atlantic 4.4 ( 4.1- 4.7) 4.1 ( 3.8- 4.5) 7.4 ( 6.1- 8.9) 2.6 ( 1.7- 4.1)
New Jersey 4.8 ( 4.1- 5.6) 4.2 ( 3.6- 5.0) 10.6 ( 7.3- 15.1) ∼
New York 4.1 ( 3.6- 4.5) 4.0 ( 3.5- 4.5) 5.3 ( 3.9- 7.1) 2.8 ( 1.5- 4.7)
Pennsylvania 4.5 ( 4.0- 5.0) 4.2 ( 3.7- 4.7) 9.4 ( 6.6- 13.2) ∼
Midwest 4.7 ( 4.4- 5.0) 4.4 ( 4.1- 4.7) 9.7 ( 8.3- 11.3) 3.1 ( 1.8- 5.4)
East North Central 4.6 ( 4.3- 4.9) 4.2 ( 3.9- 4.5) 9.6 ( 8.1- 11.4) ∼
Illinois 4.3 ( 3.7- 4.9) 4.0 ( 3.4- 4.6) 8.1 ( 5.8- 11.2) ∼
Indiana 5.0 ( 4.2- 6.0) 4.2 ( 3.4- 5.2) 19.2 ( 12.5- 28.8) ∼
Michigan 4.8 ( 4.1- 5.5) 4.5 ( 3.9- 5.3) 7.4 ( 5.0- 10.8) ∼
Ohio 4.6 ( 4.0- 5.2) 4.2 ( 3.6- 4.9) 9.6 ( 6.7- 13.5) ∼
Wisconsin 4.4 ( 3.6- 5.3) 4.2 ( 3.4- 5.1) ∼ ∼
West North Central 4.9 ( 4.5- 5.4) 4.8 ( 4.3- 5.3) 10.2 ( 6.8- 15.1) ∼
Iowa 4.6 ( 3.5- 5.8) 4.5 ( 3.5- 5.8) ∼ ∼
Kansas 5.0 ( 3.8- 6.5) 5.0 ( 3.8- 6.5) ∼ ∼
Minnesota 4.9 ( 4.0- 6.0) 5.0 ( 4.0- 6.0) ∼ ∼
Missouri 5.0 ( 4.2- 6.0) 4.5 ( 3.7- 5.5) 11.9 ( 7.4- 18.7) ∼
Nebraska 4.3 ( 3.0- 6.1) 4.3 ( 2.9- 6.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota 6.9 ( 4.5- 10.2) 6.9 ( 4.5- 10.3) ∼ ∼
South 4.7 ( 4.5- 4.9) 4.3 ( 4.1- 4.5) 8.1 ( 7.3- 9.0) 3.0 ( 2.4- 3.8)
South Atlantic 4.7 ( 4.4- 5.0) 4.2 ( 3.9- 4.5) 7.7 ( 6.7- 8.8) 2.5 ( 1.7- 3.6)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.3 ( 3.9- 4.7) 4.0 ( 3.6- 4.5) 6.4 ( 4.6- 8.9) 2.6 ( 1.8- 3.9)
Georgia 5.2 ( 4.3- 6.1) 4.8 ( 3.9- 5.9) 7.0 ( 4.9- 9.8) ∼
Maryland 4.7 ( 3.8- 5.7) 4.3 ( 3.3- 5.5) 6.7 ( 4.4- 9.9) ∼
North Carolina 4.7 ( 4.0- 5.6) 4.5 ( 3.7- 5.4) 6.1 ( 4.1- 9.0) ∼
South Carolina 5.7 ( 4.6- 7.0) 4.6 ( 3.5- 6.0) 10.0 ( 6.8- 14.3) ∼
Virginia 5.2 ( 4.4- 6.2) 4.3 ( 3.5- 5.3) 10.6 ( 7.8- 14.4) ∼
West Virginia 4.4 ( 3.1- 6.0) 4.1 ( 2.9- 5.7) ∼ ∼
East South Central 5.3 ( 4.8- 5.9) 5.0 ( 4.5- 5.6) 7.2 ( 5.6- 9.2) ∼
Alabama 5.7 ( 4.7- 6.9) 5.4 ( 4.3- 6.7) 7.3 ( 4.7- 11.0) ∼
Kentucky 5.2 ( 4.2- 6.5) 4.9 ( 3.8- 6.1) ∼ ∼
Mississippi 4.5 ( 3.3- 6.0) 4.6 ( 3.3- 6.4) ∼ ∼
Tennessee 5.4 ( 4.5- 6.5) 5.0 ( 4.1- 6.1) 8.6 ( 5.2- 13.7) ∼
West South Central 4.5 ( 4.2- 5.0) 4.0 ( 3.6- 4.4) 9.9 ( 8.1- 12.0) 3.4 ( 2.5- 4.5)
Arkansas 5.3 ( 4.0- 6.8) 4.5 ( 3.3- 6.0) ∼ ∼
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Table 2.18.1.2M: Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 7.0 ( 5.8- 8.4) 5.1 ( 4.0- 6.5) 13.6 ( 10.2- 18.0) ∼
Oklahoma 3.8 ( 2.8- 4.9) 3.7 ( 2.8- 5.0) ∼ ∼
Texas 4.0 ( 3.6- 4.5) 3.8 ( 3.3- 4.3) 7.7 ( 5.6- 10.5) 3.5 ( 2.5- 4.7)
West 4.4 ( 4.1- 4.7) 4.5 ( 4.2- 4.8) 8.3 ( 6.5- 10.6) 3.6 ( 2.9- 4.4)
Mountain 4.6 ( 4.1- 5.1) 4.6 ( 4.1- 5.1) ∼ 4.0 ( 2.6- 5.9)
Arizona 3.7 ( 2.9- 4.6) 3.6 ( 2.9- 4.5) ∼ ∼
Colorado 5.3 ( 4.2- 6.6) 5.2 ( 4.0- 6.5) ∼ ∼
Idaho 3.2 ( 1.9- 5.1) 3.1 ( 1.8- 5.0) ∼ ∼
Montana 5.4 ( 3.5- 8.2) 5.6 ( 3.6- 8.4) ∼ ∼
Nevada 4.3 ( 3.0- 6.0) 4.5 ( 3.1- 6.4) ∼ ∼
New Mexico 6.1 ( 4.5- 8.2) 5.9 ( 4.3- 8.1) ∼ ∼
Utah 5.1 ( 3.6- 7.2) 5.3 ( 3.7- 7.4) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.3 ( 4.0- 4.6) 4.5 ( 4.1- 4.8) 8.9 ( 6.8- 11.5) 3.5 ( 2.7- 4.4)
Alaska ∼ ∼ ∼ ∼
California 4.1 ( 3.8- 4.5) 4.1 ( 3.8- 4.5) 8.3 ( 6.2- 10.9) 3.6 ( 2.8- 4.5)
Hawaii 2.8 ( 1.6- 4.6) ∼ ∼ ∼
Oregon 5.8 ( 4.7- 7.2) 5.8 ( 4.7- 7.2) ∼ ∼
Washington 5.0 ( 4.2- 6.0) 5.1 ( 4.2- 6.1) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.18.1.2F: Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 3.1 ( 3.0- 3.2) 2.8 ( 2.7- 2.9) 6.3 ( 5.9- 6.7) 2.7 ( 2.4- 3.1)
Northeast 3.0 ( 2.8- 3.2) 2.8 ( 2.6- 3.0) 5.6 ( 4.8- 6.5) 3.1 ( 2.3- 4.1)
New England 3.2 ( 2.8- 3.6) 3.1 ( 2.8- 3.5) 6.2 ( 3.6- 9.8) ∼
Connecticut 3.5 ( 2.8- 4.4) 3.3 ( 2.6- 4.3) ∼ ∼
Maine 2.4 ( 1.5- 3.8) 2.4 ( 1.5- 3.8) ∼ ∼
Massachusetts 3.2 ( 2.7- 3.8) 3.2 ( 2.7- 3.9) ∼ ∼
New Hampshire 4.3 ( 2.9- 6.2) 4.2 ( 2.8- 6.2) ∼ ∼
Rhode Island 2.6 ( 1.6- 4.2) 2.6 ( 1.5- 4.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.9 ( 2.7- 3.2) 2.7 ( 2.5- 2.9) 5.5 ( 4.7- 6.5) 2.9 ( 2.1- 4.0)
New Jersey 3.3 ( 2.9- 3.9) 3.0 ( 2.5- 3.5) 7.5 ( 5.4- 10.3) ∼
New York 2.6 ( 2.3- 2.9) 2.3 ( 2.1- 2.7) 4.3 ( 3.4- 5.5) 2.5 ( 1.6- 3.8)
Pennsylvania 3.1 ( 2.8- 3.5) 2.9 ( 2.5- 3.3) 6.7 ( 4.8- 9.0) ∼
Midwest 3.2 ( 3.0- 3.4) 2.9 ( 2.8- 3.1) 6.4 ( 5.5- 7.4) ∼
East North Central 3.3 ( 3.0- 3.5) 2.9 ( 2.7- 3.2) 6.5 ( 5.5- 7.7) ∼
Illinois 3.6 ( 3.2- 4.1) 3.2 ( 2.7- 3.6) 7.3 ( 5.6- 9.5) ∼
Indiana 2.8 ( 2.3- 3.4) 2.6 ( 2.1- 3.2) ∼ ∼
Michigan 3.1 ( 2.7- 3.6) 2.9 ( 2.5- 3.4) 4.9 ( 3.3- 7.0) ∼
Ohio 3.4 ( 3.0- 3.8) 3.0 ( 2.6- 3.5) 7.0 ( 5.1- 9.4) ∼
Wisconsin 2.9 ( 2.4- 3.6) 2.8 ( 2.2- 3.4) ∼ ∼
West North Central 3.0 ( 2.7- 3.4) 2.9 ( 2.6- 3.3) 5.4 ( 3.4- 8.2) ∼
Iowa 2.9 ( 2.1- 3.8) 2.8 ( 2.1- 3.7) ∼ ∼
Kansas 3.1 ( 2.3- 4.1) 2.9 ( 2.1- 3.9) ∼ ∼
Minnesota 3.1 ( 2.5- 3.8) 3.0 ( 2.4- 3.8) ∼ ∼
Missouri 3.0 ( 2.4- 3.6) 2.9 ( 2.3- 3.6) ∼ ∼
Nebraska 3.3 ( 2.3- 4.6) 2.9 ( 2.0- 4.2) ∼ ∼
North Dakota 3.6 ( 2.1- 6.2) 3.7 ( 2.1- 6.4) ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 3.2 ( 3.0- 3.3) 2.7 ( 2.5- 2.8) 6.4 ( 5.8- 6.9) 2.3 ( 1.8- 2.8)
South Atlantic 3.2 ( 3.0- 3.4) 2.6 ( 2.4- 2.8) 6.7 ( 6.0- 7.5) 2.6 ( 1.9- 3.5)
Delaware 3.5 ( 2.0- 5.7) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.5 ( 2.2- 2.8) 2.2 ( 1.9- 2.5) 5.9 ( 4.5- 7.7) 2.7 ( 1.9- 3.6)
Georgia 3.4 ( 2.9- 4.0) 2.7 ( 2.1- 3.3) 6.0 ( 4.5- 7.9) ∼
Maryland 4.2 ( 3.5- 5.0) 3.3 ( 2.6- 4.1) 7.4 ( 5.4- 9.9) ∼
North Carolina 3.4 ( 2.9- 4.0) 2.8 ( 2.3- 3.3) 6.6 ( 4.9- 8.6) ∼
South Carolina 5.1 ( 4.3- 6.1) 3.8 ( 3.0- 4.9) 9.6 ( 7.2- 12.6) ∼
Virginia 3.1 ( 2.6- 3.7) 2.6 ( 2.1- 3.3) 5.4 ( 3.8- 7.6) ∼
West Virginia 3.5 ( 2.6- 4.8) 3.1 ( 2.2- 4.3) ∼ ∼
East South Central 3.3 ( 2.9- 3.6) 2.8 ( 2.5- 3.2) 5.9 ( 4.8- 7.3) ∼
Alabama 3.4 ( 2.7- 4.2) 2.6 ( 2.0- 3.4) 6.3 ( 4.4- 8.8) ∼
Kentucky 3.2 ( 2.5- 4.0) 3.1 ( 2.4- 4.0) ∼ ∼
Mississippi 3.5 ( 2.6- 4.5) 2.2 ( 1.5- 3.3) 6.7 ( 4.5- 9.6) ∼
Tennessee 3.1 ( 2.6- 3.8) 2.9 ( 2.3- 3.6) 5.1 ( 3.1- 7.9) ∼
West South Central 3.1 ( 2.8- 3.3) 2.7 ( 2.5- 3.0) 5.8 ( 4.7- 7.0) 2.0 ( 1.4- 2.7)
Arkansas 3.1 ( 2.4- 4.1) 2.9 ( 2.1- 4.0) ∼ ∼
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Table 2.18.1.2F: Myeloma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.6 ( 2.8- 4.4) 2.6 ( 1.9- 3.5) 6.3 ( 4.5- 8.7) ∼
Oklahoma 2.8 ( 2.1- 3.6) 2.7 ( 2.0- 3.6) ∼ ∼
Texas 3.0 ( 2.7- 3.4) 2.8 ( 2.4- 3.1) 5.5 ( 4.1- 7.3) 2.0 ( 1.4- 2.8)
West 2.8 ( 2.7- 3.0) 2.8 ( 2.6- 3.0) 7.4 ( 6.0- 9.1) 3.0 ( 2.5- 3.6)
Mountain 2.8 ( 2.5- 3.1) 2.7 ( 2.4- 3.0) ∼ 2.8 ( 1.8- 4.1)
Arizona 2.5 ( 2.0- 3.2) 2.3 ( 1.8- 3.0) ∼ ∼
Colorado 3.6 ( 2.8- 4.5) 3.3 ( 2.6- 4.2) ∼ ∼
Idaho 2.9 ( 1.8- 4.6) 3.0 ( 1.8- 4.7) ∼ ∼
Montana 3.4 ( 2.1- 5.5) 3.5 ( 2.1- 5.7) ∼ ∼
Nevada 2.2 ( 1.4- 3.3) 2.0 ( 1.2- 3.2) ∼ ∼
New Mexico 2.6 ( 1.7- 3.9) 2.9 ( 1.9- 4.3) ∼ ∼
Utah 2.4 ( 1.5- 3.6) 2.4 ( 1.5- 3.6) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.9 ( 2.6- 3.1) 2.8 ( 2.6- 3.0) 7.5 ( 6.0- 9.4) 3.1 ( 2.5- 3.8)
Alaska ∼ ∼ ∼ ∼
California 2.8 ( 2.6- 3.1) 2.7 ( 2.4- 3.0) 7.9 ( 6.2- 9.9) 3.0 ( 2.4- 3.8)
Hawaii ∼ ∼ ∼ ∼
Oregon 3.0 ( 2.3- 3.9) 2.9 ( 2.2- 3.7) ∼ ∼
Washington 3.2 ( 2.6- 3.9) 3.3 ( 2.7- 4.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.19.1.1M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 22.2 ( 21.9- 22.4) 22.6 ( 22.3- 22.9) 15.6 ( 14.9- 16.4) 18.9 ( 18.0- 19.9)
Northeast 23.9 ( 23.3- 24.5) 24.2 ( 23.6- 24.9) 17.3 ( 15.7- 19.2) 23.1 ( 20.6- 26.0)
New England 23.4 ( 22.3- 24.6) 23.5 ( 22.3- 24.8) 16.3 ( 11.8- 22.6) 22.4 ( 16.2- 31.2)
Connecticut 22.5 ( 20.3- 24.9) 23.0 ( 20.6- 25.6) 17.5 ( 10.8- 29.3) 19.1 ( 10.9- 34.3)
Maine 23.5 ( 19.9- 27.6) 23.3 ( 19.7- 27.4) ∼ ∼
Massachusetts 23.1 ( 21.3- 24.9) 23.2 ( 21.5- 25.1) 13.2 ( 7.8- 22.5) 22.6 ( 14.1- 37.0)
New Hampshire 24.8 ( 20.8- 29.3) 24.0 ( 20.1- 28.5) ∼ ∼
Rhode Island 25.9 ( 21.7- 30.8) 25.8 ( 21.5- 30.9) ∼ ∼
Vermont 25.6 ( 20.2- 32.1) 25.0 ( 19.6- 31.5) ∼ ∼
Middle Atlantic 24.1 ( 23.4- 24.8) 24.5 ( 23.7- 25.3) 17.5 ( 15.7- 19.5) 23.2 ( 20.5- 26.4)
New Jersey 25.3 ( 23.8- 27.0) 25.9 ( 24.2- 27.7) 19.0 ( 15.1- 24.0) 24.6 ( 18.8- 32.2)
New York 23.2 ( 22.2- 24.3) 24.0 ( 22.9- 25.2) 16.3 ( 14.1- 19.0) 22.6 ( 19.4- 26.3)
Pennsylvania 24.2 ( 23.0- 25.5) 24.2 ( 23.0- 25.5) 18.9 ( 15.2- 23.6) -
Midwest 22.8 ( 22.3- 23.4) 22.8 ( 22.3- 23.4) 15.7 ( 14.1- 17.5) 21.3 ( 17.5- 25.9)
East North Central 22.9 ( 22.3- 23.6) 23.1 ( 22.4- 23.8) 15.9 ( 14.1- 17.9) 21.6 ( 17.4- 26.9)
Illinois 23.0 ( 21.7- 24.3) 23.6 ( 22.2- 25.1) 15.8 ( 12.9- 19.5) -
Indiana 21.0 ( 19.3- 22.8) 21.2 ( 19.4- 23.1) 10.9 ( 6.3- 18.2) ∼
Michigan 25.9 ( 24.4- 27.5) 26.2 ( 24.6- 27.8) 18.2 ( 14.5- 22.7) 21.7 ( 11.8- 39.4)
Detroit 26.0 ( 23.6- 28.5) 27.3 ( 24.6- 30.3) 18.7 ( 14.4- 24.1) ∼
Ohio 22.0 ( 20.7- 23.3) 21.6 ( 20.3- 23.0) 15.8 ( 12.4- 20.0) 33.9 ( 19.2- 59.1)
Wisconsin 21.6 ( 19.8- 23.5) 21.9 ( 20.0- 23.8) ∼ ∼
West North Central 22.5 ( 21.5- 23.5) 22.3 ( 21.3- 23.3) 14.7 ( 10.8- 20.0) 20.1 ( 12.6- 31.5)
Iowa 21.9 ( 19.6- 24.5) 21.5 ( 19.1- 24.1) ∼ ∼
Kansas 22.4 ( 19.8- 25.2) 21.8 ( 19.2- 24.7) ∼ ∼
Minnesota 26.0 ( 23.9- 28.2) 25.5 ( 23.4- 27.8) ∼ ∼
Missouri 20.3 ( 18.6- 22.1) 20.5 ( 18.7- 22.5) 15.0 ( 10.2- 22.0) ∼
Nebraska 20.5 ( 17.5- 24.0) 20.1 ( 17.1- 23.6) ∼ ∼
North Dakota 24.0 ( 18.9- 30.2) 24.1 ( 18.9- 30.4) ∼ ∼
South Dakota 23.5 ( 18.9- 29.1) 24.1 ( 19.3- 29.9) ∼ ∼
South
South Atlantic 20.5 ( 19.9- 21.1) 21.2 ( 20.6- 21.9) 14.4 ( 13.2- 15.7) 19.6 ( 17.4- 22.0)
Delaware 18.7 ( 14.6- 23.8) 19.9 ( 15.3- 25.6) ∼ ∼
District of Columbia 20.4 ( 15.1- 27.2) ∼ 25.6 ( 18.1- 35.5) ∼
Florida 21.1 ( 20.2- 22.1) 21.5 ( 20.5- 22.6) 14.2 ( 11.8- 17.3) -
Georgia 20.7 ( 19.1- 22.5) 22.4 ( 20.5- 24.5) 13.9 ( 11.2- 17.3) 12.4 ( 5.6- 28.7)
Atlanta 21.1 ( 18.0- 24.7) 22.6 ( 18.8- 26.9) 16.5 ( 11.5- 24.1) ∼
Maryland 22.6 ( 20.7- 24.7) 23.9 ( 21.6- 26.3) 15.2 ( 12.1- 19.1) ∼
North Carolina 19.6 ( 18.1- 21.1) 20.4 ( 18.8- 22.2) 13.4 ( 10.6- 16.9) 22.9 ( 10.4- 47.4)
South Carolina 19.4 ( 17.4- 21.6) 19.9 ( 17.6- 22.4) 15.4 ( 11.9- 19.9) -
Virginia 18.9 ( 17.4- 20.5) 20.2 ( 18.5- 22.1) 11.8 ( 9.0- 15.5) ∼
West Virginia 22.6 ( 19.5- 26.0) 22.5 ( 19.5- 26.0) ∼ ∼
East South Central
Alabama 18.5 ( 16.7- 20.6) 19.8 ( 17.7- 22.2) 12.3 ( 9.1- 16.5) ∼
Kentucky 19.9 ( 17.9- 22.1) 19.4 ( 17.4- 21.7) 18.1 ( 10.5- 30.4) -
Mississippi 18.5 ( 16.1- 21.2) 19.5 ( 16.6- 22.9) 14.4 ( 10.6- 19.3) ∼
Tennessee
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Table 2.19.1.1M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 22.1 ( 21.2- 22.9) 22.5 ( 21.6- 23.4) 16.1 ( 14.1- 18.4) 17.7 ( 15.7- 19.9)
Arkansas 21.1 ( 18.6- 23.8) 21.8 ( 19.2- 24.7) 11.5 ( 6.5- 19.5) ∼
Louisiana 22.7 ( 20.6- 25.1) 23.8 ( 21.2- 26.6) 18.3 ( 14.7- 22.8) ∼
Oklahoma 22.1 ( 19.8- 24.5) 21.7 ( 19.3- 24.3) ∼ ∼
Texas 22.1 ( 21.0- 23.1) 22.5 ( 21.4- 23.7) 16.1 ( 13.3- 19.5) 17.5 ( 15.5- 19.8)
West 22.1 ( 21.5- 22.7) 22.8 ( 22.1- 23.4) 17.0 ( 14.5- 19.8) 17.3 ( 15.8- 18.9)
Mountain
Arizona
Colorado 21.6 ( 19.5- 24.0) 21.2 ( 19.1- 23.7) ∼ 16.9 ( 11.3- 25.2)
Idaho 19.4 ( 16.0- 23.4) 19.0 ( 15.5- 23.0) ∼ ∼
Montana 20.1 ( 16.2- 24.8) 19.9 ( 15.9- 24.7) ∼ ∼
Nevada 23.3 ( 20.3- 26.7) 23.3 ( 20.2- 26.9) ∼ ∼
New Mexico 17.8 ( 15.0- 21.0) 18.6 ( 15.6- 22.1) ∼ 13.2 ( 9.1- 18.7)
Utah 21.4 ( 18.3- 24.9) 21.9 ( 18.7- 25.5) ∼ ∼
Wyoming
Pacific 22.4 ( 21.7- 23.1) 23.3 ( 22.5- 24.1) 17.2 ( 14.6- 20.2) 17.5 ( 15.8- 19.3)
Alaska 18.0 ( 12.2- 26.9) 20.8 ( 13.8- 32.1) ∼ ∼
California 21.5 ( 20.7- 22.3) 22.5 ( 21.6- 23.4) 17.6 ( 14.9- 20.9) 17.6 ( 15.9- 19.4)
San Francisco-Oakland 24.3 ( 22.1- 26.7) 26.1 ( 23.4- 29.1) 25.6 ( 18.7- 34.9) 20.5 ( 14.3- 29.0)
San Jose-Monterey 24.4 ( 21.3- 27.8) 28.1 ( 24.3- 32.4) ∼ 26.3 ( 18.2- 38.0)
Los Angeles 21.2 ( 19.7- 22.8) 22.4 ( 20.6- 24.2) 18.1 ( 13.8- 23.6) 17.2 ( 14.5- 20.3)
Hawaii 19.3 ( 16.0- 23.2) 22.2 ( 15.5- 31.6) ∼ -
Oregon 23.0 ( 20.8- 25.5) 22.4 ( 20.2- 24.9) ∼ ∼
Washington 27.5 ( 25.5- 29.6) 27.8 ( 25.8- 30.0) ∼ 17.2 ( 9.3- 32.5)
Seattle-Puget Sound 29.5 ( 27.0- 32.2) 30.9 ( 28.2- 33.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.19.1.1F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 15.8 ( 15.6- 16.0) 16.2 ( 16.0- 16.4) 11.0 ( 10.5- 11.5) 14.4 ( 13.7- 15.1)
Northeast 17.3 ( 16.9- 17.8) 17.6 ( 17.1- 18.1) 12.3 ( 11.2- 13.6) 15.7 ( 14.0- 17.7)
New England 17.3 ( 16.4- 18.2) 17.4 ( 16.5- 18.4) 12.2 ( 8.8- 16.6) 13.9 ( 9.6- 20.0)
Connecticut 17.9 ( 16.1- 19.8) 18.5 ( 16.6- 20.6) 13.9 ( 8.5- 21.8) 16.4 ( 9.1- 28.3)
Maine 16.6 ( 13.9- 19.8) 16.6 ( 13.9- 19.8) ∼ ∼
Massachusetts 16.8 ( 15.5- 18.1) 16.9 ( 15.6- 18.3) 10.1 ( 5.9- 16.4) 14.2 ( 8.2- 24.1)
New Hampshire 19.5 ( 16.4- 23.2) 18.1 ( 15.1- 21.6) ∼ ∼
Rhode Island 16.2 ( 13.3- 19.8) 16.5 ( 13.4- 20.3) ∼ ∼
Vermont 19.0 ( 14.8- 24.4) 18.6 ( 14.4- 23.9) ∼ ∼
Middle Atlantic 17.3 ( 16.8- 17.9) 17.6 ( 17.1- 18.2) 12.4 ( 11.2- 13.7) 16.0 ( 14.1- 18.1)
New Jersey 18.0 ( 16.8- 19.2) 18.6 ( 17.3- 19.9) 12.4 ( 9.8- 15.7) 13.5 ( 10.1- 17.9)
New York 17.1 ( 16.3- 17.9) 17.4 ( 16.6- 18.3) 12.4 ( 10.8- 14.2) 16.8 ( 14.5- 19.4)
Pennsylvania 17.2 ( 16.3- 18.1) 17.3 ( 16.3- 18.3) 12.0 ( 9.5- 15.0) -
Midwest 16.4 ( 16.0- 16.8) 16.6 ( 16.1- 17.0) 10.2 ( 9.1- 11.4) 15.3 ( 12.5- 18.7)
East North Central 16.3 ( 15.8- 16.8) 16.6 ( 16.0- 17.1) 10.4 ( 9.2- 11.7) 15.1 ( 12.0- 18.9)
Illinois 15.7 ( 14.8- 16.7) 16.3 ( 15.3- 17.4) 10.6 ( 8.5- 13.0) -
Indiana 15.5 ( 14.2- 16.9) 15.7 ( 14.3- 17.1) 9.5 ( 6.0- 14.4) ∼
Michigan 18.3 ( 17.2- 19.5) 18.2 ( 17.0- 19.5) 13.4 ( 10.8- 16.5) ∼
Detroit 20.1 ( 18.3- 22.1) 21.3 ( 19.1- 23.6) 14.0 ( 10.9- 17.7) ∼
Ohio 15.6 ( 14.6- 16.6) 15.8 ( 14.8- 16.9) 7.7 ( 5.7- 10.2) ∼
Wisconsin 16.6 ( 15.2- 18.1) 16.8 ( 15.4- 18.4) ∼ ∼
West North Central 16.6 ( 15.9- 17.4) 16.6 ( 15.8- 17.4) 9.1 ( 6.6- 12.3) 16.0 ( 9.7- 25.2)
Iowa 16.3 ( 14.4- 18.3) 16.1 ( 14.2- 18.2) ∼ ∼
Kansas 18.4 ( 16.3- 20.8) 18.1 ( 15.9- 20.5) ∼ ∼
Minnesota 17.3 ( 15.8- 19.0) 16.8 ( 15.3- 18.5) ∼ ∼
Missouri 15.3 ( 14.0- 16.7) 15.9 ( 14.5- 17.4) 7.8 ( 5.0- 11.6) ∼
Nebraska 18.4 ( 15.8- 21.3) 18.5 ( 15.9- 21.5) ∼ ∼
North Dakota 14.7 ( 11.1- 19.3) 14.0 ( 10.5- 18.7) ∼ ∼
South Dakota 15.4 ( 12.0- 19.7) 15.4 ( 11.8- 19.8) ∼ ∼
South
South Atlantic 14.1 ( 13.7- 14.5) 14.7 ( 14.2- 15.2) 10.7 ( 9.8- 11.6) 13.6 ( 12.0- 15.4)
Delaware 13.7 ( 10.5- 17.5) 13.8 ( 10.3- 18.2) ∼ ∼
District of Columbia 13.9 ( 10.1- 19.0) 15.8 ( 9.0- 29.1) 11.2 ( 7.1- 17.5) ∼
Florida 14.4 ( 13.7- 15.1) 14.6 ( 13.8- 15.4) 11.5 ( 9.6- 13.7) -
Georgia 14.3 ( 13.1- 15.5) 15.7 ( 14.3- 17.2) 9.6 ( 7.8- 11.7) ∼
Atlanta 15.4 ( 13.3- 17.8) 17.1 ( 14.4- 20.2) 11.7 ( 8.6- 15.9) ∼
Maryland 14.7 ( 13.4- 16.2) 15.6 ( 13.9- 17.3) 12.2 ( 9.8- 15.1) ∼
North Carolina 14.1 ( 13.0- 15.2) 15.1 ( 13.9- 16.4) 9.0 ( 7.1- 11.3) ∼
South Carolina 13.4 ( 11.9- 15.0) 13.8 ( 12.1- 15.7) 11.2 ( 8.6- 14.3) -
Virginia 12.9 ( 11.8- 14.1) 13.6 ( 12.3- 14.9) 10.1 ( 7.8- 12.8) ∼
West Virginia 15.8 ( 13.5- 18.3) 16.0 ( 13.7- 18.6) ∼ ∼
East South Central
Alabama 13.1 ( 11.8- 14.6) 14.3 ( 12.7- 16.1) 8.6 ( 6.4- 11.4) ∼
Kentucky 16.3 ( 14.7- 18.0) 16.6 ( 15.0- 18.5) ∼ -
Mississippi 12.5 ( 10.8- 14.3) 13.8 ( 11.7- 16.2) 8.3 ( 5.8- 11.4) ∼
Tennessee
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Table 2.19.1.1F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 15.7 ( 15.1- 16.3) 16.0 ( 15.3- 16.7) 12.0 ( 10.5- 13.6) 14.5 ( 13.0- 16.2)
Arkansas 14.2 ( 12.4- 16.2) 14.5 ( 12.6- 16.7) ∼ ∼
Louisiana 14.5 ( 13.0- 16.1) 16.3 ( 14.4- 18.3) 9.2 ( 7.0- 11.9) ∼
Oklahoma 16.5 ( 14.7- 18.4) 16.3 ( 14.5- 18.4) ∼ ∼
Texas 16.0 ( 15.2- 16.8) 16.0 ( 15.2- 16.8) 14.7 ( 12.5- 17.3) 14.2 ( 12.7- 15.9)
West 15.8 ( 15.3- 16.2) 16.0 ( 15.6- 16.5) 11.6 ( 9.8- 13.6) 14.1 ( 12.9- 15.3)
Mountain
Arizona
Colorado 16.9 ( 15.2- 18.8) 16.8 ( 15.1- 18.7) ∼ 12.3 ( 8.0- 18.3)
Idaho 17.8 ( 14.8- 21.3) 18.1 ( 15.0- 21.7) ∼ ∼
Montana 13.7 ( 10.7- 17.3) 12.9 ( 10.0- 16.6) ∼ ∼
Nevada 14.8 ( 12.6- 17.3) 15.3 ( 12.9- 18.0) ∼ ∼
New Mexico 12.9 ( 10.7- 15.3) 13.5 ( 11.2- 16.1) ∼ 13.9 ( 10.1- 18.6)
Utah 17.1 ( 14.6- 20.0) 17.3 ( 14.7- 20.3) ∼ ∼
Wyoming
Pacific 15.8 ( 15.3- 16.3) 16.1 ( 15.5- 16.7) 11.8 ( 9.9- 13.9) 14.2 ( 12.9- 15.7)
Alaska 13.1 ( 8.5- 19.4) 13.1 ( 8.0- 20.6) ∼ ∼
California 15.0 ( 14.5- 15.6) 15.3 ( 14.7- 16.0) 11.3 ( 9.4- 13.5) 13.8 ( 12.5- 15.2)
San Francisco-Oakland 14.2 ( 12.7- 15.8) 15.4 ( 13.5- 17.5) 10.6 ( 6.7- 16.1) 13.1 ( 8.9- 18.8)
San Jose-Monterey 17.0 ( 14.7- 19.6) 17.0 ( 14.4- 20.0) ∼ 15.0 ( 9.5- 22.8)
Los Angeles 15.3 ( 14.2- 16.5) 15.7 ( 14.4- 17.0) 12.1 ( 9.2- 15.7) 12.8 ( 10.8- 15.0)
Hawaii 13.6 ( 11.0- 16.6) 14.1 ( 8.8- 22.2) ∼ -
Oregon 17.9 ( 16.1- 19.9) 17.5 ( 15.6- 19.5) ∼ ∼
Washington 19.4 ( 17.9- 21.0) 19.3 ( 17.7- 21.0) ∼ 25.5 ( 15.2- 41.5)
Seattle-Puget Sound 19.5 ( 17.7- 21.5) 20.2 ( 18.2- 22.3) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.19.1.2M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 9.3 ( 9.1- 9.5) 9.7 ( 9.5- 9.9) 5.8 ( 5.4- 6.3) 6.4 ( 5.8- 7.0)
Northeast 9.4 ( 9.0- 9.8) 9.7 ( 9.3- 10.1) 5.9 ( 4.9- 7.1) 6.2 ( 4.9- 7.9)
New England 9.7 ( 9.0- 10.5) 9.9 ( 9.2- 10.8) ∼ ∼
Connecticut 9.8 ( 8.3- 11.5) 10.2 ( 8.6- 12.0) ∼ ∼
Maine 11.6 ( 9.1- 14.7) 11.7 ( 9.1- 14.8) ∼ ∼
Massachusetts 9.4 ( 8.3- 10.6) 9.5 ( 8.4- 10.8) ∼ ∼
New Hampshire 9.0 ( 6.6- 12.0) 9.1 ( 6.7- 12.2) ∼ ∼
Rhode Island 8.8 ( 6.4- 11.8) 9.0 ( 6.6- 12.2) ∼ ∼
Vermont 11.1 ( 7.4- 16.0) 11.2 ( 7.5- 16.1) ∼ ∼
Middle Atlantic 9.3 ( 8.8- 9.7) 9.6 ( 9.2- 10.1) 6.1 ( 5.0- 7.4) 6.8 ( 5.3- 8.8)
New Jersey 10.1 ( 9.1- 11.2) 10.6 ( 9.5- 11.8) 6.5 ( 4.2- 10.0) 8.0 ( 4.6- 13.4)
New York 8.1 ( 7.5- 8.7) 8.5 ( 7.8- 9.2) 6.0 ( 4.6- 7.8) 6.9 ( 5.1- 9.3)
Pennsylvania 10.3 ( 9.5- 11.1) 10.5 ( 9.7- 11.4) 6.1 ( 4.0- 9.1) ∼
Midwest 9.9 ( 9.5- 10.2) 10.2 ( 9.8- 10.6) 5.4 ( 4.4- 6.6) 6.0 ( 4.0- 8.9)
East North Central 9.8 ( 9.4- 10.3) 10.2 ( 9.8- 10.7) 5.5 ( 4.4- 6.8) 5.5 ( 3.4- 8.8)
Illinois 9.2 ( 8.3- 10.1) 9.6 ( 8.7- 10.6) 5.6 ( 3.8- 8.1) ∼
Indiana 9.7 ( 8.5- 11.0) 9.9 ( 8.7- 11.3) ∼ ∼
Michigan 10.9 ( 9.9- 11.9) 11.6 ( 10.5- 12.7) 4.7 ( 3.0- 7.3) ∼
Ohio 10.0 ( 9.1- 10.9) 10.4 ( 9.5- 11.4) 6.2 ( 4.1- 9.3) ∼
Wisconsin 9.0 ( 7.9- 10.3) 9.3 ( 8.1- 10.6) ∼ ∼
West North Central 9.9 ( 9.3- 10.6) 10.1 ( 9.4- 10.8) 5.1 ( 2.8- 8.9) ∼
Iowa 10.7 ( 9.1- 12.6) 10.8 ( 9.2- 12.7) ∼ ∼
Kansas 10.0 ( 8.3- 11.9) 10.1 ( 8.3- 12.1) ∼ ∼
Minnesota 9.8 ( 8.5- 11.3) 9.8 ( 8.5- 11.3) ∼ ∼
Missouri 10.2 ( 8.9- 11.5) 10.6 ( 9.3- 12.1) ∼ ∼
Nebraska 9.4 ( 7.4- 11.9) 9.6 ( 7.5- 12.1) ∼ ∼
North Dakota 9.4 ( 6.3- 13.6) 9.3 ( 6.2- 13.5) ∼ ∼
South Dakota 7.4 ( 4.9- 10.8) 7.3 ( 4.8- 10.9) ∼ ∼
South 9.0 ( 8.7- 9.3) 9.5 ( 9.2- 9.8) 6.0 ( 5.4- 6.7) 6.5 ( 5.6- 7.6)
South Atlantic 8.8 ( 8.4- 9.1) 9.2 ( 8.8- 9.6) 6.1 ( 5.3- 7.1) 7.2 ( 5.8- 8.9)
Delaware 10.5 ( 7.4- 14.6) 10.4 ( 7.1- 14.8) ∼ ∼
District of Columbia 10.3 ( 6.4- 15.7) ∼ ∼ ∼
Florida 9.1 ( 8.5- 9.7) 9.4 ( 8.7- 10.0) 7.0 ( 5.1- 9.5) 8.1 ( 6.4- 10.1)
Georgia 8.4 ( 7.4- 9.6) 9.0 ( 7.7- 10.4) 6.2 ( 4.3- 8.9) ∼
Maryland 8.7 ( 7.4- 10.1) 9.7 ( 8.3- 11.4) 4.7 ( 2.9- 7.7) ∼
North Carolina 8.4 ( 7.5- 9.5) 8.9 ( 7.8- 10.1) 6.1 ( 4.2- 8.8) ∼
South Carolina 7.6 ( 6.3- 9.2) 8.3 ( 6.7- 10.1) 4.7 ( 2.7- 7.9) ∼
Virginia 7.9 ( 6.9- 9.0) 8.3 ( 7.2- 9.6) 5.8 ( 3.7- 8.9) ∼
West Virginia 11.9 ( 9.7- 14.4) 12.0 ( 9.8- 14.7) ∼ ∼
East South Central 9.9 ( 9.2- 10.7) 10.5 ( 9.7- 11.4) 5.7 ( 4.3- 7.5) ∼
Alabama 9.0 ( 7.7- 10.5) 9.5 ( 8.0- 11.3) 5.9 ( 3.6- 9.1) ∼
Kentucky 10.5 ( 9.0- 12.3) 10.9 ( 9.2- 12.7) ∼ ∼
Mississippi 8.5 ( 6.9- 10.5) 9.7 ( 7.7- 12.3) ∼ ∼
Tennessee 11.0 ( 9.6- 12.5) 11.4 ( 9.9- 13.0) 7.9 ( 4.8- 12.7) ∼
West South Central 9.1 ( 8.6- 9.7) 9.5 ( 8.9- 10.2) 6.0 ( 4.7- 7.6) 6.2 ( 4.9- 7.6)
Arkansas 10.0 ( 8.3- 11.9) 10.4 ( 8.6- 12.6) ∼ ∼
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Table 2.19.1.2M: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 9.1 ( 7.7- 10.7) 10.1 ( 8.4- 12.0) 5.9 ( 3.9- 8.8) ∼
Oklahoma 9.8 ( 8.3- 11.6) 10.0 ( 8.4- 11.9) ∼ ∼
Texas 8.8 ( 8.2- 9.6) 9.2 ( 8.5- 10.0) 6.2 ( 4.4- 8.6) 6.2 ( 5.0- 7.8)
West 9.2 ( 8.8- 9.5) 9.6 ( 9.2- 10.0) 5.4 ( 4.1- 7.1) 6.4 ( 5.5- 7.5)
Mountain 9.0 ( 8.3- 9.7) 9.1 ( 8.5- 9.9) ∼ 6.6 ( 4.9- 9.0)
Arizona 8.4 ( 7.2- 9.6) 8.5 ( 7.3- 9.8) ∼ 6.3 ( 3.5- 11.2)
Colorado 9.0 ( 7.6- 10.7) 9.2 ( 7.6- 10.9) ∼ ∼
Idaho 10.8 ( 8.3- 13.9) 10.9 ( 8.3- 14.1) ∼ ∼
Montana 9.5 ( 6.8- 13.0) 9.7 ( 6.9- 13.4) ∼ ∼
Nevada 8.5 ( 6.6- 10.8) 8.7 ( 6.7- 11.2) ∼ ∼
New Mexico 9.8 ( 7.7- 12.4) 10.1 ( 7.9- 12.8) ∼ 7.7 ( 4.6- 12.5)
Utah 8.9 ( 6.8- 11.4) 9.2 ( 7.0- 11.8) ∼ ∼
Wyoming 9.6 ( 5.7- 15.3) 9.8 ( 5.9- 15.6) ∼ ∼
Pacific 9.3 ( 8.8- 9.7) 9.9 ( 9.4- 10.4) 5.6 ( 4.1- 7.5) 6.4 ( 5.3- 7.6)
Alaska 7.5 ( 3.7- 14.9) 9.3 ( 4.7- 18.7) ∼ ∼
California 8.9 ( 8.3- 9.4) 9.5 ( 8.9- 10.1) 5.5 ( 3.9- 7.5) 6.4 ( 5.3- 7.6)
Hawaii 9.0 ( 6.8- 11.8) 10.5 ( 6.2- 17.6) ∼ ∼
Oregon 10.8 ( 9.3- 12.6) 11.0 ( 9.4- 12.8) ∼ ∼
Washington 10.5 ( 9.2- 11.9) 10.8 ( 9.5- 12.2) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.19.1.2F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 5.9 ( 5.8- 6.0) 6.1 ( 6.0- 6.2) 4.3 ( 3.9- 4.6) 4.7 ( 4.3- 5.2)
Northeast 5.9 ( 5.6- 6.2) 6.1 ( 5.8- 6.3) 4.3 ( 3.6- 5.1) 4.1 ( 3.2- 5.2)
New England 5.7 ( 5.2- 6.2) 5.8 ( 5.3- 6.3) ∼ ∼
Connecticut 5.2 ( 4.3- 6.3) 5.4 ( 4.5- 6.5) ∼ ∼
Maine 4.5 ( 3.2- 6.3) 4.4 ( 3.1- 6.2) ∼ ∼
Massachusetts 6.0 ( 5.3- 6.8) 6.0 ( 5.2- 6.8) ∼ ∼
New Hampshire 6.7 ( 5.0- 9.0) 6.8 ( 5.0- 9.1) ∼ ∼
Rhode Island 6.5 ( 4.7- 8.8) 6.8 ( 4.9- 9.2) ∼ ∼
Vermont 5.0 ( 3.0- 8.1) 5.0 ( 3.0- 8.2) ∼ ∼
Middle Atlantic 6.0 ( 5.7- 6.3) 6.2 ( 5.8- 6.5) 4.4 ( 3.6- 5.2) 4.2 ( 3.2- 5.5)
New Jersey 5.7 ( 5.1- 6.4) 5.9 ( 5.2- 6.6) 3.7 ( 2.3- 5.7) 4.2 ( 2.4- 7.2)
New York 5.4 ( 5.0- 5.9) 5.7 ( 5.2- 6.2) 4.0 ( 3.1- 5.1) 4.2 ( 3.1- 5.7)
Pennsylvania 6.8 ( 6.3- 7.4) 6.9 ( 6.4- 7.6) 5.8 ( 4.1- 8.1) ∼
Midwest 6.3 ( 6.0- 6.5) 6.5 ( 6.2- 6.8) 3.8 ( 3.1- 4.6) 4.3 ( 2.8- 6.4)
East North Central 6.3 ( 6.0- 6.6) 6.5 ( 6.2- 6.9) 3.8 ( 3.1- 4.7) 4.4 ( 2.7- 6.9)
Illinois 6.1 ( 5.5- 6.7) 6.5 ( 5.9- 7.2) 3.1 ( 2.0- 4.6) ∼
Indiana 6.6 ( 5.8- 7.5) 6.7 ( 5.9- 7.7) ∼ ∼
Michigan 6.3 ( 5.6- 6.9) 6.4 ( 5.7- 7.1) 4.4 ( 3.0- 6.4) ∼
Ohio 6.5 ( 5.9- 7.2) 6.8 ( 6.2- 7.5) 3.9 ( 2.5- 5.8) ∼
Wisconsin 5.9 ( 5.1- 6.8) 5.9 ( 5.1- 6.9) ∼ ∼
West North Central 6.3 ( 5.9- 6.8) 6.4 ( 5.9- 6.9) 3.9 ( 2.2- 6.3) ∼
Iowa 6.4 ( 5.3- 7.7) 6.5 ( 5.4- 7.8) ∼ ∼
Kansas 7.5 ( 6.2- 8.9) 7.5 ( 6.2- 9.1) ∼ ∼
Minnesota 6.1 ( 5.2- 7.1) 6.1 ( 5.2- 7.1) ∼ ∼
Missouri 6.0 ( 5.3- 6.9) 6.3 ( 5.4- 7.2) ∼ ∼
Nebraska 6.0 ( 4.6- 7.7) 6.2 ( 4.8- 8.0) ∼ ∼
North Dakota 4.7 ( 2.9- 7.5) 4.3 ( 2.5- 7.1) ∼ ∼
South Dakota 7.7 ( 5.4- 10.7) 8.0 ( 5.6- 11.2) ∼ ∼
South 5.8 ( 5.6- 6.0) 6.0 ( 5.8- 6.2) 4.5 ( 4.1- 5.0) 5.2 ( 4.5- 5.9)
South Atlantic 5.6 ( 5.3- 5.8) 5.9 ( 5.6- 6.1) 4.0 ( 3.5- 4.6) 4.9 ( 3.9- 6.1)
Delaware 3.7 ( 2.2- 6.0) ∼ ∼ ∼
District of Columbia 6.1 ( 3.8- 9.7) ∼ ∼ ∼
Florida 5.6 ( 5.2- 6.0) 5.5 ( 5.1- 6.0) 5.3 ( 4.0- 6.9) 5.4 ( 4.2- 6.7)
Georgia 5.4 ( 4.7- 6.1) 5.9 ( 5.0- 6.8) 3.6 ( 2.5- 5.1) ∼
Maryland 5.4 ( 4.6- 6.3) 6.3 ( 5.3- 7.4) 2.7 ( 1.6- 4.3) ∼
North Carolina 5.8 ( 5.2- 6.6) 6.3 ( 5.6- 7.2) 3.6 ( 2.4- 5.2) ∼
South Carolina 5.6 ( 4.7- 6.7) 6.3 ( 5.2- 7.6) 3.5 ( 2.1- 5.5) ∼
Virginia 5.7 ( 5.0- 6.5) 6.1 ( 5.2- 7.0) 4.0 ( 2.6- 5.9) ∼
West Virginia 6.3 ( 5.0- 7.9) 6.3 ( 4.9- 7.9) ∼ ∼
East South Central 6.2 ( 5.7- 6.7) 6.4 ( 5.9- 7.0) 5.1 ( 4.0- 6.4) ∼
Alabama 6.4 ( 5.5- 7.5) 6.9 ( 5.9- 8.2) 4.7 ( 3.1- 6.9) ∼
Kentucky 5.7 ( 4.8- 6.8) 5.7 ( 4.8- 6.8) ∼ ∼
Mississippi 5.6 ( 4.5- 6.9) 5.1 ( 3.9- 6.6) 6.8 ( 4.6- 9.8) ∼
Tennessee 6.6 ( 5.8- 7.6) 7.1 ( 6.2- 8.1) ∼ ∼
West South Central 5.9 ( 5.5- 6.3) 6.1 ( 5.7- 6.5) 5.3 ( 4.3- 6.5) 5.5 ( 4.5- 6.7)
Arkansas 5.2 ( 4.1- 6.4) 5.6 ( 4.5- 7.0) ∼ ∼
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Table 2.19.1.2F: Non-Hodgkin Lymphoma. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 6.3 ( 5.4- 7.4) 6.2 ( 5.1- 7.5) 6.6 ( 4.8- 9.0) ∼
Oklahoma 6.5 ( 5.5- 7.8) 6.6 ( 5.5- 8.0) ∼ ∼
Texas 5.8 ( 5.3- 6.3) 6.0 ( 5.5- 6.5) 5.1 ( 3.7- 6.7) 5.5 ( 4.5- 6.7)
West 5.6 ( 5.3- 5.8) 5.8 ( 5.5- 6.1) 3.5 ( 2.6- 4.8) 4.5 ( 3.9- 5.3)
Mountain 5.9 ( 5.5- 6.5) 5.9 ( 5.4- 6.4) ∼ 5.7 ( 4.3- 7.5)
Arizona 6.0 ( 5.1- 6.9) 5.9 ( 5.0- 6.9) ∼ 5.4 ( 3.1- 8.9)
Colorado 5.8 ( 4.9- 7.0) 6.0 ( 5.0- 7.2) ∼ ∼
Idaho 6.7 ( 5.0- 9.0) 6.7 ( 4.9- 9.0) ∼ ∼
Montana 7.0 ( 5.0- 9.7) 6.6 ( 4.6- 9.4) ∼ ∼
Nevada 5.8 ( 4.4- 7.5) 5.6 ( 4.2- 7.4) ∼ ∼
New Mexico 5.1 ( 3.8- 6.7) 5.0 ( 3.7- 6.7) ∼ 6.7 ( 4.1- 10.3)
Utah 5.7 ( 4.2- 7.4) 5.5 ( 4.1- 7.2) ∼ ∼
Wyoming 7.9 ( 4.9- 12.2) 7.6 ( 4.7- 12.0) ∼ ∼
Pacific 5.4 ( 5.2- 5.7) 5.7 ( 5.4- 6.1) 3.1 ( 2.2- 4.4) 4.2 ( 3.5- 5.0)
Alaska ∼ ∼ ∼ ∼
California 5.2 ( 4.9- 5.6) 5.6 ( 5.2- 6.0) 2.8 ( 1.9- 4.1) 4.2 ( 3.4- 5.0)
Hawaii 4.7 ( 3.3- 6.5) ∼ ∼ ∼
Oregon 6.9 ( 5.8- 8.2) 7.0 ( 5.8- 8.2) ∼ ∼
Washington 5.7 ( 4.9- 6.6) 5.5 ( 4.7- 6.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.20.1.1M: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 15.8 ( 15.6- 16.0) 15.5 ( 15.3- 15.8) 17.4 ( 16.7- 18.2) 10.4 ( 9.7- 11.2)
Northeast 15.0 ( 14.6- 15.5) 14.9 ( 14.4- 15.4) 14.5 ( 13.0- 16.2) 13.6 ( 11.7- 15.8)
New England 16.1 ( 15.2- 17.1) 16.1 ( 15.1- 17.1) 16.9 ( 12.1- 23.7) 11.3 ( 6.7- 18.7)
Connecticut 15.3 ( 13.5- 17.3) 15.2 ( 13.3- 17.3) 17.5 ( 10.6- 29.6) ∼
Maine 18.0 ( 15.0- 21.5) 18.0 ( 15.0- 21.6) ∼ ∼
Massachusetts 16.1 ( 14.7- 17.6) 16.1 ( 14.6- 17.6) 17.9 ( 10.7- 29.1) ∼
New Hampshire 16.9 ( 13.8- 20.6) 16.4 ( 13.3- 20.0) ∼ ∼
Rhode Island 16.1 ( 12.8- 20.0) 16.0 ( 12.6- 20.1) ∼ ∼
Vermont 15.7 ( 11.6- 20.9) 15.9 ( 11.7- 21.2) ∼ ∼
Middle Atlantic 14.6 ( 14.1- 15.2) 14.4 ( 13.9- 15.0) 14.2 ( 12.6- 16.0) 13.9 ( 11.8- 16.4)
New Jersey 14.3 ( 13.1- 15.5) 14.3 ( 13.1- 15.6) 13.7 ( 10.4- 18.0) 13.8 ( 9.8- 19.6)
New York 14.2 ( 13.4- 15.0) 13.8 ( 13.0- 14.7) 13.6 ( 11.6- 16.0) 14.0 ( 11.5- 17.1)
Pennsylvania 15.5 ( 14.5- 16.5) 15.3 ( 14.3- 16.3) 16.5 ( 13.0- 20.8) -
Midwest 15.3 ( 14.9- 15.7) 14.8 ( 14.4- 15.3) 17.8 ( 16.1- 19.7) 9.9 ( 7.4- 13.2)
East North Central 15.1 ( 14.6- 15.7) 14.6 ( 14.1- 15.2) 17.9 ( 16.0- 19.9) 10.9 ( 8.0- 14.9)
Illinois 15.6 ( 14.5- 16.6) 15.1 ( 14.0- 16.2) 18.8 ( 15.7- 22.6) -
Indiana 15.2 ( 13.7- 16.7) 15.2 ( 13.8- 16.8) 11.6 ( 7.2- 18.6) ∼
Michigan 15.7 ( 14.6- 16.9) 15.2 ( 14.0- 16.5) 17.7 ( 14.1- 22.0) ∼
Detroit 17.0 ( 15.1- 19.1) 17.4 ( 15.3- 19.8) 16.4 ( 12.4- 21.4) ∼
Ohio 13.5 ( 12.6- 14.6) 12.7 ( 11.7- 13.7) 17.6 ( 14.0- 22.0) ∼
Wisconsin 16.5 ( 15.0- 18.1) 15.9 ( 14.3- 17.5) 26.5 ( 16.3- 45.0) ∼
West North Central 15.6 ( 14.8- 16.4) 15.3 ( 14.4- 16.1) 17.9 ( 13.7- 23.3) ∼
Iowa 15.5 ( 13.5- 17.6) 15.2 ( 13.2- 17.3) ∼ ∼
Kansas 14.8 ( 12.8- 17.1) 14.6 ( 12.5- 16.9) ∼ ∼
Minnesota 14.0 ( 12.5- 15.7) 13.7 ( 12.2- 15.3) ∼ ∼
Missouri 17.9 ( 16.3- 19.6) 17.5 ( 15.8- 19.2) 22.2 ( 16.3- 30.1) ∼
Nebraska 15.0 ( 12.5- 18.0) 14.5 ( 12.0- 17.5) ∼ ∼
North Dakota 14.6 ( 10.7- 19.6) 14.7 ( 10.7- 19.7) ∼ ∼
South Dakota 14.3 ( 10.7- 18.7) 14.5 ( 10.8- 19.1) ∼ ∼
South
South Atlantic 17.5 ( 17.0- 18.1) 17.3 ( 16.7- 17.8) 18.8 ( 17.5- 20.3) 13.8 ( 11.9- 16.0)
Delaware 14.9 ( 11.4- 19.4) 13.3 ( 9.7- 18.1) 26.7 ( 15.0- 48.6) ∼
District of Columbia 24.6 ( 18.7- 31.9) 23.3 ( 13.8- 38.8) 27.1 ( 19.5- 37.2) ∼
Florida 18.8 ( 18.0- 19.8) 19.2 ( 18.3- 20.2) 15.8 ( 13.2- 18.9) -
Georgia 19.1 ( 17.6- 20.7) 19.4 ( 17.7- 21.2) 17.9 ( 14.8- 21.7) ∼
Atlanta 17.5 ( 14.9- 20.5) 17.7 ( 14.7- 21.4) 19.3 ( 13.8- 27.4) ∼
Maryland 18.2 ( 16.5- 20.0) 18.1 ( 16.2- 20.2) 18.3 ( 14.7- 22.8) ∼
North Carolina 16.4 ( 15.1- 17.8) 15.4 ( 14.0- 16.8) 20.4 ( 17.0- 24.4) ∼
South Carolina 16.1 ( 14.3- 18.0) 14.5 ( 12.6- 16.7) 21.2 ( 17.1- 26.3) -
Virginia 14.9 ( 13.6- 16.3) 14.2 ( 12.8- 15.8) 19.0 ( 15.5- 23.4) ∼
West Virginia 16.0 ( 13.6- 18.8) 15.7 ( 13.3- 18.6) ∼ ∼
East South Central
Alabama 18.6 ( 16.8- 20.6) 19.0 ( 17.0- 21.3) 16.1 ( 12.6- 20.6) ∼
Kentucky 18.7 ( 16.8- 20.8) 18.6 ( 16.6- 20.8) 20.1 ( 12.1- 32.7) -
Mississippi 19.1 ( 16.8- 21.8) 18.5 ( 15.8- 21.6) 20.1 ( 15.6- 25.7) ∼
Tennessee
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Table 2.20.1.1M: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 16.4 ( 15.8- 17.2) 16.2 ( 15.5- 17.0) 18.8 ( 16.7- 21.3) 9.6 ( 8.1- 11.2)
Arkansas 16.4 ( 14.3- 18.8) 17.1 ( 14.8- 19.7) 11.2 ( 6.4- 18.9) ∼
Louisiana 17.8 ( 16.0- 19.9) 16.3 ( 14.3- 18.6) 23.3 ( 19.1- 28.4) ∼
Oklahoma 19.7 ( 17.6- 22.0) 19.2 ( 17.0- 21.6) 17.5 ( 10.0- 30.2) ∼
Texas 15.6 ( 14.7- 16.4) 15.6 ( 14.7- 16.5) 17.5 ( 14.7- 20.9) 9.7 ( 8.2- 11.5)
West 14.5 ( 14.0- 15.0) 14.6 ( 14.1- 15.1) 15.2 ( 13.0- 17.8) 8.1 ( 7.1- 9.2)
Mountain
Arizona
Colorado 11.1 ( 9.6- 12.8) 10.8 ( 9.3- 12.5) ∼ ∼
Idaho 16.8 ( 13.7- 20.4) 16.8 ( 13.7- 20.5) ∼ ∼
Montana 14.5 ( 11.2- 18.5) 14.2 ( 10.9- 18.3) ∼ ∼
Nevada 16.6 ( 14.2- 19.4) 16.4 ( 13.9- 19.4) ∼ ∼
New Mexico 13.1 ( 10.8- 15.9) 13.8 ( 11.4- 16.7) ∼ 9.9 ( 6.6- 14.8)
Utah 11.1 ( 8.9- 13.7) 11.5 ( 9.2- 14.2) ∼ ∼
Wyoming
Pacific 14.8 ( 14.3- 15.3) 15.0 ( 14.4- 15.6) 16.0 ( 13.5- 18.9) 8.1 ( 7.0- 9.3)
Alaska 16.4 ( 10.7- 25.3) 14.3 ( 8.1- 24.9) ∼ ∼
California 14.6 ( 13.9- 15.2) 14.9 ( 14.2- 15.6) 16.1 ( 13.5- 19.2) 8.2 ( 7.1- 9.5)
San Francisco-Oakland 15.0 ( 13.3- 16.9) 14.2 ( 12.2- 16.4) 13.8 ( 8.8- 21.1) 8.5 ( 4.9- 14.6)
San Jose-Monterey 12.3 ( 10.2- 14.8) 12.1 ( 9.7- 14.9) ∼ ∼
Los Angeles 13.6 ( 12.5- 14.9) 14.1 ( 12.8- 15.6) 18.5 ( 14.4- 23.8) 7.8 ( 6.1- 10.1)
Hawaii 14.9 ( 12.0- 18.3) 19.1 ( 13.1- 27.6) ∼ -
Oregon 16.2 ( 14.3- 18.2) 15.8 ( 13.9- 17.8) ∼ ∼
Washington 15.3 ( 13.8- 16.8) 15.1 ( 13.6- 16.7) ∼ ∼
Seattle-Puget Sound 14.7 ( 13.0- 16.6) 15.0 ( 13.1- 17.0) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.20.1.1F: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 5.9 ( 5.8- 6.1) 5.9 ( 5.7- 6.0) 5.5 ( 5.1- 5.9) 3.5 ( 3.2- 3.9)
Northeast 5.9 ( 5.6- 6.2) 5.7 ( 5.4- 6.0) 6.3 ( 5.5- 7.3) 4.4 ( 3.5- 5.5)
New England 6.2 ( 5.7- 6.7) 6.0 ( 5.5- 6.6) 7.0 ( 4.6- 10.4) ∼
Connecticut 5.8 ( 4.9- 7.0) 5.7 ( 4.7- 6.9) ∼ ∼
Maine 7.2 ( 5.4- 9.4) 7.1 ( 5.4- 9.4) ∼ ∼
Massachusetts 6.6 ( 5.8- 7.5) 6.5 ( 5.6- 7.4) ∼ ∼
New Hampshire 7.3 ( 5.5- 9.7) 7.3 ( 5.4- 9.7) ∼ ∼
Rhode Island 3.9 ( 2.5- 5.8) 3.4 ( 2.1- 5.4) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 5.8 ( 5.5- 6.1) 5.6 ( 5.2- 5.9) 6.2 ( 5.3- 7.2) 4.4 ( 3.4- 5.6)
New Jersey 6.0 ( 5.3- 6.7) 5.3 ( 4.7- 6.1) 8.4 ( 6.2- 11.1) 4.1 ( 2.3- 6.7)
New York 5.8 ( 5.3- 6.2) 5.6 ( 5.2- 6.2) 5.5 ( 4.4- 6.7) 4.6 ( 3.4- 6.0)
Pennsylvania 5.8 ( 5.2- 6.3) 5.6 ( 5.1- 6.2) 6.2 ( 4.4- 8.5) -
Midwest 5.9 ( 5.6- 6.1) 5.8 ( 5.5- 6.0) 5.2 ( 4.4- 6.1) 3.3 ( 2.1- 5.0)
East North Central 5.9 ( 5.6- 6.2) 5.7 ( 5.4- 6.0) 5.3 ( 4.5- 6.3) 3.0 ( 1.7- 5.0)
Illinois 6.0 ( 5.4- 6.6) 6.1 ( 5.5- 6.8) 4.4 ( 3.2- 6.1) -
Indiana 5.3 ( 4.5- 6.1) 5.0 ( 4.2- 5.8) ∼ ∼
Michigan 6.3 ( 5.6- 7.0) 6.0 ( 5.3- 6.7) 7.1 ( 5.2- 9.4) ∼
Detroit 6.6 ( 5.6- 7.7) 6.1 ( 5.0- 7.4) 7.8 ( 5.5- 10.7) ∼
Ohio 5.3 ( 4.8- 5.9) 5.0 ( 4.5- 5.6) 5.1 ( 3.5- 7.2) ∼
Wisconsin 7.1 ( 6.1- 8.1) 6.8 ( 5.9- 7.9) ∼ ∼
West North Central 5.9 ( 5.4- 6.4) 5.9 ( 5.5- 6.4) 4.5 ( 2.8- 7.0) ∼
Iowa 5.4 ( 4.3- 6.6) 5.4 ( 4.3- 6.6) ∼ ∼
Kansas 6.5 ( 5.3- 8.0) 6.6 ( 5.3- 8.1) ∼ ∼
Minnesota 6.3 ( 5.4- 7.3) 6.1 ( 5.2- 7.1) ∼ ∼
Missouri 6.0 ( 5.2- 6.9) 6.3 ( 5.4- 7.3) ∼ ∼
Nebraska 5.2 ( 3.8- 6.9) 5.0 ( 3.7- 6.7) ∼ ∼
North Dakota 5.3 ( 3.2- 8.4) 5.4 ( 3.3- 8.7) ∼ ∼
South Dakota 5.0 ( 3.1- 7.8) 5.3 ( 3.3- 8.3) ∼ ∼
South
South Atlantic 6.5 ( 6.2- 6.8) 6.6 ( 6.3- 6.9) 5.4 ( 4.8- 6.1) 4.1 ( 3.2- 5.1)
Delaware 5.2 ( 3.3- 7.8) 5.2 ( 3.2- 8.4) ∼ ∼
District of Columbia 5.3 ( 3.0- 9.0) ∼ ∼ ∼
Florida 7.1 ( 6.6- 7.7) 7.4 ( 6.8- 8.0) 4.8 ( 3.6- 6.3) -
Georgia 7.2 ( 6.4- 8.0) 6.9 ( 6.0- 7.9) 7.0 ( 5.5- 8.9) ∼
Atlanta 8.3 ( 6.7- 10.1) 6.8 ( 5.1- 8.9) 11.1 ( 7.7- 15.7) ∼
Maryland 6.3 ( 5.4- 7.3) 6.0 ( 5.0- 7.2) 6.2 ( 4.5- 8.4) ∼
North Carolina 6.1 ( 5.4- 6.8) 6.2 ( 5.4- 7.1) 5.3 ( 3.9- 7.1) ∼
South Carolina 5.1 ( 4.3- 6.2) 5.7 ( 4.6- 6.9) 3.7 ( 2.3- 5.6) -
Virginia 5.9 ( 5.2- 6.8) 6.0 ( 5.2- 7.0) 5.8 ( 4.2- 8.0) ∼
West Virginia 6.0 ( 4.7- 7.7) 6.0 ( 4.6- 7.7) ∼ ∼
East South Central
Alabama 5.6 ( 4.8- 6.6) 5.4 ( 4.5- 6.6) 6.0 ( 4.2- 8.4) ∼
Kentucky 5.8 ( 4.9- 6.9) 5.8 ( 4.8- 6.9) ∼ -
Mississippi 5.4 ( 4.4- 6.8) 5.5 ( 4.2- 7.2) 5.3 ( 3.4- 7.9) ∼
Tennessee
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Table 2.20.1.1F: Oral Cavity and Pharynx. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United
States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 5.8 ( 5.5- 6.2) 5.9 ( 5.5- 6.3) 5.2 ( 4.3- 6.3) 3.0 ( 2.4- 3.8)
Arkansas 5.6 ( 4.5- 6.9) 6.5 ( 5.2- 8.1) ∼ ∼
Louisiana 6.6 ( 5.6- 7.7) 6.7 ( 5.6- 8.1) 6.1 ( 4.4- 8.3) ∼
Oklahoma 6.9 ( 5.8- 8.2) 6.8 ( 5.7- 8.2) ∼ ∼
Texas 5.5 ( 5.0- 6.0) 5.4 ( 5.0- 5.9) 5.7 ( 4.4- 7.3) 2.9 ( 2.2- 3.7)
West 5.6 ( 5.4- 5.9) 5.7 ( 5.4- 6.0) 4.6 ( 3.6- 6.0) 3.2 ( 2.7- 3.8)
Mountain
Arizona
Colorado 5.6 ( 4.6- 6.7) 5.4 ( 4.4- 6.5) ∼ ∼
Idaho 5.1 ( 3.5- 7.1) 5.0 ( 3.5- 7.1) ∼ ∼
Montana 5.0 ( 3.3- 7.5) 5.0 ( 3.2- 7.5) ∼ ∼
Nevada 6.1 ( 4.7- 7.8) 5.6 ( 4.2- 7.4) ∼ ∼
New Mexico 4.1 ( 3.0- 5.7) 4.5 ( 3.2- 6.2) ∼ ∼
Utah 3.7 ( 2.6- 5.2) 3.6 ( 2.5- 5.1) ∼ ∼
Wyoming
Pacific 5.8 ( 5.5- 6.1) 5.9 ( 5.6- 6.3) 4.4 ( 3.3- 5.8) 3.3 ( 2.7- 4.0)
Alaska ∼ ∼ ∼ ∼
California 5.7 ( 5.4- 6.1) 5.8 ( 5.4- 6.2) 4.6 ( 3.4- 6.1) 3.3 ( 2.7- 4.0)
San Francisco-Oakland 6.7 ( 5.7- 7.9) 6.9 ( 5.7- 8.4) ∼ ∼
San Jose-Monterey 5.1 ( 3.9- 6.6) 5.3 ( 3.9- 7.0) ∼ ∼
Los Angeles 5.1 ( 4.5- 5.8) 5.3 ( 4.5- 6.1) 4.4 ( 2.8- 6.8) 3.3 ( 2.4- 4.6)
Hawaii 6.3 ( 4.6- 8.6) ∼ ∼ -
Oregon 6.2 ( 5.2- 7.5) 6.1 ( 5.0- 7.4) ∼ ∼
Washington 6.0 ( 5.2- 6.9) 6.2 ( 5.4- 7.2) ∼ ∼
Seattle-Puget Sound 5.9 ( 4.9- 7.0) 6.4 ( 5.3- 7.6) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.20.1.2M: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 4.1 ( 3.9- 4.2) 3.8 ( 3.7- 3.9) 6.9 ( 6.4- 7.4) 2.7 ( 2.3- 3.1)
Northeast 3.6 ( 3.4- 3.9) 3.4 ( 3.2- 3.7) 5.4 ( 4.5- 6.6) 3.2 ( 2.3- 4.5)
New England 3.4 ( 2.9- 3.9) 3.4 ( 2.9- 3.9) ∼ ∼
Connecticut 2.9 ( 2.1- 3.8) 2.9 ( 2.1- 3.9) ∼ ∼
Maine 4.0 ( 2.6- 5.9) 4.1 ( 2.7- 6.0) ∼ ∼
Massachusetts 3.7 ( 3.0- 4.5) 3.6 ( 2.9- 4.4) ∼ ∼
New Hampshire 4.1 ( 2.7- 6.2) 4.2 ( 2.7- 6.4) ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.7 ( 3.4- 4.0) 3.5 ( 3.2- 3.8) 5.6 ( 4.6- 6.9) 3.5 ( 2.4- 5.0)
New Jersey 4.0 ( 3.4- 4.7) 3.9 ( 3.2- 4.6) 5.2 ( 3.3- 8.4) ∼
New York 3.4 ( 3.0- 3.8) 3.1 ( 2.7- 3.5) 5.2 ( 3.9- 6.9) 3.3 ( 2.1- 5.3)
Pennsylvania 3.9 ( 3.5- 4.5) 3.7 ( 3.3- 4.3) 7.0 ( 4.7- 10.3) ∼
Midwest 3.8 ( 3.6- 4.0) 3.6 ( 3.4- 3.8) 7.1 ( 6.0- 8.4) ∼
East North Central 4.0 ( 3.7- 4.3) 3.7 ( 3.4- 4.0) 7.4 ( 6.2- 8.8) ∼
Illinois 4.3 ( 3.8- 4.9) 3.6 ( 3.1- 4.2) 9.3 ( 7.0- 12.2) ∼
Indiana 3.9 ( 3.2- 4.8) 3.8 ( 3.1- 4.7) ∼ ∼
Michigan 3.7 ( 3.1- 4.3) 3.5 ( 3.0- 4.2) 5.0 ( 3.2- 7.6) ∼
Ohio 4.0 ( 3.5- 4.6) 3.6 ( 3.1- 4.2) 8.5 ( 6.0- 11.9) ∼
Wisconsin 4.0 ( 3.2- 4.8) 4.0 ( 3.3- 4.9) ∼ ∼
West North Central 3.4 ( 3.0- 3.8) 3.4 ( 3.0- 3.8) 5.8 ( 3.5- 9.6) ∼
Iowa 3.4 ( 2.5- 4.5) 3.4 ( 2.5- 4.5) ∼ ∼
Kansas 2.9 ( 2.1- 4.0) 2.9 ( 2.0- 4.0) ∼ ∼
Minnesota 3.6 ( 2.8- 4.5) 3.7 ( 2.9- 4.6) ∼ ∼
Missouri 3.5 ( 2.9- 4.3) 3.3 ( 2.6- 4.1) ∼ ∼
Nebraska 3.4 ( 2.3- 5.0) 3.3 ( 2.2- 4.9) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 4.5 ( 4.3- 4.7) 4.1 ( 3.9- 4.3) 7.5 ( 6.9- 8.3) 2.7 ( 2.2- 3.5)
South Atlantic 4.4 ( 4.1- 4.6) 3.9 ( 3.6- 4.2) 7.3 ( 6.5- 8.3) 2.8 ( 1.9- 3.9)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.5 ( 4.0- 4.9) 4.4 ( 4.0- 4.9) 5.2 ( 3.7- 7.4) 2.9 ( 2.0- 4.2)
Georgia 4.9 ( 4.1- 5.8) 4.3 ( 3.5- 5.3) 7.6 ( 5.6- 10.4) ∼
Maryland 3.9 ( 3.2- 4.9) 3.9 ( 3.1- 5.0) 4.6 ( 2.9- 7.2) ∼
North Carolina 4.5 ( 3.8- 5.3) 3.6 ( 2.9- 4.4) 8.7 ( 6.5- 11.7) ∼
South Carolina 5.5 ( 4.5- 6.7) 3.5 ( 2.6- 4.6) 13.1 ( 9.8- 17.4) ∼
Virginia 4.0 ( 3.3- 4.8) 3.5 ( 2.8- 4.3) 7.0 ( 4.9- 10.1) ∼
West Virginia 3.0 ( 1.9- 4.4) 2.9 ( 1.9- 4.4) ∼ ∼
East South Central 5.2 ( 4.7- 5.8) 4.6 ( 4.1- 5.2) 9.4 ( 7.7- 11.5) ∼
Alabama 5.3 ( 4.4- 6.5) 4.8 ( 3.8- 6.1) 7.5 ( 5.0- 10.9) ∼
Kentucky 4.7 ( 3.8- 5.9) 4.2 ( 3.2- 5.3) ∼ ∼
Mississippi 6.1 ( 4.8- 7.7) 5.4 ( 3.9- 7.3) 8.4 ( 5.6- 12.4) ∼
Tennessee 5.2 ( 4.3- 6.2) 4.4 ( 3.6- 5.4) 11.9 ( 8.1- 17.1) ∼
West South Central 4.4 ( 4.0- 4.7) 4.1 ( 3.8- 4.5) 6.6 ( 5.3- 8.2) 2.7 ( 1.9- 3.7)
Arkansas 5.2 ( 4.1- 6.7) 4.9 ( 3.7- 6.4) ∼ ∼
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Table 2.20.1.2M: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 5.4 ( 4.4- 6.6) 4.4 ( 3.4- 5.7) 8.1 ( 5.6- 11.5) ∼
Oklahoma 3.9 ( 3.0- 5.0) 3.9 ( 2.9- 5.2) ∼ ∼
Texas 4.1 ( 3.7- 4.6) 4.0 ( 3.5- 4.5) 5.3 ( 3.8- 7.5) 2.8 ( 2.0- 3.9)
West 4.0 ( 3.8- 4.2) 3.9 ( 3.7- 4.2) 6.1 ( 4.6- 8.0) 2.5 ( 1.9- 3.1)
Mountain 3.4 ( 3.0- 3.8) 3.4 ( 3.0- 3.9) ∼ 2.5 ( 1.4- 4.1)
Arizona 3.6 ( 2.9- 4.4) 3.8 ( 3.0- 4.7) ∼ ∼
Colorado 3.1 ( 2.3- 4.1) 3.0 ( 2.3- 4.1) ∼ ∼
Idaho 4.1 ( 2.6- 6.2) 4.1 ( 2.6- 6.3) ∼ ∼
Montana 3.6 ( 2.1- 5.9) 3.5 ( 2.0- 5.9) ∼ ∼
Nevada 4.7 ( 3.4- 6.5) 4.9 ( 3.5- 6.9) ∼ ∼
New Mexico 2.0 ( 1.1- 3.4) ∼ ∼ ∼
Utah 2.3 ( 1.3- 3.7) 2.4 ( 1.4- 3.8) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 4.3 ( 4.0- 4.6) 4.1 ( 3.8- 4.5) 6.7 ( 5.0- 8.9) 2.5 ( 1.9- 3.3)
Alaska ∼ ∼ ∼ ∼
California 4.2 ( 3.9- 4.6) 4.1 ( 3.7- 4.5) 6.5 ( 4.8- 8.9) 2.4 ( 1.8- 3.3)
Hawaii 5.2 ( 3.6- 7.4) ∼ ∼ ∼
Oregon 3.3 ( 2.5- 4.3) 3.3 ( 2.5- 4.4) ∼ ∼
Washington 4.9 ( 4.1- 5.9) 4.8 ( 3.9- 5.7) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.20.1.2F: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 1.5 ( 1.4- 1.5) 1.4 ( 1.4- 1.5) 1.6 ( 1.5- 1.9) 0.9 ( 0.7- 1.1)
Northeast 1.3 ( 1.2- 1.5) 1.3 ( 1.2- 1.4) 1.7 ( 1.3- 2.3) ∼
New England 1.4 ( 1.2- 1.7) 1.4 ( 1.2- 1.7) ∼ ∼
Connecticut 1.3 ( 0.9- 1.9) 1.4 ( 0.9- 2.0) ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 1.6 ( 1.2- 2.1) 1.6 ( 1.2- 2.1) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 1.3 ( 1.2- 1.5) 1.3 ( 1.1- 1.4) 1.8 ( 1.3- 2.4) ∼
New Jersey 1.4 ( 1.1- 1.8) 1.2 ( 0.9- 1.6) ∼ ∼
New York 1.3 ( 1.1- 1.5) 1.3 ( 1.1- 1.6) 1.2 ( 0.7- 1.9) ∼
Pennsylvania 1.3 ( 1.0- 1.5) 1.2 ( 0.9- 1.5) 2.5 ( 1.4- 4.1) ∼
Midwest 1.4 ( 1.3- 1.5) 1.4 ( 1.3- 1.5) 1.3 ( 0.9- 1.8) ∼
East North Central 1.4 ( 1.2- 1.5) 1.4 ( 1.2- 1.5) 1.3 ( 0.9- 1.9) ∼
Illinois 1.4 ( 1.1- 1.7) 1.3 ( 1.1- 1.7) ∼ ∼
Indiana 1.2 ( 0.9- 1.6) 1.2 ( 0.9- 1.7) ∼ ∼
Michigan 1.6 ( 1.3- 2.0) 1.5 ( 1.2- 1.9) ∼ ∼
Ohio 1.4 ( 1.1- 1.7) 1.3 ( 1.1- 1.7) ∼ ∼
Wisconsin 1.3 ( 0.9- 1.8) 1.3 ( 0.9- 1.8) ∼ ∼
West North Central 1.5 ( 1.3- 1.8) 1.5 ( 1.3- 1.8) ∼ ∼
Iowa 1.6 ( 1.1- 2.3) 1.5 ( 1.0- 2.3) ∼ ∼
Kansas 1.8 ( 1.2- 2.6) 1.7 ( 1.1- 2.6) ∼ ∼
Minnesota 1.4 ( 1.0- 2.0) 1.4 ( 1.0- 2.0) ∼ ∼
Missouri 1.5 ( 1.1- 1.9) 1.5 ( 1.1- 2.0) ∼ ∼
Nebraska 1.5 ( 0.9- 2.6) 1.6 ( 0.9- 2.7) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 1.5 ( 1.4- 1.6) 1.5 ( 1.4- 1.6) 1.6 ( 1.4- 1.9) 0.7 ( 0.4- 1.0)
South Atlantic 1.5 ( 1.3- 1.6) 1.5 ( 1.3- 1.6) 1.5 ( 1.2- 1.9) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 1.5 ( 1.3- 1.8) 1.6 ( 1.3- 1.8) 1.7 ( 1.0- 2.8) ∼
Georgia 1.6 ( 1.3- 2.1) 1.6 ( 1.2- 2.2) 1.5 ( 0.9- 2.6) ∼
Maryland 1.1 ( 0.8- 1.5) 1.0 ( 0.6- 1.5) ∼ ∼
North Carolina 1.8 ( 1.4- 2.2) 1.8 ( 1.4- 2.3) ∼ ∼
South Carolina 1.5 ( 1.1- 2.2) 1.3 ( 0.8- 2.0) ∼ ∼
Virginia 1.2 ( 0.9- 1.6) 1.2 ( 0.8- 1.6) ∼ ∼
West Virginia 1.3 ( 0.8- 2.3) 1.4 ( 0.8- 2.3) ∼ ∼
East South Central 1.6 ( 1.3- 1.8) 1.4 ( 1.2- 1.7) 2.2 ( 1.5- 3.1) ∼
Alabama 1.6 ( 1.1- 2.2) 1.3 ( 0.8- 1.9) ∼ ∼
Kentucky 1.1 ( 0.7- 1.6) 1.2 ( 0.8- 1.7) ∼ ∼
Mississippi 2.1 ( 1.4- 2.9) 2.1 ( 1.3- 3.2) ∼ ∼
Tennessee 1.7 ( 1.2- 2.2) 1.5 ( 1.1- 2.1) ∼ ∼
West South Central 1.5 ( 1.3- 1.7) 1.5 ( 1.3- 1.7) 1.6 ( 1.1- 2.3) 0.7 ( 0.4- 1.3)
Arkansas 1.4 ( 0.9- 2.1) 1.3 ( 0.8- 2.1) ∼ ∼
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Table 2.20.1.2F: Oral Cavity and Pharynx. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals,
by U.S. Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 1.5 ( 1.1- 2.1) 1.4 ( 0.9- 2.1) ∼ ∼
Oklahoma 1.9 ( 1.3- 2.6) 2.0 ( 1.4- 2.8) ∼ ∼
Texas 1.4 ( 1.2- 1.7) 1.5 ( 1.2- 1.7) ∼ ∼
West 1.6 ( 1.5- 1.8) 1.6 ( 1.5- 1.8) 2.0 ( 1.4- 3.0) 1.1 ( 0.8- 1.5)
Mountain 1.4 ( 1.2- 1.7) 1.4 ( 1.1- 1.6) ∼ ∼
Arizona 1.0 ( 0.7- 1.4) 1.0 ( 0.7- 1.5) ∼ ∼
Colorado 1.6 ( 1.1- 2.2) 1.6 ( 1.1- 2.2) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 1.8 ( 1.1- 2.8) ∼ ∼ ∼
New Mexico 1.9 ( 1.1- 3.0) 1.7 ( 1.0- 2.9) ∼ ∼
Utah 1.7 ( 1.0- 2.9) 1.8 ( 1.0- 3.0) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 1.7 ( 1.6- 1.9) 1.7 ( 1.5- 1.9) 1.9 ( 1.2- 2.9) 1.1 ( 0.7- 1.6)
Alaska ∼ ∼ ∼ ∼
California 1.7 ( 1.5- 1.9) 1.7 ( 1.5- 1.9) 2.0 ( 1.2- 3.0) 1.1 ( 0.7- 1.6)
Hawaii ∼ ∼ ∼ ∼
Oregon 1.8 ( 1.3- 2.5) 1.8 ( 1.3- 2.5) ∼ ∼
Washington 1.5 ( 1.1- 2.0) 1.5 ( 1.1- 2.0) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.21.1.1: Ovary. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 12.9 ( 12.7- 13.1) 13.3 ( 13.1- 13.5) 10.0 ( 9.5- 10.5) 10.7 ( 10.1- 11.3)
Northeast 13.9 ( 13.5- 14.3) 14.4 ( 13.9- 14.8) 9.3 ( 8.2- 10.4) 9.4 ( 8.0- 10.9)
New England 13.8 ( 13.0- 14.7) 14.0 ( 13.2- 14.9) 7.5 ( 4.9- 11.1) 8.8 ( 5.2- 14.4)
Connecticut 14.2 ( 12.6- 15.9) 14.4 ( 12.8- 16.3) ∼ ∼
Maine 11.3 ( 9.1- 14.0) 11.4 ( 9.2- 14.2) ∼ ∼
Massachusetts 14.3 ( 13.1- 15.6) 14.7 ( 13.4- 16.1) ∼ ∼
New Hampshire 15.6 ( 12.9- 18.9) 14.9 ( 12.2- 18.1) ∼ ∼
Rhode Island 13.0 ( 10.3- 16.2) 12.6 ( 9.9- 15.9) ∼ ∼
Vermont 10.1 ( 7.1- 14.2) 10.2 ( 7.2- 14.4) ∼ ∼
Middle Atlantic 13.9 ( 13.4- 14.4) 14.5 ( 14.0- 15.1) 9.5 ( 8.4- 10.6) 9.5 ( 8.1- 11.2)
New Jersey 14.4 ( 13.4- 15.5) 15.2 ( 14.0- 16.4) 10.8 ( 8.3- 13.8) 9.5 ( 6.7- 13.2)
New York 13.9 ( 13.2- 14.6) 14.8 ( 14.0- 15.7) 8.8 ( 7.4- 10.3) 9.7 ( 8.0- 11.7)
Pennsylvania 13.6 ( 12.8- 14.5) 13.8 ( 13.0- 14.8) 10.0 ( 7.7- 12.8) -
Midwest 12.8 ( 12.4- 13.2) 13.0 ( 12.6- 13.4) 9.8 ( 8.7- 11.0) 10.2 ( 8.0- 12.9)
East North Central 13.0 ( 12.6- 13.5) 13.3 ( 12.8- 13.8) 10.1 ( 8.9- 11.5) 10.2 ( 7.8- 13.3)
Illinois 12.9 ( 12.0- 13.7) 13.5 ( 12.5- 14.4) 9.4 ( 7.5- 11.7) -
Indiana 11.7 ( 10.6- 12.9) 11.9 ( 10.7- 13.2) 8.2 ( 4.9- 12.9) ∼
Michigan 13.6 ( 12.6- 14.6) 13.5 ( 12.5- 14.6) 12.9 ( 10.3- 16.1) ∼
Detroit 13.4 ( 11.9- 15.0) 13.8 ( 12.0- 15.7) 12.8 ( 9.8- 16.4) ∼
Ohio 12.6 ( 11.7- 13.5) 12.7 ( 11.8- 13.7) 8.8 ( 6.7- 11.5) ∼
Wisconsin 15.1 ( 13.7- 16.6) 15.4 ( 14.0- 16.9) ∼ ∼
West North Central 12.2 ( 11.6- 12.9) 12.3 ( 11.6- 13.0) 8.0 ( 5.7- 11.2) 10.3 ( 5.8- 17.6)
Iowa 13.0 ( 11.3- 14.8) 13.0 ( 11.3- 14.8) ∼ ∼
Kansas 13.3 ( 11.5- 15.3) 13.0 ( 11.2- 15.1) ∼ ∼
Minnesota 13.2 ( 11.9- 14.7) 13.0 ( 11.7- 14.5) ∼ ∼
Missouri 11.5 ( 10.3- 12.7) 12.0 ( 10.7- 13.3) 6.5 ( 3.9- 10.3) ∼
Nebraska 9.4 ( 7.6- 11.6) 9.5 ( 7.6- 11.7) ∼ ∼
North Dakota 9.7 ( 6.8- 13.7) 9.8 ( 6.8- 13.9) ∼ ∼
South Dakota 13.5 ( 10.2- 17.6) 13.5 ( 10.1- 17.8) ∼ ∼
South
South Atlantic 12.8 ( 12.4- 13.2) 13.4 ( 12.9- 13.8) 10.3 ( 9.5- 11.3) 10.9 ( 9.4- 12.5)
Delaware 13.3 ( 10.2- 17.2) 13.4 ( 9.9- 17.9) ∼ ∼
District of Columbia 10.1 ( 6.9- 14.8) ∼ 7.8 ( 4.4- 13.6) ∼
Florida 13.8 ( 13.1- 14.5) 14.0 ( 13.3- 14.8) 11.9 ( 9.9- 14.2) -
Georgia 12.2 ( 11.1- 13.3) 12.4 ( 11.2- 13.8) 11.7 ( 9.7- 14.1) ∼
Atlanta 11.6 ( 9.9- 13.7) 12.0 ( 9.8- 14.6) 11.8 ( 8.5- 16.2) ∼
Maryland 12.7 ( 11.5- 14.1) 13.8 ( 12.2- 15.5) 10.6 ( 8.4- 13.4) ∼
North Carolina 11.6 ( 10.6- 12.6) 12.5 ( 11.4- 13.7) 8.1 ( 6.3- 10.2) ∼
South Carolina 12.6 ( 11.2- 14.2) 13.9 ( 12.1- 15.8) 9.2 ( 6.9- 12.1) -
Virginia 12.5 ( 11.4- 13.6) 12.9 ( 11.7- 14.2) 10.3 ( 8.0- 13.1) ∼
West Virginia 14.5 ( 12.4- 17.0) 14.8 ( 12.6- 17.3) ∼ ∼
East South Central
Alabama 10.5 ( 9.3- 11.8) 10.6 ( 9.2- 12.2) 9.8 ( 7.4- 12.8) ∼
Kentucky 11.0 ( 9.7- 12.5) 11.2 ( 9.8- 12.7) ∼ -
Mississippi 11.0 ( 9.4- 12.8) 11.5 ( 9.6- 13.7) 9.3 ( 6.8- 12.6) ∼
Tennessee
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Table 2.21.1.1: Ovary. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 12.0 ( 11.5- 12.5) 12.1 ( 11.6- 12.7) 10.4 ( 9.1- 12.0) 11.2 ( 9.9- 12.7)
Arkansas 10.9 ( 9.3- 12.7) 11.4 ( 9.6- 13.3) ∼ ∼
Louisiana 11.6 ( 10.3- 13.1) 12.2 ( 10.6- 14.0) 10.2 ( 7.9- 13.0) ∼
Oklahoma 13.6 ( 12.0- 15.3) 13.2 ( 11.5- 15.0) ∼ ∼
Texas 11.9 ( 11.3- 12.6) 12.0 ( 11.3- 12.8) 11.3 ( 9.4- 13.7) 11.2 ( 9.8- 12.8)
West 13.1 ( 12.7- 13.5) 13.6 ( 13.1- 14.1) 10.5 ( 8.8- 12.5) 11.1 ( 10.1- 12.2)
Mountain
Arizona
Colorado 13.3 ( 11.8- 14.9) 13.1 ( 11.6- 14.8) ∼ 11.4 ( 7.6- 16.8)
Idaho 11.9 ( 9.4- 14.9) 12.2 ( 9.7- 15.3) ∼ ∼
Montana 11.9 ( 9.2- 15.4) 12.0 ( 9.2- 15.6) ∼ ∼
Nevada 12.9 ( 10.9- 15.2) 13.0 ( 10.8- 15.5) ∼ ∼
New Mexico 12.8 ( 10.6- 15.2) 13.1 ( 10.8- 15.8) ∼ 9.8 ( 6.8- 13.9)
Utah 12.6 ( 10.4- 15.1) 12.9 ( 10.7- 15.5) ∼ ∼
Wyoming
Pacific 13.2 ( 12.7- 13.7) 13.8 ( 13.3- 14.4) 9.9 ( 8.2- 11.9) 11.3 ( 10.2- 12.6)
Alaska 13.7 ( 9.4- 19.6) 14.7 ( 9.6- 22.0) ∼ ∼
California 12.9 ( 12.4- 13.4) 13.6 ( 13.0- 14.2) 9.6 ( 7.9- 11.7) 11.4 ( 10.2- 12.6)
San Francisco-Oakland 13.0 ( 11.6- 14.6) 13.2 ( 11.5- 15.2) 9.7 ( 6.0- 15.0) 11.2 ( 7.3- 16.7)
San Jose-Monterey 12.4 ( 10.4- 14.6) 13.5 ( 11.2- 16.2) ∼ 11.9 ( 7.3- 18.7)
Los Angeles 12.6 ( 11.6- 13.6) 13.8 ( 12.6- 15.1) 9.3 ( 6.8- 12.5) 10.5 ( 8.8- 12.5)
Hawaii 9.4 ( 7.3- 12.0) 12.1 ( 7.6- 19.3) ∼ -
Oregon 14.3 ( 12.6- 16.0) 13.7 ( 12.1- 15.5) ∼ ∼
Washington 15.0 ( 13.7- 16.4) 15.0 ( 13.6- 16.5) ∼ ∼
Seattle-Puget Sound 14.9 ( 13.4- 16.7) 15.1 ( 13.4- 17.0) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
Excludes cancers newly classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Table 2.21.1.2: Ovary. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 8.8 ( 8.7- 9.0) 9.2 ( 9.0- 9.3) 7.5 ( 7.0- 7.9) 6.0 ( 5.5- 6.5)
Northeast 9.2 ( 8.8- 9.5) 9.6 ( 9.2- 10.0) 6.9 ( 6.0- 7.9) 4.7 ( 3.7- 5.8)
New England 9.0 ( 8.4- 9.6) 9.3 ( 8.6- 10.0) ∼ ∼
Connecticut 9.2 ( 7.9- 10.6) 9.7 ( 8.3- 11.2) ∼ ∼
Maine 9.4 ( 7.4- 11.8) 9.3 ( 7.3- 11.7) ∼ ∼
Massachusetts 8.9 ( 7.9- 9.9) 9.3 ( 8.3- 10.3) ∼ ∼
New Hampshire 8.8 ( 6.8- 11.3) 8.7 ( 6.6- 11.2) ∼ ∼
Rhode Island 9.1 ( 7.0- 11.8) 9.6 ( 7.3- 12.5) ∼ ∼
Vermont 8.1 ( 5.4- 11.8) 8.1 ( 5.5- 12.0) ∼ ∼
Middle Atlantic 9.2 ( 8.8- 9.6) 9.7 ( 9.3- 10.1) 7.2 ( 6.2- 8.2) 4.7 ( 3.7- 5.9)
New Jersey 9.7 ( 8.9- 10.6) 10.3 ( 9.3- 11.3) 7.6 ( 5.5- 10.3) 4.9 ( 2.8- 8.0)
New York 9.0 ( 8.5- 9.6) 9.8 ( 9.1- 10.4) 6.8 ( 5.6- 8.2) 4.5 ( 3.4- 6.0)
Pennsylvania 9.2 ( 8.5- 9.8) 9.3 ( 8.6- 10.1) 7.6 ( 5.7- 10.1) ∼
Midwest 9.0 ( 8.7- 9.3) 9.2 ( 8.9- 9.5) 7.7 ( 6.7- 8.7) 5.1 ( 3.5- 7.3)
East North Central 9.0 ( 8.7- 9.4) 9.2 ( 8.9- 9.6) 7.8 ( 6.7- 9.0) 5.4 ( 3.6- 8.0)
Illinois 8.8 ( 8.1- 9.5) 9.0 ( 8.3- 9.8) 8.1 ( 6.3- 10.3) ∼
Indiana 9.3 ( 8.3- 10.3) 9.6 ( 8.6- 10.8) ∼ ∼
Michigan 8.6 ( 7.9- 9.5) 8.8 ( 8.0- 9.6) 8.5 ( 6.4- 11.1) ∼
Ohio 9.6 ( 8.8- 10.3) 9.8 ( 9.1- 10.7) 6.9 ( 5.0- 9.3) ∼
Wisconsin 8.8 ( 7.8- 9.9) 8.8 ( 7.8- 10.0) ∼ ∼
West North Central 9.0 ( 8.5- 9.6) 9.2 ( 8.6- 9.8) 7.0 ( 4.7- 10.0) ∼
Iowa 8.6 ( 7.3- 10.1) 8.7 ( 7.4- 10.2) ∼ ∼
Kansas 8.8 ( 7.4- 10.4) 9.1 ( 7.6- 10.8) ∼ ∼
Minnesota 9.0 ( 7.9- 10.2) 9.3 ( 8.1- 10.5) ∼ ∼
Missouri 9.1 ( 8.1- 10.2) 9.2 ( 8.1- 10.3) 8.9 ( 5.8- 13.2) ∼
Nebraska 9.6 ( 7.8- 11.8) 9.8 ( 7.9- 12.1) ∼ ∼
North Dakota 8.7 ( 6.1- 12.4) 8.6 ( 6.0- 12.4) ∼ ∼
South Dakota 9.8 ( 7.1- 13.3) 10.2 ( 7.4- 13.9) ∼ ∼
South 8.5 ( 8.2- 8.7) 8.7 ( 8.4- 9.0) 7.6 ( 7.0- 8.2) 5.3 ( 4.6- 6.1)
South Atlantic 8.5 ( 8.2- 8.8) 8.8 ( 8.4- 9.1) 7.2 ( 6.5- 8.0) 4.8 ( 3.8- 5.9)
Delaware 9.9 ( 7.2- 13.2) 10.5 ( 7.6- 14.5) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 8.2 ( 7.7- 8.8) 8.4 ( 7.9- 9.0) 6.7 ( 5.2- 8.5) 4.9 ( 3.9- 6.2)
Georgia 9.0 ( 8.1- 10.0) 9.5 ( 8.4- 10.6) 8.1 ( 6.4- 10.3) ∼
Maryland 8.1 ( 7.2- 9.2) 8.7 ( 7.5- 10.0) 6.3 ( 4.6- 8.6) ∼
North Carolina 8.6 ( 7.8- 9.5) 8.7 ( 7.8- 9.7) 8.0 ( 6.2- 10.1) ∼
South Carolina 8.5 ( 7.3- 9.7) 8.7 ( 7.4- 10.2) 8.0 ( 5.8- 10.8) ∼
Virginia 9.0 ( 8.1- 10.0) 9.5 ( 8.4- 10.6) 6.8 ( 4.9- 9.1) ∼
West Virginia 8.9 ( 7.3- 10.8) 8.9 ( 7.3- 10.9) ∼ ∼
East South Central 8.9 ( 8.4- 9.5) 9.1 ( 8.5- 9.8) 8.2 ( 6.8- 9.7) ∼
Alabama 9.3 ( 8.1- 10.5) 10.0 ( 8.7- 11.4) 6.6 ( 4.7- 9.1) ∼
Kentucky 9.1 ( 7.9- 10.4) 9.4 ( 8.2- 10.8) ∼ ∼
Mississippi 6.9 ( 5.7- 8.4) 6.6 ( 5.2- 8.3) 8.1 ( 5.7- 11.2) ∼
Tennessee 9.5 ( 8.5- 10.6) 9.2 ( 8.2- 10.4) 11.7 ( 8.6- 15.5) ∼
West South Central 8.2 ( 7.8- 8.7) 8.3 ( 7.8- 8.8) 8.0 ( 6.8- 9.4) 5.9 ( 4.9- 7.1)
Arkansas 7.8 ( 6.5- 9.3) 7.9 ( 6.5- 9.6) ∼ ∼
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Table 2.21.1.2: Ovary. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 9.1 ( 7.9- 10.4) 9.4 ( 8.0- 11.0) 8.2 ( 6.1- 10.8) ∼
Oklahoma 8.7 ( 7.4- 10.1) 9.1 ( 7.7- 10.6) ∼ ∼
Texas 8.0 ( 7.5- 8.6) 8.0 ( 7.4- 8.6) 8.4 ( 6.6- 10.4) 5.9 ( 4.9- 7.1)
West 9.1 ( 8.7- 9.4) 9.6 ( 9.2- 9.9) 7.7 ( 6.2- 9.3) 7.3 ( 6.5- 8.2)
Mountain 8.9 ( 8.4- 9.6) 9.1 ( 8.5- 9.7) ∼ 8.1 ( 6.4- 10.1)
Arizona 8.9 ( 7.8- 10.0) 9.0 ( 7.9- 10.1) ∼ 8.0 ( 5.2- 11.9)
Colorado 9.4 ( 8.1- 10.8) 9.5 ( 8.2- 11.0) ∼ 7.6 ( 4.3- 12.7)
Idaho 8.1 ( 6.1- 10.6) 8.3 ( 6.2- 10.9) ∼ ∼
Montana 9.0 ( 6.7- 12.0) 9.2 ( 6.8- 12.3) ∼ ∼
Nevada 8.8 ( 7.2- 10.8) 9.2 ( 7.4- 11.4) ∼ ∼
New Mexico 9.2 ( 7.5- 11.3) 9.2 ( 7.3- 11.4) ∼ 10.0 ( 6.8- 14.3)
Utah 8.6 ( 6.8- 10.7) 8.8 ( 7.0- 11.0) ∼ ∼
Wyoming 9.0 ( 5.8- 13.6) 9.3 ( 6.0- 14.0) ∼ ∼
Pacific 9.1 ( 8.7- 9.5) 9.8 ( 9.4- 10.2) 7.9 ( 6.3- 9.8) 7.0 ( 6.1- 8.1)
Alaska ∼ ∼ ∼ ∼
California 9.1 ( 8.7- 9.6) 9.8 ( 9.3- 10.4) 7.8 ( 6.1- 9.7) 7.1 ( 6.1- 8.1)
Hawaii 6.9 ( 5.1- 9.2) ∼ ∼ ∼
Oregon 8.8 ( 7.6- 10.2) 9.0 ( 7.8- 10.5) ∼ ∼
Washington 10.2 ( 9.1- 11.4) 10.5 ( 9.4- 11.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.22.1.1M: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 12.6 ( 12.4- 12.8) 12.3 ( 12.1- 12.5) 15.9 ( 15.1- 16.7) 10.9 ( 10.2- 11.7)
Northeast 13.7 ( 13.3- 14.2) 13.7 ( 13.2- 14.2) 14.2 ( 12.5- 16.1) 11.5 ( 9.6- 13.9)
New England 13.0 ( 12.1- 13.9) 13.0 ( 12.1- 14.0) 11.4 ( 7.2- 17.7) 10.4 ( 5.8- 18.0)
Connecticut 14.8 ( 12.9- 16.8) 14.8 ( 12.9- 16.9) ∼ ∼
Maine 13.7 ( 11.0- 17.0) 13.4 ( 10.7- 16.6) ∼ ∼
Massachusetts 12.8 ( 11.5- 14.2) 13.0 ( 11.7- 14.4) ∼ ∼
New Hampshire 10.0 ( 7.5- 13.1) 9.6 ( 7.2- 12.6) ∼ ∼
Rhode Island 13.7 ( 10.6- 17.4) 13.8 ( 10.6- 17.6) ∼ ∼
Vermont 9.4 ( 6.2- 13.8) 9.5 ( 6.2- 13.9) ∼ ∼
Middle Atlantic 14.0 ( 13.4- 14.5) 14.0 ( 13.4- 14.6) 14.6 ( 12.8- 16.6) 11.7 ( 9.6- 14.2)
New Jersey 13.3 ( 12.2- 14.6) 13.6 ( 12.3- 14.9) 14.7 ( 10.7- 19.9) 10.0 ( 6.4- 15.5)
New York 14.6 ( 13.7- 15.4) 14.7 ( 13.8- 15.6) 14.8 ( 12.4- 17.6) 12.2 ( 9.7- 15.5)
Pennsylvania 13.7 ( 12.8- 14.6) 13.5 ( 12.6- 14.5) 14.2 ( 10.9- 18.5) -
Midwest 12.6 ( 12.2- 13.0) 12.1 ( 11.7- 12.6) 17.7 ( 15.8- 19.7) 8.7 ( 6.4- 11.8)
East North Central 12.9 ( 12.4- 13.4) 12.4 ( 11.9- 12.9) 17.8 ( 15.8- 20.0) 9.5 ( 6.8- 13.2)
Illinois 14.0 ( 13.0- 15.1) 13.3 ( 12.2- 14.4) 21.0 ( 17.3- 25.5) -
Indiana 12.8 ( 11.5- 14.3) 12.5 ( 11.1- 14.0) 17.7 ( 11.9- 26.0) ∼
Michigan 13.7 ( 12.6- 14.8) 13.0 ( 11.9- 14.2) 18.8 ( 14.9- 23.5) ∼
Detroit 15.3 ( 13.5- 17.4) 14.5 ( 12.6- 16.8) 20.1 ( 15.4- 25.8) ∼
Ohio 10.9 ( 10.0- 11.8) 10.5 ( 9.6- 11.4) 12.9 ( 9.8- 16.9) ∼
Wisconsin 13.4 ( 12.0- 15.0) 13.2 ( 11.7- 14.7) ∼ ∼
West North Central 11.9 ( 11.2- 12.7) 11.7 ( 11.0- 12.4) 16.8 ( 12.4- 22.7) ∼
Iowa 12.0 ( 10.3- 13.9) 11.9 ( 10.2- 13.8) ∼ ∼
Kansas 13.1 ( 11.2- 15.3) 13.0 ( 11.0- 15.3) ∼ ∼
Minnesota 11.5 ( 10.1- 13.0) 11.4 ( 10.0- 12.9) ∼ ∼
Missouri 12.8 ( 11.4- 14.3) 12.3 ( 10.9- 13.8) 18.7 ( 12.9- 26.7) ∼
Nebraska 11.6 ( 9.3- 14.2) 11.6 ( 9.3- 14.3) ∼ ∼
North Dakota 9.0 ( 6.0- 13.0) 8.5 ( 5.6- 12.6) ∼ ∼
South Dakota 8.8 ( 6.0- 12.4) 8.9 ( 6.1- 12.6) ∼ ∼
South
South Atlantic 12.4 ( 11.9- 12.8) 11.9 ( 11.4- 12.4) 15.1 ( 13.7- 16.5) 11.6 ( 9.8- 13.7)
Delaware 8.9 ( 6.1- 12.7) 9.0 ( 6.0- 13.2) ∼ ∼
District of Columbia 13.6 ( 9.1- 19.7) ∼ 16.6 ( 10.5- 25.4) ∼
Florida 13.0 ( 12.3- 13.8) 13.0 ( 12.2- 13.8) 13.6 ( 11.0- 16.8) -
Georgia 12.3 ( 11.0- 13.7) 12.1 ( 10.6- 13.7) 13.1 ( 10.2- 16.6) ∼
Atlanta 11.1 ( 8.9- 14.0) 10.6 ( 8.0- 13.9) 12.2 ( 7.5- 19.8) ∼
Maryland 12.6 ( 11.2- 14.2) 12.7 ( 11.0- 14.5) 10.7 ( 7.9- 14.6) ∼
North Carolina 12.4 ( 11.2- 13.6) 11.1 ( 9.9- 12.5) 19.5 ( 15.9- 23.9) ∼
South Carolina 11.3 ( 9.8- 13.1) 9.7 ( 8.2- 11.6) 17.7 ( 13.5- 22.9) -
Virginia 12.4 ( 11.1- 13.8) 11.5 ( 10.1- 13.0) 16.3 ( 12.6- 20.9) ∼
West Virginia 10.0 ( 8.1- 12.3) 9.7 ( 7.8- 12.0) ∼ ∼
East South Central
Alabama 12.0 ( 10.5- 13.7) 11.4 ( 9.8- 13.4) 15.0 ( 11.3- 19.7) ∼
Kentucky 13.6 ( 11.9- 15.6) 12.9 ( 11.2- 14.9) 25.8 ( 16.0- 40.3) -
Mississippi 13.9 ( 11.8- 16.3) 12.4 ( 10.1- 15.2) 17.9 ( 13.2- 23.7) ∼
Tennessee
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Table 2.22.1.1M: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 12.2 ( 11.6- 12.8) 11.8 ( 11.1- 12.5) 16.5 ( 14.3- 19.1) 11.6 ( 10.0- 13.6)
Arkansas 10.1 ( 8.4- 12.0) 9.4 ( 7.7- 11.5) 15.3 ( 9.0- 24.9) ∼
Louisiana 14.3 ( 12.6- 16.2) 14.1 ( 12.1- 16.4) 15.5 ( 11.9- 20.0) ∼
Oklahoma 12.1 ( 10.5- 14.0) 12.1 ( 10.3- 14.1) ∼ ∼
Texas 12.0 ( 11.3- 12.9) 11.7 ( 10.9- 12.5) 17.5 ( 14.3- 21.3) 11.8 ( 10.0- 13.8)
West 11.9 ( 11.4- 12.3) 11.9 ( 11.4- 12.4) 16.5 ( 13.9- 19.6) 10.4 ( 9.2- 11.8)
Mountain
Arizona
Colorado 11.2 ( 9.7- 13.0) 11.3 ( 9.7- 13.2) ∼ 14.5 ( 9.1- 23.0)
Idaho 12.1 ( 9.5- 15.3) 12.0 ( 9.4- 15.2) ∼ ∼
Montana 12.2 ( 9.2- 15.9) 12.2 ( 9.2- 16.0) ∼ ∼
Nevada 11.2 ( 9.2- 13.7) 11.3 ( 9.2- 13.9) ∼ ∼
New Mexico 11.0 ( 8.8- 13.6) 11.0 ( 8.7- 13.7) ∼ 12.0 ( 7.9- 17.8)
Utah 11.4 ( 9.1- 14.1) 11.5 ( 9.2- 14.3) ∼ ∼
Wyoming
Pacific 12.0 ( 11.5- 12.5) 12.0 ( 11.5- 12.6) 17.1 ( 14.2- 20.4) 9.7 ( 8.4- 11.2)
Alaska 15.2 ( 9.2- 24.8) 12.8 ( 6.6- 23.9) ∼ ∼
California 11.5 ( 10.9- 12.1) 11.6 ( 11.0- 12.3) 17.1 ( 14.1- 20.6) 9.4 ( 8.0- 10.9)
San Francisco-Oakland 9.6 ( 8.2- 11.1) 9.6 ( 7.9- 11.5) 16.5 ( 10.4- 25.1) ∼
San Jose-Monterey 13.1 ( 10.8- 15.8) 13.0 ( 10.4- 16.1) ∼ ∼
Los Angeles 10.5 ( 9.4- 11.6) 10.7 ( 9.4- 12.0) 15.6 ( 11.5- 21.0) 8.6 ( 6.6- 11.1)
Hawaii 14.5 ( 11.6- 17.9) 12.1 ( 7.2- 19.8) ∼ -
Oregon 13.3 ( 11.6- 15.2) 13.2 ( 11.4- 15.1) ∼ ∼
Washington 13.1 ( 11.7- 14.6) 13.0 ( 11.6- 14.6) ∼ ∼
Seattle-Puget Sound 12.5 ( 10.9- 14.4) 12.5 ( 10.7- 14.4) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.22.1.1F: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 9.8 ( 9.6- 9.9) 9.5 ( 9.3- 9.7) 12.6 ( 12.0- 13.2) 9.0 ( 8.4- 9.6)
Northeast 10.5 ( 10.1- 10.8) 10.5 ( 10.1- 10.9) 10.6 ( 9.4- 11.8) 9.3 ( 7.9- 11.0)
New England 10.3 ( 9.7- 11.0) 10.4 ( 9.7- 11.1) 9.2 ( 6.1- 13.4) ∼
Connecticut 10.6 ( 9.3- 12.1) 10.7 ( 9.3- 12.3) ∼ ∼
Maine 9.4 ( 7.5- 11.9) 9.5 ( 7.5- 12.0) ∼ ∼
Massachusetts 10.6 ( 9.6- 11.7) 10.8 ( 9.8- 12.0) ∼ ∼
New Hampshire 10.1 ( 7.9- 12.8) 10.1 ( 7.9- 12.8) ∼ ∼
Rhode Island 10.4 ( 8.1- 13.2) 10.4 ( 8.1- 13.3) ∼ ∼
Vermont 6.9 ( 4.5- 10.5) 6.7 ( 4.3- 10.3) ∼ ∼
Middle Atlantic 10.5 ( 10.2- 11.0) 10.5 ( 10.1- 11.0) 10.7 ( 9.5- 12.0) 9.8 ( 8.2- 11.6)
New Jersey 10.8 ( 9.9- 11.7) 10.8 ( 9.8- 11.8) 11.5 ( 8.8- 14.8) 11.0 ( 7.7- 15.3)
New York 11.0 ( 10.4- 11.6) 11.3 ( 10.7- 12.0) 9.6 ( 8.1- 11.2) 9.5 ( 7.6- 11.6)
Pennsylvania 9.8 ( 9.1- 10.5) 9.5 ( 8.8- 10.2) 12.8 ( 10.1- 15.9) -
Midwest 9.8 ( 9.5- 10.1) 9.4 ( 9.1- 9.7) 14.3 ( 13.0- 15.8) 8.0 ( 5.9- 10.7)
East North Central 10.0 ( 9.6- 10.4) 9.6 ( 9.2- 10.0) 14.0 ( 12.6- 15.6) 8.2 ( 5.9- 11.3)
Illinois 10.1 ( 9.4- 10.9) 9.8 ( 9.0- 10.6) 13.2 ( 10.8- 15.9) -
Indiana 10.4 ( 9.4- 11.6) 10.0 ( 8.9- 11.1) 15.2 ( 10.5- 21.3) ∼
Michigan 10.4 ( 9.5- 11.2) 9.6 ( 8.8- 10.5) 16.1 ( 13.1- 19.6) ∼
Detroit 11.7 ( 10.3- 13.2) 10.4 ( 8.9- 12.0) 16.4 ( 12.9- 20.5) ∼
Ohio 9.3 ( 8.5- 10.0) 8.9 ( 8.2- 9.7) 12.4 ( 9.8- 15.5) ∼
Wisconsin 10.2 ( 9.1- 11.4) 10.0 ( 8.9- 11.2) 17.8 ( 9.9- 30.0) ∼
West North Central 9.4 ( 8.9- 10.0) 9.1 ( 8.5- 9.7) 16.0 ( 12.5- 20.2) ∼
Iowa 10.3 ( 8.9- 11.9) 10.4 ( 9.0- 12.0) ∼ ∼
Kansas 9.1 ( 7.7- 10.8) 8.7 ( 7.3- 10.4) ∼ ∼
Minnesota 8.9 ( 7.8- 10.1) 8.5 ( 7.4- 9.7) ∼ ∼
Missouri 10.0 ( 9.0- 11.1) 9.5 ( 8.5- 10.7) 14.2 ( 10.2- 19.3) ∼
Nebraska 7.9 ( 6.2- 9.8) 7.3 ( 5.7- 9.3) ∼ ∼
North Dakota 7.8 ( 5.3- 11.3) 7.9 ( 5.3- 11.5) ∼ ∼
South Dakota 10.8 ( 8.1- 14.3) 10.5 ( 7.8- 14.0) ∼ ∼
South
South Atlantic 9.6 ( 9.2- 9.9) 8.9 ( 8.6- 9.3) 13.0 ( 12.0- 14.0) 9.3 ( 8.0- 10.9)
Delaware 11.2 ( 8.4- 14.7) 10.6 ( 7.7- 14.5) ∼ ∼
District of Columbia 11.7 ( 8.2- 16.4) ∼ 12.7 ( 8.4- 19.2) ∼
Florida 10.0 ( 9.4- 10.6) 9.7 ( 9.1- 10.3) 13.2 ( 11.0- 15.7) -
Georgia 9.5 ( 8.5- 10.4) 7.5 ( 6.6- 8.6) 16.3 ( 13.7- 19.2) ∼
Atlanta 9.1 ( 7.5- 11.0) 7.4 ( 5.7- 9.6) 13.8 ( 10.0- 18.8) ∼
Maryland 10.4 ( 9.3- 11.6) 9.4 ( 8.2- 10.8) 14.0 ( 11.2- 17.2) ∼
North Carolina 8.8 ( 8.0- 9.7) 8.2 ( 7.3- 9.2) 11.4 ( 9.2- 14.0) ∼
South Carolina 9.2 ( 8.0- 10.5) 9.1 ( 7.8- 10.7) 9.4 ( 7.1- 12.3) -
Virginia 9.1 ( 8.2- 10.1) 8.6 ( 7.6- 9.7) 12.1 ( 9.6- 15.1) ∼
West Virginia 7.5 ( 6.1- 9.3) 7.5 ( 6.0- 9.3) ∼ ∼
East South Central
Alabama 8.1 ( 7.1- 9.3) 7.8 ( 6.7- 9.1) 9.3 ( 6.9- 12.1) ∼
Kentucky 10.0 ( 8.8- 11.4) 9.8 ( 8.6- 11.2) 13.9 ( 8.2- 22.1) -
Mississippi 10.0 ( 8.5- 11.7) 8.8 ( 7.2- 10.8) 13.4 ( 10.2- 17.3) ∼
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Table 2.22.1.1F: Pancreas. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 9.6 ( 9.2- 10.1) 9.2 ( 8.7- 9.7) 13.2 ( 11.6- 15.0) 8.8 ( 7.6- 10.3)
Arkansas 8.6 ( 7.3- 10.2) 7.9 ( 6.5- 9.5) 15.2 ( 10.1- 22.1) ∼
Louisiana 10.6 ( 9.4- 12.0) 9.8 ( 8.4- 11.3) 13.3 ( 10.6- 16.5) ∼
Oklahoma 10.0 ( 8.7- 11.5) 9.7 ( 8.3- 11.2) 18.2 ( 10.9- 28.7) ∼
Texas 9.5 ( 8.9- 10.1) 9.2 ( 8.6- 9.9) 12.4 ( 10.2- 14.9) 8.7 ( 7.4- 10.1)
West 9.3 ( 9.0- 9.7) 9.4 ( 9.0- 9.8) 12.5 ( 10.6- 14.6) 9.1 ( 8.1- 10.2)
Mountain
Arizona
Colorado 9.1 ( 7.9- 10.5) 9.0 ( 7.7- 10.4) ∼ ∼
Idaho 10.6 ( 8.3- 13.4) 10.8 ( 8.5- 13.6) ∼ ∼
Montana 8.9 ( 6.6- 11.9) 8.6 ( 6.4- 11.7) ∼ ∼
Nevada 10.2 ( 8.4- 12.3) 9.7 ( 7.8- 11.9) ∼ ∼
New Mexico 8.4 ( 6.7- 10.4) 8.6 ( 6.9- 10.8) ∼ 5.7 ( 3.3- 9.0)
Utah 7.9 ( 6.1- 9.9) 8.0 ( 6.2- 10.1) ∼ ∼
Wyoming
Pacific 9.4 ( 9.0- 9.8) 9.5 ( 9.1- 9.9) 12.4 ( 10.4- 14.7) 9.8 ( 8.7- 11.1)
Alaska 7.3 ( 4.0- 12.4) ∼ ∼ ∼
California 9.3 ( 8.9- 9.8) 9.5 ( 9.0- 10.0) 12.1 ( 10.1- 14.5) 9.8 ( 8.7- 11.1)
San Francisco-Oakland 10.3 ( 9.1- 11.7) 11.1 ( 9.5- 12.8) 14.7 ( 9.9- 21.0) 10.6 ( 6.7- 16.0)
San Jose-Monterey 7.8 ( 6.2- 9.6) 8.0 ( 6.2- 10.1) ∼ ∼
Los Angeles 9.4 ( 8.6- 10.4) 9.7 ( 8.7- 10.8) 10.3 ( 7.6- 13.7) 7.5 ( 5.9- 9.3)
Hawaii 9.4 ( 7.3- 11.9) ∼ ∼ -
Oregon 8.9 ( 7.6- 10.3) 8.7 ( 7.5- 10.2) ∼ ∼
Washington 10.2 ( 9.1- 11.4) 10.0 ( 8.9- 11.2) ∼ ∼
Seattle-Puget Sound 10.3 ( 9.0- 11.7) 10.0 ( 8.7- 11.6) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.22.1.2M: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 12.0 ( 11.9- 12.2) 11.9 ( 11.7- 12.1) 15.5 ( 14.7- 16.3) 9.2 ( 8.5- 10.0)
Northeast 12.5 ( 12.1- 12.9) 12.6 ( 12.2- 13.1) 13.1 ( 11.5- 14.9) 9.8 ( 8.0- 12.0)
New England 13.2 ( 12.3- 14.1) 13.3 ( 12.4- 14.2) 13.2 ( 8.8- 19.6) 11.5 ( 6.3- 19.7)
Connecticut 13.9 ( 12.1- 15.9) 14.0 ( 12.1- 16.0) ∼ ∼
Maine 13.3 ( 10.7- 16.6) 13.3 ( 10.6- 16.6) ∼ ∼
Massachusetts 14.0 ( 12.7- 15.5) 14.4 ( 13.0- 15.9) ∼ ∼
New Hampshire 10.2 ( 7.7- 13.4) 10.0 ( 7.5- 13.1) ∼ ∼
Rhode Island 10.5 ( 7.9- 13.9) 10.1 ( 7.4- 13.5) ∼ ∼
Vermont 11.0 ( 7.5- 15.8) 11.1 ( 7.6- 15.9) ∼ ∼
Middle Atlantic 12.3 ( 11.7- 12.8) 12.4 ( 11.9- 13.0) 13.0 ( 11.3- 15.0) 9.5 ( 7.6- 11.9)
New Jersey 12.7 ( 11.6- 13.9) 12.9 ( 11.7- 14.2) 14.8 ( 10.8- 20.0) 6.0 ( 3.4- 10.5)
New York 12.1 ( 11.4- 12.9) 12.5 ( 11.7- 13.4) 11.8 ( 9.7- 14.4) 10.8 ( 8.4- 13.9)
Pennsylvania 12.2 ( 11.3- 13.1) 12.1 ( 11.2- 13.0) 14.8 ( 11.3- 19.2) ∼
Midwest 12.3 ( 11.9- 12.7) 12.1 ( 11.7- 12.5) 16.4 ( 14.6- 18.3) 10.5 ( 7.8- 14.1)
East North Central 12.7 ( 12.2- 13.2) 12.4 ( 11.9- 13.0) 16.5 ( 14.6- 18.7) 11.3 ( 8.2- 15.5)
Illinois 12.8 ( 11.8- 13.8) 12.1 ( 11.1- 13.2) 18.2 ( 14.8- 22.4) 10.8 ( 6.8- 16.9)
Indiana 13.3 ( 12.0- 14.8) 13.3 ( 11.9- 14.9) 15.0 ( 9.6- 23.1) ∼
Michigan 12.8 ( 11.7- 13.9) 12.6 ( 11.5- 13.8) 15.0 ( 11.6- 19.2) ∼
Ohio 12.3 ( 11.3- 13.3) 11.9 ( 10.9- 13.0) 16.9 ( 13.1- 21.6) ∼
Wisconsin 12.7 ( 11.3- 14.2) 12.7 ( 11.3- 14.2) ∼ ∼
West North Central 11.4 ( 10.7- 12.2) 11.4 ( 10.7- 12.1) 15.5 ( 11.1- 21.3) ∼
Iowa 10.7 ( 9.1- 12.6) 10.7 ( 9.1- 12.6) ∼ ∼
Kansas 12.2 ( 10.3- 14.4) 11.9 ( 10.0- 14.1) ∼ ∼
Minnesota 10.8 ( 9.4- 12.3) 10.9 ( 9.5- 12.4) ∼ ∼
Missouri 12.3 ( 11.0- 13.8) 12.2 ( 10.8- 13.7) 16.5 ( 10.9- 24.4) ∼
Nebraska 10.9 ( 8.7- 13.5) 11.1 ( 8.9- 13.8) ∼ ∼
North Dakota 13.3 ( 9.6- 18.2) 13.0 ( 9.3- 17.9) ∼ ∼
South Dakota 9.2 ( 6.4- 13.0) 9.6 ( 6.6- 13.5) ∼ ∼
South 12.1 ( 11.8- 12.5) 11.6 ( 11.3- 12.0) 16.4 ( 15.3- 17.5) 9.6 ( 8.5- 10.9)
South Atlantic 11.9 ( 11.5- 12.4) 11.4 ( 10.9- 11.9) 15.5 ( 14.2- 17.0) 8.5 ( 7.0- 10.4)
Delaware 10.2 ( 7.2- 14.2) 9.7 ( 6.5- 13.9) ∼ ∼
District of Columbia 15.5 ( 10.7- 21.9) ∼ 17.0 ( 10.7- 25.8) ∼
Florida 11.8 ( 11.1- 12.5) 11.7 ( 11.0- 12.4) 14.2 ( 11.5- 17.5) 9.1 ( 7.4- 11.3)
Georgia 11.7 ( 10.4- 13.1) 11.1 ( 9.7- 12.6) 14.2 ( 11.1- 18.0) ∼
Maryland 13.0 ( 11.5- 14.6) 12.9 ( 11.3- 14.8) 13.3 ( 10.0- 17.6) ∼
North Carolina 12.5 ( 11.3- 13.8) 11.9 ( 10.6- 13.3) 16.1 ( 12.9- 20.2) ∼
South Carolina 11.3 ( 9.7- 13.0) 9.6 ( 8.0- 11.4) 17.6 ( 13.5- 22.8) ∼
Virginia 12.8 ( 11.5- 14.2) 11.6 ( 10.3- 13.1) 18.4 ( 14.6- 23.0) ∼
West Virginia 10.1 ( 8.1- 12.4) 10.0 ( 8.0- 12.4) ∼ ∼
East South Central 13.1 ( 12.3- 14.0) 12.4 ( 11.5- 13.4) 17.6 ( 15.0- 20.6) ∼
Alabama 12.5 ( 10.9- 14.3) 11.8 ( 10.1- 13.8) 15.5 ( 11.6- 20.3) ∼
Kentucky 13.4 ( 11.7- 15.3) 13.2 ( 11.4- 15.1) 18.0 ( 10.2- 30.8) ∼
Mississippi 13.5 ( 11.4- 16.0) 11.5 ( 9.3- 14.2) 19.9 ( 14.9- 26.1) ∼
Tennessee 13.2 ( 11.7- 14.7) 12.7 ( 11.2- 14.3) 17.7 ( 12.8- 24.2) ∼
West South Central 12.1 ( 11.5- 12.7) 11.6 ( 10.9- 12.3) 17.5 ( 15.2- 20.1) 10.8 ( 9.1- 12.7)
Arkansas 12.0 ( 10.1- 14.1) 10.9 ( 9.0- 13.1) 19.9 ( 12.7- 30.2) ∼
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Table 2.22.1.2M: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 14.3 ( 12.6- 16.3) 13.9 ( 12.0- 16.2) 16.2 ( 12.5- 20.9) ∼
Oklahoma 12.1 ( 10.4- 14.0) 12.6 ( 10.7- 14.6) ∼ ∼
Texas 11.6 ( 10.8- 12.4) 11.1 ( 10.3- 11.9) 18.4 ( 15.1- 22.3) 11.2 ( 9.5- 13.2)
West 11.2 ( 10.8- 11.6) 11.4 ( 11.0- 11.9) 13.7 ( 11.4- 16.5) 8.4 ( 7.4- 9.6)
Mountain 10.7 ( 10.0- 11.5) 10.9 ( 10.1- 11.7) 12.0 ( 6.6- 20.9) 9.6 ( 7.5- 12.3)
Arizona 9.9 ( 8.7- 11.3) 10.0 ( 8.7- 11.4) ∼ 9.8 ( 5.9- 15.8)
Colorado 10.6 ( 9.1- 12.3) 10.9 ( 9.3- 12.7) ∼ 14.0 ( 8.7- 22.2)
Idaho 11.0 ( 8.4- 14.1) 11.1 ( 8.5- 14.2) ∼ ∼
Montana 11.1 ( 8.2- 14.8) 11.1 ( 8.1- 14.8) ∼ ∼
Nevada 13.0 ( 10.7- 15.6) 13.2 ( 10.9- 16.1) ∼ ∼
New Mexico 10.5 ( 8.4- 13.1) 10.3 ( 8.1- 13.0) ∼ 8.8 ( 5.5- 13.7)
Utah 10.8 ( 8.5- 13.5) 11.1 ( 8.8- 13.9) ∼ ∼
Wyoming 10.0 ( 6.3- 15.6) 10.3 ( 6.4- 15.9) ∼ ∼
Pacific 11.4 ( 10.9- 11.9) 11.7 ( 11.2- 12.3) 14.2 ( 11.7- 17.3) 8.0 ( 6.8- 9.4)
Alaska 15.8 ( 9.5- 25.9) 12.3 ( 6.4- 23.1) ∼ ∼
California 11.0 ( 10.4- 11.6) 11.4 ( 10.7- 12.0) 14.6 ( 11.9- 17.9) 7.6 ( 6.5- 9.0)
Hawaii 11.8 ( 9.2- 14.9) 13.0 ( 7.9- 20.9) ∼ ∼
Oregon 12.6 ( 10.9- 14.5) 12.5 ( 10.8- 14.4) ∼ ∼
Washington 12.5 ( 11.2- 14.0) 13.0 ( 11.6- 14.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.22.1.2F: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 9.2 ( 9.1- 9.4) 9.0 ( 8.8- 9.1) 12.5 ( 11.9- 13.0) 7.4 ( 6.9- 8.0)
Northeast 9.6 ( 9.3- 9.9) 9.6 ( 9.2- 9.9) 11.2 ( 10.0- 12.4) 6.5 ( 5.3- 7.9)
New England 9.6 ( 8.9- 10.2) 9.5 ( 8.8- 10.2) 12.7 ( 9.0- 17.5) ∼
Connecticut 8.8 ( 7.7- 10.2) 8.6 ( 7.4- 10.0) 13.5 ( 7.9- 21.7) ∼
Maine 9.6 ( 7.6- 12.0) 9.5 ( 7.6- 12.0) ∼ ∼
Massachusetts 9.7 ( 8.8- 10.8) 9.7 ( 8.7- 10.8) 12.6 ( 7.5- 19.9) ∼
New Hampshire 10.5 ( 8.2- 13.2) 10.6 ( 8.3- 13.3) ∼ ∼
Rhode Island 11.0 ( 8.7- 13.9) 10.9 ( 8.5- 13.8) ∼ ∼
Vermont 7.1 ( 4.7- 10.7) 7.2 ( 4.7- 10.9) ∼ ∼
Middle Atlantic 9.6 ( 9.3- 10.0) 9.6 ( 9.2- 10.0) 11.0 ( 9.8- 12.3) 6.6 ( 5.3- 8.1)
New Jersey 9.6 ( 8.8- 10.5) 9.6 ( 8.7- 10.5) 12.2 ( 9.4- 15.6) 5.5 ( 3.2- 8.8)
New York 9.6 ( 9.1- 10.2) 9.9 ( 9.3- 10.5) 9.4 ( 7.9- 11.0) 7.0 ( 5.4- 8.9)
Pennsylvania 9.7 ( 9.0- 10.4) 9.4 ( 8.7- 10.1) 14.1 ( 11.3- 17.3) ∼
Midwest 9.3 ( 9.0- 9.6) 9.0 ( 8.7- 9.4) 12.5 ( 11.2- 13.9) 5.1 ( 3.5- 7.4)
East North Central 9.3 ( 8.9- 9.6) 9.0 ( 8.7- 9.4) 12.2 ( 10.8- 13.7) 5.3 ( 3.5- 7.9)
Illinois 9.1 ( 8.4- 9.9) 9.1 ( 8.3- 9.9) 10.5 ( 8.4- 13.0) 5.6 ( 3.2- 9.3)
Indiana 9.3 ( 8.3- 10.3) 8.8 ( 7.9- 9.9) 15.9 ( 11.1- 22.2) ∼
Michigan 9.0 ( 8.3- 9.8) 8.5 ( 7.7- 9.4) 13.8 ( 11.1- 17.1) ∼
Ohio 9.5 ( 8.8- 10.2) 9.4 ( 8.6- 10.2) 11.1 ( 8.7- 14.1) ∼
Wisconsin 9.5 ( 8.5- 10.6) 9.4 ( 8.3- 10.5) ∼ ∼
West North Central 9.2 ( 8.7- 9.8) 9.1 ( 8.5- 9.6) 14.3 ( 10.9- 18.4) ∼
Iowa 9.7 ( 8.4- 11.3) 9.8 ( 8.4- 11.4) ∼ ∼
Kansas 9.5 ( 8.1- 11.2) 9.0 ( 7.6- 10.7) ∼ ∼
Minnesota 9.3 ( 8.2- 10.5) 9.2 ( 8.1- 10.5) ∼ ∼
Missouri 9.1 ( 8.2- 10.2) 8.8 ( 7.9- 9.9) 13.5 ( 9.5- 18.6) ∼
Nebraska 8.2 ( 6.5- 10.2) 7.9 ( 6.2- 9.9) ∼ ∼
North Dakota 7.6 ( 5.2- 11.1) 7.8 ( 5.3- 11.4) ∼ ∼
South Dakota 11.4 ( 8.6- 15.0) 11.1 ( 8.3- 14.8) ∼ ∼
South 9.2 ( 9.0- 9.5) 8.7 ( 8.4- 8.9) 12.8 ( 12.0- 13.6) 7.3 ( 6.4- 8.2)
South Atlantic 9.4 ( 9.1- 9.7) 8.7 ( 8.4- 9.1) 13.2 ( 12.2- 14.3) 7.2 ( 5.9- 8.5)
Delaware 8.2 ( 5.9- 11.3) 7.2 ( 4.9- 10.5) ∼ ∼
District of Columbia 12.9 ( 9.3- 17.7) ∼ 13.2 ( 8.9- 19.8) ∼
Florida 8.9 ( 8.3- 9.4) 8.6 ( 8.1- 9.2) 12.5 ( 10.3- 15.0) 7.8 ( 6.5- 9.4)
Georgia 10.0 ( 9.1- 11.1) 8.5 ( 7.5- 9.6) 16.0 ( 13.4- 18.9) ∼
Maryland 10.7 ( 9.6- 11.9) 10.0 ( 8.7- 11.4) 13.4 ( 10.7- 16.6) ∼
North Carolina 9.4 ( 8.6- 10.3) 9.0 ( 8.1- 10.0) 11.6 ( 9.4- 14.2) ∼
South Carolina 9.2 ( 8.0- 10.5) 8.2 ( 7.0- 9.7) 12.3 ( 9.6- 15.6) ∼
Virginia 9.8 ( 8.9- 10.9) 9.2 ( 8.2- 10.3) 13.6 ( 10.9- 16.8) ∼
West Virginia 7.7 ( 6.2- 9.5) 7.6 ( 6.1- 9.4) ∼ ∼
East South Central 9.3 ( 8.7- 9.9) 9.0 ( 8.3- 9.6) 11.0 ( 9.4- 12.8) ∼
Alabama 9.1 ( 8.1- 10.3) 8.7 ( 7.5- 10.1) 10.4 ( 7.9- 13.4) ∼
Kentucky 9.2 ( 8.1- 10.6) 9.3 ( 8.0- 10.6) ∼ ∼
Mississippi 10.9 ( 9.4- 12.6) 9.9 ( 8.2- 12.0) 13.5 ( 10.3- 17.5) ∼
Tennessee 8.6 ( 7.6- 9.6) 8.5 ( 7.5- 9.6) 9.5 ( 6.7- 13.0) ∼
West South Central 8.8 ( 8.4- 9.3) 8.4 ( 7.9- 8.8) 13.1 ( 11.5- 14.8) 7.4 ( 6.2- 8.7)
Arkansas 8.9 ( 7.5- 10.5) 8.6 ( 7.2- 10.3) 11.4 ( 7.1- 17.5) ∼
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Table 2.22.1.2F: Pancreas. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 10.5 ( 9.3- 11.9) 9.5 ( 8.1- 11.0) 14.3 ( 11.4- 17.6) ∼
Oklahoma 8.0 ( 6.8- 9.3) 7.8 ( 6.6- 9.3) ∼ ∼
Texas 8.6 ( 8.0- 9.2) 8.2 ( 7.6- 8.8) 12.6 ( 10.4- 15.1) 7.6 ( 6.4- 9.0)
West 8.9 ( 8.6- 9.2) 8.9 ( 8.6- 9.2) 13.5 ( 11.5- 15.7) 8.4 ( 7.5- 9.4)
Mountain 8.2 ( 7.6- 8.8) 8.2 ( 7.6- 8.8) 10.0 ( 6.1- 15.8) 8.3 ( 6.5- 10.4)
Arizona 7.7 ( 6.7- 8.7) 7.6 ( 6.6- 8.6) ∼ 10.8 ( 7.3- 15.5)
Colorado 8.6 ( 7.4- 10.0) 8.7 ( 7.4- 10.1) ∼ ∼
Idaho 8.9 ( 6.8- 11.4) 8.8 ( 6.7- 11.4) ∼ ∼
Montana 7.0 ( 5.0- 9.7) 6.6 ( 4.7- 9.3) ∼ ∼
Nevada 8.8 ( 7.1- 10.7) 8.8 ( 7.0- 10.9) ∼ ∼
New Mexico 8.0 ( 6.4- 10.0) 8.4 ( 6.7- 10.6) ∼ 7.4 ( 4.6- 11.1)
Utah 7.7 ( 6.0- 9.7) 7.6 ( 5.9- 9.6) ∼ ∼
Wyoming 11.0 ( 7.4- 15.9) 10.8 ( 7.2- 15.8) ∼ ∼
Pacific 9.2 ( 8.8- 9.6) 9.2 ( 8.8- 9.7) 14.1 ( 11.9- 16.5) 8.4 ( 7.3- 9.5)
Alaska ∼ ∼ ∼ ∼
California 9.3 ( 8.9- 9.8) 9.3 ( 8.9- 9.9) 14.2 ( 11.9- 16.8) 8.4 ( 7.3- 9.6)
Hawaii 8.8 ( 6.9- 11.3) ∼ ∼ ∼
Oregon 8.5 ( 7.3- 9.9) 8.7 ( 7.4- 10.1) ∼ ∼
Washington 9.5 ( 8.5- 10.7) 9.4 ( 8.3- 10.5) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.23.1.1: Prostate. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 150.0 (149.3- 150.7) 138.9 (138.2- 139.6) 221.8 (218.9- 224.7) 127.7 (125.1- 130.4)
Northeast 159.2 (157.6- 160.8) 149.4 (147.8- 151.0) 238.8 (232.1- 245.7) 149.5 (142.5- 156.9)
New England 157.5 (154.5- 160.6) 154.1 (151.0- 157.2) 206.6 (188.6- 226.4) 139.8 (121.6- 160.4)
Connecticut 162.6 (156.4- 168.9) 159.7 (153.4- 166.3) 201.5 (174.5- 233.1) 131.8 (105.0- 165.2)
Maine 159.2 (149.8- 169.1) 157.9 (148.5- 167.8) ∼ ∼
Massachusetts 158.6 (154.1- 163.3) 154.8 (150.2- 159.5) 218.5 (192.3- 248.2) 143.7 (117.0- 176.3)
New Hampshire 148.2 (138.6- 158.5) 140.6 (131.2- 150.7) ∼ ∼
Rhode Island 147.5 (137.0- 158.6) 145.5 (134.8- 156.8) 178.0 (117.9- 268.6) 132.0 ( 77.9- 216.2)
Vermont 152.9 (139.2- 167.7) 153.2 (139.4- 168.1) ∼ ∼
Middle Atlantic 159.8 (158.0- 161.6) 147.4 (145.6- 149.3) 242.4 (235.1- 249.8) 150.8 (143.2- 158.8)
New Jersey 174.4 (170.3- 178.6) 158.3 (154.0- 162.6) 265.8 (249.3- 283.3) 167.0 (151.1- 184.4)
New York 156.5 (153.8- 159.1) 144.2 (141.4- 147.0) 229.2 (219.8- 239.0) 147.6 (138.4- 157.3)
Pennsylvania 155.7 (152.6- 158.8) 145.4 (142.3- 148.6) 255.0 (239.8- 270.9) -
Midwest 152.6 (151.2- 154.0) 139.5 (138.1- 141.0) 219.1 (212.6- 225.8) 114.9 (105.7- 124.9)
East North Central 154.1 (152.3- 155.8) 138.0 (136.3- 139.7) 224.3 (217.2- 231.7) 117.3 (106.9- 128.6)
Illinois 154.7 (151.4- 158.1) 138.8 (135.4- 142.3) 210.1 (198.3- 222.6) -
Indiana 133.2 (128.8- 137.7) 123.9 (119.5- 128.4) 204.9 (183.1- 229.1) 140.9 (105.2- 187.9)
Michigan 181.2 (177.3- 185.3) 160.1 (156.2- 164.2) 276.1 (260.6- 292.3) 107.8 ( 83.2- 139.5)
Detroit 204.7 (197.9- 211.7) 178.0 (170.9- 185.4) 298.0 (279.4- 317.6) 125.4 ( 85.3- 182.2)
Ohio 140.1 (137.0- 143.4) 119.5 (116.4- 122.6) 193.0 (180.2- 206.6) 143.3 (110.1- 186.1)
Wisconsin 156.1 (151.2- 161.0) 151.7 (146.9- 156.7) 254.0 (215.8- 299.6) 114.7 ( 77.6- 167.1)
West North Central 149.4 (146.9- 152.0) 142.8 (140.3- 145.3) 189.6 (174.1- 206.3) 106.2 ( 86.8- 129.4)
Iowa 137.2 (131.2- 143.3) 130.3 (124.4- 136.3) 187.3 (123.4- 281.2) ∼
Kansas 157.9 (150.9- 165.1) 147.3 (140.4- 154.5) 221.1 (177.9- 272.6) 120.9 ( 84.8- 170.8)
Minnesota 175.0 (169.5- 180.6) 166.7 (161.2- 172.3) 227.9 (174.3- 297.8) 135.9 ( 84.1- 212.1)
Missouri 124.8 (120.6- 129.1) 119.8 (115.5- 124.2) 179.3 (160.8- 199.9) 87.8 ( 54.9- 139.5)
Nebraska 153.1 (144.6- 161.9) 143.8 (135.5- 152.6) 166.9 (113.0- 244.0) ∼
North Dakota 151.7 (138.4- 166.0) 151.4 (138.0- 165.9) ∼ ∼
South Dakota 181.3 (167.9- 195.6) 180.3 (166.7- 194.8) ∼ ∼
South
South Atlantic 142.7 (141.3- 144.2) 127.5 (126.0- 129.0) 224.5 (219.4- 229.8) 136.2 (130.0- 142.6)
Delaware 169.8 (157.0- 183.5) 147.2 (134.4- 161.1) 257.5 (213.1- 310.9) 267.0 (143.6- 475.0)
District of Columbia 194.2 (176.5- 213.4) 150.3 (124.5- 181.4) 211.1 (187.8- 236.7) ∼
Florida 131.7 (129.5- 134.0) 125.1 (122.8- 127.5) 203.4 (192.9- 214.4) -
Georgia 149.8 (145.4- 154.3) 127.8 (123.3- 132.6) 238.2 (225.5- 251.5) 91.4 ( 65.5- 126.2)
Atlanta 158.4 (150.0- 167.2) 133.2 (124.2- 142.9) 237.3 (216.2- 260.6) 83.6 ( 47.6- 141.9)
Maryland 167.7 (162.4- 173.1) 145.3 (139.7- 151.1) 231.0 (217.2- 245.7) 148.8 (113.6- 193.0)
North Carolina 136.4 (132.6- 140.3) 118.6 (114.7- 122.6) 231.0 (218.2- 244.5) 99.7 ( 70.3- 140.0)
South Carolina 153.7 (148.1- 159.6) 131.9 (126.0- 138.1) 228.6 (213.4- 244.8) -
Virginia 153.7 (149.3- 158.3) 133.6 (129.0- 138.2) 225.9 (212.2- 240.5) 148.6 (113.4- 193.1)
West Virginia 124.6 (117.6- 132.1) 123.4 (116.3- 130.9) 158.5 (110.2- 222.9) ∼
East South Central
Alabama 140.8 (135.6- 146.2) 118.5 (113.2- 123.9) 194.2 (180.0- 209.4) 95.3 ( 52.4- 165.7)
Kentucky 140.0 (134.5- 145.7) 130.1 (124.6- 135.7) 240.0 (208.7- 275.4) -
Mississippi 155.2 (148.2- 162.5) 128.2 (120.9- 135.9) 229.0 (211.9- 247.2) ∼
Tennessee
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Table 2.23.1.1: Prostate. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 144.1 (142.0- 146.3) 131.7 (129.5- 133.8) 206.7 (198.7- 214.9) 108.6 (103.4- 114.2)
Arkansas 161.7 (154.9- 168.8) 153.7 (146.7- 160.9) 229.2 (202.6- 258.7) ∼
Louisiana 176.7 (170.6- 183.0) 158.0 (151.4- 164.8) 216.8 (202.7- 231.8) 152.6 (113.0- 205.9)
Oklahoma 144.8 (138.9- 150.8) 137.8 (131.8- 144.1) 216.3 (183.8- 253.8) 113.4 ( 74.3- 172.2)
Texas 133.6 (131.1- 136.2) 121.6 (119.0- 124.2) 195.1 (184.4- 206.3) 108.3 (102.9- 113.9)
West 150.4 (148.8- 151.9) 146.5 (144.9- 148.2) 207.7 (198.6- 217.2) 128.4 (124.1- 132.9)
Mountain
Arizona
Colorado 149.5 (143.7- 155.5) 137.4 (131.7- 143.3) 195.2 (156.1- 245.3) 124.6 (107.5- 144.3)
Idaho 164.1 (153.7- 174.9) 165.8 (155.4- 176.9) ∼ 112.7 ( 59.4- 202.8)
Montana 179.9 (168.0- 192.5) 178.2 (166.2- 191.0) ∼ ∼
Nevada 144.6 (137.0- 152.6) 139.1 (131.2- 147.4) 147.4 (116.1- 189.3) 149.5 (117.8- 189.2)
New Mexico 150.7 (142.5- 159.4) 157.4 (148.7- 166.6) 119.5 ( 67.8- 206.5) 125.1 (111.7- 139.9)
Utah 190.0 (180.3- 200.1) 193.1 (183.1- 203.4) ∼ 193.2 (143.9- 259.0)
Wyoming
Pacific 147.9 (146.2- 149.7) 143.5 (141.6- 145.4) 214.5 (204.7- 224.8) 128.1 (123.4- 133.1)
Alaska 132.7 (115.8- 152.3) 134.4 (115.5- 156.9) ∼ ∼
California 146.4 (144.4- 148.5) 141.1 (138.9- 143.3) 213.2 (202.9- 224.1) 129.4 (124.5- 134.5)
San Francisco-Oakland 153.9 (148.2- 159.8) 153.7 (146.9- 160.8) 197.1 (175.4- 221.2) 110.6 ( 94.7- 128.8)
San Jose-Monterey 165.9 (157.6- 174.7) 174.4 (164.8- 184.6) 250.4 (178.6- 355.2) 126.7 (107.4- 149.2)
Los Angeles 145.3 (141.3- 149.4) 131.6 (127.2- 136.1) 213.4 (197.9- 230.0) 130.7 (122.5- 139.3)
Hawaii 129.2 (120.2- 138.7) 144.1 (125.6- 165.0) 247.7 (135.9- 433.9) -
Oregon 141.6 (135.9- 147.5) 137.5 (131.8- 143.4) 214.3 (150.5- 303.9) 102.0 ( 70.4- 146.0)
Washington 165.0 (160.1- 170.0) 159.6 (154.6- 164.8) 235.3 (195.1- 283.8) 94.4 ( 70.5- 125.4)
Seattle-Puget Sound 171.9 (165.8- 178.2) 175.6 (169.1- 182.4) 230.1 (188.1- 281.7) -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.23.1.2: Prostate. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 26.6 ( 26.3- 26.9) 24.5 ( 24.2- 24.8) 58.0 ( 56.4- 59.7) 20.4 ( 19.2- 21.6)
Northeast 26.2 ( 25.5- 26.9) 24.5 ( 23.8- 25.2) 54.4 ( 50.8- 58.3) 21.0 ( 18.0- 24.5)
New England 25.9 ( 24.7- 27.2) 25.3 ( 24.0- 26.6) 58.6 ( 47.1- 72.3) ∼
Connecticut 24.5 ( 22.1- 27.1) 23.3 ( 20.9- 26.0) 55.3 ( 38.3- 78.1) ∼
Maine 27.6 ( 23.4- 32.3) 27.4 ( 23.3- 32.2) ∼ ∼
Massachusetts 26.2 ( 24.3- 28.2) 25.4 ( 23.4- 27.4) 64.1 ( 47.5- 85.1) ∼
New Hampshire 28.0 ( 23.4- 33.2) 28.3 ( 23.7- 33.6) ∼ ∼
Rhode Island 24.1 ( 19.9- 29.0) 23.5 ( 19.3- 28.5) ∼ ∼
Vermont 30.3 ( 23.8- 38.0) 30.1 ( 23.6- 37.8) ∼ ∼
Middle Atlantic 26.3 ( 25.5- 27.1) 24.2 ( 23.4- 25.0) 54.0 ( 50.1- 58.1) 22.2 ( 18.9- 26.0)
New Jersey 26.3 ( 24.7- 28.1) 24.2 ( 22.5- 26.0) 59.3 ( 50.3- 69.6) 20.1 ( 14.1- 28.2)
New York 25.9 ( 24.8- 27.1) 24.0 ( 22.8- 25.2) 47.0 ( 42.2- 52.2) 23.6 ( 19.4- 28.5)
Pennsylvania 26.7 ( 25.4- 28.0) 24.4 ( 23.1- 25.7) 65.2 ( 56.9- 74.4) ∼
Midwest 26.7 ( 26.0- 27.3) 25.2 ( 24.6- 25.9) 50.5 ( 47.0- 54.2) 14.0 ( 10.6- 18.4)
East North Central 26.6 ( 25.9- 27.4) 24.9 ( 24.1- 25.7) 50.0 ( 46.2- 54.0) 11.8 ( 8.4- 16.5)
Illinois 26.7 ( 25.3- 28.3) 23.9 ( 22.4- 25.5) 55.7 ( 48.9- 63.3) 14.2 ( 9.2- 21.4)
Indiana 27.3 ( 25.2- 29.6) 25.5 ( 23.4- 27.8) 58.5 ( 46.1- 73.6) ∼
Michigan 25.4 ( 23.9- 27.1) 23.5 ( 21.9- 25.2) 44.7 ( 38.1- 52.2) ∼
Ohio 25.9 ( 24.4- 27.4) 24.4 ( 23.0- 26.0) 44.4 ( 37.7- 52.1) ∼
Wisconsin 29.3 ( 27.1- 31.6) 28.9 ( 26.7- 31.2) 55.0 ( 34.2- 85.5) ∼
West North Central 26.7 ( 25.6- 27.8) 26.0 ( 24.9- 27.1) 53.9 ( 44.5- 64.8) 22.6 ( 13.2- 36.7)
Iowa 29.6 ( 26.8- 32.6) 29.3 ( 26.5- 32.3) ∼ ∼
Kansas 23.3 ( 20.6- 26.3) 22.1 ( 19.4- 25.1) 65.7 ( 41.8- 99.0) ∼
Minnesota 27.6 ( 25.3- 30.0) 27.3 ( 25.0- 29.7) ∼ ∼
Missouri 26.2 ( 24.1- 28.4) 24.7 ( 22.6- 27.0) 50.8 ( 39.5- 64.6) ∼
Nebraska 23.4 ( 20.1- 27.2) 23.1 ( 19.7- 26.9) ∼ ∼
North Dakota 30.4 ( 24.6- 37.2) 30.5 ( 24.7- 37.4) ∼ ∼
South Dakota 29.7 ( 24.4- 36.0) 29.3 ( 23.9- 35.7) ∼ ∼
South 27.5 ( 26.9- 28.0) 23.2 ( 22.7- 23.8) 62.5 ( 60.1- 64.9) 20.5 ( 18.7- 22.6)
South Atlantic 26.7 ( 26.0- 27.4) 22.4 ( 21.7- 23.0) 61.8 ( 58.7- 65.0) 21.5 ( 18.7- 24.6)
Delaware 25.8 ( 20.5- 32.1) 22.5 ( 17.3- 28.9) 55.5 ( 32.7- 89.7) ∼
District of Columbia 36.7 ( 28.7- 46.3) ∼ 46.5 ( 35.3- 60.3) ∼
Florida 22.7 ( 21.7- 23.6) 20.5 ( 19.6- 21.5) 61.4 ( 54.6- 68.8) 23.3 ( 20.1- 26.7)
Georgia 30.4 ( 28.1- 32.9) 23.9 ( 21.6- 26.3) 60.5 ( 53.2- 68.7) ∼
Maryland 28.2 ( 25.9- 30.8) 23.8 ( 21.4- 26.5) 52.3 ( 44.4- 61.3) ∼
North Carolina 30.9 ( 28.9- 33.1) 24.8 ( 22.8- 27.0) 67.2 ( 59.4- 75.8) ∼
South Carolina 29.7 ( 26.9- 32.8) 21.0 ( 18.4- 24.0) 65.8 ( 56.8- 76.0) ∼
Virginia 30.8 ( 28.6- 33.1) 24.7 ( 22.6- 27.0) 68.2 ( 59.8- 77.6) ∼
West Virginia 26.0 ( 22.5- 29.9) 24.8 ( 21.4- 28.7) ∼ ∼
East South Central 32.0 ( 30.6- 33.5) 26.3 ( 24.9- 27.8) 70.6 ( 64.9- 76.7) ∼
Alabama 32.5 ( 29.7- 35.5) 23.9 ( 21.3- 26.8) 71.2 ( 61.8- 81.6) ∼
Kentucky 27.3 ( 24.5- 30.2) 25.9 ( 23.1- 28.8) 57.4 ( 41.1- 78.6) ∼
Mississippi 37.4 ( 33.6- 41.6) 25.8 ( 22.0- 30.1) 73.6 ( 63.3- 85.3) ∼
Tennessee 32.5 ( 30.0- 35.1) 28.5 ( 26.1- 31.2) 70.9 ( 59.6- 83.8) ∼
West South Central 26.5 ( 25.5- 27.5) 23.4 ( 22.4- 24.4) 57.3 ( 52.6- 62.3) 20.3 ( 17.7- 23.2)
Arkansas 29.9 ( 26.8- 33.4) 25.7 ( 22.6- 29.1) 72.1 ( 56.6- 90.7) ∼
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Table 2.23.1.2: Prostate. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 30.5 ( 27.7- 33.6) 23.1 ( 20.3- 26.3) 56.1 ( 48.3- 64.9) ∼
Oklahoma 25.3 ( 22.7- 28.1) 23.2 ( 20.6- 26.1) 61.5 ( 43.1- 85.7) ∼
Texas 25.2 ( 23.9- 26.5) 23.0 ( 21.8- 24.4) 54.9 ( 48.4- 62.1) 20.1 ( 17.4- 23.1)
West 25.3 ( 24.7- 26.0) 25.6 ( 24.9- 26.3) 54.7 ( 49.4- 60.4) 20.9 ( 19.1- 22.9)
Mountain 26.2 ( 25.0- 27.5) 26.2 ( 25.0- 27.5) 45.4 ( 33.4- 61.0) 26.8 ( 22.6- 31.6)
Arizona 24.8 ( 22.8- 27.0) 24.8 ( 22.7- 27.0) ∼ 20.4 ( 14.2- 28.8)
Colorado 25.7 ( 23.0- 28.6) 25.7 ( 23.0- 28.7) ∼ 35.7 ( 25.0- 49.6)
Idaho 29.5 ( 25.0- 34.7) 29.6 ( 25.0- 34.8) ∼ ∼
Montana 26.2 ( 21.5- 31.7) 26.0 ( 21.3- 31.6) ∼ ∼
Nevada 26.2 ( 22.6- 30.4) 26.3 ( 22.5- 30.7) 40.5 ( 22.3- 72.0) ∼
New Mexico 29.1 ( 25.2- 33.4) 29.1 ( 25.1- 33.7) ∼ 29.9 ( 22.8- 38.7)
Utah 27.9 ( 23.9- 32.3) 27.8 ( 23.9- 32.3) ∼ ∼
Wyoming 21.0 ( 14.8- 29.0) 21.3 ( 15.1- 29.5) ∼ ∼
Pacific 25.0 ( 24.2- 25.7) 25.4 ( 24.6- 26.3) 56.5 ( 50.8- 62.9) 18.9 ( 16.9- 21.2)
Alaska 16.1 ( 9.3- 26.8) 18.5 ( 10.2- 31.8) ∼ ∼
California 24.7 ( 23.8- 25.6) 24.8 ( 23.9- 25.8) 57.5 ( 51.4- 64.3) 18.8 ( 16.7- 21.1)
Hawaii 19.1 ( 15.7- 23.0) 26.7 ( 18.5- 37.6) ∼ ∼
Oregon 27.2 ( 24.6- 30.0) 27.0 ( 24.4- 29.8) ∼ ∼
Washington 26.9 ( 24.8- 29.1) 27.2 ( 25.0- 29.5) 37.7 ( 21.5- 63.9) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.24.1.1M: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 10.0 ( 9.8- 10.2) 8.9 ( 8.8- 9.1) 16.9 ( 16.0- 17.7) 14.5 ( 13.7- 15.5)
Northeast 12.0 ( 11.6- 12.4) 11.1 ( 10.7- 11.5) 16.8 ( 15.0- 18.8) 18.2 ( 15.8- 20.9)
New England 10.7 ( 10.0- 11.6) 10.4 ( 9.6- 11.2) 19.3 ( 13.6- 27.0) 15.8 ( 10.0- 24.4)
Connecticut 12.4 ( 10.8- 14.3) 12.0 ( 10.3- 13.9) 20.1 ( 11.9- 33.7) ∼
Maine 9.6 ( 7.3- 12.3) 9.7 ( 7.4- 12.4) ∼ ∼
Massachusetts 10.6 ( 9.4- 11.9) 10.2 ( 9.1- 11.5) 19.8 ( 11.6- 32.3) ∼
New Hampshire 8.1 ( 5.9- 10.9) 7.3 ( 5.2- 10.1) ∼ ∼
Rhode Island 12.4 ( 9.5- 15.9) 12.4 ( 9.4- 16.1) ∼ ∼
Vermont 7.8 ( 5.0- 11.9) 7.9 ( 5.0- 12.0) ∼ ∼
Middle Atlantic 12.5 ( 12.0- 13.0) 11.4 ( 10.9- 11.9) 16.5 ( 14.6- 18.6) 18.6 ( 16.0- 21.6)
New Jersey 12.7 ( 11.6- 13.9) 11.6 ( 10.5- 12.9) 17.1 ( 13.0- 22.5) 19.7 ( 14.6- 26.6)
New York 13.8 ( 13.0- 14.6) 12.5 ( 11.7- 13.4) 16.4 ( 13.9- 19.4) 18.3 ( 15.2- 22.2)
Pennsylvania 10.5 ( 9.7- 11.3) 9.8 ( 9.0- 10.7) 16.2 ( 12.5- 20.7) -
Midwest 8.9 ( 8.6- 9.3) 8.2 ( 7.9- 8.6) 15.8 ( 14.0- 17.7) 11.9 ( 9.1- 15.5)
East North Central 9.4 ( 9.0- 9.8) 8.6 ( 8.2- 9.0) 16.4 ( 14.4- 18.6) 11.0 ( 8.2- 14.9)
Illinois 11.0 ( 10.1- 12.0) 10.2 ( 9.2- 11.2) 16.6 ( 13.3- 20.6) -
Indiana 8.1 ( 7.0- 9.3) 7.5 ( 6.5- 8.7) 17.2 ( 11.2- 25.8) ∼
Michigan 10.0 ( 9.1- 11.0) 9.1 ( 8.1- 10.1) 18.0 ( 14.0- 22.8) ∼
Detroit 12.6 ( 11.0- 14.5) 11.1 ( 9.3- 13.1) 18.2 ( 13.7- 23.9) ∼
Ohio 8.3 ( 7.5- 9.1) 7.4 ( 6.6- 8.3) 13.9 ( 10.5- 18.2) ∼
Wisconsin 8.8 ( 7.6- 10.0) 8.3 ( 7.1- 9.5) ∼ ∼
West North Central 7.9 ( 7.3- 8.5) 7.5 ( 6.9- 8.1) 12.0 ( 8.5- 16.8) 14.8 ( 8.0- 26.0)
Iowa 7.6 ( 6.3- 9.2) 7.2 ( 5.9- 8.7) ∼ ∼
Kansas 7.2 ( 5.7- 8.8) 6.9 ( 5.4- 8.6) ∼ ∼
Minnesota 8.8 ( 7.6- 10.1) 8.4 ( 7.2- 9.7) ∼ ∼
Missouri 7.7 ( 6.7- 8.9) 7.4 ( 6.4- 8.6) 11.3 ( 7.1- 17.8) ∼
Nebraska 7.3 ( 5.5- 9.4) 7.0 ( 5.3- 9.2) ∼ ∼
North Dakota 7.0 ( 4.4- 10.7) 6.9 ( 4.2- 10.7) ∼ ∼
South Dakota 9.0 ( 6.2- 12.7) 8.2 ( 5.5- 11.9) ∼ ∼
South
South Atlantic 9.2 ( 8.8- 9.6) 7.6 ( 7.2- 8.0) 17.9 ( 16.4- 19.5) 10.5 ( 8.7- 12.5)
Delaware 10.1 ( 7.1- 14.1) 8.4 ( 5.5- 12.4) ∼ ∼
District of Columbia 10.4 ( 6.6- 15.7) ∼ 11.4 ( 6.5- 18.9) ∼
Florida 9.1 ( 8.5- 9.7) 8.4 ( 7.8- 9.1) 16.2 ( 13.2- 20.0) -
Georgia 9.3 ( 8.2- 10.6) 6.5 ( 5.5- 7.7) 19.0 ( 15.4- 23.3) ∼
Atlanta 10.5 ( 8.3- 13.1) 6.3 ( 4.5- 8.8) 19.7 ( 13.2- 29.2) ∼
Maryland 9.6 ( 8.4- 11.1) 7.3 ( 6.1- 8.7) 16.2 ( 12.3- 21.1) ∼
North Carolina 8.4 ( 7.4- 9.4) 6.5 ( 5.6- 7.5) 18.0 ( 14.5- 22.2) ∼
South Carolina 10.0 ( 8.5- 11.6) 6.7 ( 5.4- 8.3) 22.3 ( 17.6- 28.1) -
Virginia 9.2 ( 8.1- 10.4) 7.2 ( 6.2- 8.4) 19.3 ( 15.2- 24.2) ∼
West Virginia 7.7 ( 6.0- 9.8) 7.7 ( 5.9- 9.8) ∼ ∼
East South Central
Alabama 8.0 ( 6.8- 9.3) 6.8 ( 5.6- 8.3) 14.1 ( 10.4- 18.8) ∼
Kentucky 7.8 ( 6.5- 9.3) 7.8 ( 6.5- 9.3) ∼ -
Mississippi 9.7 ( 8.0- 11.8) 6.6 ( 5.0- 8.6) 18.7 ( 14.0- 24.6) ∼
Tennessee
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Table 2.24.1.1M: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 10.4 ( 9.8- 10.9) 9.3 ( 8.7- 9.9) 18.5 ( 16.1- 21.2) 15.0 ( 13.1- 17.1)
Arkansas 8.8 ( 7.2- 10.6) 7.9 ( 6.4- 9.8) 14.0 ( 8.1- 23.0) ∼
Louisiana 11.3 ( 9.8- 13.1) 8.5 ( 7.0- 10.3) 20.2 ( 16.0- 25.4) ∼
Oklahoma 8.4 ( 7.0- 10.0) 8.1 ( 6.6- 9.7) ∼ ∼
Texas 10.8 ( 10.0- 11.5) 9.8 ( 9.1- 10.6) 19.0 ( 15.6- 22.9) 15.3 ( 13.4- 17.5)
West 10.1 ( 9.7- 10.5) 9.1 ( 8.7- 9.5) 14.6 ( 12.1- 17.6) 15.3 ( 13.8- 17.0)
Mountain
Arizona
Colorado 7.6 ( 6.3- 9.1) 6.9 ( 5.6- 8.4) ∼ 18.1 ( 11.6- 27.7)
Idaho 9.2 ( 6.9- 12.2) 9.2 ( 6.9- 12.2) ∼ ∼
Montana 10.9 ( 8.1- 14.5) 10.9 ( 8.0- 14.5) ∼ ∼
Nevada 7.8 ( 6.1- 10.0) 7.9 ( 6.1- 10.2) ∼ ∼
New Mexico 8.6 ( 6.6- 11.0) 8.1 ( 6.2- 10.6) ∼ 12.1 ( 8.0- 17.9)
Utah 7.5 ( 5.7- 9.8) 7.3 ( 5.5- 9.5) ∼ ∼
Wyoming
Pacific 10.7 ( 10.2- 11.1) 9.4 ( 9.0- 9.9) 15.1 ( 12.4- 18.3) 15.6 ( 13.9- 17.5)
Alaska 7.9 ( 4.3- 15.2) ∼ ∼ ∼
California 11.0 ( 10.5- 11.6) 9.9 ( 9.3- 10.5) 15.7 ( 12.9- 19.2) 15.8 ( 14.1- 17.7)
San Francisco-Oakland 10.9 ( 9.4- 12.6) 8.8 ( 7.2- 10.6) 13.8 ( 8.5- 21.7) 13.9 ( 8.6- 21.7)
San Jose-Monterey 12.0 ( 9.8- 14.5) 10.5 ( 8.2- 13.2) ∼ 15.5 ( 9.1- 25.8)
Los Angeles 14.0 ( 12.7- 15.3) 12.4 ( 11.1- 13.9) 17.8 ( 13.4- 23.5) 17.6 ( 14.7- 21.0)
Hawaii 15.1 ( 12.1- 18.6) 12.8 ( 7.5- 21.0) ∼ -
Oregon 7.6 ( 6.3- 9.0) 7.1 ( 5.9- 8.6) ∼ ∼
Washington 9.5 ( 8.3- 10.8) 8.9 ( 7.7- 10.2) ∼ ∼
Seattle-Puget Sound 9.8 ( 8.3- 11.4) 9.2 ( 7.8- 10.9) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.24.1.1F: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 4.9 ( 4.8- 5.0) 4.2 ( 4.1- 4.3) 8.4 ( 7.9- 8.9) 8.9 ( 8.3- 9.5)
Northeast 5.7 ( 5.4- 6.0) 5.1 ( 4.9- 5.4) 8.5 ( 7.5- 9.6) 11.6 ( 10.1- 13.4)
New England 4.8 ( 4.4- 5.3) 4.4 ( 4.0- 4.9) 9.2 ( 6.2- 13.2) 12.8 ( 8.3- 19.1)
Connecticut 4.7 ( 3.8- 5.7) 4.3 ( 3.5- 5.4) ∼ ∼
Maine 3.8 ( 2.6- 5.5) 3.8 ( 2.6- 5.5) ∼ ∼
Massachusetts 5.3 ( 4.6- 6.1) 4.7 ( 4.1- 5.5) 9.1 ( 5.1- 15.2) 13.1 ( 6.9- 23.4)
New Hampshire 3.3 ( 2.1- 5.1) 3.4 ( 2.2- 5.1) ∼ ∼
Rhode Island 6.1 ( 4.4- 8.4) 5.9 ( 4.2- 8.3) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 6.0 ( 5.7- 6.3) 5.4 ( 5.1- 5.7) 8.4 ( 7.3- 9.5) 11.5 ( 9.8- 13.3)
New Jersey 6.6 ( 5.9- 7.3) 6.3 ( 5.6- 7.1) 7.5 ( 5.3- 10.3) 13.7 ( 10.1- 18.4)
New York 6.8 ( 6.3- 7.2) 5.9 ( 5.5- 6.5) 9.3 ( 7.8- 10.9) 11.2 ( 9.3- 13.5)
Pennsylvania 4.6 ( 4.1- 5.1) 4.2 ( 3.7- 4.7) 7.1 ( 5.2- 9.5) -
Midwest 4.2 ( 4.0- 4.4) 3.8 ( 3.6- 4.0) 8.0 ( 7.0- 9.1) 8.4 ( 6.3- 11.1)
East North Central 4.6 ( 4.3- 4.8) 4.0 ( 3.8- 4.3) 8.5 ( 7.4- 9.7) 8.1 ( 5.8- 11.2)
Illinois 5.3 ( 4.7- 5.8) 4.7 ( 4.2- 5.3) 7.9 ( 6.1- 10.1) -
Indiana 3.1 ( 2.5- 3.7) 2.7 ( 2.2- 3.4) 8.6 ( 5.2- 13.6) ∼
Michigan 4.5 ( 4.0- 5.1) 3.8 ( 3.3- 4.4) 10.4 ( 8.0- 13.2) ∼
Detroit 6.3 ( 5.3- 7.4) 5.3 ( 4.3- 6.5) 10.4 ( 7.7- 13.7) ∼
Ohio 4.3 ( 3.8- 4.8) 3.7 ( 3.2- 4.2) 7.5 ( 5.6- 10.0) ∼
Wisconsin 5.2 ( 4.5- 6.1) 5.1 ( 4.3- 6.0) ∼ ∼
West North Central 3.5 ( 3.2- 3.9) 3.2 ( 2.9- 3.6) 5.2 ( 3.3- 7.9) ∼
Iowa 3.8 ( 2.9- 4.8) 3.5 ( 2.7- 4.6) ∼ ∼
Kansas 2.8 ( 2.0- 3.8) 2.7 ( 1.9- 3.7) ∼ ∼
Minnesota 3.6 ( 2.9- 4.4) 3.3 ( 2.7- 4.1) ∼ ∼
Missouri 3.7 ( 3.1- 4.5) 3.4 ( 2.8- 4.2) ∼ ∼
Nebraska 2.6 ( 1.8- 3.9) 2.5 ( 1.6- 3.8) ∼ ∼
North Dakota 5.4 ( 3.3- 8.5) 5.2 ( 3.2- 8.4) ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South
South Atlantic 4.7 ( 4.5- 5.0) 3.8 ( 3.6- 4.1) 8.7 ( 7.9- 9.5) 6.1 ( 5.0- 7.4)
Delaware 4.2 ( 2.6- 6.6) ∼ ∼ ∼
District of Columbia 6.4 ( 3.9- 10.3) ∼ 9.2 ( 5.6- 15.2) ∼
Florida 4.9 ( 4.5- 5.3) 4.1 ( 3.8- 4.6) 12.5 ( 10.3- 14.9) -
Georgia 4.9 ( 4.2- 5.6) 3.6 ( 3.0- 4.4) 8.1 ( 6.4- 10.3) ∼
Atlanta 5.7 ( 4.4- 7.3) 3.9 ( 2.7- 5.6) 9.0 ( 5.9- 13.2) ∼
Maryland 4.7 ( 4.0- 5.6) 3.3 ( 2.6- 4.1) 8.0 ( 6.0- 10.5) ∼
North Carolina 4.3 ( 3.7- 5.0) 3.6 ( 3.1- 4.3) 6.7 ( 5.1- 8.7) ∼
South Carolina 4.5 ( 3.7- 5.4) 3.3 ( 2.5- 4.3) 7.3 ( 5.2- 9.9) -
Virginia 4.5 ( 3.9- 5.2) 3.5 ( 2.9- 4.3) 8.2 ( 6.1- 10.7) ∼
West Virginia 5.5 ( 4.3- 7.1) 5.7 ( 4.4- 7.3) ∼ ∼
East South Central
Alabama 4.3 ( 3.5- 5.1) 3.2 ( 2.5- 4.1) 7.9 ( 5.7- 10.6) ∼
Kentucky 3.8 ( 3.1- 4.7) 3.5 ( 2.8- 4.4) ∼ -
Mississippi 5.1 ( 4.1- 6.4) 4.2 ( 3.1- 5.7) 7.6 ( 5.2- 10.6) ∼
Tennessee
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Table 2.24.1.1F: Stomach. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 4.9 ( 4.5- 5.2) 4.1 ( 3.8- 4.5) 9.0 ( 7.7- 10.4) 8.7 ( 7.5- 10.1)
Arkansas 4.4 ( 3.4- 5.6) 3.2 ( 2.4- 4.4) 11.7 ( 7.3- 17.8) ∼
Louisiana 5.6 ( 4.7- 6.6) 4.0 ( 3.1- 5.0) 10.3 ( 7.9- 13.2) ∼
Oklahoma 4.5 ( 3.6- 5.5) 3.5 ( 2.7- 4.6) ∼ ∼
Texas 4.8 ( 4.4- 5.3) 4.4 ( 4.0- 4.9) 7.4 ( 5.8- 9.3) 9.0 ( 7.7- 10.5)
West 5.1 ( 4.9- 5.4) 4.3 ( 4.1- 4.6) 7.7 ( 6.2- 9.4) 9.2 ( 8.2- 10.2)
Mountain
Arizona
Colorado 3.7 ( 3.0- 4.7) 3.6 ( 2.8- 4.6) ∼ 10.9 ( 6.8- 16.8)
Idaho 3.3 ( 2.1- 5.0) 3.1 ( 1.9- 4.8) ∼ ∼
Montana 3.9 ( 2.4- 6.2) 3.5 ( 2.1- 5.8) ∼ ∼
Nevada 4.4 ( 3.2- 5.8) 3.7 ( 2.6- 5.2) ∼ ∼
New Mexico 5.0 ( 3.7- 6.6) 5.1 ( 3.7- 6.8) ∼ 9.4 ( 6.4- 13.6)
Utah 3.7 ( 2.6- 5.2) 3.1 ( 2.0- 4.5) ∼ ∼
Wyoming
Pacific 5.4 ( 5.1- 5.7) 4.5 ( 4.3- 4.9) 7.5 ( 6.0- 9.3) 9.2 ( 8.2- 10.4)
Alaska ∼ ∼ ∼ ∼
California 5.7 ( 5.4- 6.1) 4.9 ( 4.5- 5.3) 7.8 ( 6.1- 9.7) 9.4 ( 8.3- 10.6)
San Francisco-Oakland 6.0 ( 5.1- 7.1) 4.5 ( 3.5- 5.7) 9.7 ( 6.0- 15.1) 8.4 ( 5.1- 13.3)
San Jose-Monterey 5.6 ( 4.3- 7.1) 4.7 ( 3.4- 6.4) ∼ 11.0 ( 6.5- 17.8)
Los Angeles 7.6 ( 6.8- 8.4) 6.6 ( 5.8- 7.6) 7.8 ( 5.6- 10.8) 9.7 ( 8.0- 11.7)
Hawaii 8.8 ( 6.9- 11.3) ∼ ∼ -
Oregon 3.4 ( 2.6- 4.3) 3.1 ( 2.4- 4.1) ∼ ∼
Washington 4.2 ( 3.5- 5.0) 3.9 ( 3.2- 4.7) ∼ ∼
Seattle-Puget Sound 4.1 ( 3.3- 5.0) 3.8 ( 3.0- 4.8) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.24.1.2M: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 5.7 ( 5.6- 5.8) 5.0 ( 4.9- 5.1) 11.4 ( 10.8- 12.1) 8.6 ( 7.9- 9.3)
Northeast 6.2 ( 5.9- 6.6) 5.7 ( 5.4- 6.0) 10.5 ( 9.1- 12.2) 9.7 ( 7.9- 12.0)
New England 5.5 ( 5.0- 6.2) 5.4 ( 4.8- 6.0) 10.7 ( 6.5- 17.2) ∼
Connecticut 5.2 ( 4.1- 6.4) 5.0 ( 3.9- 6.3) ∼ ∼
Maine 4.1 ( 2.6- 6.1) 4.1 ( 2.6- 6.2) ∼ ∼
Massachusetts 5.8 ( 5.0- 6.8) 5.6 ( 4.8- 6.6) ∼ ∼
New Hampshire 5.0 ( 3.4- 7.3) 5.1 ( 3.4- 7.4) ∼ ∼
Rhode Island 7.1 ( 4.9- 9.9) 7.1 ( 4.9- 10.1) ∼ ∼
Vermont 6.3 ( 3.7- 10.1) 6.0 ( 3.5- 9.8) ∼ ∼
Middle Atlantic 6.5 ( 6.1- 6.9) 5.8 ( 5.5- 6.2) 10.5 ( 9.0- 12.2) 10.3 ( 8.3- 12.7)
New Jersey 7.2 ( 6.3- 8.1) 6.7 ( 5.9- 7.7) 11.3 ( 7.9- 15.9) 10.1 ( 6.5- 15.7)
New York 6.7 ( 6.2- 7.3) 5.9 ( 5.3- 6.5) 9.4 ( 7.6- 11.7) 10.7 ( 8.2- 13.9)
Pennsylvania 5.7 ( 5.1- 6.4) 5.2 ( 4.7- 5.9) 12.3 ( 9.1- 16.5) ∼
Midwest 5.2 ( 4.9- 5.5) 4.7 ( 4.5- 5.0) 10.5 ( 9.1- 12.1) 6.7 ( 4.6- 9.6)
East North Central 5.5 ( 5.1- 5.8) 4.9 ( 4.6- 5.3) 10.8 ( 9.2- 12.5) 6.3 ( 4.2- 9.5)
Illinois 6.6 ( 5.9- 7.3) 5.8 ( 5.1- 6.6) 12.1 ( 9.3- 15.6) 6.9 ( 4.1- 11.8)
Indiana 4.5 ( 3.7- 5.4) 4.0 ( 3.3- 4.9) 11.2 ( 6.6- 18.4) ∼
Michigan 5.5 ( 4.8- 6.3) 5.0 ( 4.3- 5.8) 9.8 ( 7.0- 13.5) ∼
Ohio 4.9 ( 4.3- 5.5) 4.4 ( 3.8- 5.1) 9.8 ( 7.1- 13.5) ∼
Wisconsin 5.2 ( 4.3- 6.2) 4.9 ( 4.0- 5.9) ∼ ∼
West North Central 4.6 ( 4.2- 5.1) 4.4 ( 3.9- 4.9) 9.1 ( 5.9- 13.8) ∼
Iowa 4.2 ( 3.2- 5.4) 4.0 ( 3.1- 5.3) ∼ ∼
Kansas 5.5 ( 4.3- 7.0) 5.4 ( 4.1- 6.9) ∼ ∼
Minnesota 4.6 ( 3.7- 5.6) 4.4 ( 3.6- 5.5) ∼ ∼
Missouri 4.7 ( 3.9- 5.6) 4.3 ( 3.5- 5.3) 10.3 ( 6.1- 16.9) ∼
Nebraska 3.4 ( 2.2- 5.0) 3.4 ( 2.2- 5.0) ∼ ∼
North Dakota 5.0 ( 2.8- 8.3) ∼ ∼ ∼
South Dakota 4.3 ( 2.5- 7.1) ∼ ∼ ∼
South 5.6 ( 5.4- 5.9) 4.7 ( 4.5- 4.9) 12.2 ( 11.3- 13.3) 7.4 ( 6.4- 8.5)
South Atlantic 5.4 ( 5.1- 5.7) 4.4 ( 4.1- 4.7) 12.0 ( 10.7- 13.3) 4.3 ( 3.2- 5.6)
Delaware 6.3 ( 3.9- 9.7) ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.9 ( 4.5- 5.4) 4.5 ( 4.1- 5.0) 11.5 ( 8.9- 14.8) 4.6 ( 3.4- 6.2)
Georgia 5.4 ( 4.6- 6.4) 3.9 ( 3.1- 4.9) 10.8 ( 8.1- 14.1) ∼
Maryland 5.6 ( 4.6- 6.7) 4.4 ( 3.5- 5.6) 10.8 ( 7.6- 15.0) ∼
North Carolina 5.3 ( 4.5- 6.2) 3.9 ( 3.2- 4.7) 13.1 ( 10.1- 16.9) ∼
South Carolina 7.0 ( 5.8- 8.4) 4.7 ( 3.6- 6.1) 15.4 ( 11.4- 20.5) ∼
Virginia 6.0 ( 5.1- 7.0) 4.8 ( 3.9- 5.8) 12.6 ( 9.4- 16.8) ∼
West Virginia 4.7 ( 3.3- 6.4) 4.6 ( 3.2- 6.3) ∼ ∼
East South Central 5.3 ( 4.8- 5.9) 4.3 ( 3.8- 4.9) 11.2 ( 9.2- 13.6) ∼
Alabama 5.8 ( 4.8- 7.1) 4.1 ( 3.2- 5.3) 13.3 ( 9.7- 17.9) ∼
Kentucky 4.6 ( 3.6- 5.9) 4.5 ( 3.4- 5.7) ∼ ∼
Mississippi 6.4 ( 5.0- 8.1) 4.0 ( 2.8- 5.7) 13.1 ( 9.1- 18.2) ∼
Tennessee 4.8 ( 4.0- 5.8) 4.5 ( 3.7- 5.6) 7.7 ( 4.4- 12.8) ∼
West South Central 6.2 ( 5.8- 6.7) 5.4 ( 5.0- 5.9) 13.7 ( 11.6- 16.1) 10.2 ( 8.6- 12.1)
Arkansas 5.0 ( 3.8- 6.4) 4.4 ( 3.2- 5.8) ∼ ∼
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Table 2.24.1.2M: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 7.3 ( 6.1- 8.8) 4.4 ( 3.3- 5.7) 17.1 ( 13.1- 22.1) ∼
Oklahoma 4.9 ( 3.9- 6.2) 4.6 ( 3.5- 5.9) ∼ ∼
Texas 6.5 ( 5.9- 7.1) 5.9 ( 5.4- 6.6) 12.8 ( 10.0- 16.3) 10.5 ( 8.9- 12.5)
West 5.9 ( 5.6- 6.2) 5.2 ( 4.9- 5.5) 10.7 ( 8.6- 13.3) 9.7 ( 8.6- 11.0)
Mountain 4.8 ( 4.4- 5.4) 4.6 ( 4.1- 5.1) ∼ 11.6 ( 9.1- 14.5)
Arizona 4.4 ( 3.6- 5.3) 4.2 ( 3.4- 5.2) ∼ 11.1 ( 7.4- 16.8)
Colorado 5.1 ( 4.0- 6.4) 4.8 ( 3.7- 6.1) ∼ 11.5 ( 6.5- 19.6)
Idaho 3.9 ( 2.4- 6.0) 3.9 ( 2.4- 6.1) ∼ ∼
Montana 3.6 ( 2.1- 6.0) 3.7 ( 2.1- 6.2) ∼ ∼
Nevada 5.7 ( 4.2- 7.7) 5.6 ( 4.1- 7.7) ∼ ∼
New Mexico 7.3 ( 5.5- 9.5) 6.5 ( 4.7- 8.7) ∼ 13.3 ( 8.9- 19.3)
Utah 3.6 ( 2.4- 5.3) 2.9 ( 1.8- 4.5) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 6.3 ( 6.0- 6.7) 5.5 ( 5.1- 5.8) 10.9 ( 8.6- 13.7) 9.0 ( 7.8- 10.5)
Alaska ∼ ∼ ∼ ∼
California 6.6 ( 6.2- 7.0) 5.9 ( 5.4- 6.3) 10.6 ( 8.3- 13.6) 9.2 ( 7.9- 10.7)
Hawaii 11.7 ( 9.1- 14.8) ∼ ∼ ∼
Oregon 4.1 ( 3.2- 5.2) 3.9 ( 3.0- 5.0) ∼ ∼
Washington 5.1 ( 4.2- 6.1) 4.6 ( 3.8- 5.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.24.1.2F: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 3.0 ( 2.9- 3.0) 2.6 ( 2.5- 2.7) 5.4 ( 5.1- 5.8) 5.0 ( 4.6- 5.5)
Northeast 3.3 ( 3.1- 3.5) 3.0 ( 2.8- 3.2) 5.5 ( 4.7- 6.3) 5.2 ( 4.2- 6.4)
New England 3.0 ( 2.6- 3.4) 2.8 ( 2.5- 3.2) 6.4 ( 3.9- 10.0) ∼
Connecticut 3.5 ( 2.8- 4.4) 3.3 ( 2.6- 4.3) ∼ ∼
Maine 3.0 ( 1.9- 4.5) 3.0 ( 2.0- 4.6) ∼ ∼
Massachusetts 3.0 ( 2.5- 3.6) 2.8 ( 2.3- 3.3) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 2.6 ( 1.6- 4.1) 2.6 ( 1.6- 4.2) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 3.4 ( 3.2- 3.7) 3.1 ( 2.9- 3.3) 5.3 ( 4.5- 6.3) 5.2 ( 4.1- 6.5)
New Jersey 3.3 ( 2.9- 3.9) 3.1 ( 2.6- 3.7) 5.1 ( 3.3- 7.5) 4.2 ( 2.4- 7.0)
New York 3.7 ( 3.3- 4.0) 3.3 ( 3.0- 3.7) 5.1 ( 4.1- 6.3) 5.6 ( 4.2- 7.2)
Pennsylvania 3.1 ( 2.7- 3.5) 2.8 ( 2.4- 3.2) 6.2 ( 4.4- 8.5) ∼
Midwest 2.5 ( 2.4- 2.7) 2.3 ( 2.1- 2.4) 5.5 ( 4.7- 6.5) 3.4 ( 2.1- 5.3)
East North Central 2.6 ( 2.4- 2.8) 2.3 ( 2.1- 2.5) 5.8 ( 4.9- 6.9) 3.2 ( 1.8- 5.4)
Illinois 3.0 ( 2.7- 3.5) 2.4 ( 2.1- 2.8) 7.3 ( 5.5- 9.4) ∼
Indiana 2.0 ( 1.5- 2.5) 1.7 ( 1.3- 2.2) ∼ ∼
Michigan 2.9 ( 2.5- 3.4) 2.5 ( 2.1- 3.0) 5.6 ( 3.9- 7.9) ∼
Ohio 2.4 ( 2.0- 2.8) 2.2 ( 1.8- 2.6) 4.6 ( 3.1- 6.6) ∼
Wisconsin 2.5 ( 2.0- 3.2) 2.5 ( 2.0- 3.1) ∼ ∼
West North Central 2.3 ( 2.0- 2.6) 2.2 ( 2.0- 2.5) 3.6 ( 2.0- 6.0) ∼
Iowa 2.6 ( 1.9- 3.4) 2.6 ( 1.9- 3.5) ∼ ∼
Kansas 1.8 ( 1.2- 2.6) 1.7 ( 1.2- 2.6) ∼ ∼
Minnesota 2.1 ( 1.6- 2.7) 1.9 ( 1.4- 2.6) ∼ ∼
Missouri 2.6 ( 2.1- 3.2) 2.5 ( 1.9- 3.1) ∼ ∼
Nebraska 2.5 ( 1.7- 3.8) 2.4 ( 1.6- 3.7) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.9 ( 2.8- 3.1) 2.5 ( 2.3- 2.6) 5.4 ( 4.9- 5.9) 4.9 ( 4.2- 5.6)
South Atlantic 2.9 ( 2.7- 3.1) 2.4 ( 2.2- 2.6) 5.2 ( 4.6- 5.9) 4.1 ( 3.2- 5.1)
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 2.9 ( 2.6- 3.2) 2.4 ( 2.1- 2.7) 7.6 ( 6.0- 9.6) 4.1 ( 3.1- 5.2)
Georgia 2.8 ( 2.3- 3.3) 2.0 ( 1.5- 2.5) 4.7 ( 3.4- 6.3) ∼
Maryland 2.7 ( 2.2- 3.4) 2.3 ( 1.7- 3.0) 4.3 ( 2.8- 6.3) ∼
North Carolina 3.0 ( 2.6- 3.6) 2.8 ( 2.3- 3.3) 4.3 ( 3.0- 6.0) ∼
South Carolina 2.8 ( 2.2- 3.6) 2.0 ( 1.4- 2.9) 5.0 ( 3.3- 7.2) ∼
Virginia 2.9 ( 2.4- 3.5) 2.4 ( 1.9- 3.1) 4.8 ( 3.3- 6.8) ∼
West Virginia 3.1 ( 2.2- 4.3) 3.2 ( 2.3- 4.5) ∼ ∼
East South Central 2.7 ( 2.4- 3.1) 2.3 ( 2.0- 2.7) 4.8 ( 3.8- 6.0) ∼
Alabama 2.5 ( 1.9- 3.2) 1.9 ( 1.3- 2.6) 4.7 ( 3.1- 6.9) ∼
Kentucky 2.9 ( 2.3- 3.7) 2.8 ( 2.1- 3.6) ∼ ∼
Mississippi 2.5 ( 1.8- 3.4) 1.8 ( 1.1- 2.8) 4.4 ( 2.7- 6.9) ∼
Tennessee 2.9 ( 2.3- 3.5) 2.5 ( 2.0- 3.1) 5.0 ( 3.1- 7.7) ∼
West South Central 3.2 ( 2.9- 3.4) 2.7 ( 2.5- 3.0) 6.3 ( 5.2- 7.5) 5.7 ( 4.7- 6.9)
Arkansas 2.8 ( 2.1- 3.8) 2.0 ( 1.3- 2.9) 9.7 ( 5.7- 15.5) ∼
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Table 2.24.1.2F: Stomach. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 3.3 ( 2.6- 4.1) 2.1 ( 1.5- 2.9) 6.7 ( 4.8- 9.1) ∼
Oklahoma 2.7 ( 2.1- 3.6) 2.4 ( 1.8- 3.3) ∼ ∼
Texas 3.3 ( 2.9- 3.6) 3.0 ( 2.7- 3.4) 5.4 ( 4.0- 7.1) 5.9 ( 4.8- 7.1)
West 3.1 ( 3.0- 3.3) 2.7 ( 2.5- 2.9) 5.5 ( 4.3- 7.0) 5.4 ( 4.7- 6.2)
Mountain 2.5 ( 2.2- 2.8) 2.3 ( 2.0- 2.6) ∼ 5.6 ( 4.2- 7.4)
Arizona 2.3 ( 1.8- 2.9) 2.1 ( 1.6- 2.7) ∼ 4.6 ( 2.5- 7.8)
Colorado 2.5 ( 1.9- 3.3) 2.4 ( 1.8- 3.2) ∼ 9.6 ( 5.7- 15.3)
Idaho ∼ ∼ ∼ ∼
Montana 3.2 ( 1.9- 5.3) ∼ ∼ ∼
Nevada 2.7 ( 1.8- 3.9) 2.3 ( 1.4- 3.5) ∼ ∼
New Mexico 2.8 ( 1.9- 4.1) 2.9 ( 1.9- 4.3) ∼ 5.4 ( 3.1- 8.7)
Utah 3.0 ( 2.0- 4.3) 2.8 ( 1.8- 4.2) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 3.4 ( 3.2- 3.7) 2.9 ( 2.7- 3.2) 5.7 ( 4.4- 7.4) 5.3 ( 4.5- 6.2)
Alaska ∼ ∼ ∼ ∼
California 3.5 ( 3.3- 3.8) 3.0 ( 2.8- 3.3) 5.9 ( 4.5- 7.6) 5.2 ( 4.4- 6.1)
Hawaii 5.1 ( 3.7- 7.0) ∼ ∼ ∼
Oregon 2.6 ( 2.0- 3.5) 2.4 ( 1.7- 3.2) ∼ ∼
Washington 2.8 ( 2.3- 3.5) 2.7 ( 2.1- 3.4) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.25.1.1: Testis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 5.2 ( 5.1- 5.3) 6.0 ( 5.8- 6.1) 1.3 ( 1.2- 1.5) 3.8 ( 3.5- 4.1)
Northeast 5.6 ( 5.4- 5.9) 6.5 ( 6.2- 6.9) 1.4 ( 1.0- 2.0) 3.0 ( 2.5- 3.9)
New England 5.9 ( 5.3- 6.5) 6.4 ( 5.8- 7.1) ∼ 3.4 ( 2.0- 7.7)
Connecticut 5.1 ( 4.1- 6.3) 5.8 ( 4.6- 7.3) ∼ ∼
Maine 5.9 ( 4.1- 8.2) 6.1 ( 4.3- 8.5) ∼ ∼
Massachusetts 6.1 ( 5.3- 7.0) 6.8 ( 5.9- 7.8) ∼ ∼
New Hampshire 7.7 ( 5.7- 10.4) 7.9 ( 5.8- 10.6) ∼ ∼
Rhode Island 4.8 ( 3.1- 7.2) 5.4 ( 3.5- 8.1) ∼ ∼
Vermont 5.6 ( 3.2- 9.1) 5.7 ( 3.3- 9.4) ∼ ∼
Middle Atlantic 5.6 ( 5.2- 5.9) 6.5 ( 6.1- 6.9) 1.6 ( 1.1- 2.2) 3.0 ( 2.4- 3.9)
New Jersey 5.9 ( 5.2- 6.7) 7.0 ( 6.1- 8.0) ∼ 3.6 ( 2.5- 6.6)
New York 5.4 ( 4.9- 5.9) 6.5 ( 5.9- 7.1) 1.5 ( 0.9- 2.4) 2.9 ( 2.1- 4.2)
Pennsylvania 5.6 ( 5.0- 6.3) 6.3 ( 5.6- 7.1) ∼ -
Midwest 5.6 ( 5.4- 5.9) 6.0 ( 5.8- 6.3) 1.4 ( 1.0- 2.0) 3.1 ( 2.3- 4.6)
East North Central 5.5 ( 5.2- 5.8) 6.0 ( 5.7- 6.4) 1.3 ( 0.9- 2.0) 3.3 ( 2.4- 5.2)
Illinois 5.1 ( 4.5- 5.7) 5.9 ( 5.3- 6.6) ∼ -
Indiana 6.0 ( 5.2- 7.0) 6.2 ( 5.3- 7.2) ∼ ∼
Michigan 5.3 ( 4.7- 6.0) 6.1 ( 5.4- 7.0) ∼ ∼
Detroit 4.9 ( 3.9- 6.0) 6.2 ( 5.0- 7.7) ∼ ∼
Ohio 5.2 ( 4.6- 5.8) 5.3 ( 4.7- 6.0) ∼ ∼
Wisconsin 6.7 ( 5.7- 7.7) 7.1 ( 6.1- 8.3) ∼ ∼
West North Central 6.0 ( 5.5- 6.5) 6.1 ( 5.6- 6.7) ∼ ∼
Iowa 6.1 ( 4.9- 7.6) 6.2 ( 4.9- 7.7) ∼ ∼
Kansas 5.0 ( 3.9- 6.4) 5.0 ( 3.8- 6.4) ∼ ∼
Minnesota 7.2 ( 6.2- 8.3) 7.2 ( 6.1- 8.4) ∼ ∼
Missouri 4.9 ( 4.1- 5.8) 5.4 ( 4.5- 6.4) ∼ ∼
Nebraska 6.7 ( 5.1- 8.7) 6.7 ( 5.1- 8.8) ∼ ∼
North Dakota 4.7 ( 2.6- 7.8) ∼ ∼ ∼
South Dakota 7.4 ( 4.9- 10.9) 7.6 ( 4.9- 11.4) ∼ ∼
South
South Atlantic 4.5 ( 4.2- 4.8) 5.5 ( 5.2- 5.8) 1.3 ( 1.0- 1.7) 3.4 ( 2.8- 4.3)
Delaware 4.6 ( 2.8- 7.5) 5.8 ( 3.4- 9.3) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.9 ( 4.4- 5.4) 5.7 ( 5.1- 6.3) 1.3 ( 0.7- 2.6) -
Georgia 4.0 ( 3.4- 4.7) 5.2 ( 4.4- 6.1) ∼ ∼
Atlanta 3.6 ( 2.7- 5.0) 5.1 ( 3.8- 7.0) ∼ ∼
Maryland 4.6 ( 3.8- 5.5) 6.4 ( 5.3- 7.7) ∼ ∼
North Carolina 4.3 ( 3.7- 5.0) 5.1 ( 4.4- 6.0) ∼ 4.1 ( 2.2- 19.7)
South Carolina 4.4 ( 3.5- 5.4) 5.6 ( 4.4- 7.1) ∼ -
Virginia 4.4 ( 3.7- 5.1) 5.3 ( 4.5- 6.2) ∼ ∼
West Virginia 5.2 ( 3.8- 7.0) 5.5 ( 4.0- 7.4) ∼ ∼
East South Central
Alabama 3.5 ( 2.8- 4.5) 4.3 ( 3.4- 5.6) ∼ ∼
Kentucky 4.3 ( 3.5- 5.4) 4.6 ( 3.7- 5.7) ∼ -
Mississippi 2.2 ( 1.5- 3.2) 2.6 ( 1.7- 4.0) ∼ ∼
Tennessee
continued
C
ancer Incidence and M
ortality, by U
.S. C
ensus R
egion and D
ivision, State, and M
etropolitan A
rea
199
Table 2.25.1.1: Testis. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 4.8 ( 4.5- 5.2) 5.6 ( 5.2- 6.0) 1.4 ( 0.9- 2.1) 4.4 ( 3.8- 5.2)
Arkansas 5.0 ( 3.9- 6.4) 5.5 ( 4.2- 7.1) ∼ ∼
Louisiana 4.3 ( 3.5- 5.4) 5.8 ( 4.6- 7.2) ∼ ∼
Oklahoma 5.9 ( 4.8- 7.3) 6.6 ( 5.3- 8.1) ∼ ∼
Texas 4.8 ( 4.4- 5.2) 5.4 ( 4.9- 5.9) ∼ 4.4 ( 3.7- 5.2)
West 5.6 ( 5.3- 5.8) 6.3 ( 6.0- 6.6) 1.1 ( 0.7- 2.0) 4.1 ( 3.6- 4.6)
Mountain
Arizona
Colorado 6.0 ( 5.1- 7.2) 6.4 ( 5.4- 7.6) ∼ 5.9 ( 3.8- 10.8)
Idaho 5.8 ( 4.1- 8.1) 6.1 ( 4.3- 8.4) ∼ ∼
Montana 7.4 ( 5.1- 10.6) 7.6 ( 5.2- 11.0) ∼ ∼
Nevada 5.9 ( 4.6- 7.6) 6.5 ( 5.1- 8.5) ∼ ∼
New Mexico 5.3 ( 3.9- 7.1) 5.1 ( 3.6- 7.0) ∼ 5.0 ( 3.1- 8.4)
Utah 7.7 ( 6.1- 9.6) 8.0 ( 6.4- 10.0) ∼ ∼
Wyoming
Pacific 5.4 ( 5.1- 5.7) 6.2 ( 5.8- 6.6) 1.1 ( 0.7- 2.1) 3.9 ( 3.4- 4.5)
Alaska 5.5 ( 3.3- 11.3) ∼ ∼ ∼
California 5.2 ( 4.9- 5.5) 6.1 ( 5.7- 6.5) 1.2 ( 0.7- 2.2) 3.9 ( 3.5- 4.5)
San Francisco-Oakland 5.0 ( 4.1- 6.0) 6.8 ( 5.5- 8.3) ∼ 4.5 ( 2.6- 8.8)
San Jose-Monterey 6.7 ( 5.4- 8.4) 8.0 ( 6.3- 10.1) ∼ 5.5 ( 3.4- 11.2)
Los Angeles 4.5 ( 3.9- 5.1) 5.5 ( 4.8- 6.3) ∼ 3.6 ( 2.9- 4.7)
Hawaii 4.5 ( 2.9- 6.5) ∼ ∼ -
Oregon 6.5 ( 5.4- 7.8) 6.6 ( 5.4- 8.0) ∼ ∼
Washington 6.0 ( 5.2- 6.9) 6.5 ( 5.6- 7.6) ∼ ∼
Seattle-Puget Sound 5.5 ( 4.6- 6.6) 6.4 ( 5.3- 7.7) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.25.1.2: Testis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) 0.2 ( 0.1- 0.3) 0.2 ( 0.2- 0.3)
Northeast 0.2 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) ∼ ∼
New England ∼ ∼ ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
New Jersey ∼ ∼ ∼ ∼
New York 0.2 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Pennsylvania 0.3 ( 0.2- 0.4) ∼ ∼ ∼
Midwest 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.3) ∼ ∼
East North Central 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
Illinois ∼ ∼ ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan ∼ ∼ ∼ ∼
Ohio 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.3 ( 0.2- 0.3) 0.3 ( 0.3- 0.4) ∼ 0.4 ( 0.2- 0.6)
South Atlantic 0.3 ( 0.2- 0.3) 0.3 ( 0.2- 0.4) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.3 ( 0.2- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Georgia ∼ ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.4) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.25.1.2: Testis. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.3 ( 0.2- 0.4) 0.3 ( 0.2- 0.5) ∼ ∼
West 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
Mountain 0.2 ( 0.1- 0.3) ∼ ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.2 ( 0.2- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.2 ( 0.1- 0.3) 0.2 ( 0.2- 0.3) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.26.1.1M: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 4.3 ( 4.2- 4.4) 4.5 ( 4.4- 4.6) 2.4 ( 2.1- 2.7) 3.1 ( 2.8- 3.5)
Northeast 5.5 ( 5.2- 5.8) 5.7 ( 5.4- 6.0) 2.8 ( 2.2- 3.6) 3.5 ( 2.6- 4.7)
New England 5.5 ( 4.9- 6.0) 5.5 ( 4.9- 6.1) ∼ ∼
Connecticut 6.2 ( 5.1- 7.5) 6.5 ( 5.2- 7.9) ∼ ∼
Maine 3.4 ( 2.1- 5.2) 3.3 ( 2.1- 5.1) ∼ ∼
Massachusetts 6.0 ( 5.2- 6.9) 6.2 ( 5.3- 7.2) ∼ ∼
New Hampshire 3.5 ( 2.2- 5.4) 3.0 ( 1.8- 4.8) ∼ ∼
Rhode Island 5.1 ( 3.4- 7.6) 4.9 ( 3.1- 7.5) ∼ ∼
Vermont 5.4 ( 3.1- 8.9) 5.1 ( 2.9- 8.6) ∼ ∼
Middle Atlantic 5.5 ( 5.2- 5.8) 5.8 ( 5.5- 6.2) 2.7 ( 2.1- 3.6) 3.2 ( 2.3- 4.5)
New Jersey 5.9 ( 5.2- 6.7) 6.4 ( 5.6- 7.3) ∼ 3.5 ( 1.8- 7.1)
New York 5.0 ( 4.6- 5.5) 5.4 ( 4.9- 6.0) 2.1 ( 1.3- 3.2) 3.2 ( 2.1- 4.9)
Pennsylvania 5.9 ( 5.3- 6.5) 5.9 ( 5.3- 6.6) 3.9 ( 2.4- 6.4) -
Midwest 4.2 ( 3.9- 4.4) 4.1 ( 3.9- 4.4) 2.8 ( 2.1- 3.6) 2.2 ( 1.4- 3.9)
East North Central 4.1 ( 3.8- 4.4) 4.1 ( 3.8- 4.4) 2.8 ( 2.1- 3.7) 1.8 ( 1.0- 3.8)
Illinois 4.0 ( 3.5- 4.5) 4.0 ( 3.5- 4.6) ∼ -
Indiana 4.1 ( 3.4- 5.0) 4.1 ( 3.4- 5.0) ∼ ∼
Michigan 4.0 ( 3.5- 4.7) 3.9 ( 3.3- 4.6) 4.4 ( 2.7- 6.9) ∼
Detroit 5.0 ( 4.0- 6.1) 4.9 ( 3.8- 6.3) 5.0 ( 3.0- 8.2) ∼
Ohio 4.0 ( 3.4- 4.5) 4.0 ( 3.4- 4.6) ∼ ∼
Wisconsin 4.6 ( 3.8- 5.5) 4.5 ( 3.7- 5.4) ∼ ∼
West North Central 4.3 ( 3.9- 4.8) 4.4 ( 3.9- 4.8) ∼ ∼
Iowa 5.0 ( 3.9- 6.3) 4.9 ( 3.8- 6.2) ∼ ∼
Kansas 5.0 ( 3.8- 6.4) 5.2 ( 4.0- 6.7) ∼ ∼
Minnesota 4.0 ( 3.3- 4.9) 4.1 ( 3.3- 5.0) ∼ ∼
Missouri 4.0 ( 3.3- 4.8) 3.9 ( 3.2- 4.8) ∼ ∼
Nebraska 3.5 ( 2.4- 5.1) 3.6 ( 2.4- 5.2) ∼ ∼
North Dakota 5.4 ( 3.1- 8.8) ∼ ∼ ∼
South Dakota 5.3 ( 3.2- 8.2) 5.6 ( 3.4- 8.8) ∼ ∼
South
South Atlantic 3.9 ( 3.7- 4.2) 4.3 ( 4.0- 4.6) 2.0 ( 1.6- 2.5) 4.0 ( 3.2- 5.2)
Delaware 5.0 ( 3.1- 8.0) 5.8 ( 3.5- 9.3) ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 4.3 ( 3.9- 4.8) 4.6 ( 4.2- 5.2) 2.2 ( 1.3- 3.7) -
Georgia 3.6 ( 3.0- 4.3) 4.4 ( 3.6- 5.3) ∼ ∼
Atlanta 4.5 ( 3.3- 6.3) 6.3 ( 4.5- 8.7) ∼ ∼
Maryland 5.3 ( 4.5- 6.3) 6.0 ( 4.9- 7.2) 2.2 ( 1.3- 4.2) ∼
North Carolina 2.7 ( 2.2- 3.3) 2.8 ( 2.3- 3.5) ∼ ∼
South Carolina 3.5 ( 2.8- 4.5) 4.1 ( 3.1- 5.4) ∼ -
Virginia 3.8 ( 3.2- 4.6) 4.2 ( 3.4- 5.1) 3.1 ( 1.7- 5.3) ∼
West Virginia 2.8 ( 1.8- 4.2) 2.8 ( 1.8- 4.3) ∼ ∼
East South Central
Alabama 3.5 ( 2.7- 4.4) 3.8 ( 2.9- 4.9) ∼ ∼
Kentucky 3.5 ( 2.7- 4.5) 3.6 ( 2.8- 4.6) ∼ -
Mississippi 3.6 ( 2.6- 4.9) 3.7 ( 2.5- 5.4) ∼ ∼
Tennessee
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Table 2.26.1.1M: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 3.8 ( 3.5- 4.1) 4.0 ( 3.7- 4.4) 2.2 ( 1.6- 3.2) 2.8 ( 2.1- 3.7)
Arkansas 3.6 ( 2.7- 4.9) 4.0 ( 2.9- 5.4) ∼ ∼
Louisiana 4.4 ( 3.6- 5.5) 5.5 ( 4.4- 6.9) ∼ ∼
Oklahoma 2.5 ( 1.8- 3.4) 2.7 ( 1.9- 3.7) ∼ ∼
Texas 3.9 ( 3.5- 4.3) 4.0 ( 3.5- 4.4) 2.9 ( 1.9- 4.6) 2.7 ( 2.0- 3.6)
West 4.3 ( 4.1- 4.6) 4.5 ( 4.2- 4.7) 2.3 ( 1.5- 3.5) 2.9 ( 2.4- 3.6)
Mountain
Arizona
Colorado 5.4 ( 4.4- 6.5) 5.7 ( 4.6- 6.9) ∼ ∼
Idaho 4.6 ( 3.1- 6.7) 4.8 ( 3.2- 6.9) ∼ ∼
Montana 4.0 ( 2.4- 6.4) 4.0 ( 2.4- 6.6) ∼ ∼
Nevada 4.3 ( 3.1- 5.8) 4.7 ( 3.4- 6.5) ∼ ∼
New Mexico 4.0 ( 2.8- 5.7) 4.4 ( 3.0- 6.2) ∼ ∼
Utah 6.5 ( 5.0- 8.5) 6.7 ( 5.1- 8.8) ∼ ∼
Wyoming
Pacific 4.1 ( 3.8- 4.4) 4.2 ( 3.9- 4.5) 2.4 ( 1.6- 3.8) 2.9 ( 2.3- 3.6)
Alaska ∼ ∼ ∼ ∼
California 4.0 ( 3.7- 4.3) 4.2 ( 3.9- 4.6) 2.4 ( 1.5- 3.8) 2.8 ( 2.2- 3.5)
San Francisco-Oakland 3.0 ( 2.3- 3.9) 2.9 ( 2.1- 4.0) ∼ ∼
San Jose-Monterey 3.5 ( 2.4- 4.9) 4.0 ( 2.7- 5.7) ∼ ∼
Los Angeles 4.0 ( 3.4- 4.7) 4.5 ( 3.8- 5.3) ∼ 2.8 ( 2.0- 4.1)
Hawaii 4.3 ( 2.8- 6.3) ∼ ∼ -
Oregon 4.5 ( 3.5- 5.6) 4.3 ( 3.3- 5.4) ∼ ∼
Washington 4.4 ( 3.7- 5.2) 4.2 ( 3.5- 5.1) ∼ ∼
Seattle-Puget Sound 4.2 ( 3.4- 5.3) 4.3 ( 3.4- 5.5) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.26.1.1F: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 12.7 ( 12.5- 12.9) 13.2 ( 13.0- 13.5) 7.9 ( 7.5- 8.3) 11.8 ( 11.3- 12.4)
Northeast 16.3 ( 15.8- 16.8) 17.0 ( 16.4- 17.5) 8.9 ( 7.9- 9.9) 12.3 ( 11.0- 13.9)
New England 16.6 ( 15.7- 17.6) 16.8 ( 15.8- 17.8) 8.5 ( 6.1- 12.0) 18.2 ( 13.8- 24.1)
Connecticut 17.0 ( 15.1- 19.0) 18.0 ( 16.0- 20.2) ∼ 19.5 ( 12.5- 30.6)
Maine 16.8 ( 13.8- 20.2) 16.8 ( 13.8- 20.3) ∼ ∼
Massachusetts 18.4 ( 17.0- 19.9) 18.4 ( 16.9- 20.0) 11.0 ( 7.1- 16.9) 15.0 ( 9.4- 24.1)
New Hampshire 10.2 ( 7.9- 13.0) 10.1 ( 7.8- 12.9) ∼ ∼
Rhode Island 15.5 ( 12.4- 19.1) 15.6 ( 12.4- 19.5) ∼ ∼
Vermont 11.4 ( 8.0- 15.9) 11.3 ( 7.9- 15.9) ∼ ∼
Middle Atlantic 16.2 ( 15.6- 16.7) 17.0 ( 16.4- 17.7) 8.9 ( 7.9- 10.0) 11.3 ( 9.9- 12.9)
New Jersey 17.7 ( 16.5- 19.0) 18.9 ( 17.5- 20.4) 10.5 ( 8.1- 13.4) 13.4 ( 10.3- 17.2)
New York 13.4 ( 12.7- 14.1) 14.3 ( 13.4- 15.1) 6.7 ( 5.6- 8.0) 10.6 ( 8.9- 12.5)
Pennsylvania 19.4 ( 18.4- 20.5) 19.6 ( 18.4- 20.8) 13.3 ( 10.7- 16.5) -
Midwest 12.2 ( 11.9- 12.6) 12.5 ( 12.1- 13.0) 7.1 ( 6.2- 8.1) 11.8 ( 9.8- 14.3)
East North Central 12.0 ( 11.5- 12.4) 12.4 ( 11.9- 12.9) 6.8 ( 5.9- 7.9) 11.6 ( 9.4- 14.4)
Illinois 13.3 ( 12.4- 14.2) 14.4 ( 13.4- 15.5) 7.0 ( 5.4- 9.0) -
Indiana 10.8 ( 9.7- 12.0) 11.1 ( 9.9- 12.4) 6.3 ( 3.7- 10.4) ∼
Michigan 12.3 ( 11.4- 13.3) 12.9 ( 11.8- 14.0) 7.3 ( 5.5- 9.7) ∼
Detroit 12.8 ( 11.3- 14.4) 14.8 ( 13.0- 16.9) 7.8 ( 5.6- 10.6) ∼
Ohio 11.1 ( 10.3- 12.0) 11.0 ( 10.1- 12.0) 6.6 ( 4.8- 8.9) ∼
Wisconsin 11.4 ( 10.2- 12.7) 11.6 ( 10.3- 13.0) ∼ ∼
West North Central 12.9 ( 12.2- 13.6) 12.9 ( 12.2- 13.7) 8.4 ( 6.1- 11.3) 12.6 ( 7.9- 19.9)
Iowa 14.8 ( 12.9- 16.9) 14.2 ( 12.3- 16.3) ∼ ∼
Kansas 14.6 ( 12.7- 16.8) 15.6 ( 13.5- 18.0) ∼ ∼
Minnesota 12.0 ( 10.7- 13.4) 11.7 ( 10.4- 13.2) ∼ ∼
Missouri 12.0 ( 10.8- 13.3) 12.0 ( 10.7- 13.5) 10.3 ( 7.1- 14.5) ∼
Nebraska 14.4 ( 12.0- 17.3) 14.8 ( 12.3- 17.8) ∼ ∼
North Dakota 9.3 ( 6.3- 13.3) 9.5 ( 6.4- 13.7) ∼ ∼
South Dakota 11.3 ( 8.1- 15.3) 11.9 ( 8.5- 16.4) ∼ ∼
South
South Atlantic 11.3 ( 10.9- 11.7) 12.1 ( 11.7- 12.6) 7.7 ( 7.0- 8.4) 13.8 ( 12.3- 15.5)
Delaware 13.6 ( 10.3- 17.6) 14.2 ( 10.4- 19.0) ∼ ∼
District of Columbia 15.7 ( 11.6- 21.1) 18.5 ( 11.3- 32.2) 12.5 ( 8.0- 19.3) ∼
Florida 12.2 ( 11.4- 12.9) 12.8 ( 11.9- 13.6) 8.4 ( 6.8- 10.2) -
Georgia 10.4 ( 9.4- 11.4) 11.7 ( 10.5- 13.0) 6.8 ( 5.4- 8.5) 10.7 ( 6.0- 20.8)
Atlanta 12.1 ( 10.4- 14.1) 15.1 ( 12.7- 18.0) 6.7 ( 4.7- 9.7) ∼
Maryland 15.5 ( 14.1- 17.0) 17.4 ( 15.6- 19.4) 9.9 ( 7.9- 12.4) 14.4 ( 8.1- 25.7)
North Carolina 9.1 ( 8.2- 10.0) 9.7 ( 8.6- 10.8) 5.8 ( 4.4- 7.6) 10.5 ( 5.1- 23.8)
South Carolina 8.9 ( 7.7- 10.3) 10.5 ( 8.9- 12.3) 5.4 ( 3.7- 7.6) -
Virginia 10.6 ( 9.6- 11.7) 11.3 ( 10.1- 12.6) 7.1 ( 5.4- 9.4) 12.4 ( 7.0- 22.7)
West Virginia 10.1 ( 8.2- 12.3) 9.8 ( 7.9- 12.1) ∼ ∼
East South Central
Alabama 9.1 ( 8.0- 10.4) 9.5 ( 8.1- 11.1) 8.4 ( 6.3- 11.2) ∼
Kentucky 11.6 ( 10.2- 13.1) 11.5 ( 10.1- 13.1) 11.5 ( 6.8- 18.6) -
Mississippi 10.9 ( 9.3- 12.7) 12.3 ( 10.1- 14.8) 8.8 ( 6.4- 12.0) ∼
Tennessee
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Table 2.26.1.1F: Thyroid. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence Intervals, by
U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity, United States†‡
(continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 10.7 ( 10.2- 11.2) 11.2 ( 10.6- 11.8) 7.3 ( 6.2- 8.5) 11.0 ( 9.9- 12.4)
Arkansas 7.4 ( 6.0- 8.9) 7.7 ( 6.2- 9.5) ∼ ∼
Louisiana 10.4 ( 9.2- 11.9) 11.6 ( 10.0- 13.5) 8.2 ( 6.2- 10.7) ∼
Oklahoma 7.7 ( 6.5- 9.2) 8.0 ( 6.6- 9.6) ∼ ∼
Texas 11.7 ( 11.0- 12.3) 12.1 ( 11.4- 12.8) 7.3 ( 5.9- 9.1) 11.3 ( 10.0- 12.6)
West 12.7 ( 12.3- 13.1) 12.9 ( 12.5- 13.4) 7.9 ( 6.6- 9.5) 11.4 ( 10.5- 12.3)
Mountain
Arizona
Colorado 14.4 ( 12.9- 16.0) 14.2 ( 12.7- 16.0) ∼ 14.7 ( 10.5- 20.3)
Idaho 15.0 ( 12.2- 18.3) 14.9 ( 12.1- 18.3) ∼ ∼
Montana 16.8 ( 13.2- 21.1) 17.3 ( 13.5- 21.9) ∼ ∼
Nevada 16.9 ( 14.6- 19.6) 17.9 ( 15.2- 20.8) ∼ 16.1 ( 10.2- 26.1)
New Mexico 16.9 ( 14.4- 19.8) 18.3 ( 15.4- 21.5) ∼ 12.4 ( 9.0- 16.7)
Utah 15.6 ( 13.3- 18.3) 16.1 ( 13.6- 18.9) ∼ ∼
Wyoming
Pacific 11.9 ( 11.5- 12.4) 11.9 ( 11.4- 12.4) 7.6 ( 6.2- 9.4) 11.0 ( 10.0- 12.0)
Alaska 13.0 ( 9.3- 18.3) 12.7 ( 8.5- 18.9) ∼ ∼
California 11.4 ( 10.9- 11.9) 11.8 ( 11.2- 12.4) 7.3 ( 5.9- 9.1) 11.1 ( 10.1- 12.1)
San Francisco-Oakland 9.4 ( 8.2- 10.8) 9.9 ( 8.3- 11.7) 8.2 ( 4.9- 13.2) 7.5 ( 4.7- 11.6)
San Jose-Monterey 12.5 ( 10.6- 14.8) 12.5 ( 10.3- 15.1) ∼ 13.4 ( 9.0- 19.7)
Los Angeles 12.2 ( 11.3- 13.3) 12.6 ( 11.5- 13.9) 6.9 ( 4.8- 9.7) 11.9 ( 10.2- 13.7)
Hawaii 16.1 ( 13.2- 19.6) ∼ ∼ -
Oregon 11.2 ( 9.7- 12.9) 10.2 ( 8.8- 11.9) ∼ ∼
Washington 14.2 ( 12.9- 15.6) 14.1 ( 12.7- 15.6) ∼ 12.4 ( 7.7- 22.2)
Seattle-Puget Sound 15.1 ( 13.5- 16.9) 15.6 ( 13.9- 17.6) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Invasive cancers only.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.26.1.2M: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.3 ( 0.2- 0.4) 0.5 ( 0.3- 0.7)
Northeast 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
New England 0.3 ( 0.2- 0.5) 0.3 ( 0.2- 0.5) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts ∼ ∼ ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
New Jersey 0.4 ( 0.3- 0.7) ∼ ∼ ∼
New York 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.5) ∼ ∼
Pennsylvania 0.5 ( 0.3- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Midwest 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) ∼ ∼
East North Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
Illinois 0.4 ( 0.2- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.6 ( 0.4- 0.9) 0.6 ( 0.4- 0.9) ∼ ∼
Ohio 0.4 ( 0.2- 0.6) 0.4 ( 0.2- 0.6) ∼ ∼
Wisconsin ∼ ∼ ∼ ∼
West North Central 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota ∼ ∼ ∼ ∼
Missouri ∼ ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) ∼ ∼
South Atlantic 0.4 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Georgia 0.6 ( 0.3- 0.9) ∼ ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina 0.6 ( 0.4- 1.0) 0.7 ( 0.4- 1.1) ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia ∼ ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.3 ( 0.2- 0.5) 0.4 ( 0.2- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky ∼ ∼ ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.4 ( 0.3- 0.5) 0.5 ( 0.3- 0.6) ∼ ∼
Arkansas ∼ ∼ ∼ ∼
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Table 2.26.1.2M: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana ∼ ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.4 ( 0.2- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
West 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ 0.7 ( 0.4- 1.1)
Mountain 0.5 ( 0.4- 0.7) 0.6 ( 0.4- 0.8) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Alaska ∼ ∼ ∼ ∼
California 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.6) ∼ ∼
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.26.1.2F: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.5 ( 0.4- 0.7)
Northeast 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
New England 0.6 ( 0.4- 0.8) 0.6 ( 0.4- 0.8) ∼ ∼
Connecticut ∼ ∼ ∼ ∼
Maine ∼ ∼ ∼ ∼
Massachusetts 0.7 ( 0.4- 1.0) 0.7 ( 0.4- 1.0) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island ∼ ∼ ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
New Jersey 0.5 ( 0.4- 0.8) 0.5 ( 0.3- 0.8) ∼ ∼
New York 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Pennsylvania 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Midwest 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ ∼
East North Central 0.5 ( 0.4- 0.5) 0.5 ( 0.4- 0.6) ∼ ∼
Illinois 0.5 ( 0.4- 0.7) 0.5 ( 0.3- 0.7) ∼ ∼
Indiana ∼ ∼ ∼ ∼
Michigan 0.4 ( 0.3- 0.6) 0.5 ( 0.3- 0.7) ∼ ∼
Ohio 0.4 ( 0.3- 0.6) 0.4 ( 0.3- 0.6) ∼ ∼
Wisconsin 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.9) ∼ ∼
West North Central 0.5 ( 0.4- 0.7) 0.5 ( 0.4- 0.7) ∼ ∼
Iowa ∼ ∼ ∼ ∼
Kansas ∼ ∼ ∼ ∼
Minnesota 0.7 ( 0.4- 1.1) 0.7 ( 0.4- 1.1) ∼ ∼
Missouri 0.4 ( 0.2- 0.7) ∼ ∼ ∼
Nebraska ∼ ∼ ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) 0.4 ( 0.3- 0.6) 0.6 ( 0.4- 0.9)
South Atlantic 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) 0.5 ( 0.3- 0.7) ∼
Delaware ∼ ∼ ∼ ∼
District of Columbia ∼ ∼ ∼ ∼
Florida 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Georgia 0.5 ( 0.3- 0.8) 0.5 ( 0.3- 0.9) ∼ ∼
Maryland ∼ ∼ ∼ ∼
North Carolina ∼ ∼ ∼ ∼
South Carolina ∼ ∼ ∼ ∼
Virginia 0.4 ( 0.2- 0.7) ∼ ∼ ∼
West Virginia ∼ ∼ ∼ ∼
East South Central 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.6) ∼ ∼
Alabama ∼ ∼ ∼ ∼
Kentucky 0.7 ( 0.4- 1.1) 0.7 ( 0.4- 1.2) ∼ ∼
Mississippi ∼ ∼ ∼ ∼
Tennessee ∼ ∼ ∼ ∼
West South Central 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ 0.7 ( 0.4- 1.2)
Arkansas ∼ ∼ ∼ ∼
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Table 2.26.1.2F: Thyroid. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S. Census
Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 0.6 ( 0.4- 1.1) ∼ ∼ ∼
Oklahoma ∼ ∼ ∼ ∼
Texas 0.5 ( 0.4- 0.7) 0.6 ( 0.4- 0.7) ∼ 0.8 ( 0.4- 1.3)
West 0.4 ( 0.4- 0.5) 0.4 ( 0.4- 0.5) ∼ 0.7 ( 0.4- 1.0)
Mountain 0.4 ( 0.3- 0.5) 0.4 ( 0.3- 0.5) ∼ ∼
Arizona ∼ ∼ ∼ ∼
Colorado ∼ ∼ ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada ∼ ∼ ∼ ∼
New Mexico ∼ ∼ ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 0.5 ( 0.4- 0.6) 0.4 ( 0.4- 0.5) ∼ 0.6 ( 0.4- 1.0)
Alaska ∼ ∼ ∼ ∼
California 0.5 ( 0.4- 0.6) 0.5 ( 0.4- 0.6) ∼ 0.7 ( 0.4- 1.0)
Hawaii ∼ ∼ ∼ ∼
Oregon ∼ ∼ ∼ ∼
Washington ∼ ∼ ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Table 2.27.1.1M: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Males, 2003
Area All Races White Black Hispanic§‖
United States 36.9 ( 36.5- 37.2) 38.8 ( 38.5- 39.2) 18.2 ( 17.3- 19.1) 20.9 ( 19.8- 22.0)
Northeast 43.5 ( 42.7- 44.3) 46.0 ( 45.2- 47.0) 16.9 ( 15.0- 18.9) 25.8 ( 22.7- 29.3)
New England 45.5 ( 43.9- 47.2) 46.9 ( 45.2- 48.6) 17.2 ( 11.9- 24.6) 26.4 ( 18.3- 37.6)
Connecticut 42.0 ( 38.9- 45.4) 44.0 ( 40.7- 47.5) 18.4 ( 10.3- 32.3) 32.9 ( 18.7- 55.1)
Maine 54.7 ( 49.1- 60.9) 54.4 ( 48.8- 60.6) ∼ ∼
Massachusetts 46.0 ( 43.5- 48.5) 47.6 ( 45.1- 50.3) 18.2 ( 10.8- 29.7) ∼
New Hampshire 43.7 ( 38.3- 49.6) 43.5 ( 38.1- 49.5) ∼ ∼
Rhode Island 46.1 ( 40.4- 52.5) 48.3 ( 42.2- 55.0) ∼ ∼
Vermont 42.9 ( 35.6- 51.4) 43.3 ( 35.9- 51.8) ∼ ∼
Middle Atlantic 42.8 ( 41.8- 43.7) 45.7 ( 44.7- 46.8) 16.8 ( 14.9- 19.0) 25.7 ( 22.4- 29.5)
New Jersey 43.7 ( 41.6- 45.9) 47.4 ( 45.1- 49.8) 14.2 ( 10.3- 19.2) 26.9 ( 20.2- 35.6)
New York 41.3 ( 39.9- 42.7) 45.1 ( 43.6- 46.8) 15.8 ( 13.3- 18.8) 24.7 ( 20.8- 29.3)
Pennsylvania 44.1 ( 42.4- 45.8) 45.4 ( 43.7- 47.2) 21.4 ( 17.0- 26.7) -
Midwest 38.0 ( 37.3- 38.7) 38.4 ( 37.6- 39.1) 19.5 ( 17.5- 21.7) 21.9 ( 17.8- 26.9)
East North Central 38.6 ( 37.8- 39.5) 39.3 ( 38.4- 40.2) 19.1 ( 16.9- 21.4) 22.1 ( 17.5- 27.9)
Illinois 40.3 ( 38.5- 42.1) 42.5 ( 40.6- 44.5) 17.6 ( 14.2- 21.8) -
Indiana 35.9 ( 33.6- 38.3) 35.2 ( 32.8- 37.6) 17.3 ( 11.2- 26.1) ∼
Michigan 40.4 ( 38.5- 42.4) 41.6 ( 39.5- 43.7) 23.2 ( 18.7- 28.5) ∼
Detroit 42.4 ( 39.3- 45.7) 47.7 ( 44.0- 51.7) 22.1 ( 17.1- 28.3) ∼
Ohio 38.2 ( 36.5- 39.9) 37.9 ( 36.2- 39.8) 17.9 ( 13.9- 22.7) 31.4 ( 17.3- 56.0)
Wisconsin 35.9 ( 33.6- 38.4) 36.4 ( 34.0- 38.9) ∼ ∼
West North Central 36.7 ( 35.4- 38.0) 36.6 ( 35.3- 37.9) 22.0 ( 16.7- 28.8) 20.9 ( 12.4- 33.7)
Iowa 39.1 ( 36.0- 42.5) 37.6 ( 34.5- 41.0) ∼ ∼
Kansas 34.2 ( 31.0- 37.7) 33.4 ( 30.2- 37.0) ∼ ∼
Minnesota 38.2 ( 35.6- 40.9) 37.8 ( 35.1- 40.5) ∼ ∼
Missouri 34.8 ( 32.5- 37.1) 35.8 ( 33.4- 38.3) 18.0 ( 12.0- 26.4) ∼
Nebraska 34.7 ( 30.7- 39.1) 34.6 ( 30.5- 39.1) ∼ ∼
North Dakota 36.7 ( 30.3- 44.1) 36.5 ( 30.1- 44.0) ∼ ∼
South Dakota 43.3 ( 36.9- 50.6) 44.3 ( 37.7- 51.9) ∼ ∼
South
South Atlantic 34.8 ( 34.1- 35.6) 37.6 ( 36.8- 38.4) 17.3 ( 15.8- 18.9) 26.7 ( 23.9- 29.9)
Delaware 42.6 ( 36.2- 50.1) 44.3 ( 37.2- 52.4) ∼ ∼
District of Columbia 26.2 ( 20.0- 34.0) 36.1 ( 24.1- 54.1) 20.9 ( 14.1- 30.3) ∼
Florida 37.4 ( 36.2- 38.6) 39.2 ( 37.9- 40.5) 15.3 ( 12.2- 18.9) -
Georgia 32.8 ( 30.7- 35.1) 36.7 ( 34.2- 39.4) 17.8 ( 14.3- 22.1) ∼
Atlanta 29.6 ( 25.8- 33.9) 34.0 ( 29.3- 39.4) 17.4 ( 11.7- 25.8) ∼
Maryland 32.2 ( 29.8- 34.7) 36.9 ( 34.0- 39.9) 15.9 ( 12.0- 20.9) ∼
North Carolina 31.9 ( 30.0- 33.9) 34.3 ( 32.1- 36.6) 19.8 ( 16.0- 24.4) ∼
South Carolina 32.1 ( 29.4- 35.0) 36.5 ( 33.2- 40.0) 13.9 ( 10.2- 18.8) -
Virginia 33.3 ( 31.2- 35.5) 35.9 ( 33.5- 38.5) 20.1 ( 16.1- 25.1) ∼
West Virginia 37.7 ( 33.8- 42.0) 38.6 ( 34.6- 43.0) ∼ ∼
East South Central
Alabama 30.3 ( 27.8- 32.9) 33.7 ( 30.8- 36.8) 16.2 ( 12.2- 21.4) ∼
Kentucky 36.2 ( 33.4- 39.3) 37.1 ( 34.1- 40.2) 17.8 ( 10.0- 30.5) -
Mississippi 27.6 ( 24.6- 30.9) 32.4 ( 28.5- 36.6) 14.3 ( 10.1- 19.9) ∼
Tennessee
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Table 2.27.1.1M: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Males, 2003
Area All Races White Black Hispanic§‖
West South Central 30.7 ( 29.7- 31.7) 32.1 ( 31.1- 33.3) 18.7 ( 16.2- 21.4) 16.9 ( 14.8- 19.3)
Arkansas 33.8 ( 30.6- 37.3) 35.6 ( 32.1- 39.4) ∼ ∼
Louisiana 34.8 ( 32.1- 37.8) 40.0 ( 36.6- 43.6) 19.0 ( 14.8- 24.1) ∼
Oklahoma 34.4 ( 31.5- 37.5) 35.5 ( 32.4- 38.8) 20.6 ( 11.3- 35.6) ∼
Texas 28.5 ( 27.3- 29.8) 29.5 ( 28.2- 30.8) 19.7 ( 16.2- 23.8) 16.4 ( 14.3- 18.8)
West 35.1 ( 34.3- 35.9) 37.4 ( 36.5- 38.2) 23.0 ( 19.8- 26.6) 18.0 ( 16.4- 19.8)
Mountain
Arizona
Colorado 34.6 ( 31.7- 37.7) 34.5 ( 31.6- 37.7) ∼ 19.5 ( 12.8- 29.2)
Idaho 35.6 ( 30.8- 41.0) 36.1 ( 31.3- 41.6) ∼ ∼
Montana 44.1 ( 38.1- 50.8) 44.3 ( 38.2- 51.2) ∼ ∼
Nevada 44.2 ( 39.9- 48.9) 46.5 ( 41.9- 51.6) ∼ 23.0 ( 12.2- 42.6)
New Mexico 27.3 ( 23.7- 31.4) 28.8 ( 24.9- 33.1) ∼ 13.9 ( 9.4- 20.0)
Utah 30.2 ( 26.4- 34.5) 30.9 ( 27.0- 35.3) ∼ ∼
Wyoming
Pacific 35.0 ( 34.1- 35.9) 37.7 ( 36.7- 38.7) 23.8 ( 20.4- 27.8) 17.9 ( 16.0- 19.9)
Alaska 38.5 ( 28.9- 51.4) 39.8 ( 29.2- 54.5) ∼ ∼
California 34.1 ( 33.1- 35.1) 37.1 ( 35.9- 38.3) 23.2 ( 19.7- 27.2) 17.5 ( 15.7- 19.5)
San Francisco-Oakland 32.1 ( 29.5- 34.9) 38.6 ( 35.2- 42.3) 16.4 ( 10.4- 25.0) 14.1 ( 8.5- 22.4)
San Jose-Monterey 33.4 ( 29.6- 37.5) 38.2 ( 33.6- 43.3) ∼ 10.9 ( 6.1- 19.3)
Los Angeles 34.0 ( 32.0- 36.1) 37.4 ( 35.1- 39.9) 27.4 ( 21.7- 34.2) 19.8 ( 16.7- 23.5)
Hawaii 25.2 ( 21.3- 29.6) 50.0 ( 39.2- 63.4) ∼ -
Oregon 37.5 ( 34.6- 40.7) 37.0 ( 34.0- 40.1) ∼ ∼
Washington 40.4 ( 37.9- 43.0) 40.3 ( 37.7- 43.0) 29.7 ( 15.8- 53.6) ∼
Seattle-Puget Sound 41.7 ( 38.6- 45.0) 43.6 ( 40.3- 47.1) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Includes invasive and in situ.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1M. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.27.1.1F: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡
Females, 2003
Area All Races White Black Hispanic§‖
United States 9.5 ( 9.4- 9.7) 10.0 ( 9.8- 10.2) 6.4 ( 6.0- 6.8) 5.3 ( 4.9- 5.8)
Northeast 11.5 ( 11.1- 11.9) 12.2 ( 11.8- 12.6) 6.0 ( 5.2- 7.0) 6.4 ( 5.3- 7.8)
New England 12.4 ( 11.7- 13.2) 12.9 ( 12.1- 13.7) ∼ ∼
Connecticut 11.9 ( 10.4- 13.4) 12.5 ( 11.0- 14.3) ∼ ∼
Maine 12.4 ( 10.1- 15.1) 12.4 ( 10.1- 15.1) ∼ ∼
Massachusetts 12.6 ( 11.5- 13.7) 13.2 ( 12.0- 14.5) ∼ ∼
New Hampshire 12.5 ( 10.0- 15.4) 12.4 ( 9.9- 15.4) ∼ ∼
Rhode Island 13.4 ( 10.8- 16.6) 13.6 ( 10.9- 16.9) ∼ ∼
Vermont 12.8 ( 9.5- 17.3) 12.9 ( 9.5- 17.4) ∼ ∼
Middle Atlantic 11.2 ( 10.8- 11.6) 11.9 ( 11.4- 12.4) 6.2 ( 5.3- 7.2) 6.8 ( 5.5- 8.3)
New Jersey 11.3 ( 10.4- 12.2) 11.9 ( 10.9- 13.0) 7.5 ( 5.4- 10.3) 7.0 ( 4.5- 10.5)
New York 11.0 ( 10.4- 11.6) 12.1 ( 11.4- 12.9) 4.7 ( 3.7- 5.9) 7.1 ( 5.5- 9.1)
Pennsylvania 11.4 ( 10.6- 12.1) 11.6 ( 10.8- 12.4) 8.9 ( 6.8- 11.6) -
Midwest 10.0 ( 9.7- 10.4) 10.2 ( 9.8- 10.5) 7.0 ( 6.1- 8.1) 5.6 ( 3.9- 7.9)
East North Central 10.1 ( 9.8- 10.5) 10.4 ( 10.0- 10.8) 6.6 ( 5.6- 7.7) 5.9 ( 3.9- 8.6)
Illinois 11.0 ( 10.2- 11.8) 11.8 ( 10.9- 12.7) 5.8 ( 4.2- 7.7) -
Indiana 9.6 ( 8.6- 10.7) 9.7 ( 8.6- 10.8) ∼ ∼
Michigan 10.5 ( 9.6- 11.3) 10.7 ( 9.8- 11.6) 8.5 ( 6.4- 11.2) ∼
Detroit 9.7 ( 8.5- 11.1) 10.4 ( 8.9- 12.0) 8.4 ( 6.0- 11.5) ∼
Ohio 8.8 ( 8.1- 9.6) 8.7 ( 8.0- 9.5) 6.6 ( 4.7- 8.9) ∼
Wisconsin 11.1 ( 10.0- 12.3) 11.2 ( 10.1- 12.5) ∼ ∼
West North Central 9.8 ( 9.3- 10.4) 9.8 ( 9.2- 10.4) 9.3 ( 6.7- 12.8) ∼
Iowa 10.6 ( 9.1- 12.2) 10.0 ( 8.6- 11.6) ∼ ∼
Kansas 7.7 ( 6.4- 9.2) 7.3 ( 6.0- 8.8) ∼ ∼
Minnesota 11.3 ( 10.0- 12.6) 11.3 ( 10.0- 12.7) ∼ ∼
Missouri 9.4 ( 8.4- 10.5) 9.5 ( 8.4- 10.6) 9.1 ( 5.9- 13.4) ∼
Nebraska 9.5 ( 7.7- 11.7) 9.6 ( 7.8- 11.9) ∼ ∼
North Dakota 11.6 ( 8.5- 15.8) 12.0 ( 8.7- 16.4) ∼ ∼
South Dakota 8.3 ( 5.9- 11.6) 8.7 ( 6.1- 12.1) ∼ ∼
South
South Atlantic 9.1 ( 8.8- 9.5) 9.7 ( 9.3- 10.1) 6.3 ( 5.6- 7.1) 6.4 ( 5.2- 7.7)
Delaware 10.3 ( 7.6- 13.7) 11.1 ( 8.1- 15.1) ∼ ∼
District of Columbia 10.0 ( 6.9- 14.5) ∼ 9.7 ( 6.0- 15.6) ∼
Florida 10.0 ( 9.4- 10.6) 10.4 ( 9.7- 11.0) 5.9 ( 4.4- 7.6) -
Georgia 7.9 ( 7.0- 8.8) 8.9 ( 7.9- 10.1) 4.6 ( 3.3- 6.3) ∼
Atlanta 8.8 ( 7.1- 10.7) 10.2 ( 8.1- 12.7) 5.9 ( 3.4- 9.7) ∼
Maryland 9.7 ( 8.6- 10.9) 10.8 ( 9.5- 12.3) 6.7 ( 4.8- 9.1) ∼
North Carolina 8.3 ( 7.5- 9.1) 8.4 ( 7.5- 9.4) 7.4 ( 5.6- 9.5) ∼
South Carolina 8.3 ( 7.2- 9.6) 9.1 ( 7.8- 10.7) 6.1 ( 4.3- 8.6) -
Virginia 8.5 ( 7.6- 9.5) 9.0 ( 8.0- 10.1) 6.7 ( 4.9- 9.1) ∼
West Virginia 10.2 ( 8.5- 12.2) 10.2 ( 8.5- 12.3) ∼ ∼
East South Central
Alabama 7.0 ( 6.0- 8.1) 7.6 ( 6.5- 8.9) 4.6 ( 3.0- 6.7) ∼
Kentucky 10.3 ( 9.0- 11.7) 10.2 ( 8.9- 11.6) 12.2 ( 7.0- 20.0) -
Mississippi 7.5 ( 6.3- 9.0) 8.5 ( 6.9- 10.4) 4.9 ( 3.0- 7.4) ∼
Tennessee
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Table 2.27.1.1F: Urinary Bladder. Age-Adjusted Invasive Cancer Incidence Rates∗ and 95% Conﬁdence
Intervals, by U.S. Census Region and Division, State and Metropolitan Area, and Race and Ethnicity,
United States†‡ (continued)
Females, 2003
Area All Races White Black Hispanic§‖
West South Central 7.8 ( 7.3- 8.2) 8.0 ( 7.6- 8.5) 6.1 ( 5.1- 7.4) 4.1 ( 3.2- 5.1)
Arkansas 8.4 ( 7.0- 9.9) 8.7 ( 7.2- 10.4) ∼ ∼
Louisiana 8.6 ( 7.5- 9.8) 9.9 ( 8.5- 11.5) 4.7 ( 3.2- 6.8) ∼
Oklahoma 8.4 ( 7.2- 9.7) 8.6 ( 7.3- 10.1) ∼ ∼
Texas 7.4 ( 6.9- 7.9) 7.5 ( 6.9- 8.1) 7.2 ( 5.5- 9.1) 4.0 ( 3.2- 5.1)
West 8.4 ( 8.1- 8.7) 8.9 ( 8.5- 9.2) 7.1 ( 5.7- 8.8) 4.8 ( 4.1- 5.6)
Mountain
Arizona
Colorado 8.9 ( 7.7- 10.3) 9.0 ( 7.7- 10.4) ∼ ∼
Idaho 7.0 ( 5.2- 9.4) 7.1 ( 5.2- 9.5) ∼ ∼
Montana 7.8 ( 5.6- 10.6) 7.9 ( 5.7- 10.9) ∼ ∼
Nevada 9.8 ( 8.0- 11.9) 10.0 ( 8.1- 12.3) ∼ ∼
New Mexico 6.6 ( 5.2- 8.5) 7.1 ( 5.5- 9.1) ∼ ∼
Utah 5.5 ( 4.1- 7.2) 5.7 ( 4.2- 7.5) ∼ ∼
Wyoming
Pacific 8.5 ( 8.1- 8.9) 9.1 ( 8.7- 9.6) 7.0 ( 5.5- 8.8) 4.9 ( 4.1- 5.8)
Alaska 8.6 ( 5.0- 14.2) 10.8 ( 6.1- 17.9) ∼ ∼
California 8.0 ( 7.6- 8.5) 8.7 ( 8.2- 9.2) 7.1 ( 5.6- 9.0) 4.9 ( 4.1- 5.8)
San Francisco-Oakland 8.7 ( 7.5- 10.0) 10.5 ( 9.0- 12.3) ∼ ∼
San Jose-Monterey 8.1 ( 6.5- 9.9) 8.9 ( 7.0- 11.1) ∼ ∼
Los Angeles 7.4 ( 6.7- 8.3) 7.8 ( 6.9- 8.8) 8.2 ( 5.8- 11.3) 3.7 ( 2.7- 5.1)
Hawaii 6.8 ( 5.0- 9.0) 13.0 ( 8.1- 20.8) ∼ -
Oregon 10.1 ( 8.8- 11.7) 9.6 ( 8.3- 11.2) ∼ ∼
Washington 10.5 ( 9.4- 11.7) 10.6 ( 9.5- 11.9) ∼ ∼
Seattle-Puget Sound 10.6 ( 9.2- 12.1) 11.0 ( 9.5- 12.6) ∼ -
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined. See
Appendix C for data quality criteria and registry-specific data quality information. Rates cover approximately 96% of the U.S. population.
‡ Includes invasive and in situ.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
- Rates are suppressed at the state’s or metropolitan area’s request. See Technical Notes.
Notes: Cases from suppressed rates are included in the U.S. and region/division rates. Observed region/division age-adjusted incidence rates are
presented for regions/divisions with ≥ 80% of the population covered by registries that meet the data quality criteria specified above, and
if the 95% confidence intervals around the observed region/division rates for each of four major cancers include "bias-corrected" estimated
region/division rates (see Appendix D) for each of those cancers. U.S. rates are as presented in Table 1.1.1.1F. Michigan, Georgia, California,
and Washington state rates each include cases from the SEER metropolitan areas.
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Table 2.27.1.2M: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Males, 2003
Area All Races White Black Hispanic‡§
United States 7.4 ( 7.2- 7.5) 7.7 ( 7.5- 7.9) 5.4 ( 5.0- 6.0) 4.1 ( 3.6- 4.6)
Northeast 7.9 ( 7.6- 8.3) 8.3 ( 7.9- 8.7) 4.7 ( 3.7- 5.9) 3.6 ( 2.5- 5.2)
New England 8.5 ( 7.8- 9.3) 8.7 ( 8.0- 9.5) ∼ ∼
Connecticut 8.8 ( 7.4- 10.4) 9.1 ( 7.6- 10.8) ∼ ∼
Maine 7.4 ( 5.4- 9.9) 7.4 ( 5.4- 10.0) ∼ ∼
Massachusetts 8.7 ( 7.6- 9.9) 8.9 ( 7.8- 10.1) ∼ ∼
New Hampshire 8.4 ( 6.0- 11.4) 8.5 ( 6.1- 11.5) ∼ ∼
Rhode Island 8.5 ( 6.1- 11.5) 8.8 ( 6.3- 12.0) ∼ ∼
Vermont 8.1 ( 5.0- 12.4) 8.1 ( 5.1- 12.5) ∼ ∼
Middle Atlantic 7.7 ( 7.3- 8.1) 8.1 ( 7.7- 8.6) 4.7 ( 3.6- 6.0) 3.9 ( 2.6- 5.6)
New Jersey 7.3 ( 6.4- 8.2) 7.9 ( 6.9- 8.9) ∼ ∼
New York 7.3 ( 6.7- 7.9) 7.8 ( 7.1- 8.5) 4.5 ( 3.2- 6.4) 3.5 ( 2.0- 5.7)
Pennsylvania 8.4 ( 7.7- 9.2) 8.6 ( 7.9- 9.4) 6.7 ( 4.3- 10.1) ∼
Midwest 7.8 ( 7.5- 8.2) 8.0 ( 7.7- 8.4) 5.7 ( 4.5- 7.0) 3.3 ( 1.7- 5.9)
East North Central 8.2 ( 7.8- 8.6) 8.5 ( 8.1- 9.0) 5.8 ( 4.6- 7.2) ∼
Illinois 7.9 ( 7.1- 8.8) 8.5 ( 7.7- 9.5) 3.8 ( 2.2- 6.2) ∼
Indiana 7.6 ( 6.5- 8.8) 7.7 ( 6.6- 9.0) ∼ ∼
Michigan 8.1 ( 7.2- 9.0) 8.3 ( 7.4- 9.3) 7.0 ( 4.5- 10.3) ∼
Ohio 9.3 ( 8.4- 10.2) 9.6 ( 8.7- 10.5) 6.8 ( 4.3- 10.3) ∼
Wisconsin 7.4 ( 6.3- 8.6) 7.4 ( 6.4- 8.7) ∼ ∼
West North Central 7.0 ( 6.5- 7.6) 7.1 ( 6.6- 7.7) ∼ ∼
Iowa 6.6 ( 5.4- 8.1) 6.7 ( 5.4- 8.2) ∼ ∼
Kansas 6.0 ( 4.6- 7.6) 6.0 ( 4.6- 7.6) ∼ ∼
Minnesota 7.2 ( 6.1- 8.5) 7.3 ( 6.2- 8.6) ∼ ∼
Missouri 7.7 ( 6.6- 8.9) 7.9 ( 6.8- 9.2) ∼ ∼
Nebraska 5.9 ( 4.3- 8.0) 6.0 ( 4.3- 8.0) ∼ ∼
North Dakota 7.0 ( 4.4- 10.8) 6.8 ( 4.2- 10.6) ∼ ∼
South Dakota 8.5 ( 5.8- 12.2) 8.8 ( 5.9- 12.6) ∼ ∼
South 6.9 ( 6.7- 7.2) 7.2 ( 6.9- 7.5) 5.5 ( 4.9- 6.3) 4.4 ( 3.6- 5.3)
South Atlantic 7.3 ( 6.9- 7.7) 7.6 ( 7.2- 8.0) 5.8 ( 4.9- 6.9) 6.1 ( 4.7- 7.8)
Delaware 8.6 ( 5.8- 12.4) 8.7 ( 5.7- 12.9) ∼ ∼
District of Columbia 11.7 ( 7.5- 17.7) ∼ 13.3 ( 7.7- 21.6) ∼
Florida 7.1 ( 6.6- 7.7) 7.5 ( 6.9- 8.1) 3.4 ( 2.0- 5.5) 6.7 ( 5.2- 8.7)
Georgia 7.0 ( 6.0- 8.1) 7.2 ( 6.1- 8.6) 6.1 ( 4.0- 9.0) ∼
Maryland 7.9 ( 6.7- 9.2) 8.9 ( 7.5- 10.5) 4.1 ( 2.3- 7.2) ∼
North Carolina 7.2 ( 6.2- 8.3) 7.4 ( 6.3- 8.5) 6.3 ( 4.2- 9.3) ∼
South Carolina 7.0 ( 5.8- 8.6) 7.3 ( 5.9- 9.1) 5.8 ( 3.4- 9.4) ∼
Virginia 8.1 ( 7.0- 9.3) 8.4 ( 7.2- 9.8) 7.4 ( 4.8- 10.9) ∼
West Virginia 6.0 ( 4.5- 8.0) 6.0 ( 4.5- 8.0) ∼ ∼
East South Central 6.9 ( 6.2- 7.5) 7.0 ( 6.3- 7.7) 6.4 ( 4.8- 8.4) ∼
Alabama 6.3 ( 5.2- 7.7) 6.5 ( 5.2- 8.1) 5.8 ( 3.4- 9.3) ∼
Kentucky 7.9 ( 6.5- 9.5) 7.7 ( 6.3- 9.3) ∼ ∼
Mississippi 5.3 ( 3.9- 7.0) 5.4 ( 3.8- 7.5) ∼ ∼
Tennessee 7.2 ( 6.1- 8.5) 7.3 ( 6.2- 8.7) 6.8 ( 3.8- 11.6) ∼
West South Central 6.2 ( 5.8- 6.7) 6.6 ( 6.1- 7.2) 4.1 ( 2.9- 5.5) 3.0 ( 2.1- 4.2)
Arkansas 5.6 ( 4.3- 7.1) 6.1 ( 4.6- 7.8) ∼ ∼
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Table 2.27.1.2M: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Males, 2003
Area All Races White Black Hispanic‡§
Louisiana 6.8 ( 5.6- 8.3) 7.5 ( 6.0- 9.2) 4.9 ( 2.9- 7.9) ∼
Oklahoma 6.8 ( 5.5- 8.4) 7.3 ( 5.8- 9.0) ∼ ∼
Texas 6.1 ( 5.5- 6.7) 6.4 ( 5.8- 7.1) 4.2 ( 2.6- 6.5) 3.1 ( 2.2- 4.4)
West 7.1 ( 6.8- 7.4) 7.6 ( 7.2- 8.0) 5.9 ( 4.4- 8.0) 4.1 ( 3.3- 5.0)
Mountain 7.5 ( 6.8- 8.1) 7.6 ( 6.9- 8.3) ∼ 3.7 ( 2.3- 5.7)
Arizona 7.1 ( 6.1- 8.3) 7.3 ( 6.2- 8.5) ∼ ∼
Colorado 7.4 ( 6.0- 9.0) 7.4 ( 6.0- 9.1) ∼ ∼
Idaho 8.3 ( 6.0- 11.2) 8.4 ( 6.1- 11.3) ∼ ∼
Montana 7.9 ( 5.5- 11.2) 8.1 ( 5.6- 11.5) ∼ ∼
Nevada 9.6 ( 7.5- 12.2) 9.6 ( 7.4- 12.3) ∼ ∼
New Mexico 6.4 ( 4.7- 8.6) 6.9 ( 5.0- 9.2) ∼ ∼
Utah 7.1 ( 5.2- 9.5) 7.2 ( 5.3- 9.6) ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 6.9 ( 6.6- 7.4) 7.6 ( 7.1- 8.0) 5.6 ( 4.0- 7.8) 4.2 ( 3.2- 5.3)
Alaska 12.5 ( 6.6- 22.4) ∼ ∼ ∼
California 6.8 ( 6.3- 7.3) 7.4 ( 6.9- 8.0) 5.8 ( 4.1- 8.2) 4.1 ( 3.2- 5.3)
Hawaii 4.2 ( 2.7- 6.3) ∼ ∼ ∼
Oregon 8.4 ( 7.0- 10.0) 8.4 ( 7.0- 10.0) ∼ ∼
Washington 7.2 ( 6.2- 8.4) 7.5 ( 6.4- 8.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2M.
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Table 2.27.1.2F: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States†
Females, 2003
Area All Races White Black Hispanic‡§
United States 2.2 ( 2.1- 2.3) 2.2 ( 2.1- 2.3) 2.7 ( 2.4- 2.9) 1.4 ( 1.1- 1.6)
Northeast 2.4 ( 2.3- 2.6) 2.5 ( 2.3- 2.7) 2.5 ( 1.9- 3.1) 1.7 ( 1.1- 2.4)
New England 2.5 ( 2.2- 2.8) 2.6 ( 2.2- 2.9) ∼ ∼
Connecticut 2.2 ( 1.6- 2.9) 2.2 ( 1.7- 3.0) ∼ ∼
Maine 3.2 ( 2.1- 4.7) 3.2 ( 2.1- 4.8) ∼ ∼
Massachusetts 2.6 ( 2.1- 3.2) 2.7 ( 2.2- 3.3) ∼ ∼
New Hampshire ∼ ∼ ∼ ∼
Rhode Island 2.7 ( 1.6- 4.4) 2.8 ( 1.7- 4.6) ∼ ∼
Vermont ∼ ∼ ∼ ∼
Middle Atlantic 2.4 ( 2.2- 2.6) 2.4 ( 2.2- 2.7) 2.6 ( 2.0- 3.3) 1.6 ( 1.0- 2.5)
New Jersey 2.6 ( 2.2- 3.1) 2.6 ( 2.2- 3.1) 3.2 ( 1.8- 5.2) ∼
New York 2.2 ( 2.0- 2.5) 2.3 ( 2.1- 2.7) 1.9 ( 1.3- 2.7) ∼
Pennsylvania 2.5 ( 2.2- 2.9) 2.5 ( 2.1- 2.8) 3.6 ( 2.3- 5.4) ∼
Midwest 2.3 ( 2.1- 2.4) 2.2 ( 2.1- 2.4) 3.3 ( 2.7- 4.1) ∼
East North Central 2.4 ( 2.2- 2.6) 2.3 ( 2.1- 2.5) 3.3 ( 2.6- 4.1) ∼
Illinois 2.4 ( 2.0- 2.7) 2.3 ( 1.9- 2.7) 3.2 ( 2.1- 4.7) ∼
Indiana 2.5 ( 2.0- 3.1) 2.5 ( 2.0- 3.1) ∼ ∼
Michigan 2.4 ( 2.0- 2.8) 2.3 ( 1.9- 2.7) 3.2 ( 2.0- 5.0) ∼
Ohio 2.4 ( 2.1- 2.8) 2.3 ( 2.0- 2.7) 3.8 ( 2.4- 5.7) ∼
Wisconsin 2.1 ( 1.6- 2.6) 2.1 ( 1.6- 2.7) ∼ ∼
West North Central 2.1 ( 1.9- 2.4) 2.0 ( 1.8- 2.3) ∼ ∼
Iowa 2.3 ( 1.7- 3.1) 2.3 ( 1.7- 3.1) ∼ ∼
Kansas 2.1 ( 1.4- 2.9) 2.1 ( 1.5- 3.0) ∼ ∼
Minnesota 2.6 ( 2.0- 3.2) 2.5 ( 1.9- 3.1) ∼ ∼
Missouri 1.8 ( 1.4- 2.3) 1.6 ( 1.2- 2.1) ∼ ∼
Nebraska 1.9 ( 1.2- 3.0) 2.0 ( 1.2- 3.1) ∼ ∼
North Dakota ∼ ∼ ∼ ∼
South Dakota ∼ ∼ ∼ ∼
South 2.1 ( 2.0- 2.2) 2.1 ( 1.9- 2.2) 2.4 ( 2.1- 2.8) 1.2 ( 0.8- 1.6)
South Atlantic 2.2 ( 2.0- 2.3) 2.1 ( 1.9- 2.2) 2.8 ( 2.4- 3.3) 1.1 ( 0.6- 1.7)
Delaware ∼ ∼ ∼ ∼
District of Columbia 4.4 ( 2.5- 7.7) ∼ 6.7 ( 3.8- 11.9) ∼
Florida 2.0 ( 1.8- 2.3) 2.0 ( 1.8- 2.3) 2.6 ( 1.7- 3.9) 1.3 ( 0.7- 2.0)
Georgia 2.0 ( 1.6- 2.5) 1.7 ( 1.3- 2.3) 3.2 ( 2.1- 4.6) ∼
Maryland 2.5 ( 2.0- 3.1) 2.5 ( 1.9- 3.3) 2.5 ( 1.4- 4.2) ∼
North Carolina 2.0 ( 1.6- 2.5) 1.9 ( 1.5- 2.4) 2.4 ( 1.5- 3.7) ∼
South Carolina 2.0 ( 1.5- 2.7) 1.9 ( 1.3- 2.6) ∼ ∼
Virginia 2.4 ( 1.9- 2.9) 2.4 ( 1.9- 3.0) 2.6 ( 1.5- 4.2) ∼
West Virginia 2.5 ( 1.8- 3.7) 2.6 ( 1.8- 3.7) ∼ ∼
East South Central 2.1 ( 1.8- 2.3) 2.1 ( 1.8- 2.4) 1.8 ( 1.2- 2.6) ∼
Alabama 1.7 ( 1.2- 2.2) 1.8 ( 1.3- 2.5) ∼ ∼
Kentucky 2.4 ( 1.8- 3.1) 2.3 ( 1.7- 3.0) ∼ ∼
Mississippi 1.6 ( 1.0- 2.4) 1.7 ( 1.1- 2.7) ∼ ∼
Tennessee 2.4 ( 1.9- 2.9) 2.4 ( 1.9- 3.0) ∼ ∼
West South Central 2.0 ( 1.8- 2.3) 2.1 ( 1.8- 2.3) 2.0 ( 1.4- 2.8) 1.3 ( 0.8- 1.9)
Arkansas 2.0 ( 1.4- 2.8) 2.1 ( 1.5- 3.0) ∼ ∼
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Table 2.27.1.2F: Urinary Bladder. Age-Adjusted Cancer Death Rates∗ and 95% Conﬁdence Intervals, by U.S.
Census Region and Division, State, and Race and Ethnicity, United States† (continued)
Females, 2003
Area All Races White Black Hispanic‡§
Louisiana 1.8 ( 1.3- 2.4) 1.9 ( 1.4- 2.7) ∼ ∼
Oklahoma 2.1 ( 1.5- 2.9) 2.1 ( 1.5- 2.9) ∼ ∼
Texas 2.1 ( 1.8- 2.4) 2.1 ( 1.8- 2.4) 2.6 ( 1.7- 3.9) 1.3 ( 0.9- 2.0)
West 2.1 ( 1.9- 2.2) 2.1 ( 2.0- 2.3) 3.3 ( 2.4- 4.5) 1.6 ( 1.2- 2.1)
Mountain 1.8 ( 1.6- 2.1) 1.9 ( 1.6- 2.2) ∼ ∼
Arizona 2.0 ( 1.5- 2.6) 2.1 ( 1.6- 2.7) ∼ ∼
Colorado 1.6 ( 1.1- 2.3) 1.6 ( 1.1- 2.3) ∼ ∼
Idaho ∼ ∼ ∼ ∼
Montana ∼ ∼ ∼ ∼
Nevada 2.4 ( 1.5- 3.5) 2.6 ( 1.6- 3.8) ∼ ∼
New Mexico 1.7 ( 1.0- 2.7) 1.8 ( 1.1- 2.9) ∼ ∼
Utah ∼ ∼ ∼ ∼
Wyoming ∼ ∼ ∼ ∼
Pacific 2.2 ( 2.0- 2.4) 2.3 ( 2.1- 2.5) 3.8 ( 2.7- 5.2) 1.5 ( 1.1- 2.1)
Alaska ∼ ∼ ∼ ∼
California 2.0 ( 1.8- 2.2) 2.1 ( 1.9- 2.3) 3.6 ( 2.5- 5.0) 1.6 ( 1.1- 2.2)
Hawaii ∼ ∼ ∼ ∼
Oregon 2.6 ( 1.9- 3.4) 2.6 ( 2.0- 3.4) ∼ ∼
Washington 2.9 ( 2.3- 3.5) 2.9 ( 2.3- 3.6) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data are from the National Vital Statistics System (NVSS).
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black).
∼ Rates are suppressed if fewer than 16 cases were reported in a specific category (area, race, ethnicity).
Notes: U.S rates are as presented in Table 1.1.1.2F.
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Figure 3.1.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10
Primary Sites with the Highest Rates within Race- and Ethnic-Speciﬁc
Categories
United States,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information. Rates cover
approximately 96% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.1M for 95%
confidence intervals for rates. Rates are suppressed and not ranked if the population of the specific category (race, ethnicity)
is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.1.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
United States,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.2M for 95%
confidence intervals for rates. Rates are suppressed and not ranked if the population of the specific category (race, ethnicity)
is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.1.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10
Primary Sites with the Highest Rates within Race- and Ethnic-Speciﬁc
Categories
United States,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information. Rates cover
approximately 96% of the U.S. population.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.1F for 95%
confidence intervals for rates. Rates are suppressed and not ranked if the population of the specific category (race, ethnicity)
is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.1.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
United States,∗ Females, 2003
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Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 1.1.1.2F for 95%
confidence intervals for rates. Rates are suppressed and not ranked if the population of the specific category (race, ethnicity)
is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.2.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alabama,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.2.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alabama,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.2.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alabama,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.2.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alabama,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
228
Figure 3.3.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alaska,∗† Males, 2003
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ranked when the population
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.3.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alaska,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
230
Figure 3.3.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alaska,∗† Females, 2003
Pancreas
Urinary Bladder
Kidney & Renal Pelvis
Thyroid
Non-Hodgkin Lymphoma
Ovary
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
7.3
8.6
10.2
13.0
13.1
13.7
19.3
36.5
57.0
132.1
Melanomas of the Skin
Urinary Bladder
Thyroid
Non-Hodgkin Lymphoma
Ovary
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
9.3
10.8
12.7
13.1
14.7
19.9
26.7
53.8
123.6
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
76.2
77.8
179.5
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.3.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Alaska,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.4.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arizona,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.4.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arizona,∗ Females, 2003
Corpus & Uterus, NOS
Liver & IBD
Brain & ONS
Leukemias
Non-Hodgkin Lymphoma
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
2.7
2.7
3.1
5.6
6.0
7.7
8.9
14.9
22.4
37.8
Liver & IBD
Corpus & Uterus, NOS
Brain & ONS
Leukemias
Non-Hodgkin Lymphoma
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
2.4
2.7
3.1
5.6
5.9
7.6
9.0
15.0
22.5
39.0
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
25.5
41.0
41.6
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Leukemias
Stomach
Non-Hodgkin Lymphoma
Liver & IBD
Ovary
Pancreas
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
4.4
4.6
5.4
5.8
8.0
10.8
16.4
18.0
20.4
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.5.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arkansas,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Rate‡ per 100,000Rate‡ per 100,000
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.5.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arkansas,∗ Males, 2003
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.5.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arkansas,∗† Females, 2003
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ranked when the population
size was less than 50,000
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.5.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Arkansas,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.6.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
California,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.6.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
California,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.6.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
California,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.6.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
California,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
244
Figure 3.7.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Los Angeles,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.7.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Los Angeles,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
State and Metropolitan-Area Incidence Rates and State Death Rates for the Most Common Cancers
247
Mortality data are not presented for metropolitan areas.
United States Cancer Statistics: 2003 Incidence and Mortality
248
Figure 3.8.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
San Francisco-Oakland,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.8.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
San Francisco-Oakland,∗† Females, 2003
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Incidence rates were not
ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.9.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
San Jose-Monterey,∗† Males, 2003
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or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.9.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
San Jose-Monterey,∗† Females, 2003
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.10.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Colorado,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.10.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Colorado,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.10.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Colorado,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.10.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Colorado,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.11.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Connecticut,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.11.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Connecticut,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.11.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Connecticut,∗† Females, 2003
Pancreas
Urinary Bladder
Ovary
Thyroid
Non-Hodgkin Lymphoma
Melanomas of the Skin
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
10.6
11.9
14.2
17.0
17.9
17.9
27.8
44.0
58.4
127.8
Pancreas
Urinary Bladder
Ovary
Thyroid
Non-Hodgkin Lymphoma
Melanomas of the Skin
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
10.7
12.5
14.4
18.0
18.5
19.3
28.7
43.6
59.4
130.1
Cervix Uteri
Non-Hodgkin Lymphoma
Corpus & Uterus, NOS
Lung & Bronchus
Colon & Rectum
Breast
0 50 100 150 200 250 300
13.2
13.9
18.3
47.7
50.6
108.6 Breast
0 50 100 150 200 250 300
82.2
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.11.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Connecticut,∗ Females, 2003
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.12.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Delaware,∗† Males, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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size was less than 50,000
or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.12.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Delaware,∗ Males, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.12.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Delaware,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.12.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Delaware,∗ Females, 2003
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.13.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
District of Columbia,∗† Males, 2003
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or case counts were fewer
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.13.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
District of Columbia,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.13.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
District of Columbia,∗† Females, 2003
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Incidence rates were not
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size was less than 50,000
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Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.13.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
District of Columbia,∗ Females, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.14.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Florida,∗† Males, 2003
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Incidence rates were not
ranked when the population
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.14.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Florida,∗ Males, 2003
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.14.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Florida,∗† Females, 2003
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ranked when the population
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.14.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Florida,∗ Females, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.15.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Georgia,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.15.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Georgia,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.15.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Georgia,∗† Females, 2003
Kidney & Renal Pelvis
Cervix Uteri
Thyroid
Ovary
Non-Hodgkin Lymphoma
Melanomas of the Skin
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
9.6
9.6
10.4
12.2
14.3
14.4
18.5
42.5
53.0
120.5
Leukemias
Kidney & Renal Pelvis
Thyroid
Ovary
Non-Hodgkin Lymphoma
Corpus & Uterus, NOS
Melanomas of the Skin
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
9.6
9.7
11.7
12.4
15.7
19.2
19.9
39.9
56.7
122.2
Leukemias
Non-Hodgkin Lymphoma
Kidney & Renal Pelvis
Ovary
Cervix Uteri
Pancreas
Corpus & Uterus, NOS
Lung & Bronchus
Colon & Rectum
Breast
0 50 100 150 200 250 300
9.1
9.6
9.7
11.7
12.2
16.3
17.5
42.7
50.4
118.1 Breast
0 50 100 150 200 250 300
57.4
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.15.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Georgia,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.16.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Atlanta,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Mortality data are not presented for metropolitan areas.
United States Cancer Statistics: 2003 Incidence and Mortality
282
Figure 3.16.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Atlanta,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Mortality data are not presented for metropolitan areas.
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Figure 3.17.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Hawaii,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.17.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Hawaii,∗ Males, 2003
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Death rates were not
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size was less than 50,000
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.17.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Hawaii,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.17.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Hawaii,∗ Females, 2003
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ranked when the population
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or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
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or case counts were fewer
than 16 in each of the site
categories.
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.18.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Idaho,∗† Males, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.18.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Idaho,∗ Males, 2003
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than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.18.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Idaho,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.18.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Idaho,∗ Females, 2003
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size was less than 50,000
or case counts were fewer
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.19.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Illinois,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.19.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Illinois,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.19.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Illinois,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.19.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Illinois,∗ Females, 2003
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.20.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Indiana,∗† Males, 2003
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ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.20.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Indiana,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.20.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Indiana,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.20.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Indiana,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.21.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Iowa,∗† Males, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.21.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Iowa,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.21.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Iowa,∗† Females, 2003
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Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.21.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Iowa,∗ Females, 2003
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ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.22.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kansas,∗† Males, 2003
Pancreas
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Leukemias
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.1
14.8
16.5
17.1
21.1
22.4
34.2
65.0
88.6
157.9
Pancreas
Oral Cavity & Pharynx
Leukemias
Kidney & Renal Pelvis
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.0
14.6
15.8
16.4
21.2
21.8
33.4
63.6
87.8
147.3
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
65.6
113.3
221.1
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.22.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kansas,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.22.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kansas,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.22.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kansas,∗ Females, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.23.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kentucky,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.23.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kentucky,∗ Males, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.23.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kentucky,∗† Females, 2003
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Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.23.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Kentucky,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.24.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Louisiana,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.24.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Louisiana,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.24.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Louisiana,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.24.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Louisiana,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.25.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maine,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.25.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maine,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.25.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maine,∗† Females, 2003
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Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.25.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maine,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.26.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maryland,∗† Males, 2003
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Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.26.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maryland,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.26.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maryland,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.26.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Maryland,∗ Females, 2003
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.27.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Massachusetts,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.27.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Massachusetts,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.27.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Massachusetts,∗† Females, 2003
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Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.27.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Massachusetts,∗ Females, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.28.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Michigan,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.28.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Michigan,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.28.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Michigan,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
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categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.28.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Michigan,∗ Females, 2003
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size was less than 50,000
or case counts were fewer
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All Races White
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.29.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Detroit,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Mortality data are not presented for metropolitan areas.
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Figure 3.29.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Detroit,∗† Females, 2003
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Incidence rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Mortality data are not presented for metropolitan areas.
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Figure 3.30.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Minnesota,∗† Males, 2003
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than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.30.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Minnesota,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.30.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Minnesota,∗† Females, 2003
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ranked when the population
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.30.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Minnesota,∗ Females, 2003
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Death rates were not
ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.31.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Mississippi,∗† Males, 2003
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ranked when the population
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size was less than 50,000
or case counts were fewer
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.31.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Mississippi,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.31.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Mississippi,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.31.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Mississippi,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.32.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Missouri,∗† Males, 2003
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.32.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Missouri,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.32.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Missouri,∗† Females, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Breast
0 50 100 150 200 250 300
93.7
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.32.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Missouri,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.33.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Montana,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.33.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Montana,∗ Males, 2003
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.33.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Montana,∗† Females, 2003
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ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.33.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Montana,∗ Females, 2003
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.34.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nebraska,∗† Males, 2003
Pancreas
Leukemias
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Melanomas of the Skin
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
11.6
14.9
15.0
17.6
18.2
20.5
34.7
69.6
79.7
153.1
Pancreas
Leukemias
Oral Cavity & Pharynx
Melanomas of the Skin
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
11.6
14.0
14.5
16.7
17.7
20.1
34.6
68.7
77.9
143.8
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.34.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nebraska,∗ Males, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.34.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nebraska,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.34.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nebraska,∗ Females, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.35.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nevada,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.35.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nevada,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.35.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nevada,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.35.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Nevada,∗ Females, 2003
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ranked when the population
size was less than 50,000
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.36.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Hampshire,∗† Males, 2003
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ranked when the population
size was less than 50,000
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Incidence rates were not
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size was less than 50,000
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.36.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Hampshire,∗ Males, 2003
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.36.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Hampshire,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.36.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Hampshire,∗ Females, 2003
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or case counts were fewer
than 16 in each of the site
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.37.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Jersey,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.37.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Jersey,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.37.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Jersey,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
State and Metropolitan-Area Incidence Rates and State Death Rates for the Most Common Cancers
367
Figure 3.37.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Jersey,∗ Females, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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Stomach
Non-Hodgkin Lymphoma
Leukemias
Ovary
Pancreas
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
4.2
4.2
4.4
4.9
5.5
9.1
13.5
13.8
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.38.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Mexico,∗† Males, 2003
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or case counts were fewer
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.38.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Mexico,∗ Males, 2003
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.38.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Mexico,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.38.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New Mexico,∗ Females, 2003
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Black Asian/Paciﬁc Islander‡
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.39.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New York,∗† Males, 2003
Oral Cavity & Pharynx
Melanomas of the Skin
Pancreas
Leukemias
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
14.2
14.3
14.6
15.8
19.2
23.2
41.3
62.2
79.9
156.5
Oral Cavity & Pharynx
Pancreas
Melanomas of the Skin
Leukemias
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.8
14.7
15.8
16.5
20.2
24.0
45.1
61.5
81.8
144.2
Liver & IBD
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Pancreas
Urinary Bladder
Non-Hodgkin Lymphoma
Stomach
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
12.3
13.6
14.1
14.8
15.8
16.3
16.4
62.0
70.8
229.2
Kidney & Renal Pelvis
Pancreas
Non-Hodgkin Lymphoma
Oral Cavity & Pharynx
Urinary Bladder
Liver & IBD
Stomach
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150 200 250 300
8.3
9.0
10.7
11.8
14.4
22.5
27.0
42.1
53.2
53.5
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
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or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.39.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New York,∗ Males, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.39.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
New York,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.39.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
New York,∗ Females, 2003
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Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.40.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Carolina,∗† Males, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.40.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Carolina,∗ Males, 2003
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size was less than 50,000
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than 16 in each of the site
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.40.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Carolina,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.40.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Carolina,∗ Females, 2003
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than 16 in each of the site
categories.
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.41.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Dakota,∗† Males, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.41.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Dakota,∗ Males, 2003
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ranked when the population
size was less than 50,000
or case counts were fewer
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.41.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Dakota,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
State and Metropolitan-Area Incidence Rates and State Death Rates for the Most Common Cancers
383
Figure 3.41.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
North Dakota,∗ Females, 2003
Myeloma
Corpus & Uterus, NOS
Non-Hodgkin Lymphoma
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.6
4.6
4.7
7.6
8.7
14.8
23.2
36.3
Myeloma
Non-Hodgkin Lymphoma
Corpus & Uterus, NOS
Pancreas
Ovary
Colon & Rectum
Breast
Lung & Bronchus
0 50 100 150
3.7
4.3
4.8
7.8
8.6
14.6
23.4
34.5
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
Rate† per 100,000Rate† per 100,000
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.42.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Ohio,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.42.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Ohio,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.42.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Ohio,∗† Females, 2003
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Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.42.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Ohio,∗ Females, 2003
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
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size was less than 50,000
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.43.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oklahoma,∗† Males, 2003
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.43.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oklahoma,∗ Males, 2003
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
390
Figure 3.43.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oklahoma,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.43.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oklahoma,∗ Females, 2003
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size was less than 50,000
or case counts were fewer
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Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.44.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oregon,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.44.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oregon,∗ Males, 2003
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Death rates were not
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size was less than 50,000
or case counts were fewer
than 16 in each of the site
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.44.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oregon,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.44.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Oregon,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.45.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Pennsylvania,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.45.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Pennsylvania,∗ Males, 2003
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Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.45.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Pennsylvania,∗† Females, 2003
Kidney & Renal Pelvis
Urinary Bladder
Ovary
Melanomas of the Skin
Non-Hodgkin Lymphoma
Thyroid
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
10.5
11.4
13.6
14.8
17.2
19.4
29.7
48.2
54.2
121.4
Kidney & Renal Pelvis
Urinary Bladder
Ovary
Melanomas of the Skin
Non-Hodgkin Lymphoma
Thyroid
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
10.3
11.6
13.8
15.0
17.3
19.6
30.6
48.1
53.0
121.5
Ovary
Myeloma
Non-Hodgkin Lymphoma
Kidney & Renal Pelvis
Pancreas
Thyroid
Corpus & Uterus, NOS
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
10.0
10.0
12.0
12.2
12.8
13.3
21.2
47.7
67.5
116.3
Corpus & Uterus, NOS
Thyroid
Colon & Rectum
Lung & Bronchus
Breast
0 50 100 150 200 250 300
13.7
20.0
22.2
24.2
60.8
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates are
suppressed and not
ranked at state’s request.
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.45.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Pennsylvania,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.46.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Rhode Island,∗† Males, 2003
Pancreas
Leukemias
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Melanomas of the Skin
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.7
14.5
16.1
19.7
25.9
30.5
46.1
62.3
91.6
147.5
Pancreas
Leukemias
Oral Cavity & Pharynx
Kidney & Renal Pelvis
Non-Hodgkin Lymphoma
Melanomas of the Skin
Urinary Bladder
Colon & Rectum
Lung & Bronchus
Prostate
0 50 100 150 200 250 300
13.8
14.8
16.0
20.3
25.8
31.2
48.3
63.4
91.8
145.5
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150 200 250 300
Incidence rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
Prostate
0 50 100 150 200 250 300
132.0
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.46.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Rhode Island,∗ Males, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.46.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Rhode Island,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.46.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Rhode Island,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.47.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Carolina,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.47.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Carolina,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.47.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Carolina,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.47.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Carolina,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
408
Figure 3.48.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Dakota,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.48.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Dakota,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.48.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Dakota,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.48.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
South Dakota,∗ Females, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.49.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Tennessee,∗ Males, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.49.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Tennessee,∗ Females, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.50.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Texas,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.50.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Texas,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.50.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Texas,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.50.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Texas,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
420
Figure 3.51.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Utah,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.51.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Utah,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.51.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Utah,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.51.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Utah,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.52.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Vermont,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.52.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Vermont,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.52.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Vermont,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.52.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Vermont,∗ Females, 2003
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.53.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Virginia,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.53.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Virginia,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.53.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Virginia,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.53.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Virginia,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.54.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Washington,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.54.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Washington,∗ Males, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
United States Cancer Statistics: 2003 Incidence and Mortality
434
Figure 3.54.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Washington,∗† Females, 2003
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All Races White
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American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.54.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Washington,∗ Females, 2003
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Black Asian/Paciﬁc Islander‡
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.55.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Seattle-Puget Sound,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
State and Metropolitan-Area Incidence Rates and State Death Rates for the Most Common Cancers
437
Mortality data are not presented for metropolitan areas.
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Figure 3.55.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Seattle-Puget Sound,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Mortality data are not presented for metropolitan areas.
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Figure 3.56.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
West Virginia,∗† Males, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.56.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
West Virginia,∗ Males, 2003
Kidney & Renal Pelvis
Urinary Bladder
Liver & IBD
Esophagus
Pancreas
Leukemias
Non-Hodgkin Lymphoma
Prostate
Colon & Rectum
Lung & Bronchus
0 50 100 150
5.8
6.0
6.4
8.7
10.1
10.9
11.9
26.0
27.2
90.9
Melanomas of the Skin
Urinary Bladder
Liver & IBD
Esophagus
Pancreas
Leukemias
Non-Hodgkin Lymphoma
Prostate
Colon & Rectum
Lung & Bronchus
0 50 100 150
5.9
6.0
6.4
8.8
10.0
11.1
12.0
24.8
26.8
91.5
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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Death rates were not
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than 16 in each of the site
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.56.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
West Virginia,∗† Females, 2003
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Rate‡ per 100,000Rate‡ per 100,000
All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.56.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
West Virginia,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.57.M1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wisconsin,∗† Males, 2003
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ranked when the population
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or case counts were fewer
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.57.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wisconsin,∗ Males, 2003
Kidney & Renal Pelvis
Liver & IBD
Urinary Bladder
Esophagus
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
6.1
6.8
7.4
8.8
9.0
10.2
12.7
22.2
29.3
63.9
Kidney & Renal Pelvis
Liver & IBD
Urinary Bladder
Esophagus
Non-Hodgkin Lymphoma
Leukemias
Pancreas
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
6.1
6.5
7.4
8.6
9.3
10.3
12.7
21.8
28.9
62.6
Colon & Rectum
Prostate
Lung & Bronchus
0 50 100 150
30.3
55.0
137.3
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
ranked when the population
size was less than 50,000
or case counts were fewer
than 16 in each of the site
categories.
0 50 100 150
Death rates were not
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American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Figure 3.57.F1: Age-Adjusted Invasive Cancer Incidence Rates for the 10 Primary Sites
with the Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wisconsin,∗† Females, 2003
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All Races White
Black Asian/Paciﬁc Islander§
American Indian/Alaska Native§ Hispanic§‖
∗ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive
cancer sites combined. See Appendix C for data quality criteria and registry-specific data quality information.
† Excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in
situ cancers except urinary bladder.
‡ Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.1M-2.27.1.1F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if cases are fewer than 16.
§ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
‖ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct. Ovary excludes cancers newly
classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
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Figure 3.57.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wisconsin,∗ Females, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.58.M2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wyoming,∗ Males, 2003
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All Races White
Black Asian/Paciﬁc Islander‡
American Indian/Alaska Native‡ Hispanic‡§
∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Incidence data are not presented for states that did not meet the
USCS data quality criteria.
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Figure 3.58.F2: Age-Adjusted Cancer Death Rates for the 10 Primary Sites with the
Highest Rates within Race- and Ethnic-Speciﬁc Categories
Wyoming,∗ Females, 2003
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∗ Data are from the National Vital Statistics System (NVSS).
† Rates are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130). See Table 2.1.1.2M-2.27.1.2F
and Appendix E.1-E.2 for 95% confidence intervals for rates. Rates are suppressed and not ranked if the population of a specific
category (race, ethnicity) is less than 50,000 or if deaths are fewer than 16.
‡ Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical
Notes.
§ Hispanic origin is not mutually exclusive from race categories (white, black, Asian/Pacific Islander, American Indian/Alaska
Native).
Note: ONS — Other Nervous System; NOS — Not Otherwise Specified; IBD — Intrahepatic Bile Duct.
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Alabama 90-94 99.94 2.19 0.00 0.99 0.00
Alaska 95 100.00 0.35 0.00 2.28 0.00
Arizona 90 100.00 2.38 0.01 2.79 0.08
Arkansas 90-94 100.00 0.25 0.01 0.91 0.00
California 95 100.00 0.94 0.01 1.83 0.02
Greater Bay¶ 95 100.00 1.04 0.00 2.14 0.03
Los Angeles 95 100.00 0.95 0.01 2.51 0.01
Colorado 95 100.00 2.49 0.00 2.68 0.05
Connecticut 95 100.00 1.16 0.01 0.29 0.00
Delaware 95 100.00 1.64 0.00 1.98 0.00
District of Columbia 95 100.00 2.44 0.00 1.64 0.00
Florida 95 100.00 2.88 0.02 0.47 0.00
Georgia 95 100.00 2.36 0.00 0.54 0.00
Atlanta 95 100.00 1.34 0.00 0.93 0.00
Hawaii 95 100.00 1.34 0.00 2.56 0.00
Idaho 95 100.00 2.69 0.00 0.29 0.00
Illinois 95 100.00 1.63 0.00 2.01 0.00
Indiana 90-94 100.00 2.83 0.00 1.71 0.00
Iowa 95 100.00 1.26 0.00 3.11 0.00
Kansas 95 99.97 2.85 0.02 2.97 0.00
Kentucky 95 100.00 1.35 0.00 1.48 0.00
Louisiana 95 100.00 1.05 0.00 0.92 0.00
Maine 95 99.95 1.15 0.00 0.69 0.00
Maryland 95 99.95 0.40 0.00 1.77 0.01
Massachusetts 95 100.00 1.45 0.00 1.27 0.00
Michigan 95 100.00 1.23 0.04 2.57 0.00
Detroit 95 100.00 1.17 0.03 2.30 0.00
Minnesota 95 99.99 1.41 0.00 2.12 0.01
Mississippi 90-94 99.99 4.55 0.00 0.47 0.01
Missouri 95 100.00 2.37 0.00 0.37 0.00
Montana 95 100.00 3.10 0.00 1.00 0.00
Nebraska 95 100.00 1.74 0.00 2.27 0.00
Nevada 95 99.94 2.13 0.00 2.09 0.02
New Hampshire 95 100.00 1.58 0.09 3.40 0.02
New Jersey 95 100.00 1.31 0.00 1.58 0.01
New Mexico 90-94 100.00 2.55 0.00 0.03 0.00
New York 95 100.00 1.17 0.00 1.95 0.00
North Carolina 90-94 99.99 3.10 0.01 0.26 0.00
North Dakota 95 100.00 0.95 0.00 0.16 0.00
Ohio 90-94 99.75 2.44 0.00 4.25 0.01
Oklahoma 95 100.00 2.32 0.00 0.63 0.01
Oregon 95 100.00 0.77 0.00 2.31 0.00
Pennsylvania 95 100.00 1.63 0.00 1.37 0.01
Rhode Island 95 100.00 2.11 0.00 0.74 0.00
South Carolina 95 100.00 2.42 0.00 0.67 0.00
Table C.1: Achievement of Selected Data Quality Criteria,* by State and SEER
Metropolitan-Area Cancer Registries, 2003
Data from the shaded states and metropolitan areas are NOT included in United States
Cancer Statistics: 2003 Incidence and Mortality.
% Case % Passing % % Missing % Missing % Missing
Cancer Registry Ascertainment† Edits‡ DCOs§ Sex Race Age
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South Dakota 95 100.00 2.83 0.00 0.39 0.00
Tennessee 90 99.94 4.42 0.00 0.57 0.01
Texas 95 100.00 3.20 0.00 1.50 0.00
Utah 90-94 100.00 0.41 0.00 0.04 0.00
Vermont 95 99.92 1.03 0.09 0.61 0.00
Virginia 90-94 100.00 4.47 0.00 1.52 0.00
Washington 95 99.99 0.88 0.00 2.23 0.00
Seattle-Puget Sound 95 100.00 0.47 0.00 0.30 0.00
West Virginia 95 100.00 2.26 0.00 0.00 0.00
Wisconsin 95 100.00 2.18 0.00 0.66 0.00
Wyoming 95 100.00 NDC# 0.00 1.35 0.00
Table C.1: Achievement of Selected Data Quality Criteria,* by State and SEER
Metropolitan-Area Cancer Registries, 2003 (continued)
Data from the shaded states and metropolitan areas are NOT included in United States
Cancer Statistics: 2003 Incidence and Mortality.
% Case % Passing % % Missing % Missing % Missing
Cancer Registry Ascertainment† Edits‡ DCOs§ Sex Race Age
Note: Cancer incidence data included in this report are from statewide or metropolitan-area cancer registries that meet
the following data quality criteria for all cancer sites combined:
• Case ascertainment is 90% or more complete.
• No more than 5% of cases are ascertained solely on the basis of a death certificate.
• No more than 3% of cases are missing information on sex.
• No more than 3% of cases are missing information on age.
• No more that 5% of cases are missing information on race.
• At least 97% of the registry's records passed a set of core single-field, interfield, and interrecord computerized edits.
* National Program of Cancer Registries (including California, Kentucky, Louisiana, and New Jersey) data quality based
on January 2006 data submission; SEER data quality based on November 2005 data submission.
† Completeness of case ascertainment was estimated by methods developed by the North American Association of Central
Cancer Registries.
Sources:
Howe HL. Conclusions of the Workgroup for High-Quality Criteria for Data Use: The NAACCR Narrative. Springfield,
IL: North American Association of Central Cancer Registries; 2001.
Tucker TC, Howe HL, Weir HK. Certification of population-based cancer registries. Journal of Registry Management
1999;26(1):24-27.
‡ Computerized edits test the validity and logic of data components reported for selected items.
§ DCOs = death certificate only cases; that is, cancer cases ascertained solely on the basis of a death certificate after the
registry has completed a routine procedure known as death clearance and followback. 
¶ Greater Bay includes San Francisco-Oakland and San Jose-Monterey registries.
# NDC = no death clearance; registry did not conduct death clearance and followback.
SEER = Surveillance, Epidemiology, and End Results.
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Criteria for Reporting Age-Adjusted Cancer
Incidence Rates for U.S. Census Regions 
and Divisions 
The annual age-adjusted cancer incidence rates for some
U.S. Census regions and divisions are not available
because the data from the cancer registries of some states
in those regions or divisions do not meet the eligibility
criteria for inclusion in this report. In contrast, the annual
age-adjusted cancer death rates are available for all states
in every Census region or division. However, the age-
adjusted incidence rate for Census regions or divisions in
which the data of less than 100% of the cancer registries
meet eligibility criteria can be estimated by assuming 
the following: the incidence-to-mortality ratio for states
without eligible cancer registry data in that Census region
or division equals the incidence-to-mortality ratio for
states with eligible cancer registry data in that Census
region or division.  
Let
M1 = age-adjusted death rate in states with eligible
cancer registries
M0 = age-adjusted death rate in states without eligible
cancer registries
I1 = age-adjusted incidence rate in states with eligible
cancer registries
I0 = age-adjusted incidence rate in states without
eligible cancer registries (incidence data are not
available)
P1 = proportion of the population in the Census region
or division that resides in states with eligible
cancer registries
R =
Îtotal = age-adjusted incidence rate for the entire Census
region or division where “eligible” refers to the
state and metropolitan-area cancer registries that
meet this report’s data quality criteria for all inva-
sive cancer sites combined.  
Since we are assuming that                 
,
the estimate of the age-adjusted incidence rate for states
without eligible cancer registries is                              
Thus, an estimate of the age-adjusted incidence rate for
100% of the Census region or division is computed as
the following weighted average:
As an example, consider invasive female breast cancer 
in a hypothetical Census region with seven states.
Incidence data for five states that cover 86.3% of the
population (P1 = 0.863) are eligible for inclusion in the
calculation of the regional incidence rate; data for two
states are not eligible. The female breast cancer death
rate for the five eligible states is 
M1 =          ,      
and the rate for the two ineligible states is 
M0 =          .          
The age-adjusted incidence rate for states with eligible
cancer registries is 
I1 =           .
The age-adjusted incidence rate for female invasive
breast cancer in the entire Census region (i.e., corrected
for the data not available from the ineligible registries) is 
I1
M1
I0
M0
=
M0
M1
I0 = I1 (      ) = I1R.
Îtotal = P1I1 + (1 – P1)I0 = P1I1 + (1 – P1)I1R
= I1 [P1 + (1 – P1)R].
Îtotal =           * [0.863 + 0.137 (        )] =              .
145.1
105
145.39
105
27.7
27.3
27.3
105
27.7
105
145.1
105
M0
M1
The underlying assumptions for this method are that 
the age-adjusted death rates for states with and without
eligible cancer registries are accurate and that the
incidence-to-mortality ratio for states without eligible
cancer registries in that Census region or division equals
the incidence-to-mortality ratio for states with eligible
cancer registries in that Census region or division.
For each Census region or division in which less than
100% of the registries provided data eligible for this
report, we used the above-described method to estimate
the age-adjusted incidence rates (Îtotal ) for the six major
cancer sex-site groups: breast (female only), prostate, male
and female colorectal, and male and female lung and
bronchus. If the estimate of the age-adjusted incidence
rate for each of the six cancer sites for that Census
region or division falls within the confidence interval of
the observed age-adjusted incidence rate for states with
eligible cancer registries, then the observed age-adjusted
incidence rates for all cancer sites are published. If one
or more of the six estimates of age-adjusted incidence
rates falls outside the confidence interval, then the
observed age-adjusted cancer incidence rates are not
reported for that U.S. Census region or division.  
We emphasize, however, that all cancer incidence rates 
in this report (1) are based exclusively on data obtained
from states with eligible cancer registries and (2) are 
not the estimates of the age-adjusted incidence rates
calculated using the methods described in this appendix.  
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E–2 Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
United States
Prostate 81.1 ( 78.2- 84.1) 11.0 ( 9.8- 12.3)
Breast 76.5 ( 74.3- 78.8) 12.6 (11.7-13.6)
Lung & Bronchus 50.9 ( 48.6- 53.3) 26.2 ( 24.8- 27.7) 38.2 (36.2- 40.3) 18.9 (17.7-20.1)
Colon & Rectum 45.0 ( 42.8- 47.2) 31.2 ( 29.7- 32.8) 14.0 (12.8- 15.3) 10.7 ( 9.8-11.7)
Liver & IBD 20.4 ( 19.0- 21.8) 7.6 ( 6.9- 8.4) 15.6 (14.4- 16.9) 7.4 ( 6.6- 8.2)
Stomach 17.0 ( 15.7- 18.4) 10.3 ( 9.4- 11.2) 10.4 ( 9.3- 11.5) 6.1 ( 5.4- 6.8)
Urinary Bladder 14.8 ( 13.5- 16.2) ∼ ∼ ∼
Corpus & Uterus, NOS 14.2 ( 13.2- 15.2) 2.5 ( 2.1- 3.0)
Non-Hodgkin Lymphoma 14.1 ( 12.9- 15.3) 10.8 ( 9.9- 11.8) 6.0 ( 5.2- 6.9) 4.2 ( 3.6- 4.8)
Thyroid ∼ 12.5 ( 11.7- 13.4) ∼ ∼
Oral Cavity & Pharynx 10.1 ( 9.1- 11.0) ∼ 3.7 ( 3.1- 4.3) ∼
Kidney & Renal Pelvis 9.3 ( 8.4- 10.3) ∼ ∼ ∼
Ovary‖ 9.1 ( 8.3- 9.9) 5.0 ( 4.4- 5.6)
Pancreas 8.8 ( 7.9- 9.9) 7.2 ( 6.4- 8.0) 7.7 ( 6.8- 8.7) 6.7 ( 6.0- 7.5)
Esophagus ∼ ∼ 3.2 ( 2.7- 3.9) ∼
Leukemias ∼ ∼ 4.1 ( 3.5- 4.8) 3.2 ( 2.7- 3.7)
California
Prostate 90.0 ( 85.3- 94.9) 10.1 ( 8.4- 12.1)
Breast 81.5 ( 77.9- 85.3) 13.8 (12.3-15.4)
Lung & Bronchus 54.2 ( 50.6- 58.1) 26.7 ( 24.5- 29.0) 42.0 (38.8- 45.5) 21.4 (19.4-23.5)
Colon & Rectum 46.1 ( 42.8- 49.7) 31.8 ( 29.4- 34.3) 15.4 (13.4- 17.6) 11.2 ( 9.8-12.8)
Liver & IBD 20.9 ( 18.8- 23.3) 8.0 ( 6.8- 9.3) 16.5 (14.6- 18.7) 8.1 ( 6.9- 9.4)
Stomach 16.8 ( 14.8- 19.0) 10.5 ( 9.1- 12.0) 10.6 ( 8.9- 12.5) 6.1 ( 5.0- 7.2)
Urinary Bladder 16.4 ( 14.3- 18.6) ∼ ∼ ∼
Corpus & Uterus, NOS 15.3 ( 13.7- 17.0) 3.0 ( 2.3- 3.9)
Non-Hodgkin Lymphoma 13.8 ( 12.0- 15.8) 11.8 ( 10.4- 13.4) 5.9 ( 4.7- 7.3) 4.1 ( 3.2- 5.1)
Thyroid ∼ 11.5 ( 10.2- 12.9) ∼ ∼
Oral Cavity & Pharynx 9.9 ( 8.6- 11.5) ∼ 4.5 ( 3.5- 5.7) ∼
Ovary‖ 9.7 ( 8.5- 11.1) 5.5 ( 4.6- 6.6)
Kidney & Renal Pelvis 9.1 ( 7.7- 10.8) ∼ ∼ ∼
Leukemias 9.0 ( 7.7- 10.6) ∼ 4.0 ( 3.0- 5.2) 3.7 ( 2.9- 4.6)
Cervix Uteri 7.8 ( 6.7- 9.0) ∼
Esophagus ∼ ∼ 3.2 ( 2.4- 4.2) ∼
Pancreas ∼ ∼ 7.1 ( 5.9- 8.7) 7.0 ( 5.9- 8.3)
Los Angeles
Prostate 90.8 ( 82.7- 99.5)
Breast 88.2 ( 81.6- 95.2)
Colon & Rectum 53.8 ( 47.7- 60.6) 36.5 ( 32.2- 41.4)
Lung & Bronchus 48.4 ( 42.5- 54.9) 25.4 ( 21.7- 29.6)
Liver & IBD 22.0 ( 18.3- 26.5) ∼
Urinary Bladder 19.6 ( 15.9- 24.0) ∼
Stomach 19.2 ( 15.6- 23.6) 12.2 ( 9.7- 15.2)
Corpus & Uterus, NOS 14.6 ( 12.0- 17.7)
Thyroid ∼ 14.4 ( 11.8- 17.5)
Non-Hodgkin Lymphoma 14.3 ( 11.3- 18.0) 12.6 ( 10.1- 15.6)
Leukemias 9.7 ( 7.3- 12.9) ∼
Cervix Uteri 9.2 ( 7.1- 11.7)
Ovary‖ 9.1 ( 7.1- 11.7)
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Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Kidney & Renal Pelvis 8.2 ( 5.9- 11.2) ∼
Pancreas ∼ 7.8 ( 5.8- 10.3)
Oral Cavity & Pharynx 7.5 ( 5.5- 10.3) ∼
San Francisco-Oakland
Prostate 98.9 ( 89.1-109.8)
Breast 78.0 ( 70.6- 86.1)
Lung & Bronchus 61.8 ( 53.9- 70.6) 29.4 ( 24.8- 34.6)
Colon & Rectum 48.0 ( 41.2- 55.7) 31.6 ( 26.8- 37.0)
Liver & IBD 21.6 ( 17.3- 26.8) 9.2 ( 6.7- 12.4)
Oral Cavity & Pharynx 17.3 ( 13.5- 22.0) 5.6 ( 3.8- 8.2)
Stomach 16.8 ( 12.7- 21.9) 9.0 ( 6.6- 12.2)
Corpus & Uterus, NOS 16.2 ( 12.9- 20.2)
Urinary Bladder 15.6 ( 11.6- 20.6) ∼
Non-Hodgkin Lymphoma 15.4 ( 11.6- 20.2) 9.8 ( 7.2- 13.1)
Ovary‖ 11.1 ( 8.4- 14.5)
Kidney & Renal Pelvis 9.6 ( 6.7- 13.5) ∼
Thyroid ∼ 7.8 ( 5.6- 10.7)
Pancreas 7.1 ( 4.6- 10.7) ∼
San Jose-Monterey
Prostate 86.0 ( 72.5-101.6)
Breast 80.8 ( 70.2- 93.0)
Lung & Bronchus 51.7 ( 41.3- 64.3) 23.3 ( 17.2- 31.0)
Colon & Rectum 35.6 ( 27.1- 46.4) 32.7 ( 25.7- 41.4)
Liver & IBD 21.7 ( 15.6- 30.1) 8.0 ( 4.6- 13.3)
Non-Hodgkin Lymphoma 10.2 ( 6.3- 16.5) 16.8 ( 11.8- 23.6)
Stomach 16.3 ( 10.8- 24.2) 9.4 ( 5.6- 15.1)
Corpus & Uterus, NOS 15.8 ( 11.2- 22.0)
Urinary Bladder 15.7 ( 10.0- 23.8) ∼
Thyroid ∼ 12.7 ( 8.7- 18.2)
Leukemias 11.5 ( 7.1- 18.2) ∼
Oral Cavity & Pharynx 10.9 ( 6.9- 17.2) ∼
Pancreas 10.6 ( 6.3- 17.4) ∼
Ovary‖ 9.3 ( 5.9- 14.4)
Cervix Uteri 8.5 ( 5.3- 13.4)
Colorado
Breast 83.3 ( 59.8-116.7) ∼
Lung & Bronchus 61.2 ( 35.4-106.0) ∼ ∼ ∼
Prostate 49.0 ( 27.8- 88.9) ∼
Connecticut
Breast 82.2 ( 53.7-125.1) ∼
Prostate 62.8 ( 35.6-114.1) ∼
Florida
Breast 57.9 ( 46.2- 72.8) ∼
Prostate 40.3 ( 28.9- 56.5) ∼
Colon & Rectum 31.1 ( 20.7- 46.6) 24.4 ( 16.2- 36.3) ∼ ∼
Lung & Bronchus 29.6 ( 19.6- 44.8) 24.9 ( 16.7- 36.6) 24.5 (15.4- 38.7) 14.5 ( 8.3-24.6)
Liver & IBD 15.2 ( 8.7- 27.1) ∼ ∼ ∼
Corpus & Uterus, NOS 12.7 ( 7.7- 21.1) ∼
Thyroid ∼ 11.5 ( 7.3- 19.2) ∼ ∼
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E–4 Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Georgia
Breast 57.4 ( 42.1- 81.1) ∼
Lung & Bronchus 53.5 ( 29.7- 92.7) ∼ ∼ ∼
Prostate 52.2 ( 31.4- 87.1) ∼
Colon & Rectum 34.6 ( 19.4- 64.1) ∼ ∼ ∼
Atlanta
Breast 51.0 ( 34.9- 82.2)
Prostate 45.1 ( 21.7- 93.1)
Hawaii
Prostate 114.8 (104.9-125.4) 16.4 (12.8- 20.6)
Breast 112.4 (103.3-122.0) 14.3 (11.3-18.0)
Lung & Bronchus 65.3 ( 58.0- 73.4) 33.4 ( 28.7- 38.6) 48.2 (41.9- 55.2) 22.6 (18.8-26.9)
Colon & Rectum 62.4 ( 55.1- 70.3) 38.9 ( 33.9- 44.5) 23.7 (19.4- 28.8) 13.1 (10.3-16.5)
Corpus & Uterus, NOS 24.0 ( 19.9- 28.8) 5.0 ( 3.2- 7.4)
Thyroid ∼ 18.5 ( 14.8- 22.8) ∼ ∼
Non-Hodgkin Lymphoma 17.9 ( 14.2- 22.4) 13.2 ( 10.3- 16.6) 8.5 ( 6.0- 11.8) 4.4 ( 2.9- 6.6)
Liver & IBD 17.7 ( 14.0- 22.2) ∼ 12.1 ( 9.0- 15.9) 4.8 ( 3.1- 7.1)
Stomach 16.1 ( 12.6- 20.4) 10.7 ( 8.2- 13.8) 13.4 (10.2- 17.4) 5.9 ( 4.2- 8.3)
Pancreas 15.7 ( 12.3- 20.0) 9.8 ( 7.4- 12.8) 11.7 ( 8.7- 15.4) 9.1 ( 6.9-12.1)
Urinary Bladder 15.6 ( 12.1- 19.9) ∼ ∼ ∼
Kidney & Renal Pelvis 15.3 ( 11.8- 19.5) ∼ 4.3 ( 2.6- 6.8) ∼
Oral Cavity & Pharynx 13.0 ( 9.8- 16.9) ∼ 4.5 ( 2.7- 7.0) ∼
Cervix Uteri 8.9 ( 6.3- 12.1) ∼
Leukemias ∼ 8.5 ( 6.2- 11.5) 5.7 ( 3.6- 8.5) 3.3 ( 2.0- 5.3)
Ovary‖ ∼ 6.3 ( 4.4- 8.9)
Illinois
Breast 73.3 ( 62.3- 86.1) 13.7 ( 9.1-20.4)
Prostate 56.3 ( 44.4- 71.6) ∼
Lung & Bronchus 39.9 ( 29.0- 54.5) 18.6 ( 12.7- 26.7) 33.8 (24.3- 46.8) ∼
Colon & Rectum 33.5 ( 23.9- 46.7) 29.2 ( 21.9- 38.6) 12.9 ( 7.0- 22.8) 8.6 ( 4.7-14.7)
Urinary Bladder 15.5 ( 8.8- 26.3) ∼ ∼ ∼
Corpus & Uterus, NOS 13.6 ( 9.2- 19.9) ∼
Liver & IBD 13.1 ( 7.8- 22.1) ∼ 14.3 ( 8.4- 24.0) ∼
Stomach ∼ 11.4 ( 6.8- 18.3) ∼ ∼
Non-Hodgkin Lymphoma 11.3 ( 6.5- 19.8) 11.1 ( 6.6- 17.9) ∼ ∼
Thyroid ∼ 8.0 ( 4.9- 13.2) ∼ ∼
Ovary‖ 7.5 ( 4.1- 13.2) ∼
Pancreas ∼ ∼ 11.7 ( 6.3- 21.2) ∼
Maryland
Breast 58.5 ( 46.0- 74.6) ∼
Prostate 56.9 ( 41.4- 78.6) ∼
Colon & Rectum 37.1 ( 24.2- 56.7) 24.4 ( 15.9- 37.2) ∼ ∼
Lung & Bronchus 34.0 ( 22.5- 52.0) 23.1 ( 14.0- 36.8) 33.0 (20.0- 53.1) 19.5 (11.5-31.8)
Non-Hodgkin Lymphoma 22.9 ( 12.7- 40.4) ∼ ∼ ∼
Stomach 22.3 ( 12.9- 38.6) ∼ ∼ ∼
Thyroid ∼ 18.6 ( 12.2- 29.0) ∼ ∼
Massachusetts
Prostate 73.9 ( 54.8- 99.5) ∼
Breast 62.9 ( 48.3- 81.6) ∼
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Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Colon & Rectum 45.9 ( 30.7- 68.1) 24.4 ( 15.2- 38.1) ∼ ∼
Lung & Bronchus 41.3 ( 27.1- 62.3) 30.6 ( 19.8- 46.0) 60.1 (41.4- 85.9) ∼
Liver & IBD 29.7 ( 19.4- 46.3) ∼ 20.0 (11.4- 35.5) ∼
Corpus & Uterus, NOS 18.6 ( 10.9- 30.6) ∼
Thyroid ∼ 18.3 ( 11.3- 29.4) ∼ ∼
Michigan
Prostate 77.9 ( 52.5-115.6) ∼
Colon & Rectum 55.6 ( 34.3- 89.8) 28.4 ( 16.4- 48.4) ∼ ∼
Breast 55.2 ( 39.8- 77.6) ∼
Detroit
Prostate 82.0 ( 51.1-131.5)
Breast 49.7 ( 32.1- 78.2)
Minnesota
Breast 34.6 ( 20.2- 59.9) ∼
Liver & IBD ∼ ∼ 55.1 (29.2-100.1) ∼
Nevada
Breast 55.8 ( 40.3- 80.0) ∼
Lung & Bronchus 49.2 ( 30.7- 81.6) 25.6 ( 15.4- 45.5) ∼ ∼
Prostate 46.0 ( 28.4- 77.6) ∼
Colon & Rectum 37.6 ( 19.7- 70.7) 42.0 ( 25.6- 68.4) ∼ ∼
New Jersey
Prostate 81.9 ( 67.6- 99.5) ∼
Breast 74.5 ( 63.8- 87.0) 8.9 ( 5.5-14.5)
Colon & Rectum 47.7 ( 36.1- 62.9) 39.8 ( 30.7- 51.2) ∼ 10.6 ( 6.0-17.7)
Lung & Bronchus 44.0 ( 32.9- 58.7) 17.0 ( 11.5- 24.6) 24.3 (15.9- 36.5) 18.7 (12.5-27.4)
Stomach 18.1 ( 11.7- 28.0) ∼ ∼ ∼
Liver & IBD 15.5 ( 9.9- 24.6) ∼ 8.1 ( 4.4- 15.6) ∼
Non-Hodgkin Lymphoma 15.0 ( 9.1- 24.6) 11.4 ( 7.0- 18.2) ∼ ∼
Urinary Bladder 14.9 ( 8.9- 24.7) ∼ ∼ ∼
Thyroid ∼ 13.8 ( 9.8- 19.9) ∼ ∼
Corpus & Uterus, NOS 12.4 ( 8.5- 18.4) ∼
Ovary‖ 10.2 ( 6.2- 16.4) ∼
Kidney & Renal Pelvis 10.0 ( 5.6- 18.2) ∼ ∼ ∼
Oral Cavity & Pharynx 9.2 ( 5.3- 16.8) ∼ ∼ ∼
Leukemias ∼ 6.0 ( 3.4- 10.7) ∼ ∼
New York
Breast 71.6 ( 64.9- 79.1) 10.9 ( 8.3-14.4)
Lung & Bronchus 53.5 ( 45.9- 62.2) 21.8 ( 17.6- 26.7) 37.7 (31.2- 45.4) 12.4 ( 9.3-16.3)
Prostate 53.2 ( 45.9- 61.6) 10.8 ( 7.1- 15.9)
Colon & Rectum 42.1 ( 35.6- 49.8) 29.4 ( 24.6- 35.1) 12.4 ( 8.8- 17.2) 7.6 ( 5.2-10.7)
Stomach 27.0 ( 21.7- 33.5) 11.8 ( 8.9- 15.5) 14.1 (10.2- 19.2) 7.2 ( 4.8-10.4)
Liver & IBD 22.5 ( 18.2- 27.9) 8.3 ( 5.8- 11.5) 12.3 ( 9.1- 16.7) 5.1 ( 3.2- 7.8)
Urinary Bladder 14.4 ( 10.6- 19.3) ∼ ∼ ∼
Corpus & Uterus, NOS 13.8 ( 10.8- 17.5) ∼
Oral Cavity & Pharynx 11.8 ( 8.8- 16.0) ∼ 4.1 ( 2.4- 7.1) ∼
Thyroid ∼ 11.5 ( 9.1- 14.6) ∼ ∼
Non-Hodgkin Lymphoma 10.7 ( 7.8- 14.8) 8.3 ( 5.9- 11.4) 4.3 ( 2.6- 7.2) 3.6 ( 2.0- 6.1)
Ovary‖ 9.1 ( 6.7- 12.3) 3.7 ( 2.2- 6.0)
Pancreas 9.0 ( 6.0- 13.4) 7.9 ( 5.4- 11.1) 7.4 ( 4.6- 11.6) 6.5 ( 4.4- 9.6)
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E–6 Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Kidney & Renal Pelvis 8.3 ( 5.7- 12.0) ∼ ∼ ∼
Leukemias ∼ ∼ 3.9 ( 2.2- 6.8) ∼
North Carolina
Breast 43.9 ( 29.8- 69.4) ∼
Ohio
Breast 70.6 ( 51.0- 98.1) ∼
Lung & Bronchus 54.0 ( 29.2- 94.9) ∼ ∼ ∼
Colon & Rectum 42.2 ( 23.9- 75.2) 45.7 ( 27.4- 73.3) ∼ ∼
Oregon
Breast 69.8 ( 48.9- 98.1) ∼
Colon & Rectum 67.4 ( 41.9-105.8) ∼ ∼ ∼
Prostate 50.2 ( 29.4- 83.9) ∼
Liver & IBD 39.9 ( 23.0- 69.2) ∼ ∼ ∼
Pennsylvania
Prostate 67.4 ( 47.6- 94.9) ∼
Breast 60.8 ( 46.5- 79.4) ∼
Lung & Bronchus 41.7 ( 26.8- 64.5) 24.2 ( 13.9- 40.0) 23.8 (12.9- 43.0) ∼
Colon & Rectum 41.2 ( 24.8- 66.3) 22.2 ( 12.3- 37.6) ∼ ∼
Liver & IBD 27.1 ( 15.2- 47.2) ∼ ∼ ∼
Thyroid ∼ 20.0 ( 12.8- 31.8) ∼ ∼
Stomach 19.4 ( 10.1- 36.9) ∼ ∼ ∼
Corpus & Uterus, NOS 13.7 ( 7.8- 24.5) ∼
Texas
Breast 54.4 ( 46.1- 64.6) 9.9 ( 6.1-16.0)
Prostate 46.6 ( 35.7- 60.9) ∼
Lung & Bronchus 44.2 ( 34.2- 57.5) 35.5 ( 26.6- 46.8) 27.3 (19.3- 38.8) 23.1 (16.0-32.7)
Colon & Rectum 36.6 ( 26.8- 49.9) 24.5 ( 17.9- 33.4) ∼ 9.5 ( 5.5-16.0)
Liver & IBD 19.7 ( 13.4- 29.4) 9.4 ( 5.4- 15.9) 17.5 (11.4- 27.1) 8.2 ( 4.5-14.3)
Stomach 12.4 ( 6.9- 21.7) ∼ ∼ ∼
Pancreas ∼ 9.4 ( 5.3- 15.9) ∼ ∼
Kidney & Renal Pelvis 9.4 ( 5.1- 17.5) ∼ ∼ ∼
Thyroid ∼ 9.3 ( 6.0- 14.8) ∼ ∼
Non-Hodgkin Lymphoma 9.3 ( 4.9- 17.5) 6.6 ( 3.5- 12.0) ∼ ∼
Corpus & Uterus, NOS 8.7 ( 5.3- 14.5) ∼
Ovary‖ 6.9 ( 3.9- 12.2) ∼
Virginia
Breast 67.0 ( 54.8- 82.8) 12.0 ( 7.1-21.1)
Prostate 58.0 ( 41.6- 81.6) ∼
Liver & IBD 33.1 ( 20.6- 53.5) ∼ 22.6 (13.0- 40.2) ∼
Colon & Rectum 30.7 ( 17.6- 52.3) 26.4 ( 17.5- 39.6) ∼ ∼
Lung & Bronchus 29.2 ( 18.3- 47.7) 26.0 ( 17.1- 39.3) 32.9 (20.0- 53.8) 16.7 ( 9.6-28.4)
Corpus & Uterus, NOS 13.3 ( 7.4- 23.7) ∼
Thyroid ∼ 12.5 ( 7.8- 21.3) ∼ ∼
Ovary‖ 11.8 ( 7.0- 20.8) ∼
Washington
Prostate 90.5 ( 73.3-111.1) ∼
Breast 76.0 ( 64.4- 89.6) 18.7 (13.0-26.6)
Lung & Bronchus 68.1 ( 53.1- 86.7) 25.0 ( 17.9- 34.4) 52.2 (38.8- 69.4) 17.4 (11.5-25.7)
Colon & Rectum 47.3 ( 35.2- 63.1) 35.6 ( 27.0- 46.5) 13.5 ( 7.5- 23.4) 13.3 ( 8.1-20.9)
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Table E.1: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for Asian/Paciﬁc
Islanders,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Liver & IBD 25.9 ( 17.8- 37.4) ∼ 24.2 (15.9- 36.1) ∼
Urinary Bladder 22.2 ( 13.7- 34.8) ∼ ∼ ∼
Stomach 18.7 ( 11.4- 29.8) ∼ ∼ ∼
Non-Hodgkin Lymphoma 18.7 ( 11.5- 29.6) 13.6 ( 8.6- 21.0) ∼ ∼
Kidney & Renal Pelvis 15.5 ( 9.2- 25.6) ∼ ∼ ∼
Thyroid ∼ 15.2 ( 10.5- 21.9) ∼ ∼
Ovary‖ 12.1 ( 7.7- 18.7) ∼
Leukemias 11.2 ( 6.4- 19.5) ∼ ∼ ∼
Oral Cavity & Pharynx 11.1 ( 6.2- 19.7) ∼ ∼ ∼
Corpus & Uterus, NOS 10.4 ( 6.4- 16.7) ∼
Cervix Uteri 7.7 ( 4.3- 13.4) ∼
Seattle-Puget Sound
Prostate 86.5 ( 69.2-107.7)
Breast 74.7 ( 62.7- 88.8)
Lung & Bronchus 71.1 ( 55.0- 91.3) 24.8 ( 17.4- 34.7)
Colon & Rectum 45.2 ( 33.0- 61.4) 38.0 ( 28.6- 49.9)
Liver & IBD 24.4 ( 16.1- 36.6) ∼
Urinary Bladder 19.5 ( 11.3- 32.0) ∼
Non-Hodgkin Lymphoma 17.8 ( 10.5- 29.3) 13.8 ( 8.5- 21.8)
Stomach 17.7 ( 10.4- 29.4) ∼
Thyroid ∼ 15.3 ( 10.4- 22.5)
Ovary‖ 12.8 ( 8.1- 20.0)
Leukemias 10.9 ( 6.0- 19.8) ∼
Corpus & Uterus, NOS 10.3 ( 6.1- 16.9)
Wisconsin
Prostate 104.8 ( 58.9-180.1) ∼
Breast 89.7 ( 58.4-136.0) ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined that have an
Asian/Pacific Islander population of at least 50,000. See Appendix C for data quality criteria and registry-specific data quality information.
§ Data are from the National Vital Statistics System (NVSS).
‖ Ovary excludes cancers newly classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∼ Rates are suppressed if the Asian/Pacific Islander population of a specific category (area, sex) is less than 50,000 or if cases are fewer than 16.
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E–8 Table E.2: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for American
Indian/Alaska Natives,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
United States
Prostate 72.2 ( 65.8- 79.2) 18.2 (14.6- 22.4)
Breast 63.8 ( 58.9- 69.0) 14.3 (12.0- 16.9)
Lung & Bronchus 54.0 ( 48.4- 60.3) 36.8 ( 32.8- 41.1) 38.3 (33.8- 43.4) 26.6 (23.3- 30.2)
Colon & Rectum 41.9 ( 36.9- 47.5) 33.4 ( 29.6- 37.6) 15.4 (12.4- 19.0) 9.7 ( 7.7- 12.0)
Urinary Bladder 15.0 ( 11.9- 18.7) ∼ ∼ ∼
Kidney & Renal Pelvis 14.4 ( 11.8- 17.5) 10.4 ( 8.4- 12.8) 5.5 ( 4.0- 7.6) 3.2 ( 2.1- 4.6)
Non-Hodgkin Lymphoma 14.1 ( 11.3- 17.5) 9.9 ( 7.9- 12.3) 3.8 ( 2.6- 5.7) 3.6 ( 2.5- 5.1)
Corpus & Uterus, NOS 13.9 ( 11.6- 16.5) ∼
Oral Cavity & Pharynx 11.6 ( 9.2- 14.6) ∼ ∼ ∼
Stomach 10.2 ( 7.7- 13.4) ∼ 6.5 ( 4.6- 8.9) 3.2 ( 2.2- 4.6)
Ovary‖ 9.5 ( 7.6- 11.7) 6.2 ( 4.7- 8.1)
Liver & IBD 8.4 ( 6.5- 10.8) ∼ 7.6 ( 5.8- 10.0) ∼
Pancreas 7.2 ( 5.3- 9.7) 6.2 ( 4.6- 8.1) 6.1 ( 4.4- 8.4) 5.2 ( 3.8- 6.9)
Leukemias ∼ 6.3 ( 4.7- 8.1) ∼ 3.8 ( 2.6- 5.3)
Cervix Uteri 6.2 ( 4.8- 7.9) ∼
Esophagus ∼ ∼ 4.4 ( 3.0- 6.4) ∼
Myeloma ∼ ∼ 3.6 ( 2.2- 5.8) 3.4 ( 2.3- 5.0)
Alaska
Breast 179.5 (138.8-230.9) ∼
Lung & Bronchus 130.1 ( 85.2-200.3) 77.8 ( 50.2-117.3) 91.2 (53.9-155.2) 63.4 (37.7-101.7)
Colon & Rectum 118.8 ( 75.7-187.6) 76.2 ( 48.0-116.8) ∼ ∼
Prostate 91.1 ( 54.3-154.3) ∼
New Mexico
Prostate 60.1 ( 39.2- 90.2) ∼
Breast 37.1 ( 24.7- 54.8) ∼
Colon & Rectum 30.2 ( 16.8- 52.8) ∼ ∼ ∼
North Carolina
Prostate 138.9 ( 99.9-193.8) ∼
Lung & Bronchus 97.8 ( 66.3-145.4) 34.9 ( 19.7- 58.5) 52.7 (30.8- 91.6) ∼
Breast 68.7 ( 46.5- 98.9) ∼
Colon & Rectum ∼ 42.1 ( 24.2- 68.7) ∼ ∼
Oklahoma
Prostate 153.8 (128.7-184.0) 35.9 (22.0- 56.2)
Lung & Bronchus 111.8 ( 90.8-137.8) 67.8 ( 53.9- 84.3) 59.9 (44.6- 80.4) 31.5 (22.2- 43.5)
Breast 106.6 ( 89.4-126.3) 16.0 ( 9.6- 25.3)
Colon & Rectum 69.3 ( 52.3- 91.6) 61.0 ( 47.9- 76.7) 16.9 ( 9.0- 30.7) ∼
Non-Hodgkin Lymphoma 32.5 ( 21.6- 48.9) 22.5 ( 14.8- 33.1) ∼ ∼
Urinary Bladder 27.9 ( 17.5- 44.0) ∼ ∼ ∼
Oral Cavity & Pharynx 22.6 ( 13.6- 37.1) ∼ ∼ ∼
Kidney & Renal Pelvis 21.7 ( 13.4- 35.4) 17.6 ( 10.8- 27.2) ∼ ∼
Ovary‖ 21.3 ( 14.0- 31.4) ∼
Corpus & Uterus, NOS 18.4 ( 11.6- 28.1) ∼
Leukemias ∼ 12.4 ( 7.0- 20.7) ∼ ∼
Texas
continued
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Table E.2: Age-Adjusted Invasive Cancer Incidence and Death Rates∗ and 95% Conﬁdence Intervals for American
Indian/Alaska Natives,† by State and Metropolitan Area, Primary Site, and Sex, United States, 2003 (continued)
Incidence‡ Rate Death§ Rate
Area and Primary Site Male Female Male Female
Breast 46.1 ( 30.3- 69.6) ∼
Prostate 33.3 ( 18.0- 60.7) ∼
Washington
Prostate 112.4 ( 75.2-167.3) ∼
Breast 98.1 ( 66.8-141.3) ∼
Lung & Bronchus 81.5 ( 47.7-134.8) 78.3 ( 48.7-120.8) ∼ ∼
Colon & Rectum 75.9 ( 40.5-132.6) 55.0 ( 31.3- 91.8) ∼ ∼
∗ Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups - Census P25-1130).
† Data for specified racial or ethnic populations other than white and black should be interpreted with caution. See Technical Notes.
‡ Data are from selected state and metropolitan area cancer registries that meet the data quality criteria for all invasive cancer sites combined that have an
American Indian/Alaska Native population of at least 50,000. See Appendix C for data quality criteria and registry-specific data quality information.
§ Data are from the National Vital Statistics System (NVSS).
‖ Ovary excludes cancers newly classified as borderline according to ICD-O-3, beginning with 2001 diagnoses. See Technical Notes.
∼ Rates are suppressed if the American Indian/Alaska Native population of a specific category (area, sex) is less than 50,000 or if cases are fewer than 16.

List of Abbreviations
ACME Automated Classification of Medical Entities
ALL acute lymphatic leukemia
CDC Centers for Disease Control and Prevention
CI confidence interval
CMPD chronic myeloproliferative diseases
CNS central nervous system
CTR Certified Tumor Registrar
IARC International Agency for Research on Cancer
IBD intrahepatic bile duct
ICCC International Classification of Childhood Cancer
ICD–9 International Classification of Diseases, Ninth Edition
ICD–O International Classification of Diseases for Oncology
ICD–10 International Classification of Diseases, Tenth Edition
IHS Indian Health Service
KS Kaposi sarcoma
MDS myelodysplastic syndromes
MICAR Mortality Medical Indexing Classification and Retrieval
system
NAACCR North American Association of Central Cancer Registries
NCHS National Center for Health Statistics
NCI National Cancer Institute
NHIA NAACCR Hispanic Identification Algorithm
NHL non-Hodgkin lymphoma
NIH National Institutes of Health
NOS not otherwise specified
NPCR National Program of Cancer Registries
NVSS National Vital Statistics System
ONS other nervous system
SEER Surveillance, Epidemiology, and End Results
USCS United States Cancer Statistics

